Gene	gene_allele	U2OS_cc_t_stat	U2OS_cc_t_pval	U2OS_abun_t_stat	U2OS_abun_t_pval	Metadata_Bio_Batch	AUROC_BioRep1_Morph	AUROC_BioRep1_AGP	AUROC_BioRep1_GFP	AUROC_BioRep1_Mito	AUROC_BioRep1_DNA	AUROC_BioRep2_Morph	AUROC_BioRep2_AGP	AUROC_BioRep2_GFP	AUROC_BioRep2_Mito	AUROC_BioRep2_DNA	AUROC_Mean_Morph	AUROC_Mean_AGP	AUROC_Mean_GFP	AUROC_Mean_Mito	AUROC_Mean_DNA	Altered_95th_perc_Morph	Altered_95th_perc_AGP	Altered_95th_perc_GFP	Altered_95th_perc_Mito	Altered_95th_perc_DNA	Altered_99th_perc_Morph	Altered_99th_perc_AGP	Altered_99th_perc_GFP	Altered_99th_perc_Mito	Altered_99th_perc_DNA	image_assayed	symbol	ensembl_gene_id	orf_id	mut_id	ccsb_mutation_id	ccsb_allele_id	spdi	nt_change	aa_change	collection	entry_plate_orig	entry_well_orig	entry_plate_conso	entry_well_conso	entry_seq_pool	db_plate	db_well	n2h_plate	n2h_well	dualip_plate	dualip_well	mislocalization_plate	mislocalization_well	entry_sequenced	entry_sequence_confirmation_class	db_sequenced	db_sequence_confirmation_class	n2h_sequenced	n2h_sequence_confirmation_class	n2h_ref_sequence_confirmation_class	dualip_sequenced	dualip_sequence_confirmation_class	dualip_ref_sequence_confirmation_class	mislocalization_sequenced	mislocalization_sequence_confirmation_class	mislocalization_ref_sequence_confirmation_class	gene_variant	chr_num	nuc_loc	ref_allele	alt_allele	Chrom	node_type	nt_change_cdna	dest_well	dest_plate	imaging_well	imaging_plate_R1	imaging_plate_R2	seq_confirmed_wt_ppi	seq_confirmed_allele_ppi	seq_confirmed_final	varid	clinvar_id	#chr	pos(1-based)	ref	alt	aaref	aaalt	rs_dbSNP	hg19_chr	hg19_pos(1-based)	hg18_chr	hg18_pos(1-based)	aapos	genename	Ensembl_geneid	Ensembl_transcriptid	Ensembl_proteinid	Uniprot_acc	Uniprot_entry	HGVSc_snpEff	HGVSp_snpEff	HGVSc_VEP	HGVSp_VEP	APPRIS	GENCODE_basic	TSL	VEP_canonical	MANE	cds_strand	refcodon	codonpos	codon_degeneracy	Ancestral_allele	AltaiNeandertal	Denisova	VindijiaNeandertal	ChagyrskayaNeandertal	SIFT_score	SIFT_converted_rankscore	SIFT_pred	SIFT4G_score	SIFT4G_converted_rankscore	SIFT4G_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationTaster_model	MutationTaster_trees_benign	MutationTaster_trees_deleterious	MutationAssessor_score	MutationAssessor_rankscore	MutationAssessor_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST4_score	VEST4_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	Reliability_index	MetaRNN_score	MetaRNN_rankscore	MetaRNN_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	REVEL_score	REVEL_rankscore	MutPred_score	MutPred_rankscore	MutPred_protID	MutPred_AAchange	MutPred_Top5features	MVP_score	MVP_rankscore	gMVP_score	gMVP_rankscore	MPC_score	MPC_rankscore	PrimateAI_score	PrimateAI_rankscore	PrimateAI_pred	DEOGEN2_score	DEOGEN2_rankscore	DEOGEN2_pred	BayesDel_addAF_score	BayesDel_addAF_rankscore	BayesDel_addAF_pred	BayesDel_noAF_score	BayesDel_noAF_rankscore	BayesDel_noAF_pred	ClinPred_score	ClinPred_rankscore	ClinPred_pred	LIST-S2_score	LIST-S2_rankscore	LIST-S2_pred	VARITY_R_score	VARITY_R_rankscore	VARITY_ER_score	VARITY_ER_rankscore	VARITY_R_LOO_score	VARITY_R_LOO_rankscore	VARITY_ER_LOO_score	VARITY_ER_LOO_rankscore	ESM1b_score	ESM1b_rankscore	ESM1b_pred	AlphaMissense_score	AlphaMissense_rankscore	AlphaMissense_pred	PHACTboost_score	PHACTboost_rankscore	MutFormer_score	MutFormer_rankscore	MutScore_score	MutScore_rankscore	Aloft_Fraction_transcripts_affected	Aloft_prob_Tolerant	Aloft_prob_Recessive	Aloft_prob_Dominant	Aloft_pred	Aloft_Confidence	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-XF_coding_score	fathmm-XF_coding_rankscore	fathmm-XF_coding_pred	Eigen-raw_coding	Eigen-raw_coding_rankscore	Eigen-phred_coding	Eigen-PC-raw_coding	Eigen-PC-raw_coding_rankscore	Eigen-PC-phred_coding	GERP++_NR	GERP++_RS	GERP++_RS_rankscore	GERP_91_mammals	GERP_91_mammals_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP470way_mammalian	phyloP470way_mammalian_rankscore	phyloP17way_primate	phyloP17way_primate_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons470way_mammalian	phastCons470way_mammalian_rankscore	phastCons17way_primate	phastCons17way_primate_rankscore	bStatistic	bStatistic_converted_rankscore	1000Gp3_AC	1000Gp3_AF	1000Gp3_AFR_AC	1000Gp3_AFR_AF	1000Gp3_EUR_AC	1000Gp3_EUR_AF	1000Gp3_AMR_AC	1000Gp3_AMR_AF	1000Gp3_EAS_AC	1000Gp3_EAS_AF	1000Gp3_SAS_AC	1000Gp3_SAS_AF	TOPMed_frz8_AC	TOPMed_frz8_AN	TOPMed_frz8_AF	gnomAD2.1.1_exomes_flag	gnomAD2.1.1_exomes_controls_AC	gnomAD2.1.1_exomes_controls_AN	gnomAD2.1.1_exomes_controls_AF	gnomAD2.1.1_exomes_controls_nhomalt	gnomAD2.1.1_exomes_non_neuro_AC	gnomAD2.1.1_exomes_non_neuro_AN	gnomAD2.1.1_exomes_non_neuro_AF	gnomAD2.1.1_exomes_non_neuro_nhomalt	gnomAD2.1.1_exomes_non_cancer_AC	gnomAD2.1.1_exomes_non_cancer_AN	gnomAD2.1.1_exomes_non_cancer_AF	gnomAD2.1.1_exomes_non_cancer_nhomalt	gnomAD2.1.1_exomes_controls_AFR_AC	gnomAD2.1.1_exomes_controls_AFR_AN	gnomAD2.1.1_exomes_controls_AFR_AF	gnomAD2.1.1_exomes_controls_AFR_nhomalt	gnomAD2.1.1_exomes_controls_AMR_AC	gnomAD2.1.1_exomes_controls_AMR_AN	gnomAD2.1.1_exomes_controls_AMR_AF	gnomAD2.1.1_exomes_controls_AMR_nhomalt	gnomAD2.1.1_exomes_controls_ASJ_AC	gnomAD2.1.1_exomes_controls_ASJ_AN	gnomAD2.1.1_exomes_controls_ASJ_AF	gnomAD2.1.1_exomes_controls_ASJ_nhomalt	gnomAD2.1.1_exomes_controls_EAS_AC	gnomAD2.1.1_exomes_controls_EAS_AN	gnomAD2.1.1_exomes_controls_EAS_AF	gnomAD2.1.1_exomes_controls_EAS_nhomalt	gnomAD2.1.1_exomes_controls_FIN_AC	gnomAD2.1.1_exomes_controls_FIN_AN	gnomAD2.1.1_exomes_controls_FIN_AF	gnomAD2.1.1_exomes_controls_FIN_nhomalt	gnomAD2.1.1_exomes_controls_NFE_AC	gnomAD2.1.1_exomes_controls_NFE_AN	gnomAD2.1.1_exomes_controls_NFE_AF	gnomAD2.1.1_exomes_controls_NFE_nhomalt	gnomAD2.1.1_exomes_controls_SAS_AC	gnomAD2.1.1_exomes_controls_SAS_AN	gnomAD2.1.1_exomes_controls_SAS_AF	gnomAD2.1.1_exomes_controls_SAS_nhomalt	gnomAD2.1.1_exomes_controls_POPMAX_AC	gnomAD2.1.1_exomes_controls_POPMAX_AN	gnomAD2.1.1_exomes_controls_POPMAX_AF	gnomAD2.1.1_exomes_controls_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_neuro_AFR_AC	gnomAD2.1.1_exomes_non_neuro_AFR_AN	gnomAD2.1.1_exomes_non_neuro_AFR_AF	gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt	gnomAD2.1.1_exomes_non_neuro_AMR_AC	gnomAD2.1.1_exomes_non_neuro_AMR_AN	gnomAD2.1.1_exomes_non_neuro_AMR_AF	gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt	gnomAD2.1.1_exomes_non_neuro_ASJ_AC	gnomAD2.1.1_exomes_non_neuro_ASJ_AN	gnomAD2.1.1_exomes_non_neuro_ASJ_AF	gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt	gnomAD2.1.1_exomes_non_neuro_EAS_AC	gnomAD2.1.1_exomes_non_neuro_EAS_AN	gnomAD2.1.1_exomes_non_neuro_EAS_AF	gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_FIN_AC	gnomAD2.1.1_exomes_non_neuro_FIN_AN	gnomAD2.1.1_exomes_non_neuro_FIN_AF	gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt	gnomAD2.1.1_exomes_non_neuro_NFE_AC	gnomAD2.1.1_exomes_non_neuro_NFE_AN	gnomAD2.1.1_exomes_non_neuro_NFE_AF	gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt	gnomAD2.1.1_exomes_non_neuro_SAS_AC	gnomAD2.1.1_exomes_non_neuro_SAS_AN	gnomAD2.1.1_exomes_non_neuro_SAS_AF	gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_POPMAX_AC	gnomAD2.1.1_exomes_non_neuro_POPMAX_AN	gnomAD2.1.1_exomes_non_neuro_POPMAX_AF	gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_cancer_AFR_AC	gnomAD2.1.1_exomes_non_cancer_AFR_AN	gnomAD2.1.1_exomes_non_cancer_AFR_AF	gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt	gnomAD2.1.1_exomes_non_cancer_AMR_AC	gnomAD2.1.1_exomes_non_cancer_AMR_AN	gnomAD2.1.1_exomes_non_cancer_AMR_AF	gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt	gnomAD2.1.1_exomes_non_cancer_ASJ_AC	gnomAD2.1.1_exomes_non_cancer_ASJ_AN	gnomAD2.1.1_exomes_non_cancer_ASJ_AF	gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt	gnomAD2.1.1_exomes_non_cancer_EAS_AC	gnomAD2.1.1_exomes_non_cancer_EAS_AN	gnomAD2.1.1_exomes_non_cancer_EAS_AF	gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_FIN_AC	gnomAD2.1.1_exomes_non_cancer_FIN_AN	gnomAD2.1.1_exomes_non_cancer_FIN_AF	gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt	gnomAD2.1.1_exomes_non_cancer_NFE_AC	gnomAD2.1.1_exomes_non_cancer_NFE_AN	gnomAD2.1.1_exomes_non_cancer_NFE_AF	gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt	gnomAD2.1.1_exomes_non_cancer_SAS_AC	gnomAD2.1.1_exomes_non_cancer_SAS_AN	gnomAD2.1.1_exomes_non_cancer_SAS_AF	gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_POPMAX_AC	gnomAD2.1.1_exomes_non_cancer_POPMAX_AN	gnomAD2.1.1_exomes_non_cancer_POPMAX_AF	gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt	gnomAD4.1_joint_flag	gnomAD4.1_joint_AC	gnomAD4.1_joint_AN	gnomAD4.1_joint_AF	gnomAD4.1_joint_nhomalt	gnomAD4.1_joint_POPMAX_AC	gnomAD4.1_joint_POPMAX_AN	gnomAD4.1_joint_POPMAX_AF	gnomAD4.1_joint_POPMAX_nhomalt	gnomAD4.1_joint_AFR_AC	gnomAD4.1_joint_AFR_AN	gnomAD4.1_joint_AFR_AF	gnomAD4.1_joint_AFR_nhomalt	gnomAD4.1_joint_AMI_AC	gnomAD4.1_joint_AMI_AN	gnomAD4.1_joint_AMI_AF	gnomAD4.1_joint_AMI_nhomalt	gnomAD4.1_joint_AMR_AC	gnomAD4.1_joint_AMR_AN	gnomAD4.1_joint_AMR_AF	gnomAD4.1_joint_AMR_nhomalt	gnomAD4.1_joint_ASJ_AC	gnomAD4.1_joint_ASJ_AN	gnomAD4.1_joint_ASJ_AF	gnomAD4.1_joint_ASJ_nhomalt	gnomAD4.1_joint_EAS_AC	gnomAD4.1_joint_EAS_AN	gnomAD4.1_joint_EAS_AF	gnomAD4.1_joint_EAS_nhomalt	gnomAD4.1_joint_FIN_AC	gnomAD4.1_joint_FIN_AN	gnomAD4.1_joint_FIN_AF	gnomAD4.1_joint_FIN_nhomalt	gnomAD4.1_joint_MID_AC	gnomAD4.1_joint_MID_AN	gnomAD4.1_joint_MID_AF	gnomAD4.1_joint_MID_nhomalt	gnomAD4.1_joint_NFE_AC	gnomAD4.1_joint_NFE_AN	gnomAD4.1_joint_NFE_AF	gnomAD4.1_joint_NFE_nhomalt	gnomAD4.1_joint_SAS_AC	gnomAD4.1_joint_SAS_AN	gnomAD4.1_joint_SAS_AF	gnomAD4.1_joint_SAS_nhomalt	ALFA_European_AC	ALFA_European_AN	ALFA_European_AF	ALFA_African_Others_AC	ALFA_African_Others_AN	ALFA_African_Others_AF	ALFA_East_Asian_AC	ALFA_East_Asian_AN	ALFA_East_Asian_AF	ALFA_African_American_AC	ALFA_African_American_AN	ALFA_African_American_AF	ALFA_Latin_American_1_AC	ALFA_Latin_American_1_AN	ALFA_Latin_American_1_AF	ALFA_Latin_American_2_AC	ALFA_Latin_American_2_AN	ALFA_Latin_American_2_AF	ALFA_Other_Asian_AC	ALFA_Other_Asian_AN	ALFA_Other_Asian_AF	ALFA_South_Asian_AC	ALFA_South_Asian_AN	ALFA_South_Asian_AF	ALFA_Other_AC	ALFA_Other_AN	ALFA_Other_AF	ALFA_African_AC	ALFA_African_AN	ALFA_African_AF	ALFA_Asian_AC	ALFA_Asian_AN	ALFA_Asian_AF	ALFA_Total_AC	ALFA_Total_AN	ALFA_Total_AF	clinvar_clnsig	clinvar_trait	clinvar_review	clinvar_hgvs	clinvar_var_source	clinvar_MedGen_id	clinvar_OMIM_id	clinvar_Orphanet_id	Interpro_domain	aaref_3	aaalt_3	#AlleleID	Type	Name	GeneID	GeneSymbol	HGNC_ID	ClinicalSignificance	ClinSigSimple	LastEvaluated	RS# (dbSNP)	nsv/esv (dbVar)	RCVaccession	PhenotypeIDS	PhenotypeList	Origin	OriginSimple	Assembly	ChromosomeAccession	Chromosome	Start	Stop	Cytogenetic	ReviewStatus	NumberSubmitters	Guidelines	TestedInGTR	OtherIDs	SubmitterCategories	VariationID	PositionVCF	ReferenceAlleleVCF	AlternateAlleleVCF	SomaticClinicalImpact	SomaticClinicalImpactLastEvaluated	ReviewStatusClinicalImpact	Oncogenicity	OncogenicityLastEvaluated	ReviewStatusOncogenicity	SCVsForAggregateGermlineClassification	SCVsForAggregateSomaticClinicalImpact	SCVsForAggregateOncogenicityClassification	clinvar_nt_change	clinvar_aa_change	RefSeq_mRNA	StarStatus	clinvar_clnsig_clean	chr	chr_pos_38	ref_right	alt_right	gnomad_af	""	ID	Dataset	Gene_right	HGNC_id	STRAND	hg19_pos	hg38_start	hg38_end	auth_transcript_id	transcript_pos	transcript_ref	transcript_alt	aa_pos	aa_ref	aa_alt	hgvs_c	hgvs_p	consequence	auth_reported_score	auth_reported_rep_score	auth_reported_func_class	splice_measure	gnomad_MAF	clinvar_sig	clinvar_star	clinvar_date_last_reviewed	nucleotide_or_aa	MaveDB URN (score set)	Ensembl_transript_ID	Ref_seq_transcript_ID	Model_system	Assay_type	Phenotype_measured	Phenotype_detail	IGVF_produced	simplified_consequence	Flag	REVEL	Interval 1 name	Interval 1 range	Interval 1 MaveDB class	Interval 2 name	Interval 2 range	Interval 2 MaveDB class	Interval 3 name	Interval 3 range	Interval 3 MaveDB class	Interval 4 name	Interval 4 range	Interval 4 MaveDB class	Interval 5 name	Interval 5 range	Interval 5 MaveDB class	Interval 6 name	Interval 6 range	Interval 6 MaveDB class	Segregation LR_PMID:31131967	Pathology LR_PMID:31131967	Co-occurrence LR_PMID:31131967	Family History LR_PMID:31131967	Case-Control LR_PMID:31131967	Combined LR (Odds for Causality)_PMID:31131967	Naive_prior_prob_PMID:31131967	Calcualted_post_prob_PMID:31131967	calculated_classification_PMID:31131967	SGR LR_PMID:34273903	Personal and Family History LR (Combined)_PMID:34273903	Breast Tumor Pathology LR_PMID:34273903	Population Allele Frequency LR_PMID:34273903	BS2 LR_PMID:34273903	Calculated_combined_LR_PMID:34273903	Naive_prior_prob_PMID:34273903	Calculated_post_prob_PMID:34273903	calculated_classification_PMID:34273903	Reference Group*_presumed_PMID:34273903	Component_presumed_PMID:34273903	Rationale_presumed_PMID:34273903	ClinVar Variation Id_ClinGen_repo	Allele Registry Id_ClinGen_repo	Disease_ClinGen_repo	Mondo Id_ClinGen_repo	Mode of Inheritance_ClinGen_repo	Assertion_ClinGen_repo	Applied Evidence Codes (Met)_ClinGen_repo	Applied Evidence Codes (Not Met)_ClinGen_repo	Summary of interpretation_ClinGen_repo	PubMed Articles_ClinGen_repo	Expert Panel_ClinGen_repo	Guideline_ClinGen_repo	Approval Date_ClinGen_repo	Published Date_ClinGen_repo	Retracted_ClinGen_repo	Evidence Repo Link_ClinGen_repo	Uuid_ClinGen_repo	Updated_Classification_ClinGen_repo	Updated_Evidence Codes_ClinGen_repo	gene_variant_pp	aa_change_pp	pillar_tested
CCM2	CCM2_Arg40Cys	-0.09954466407192102	1.0	6.132210016683774	1.0	2025_01_Batch_13-14	0.8632607704453149	0.8145020473108954	0.8290173279889622	0.7764096433201805	0.8291248057519199	0.9663124910763196	0.8978392973530259	0.8694855176897668	0.9290102074602288	0.9045038658061232	0.9147866307608172	0.8561706723319606	0.8492514228393645	0.8527099253902046	0.8668143357790216	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038613		NC_000007.14:45038340:C:T		Arg40Cys																												CCM2_Arg40Cys	7	45038340	C	T	7	allele	118C>T	A07	527_CAVA_Array_P06	A14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038340-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Gly309Ser	0.9477119419492293	1.0	-3.676692343777721	0.008971916021034814	2025_01_Batch_13-14	0.8870193180070034	0.8998650905263066	0.9351462181651714	0.9057682218651986	0.7143682582373676	0.5686633110620103	0.7744023055282723	0.8854617174445364	0.7654933384954046	0.5584482783869892	0.7278413145345068	0.8371336980272894	0.9103039678048539	0.8356307801803016	0.6364082683121783	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011917		NC_000006.12:5545200:G:A		Gly309Ser																												FARS2_Gly309Ser	6	5545200	G	A	6	allele	925G>A	H01	527_CAVA_Array_P03	P01	B13A7A8P1_R1	B14A7A8P1_R2				6-5545200-G-A	587672	6	5545200	G	A	G	S	rs746746116	6	5545433	6	5490432	309	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.925G>A	p.Gly309Ser	c.925G>A	p.Gly309Ser	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.009	0.67073	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.685	0.94401	H	-5.03	0.82599	D	0.947	0.95504	0.3946	0.88971	D	0.5964	0.85552	D	10	0.9779998	0.97630	D	0.369966	0.92707	D	0.885	0.96643	0.858	0.95637	O95363	G309S	Loss of sheet (P = 0.0817)| Gain of disorder (P = 0.1887)| Gain of loop (P = 0.2045)| Loss of catalytic residue at L314 (P = 0.2562)| Gain of MoRF binding (P = 0.4653)	0.888883061527	0.88693	.	0.92879	.	0.58884	0.59725445509	0.52451	T	0.449003	0.78909	T	0.390908	0.89307	D	0.323736	0.89172	D	0.998481690883636	0.94233	D	0.986551	0.95437	D	0.8830356	0.89777	0.78077585	0.86915	0.86086655	0.87992	0.7646657	0.85927	-10.138	0.74812	D	0.436	0.63025	A	0.990712134343876	0.88703	0.96428716	0.94244	0.855	0.92066	.	.	.	.	.	.	5.233765	0.87878	29.4	0.99892301299548369	0.96592	0.940941	0.94336	D	0.851669104685455	0.89143	9.876117	0.738735397986046	0.85233	8.543429	5.27	5.27	0.73761	.	.	9.507	0.96998	11.605000	0.93514	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.947	0.4917	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613742	1.239360e-06	0	1	75024	1.332910e-05	0	1	75024	1.332910e-05	0	0	912	0.000000e+00	0	0	59968	0.000000e+00	0	0	29600	0.000000e+00	0	0	44878	0.000000e+00	0	0	64020	0.000000e+00	0	0	6058	0.000000e+00	0	1	1179784	8.476130e-07	0	0	91016	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5545200G>A	.	C4755312|C3661900	614946	319519	Aminoacyl-tRNA synthetase, class II	Gly	Ser	578624	single nucleotide variant	NM_006567.5(FARS2):c.925G>A (p.Gly309Ser)	10667	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1	Feb 23, 2023	746746116	-	RCV001092144|RCV000714943	MedGen:C3661900|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Combined oxidative phosphorylation defect type 14	germline;unknown	germline	GRCh38	NC_000006.12	6	5545200	5545200	6p25.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA362736415	2	587672	5545200	G	A	-	-	-	-	-	-	SCV000845713|SCV001248521|SCV001582544|SCV003842096	-	-	925G>A 	Gly309Ser	NM_006567.5	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Arg19Gln	-0.2371678623698131	1.0	10.201013936641383	0.00004011573669375167	2025_01_Batch_13-14	0.82582264684747	0.8947455593072773	0.9613748673291802	0.8886938896411096	0.7970737717496698	0.8204106466446573	0.9338297629269102	0.9834121135786457	0.9502034379783503	0.795231275190222	0.8231166467460637	0.9142876611170938	0.9723934904539129	0.9194486638097299	0.7961525234699458	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038607		NC_000007.14:45038278:G:A		Arg19Gln																												CCM2_Arg19Gln	7	45038278	G	A	7	allele	56G>A	D06	527_CAVA_Array_P06	G12	B13A7A8P2_R1	B14A7A8P2_R2				7-45038278-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu51Ala	4.752879683394082	1.0	6.640781251915293	0.0083156478853054	2025_01_Batch_13-14	0.8347297801595407	0.7913418283355199	0.8179766754194023	0.8185886621933278	0.818436439054949	0.7678403899174903	0.8818769223813939	0.921665881151009	0.8498806507984513	0.7593910946234778	0.8012850850385155	0.8366093753584569	0.8698212782852057	0.8342346564958896	0.7889137668392134	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038618		NC_000007.14:45038374:A:C		Glu51Ala																												CCM2_Glu51Ala	7	45038374	A	C	7	allele	152A>C	G07	527_CAVA_Array_P06	M14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038374-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp410Val	4.201578296076572	1.0	4.807215573826536	1.0	2025_01_Batch_13-14	0.7341103056163335	0.8237460974756935	0.8402708993233899	0.8348737852629808	0.6725276108468762	0.7194132336013431	0.806292836471413	0.6591730907941857	0.6250900232884447	0.6795309317143116	0.7267617696088383	0.8150194669735533	0.7497219950587879	0.7299819042757127	0.6760292712805939	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038828		NC_000007.14:45075951:A:T		Asp410Val																												CCM2_Asp410Val	7	45075951	A	T	7	allele	1229A>T	C01	527_CAVA_Array_P08	F02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075951-A-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser83Phe	1.9279855775182575	1.0	6.590885428746624	0.0018940874987058405	2025_01_Batch_13-14	0.8051775986871093	0.8268946074435352	0.8452297188204932	0.8584060721045254	0.7022231096150713	0.7133356664120991	0.8127105844375797	0.8383382316687071	0.7237715623192275	0.6589489487349476	0.7592566325496042	0.8198025959405575	0.8417839752446001	0.7910888172118764	0.6805860291750094	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038634		NC_000007.14:45063961:C:T		Ser83Phe																												CCM2_Ser83Phe	7	45063961	C	T	7	allele	248C>T	G09	527_CAVA_Array_P06	M18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063961-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
ZC4H2	ZC4H2_Val63Leu	-3.772508957351957	0.009520442136421024	-2.514597705164753	1.0	2025_01_Batch_13-14	0.6066181739777775	0.837648116185566	0.8783777829289516	0.8099086609881108	0.7024057124056164	0.6080136834909066	0.9321174949448261	0.9633767822285377	0.9443145016579653	0.673811281093341	0.607315928734342	0.884882805565196	0.9208772825787447	0.877111581323038	0.6881084967494787	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC005916		NC_000023.11:64921855:C:G		Val63Leu																												ZC4H2_Val63Leu	23	64921855	C	G	X	allele	187G>C	G03	527_CAVA_Array_P06	M06	B13A7A8P2_R1	B14A7A8P2_R2				X-64921855-C-G	50980	X	64921855	C	G	V	L	rs398122938	X	64141735	X	64058460	63	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.187G>C	p.Val63Leu	c.187G>C	p.Val63Leu	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.052	0.92967	T	0.992	0.64752	D	0.983	0.75798	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.465	0.71362	M	-2.24	0.50191	N	0.845	0.84047	-0.1655	0.78440	T	0.4181	0.76324	T	9	0.84414655	0.83403	D	0.205808	0.86973	D	0.743	0.91077	0.716	0.85070	Q9NQZ6	V63L	Gain of disorder (P = 0.0736)| Loss of ubiquitination at K59 (P = 0.0816)| Gain of stability (P = 0.1765)| Gain of glycosylation at K59 (P = 0.3702)| Gain of methylation at R67 (P = 0.5403)	0.884996165071	0.88298	0.8373184595511529	0.83593	1.97721070638	0.93584	0.891219079494	0.95406	D	0.512428	0.82640	D	0.470646	0.93309	D	0.438274	0.93226	D	0.97698700428009	0.71437	D	0.969003	0.92268	D	0.85009694	0.87173	0.87122726	0.92856	0.8581468	0.87783	0.87122726	0.92856	-7.039	0.54387	T	0.9994	0.99054	P	0.996518372777224	0.92210	0.99788480	0.98543	0.933	0.96717	.	.	.	.	.	.	4.346719	0.66797	25.0	0.99821887779931795	0.90510	.	.	.	.	.	.	.	.	.	5.56	5.56	0.83655	4.31	0.81542	7.641	0.82558	5.916000	0.51166	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921855C>G	ClinGen:CA143907|OMIM:300897.0001|UniProtKB:Q9NQZ6#VAR_069621	C0796200	314580	3454|85283	.	Val	Leu	65651	single nucleotide variant	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	55906	ZC4H2	HGNC:24931	Pathogenic	1	May 02, 2013	398122938	-	RCV000043676	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921855	64921855	Xq11.2	no assertion criteria provided	1	-	N	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	1	50980	64921855	C	G	-	-	-	-	-	-	SCV000071687	-	-	187G>C 	Val63Leu	NM_018684.4		1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Val63Leu	-3.772508957351957	0.009520442136421024	-2.514597705164753	1.0	2025_01_Batch_13-14	0.6066181739777775	0.837648116185566	0.8783777829289516	0.8099086609881108	0.7024057124056164	0.6080136834909066	0.9321174949448261	0.9633767822285377	0.9443145016579653	0.673811281093341	0.607315928734342	0.884882805565196	0.9208772825787447	0.877111581323038	0.6881084967494787	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC005916		NC_000023.11:64921855:C:G		Val63Leu																												ZC4H2_Val63Leu	23	64921855	C	G	X	allele	187G>C	H03	527_CAVA_Array_P06	O06	B13A7A8P2_R1	B14A7A8P2_R2				X-64921855-C-G	50980	X	64921855	C	G	V	L	rs398122938	X	64141735	X	64058460	63	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.187G>C	p.Val63Leu	c.187G>C	p.Val63Leu	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.052	0.92967	T	0.992	0.64752	D	0.983	0.75798	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.465	0.71362	M	-2.24	0.50191	N	0.845	0.84047	-0.1655	0.78440	T	0.4181	0.76324	T	9	0.84414655	0.83403	D	0.205808	0.86973	D	0.743	0.91077	0.716	0.85070	Q9NQZ6	V63L	Gain of disorder (P = 0.0736)| Loss of ubiquitination at K59 (P = 0.0816)| Gain of stability (P = 0.1765)| Gain of glycosylation at K59 (P = 0.3702)| Gain of methylation at R67 (P = 0.5403)	0.884996165071	0.88298	0.8373184595511529	0.83593	1.97721070638	0.93584	0.891219079494	0.95406	D	0.512428	0.82640	D	0.470646	0.93309	D	0.438274	0.93226	D	0.97698700428009	0.71437	D	0.969003	0.92268	D	0.85009694	0.87173	0.87122726	0.92856	0.8581468	0.87783	0.87122726	0.92856	-7.039	0.54387	T	0.9994	0.99054	P	0.996518372777224	0.92210	0.99788480	0.98543	0.933	0.96717	.	.	.	.	.	.	4.346719	0.66797	25.0	0.99821887779931795	0.90510	.	.	.	.	.	.	.	.	.	5.56	5.56	0.83655	4.31	0.81542	7.641	0.82558	5.916000	0.51166	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921855C>G	ClinGen:CA143907|OMIM:300897.0001|UniProtKB:Q9NQZ6#VAR_069621	C0796200	314580	3454|85283	.	Val	Leu	65651	single nucleotide variant	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	55906	ZC4H2	HGNC:24931	Pathogenic	1	May 02, 2013	398122938	-	RCV000043676	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921855	64921855	Xq11.2	no assertion criteria provided	1	-	N	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	1	50980	64921855	C	G	-	-	-	-	-	-	SCV000071687	-	-	187G>C 	Val63Leu	NM_018684.4		1_Pathogenic																																																																																																									
SDHD	SDHD_Gly106Val	3.3461453651413797	0.013103277931052443	-1.3929891888092012	1.0	2025_01_Batch_13-14	0.7781633021684375	0.8343392162525063	0.7996012165652717	0.8582827131921871	0.6972959118318091	0.7551675962343357	0.8070916842991093	0.7695054555275767	0.7931835167663557	0.6723056539635265	0.7666654492013867	0.8207154502758078	0.7845533360464242	0.8257331149792714	0.6848007828976678	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023331		NC_000011.10:112094807:G:T		Gly106Val																												SDHD_Gly106Val	11	112094807	G	T	11	allele	317G>T	F12	527_CAVA_Array_P05	K23	B13A7A8P2_R1	B14A7A8P2_R2				11-112094807-G-T	480806	11	112094807	G	T	G	V	rs1555187574	11	111965531	11	111470741	106	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.317G>T	p.Gly106Val	c.317G>T	p.Gly106Val	principal1	Y	1	YES	Select	+	GGC	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.006	0.70891	D	1.0	0.90580	D	0.99	0.78943	D	0.78	0.86494	A	simple_aae	22.0	78.0	.	.	.	-8.4	0.97150	D	0.975	0.98575	0.8648	0.95197	D	0.9966	0.99920	D	10	0.99544626	0.99985	D	0.45813	0.94454	D	0.929	0.98302	0.982	0.99827	O14521	G106V	Loss of sheet (P = 0.0817)| Gain of helix (P = 0.132)| Loss of catalytic residue at L107 (P = 0.1641)| Loss of loop (P = 0.2237)| Loss of relative solvent accessibility (P = 0.3219)	0.957054369045	0.95622	0.98444967902886	0.98430	0.842846843757	0.67951	0.55555254221	0.46573	T	0.980291	0.99837	D	0.324438	0.84673	D	0.228256	0.84473	D	0.993092656135559	0.83635	D	0.79822	0.47259	T	0.94609135	0.95803	0.9640038	0.99168	0.9659864	0.97841	0.9694429	0.99432	-12.833	0.90765	D	0.8109	0.77749	P	0.998577411365903	0.94680	0.99942360	0.99371	0.988	0.99594	.	.	.	.	.	.	4.321877	0.66223	24.9	0.98815045644021704	0.46791	0.966887	0.98931	D	0.927619938196907	0.93007	11.78742	0.847271321840749	0.92817	11.67327	4.53	4.53	0.54956	.	.	9.578	0.97363	9.853000	0.82031	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.998	0.85369	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Paragangliomas_1|SDHD-related_disorder|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094807G>T	ClinGen:CA382618730	C3494181|C1847319|C0031511|CN166604|C1868633|C0027672	168000|606864|171300	29072|97286|29072|201|140162	.	Gly	Val	476439	single nucleotide variant	NM_003002.4(SDHD):c.317G>T (p.Gly106Val)	6392	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1	Sep 01, 2024	1555187574	-	RCV000561906|RCV000660262|RCV002232089|RCV004808786|RCV003420005	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|not provided|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112094807	112094807	11q23.1	criteria provided, multiple submitters, no conflicts	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618730	2	480806	112094807	G	T	-	-	-	-	-	-	SCV000664565|SCV000782286|SCV000961779|SCV004107262|SCV005434052	-	-	317G>T 	Gly106Val	NM_003002.4	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Cys170Tyr	4.804394500554594	1.0	7.5362877516349585	0.2835109879045649	2025_01_Batch_13-14	0.8322896785060547	0.766425945786586	0.806224019485582	0.8302145335533339	0.6853906173933352	0.635487832608365	0.7320290271214153	0.7763405738185533	0.6817296812631781	0.573846519880442	0.7338887555572099	0.7492274864540006	0.7912822966520676	0.7559721074082559	0.6296185686368886	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038690		NC_000007.14:45068479:G:A		Cys170Tyr																												CCM2_Cys170Tyr	7	45068479	G	A	7	allele	509G>A	F02	527_CAVA_Array_P07	L03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068479-G-A	3264484	7	45068479	G	A	C	Y	rs1336425364	7	45108078	7	45074603	170	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.017	0.52650	D	0.192	0.29658	T	0.571	0.38607	P	0.181	0.35895	B	0.19	0.59775	N	simple_aae	81.0	19.0	2.125	0.58867	M	-2.66	0.56973	D	0.786	0.79815	-0.9847	0.33781	T	0.1130	0.40140	T	10	0.61462045	0.67353	D	0.020733	0.43153	T	0.129	0.35107	0.171	0.07609	Q9BSQ5	C170Y	Gain of phosphorylation at C170 (P = 0.0249)| Gain of loop (P = 0.1081)| Gain of glycosylation at S168 (P = 0.1127)| Loss of catalytic residue at L169 (P = 0.2182)| Loss of stability (P = 0.258)	0.58308304948	0.57664	.	0.71997	.	0.79454	0.795796871185	0.81290	T	0.154663	0.49340	T	-0.170846	0.24766	T	-0.257483	0.48746	T	0.784381866455078	0.45037	D	0.936906	0.76276	D	0.25384942	0.48079	0.29498482	0.55315	0.25384942	0.48078	0.29498482	0.55314	-5.645	0.43255	T	0.2007	0.47656	B	0.85452612703403	0.73343	0.94850170	0.93293	0.358	0.61555	.	.	.	.	.	.	4.77726	0.77444	26.7	0.98676366688385631	0.44667	0.886443	0.81716	D	0.209354527483091	0.51411	3.344795	0.248545026890169	0.52319	3.430705	4.68	3.78	0.42561	1.55	0.34681	5.913	0.69762	9.627000	0.81147	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	0	109390	0.000000e+00	0	1	208116	4.805010e-06	0	2	236936	8.441100e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13376	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	0	16716	0.000000e+00	0	0	89556	0.000000e+00	0	0	30608	0.000000e+00	0	1	13416	7.453790e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	2	17692	1.130450e-04	0	0	21614	0.000000e+00	0	0	102750	0.000000e+00	0	0	30526	0.000000e+00	0	2	17692	1.130450e-04	0	.	4	1614084	2.478190e-06	0	3	44892	6.682710e-05	0	0	74928	0.000000e+00	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29608	0.000000e+00	0	3	44892	6.682710e-05	0	0	64022	0.000000e+00	0	0	6084	0.000000e+00	0	0	1180044	0.000000e+00	0	0	91094	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45068479G>A	.	C0950123	.	.	PTB/PI domain	Cys	Tyr	3428566	single nucleotide variant	NM_031443.4(CCM2):c.509G>A (p.Cys170Tyr)	83605	CCM2	HGNC:21708	Uncertain significance	0	Apr 01, 2024	-1	-	RCV004604772	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45068479	45068479	7p13	criteria provided, single submitter	1	-	N	-	2	3264484	45068479	G	A	-	-	-	-	-	-	SCV005096433	-	-	509G>A 	Cys170Tyr	NM_031443.4	1	4_VUS																																																																																																									
FARS2	FARS2_Ser57Cys	1.8559224483749528	1.0	-0.6872432004263447	1.0	2025_01_Batch_13-14	0.6962621920646234	0.6479026046562409	0.6005724849895941	0.6904932126070964	0.5069699651989267	0.4253840139485349	0.6189456711032676	0.6607529821067415	0.6095850052596933	0.436106404793524	0.5608231030065791	0.6334241378797543	0.6306627335481678	0.6500391089333948	0.47153818499622535	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011870		NC_000006.12:5368740:C:G		Ser57Cys																												FARS2_Ser57Cys	6	5368740	C	G	6	allele	170C>G	F12	527_CAVA_Array_P02	K24	B13A7A8P1_R1	B14A7A8P1_R2				6-5368740-C-G	214327	6	5368740	C	G	S	C	rs34382405	6	5368973	6	5313972	57	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.170C>G	p.Ser57Cys	c.170C>G	p.Ser57Cys	principal1	Y	1	.	.	+	TCC	2	0	C	C/C	C/C	C/C	C/C	0.02	0.49772	D	0.028	0.55281	D	0.533	0.37784	P	0.062	0.26932	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.625	0.41446	L	-2.77	0.58763	D	0.439	0.47612	-1.0166	0.24757	T	0.0532	0.22381	T	10	0.0069410205	0.00155	T	.	.	.	0.081	0.23465	.	.	.	.	.	0.650100694605	0.64445	0.6181731990165388	0.61574	0.193570370082	0.21414	0.456006199121	0.32723	T	0.255173	0.62383	T	-0.4711	0.00788	T	-0.429882	0.29590	T	0.0278036979532336	0.01650	T	.	0.50927	.	0.19544396	0.41017	0.09490794	0.22449	0.18928379	0.40151	0.09419375	0.22246	-8.409	0.63900	D	0.0774	0.06880	LB	0.305673527694043	0.54432	0.28674290	0.76416	0.65	0.80521	.	.	.	.	.	.	3.426274	0.47684	22.5	0.98028766321917793	0.37846	0.207729	0.33177	N	-0.0754966821653467	0.38198	2.253606	0.0205336924994149	0.40378	2.430867	5.45	5.45	0.79660	3.61	0.66044	1.388	0.34154	4.823000	0.45211	0.599	0.40292	0.001	0.13799	1.000000	0.68239	0.985	0.61072	944	0.12756	41	0.008186900958466454	37	0.02798789712556732	0	0.0	3	0.004322766570605188	1	9.92063492063492E-4	0	0.0	2308	264690	0.008719634	.	257	109370	2.349820e-03	1	520	207938	2.500750e-03	5	500	236460	2.114520e-03	4	190	7160	2.653630e-02	1	56	17106	3.273710e-03	0	0	2320	0.000000e+00	0	0	9032	0.000000e+00	0	0	13392	0.000000e+00	0	9	42758	2.104870e-04	0	1	15688	6.374300e-05	0	190	7160	2.653630e-02	1	397	16210	2.449110e-02	5	96	30512	3.146300e-03	0	0	6208	0.000000e+00	0	0	13386	0.000000e+00	0	0	16732	0.000000e+00	0	18	89426	2.012840e-04	0	2	30606	6.534670e-05	0	397	16210	2.449110e-02	5	368	14898	2.470130e-02	4	105	34248	3.065870e-03	0	0	9554	0.000000e+00	0	0	17666	0.000000e+00	0	0	21626	0.000000e+00	0	19	102338	1.856590e-04	0	2	30524	6.552220e-05	0	368	14898	2.470130e-02	4	.	2436	1614106	1.509190e-03	25	1902	75000	2.536000e-02	24	1902	75000	2.536000e-02	24	0	912	0.000000e+00	0	213	60010	3.549410e-03	0	0	29604	0.000000e+00	0	0	44870	0.000000e+00	0	0	64040	0.000000e+00	0	6	6062	9.897720e-04	1	181	1180024	1.533870e-04	0	4	91074	4.392030e-05	0	15	92548	1.620780567921511E-4	9	174	0.05172413793103448	0	2676	0	93	4216	0.022058823529411766	6	794	0.007556675062972292	1	958	0.0010438413361169101	0	656	0	0	274	0	16	8052	0.001987083954297069	102	4390	0.023234624145785875	0	3332	0	140	110348	0.001268713524486171	Benign/Likely_benign	not_specified|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5368740C>G	ClinGen:CA320525|UniProtKB:O95363#VAR_052642	CN169374|C4755312	614946	319519	.	Ser	Cys	211248	single nucleotide variant	NM_006567.5(FARS2):c.170C>G (p.Ser57Cys)	10667	FARS2	HGNC:21062	Benign/Likely benign	0	Jan 30, 2025	34382405	-	RCV000196113|RCV000539812|RCV004705026	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline	germline	GRCh38	NC_000006.12	6	5368740	5368740	6p25.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA320525,UniProtKB:O95363#VAR_052642	2	214327	5368740	C	G	-	-	-	-	-	-	SCV000251367|SCV000652839|SCV000845669|SCV005222705	-	-	170C>G 	Ser57Cys	NM_006567.5	2	2_Benign																																																																																																									
CCM2	CCM2_Ala295Thr	-0.4093649597394616	1.0	5.5710914456517076	1.0	2025_01_Batch_13-14	0.8478532729817004	0.8713832839753212	0.867346937321794	0.8725171077591586	0.7320789487550495	0.8247364736070647	0.8994232809010416	0.8461870058783812	0.808891148294791	0.7376505502834333	0.8362948732943826	0.8854032824381814	0.8567669716000876	0.8407041280269748	0.7348647495192414	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038762		NC_000007.14:45073539:G:A		Ala295Thr																												CCM2_Ala295Thr	7	45073539	G	A	7	allele	883G>A	A09	527_CAVA_Array_P07	B17	B13A7A8P2_R1	B14A7A8P2_R2				7-45073539-G-A	1696575	7	45073539	G	A	A	T	rs762020337	7	45113138	7	45079663	295	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.883G>A	p.Ala295Thr	c.883G>A	p.Ala295Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.016	0.52012	D	0.015	0.63436	D	0.996	0.68795	D	0.794	0.57875	P	0.56	0.79151	D	simple_aae	44.0	56.0	2.43	0.70264	M	-1.43	0.38336	N	0.685	0.69238	-0.6304	0.63395	T	0.2576	0.62666	T	10	0.63557434	0.68486	D	0.062861	0.68674	D	0.141	0.37580	.	.	.	.	.	0.73892189243	0.73451	.	0.51266	.	0.72771	0.603517413139	0.53334	T	0.068359	0.33187	T	-0.124908	0.31965	T	-0.18053	0.56172	T	0.802204787731171	0.46219	D	0.827017	0.50007	T	0.57490176	0.71038	0.37850404	0.62681	0.57490176	0.71039	0.37850404	0.62680	-5.289	0.42124	T	0.3932	0.65287	A	0.0774082825929719	0.41018	0.98156070	0.95678	0.329	0.59271	.	.	.	.	.	.	4.226998	0.64055	24.6	0.99932002856768254	0.99439	0.853143	0.76924	D	0.611683799263381	0.73773	6.044293	0.559600841176694	0.71915	5.751905	5.71	5.71	0.89013	3.63	0.66478	6.347	0.73019	11.624000	0.93654	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.539	0.29961	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	9	264690	3.400204E-5	.	1	108754	9.195060e-06	0	5	206476	2.421590e-05	0	5	235754	2.120850e-05	0	1	7160	1.396650e-04	0	0	17096	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	12792	0.000000e+00	0	0	42750	0.000000e+00	0	0	15684	0.000000e+00	0	1	7160	1.396650e-04	0	2	16128	1.240080e-04	0	0	30490	0.000000e+00	0	0	6172	0.000000e+00	0	0	13388	0.000000e+00	0	0	16128	0.000000e+00	0	2	88752	2.253470e-05	0	0	30594	0.000000e+00	0	2	16128	1.240080e-04	0	2	14872	1.344810e-04	0	0	34228	0.000000e+00	0	0	9560	0.000000e+00	0	0	17688	0.000000e+00	0	0	21020	0.000000e+00	0	2	102268	1.955650e-05	0	0	30516	0.000000e+00	0	2	14872	1.344810e-04	0	.	16	1612230	9.924140e-06	0	1	6068	1.647990e-04	0	9	74886	1.201830e-04	0	0	910	0.000000e+00	0	0	60000	0.000000e+00	0	0	29598	0.000000e+00	0	0	44866	0.000000e+00	0	0	62732	0.000000e+00	0	1	6068	1.647990e-04	0	4	1179672	3.390770e-06	0	2	91054	2.196500e-05	0	0	25814	0	0	306	0	0	112	0	5	8024	6.231306081754736E-4	0	146	0	0	610	0	0	56	0	0	98	0	0	4204	0	5	8330	6.002400960384153E-4	0	168	0	5	39370	1.27000254000508E-4	Uncertain_significance	Cerebral_cavernous_malformation_2	criteria_provided,_single_submitter	NC_000007.14:g.45073539G>A	.	C1864041	603284	221061	Cerebral cavernous malformations 2, harmonin-homology domain|Cerebral cavernous malformations 2, harmonin-homology domain	Ala	Thr	1688977	single nucleotide variant	NM_031443.4(CCM2):c.883G>A (p.Ala295Thr)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jul 09, 2021	762020337	-	RCV002266705	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Cerebral cavernous malformation 2	inherited	germline	GRCh38	NC_000007.14	7	45073539	45073539	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4247170	2	1696575	45073539	G	A	-	-	-	-	-	-	SCV002548778	-	-	883G>A 	Ala295Thr	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Asp376His	3.4119750253611003	1.0	13.714684723305425	4.748689003205377e-6	2025_01_Batch_13-14	0.8835396704488878	0.9477103544959412	0.9737489261201416	0.9551299718863809	0.817955296698209	0.8167050357276633	0.9242286873543161	0.9659939619359608	0.9046706960511977	0.7241986650583966	0.8501223530882756	0.9359695209251286	0.9698714440280511	0.9299003339687892	0.7710769808783028	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038805		NC_000007.14:45075848:G:C		Asp376His																												CCM2_Asp376His	7	45075848	G	C	7	allele	1126G>C	E11	527_CAVA_Array_P07	J21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075848-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Arg70Thr	6.934747073445434	0.00024459787473878774	-2.639814962822817	0.48151603696647616	2025_01_Batch_13-14	0.8769079704335451	0.8712931700523606	0.837882280490174	0.890962358682571	0.8490884350443753	0.8022562630952141	0.8071245964094022	0.8143015360046635	0.804810928005952	0.6776231988824442	0.8395821167643795	0.8392088832308814	0.8260919082474187	0.8478866433442616	0.7633558169634097	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023288		NC_000011.10:112088906:G:C		Arg70Thr																												SDHD_Arg70Thr	11	112088906	G	C	11	allele	209G>C	G11	527_CAVA_Array_P05	M21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088906-G-C	820714	11	112088906	G	C	R	T	rs755047928	11	111959630	11	111464840	70	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.209G>C	p.Arg70Thr	c.209G>C	p.Arg70Thr	principal1	Y	1	YES	Select	+	AGG	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.004	0.74454	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.88	0.95915	H	-5.8	0.88177	D	0.956	0.96546	1.0507	0.98128	D	0.9847	0.99536	D	10	0.9923693	0.99772	D	0.720854	0.97738	D	0.962	0.99434	0.984	0.99843	O14521	R70T	Gain of catalytic residue at S73 (P = 0.146)| Loss of helix (P = 0.1706)| Loss of stability (P = 0.1869)| Loss of MoRF binding (P = 0.2156)| Gain of disorder (P = 0.2602)	0.983230327024	0.98287	0.9568632122871339	0.95645	0.91655607726	0.71085	0.688868284225	0.65485	T	0.981408	0.99854	D	0.576146	0.96900	D	0.589817	0.96849	D	0.999165654182434	0.96363	D	0.946705	0.81107	D	0.9203629	0.93183	0.85851985	0.91973	0.9137901	0.92543	0.8970499	0.94695	-11.753	0.91834	D	0.8906	0.82186	P	0.996839713185994	0.92509	0.99914825	0.99178	0.966	0.98629	.	.	.	.	.	.	4.65578	0.74309	26.1	0.98501578728992878	0.42352	0.955196	0.97277	D	0.796092789603072	0.85785	8.704333	0.69577891730792	0.81957	7.673905	5.04	4.1	0.47135	.	.	7.535	0.80966	7.554000	0.60397	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.998	0.85369	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088906G>C	.	C1868633|C0031511|CN166604|C1847319|C0027672|C3661900	171300|606864	29072|201|97286|140162	.	Arg	Thr	810762	single nucleotide variant	NM_003002.4(SDHD):c.209G>C (p.Arg70Thr)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1	Feb 25, 2023	755047928	-	RCV001014432|RCV001597242|RCV003769463	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112088906	112088906	11q23.1	criteria provided, conflicting classifications	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617234	2	820714	112088906	G	C	-	-	-	-	-	-	SCV001175136|SCV001831914|SCV004570824	-	-	209G>C 	Arg70Thr	NM_003002.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Ser60Arg	1.0243685023237405	1.0	6.387102471668179	1.0	2025_01_Batch_13-14	0.9250434550730523	0.9353055234657718	0.9225076776055162	0.9271610219988188	0.8359729520555702	0.8569368160036206	0.9021193769311032	0.7952427588626211	0.7813880232745422	0.7922252318543875	0.8909901355383365	0.9187124501984375	0.8588752182340686	0.8542745226366805	0.8140990919549789	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038624		NC_000007.14:45038400:A:C		Ser60Arg																												CCM2_Ser60Arg	7	45038400	A	C	7	allele	178A>C	C08	527_CAVA_Array_P06	E16	B13A7A8P2_R1	B14A7A8P2_R2				7-45038400-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Lys65Glu	0.724081854129908	1.0	-1.5723702032109852	1.0	2025_01_Batch_13-14	0.8175349257866151	0.7561416134773054	0.8376296751216863	0.8706351683185498	0.7866469429152625	0.7947760703922739	0.7548360359372562	0.8078121891604009	0.8065018108192943	0.7703538762936247	0.8061554980894445	0.7554888247072808	0.8227209321410436	0.838568489568922	0.7785004096044437	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038626		NC_000007.14:45038415:A:G		Lys65Glu																												CCM2_Lys65Glu	7	45038415	A	G	7	allele	193A>G	F08	527_CAVA_Array_P06	K16	B13A7A8P2_R1	B14A7A8P2_R2				7-45038415-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Lys30Glu	0.03221205812744913	1.0	5.714519186898584	0.023864110276644993	2025_01_Batch_13-14	0.8445500657197549	0.8706468893805076	0.8753685770315395	0.8700785733793003	0.817051856476593	0.7439318264448874	0.775510595025548	0.8168433648169652	0.7774525365706335	0.7335653244904744	0.7942409460823212	0.8230787422030278	0.8461059709242523	0.823765554974967	0.7753085904835337	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038611		NC_000007.14:45038310:A:G		Lys30Glu																												CCM2_Lys30Glu	7	45038310	A	G	7	allele	88A>G	H06	527_CAVA_Array_P06	O12	B13A7A8P2_R1	B14A7A8P2_R2				7-45038310-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser393Gly	6.181468809078697	0.018514973966631	2.350988615427353	1.0	2025_01_Batch_13-14	0.9191817977664046	0.9454022111974787	0.9386821478752444	0.9205645945157904	0.8786090491513642	0.7652882835687026	0.8570632367241967	0.8398670140929724	0.8046065173658943	0.7132886641448078	0.8422350406675536	0.9012327239608378	0.8892745809841084	0.8625855559408424	0.795948856648086	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038816		NC_000007.14:45075899:A:G		Ser393Gly																												CCM2_Ser393Gly	7	45075899	A	G	7	allele	1177A>G	B12	527_CAVA_Array_P07	D23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075899-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp129His	0.33779973655126366	1.0	8.826081115615883	0.27061963394690414	2025_01_Batch_13-14	0.9033301007435045	0.8485131248679513	0.8473225471837229	0.8527925990592792	0.8364708793605272	0.7518196845807829	0.8249814460458627	0.8092142887105981	0.7713870478727435	0.6851766815976271	0.8275748926621437	0.8367472854569069	0.8282684179471604	0.8120898234660113	0.7608237804790772	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038665		NC_000007.14:45064559:G:C		Asp129His																												CCM2_Asp129His	7	45064559	G	C	7	allele	385G>C	E12	527_CAVA_Array_P06	I24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064559-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu2Lys	-0.35144544088186197	1.0	-5.694015489872153	1.0	2025_01_Batch_13-14	0.8049118010894519	0.8799930039258874	0.9527717819038503	0.9425428441292141	0.7837195783394934	0.8555370787652622	0.877817733236237	0.939403356464071	0.9121710012947705	0.8671347197405672	0.8302244399273571	0.8789053685810622	0.9460875691839606	0.9273569227119922	0.8254271490400302	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038603		NC_000007.14:45000337:G:A		Glu2Lys																												CCM2_Glu2Lys	7	45000337	G	A	7	allele	4G>A	H05	527_CAVA_Array_P06	O10	B13A7A8P2_R1	B14A7A8P2_R2				7-45000337-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala205Asp	1.4108174680315244	1.0	11.357995081978785	0.05000832458511093	2025_01_Batch_13-14	0.8765250630646725	0.8954220517118685	0.8223842311363824	0.8572629931239802	0.6610998978159758	0.8951846893946668	0.9289947716397678	0.8886212181879124	0.8797178144443047	0.7925128158659639	0.8858548762296696	0.9122084116758182	0.8555027246621474	0.8684904037841426	0.7268063568409698	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038718		NC_000007.14:45069830:C:A		Ala205Asp																												CCM2_Ala205Asp	7	45069830	C	A	7	allele	614C>A	A05	527_CAVA_Array_P07	B09	B13A7A8P2_R1	B14A7A8P2_R2				7-45069830-C-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_His137Gln	4.866837405107969	1.0	16.250986810814123	0.00020235711709655352	2025_01_Batch_13-14	0.8123200040798393	0.866587415735303	0.8762585477548984	0.8781899740236274	0.7590876274084394	0.7674720642414906	0.8257400705705619	0.8113728511472	0.7555191281947893	0.7454856583552155	0.7898960341606649	0.8461637431529324	0.8438156994510493	0.8168545511092083	0.7522866428818274	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038670		NC_000007.14:45064585:T:G		His137Gln																												CCM2_His137Gln	7	45064585	T	G	7	allele	411T>G	C01	527_CAVA_Array_P07	F01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064585-T-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp227Asn	3.3724069490745188	1.0	9.192559571486248	0.006958934530275017	2025_01_Batch_13-14	0.7964291400833029	0.7681309538203438	0.8216537796853703	0.7983783476660805	0.7523720735860912	0.8292112390818834	0.8211327314244588	0.8557760373077863	0.7915512793246106	0.7832404986451107	0.8128201895825932	0.7946318426224013	0.8387149084965784	0.7949648134953455	0.767806286115601	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038729		NC_000007.14:45069895:G:A		Asp227Asn																												CCM2_Asp227Asn	7	45069895	G	A	7	allele	679G>A	D06	527_CAVA_Array_P07	H11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069895-G-A	1347252	7	45069895	G	A	D	N	rs770430978	7	45109494	7	45076019	227	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.679G>A	p.Asp227Asn	c.679G>A	p.Asp227Asn	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.265	0.17858	T	0.027	0.58950	D	1.0	0.90580	D	0.998	0.88579	D	0.88	0.91311	D	simple_aae	12.0	88.0	2.25	0.63621	M	-2.48	0.54082	N	0.903	0.90358	-0.7048	0.60038	T	0.2179	0.57861	T	10	0.766184	0.76496	D	0.01934	0.41442	T	0.218	0.51046	0.379	0.39338	Q9BSQ5	D227N	Loss of stability (P = 0.0952)| Gain of glycosylation at T225 (P = 0.2322)| Gain of catalytic residue at R231 (P = 0.3716)| Loss of helix (P = 0.3949)| Loss of phosphorylation at T225 (P = 0.4218)	0.593227656836	0.58690	.	0.55828	.	0.69275	0.807291984558	0.83047	D	0.124852	0.44711	T	-0.141925	0.29229	T	-0.441642	0.28267	T	0.949749708175659	0.62954	D	0.986901	0.95531	D	0.45838416	0.64254	0.20907654	0.45074	0.45838416	0.64255	0.20907654	0.45073	-5.55	0.43935	T	0.6622	0.72588	P	0.112602498629974	0.44411	0.90811670	0.91506	0.504	0.71706	.	.	.	.	.	.	5.234396	0.87888	29.4	0.99908619585246528	0.97876	0.941547	0.94476	D	0.869487793944095	0.90134	10.2915	0.856936425243756	0.93377	12.02731	5.32	5.32	0.75341	.	.	9.936	0.98853	8.446000	0.77241	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109380	0.000000e+00	0	1	208082	4.805800e-06	0	1	236924	4.220760e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13366	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16706	0.000000e+00	0	1	89538	1.116840e-05	0	0	30608	0.000000e+00	0	1	89538	1.116840e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21604	0.000000e+00	0	1	102748	9.732550e-06	0	0	30526	0.000000e+00	0	1	102748	9.732550e-06	0	.	9	1614144	5.575710e-06	0	1	91080	1.097940e-05	0	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44880	0.000000e+00	0	0	64006	0.000000e+00	0	0	6062	0.000000e+00	0	8	1180024	6.779520e-06	0	1	91080	1.097940e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Cerebral_cavernous_malformation_2	criteria_provided,_single_submitter	NC_000007.14:g.45069895G>A	.	C1864041	603284	221061	.	Asp	Asn	1465682	single nucleotide variant	NM_031443.4(CCM2):c.679G>A (p.Asp227Asn)	83605	CCM2	HGNC:21708	Uncertain significance	0	Dec 30, 2021	770430978	-	RCV002041620	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45069895	45069895	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4247061	2	1347252	45069895	G	A	-	-	-	-	-	-	SCV002113513	-	-	679G>A 	Asp227Asn	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Ser426Leu	0.18228056760792866	1.0	6.946350754139836	0.03162238321129342	2025_01_Batch_13-14	0.8105051030575012	0.8449009024997549	0.8315457736886028	0.8328175257352682	0.6460903884358461	0.7627049295726286	0.9030201410314077	0.9257772632627099	0.8928111903483887	0.6668607082473295	0.7866050163150649	0.8739605217655813	0.8786615184756563	0.8628143580418285	0.6564755483415878	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038843		NC_000007.14:45075999:C:T		Ser426Leu																												CCM2_Ser426Leu	7	45075999	C	T	7	allele	1277C>T	A03	527_CAVA_Array_P08	B06	B13A7A8P2_R1	B14A7A8P2_R2				7-45075999-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Pro240Leu	-0.25434750102330755	1.0	8.44709183968468	0.0017992219508316694	2025_01_Batch_13-14	0.9011078106010407	0.9180498462386559	0.8869690077369929	0.9363312347332399	0.843229915376757	0.9008788265868901	0.7710571660398083	0.8079692771526794	0.780880628652653	0.8981198004709623	0.9009933185939654	0.8445535061392322	0.8474691424448362	0.8586059316929464	0.8706748579238597	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038734		NC_000007.14:45069935:C:T		Pro240Leu																												CCM2_Pro240Leu	7	45069935	C	T	7	allele	719C>T	H06	527_CAVA_Array_P07	P11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069935-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Leu392Val	2.0803019324002063	1.0	14.657940472983933	0.017341710203377544	2025_01_Batch_13-14	0.9020237289832194	0.9551178430154627	0.940522942216175	0.9290847090376472	0.8048826495590421	0.8076491551475391	0.9288720918713982	0.840868085741109	0.7959564340315386	0.7562944201055661	0.8548364420653792	0.9419949674434305	0.8906955139786421	0.8625205715345929	0.7805885348323041	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038815		NC_000007.14:45075896:C:G		Leu392Val																												CCM2_Leu392Val	7	45075896	C	G	7	allele	1174C>G	A12	527_CAVA_Array_P07	B23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075896-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gln218Arg	-1.7222661596859232	1.0	11.934222004169962	0.00029982867241996707	2025_01_Batch_13-14	0.9095174194863827	0.923215974033953	0.9188534916424796	0.9558874595197281	0.8854929180268192	0.8635015230907763	0.9274500697381369	0.9447257175498872	0.8815407622727084	0.8312578016279365	0.8865094712885795	0.9253330218860449	0.9317896045961834	0.9187141108962182	0.8583753598273778	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038724		NC_000007.14:45069869:A:G		Gln218Arg																												CCM2_Gln218Arg	7	45069869	A	G	7	allele	653A>G	H05	527_CAVA_Array_P07	P09	B13A7A8P2_R1	B14A7A8P2_R2				7-45069869-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly24Asp	-2.481104784469633	1.0	1.4329783308060777	0.24974558225555074	2025_01_Batch_13-14	0.8632252535963265	0.9124878891697304	0.9688629390650089	0.9298496433458125	0.8404840189960122		0.8543849259885008	0.7844504125157999	0.966128272271281			0.8834364075791157	0.8766566757904044	0.9479889578085468		0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038610		NC_000007.14:45038293:G:A		Gly24Asp																												CCM2_Gly24Asp	7	45038293	G	A	7	allele	71G>A	G06	527_CAVA_Array_P06	M12	B13A7A8P2_R1	B14A7A8P2_R2				7-45038293-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp411Glu	1.6158333502939157	1.0	7.13447728072268	1.0	2025_01_Batch_13-14	0.8782864804221336	0.869836877706617	0.8233972745182637	0.836509320374028	0.7491861470494271	0.721443054514455	0.7411175791060574	0.7029138553528371	0.6926362619149529	0.6074474960651998	0.7998647674682944	0.8054772284063372	0.7631555649355504	0.7645727911444904	0.6783168215573134	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038830		NC_000007.14:45075955:C:G		Asp411Glu																												CCM2_Asp411Glu	7	45075955	C	G	7	allele	1233C>G	E01	527_CAVA_Array_P08	J02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075955-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala179Ser	1.680741771064963	1.0	7.6523251994348955	1.0	2025_01_Batch_13-14	0.7743634688186161	0.8438776052793217	0.8135459575387586	0.8064917858343441	0.6647232588323214	0.831867673489285	0.8660982754947909	0.7785692637363048	0.7733739719983498	0.7663160694456923	0.8031155711539506	0.8549879403870563	0.7960576106375317	0.7899328789163469	0.7155196641390069	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038696		NC_000007.14:45068505:G:T		Ala179Ser																												CCM2_Ala179Ser	7	45068505	G	T	7	allele	535G>T	A03	527_CAVA_Array_P07	B05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068505-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu264Asp	-0.6187936869315993	1.0	-1.66332059375984	1.0	2025_01_Batch_13-14	0.9048954021041326	0.9001896060023356	0.8675169639790238	0.8886655821799151	0.7353199988445699	0.8629082381555305	0.901495495424136	0.797730135639836	0.7946928238765701	0.7969237687625087	0.8839018201298315	0.9008425507132358	0.8326235498094299	0.8416792030282426	0.7661218838035393	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038745		NC_000007.14:45072772:A:C		Glu264Asp																												CCM2_Glu264Asp	7	45072772	A	C	7	allele	792A>C	A08	527_CAVA_Array_P07	B15	B13A7A8P2_R1	B14A7A8P2_R2				7-45072772-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Asn71Ser	0.6062636477246899	1.0	0.44825035148598597	1.0	2025_01_Batch_13-14	0.5478643627268202	0.6137224913396894	0.6101961753365123	0.6191672504260337	0.5349339648391073	0.7201265609384727	0.7134220825236429	0.6426453264081347	0.7139488743137018	0.6168838101823942	0.6339954618326464	0.6635722869316661	0.6264207508723234	0.6665580623698677	0.5759088875107508	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008840		NC_000003.12:12612058:T:C		Asn71Ser																												RAF1_Asn71Ser	3	12612058	T	C	3	allele	212A>G	G04	527_CAVA_Array_P05	M07	B13A7A8P2_R1	B14A7A8P2_R2				3-12612058-T-C	40588	3	12612058	T	C	N	S	rs184022679	3	12653557	3	12628557	71	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.212A>G	p.Asn71Ser	c.212A>G	p.Asn71Ser	principal3	Y	1	YES	Select	-	AAT	2	0	T	T/T	T/T	T/T	T/T	0.466	0.08637	T	0.461	0.12752	T	0.107	0.26097	B	0.199	0.36806	B	0.51	0.71892	D	simple_aae	49.0	51.0	2.075	0.56867	M	-0.85	0.23101	N	0.396	0.46496	-0.7029	0.60130	T	0.2684	0.63840	T	10	0.023561597	0.00618	T	0.047179	0.62660	D	0.194	0.47225	.	.	.	.	.	0.700826663726	0.69587	.	0.38507	0.399458701232	0.40688	0.769439399242	0.77301	T	0.544649	0.84330	D	-0.441197	0.01189	T	-0.441903	0.28238	T	0.0241761773584133	0.01162	T	.	0.55502	.	0.367634	0.58081	0.13760614	0.32795	0.39323702	0.59936	0.16458307	0.37996	-5.34	0.40718	T	0.1357	0.33297	B	0.847923193550861	0.73002	0.26023328	0.75518	0.216	0.48172	.	.	.	.	.	.	2.411032	0.31048	18.61	0.96689436356771608	0.30927	0.643219	0.61854	D	-0.0733448836148503	0.38295	2.260626	0.0541083710929102	0.41984	2.553849	5.81	4.65	0.57575	3.15	0.57234	4.539	0.60453	1.237000	0.25166	-0.188	0.09552	1.0	0.71675	0.965000	0.29555	0.34	0.25482	637	0.64339	3	5.990415335463259E-4	0	0.0	0	0.0	3	0.004322766570605188	0	0.0	0	0.0	48	264690	1.813442E-4	.	31	109408	2.833430e-04	0	57	208132	2.738650e-04	0	60	236954	2.532140e-04	0	0	7164	0.000000e+00	0	27	17112	1.577840e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	3	42768	7.014590e-05	0	1	15690	6.373490e-05	0	27	17112	1.577840e-03	0	1	16218	6.165990e-05	0	48	30524	1.572530e-03	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	6	89556	6.699720e-05	0	2	30608	6.534240e-05	0	48	30524	1.572530e-03	0	1	14902	6.710510e-05	0	49	34260	1.430240e-03	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	7	102752	6.812520e-05	0	2	30526	6.551790e-05	0	49	34260	1.430240e-03	0	.	152	1613932	9.417990e-05	0	63	60008	1.049860e-03	0	8	75034	1.066180e-04	0	0	912	0.000000e+00	0	63	60008	1.049860e-03	0	0	29602	0.000000e+00	0	4	44860	8.916630e-05	0	0	64018	0.000000e+00	0	0	6056	0.000000e+00	0	63	1179858	5.339630e-05	0	11	91088	1.207620e-04	0	28	178468	1.5689087119259476E-4	0	352	0	0	4476	0	0	8846	0	0	796	0	0	968	0	0	1818	0	0	280	0	1	15160	6.596306068601583E-5	0	9198	0	0	6294	0	29	211164	1.3733401526775396E-4	Benign	not_specified|Cardiovascular_phenotype|RASopathy|not_provided|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12612058T>C	ClinGen:CA134721	CN169374|CN230736|C5555857|C3661900	.	536391	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	Asn	Ser	49058	single nucleotide variant	NM_002880.4(RAF1):c.212A>G (p.Asn71Ser)	5894	RAF1	HGNC:9829	Benign	0	Apr 03, 2017	184022679	-	RCV000037686|RCV004532499|RCV000461248|RCV000586687|RCV000620637	MedGen:CN169374||MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN230736	not specified|RAF1-related disorder|RASopathy|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12612058	12612058	3p25.2	reviewed by expert panel	8	-	N	ClinGen:CA134721	2	40588	12612058	T	C	-	-	-	-	-	-	SCV000616420	-	-	212A>G 	Asn71Ser	NM_002880.4	3	2_Benign																																																																																																									
FARS2	FARS2_Gly3Val	-2.1910901347520046	0.41370840506561246	-2.0289898882089776	0.1046229420390252	2025_01_Batch_13-14	0.6300724190845303	0.7579250535477255	0.7324038549786723	0.6785107013649005	0.613947755326278	0.6207307304139534	0.7254778234244152	0.7172547134442959	0.7504674270590193	0.48258131790836933	0.6254015747492419	0.7417014384860704	0.7248292842114841	0.7144890642119599	0.5482645366173237	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011880		NC_000006.12:5368578:G:T		Gly3Val																												FARS2_Gly3Val	6	5368578	G	T	6	allele	8G>T	G01	527_CAVA_Array_P03	N01	B13A7A8P1_R1	B14A7A8P1_R2				6-5368578-G-T	975692	6	5368578	G	T	G	V	rs200380429	6	5368811	6	5313810	3	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.8G>T	p.Gly3Val	c.8G>T	p.Gly3Val	principal1	Y	1	YES	Select	+	GGC	2	0	G	G/G	G/G	G/G	G/G	0.108	0.29555	T	0.173	0.33996	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	0.69	0.16877	N	0.37	0.03617	N	0.201	0.22970	-1.0183	0.24210	T	0.0490	0.20756	T	10	0.06419563	0.08450	T	0.011909	0.29732	T	0.063	0.18106	0.264	0.20839	O95363	G3V	Gain of stability (P = 0.0417)| Gain of helix (P = 0.0425)| Loss of disorder (P = 0.0976)| Loss of loop (P = 0.1242)| Loss of methylation at R7 (P = 0.1536)	0.533179623451	0.52623	.	0.50277	.	0.21965	0.352800011635	0.18315	T	0.028576	0.20467	T	-0.160298	0.26369	T	-0.468033	0.25378	T	0.0261529918185712	0.01420	T	0.706229	0.31439	T	0.04899978	0.08549	0.05854014	0.10844	0.04899978	0.08549	0.05854014	0.10843	-2.72	0.07480	T	0.0811	0.19666	B	0.0342656122538894	0.33942	0.14797659	0.70290	0.104	0.28905	.	.	.	.	.	.	0.478147	0.08506	5.236	0.72636894617756464	0.10205	0.048075	0.08031	N	-1.29901716008698	0.03647	0.1651864	-1.25431266583447	0.04988	0.2405891	5.01	1.67	0.23089	0.277	0.23484	0.253	0.18128	1.445000	0.26644	-0.779	0.0337	0.0	0.06393	0.002000	0.18256	0.033	0.13527	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1608378	1.865230e-06	0	3	1176546	2.549840e-06	0	0	74836	0.000000e+00	0	0	912	0.000000e+00	0	0	59726	0.000000e+00	0	0	29148	0.000000e+00	0	0	44808	0.000000e+00	0	0	63832	0.000000e+00	0	0	6032	0.000000e+00	0	3	1176546	2.549840e-06	0	0	90348	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Likely_benign	Intellectual_disability	no_assertion_criteria_provided	NC_000006.12:g.5368578G>T	.	C3714756	.	.	.	Gly	Val	963613	single nucleotide variant	NM_006567.5(FARS2):c.8G>T (p.Gly3Val)	10667	FARS2	HGNC:21062	Likely benign	0	Jan 01, 2019	200380429	-	RCV001252485	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000006.12	6	5368578	5368578	6p25.1	no assertion criteria provided	1	-	N	ClinGen:CA3623578	2	975692	5368578	G	T	-	-	-	-	-	-	SCV001428242	-	-	8G>T 	Gly3Val	NM_006567.5		2_Benign																																																																																																									
RAF1	RAF1_Leu603Pro	-1.790881684197182	1.0	-2.761223855400645	0.028913933298763714	2025_01_Batch_13-14	0.8072334686400157	0.9398959418348838	0.9632003901983831	0.9276792657133388	0.8371185622746348	0.7472667962186551	0.9145242728294307	0.9377890502524259	0.9052702480327363	0.7247164039514323	0.7772501324293354	0.9272101073321573	0.9504947202254045	0.9164747568730376	0.7809174831130336	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008861		NC_000003.12:12584653:A:G		Leu603Pro																												RAF1_Leu603Pro	3	12584653	A	G	3	allele	1808T>C	E04	527_CAVA_Array_P05	I07	B13A7A8P2_R1	B14A7A8P2_R2				3-12584653-A-G	142296	3	12584653	A	G	L	P	rs587777586	3	12626152	3	12601152	603	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1808T>C	p.Leu603Pro	c.1808T>C	p.Leu603Pro	principal3	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.006	0.72530	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.055	0.86694	M	-5.94	0.89120	D	0.954	0.97221	1.0563	0.98251	D	0.9820	0.99448	D	10	0.9554792	0.94850	D	0.905219	0.99287	D	0.986	0.99942	0.791	0.91245	P04049	L603P	Gain of disorder (P = 0.017)| Gain of helix (P = 0.0325)| Gain of glycosylation at S604 (P = 0.0488)| Loss of loop (P = 0.0804)| Loss of stability (P = 0.1069)	0.973766025508	0.97323	.	0.95923	1.08258798955	0.77046	0.886617004871	0.94825	D	0.932912	0.98867	D	0.575938	0.96897	D	0.589519	0.96846	D	0.999162554740906	0.96363	D	.	0.93270	.	0.99187005	0.99851	0.9862118	0.99940	0.9903099	0.99776	0.98532397	0.99928	-13.29	0.90541	D	0.9993	0.98761	P	0.999902317115662	0.98723	0.99897957	0.99072	0.987	0.99559	.	.	.	.	.	.	5.064217	0.84452	28.3	0.99912388320110823	0.98168	0.956235	0.97455	D	0.915325109665532	0.92448	11.45292	0.863677081222081	0.93754	12.28152	5.51	5.51	0.81744	.	.	8.809	0.91585	11.190000	0.88645	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Dilated_cardiomyopathy_1NN	no_assertion_criteria_provided	NC_000003.12:g.12584653A>G	ClinGen:CA167980|OMIM:164760.0005|UniProtKB:P04049#VAR_071847	C4014656	615916	154	Protein kinase domain|Protein kinase domain|Protein kinase domain	Leu	Pro	152010	single nucleotide variant	NM_002880.4(RAF1):c.1808T>C (p.Leu603Pro)	5894	RAF1	HGNC:9829	Pathogenic	1	Jun 01, 2014	587777586	-	RCV000131334	MONDO:MONDO:0014396,MedGen:C4014656,OMIM:615916,Orphanet:154	Dilated cardiomyopathy 1NN	germline	germline	GRCh38	NC_000003.12	3	12584653	12584653	3p25.2	no assertion criteria provided	1	-	N	ClinGen:CA167980,UniProtKB:P04049#VAR_071847,OMIM:164760.0005	1	142296	12584653	A	G	-	-	-	-	-	-	SCV000186308	-	-	1808T>C 	Leu603Pro	NM_002880.4		1_Pathogenic																																																																																																									
CCM2	CCM2_Asn81Lys	1.101675849008971	1.0	0.5068714835976135	1.0	2025_01_Batch_13-14	0.8493736454037726	0.7733403702252746	0.8045442278394832	0.8804055242976636	0.7438541781201936	0.7492481775458592	0.7559123199971922	0.7720492792682404	0.8135260990064168	0.7240174919541144	0.7993109114748158	0.7646263451112334	0.7882967535538619	0.8469658116520402	0.733935835037154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038633		NC_000007.14:45063956:T:A		Asn81Lys																												CCM2_Asn81Lys	7	45063956	T	A	7	allele	243T>A	F09	527_CAVA_Array_P06	K18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063956-T-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala205Ser	0.5822464043919009	1.0	2.47861596791534	1.0	2025_01_Batch_13-14	0.8954899640419306	0.8654371083982267	0.9256787737546616	0.926529025679612	0.8571745201782174	0.7410793407328834	0.8130385166085071	0.7552041566542494	0.7336444328540405	0.705658606615753	0.818284652387407	0.8392378125033669	0.8404414652044555	0.8300867292668263	0.7814165633969852	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038717		NC_000007.14:45069829:G:T		Ala205Ser																												CCM2_Ala205Ser	7	45069829	G	T	7	allele	613G>T	H04	527_CAVA_Array_P07	P07	B13A7A8P2_R1	B14A7A8P2_R2				7-45069829-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Tyr144Cys	3.5015985572462505	1.0	-1.2829440552661655	1.0	2025_01_Batch_13-14	0.874802306346691	0.8517736011112564	0.8549907639421453	0.8693140246253347	0.7598006269895752	0.7439451978045868	0.752189126554685	0.8368803355037464	0.7368295615185543	0.6923924721748065	0.8093737520756389	0.8019813638329707	0.8459355497229459	0.8030717930719444	0.7260965495821908	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038675		NC_000007.14:45064605:A:G		Tyr144Cys																												CCM2_Tyr144Cys	7	45064605	A	G	7	allele	431A>G	F01	527_CAVA_Array_P07	L01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064605-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala179Thr	1.3747532128270599	1.0	7.763443963229797	0.014781622069781388	2025_01_Batch_13-14	0.8660878168013966	0.8293096945201711	0.8687232834214235	0.8221192403284294	0.7531287342559607	0.8453857483902422	0.7858229696802597	0.8188878324866461	0.7367193808249026	0.8308346546758741	0.8557367825958193	0.8075663321002153	0.8438055579540348	0.779419310576666	0.7919816944659175	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038695		NC_000007.14:45068505:G:A		Ala179Thr																												CCM2_Ala179Thr	7	45068505	G	A	7	allele	535G>A	H02	527_CAVA_Array_P07	P03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068505-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr241Ile	0.2758675632096231	1.0	4.087539729998186	1.0	2025_01_Batch_13-14	0.8912645209035395	0.9217400395486214	0.8680456180510235	0.8789975783274349	0.7149164864262093	0.9617230669853504	0.9619086835023911	0.8348486529247687	0.8976007959972826	0.9282108923115105	0.9264937939444449	0.9418243615255062	0.8514471354878961	0.8882991871623587	0.8215636893688599	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038735		NC_000007.14:45069938:C:T		Thr241Ile																												CCM2_Thr241Ile	7	45069938	C	T	7	allele	722C>T	A07	527_CAVA_Array_P07	B13	B13A7A8P2_R1	B14A7A8P2_R2				7-45069938-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Arg423Cys	2.9762525370828947	1.0	2.5440946453180544	1.0	2025_01_Batch_13-14	0.7666675046264338	0.7418462178119639	0.8400892415555745	0.7728709783527843	0.669379406763801	0.6708428342937188	0.6930264897054216	0.7160132509064241	0.6240100895487098	0.6182844498415188	0.7187551694600763	0.7174363537586927	0.7780512462309993	0.6984405339507471	0.6438319283026599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038838		NC_000007.14:45075989:C:T		Arg423Cys																												CCM2_Arg423Cys	7	45075989	C	T	7	allele	1267C>T	D02	527_CAVA_Array_P08	H04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075989-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Ile31Val	4.150235795989882	0.009338842715277238	1.6670333692872967	1.0	2025_01_Batch_13-14	0.8632571331477497	0.9092146244980089	0.8648443535593294	0.7855611845527318	0.759573299204002	0.751312878625422	0.8060784152900309	0.8239304512340127	0.788634996757791	0.7252208725648839	0.8072850058865858	0.85764651989402	0.8443874023966711	0.7870980906552614	0.7423970858844429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023265		NC_000011.10:112087895:A:G		Ile31Val																												SDHD_Ile31Val	11	112087895	A	G	11	allele	91A>G	E01	527_CAVA_Array_P06	I02	B13A7A8P2_R1	B14A7A8P2_R2				11-112087895-A-G	860158	11	112087895	A	G	I	V	rs1865653068	11	111958619	11	111463829	31	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.91A>G	p.Ile31Val	c.91A>G	p.Ile31Val	principal1	Y	1	YES	Select	+	ATC	1	0	A	./.	./.	./.	./.	1.0	0.00968	T	1.0	0.03973	T	0.0	0.02950	B	0.0	0.01384	B	0.08	0.31989	N	simple_aae	92.0	8.0	-1.025	0.01134	N	0.18	0.05010	N	0.085	0.06176	-0.5465	0.66773	T	0.4158	0.76166	T	10	0.04787895	0.04166	T	0.031946	0.53719	D	0.476	0.76693	0.381	0.39663	O14521	I31V	Gain of sheet (P = 0.1208)| Gain of methylation at R27 (P = 0.1334)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Gain of catalytic residue at I31 (P = 0.2808)	0.786847784675	0.78318	0.43965305476109695	0.43682	0.15461328637	0.17194	0.309365063906	0.11802	T	0.146378	0.48116	T	0.0852895	0.62390	D	-0.115264	0.61922	T	0.0309518799185753	0.02125	T	0.533947	0.19158	T	0.02366694	0.01119	0.026847782	0.00805	0.02366694	0.01119	0.026847782	0.00805	-2.33	0.06038	T	0.0626	0.12187	B	0.00494223008028627	0.18766	0.92538464	0.92192	0.029	0.05809	.	.	.	.	.	.	0.134814	0.05315	1.791	0.74706428750991605	0.10972	0.118743	0.22993	N	-1.22373084351358	0.04605	0.2106841	-1.06657851552802	0.08227	0.4109787	4.81	2.78	0.31620	.	.	0.472	0.21905	2.708000	0.34295	-0.743	0.03658	0.37	0.26012	0.994000	0.32271	0.663	0.33093	635	0.64545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_specified|Hereditary_pheochromocytoma-paraganglioma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112087895A>G	.	CN169374|C1708353|CN166604|C1847319|C0031511|C1868633|C0027672	606864|171300	29072|201|97286|29072|140162	.	Ile	Val	837951	single nucleotide variant	NM_003002.4(SDHD):c.91A>G (p.Ile31Val)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0	May 11, 2024	1865653068	-	RCV002240532|RCV002374977|RCV003151276|RCV004000160	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary cancer-predisposing syndrome|not specified|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112087895	112087895	11q23.1	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382616974	2	860158	112087895	A	G	-	-	-	-	-	-	SCV001231428|SCV002688111|SCV004822330	-	-	91A>G 	Ile31Val	NM_003002.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_His109Arg	2.228950003139328	1.0	3.552886427688311	1.0	2025_01_Batch_13-14	0.9148785131407426	0.8732270592473507	0.8746983920908312	0.8907747757123253	0.8377275009492865	0.8429670270034343	0.7984251194938521	0.7512189488589577	0.8128613135678454	0.7758053181571496	0.8789227700720885	0.8358260893706013	0.8129586704748945	0.8518180446400854	0.8067664095532181	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038651		NC_000007.14:45064500:A:G		His109Arg																												CCM2_His109Arg	7	45064500	A	G	7	allele	326A>G	F11	527_CAVA_Array_P06	K22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064500-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile136Val	0.9101879729344521	1.0	4.021913199172586	1.0	2025_01_Batch_13-14	0.943614090100534	0.8615815163844572	0.8226947359042652	0.8343866827884098	0.8024901509159368	0.8376246379918405	0.8490385479549226	0.7512970173000318	0.7533190502878117	0.7915650857631206	0.8906193640461872	0.8553100321696899	0.7869958766021485	0.7938528665381107	0.7970276183395286	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038668		NC_000007.14:45064580:A:G		Ile136Val																												CCM2_Ile136Val	7	45064580	A	G	7	allele	406A>G	H12	527_CAVA_Array_P06	O24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064580-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser251Tyr	1.807724159367112	1.0	20.938589434715308	1.5620709580802553e-6	2025_01_Batch_13-14	0.8277939061407555	0.8502940072845977	0.9370310503893277	0.839611845581295	0.7705788614507042	0.6890787144949896	0.9013088046606961	0.9697032742583224	0.8947366051185094	0.6737323849543451	0.7584363103178726	0.8758014059726469	0.953367162323825	0.8671742253499022	0.7221556232025246	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038740		NC_000007.14:45072732:C:A		Ser251Tyr																												CCM2_Ser251Tyr	7	45072732	C	A	7	allele	752C>A	E07	527_CAVA_Array_P07	J13	B13A7A8P2_R1	B14A7A8P2_R2				7-45072732-C-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser245Cys	-1.0379705432604147	1.0	-3.822648708895952	1.0	2025_01_Batch_13-14	0.8328564638068309	0.7517473800508396	0.8309830040814905	0.7984860884845713	0.7738516572346142	0.8601224156084578	0.7846839748706458	0.8408947363542679	0.8525952864747266	0.7969907722681085	0.8464894397076443	0.7682156774607427	0.8359388702178792	0.8255406874796489	0.7854212147513614	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038736		NC_000007.14:45069950:C:G		Ser245Cys																												CCM2_Ser245Cys	7	45069950	C	G	7	allele	734C>G	B07	527_CAVA_Array_P07	D13	B13A7A8P2_R1	B14A7A8P2_R2				7-45069950-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser248Gly	6.0576249389867804	0.3155986432849373	19.452904782139427	0.00005892912237046486	2025_01_Batch_13-14	0.8187817594883972	0.8182802577383493	0.8261091168305187	0.8318819780762726	0.7765376984369737	0.7451904343240013	0.7638038468663794	0.8422785636572259	0.7531124549584602	0.7138507114362718	0.7819860969061992	0.7910420523023644	0.8341938402438722	0.7924972165173665	0.7451942049366227	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038738		NC_000007.14:45069958:A:G		Ser248Gly																												CCM2_Ser248Gly	7	45069958	A	G	7	allele	742A>G	D07	527_CAVA_Array_P07	H13	B13A7A8P2_R1	B14A7A8P2_R2				7-45069958-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu366Lys	2.430210938387908	1.0	14.046510743453249	0.000019286758174013895	2025_01_Batch_13-14	0.894805852693601	0.953628796776974	0.9572043258469867	0.9325580530289952	0.8100842261618991	0.8867420519330925	0.961726221565331	0.9452609395230348	0.8916207768325431	0.8306555178770776	0.8907739523133468	0.9576775091711525	0.9512326326850107	0.9120894149307692	0.8203698720194883	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038799		NC_000007.14:45075818:G:A		Glu366Lys																												CCM2_Glu366Lys	7	45075818	G	A	7	allele	1096G>A	A11	527_CAVA_Array_P07	B21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075818-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Arg52Cys	0.4505884994439837	1.0	3.5693120857681233	1.0	2025_01_Batch_13-14	0.8708112921759003	0.8320754842408546	0.845746468391137	0.8598008454787301	0.8243700212132691	0.7857422793546178	0.7681952686663347	0.6990011799128841	0.6705828315342461	0.7734648034456805	0.8282767857652591	0.8001353764535947	0.7723738241520106	0.7651918385064882	0.7989174123294748	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038620		NC_000007.14:45038376:C:T		Arg52Cys																												CCM2_Arg52Cys	7	45038376	C	T	7	allele	154C>T	H07	527_CAVA_Array_P06	O14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038376-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr86Ile	-0.15875900038261945	1.0	9.40864394967323	0.0005474480077117845	2025_01_Batch_13-14	0.8818295837452458	0.9319910856546324	0.9316318646380162	0.9278166504722206	0.8280369328558583	0.8275619244906388	0.9122097298305354	0.9419379104833902	0.8869044717308222	0.7827896800887694	0.8546957541179423	0.9221004077425838	0.9367848875607032	0.9073605611015214	0.8054133064723139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038637		NC_000007.14:45063970:C:T		Thr86Ile																												CCM2_Thr86Ile	7	45063970	C	T	7	allele	257C>T	B10	527_CAVA_Array_P06	C20	B13A7A8P2_R1	B14A7A8P2_R2				7-45063970-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Asp486Asn	0.45327533329345343	1.0	-3.1778243081480344	0.02572498582917983	2025_01_Batch_13-14	0.8739391265851167	0.9053125702290953	0.9058966866448821	0.9293565178076245	0.7916608191821694	0.7864937187645036	0.8715175779120291	0.8858534683267907	0.8838538667961265	0.6808674936830288	0.8302164226748101	0.8884150740705622	0.8958750774858364	0.9066051923018755	0.7362641564325991	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1	ENSG00000132155	732	213824	CCSBVarC003426	ALE00003426	NC_000003.12:12585761:C:T	1456G>A	Asp486Asn	CEGS2	CegsMutGDEh1014	G11	GDEhDisVCh_40029	D08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RAF1_Asp486Asn	3	12585761	C	T	3											3-12585761-C-T	21341	3	12585761	C	T	D	N	rs80338798	3	12627260	3	12602260	486	RAF1	ENSG00000132155	ENST00000685653	ENSP00000509968	P04049	RAF1_HUMAN	.	.	c.1456G>A	p.Asp486Asn	principal3	Y	.	.	.	-	GAT	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.998	0.88579	D	.	0.92286	.	.	.	.	2.89	0.83536	M	.	0.78079	.	.	0.99419	0.9420	0.96265	D	0.9946	0.99877	D	9	.	0.99202	.	0.825636	0.98643	D	.	0.97963	0.968	0.99690	P04049	D486N	Gain of MoRF binding (P = 0.0343)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K483 (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K483 (P = 0.1041)	.	0.95330	.	0.98776	.	0.97323	0.879874408245	0.93935	D	0.949346	0.99250	D	0.270705	0.80361	D	0.151072	0.80106	D	0.998047471046448	0.93025	D	0.9975	0.98985	D	0.94164735	0.95344	0.889279	0.94137	0.94205755	0.95387	0.8781777	0.93345	-14.009	0.93099	D	.	0.98152	.	0.99999342572825	0.99831	0.99668110	0.98129	0.995	0.99826	.	.	.	.	.	.	5.650199	0.92811	33.0	0.99921808742760565	0.98788	0.892841	0.82954	D	1.01881719419438	0.96274	14.52467	0.933976822940601	0.96872	15.28689	5.26	5.26	0.73443	5.35	0.93259	7.9	0.86061	7.684000	0.65502	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Noonan_syndrome_with_multiple_lentigines	no_classification_provided	NC_000003.12:g.12585761C>T	ClinGen:CA341928|UniProtKB:P04049#VAR_037817	C0175704	PS151100	500	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	34193	single nucleotide variant	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)	5894	RAF1	HGNC:9829	not provided	0	-	80338798	-	RCV000020506	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	Noonan syndrome with multiple lentigines	unknown	unknown	GRCh38	NC_000003.12	3	12585761	12585761	3p25.2	no classification provided	1	-	N	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	1	21341	12585761	C	T	-	-	-	-	-	-	SCV000040957	-	-	1456G>A 	Asp486Asn	NM_002880.4		5_Others																																																																																																									
RAF1	RAF1_Asp486Asn	0.45327533329345343	1.0	-3.1778243081480344	0.02572498582917983	2025_01_Batch_13-14	0.8739391265851167	0.9053125702290953	0.9058966866448821	0.9293565178076245	0.7916608191821694	0.7864937187645036	0.8715175779120291	0.8858534683267907	0.8838538667961265	0.6808674936830288	0.8302164226748101	0.8884150740705622	0.8958750774858364	0.9066051923018755	0.7362641564325991	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008873		NC_000003.12:12590889:T:C		Asp486Asn																												RAF1_Asp486Asn	3	12590889	T	C	3	allele	1456G>A	A04	527_CAVA_Array_P05	A07	B13A7A8P2_R1	B14A7A8P2_R2				3-12590889-T-C	40616	3	12590889	T	C	S	G	rs730881002	3	12632388	3	12607388	427	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.1279A>G	p.Ser427Gly	principal3	Y	.	.	.	-	AGC	1	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.39532	.	1.0	0.90580	D	0.999	0.92348	D	.	0.93300	.	.	.	.	-1.72	0.00342	N	.	0.71557	.	.	0.91505	-0.2179	0.77104	T	0.2268	0.59002	T	10	.	0.70236	.	0.179624	0.85398	D	.	0.89880	0.82	0.93292	P04049	S427G	Loss of ubiquitination at K431 (P = 0.0801)| Loss of stability (P = 0.2308)| Gain of catalytic residue at S427 (P = 0.2489)| Gain of methylation at K431 (P = 0.262)| Loss of disorder (P = 0.2717)	.	0.96743	.	0.97149	.	0.96921	0.699861168861	0.67068	T	0.897908	0.97955	D	0.30741	0.83430	D	0.203797	0.83214	D	0.995037019252777	0.86609	D	.	0.92775	.	0.93729275	0.94895	0.8914141	0.94290	0.9370056	0.94866	0.8904818	0.94223	-13.689	0.92018	D	.	0.65901	.	0.999960555285628	0.99297	0.99608827	0.97958	0.619	0.78728	.	.	.	.	.	.	5.003768	0.83076	27.9	0.99859374417457669	0.93824	0.534511	0.55195	D	0.247654629085886	0.53289	3.520768	0.331680700016892	0.57182	3.906654	4.75	4.75	0.59904	5.35	0.93259	2.072	0.41239	7.869000	0.71902	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	690	0.58843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|RASopathy|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12590889T>C	ClinGen:CA297127	C3661900|C5555857|C5681679|CN230736	.	536391|98733	Protein kinase domain|Protein kinase domain|Protein kinase domain	Ser	Gly	49086	single nucleotide variant	NM_002880.4(RAF1):c.1279A>G (p.Ser427Gly)	5894	RAF1	HGNC:9829	Pathogenic/Likely pathogenic	1	Mar 26, 2024	730881002	-	RCV000159084|RCV001813271|RCV004668748|RCV001852678	MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MedGen:CN230736|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12590889	12590889	3p25.2	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA297127	2	40616	12590889	T	C	-	-	-	-	-	-	SCV000209027|SCV002060957|SCV002228531|SCV005163541	-	-	1279A>G 	Ser427Gly	NM_002880.4	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Thr44Ile	-0.37504377223176144	1.0	7.031248570408793	0.0010912431609496737	2025_01_Batch_13-14	0.8610503803716635	0.8036315325396365	0.8530348121643258	0.832536689382407	0.8112230512776734	0.7958519826993652	0.9002641777465802	0.9558246414867057	0.8784554681228354	0.7895466716000743	0.8284511815355143	0.8519478551431083	0.9044297268255157	0.8554960787526211	0.8003848614388738	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038616		NC_000007.14:45038353:C:T		Thr44Ile																												CCM2_Thr44Ile	7	45038353	C	T	7	allele	131C>T	D07	527_CAVA_Array_P06	G14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038353-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly188Glu	1.9020482410994124	1.0	8.426864756752837	0.15072357598419847	2025_01_Batch_13-14	0.8325259396225277	0.7414781365685089	0.7746428804247841	0.7950885484482219	0.7498820888309895	0.744716718117997	0.8445473713616461	0.8516884284906655	0.7845181201049113	0.6962981818750179	0.7886213288702624	0.7930127539650775	0.8131656544577248	0.7898033342765666	0.7230901353530037	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038707		NC_000007.14:45068533:G:A		Gly188Glu																												CCM2_Gly188Glu	7	45068533	G	A	7	allele	563G>A	G03	527_CAVA_Array_P07	N05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068533-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_His151Tyr	0.44179659083902906	1.0	-3.8816623005043365	1.0	2025_01_Batch_13-14	0.9708182645290951	0.928357558805902	0.9621724654055575	0.9568087684142368	0.9346564822157637	0.7965128466442958	0.805427558847359	0.883393316047357	0.8344430419081285	0.7529843497713511	0.8836655555866955	0.8668925588266305	0.9227828907264572	0.8956259051611826	0.8438204159935574	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038683		NC_000007.14:45064625:C:T		His151Tyr																												CCM2_His151Tyr	7	45064625	C	T	7	allele	451C>T	H01	527_CAVA_Array_P07	P01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064625-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp419Tyr	1.1081156676730253	1.0	9.231049198997352	0.0005083848973808923	2025_01_Batch_13-14	0.749248260756011	0.8252838472359086	0.8800828918757674	0.8357541672609913	0.6449021117167926	0.6916200687721787	0.857659204836287	0.8921044706501581	0.7982546184867229	0.6237248458287414	0.7204341647640948	0.8414715260360979	0.8860936812629627	0.8170043928738571	0.634313478772767	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038836		NC_000007.14:45075977:G:T		Asp419Tyr																												CCM2_Asp419Tyr	7	45075977	G	T	7	allele	1255G>T	C02	527_CAVA_Array_P08	F04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075977-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr267Ile	0.9568914494099278	1.0	3.5201386628918496	1.0	2025_01_Batch_13-14	0.8708237793933261	0.8497218685391096	0.863258663460125	0.864295302048995	0.76126232918272	0.9065906471388311	0.9148945710464393	0.8308304751963981	0.8574263304291664	0.875699539137718	0.8887072132660786	0.8823082197927745	0.8470445693282616	0.8608608162390807	0.818480934160219	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038747		NC_000007.14:45072780:C:T		Thr267Ile																												CCM2_Thr267Ile	7	45072780	C	T	7	allele	800C>T	C08	527_CAVA_Array_P07	F15	B13A7A8P2_R1	B14A7A8P2_R2				7-45072780-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala232Val	-1.653956572325234	1.0	-2.006018234968377	1.0	2025_01_Batch_13-14	0.8263925578026446	0.7957349160809177	0.8661741424535152	0.9181326607219549	0.7723694481415823	0.8053927832533851	0.7746451789856525	0.821024864385758	0.8388463697685958	0.7203054155667327	0.815892670528015	0.7851900475332851	0.8435995034196366	0.8784895152452754	0.7463374318541575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038731		NC_000007.14:45069911:C:T		Ala232Val																												CCM2_Ala232Val	7	45069911	C	T	7	allele	695C>T	E06	527_CAVA_Array_P07	J11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069911-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu66Lys	0.7197459845528407	1.0	13.559877297001123	6.849362812623817e-6	2025_01_Batch_13-14	0.8148113738047553	0.8786457795547754	0.9393275702369617	0.8755487837053314	0.7486729702129642	0.7943478513936437	0.8615112124471521	0.9494408825488914	0.8777804816466793	0.7698077524021739	0.8045796125991995	0.8700784960009638	0.9443842263929265	0.8766646326760054	0.7592403613075691	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038627		NC_000007.14:45038418:G:A		Glu66Lys																												CCM2_Glu66Lys	7	45038418	G	A	7	allele	196G>A	G08	527_CAVA_Array_P06	M16	B13A7A8P2_R1	B14A7A8P2_R2				7-45038418-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Phe22Leu	0.9979103452561944	1.0	0.5106342537669916	1.0	2025_01_Batch_13-14	0.6611114622240368	0.6959964161221559	0.6718233999906628	0.6634187249330441	0.6234668786162717	0.6575876991241759	0.7217617961169218	0.6471376378290921	0.686803693517124	0.6015017258743621	0.6593495806741063	0.7088791061195389	0.6594805189098774	0.675111209225084	0.6124843022453169	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008857		NC_000003.12:12618656:A:C		Phe22Leu																												RAF1_Phe22Leu	3	12618656	A	C	3	allele	66T>G	D05	527_CAVA_Array_P05	G09	B13A7A8P2_R1	B14A7A8P2_R2				3-12618656-A-C	40583	3	12618656	A	C	F	L	rs397516824	3	12660155	3	12635155	22	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.66T>G	p.Phe22Leu	principal3	Y	.	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.51407	.	.	0.25352	.	0.06	0.23134	B	0.018	0.18486	B	.	0.78586	.	.	.	.	1.83	0.47902	L	.	0.21370	.	.	0.61652	-0.9080	0.46899	T	0.2084	0.56595	T	10	.	0.52770	.	0.038866	0.58315	D	.	0.31809	0.372	0.38195	P04049	F22L	Loss of sheet (P = 0.0181)| Gain of loop (P = 0.0312)| Loss of methylation at K18 (P = 0.0891)| Gain of relative solvent accessibility (P = 0.09)| Loss of ubiquitination at K18 (P = 0.1216)	.	0.74448	.	0.36376	.	0.85880	0.814390659332	0.84138	D	0.468965	0.80119	T	-0.176835	0.23871	T	-0.255119	0.48980	T	0.135316427567574	0.15665	T	.	0.44238	.	0.10763881	0.25223	0.120846346	0.29089	0.14490148	0.32960	0.14525777	0.34355	-2.426	0.05558	T	.	0.68345	.	0.900999158324285	0.76121	0.35689947	0.78477	0.566	0.75580	.	.	.	.	.	.	2.085276	0.2657	17.15	0.99825905109529411	0.90858	0.234715	0.35536	N	-0.344430833306449	0.27198	1.507842	-0.211098281217204	0.30821	1.759308	6.03	0.769	0.17595	0.598	0.25895	1.009	0.29585	1.026000	0.23526	0.756	0.943	1.0	0.71675	0.989000	0.31253	0.999	0.91597	615	0.66487	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	5	109406	4.570130e-05	0	12	208126	5.765740e-05	0	14	236942	5.908620e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	5	42768	1.169100e-04	0	0	15690	0.000000e+00	0	5	42768	1.169100e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	12	89554	1.339970e-04	0	0	30608	0.000000e+00	0	12	89554	1.339970e-04	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	14	102744	1.362610e-04	0	0	30526	0.000000e+00	0	14	102744	1.362610e-04	0	.	199	1614116	1.232870e-04	1	196	1180052	1.660940e-04	1	0	74934	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64042	0.000000e+00	0	0	6084	0.000000e+00	0	196	1180052	1.660940e-04	1	0	91094	0.000000e+00	0	3	37246	8.054556193953713E-5	0	122	0	0	112	0	0	3438	0	0	500	0	0	628	0	0	56	0	0	98	0	1	7060	1.4164305949008498E-4	0	3560	0	0	168	0	4	49260	8.120178643930166E-5	Likely_benign	RASopathy|Cardiovascular_phenotype|not_specified|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12618656A>C	ClinGen:CA134746	C5555857|CN230736|CN169374	.	536391	.	Phe	Leu	49053	single nucleotide variant	NM_002880.4(RAF1):c.66T>G (p.Phe22Leu)	5894	RAF1	HGNC:9829	Likely benign	0	Apr 03, 2017	397516824	-	RCV004541061|RCV000037696|RCV000168020|RCV003362667	|MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RAF1-related disorder|not specified|RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12618656	12618656	3p25.2	reviewed by expert panel	5	-	N	ClinGen:CA134746	2	40583	12618656	A	C	-	-	-	-	-	-	SCV000616418	-	-	66T>G 	Phe22Leu	NM_002880.4	3	2_Benign																																																																																																									
CCM2	CCM2_Pro102Ser	-0.1440321125795081	1.0	9.070789008267747	0.009852725256252455	2025_01_Batch_13-14	0.8226637344705291	0.748271894623218	0.8051621323347176	0.8221587292503484	0.757512951999754	0.8502476993468551	0.9164125535379942	0.9094482997771779	0.91344523847991	0.7410809875453079	0.8364557169086921	0.8323422240806061	0.8573052160559478	0.8678019838651292	0.7492969697725309	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038645		NC_000007.14:45064478:C:T		Pro102Ser																												CCM2_Pro102Ser	7	45064478	C	T	7	allele	304C>T	H10	527_CAVA_Array_P06	O20	B13A7A8P2_R1	B14A7A8P2_R2				7-45064478-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile131Asn	-0.47349479026483987	1.0	-0.09538631558297084	1.0	2025_01_Batch_13-14	0.9275563631269278	0.7808867169828521	0.8439340923927728	0.8748332819505222	0.7881014359532656	0.7680672978847154	0.7465032899577911	0.8490765722608468	0.7706399777166885	0.7243270287068483	0.8478118305058215	0.7636950034703216	0.8465053323268098	0.8227366298336054	0.7562142323300569	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038667		NC_000007.14:45064566:T:A		Ile131Asn																												CCM2_Ile131Asn	7	45064566	T	A	7	allele	392T>A	G12	527_CAVA_Array_P06	M24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064566-T-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala98Pro	1.9477265378836826	1.0	2.1877217961028457	1.0	2025_01_Batch_13-14	0.8708161446170863	0.812323493800029	0.8364073719464606	0.8658826798304835	0.7268602764791542	0.7327309963792749	0.8120134127964382	0.7594469818269469	0.7969060164597161	0.6473945479787631	0.8017735704981805	0.8121684532982336	0.7979271768867038	0.8313943481450998	0.6871274122289586	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038643		NC_000007.14:45064466:G:C		Ala98Pro																												CCM2_Ala98Pro	7	45064466	G	C	7	allele	292G>C	G10	527_CAVA_Array_P06	M20	B13A7A8P2_R1	B14A7A8P2_R2				7-45064466-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser84Asn	-0.6352572735570245	1.0	8.258038222257563	0.0003198503708423377	2025_01_Batch_13-14	0.8338278796694617	0.7889791105666181	0.8666674260941472	0.8094813020778583	0.7686441524466513	0.7953320186282066	0.90558407641889	0.9556379595490138	0.9056796017520835	0.7115120323293965	0.8145799491488341	0.847281593492754	0.9111526928215805	0.8575804519149709	0.7400780923880239	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038635		NC_000007.14:45063964:G:A		Ser84Asn																												CCM2_Ser84Asn	7	45063964	G	A	7	allele	251G>A	H09	527_CAVA_Array_P06	O18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063964-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Asn140His	-0.04961800914186328	1.0	-0.26453384717819656	1.0	2025_01_Batch_13-14	0.8768500439669253	0.8008637628205076	0.7526688883548288	0.8566458710111035	0.7498309272648557	0.7498700589060513	0.7908219336296483	0.7561533297498351	0.7553379890980602	0.6702817161096603	0.8133600514364883	0.7958428482250779	0.754411109052332	0.8059919300545818	0.710056321687258	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008912		NC_000003.12:12609238:T:G		Asn140His																												RAF1_Asn140His	3	12609238	T	G	3	allele	418A>C	B05	527_CAVA_Array_P05	C09	B13A7A8P2_R1	B14A7A8P2_R2				3-12609238-T-G	40590	3	12609238	T	G	N	H	rs730881009	3	12650737	3	12625737	140	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.418A>C	p.Asn140His	principal3	Y	.	.	.	-	AAC	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.50294	.	1.0	0.90580	D	0.994	0.82066	D	.	0.76851	.	.	.	.	1.78	0.46014	L	.	0.72035	.	.	0.89342	0.8725	0.95294	D	0.8467	0.94874	D	10	.	0.81918	.	0.486445	0.94918	D	.	0.92184	0.507	0.60104	P04049	N140H	Loss of loop (P = 0.0374)| Loss of glycosylation at T138 (P = 0.0472)| Loss of catalytic residue at N140 (P = 0.0473)| Gain of sheet (P = 0.1208)| Gain of methylation at K144 (P = 0.1389)	.	0.93906	.	0.78656	.	0.84295	0.864215731621	0.91719	D	0.90447	0.98131	D	0.19048	0.72806	D	0.0358342	0.72452	D	0.969879031181335	0.68540	D	.	0.92893	.	0.7594829	0.81195	0.8015472	0.88218	0.8018196	0.83820	0.7257919	0.83611	-10.417	0.76444	D	.	0.80100	.	0.999536362008549	0.96903	0.94453880	0.93084	0.975	0.99076	.	.	.	.	.	.	4.983822	0.82606	27.8	0.99556719294456497	0.71556	0.925488	0.90478	D	0.743491548643859	0.82383	7.773029	0.718547825165139	0.83700	8.114436	5.84	5.84	0.93363	5.35	0.93259	8.012	0.88241	7.876000	0.72273	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	646	0.63408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.12609238T>G	ClinGen:CA297148	CN517202	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Asn	His	49060	single nucleotide variant	NM_002880.4(RAF1):c.418A>C (p.Asn140His)	5894	RAF1	HGNC:9829	Likely pathogenic	1	Oct 03, 2012	730881009	-	RCV000159094	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12609238	12609238	3p25.2	criteria provided, single submitter	1	-	N	ClinGen:CA297148	2	40590	12609238	T	G	-	-	-	-	-	-	SCV000209037	-	-	418A>C 	Asn140His	NM_002880.4	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Ser15Leu	1.0648827300409174	1.0	1.8213513689743237	0.3714959353263662	2025_01_Batch_13-14	0.8662346108519653	0.907602819332685	0.8553392327769186	0.8425727016653686	0.775223829079267											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038606		NC_000007.14:45038266:C:T		Ser15Leu																												CCM2_Ser15Leu	7	45038266	C	T	7	allele	44C>T	C06	527_CAVA_Array_P06	E12	B13A7A8P2_R1	B14A7A8P2_R2				7-45038266-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BRIP1	BRIP1_Val76Ile	0.573151287218121	0.5988089065274733	-0.1501928285335794	1.0	2025_01_Batch_13-14	0.8091988361109888	0.6844133981290228	0.6783701732387314	0.6731480580521042	0.7665337621531135	0.6712085747597284	0.6745958346966116	0.710337530479982	0.6764891815029795	0.644690981329773	0.7402037054353585	0.6795046164128171	0.6943538518593567	0.6748186197775419	0.7056123717414433	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1		55128		CCSBVarC031290		NC_000017.11:61857211:C:T		Val76Ile																												BRIP1_Val76Ile	17	61857211	C	T	17	allele	226G>A	F12	527_CAVA_Array_P01	K23	B13A7A8P1_R1	B14A7A8P1_R2				17-61857211-C-T	407851	17	61857211	C	T	V	I	rs769573395	17	59934572	17	57289354	76	BRIP1	ENSG00000136492	ENST00000259008	ENSP00000259008	Q9BX63	FANCJ_HUMAN	c.226G>A	p.Val76Ile	c.226G>A	p.Val76Ile	principal2	Y	1	YES	Select	-	GTA	1	0	C	C/C	C/C	C/C	C/C	0.279	0.15648	T	0.352	0.19614	T	0.0	0.02950	B	0.0	0.01384	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.55	0.14367	N	0.03	0.06578	N	0.068	0.08480	-0.9732	0.36374	T	0.1619	0.49568	T	9	0.046871662	0.03935	T	0.039492	0.58683	D	0.127	0.34681	0.421	0.46221	Q9BX63	V76I	Gain of loop (P = 0.1069)| Loss of disorder (P = 0.1257)| Gain of helix (P = 0.132)| Loss of catalytic residue at V76 (P = 0.1841)| Loss of phosphorylation at S77 (P = 0.1941)	0.233150807113	0.22520	0.11234678450338882	0.11014	0.129564647105	0.14353	0.25607085228	0.04436	T	0.067288	0.32914	T	-0.358382	0.04058	T	-0.57104	0.15067	T	0.064310478718449	0.07741	T	.	0.05921	.	0.021931265	0.00820	0.01949408	0.00093	0.021931265	0.00820	0.01949408	0.00093	-3.56	0.17295	T	0.0643	0.01788	B	0.000209254300804412	0.04287	0.13816178	0.69646	0.033	0.07179	.	.	.	.	.	.	-0.178575	0.0321	0.53	0.57826123189942369	0.05936	0.021994	0.01033	N	-1.75017022248378	0.00673	0.02929016	-1.70554440226488	0.01101	0.05002578	5.24	-1.16	0.09157	-8.68	0.00559	0.283	0.18669	-0.247000	0.10584	-1.852	0.00571	0.001	0.13799	0.000000	0.08389	0.003	0.0525	42	0.97870	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109368	0.000000e+00	0	1	208030	4.807000e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	13386	0.000000e+00	0	0	42760	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	1	16218	6.165990e-05	0	0	30504	0.000000e+00	0	0	6212	0.000000e+00	0	0	13400	0.000000e+00	0	0	16726	0.000000e+00	0	0	89504	0.000000e+00	0	0	30604	0.000000e+00	0	1	16218	6.165990e-05	0	1	14902	6.710510e-05	0	0	34242	0.000000e+00	0	0	9570	0.000000e+00	0	0	17678	0.000000e+00	0	0	21620	0.000000e+00	0	0	102668	0.000000e+00	0	0	30522	0.000000e+00	0	1	14902	6.710510e-05	0	.	6	1613616	3.718360e-06	0	1	29598	3.378610e-05	0	2	74908	2.669940e-05	0	0	912	0.000000e+00	0	0	59992	0.000000e+00	0	1	29598	3.378610e-05	0	0	44880	0.000000e+00	0	0	63982	0.000000e+00	0	0	6084	0.000000e+00	0	3	1179728	2.542960e-06	0	0	91058	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia_complementation_group_J	criteria_provided,_conflicting_classifications	NC_000017.11:g.61857211C>T	ClinGen:CA16615534	C0027672|C3661900|C0346153|C1836860	114480|609054	140162|227535|84	.	Val	Ile	402301	single nucleotide variant	NM_032043.3(BRIP1):c.226G>A (p.Val76Ile)	83990	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0	Nov 10, 2024	769573395	-	RCV000562576|RCV000473938|RCV002056711	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided	germline	germline	GRCh38	NC_000017.11	17	61857211	61857211	17q23.2	criteria provided, conflicting classifications	5	-	N	ClinGen:CA16615534	2	407851	61857211	C	T	-	-	-	-	-	-	SCV000547345|SCV000666205|SCV000911292|SCV002496263|SCV002531402	-	-	226G>A 	Val76Ile	NM_032043.3	1	3_Conflicting																																																																																																									
CCM2	CCM2_Glu54Lys	-0.21668852363692906	1.0	-1.1963637343410964	1.0	2025_01_Batch_13-14	0.8813954669615237	0.864799724226625	0.875930999195235	0.8107244583036942	0.8101609946383111	0.8587442143954428	0.8915444613855789	0.7926396742719674	0.8075933020999447	0.796434287433822	0.8700698406784833	0.8781720928061019	0.8342853367336012	0.8091588802018195	0.8032976410360666	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038622		NC_000007.14:45038382:G:A		Glu54Lys																												CCM2_Glu54Lys	7	45038382	G	A	7	allele	160G>A	A08	527_CAVA_Array_P06	A16	B13A7A8P2_R1	B14A7A8P2_R2				7-45038382-G-A	1054801	7	45038382	G	A	E	K	rs759104121	7	45077981	7	45044506	54	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.160G>A	p.Glu54Lys	c.160G>A	p.Glu54Lys	principal1	Y	1	YES	Select	+	GAG	1	0	G	G/G	G/G	G/G	G/G	0.012	0.54841	D	0.026	0.56982	D	0.986	0.61540	D	0.555	0.49370	P	0.09	0.58915	N	simple_aae	91.0	9.0	1.79	0.46598	L	-2.37	0.52471	N	0.468	0.50447	-0.7457	0.57983	T	0.1806	0.52564	T	10	0.38358703	0.54018	D	0.029413	0.51738	D	0.199	0.48047	.	.	.	.	.	0.603641259496	0.59744	.	0.32367	.	0.64258	0.667770028114	0.62459	T	0.145291	0.47953	T	-0.159928	0.26423	T	-0.270531	0.47432	T	0.341450542211533	0.26383	T	0.985835	0.95233	D	0.3745399	0.58590	0.26199895	0.51787	0.3745399	0.58591	0.26199895	0.51786	-13.81	0.94759	D	0.5152	0.69302	A	0.256263507198636	0.52490	0.95056190	0.93405	0.459	0.68744	.	.	.	.	.	.	5.305256	0.89078	29.8	0.99921559870460364	0.98788	0.923770	0.90042	D	0.736444553150161	0.81924	7.660593	0.76033862084588	0.86857	9.049166	5.36	5.36	0.76590	.	.	9.398	0.9664	11.438000	0.92769	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	740	0.53031	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	3	109362	2.743180e-05	0	4	208022	1.922870e-05	0	9	236832	3.800160e-05	0	0	7164	0.000000e+00	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13350	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	1	17110	5.844540e-05	0	0	16216	0.000000e+00	0	2	30522	6.552650e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16690	0.000000e+00	0	2	89494	2.234790e-05	0	0	30608	0.000000e+00	0	2	30522	6.552650e-05	0	0	14902	0.000000e+00	0	3	34258	8.757080e-05	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21588	0.000000e+00	0	6	102678	5.843510e-05	0	0	30526	0.000000e+00	0	3	34258	8.757080e-05	0	.	66	1614128	4.088900e-05	0	3	60024	4.998000e-05	0	1	75024	1.332910e-05	0	0	912	0.000000e+00	0	3	60024	4.998000e-05	0	0	29608	0.000000e+00	0	0	44886	0.000000e+00	0	0	63990	0.000000e+00	0	0	6062	0.000000e+00	0	57	1180036	4.830360e-05	0	1	91082	1.097910e-05	0	4	36640	1.091703056768559E-4	0	298	0	0	86	0	0	7458	0	0	494	0	0	628	0	0	26	0	0	98	0	0	6012	0	0	7756	0	0	112	0	4	51740	7.730962504831851E-5	Conflicting_classifications_of_pathogenicity	Inborn_genetic_diseases|Cerebral_cavernous_malformation_2	criteria_provided,_conflicting_classifications	NC_000007.14:g.45038382G>A	.	C0950123|C1864041	603284	221061	.	Glu	Lys	1044963	single nucleotide variant	NM_031443.4(CCM2):c.160G>A (p.Glu54Lys)	83605	CCM2	HGNC:21708	Conflicting classifications of pathogenicity	0	Sep 26, 2024	759104121	-	RCV003246944|RCV001363376	MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Inborn genetic diseases|Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45038382	45038382	7p13	criteria provided, conflicting classifications	2	-	N	ClinGen:CA4246883	2	1054801	45038382	G	A	-	-	-	-	-	-	SCV001559485|SCV003940435	-	-	160G>A 	Glu54Lys	NM_031443.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Thr86Ser	0.6181178087399735	1.0	5.0175118859098795	0.16041299799753767	2025_01_Batch_13-14	0.877835098278939	0.8789708501552077	0.8232441786861001	0.8414527796037204	0.7736362242226708	0.89084127255986	0.9221820024891599	0.893344135802224	0.88483779395539	0.8114198422374339	0.8843381854193995	0.9005764263221838	0.858294157244162	0.8631452867795553	0.7925280332300524	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038636		NC_000007.14:45063970:C:G		Thr86Ser																												CCM2_Thr86Ser	7	45063970	C	G	7	allele	257C>G	A10	527_CAVA_Array_P06	A20	B13A7A8P2_R1	B14A7A8P2_R2				7-45063970-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Val374Met	5.536261521639839	1.0	9.243442174089372	0.16448524465932826	2025_01_Batch_13-14	0.8713335103106564	0.8750755506248921	0.8693108695656445	0.8692619399489298	0.7785918931572171	0.848255413204102	0.8680389122253304	0.8459971904077848	0.7605630293691165	0.7806679497482036	0.8597944617573792	0.8715572314251112	0.8576540299867146	0.8149124846590231	0.7796299214527104	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038803		NC_000007.14:45075842:G:A		Val374Met																												CCM2_Val374Met	7	45075842	G	A	7	allele	1120G>A	D11	527_CAVA_Array_P07	H21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075842-G-A	1482493	7	45075842	G	A	V	M	rs200669376	7	45115441	7	45081966	374	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1120G>A	p.Val374Met	c.1120G>A	p.Val374Met	principal1	Y	1	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.003	0.76775	D	1.0	0.90580	D	0.948	0.68533	D	0.63	0.79151	D	simple_aae	37.0	63.0	2.015	0.54854	M	-1.52	0.39112	N	0.725	0.74257	-1.0286	0.20873	T	0.1010	0.37235	T	10	0.63563335	0.68489	D	0.023911	0.46675	T	0.271	0.58427	.	.	.	.	.	0.308278614506	0.30023	.	0.79926	.	0.73896	0.838439106941	0.87837	D	0.092014	0.38636	T	-0.0342262	0.46467	T	-0.179283	0.56288	T	0.701155004073279	0.40472	D	0.978402	0.92397	D	0.67676175	0.76533	0.43399978	0.66678	0.67676175	0.76535	0.43399978	0.66679	-8.465	0.64273	D	0.9271	0.84736	P	0.344076581307946	0.55809	0.96515500	0.94303	0.244	0.51390	.	.	.	.	.	.	5.249725	0.88155	29.5	0.99897651919516584	0.97050	0.843042	0.75921	D	0.694769125459198	0.79178	7.046533	0.649911028172494	0.78486	6.909817	4.67	4.67	0.58039	1.7	0.36309	5.092	0.64425	11.696000	0.94435	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.898	0.43497	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	9	264690	3.400204E-5	.	2	109394	1.828250e-05	0	3	207598	1.445100e-05	0	3	236810	1.266840e-05	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	2	42762	4.677050e-05	0	0	15690	0.000000e+00	0	2	42762	4.677050e-05	0	0	16174	0.000000e+00	0	0	30516	0.000000e+00	0	0	6180	0.000000e+00	0	0	13408	0.000000e+00	0	0	16728	0.000000e+00	0	3	89136	3.365640e-05	0	0	30604	0.000000e+00	0	3	89136	3.365640e-05	0	0	14886	0.000000e+00	0	0	34250	0.000000e+00	0	0	9564	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	3	102646	2.922670e-05	0	0	30526	0.000000e+00	0	3	102646	2.922670e-05	0	.	89	1613646	5.515460e-05	0	1	6084	1.643660e-04	0	0	74932	0.000000e+00	0	0	910	0.000000e+00	0	0	60006	0.000000e+00	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	1	63616	1.571930e-05	0	1	6084	1.643660e-04	0	84	1180032	7.118450e-05	0	1	91092	1.097790e-05	0	1	41134	2.43107891282151E-5	0	298	0	0	86	0	0	7458	0	0	500	0	0	628	0	0	26	0	0	98	0	0	6030	0	0	7756	0	0	112	0	1	56258	1.7775249742258878E-5	Uncertain_significance	Cerebral_cavernous_malformation_2|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.45075842G>A	.	C1864041|C0950123	603284	221061	Cerebral cavernous malformations 2, harmonin-homology domain|Cerebral cavernous malformations 2, harmonin-homology domain	Val	Met	1441860	single nucleotide variant	NM_031443.4(CCM2):c.1120G>A (p.Val374Met)	83605	CCM2	HGNC:21708	Uncertain significance	0	Dec 05, 2024	200669376	-	RCV001995652|RCV002573557|RCV004793671	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Cerebral cavernous malformation 2|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	45075842	45075842	7p13	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA4247266	2	1482493	45075842	G	A	-	-	-	-	-	-	SCV002276717|SCV003694308|SCV005409254	-	-	1120G>A 	Val374Met	NM_031443.4	2	4_VUS																																																																																																									
CCM2	CCM2_Ser166Ile	3.0874200476135756	1.0	12.498745789899274	0.05045004147222861	2025_01_Batch_13-14	0.8487583256880146	0.7824235517977263	0.8115894448838756	0.8170204927499984	0.7687849829148243	0.7829013595230785	0.7269948964272968	0.7502459310745541	0.6935893684566927	0.7233582736873996	0.8158298426055466	0.7547092241125115	0.7809176879792148	0.7553049306033456	0.746071628301112	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038689		NC_000007.14:45068467:G:T		Ser166Ile																												CCM2_Ser166Ile	7	45068467	G	T	7	allele	497G>T	E02	527_CAVA_Array_P07	J03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068467-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile76Met	3.320555892934314	1.0	4.2103348619923695	1.0	2025_01_Batch_13-14	0.8780000327465242	0.8664313255042909	0.8748916975354217	0.8578349570923112	0.681724372179019	0.7791296112548918	0.7766729985378699	0.6755638098209	0.6997387985288407	0.7393300465184262	0.828564822000708	0.8215521620210804	0.7752277536781609	0.778786877810576	0.7105272093487226	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038630		NC_000007.14:45063941:A:G		Ile76Met																												CCM2_Ile76Met	7	45063941	A	G	7	allele	228A>G	B09	527_CAVA_Array_P06	C18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063941-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Arg423Pro	-0.3439010423464959	1.0	8.34238862599393	0.0030888903389839333	2025_01_Batch_13-14	0.8209575943447599	0.9577271981884263	0.9791141309575099	0.9222362226983946	0.9134099624561621	0.7404755181720857	0.9411642968383783	0.9707043176674821	0.9137098040807797	0.8673406199828504	0.7807165562584228	0.9494457475134024	0.9749092243124959	0.9179730133895871	0.8903752912195062	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038840		NC_000007.14:45075990:G:C		Arg423Pro																												CCM2_Arg423Pro	7	45075990	G	C	7	allele	1268G>C	F02	527_CAVA_Array_P08	L04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075990-G-C	2242822	7	45075990	G	C	R	P	rs371640199	7	45115589	7	45082114	423	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1268G>C	p.Arg423Pro	c.1268G>C	p.Arg423Pro	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.003	0.76775	D	0.998	0.73231	D	0.93	0.66460	D	0.91	0.92786	D	simple_aae	9.0	91.0	2.36	0.67699	M	-3.64	0.73078	D	0.952	0.96202	-0.0853	0.80346	T	0.4554	0.78692	T	10	0.8404837	0.83027	D	0.232044	0.88275	D	0.499	0.78174	.	.	.	.	.	0.839648149646	0.83685	.	0.89610	.	0.80596	0.67018020153	0.62804	T	0.348832	0.71503	T	0.354374	0.86719	D	0.286743	0.87393	D	0.959103047847748	0.65227	D	0.968403	0.88541	D	0.8815152	0.89648	0.82457274	0.89701	0.8815152	0.89650	0.82457274	0.89702	-13.568	0.95133	D	0.9685	0.91363	P	0.928994411263463	0.78310	0.99640500	0.98046	0.816	0.89837	.	.	.	.	.	.	5.340602	0.89623	31.0	0.99711453532630756	0.81371	0.980140	0.99832	D	0.68704215930326	0.78670	6.941667	0.614228125840817	0.75840	6.406137	4.49	3.61	0.40424	2.56	0.46987	9.516	0.97049	9.784000	0.81642	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.999	0.91597	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	0	109298	0.000000e+00	0	2	206252	9.696880e-06	0	2	236174	8.468330e-06	0	0	7152	0.000000e+00	0	0	17100	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13360	0.000000e+00	0	0	42728	0.000000e+00	0	0	15682	0.000000e+00	0	.	.	.	.	0	16018	0.000000e+00	0	0	30476	0.000000e+00	0	0	6144	0.000000e+00	0	0	13382	0.000000e+00	0	0	16696	0.000000e+00	0	2	88118	2.269680e-05	0	0	30592	0.000000e+00	0	2	88118	2.269680e-05	0	0	14804	0.000000e+00	0	0	34232	0.000000e+00	0	0	9568	0.000000e+00	0	0	17690	0.000000e+00	0	0	21502	0.000000e+00	0	2	102254	1.955910e-05	0	0	30516	0.000000e+00	0	2	102254	1.955910e-05	0	.	8	1612976	4.959780e-06	0	1	74922	1.334720e-05	0	1	74922	1.334720e-05	0	0	910	0.000000e+00	0	0	60000	0.000000e+00	0	0	29608	0.000000e+00	0	0	44898	0.000000e+00	0	0	62976	0.000000e+00	0	0	6084	0.000000e+00	0	7	1180018	5.932110e-06	0	0	91084	0.000000e+00	0	0	26578	0	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4584	0	0	2918	0	0	112	0	0	35418	0	Uncertain_significance	not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.45075990G>C	.	C3661900|C0950123	.	.	.	Arg	Pro	2233113	single nucleotide variant	NM_031443.4(CCM2):c.1268G>C (p.Arg423Pro)	83605	CCM2	HGNC:21708	Uncertain significance	0	Sep 20, 2022	-1	-	RCV002732531|RCV003154279	MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	45075990	45075990	7p13	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA4247301	2	2242822	45075990	G	C	-	-	-	-	-	-	SCV003570264|SCV003842599	-	-	1268G>C 	Arg423Pro	NM_031443.4	2	4_VUS																																																																																																									
SDHD	SDHD_Ala90Val	3.9356948777612146	0.00674516202223278	1.0316194490045085	1.0	2025_01_Batch_13-14	0.7664720793721204	0.7787970486630793	0.7485959972249652	0.726195561365361	0.7396530881799547	0.641359679219435	0.7325650632500709	0.75415375541077	0.7141598576600099	0.6106354907409622	0.7039158792957777	0.7556810559565751	0.7513748763178676	0.7201777095126854	0.6751442894604585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023308		NC_000011.10:112088966:C:T		Ala90Val																												SDHD_Ala90Val	11	112088966	C	T	11	allele	269C>T	A12	527_CAVA_Array_P05	A23	B13A7A8P2_R1	B14A7A8P2_R2				11-112088966-C-T	412511	11	112088966	C	T	A	V	rs200255724	11	111959690	11	111464900	90	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.269C>T	p.Ala90Val	c.269C>T	p.Ala90Val	principal1	Y	1	YES	Select	+	GCG	2	0	C	./.	./.	./.	./.	0.458	0.15912	T	1.0	0.17298	T	0.006	0.13655	B	0.002	0.06938	B	0.13	0.45549	N	simple_aae	87.0	13.0	-0.4	0.02998	N	-0.49	0.18604	N	0.325	0.37474	-0.0242	0.81670	T	0.7223	0.90456	D	10	0.033454627	0.01525	T	0.039239	0.58532	D	0.538	0.80564	0.554	0.67018	O14521	A90V	Gain of catalytic residue at A90 (P = 0.0619)| Loss of glycosylation at S94 (P = 0.2021)| Loss of helix (P = 0.3949)| Gain of solvent accessibility (P = 0.4304)| Loss of sheet (P = 0.5184)	0.97841390163	0.97797	0.6562659735392878	0.65397	0.186988364634	0.20745	0.404172539711	0.25620	T	0.612815	0.87639	D	-0.096085	0.36716	T	0.0203817	0.71444	D	0.0642470002855991	0.07730	T	0.778722	0.41636	T	0.025199682	0.01422	0.04753903	0.06884	0.025199682	0.01422	0.04753903	0.06884	-3.974	0.23434	T	0.063	0.13138	B	0.0286794542137332	0.32439	0.96888520	0.94571	0.063	0.17447	.	.	.	.	.	.	1.598506	0.20471	14.75	0.96925041798389644	0.31823	0.374914	0.45781	N	-0.764187358777515	0.14078	0.7083525	-0.647685205617222	0.17985	0.9755563	5.04	1.52	0.22101	.	.	0.348	0.19856	-0.210000	0.10908	0.549	0.27038	0.03	0.20497	0.000000	0.08389	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	17	109406	1.553850e-04	0	32	208128	1.537520e-04	0	31	236928	1.308410e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	17	15690	1.083490e-03	0	17	15690	1.083490e-03	0	0	16218	0.000000e+00	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16734	0.000000e+00	0	2	89554	2.233290e-05	0	28	30608	9.147940e-04	0	28	30608	9.147940e-04	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	2	102728	1.946890e-05	0	28	30526	9.172510e-04	0	28	30526	9.172510e-04	0	.	119	1614014	7.372920e-05	1	101	91090	1.108790e-03	1	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	2	60008	3.332890e-05	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	15	1179998	1.271190e-05	0	101	91090	1.108790e-03	1	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|not_specified	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088966C>T	ClinGen:CA070974	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|CN169374	606864|171300	140162|97286|29072|201	.	Ala	Val	398394	single nucleotide variant	NM_003002.4(SDHD):c.269C>T (p.Ala90Val)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0	Nov 06, 2024	200255724	-	RCV000562410|RCV001584171|RCV001821298|RCV002230663	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Hereditary cancer-predisposing syndrome|not provided|not specified|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3	germline;unknown	germline	GRCh38	NC_000011.10	11	112088966	112088966	11q23.1	criteria provided, conflicting classifications	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070974	2	412511	112088966	C	T	-	-	-	-	-	-	SCV000554063|SCV000675115|SCV001811695|SCV002065336|SCV002774237	-	-	269C>T 	Ala90Val	NM_003002.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Glu366Gln	2.4522702545910287	1.0	2.9606272686861437	0.16168022240759106	2025_01_Batch_13-14	0.8833896366087067	0.9445227431272113	0.9430814447647435	0.9423350574057411	0.7705122504319296	0.8360062358425798	0.8485404296942335	0.7991782191118784	0.8543235681911813	0.7627935236524989	0.8596979362256433	0.8965315864107224	0.871129831938311	0.8983293127984612	0.7666528870422142	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038800		NC_000007.14:45075818:G:C		Glu366Gln																												CCM2_Glu366Gln	7	45075818	G	C	7	allele	1096G>C	B11	527_CAVA_Array_P07	D21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075818-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu290Lys	2.5162494776184734	1.0	6.412327669609529	1.0	2025_01_Batch_13-14	0.7939800438092178	0.7457979967033296	0.7945091967702617	0.7787475629287909	0.7535259876636325	0.7726084738958675	0.7554367426529175	0.8277563877904344	0.7447729137388582	0.7665935355845406	0.7832942588525427	0.7506173696781235	0.811132792280348	0.7617602383338246	0.7600597616240865	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038759		NC_000007.14:45073524:G:A		Glu290Lys																												CCM2_Glu290Lys	7	45073524	G	A	7	allele	868G>A	G08	527_CAVA_Array_P07	N15	B13A7A8P2_R1	B14A7A8P2_R2				7-45073524-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly407Asp	2.1977682214272956	1.0	3.9909635467728726	0.013363774915401532	2025_01_Batch_13-14	0.8856745280475824	0.9268910945045151	0.958820855313264	0.9056661986514077	0.7838290005633345	0.7732066439379877	0.8375793390689283	0.805571447375617	0.7714221848104298	0.6885289081326423	0.829440585992785	0.8822352167867218	0.8821961513444405	0.8385441917309188	0.7361789543479884	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038825		NC_000007.14:45075942:G:A		Gly407Asp																												CCM2_Gly407Asp	7	45075942	G	A	7	allele	1220G>A	G12	527_CAVA_Array_P07	N23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075942-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser202Asn	3.4711777742323595	1.0	8.664064048595863	0.08147200896921779	2025_01_Batch_13-14	0.8035795417731605	0.7696293047433178	0.8068400881922386	0.7842919230203859	0.7619145465093914	0.7048780421811179	0.7706631776185998	0.7450364579288299	0.6807153195096127	0.6662454808694813	0.7542287919771392	0.7701462411809588	0.7759382730605342	0.7325036212649993	0.7140800136894363	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038714		NC_000007.14:45068575:G:A		Ser202Asn																												CCM2_Ser202Asn	7	45068575	G	A	7	allele	605G>A	E04	527_CAVA_Array_P07	J07	B13A7A8P2_R1	B14A7A8P2_R2				7-45068575-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp410His	3.0462255582421904	1.0	9.421750503928658	1.0	2025_01_Batch_13-14	0.8276077339599168	0.777879511085493	0.7768564792736483	0.7910137412432778	0.7274299028250805	0.6806886663199411	0.6598046162987334	0.6083719754042519	0.6278599997419836	0.6295008565646074	0.7541482001399289	0.7188420636921132	0.6926142273389502	0.7094368704926307	0.6784653796948439	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038827		NC_000007.14:45075950:G:C		Asp410His																												CCM2_Asp410His	7	45075950	G	C	7	allele	1228G>C	B01	527_CAVA_Array_P08	D02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075950-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly214Cys	0.6219475979618732	1.0	9.651914731022455	0.0001382785100215331	2025_01_Batch_13-14	0.8375494283992176	0.8053362973045033	0.8707008733825291	0.8119791148468725	0.8051299043039736	0.7669271998546731	0.8473575128225727	0.9486231241470584	0.8180135020579464	0.7431401391194903	0.8022383141269454	0.8263469050635379	0.9096619987647938	0.8149963084524094	0.774135021711732	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038721		NC_000007.14:45069856:G:T		Gly214Cys																												CCM2_Gly214Cys	7	45069856	G	T	7	allele	640G>T	D05	527_CAVA_Array_P07	H09	B13A7A8P2_R1	B14A7A8P2_R2				7-45069856-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_His102Arg	4.23284378127999	0.003902401439764406	-4.0992567991501385	0.052371008319831956	2025_01_Batch_13-14	0.7646330805473627	0.8300745460760569	0.7906816420510188	0.8447132748304026	0.731416119505325	0.6939391861387718	0.7733546771280568	0.7555159861396368	0.6844357460076645	0.6874179832524896	0.7292861333430672	0.8017146116020568	0.7730988140953278	0.7645745104190336	0.7094170513789073	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023323		NC_000011.10:112089002:A:G		His102Arg																												SDHD_His102Arg	11	112089002	A	G	11	allele	305A>G	D12	527_CAVA_Array_P05	G23	B13A7A8P2_R1	B14A7A8P2_R2				11-112089002-A-G	656860	11	112089002	A	G	H	R	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>G	p.His102Arg	c.305A>G	p.His102Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.002	0.91343	D	0.005	0.92967	D	0.999	0.77914	D	0.96	0.70309	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.58	0.93458	H	-7.95	0.96333	D	0.981	0.99987	0.8464	0.94968	D	0.9986	0.99961	D	10	0.9932964	0.99869	D	0.668847	0.97228	D	0.925	0.98152	0.96	0.99581	O14521	H102R	Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1319)| Loss of catalytic residue at L101 (P = 0.168)| Gain of loop (P = 0.2045)| Gain of MoRF binding (P = 0.3566)	0.99569366784	0.99559	0.9941230044772663	0.99408	0.822716399301	0.67041	0.615795195103	0.55067	T	0.978249	0.99805	D	0.565929	0.96317	D	0.575142	0.96257	D	0.995160043239594	0.86836	D	0.931507	0.74447	D	0.95057625	0.96266	0.9087782	0.95540	0.93406326	0.94564	0.9051902	0.95282	-9.682	0.83515	D	0.8694	0.80800	P	0.9963025324275	0.92025	0.99930870	0.99288	0.993	0.99760	.	.	.	.	.	.	4.730387	0.76234	26.5	0.99595436499868495	0.73897	0.960222	0.98087	D	0.663599630439143	0.77127	6.639008	0.502772132901211	0.68002	5.184201	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	109408	0.000000e+00	0	1	208128	4.804740e-06	0	1	236948	4.220340e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	1	89552	1.116670e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102746	9.732740e-06	0	0	30526	0.000000e+00	0	1	102746	9.732740e-06	0	.	5	1614116	3.097670e-06	0	5	1180006	4.237270e-06	0	0	75020	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29608	0.000000e+00	0	0	44878	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	5	1180006	4.237270e-06	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>G	.	C0027672|C3494181|C1847319|CN166604|C0031511|C1868633	168000|606864|171300	140162|29072|97286|201|29072	.	His	Arg	639710	single nucleotide variant	NM_003002.4(SDHD):c.305A>G (p.His102Arg)	6392	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1	Dec 02, 2024	104894302	-	RCV001018360|RCV002538159|RCV004028788	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1	germline;unknown	germline	GRCh38	NC_000011.10	11	112089002	112089002	11q23.1	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071040	2	656860	112089002	A	G	-	-	-	-	-	-	SCV000953725|SCV001179586|SCV004933595	-	-	305A>G 	His102Arg	NM_003002.4	2	1_Pathogenic	11	112089002	A	G	3.42028e-6																																																																																																				
CCM2	CCM2_Ala149Thr	3.740941654337485	0.28784618721061805	4.0508341317772665	1.0	2025_01_Batch_13-14	0.8508243699552412	0.8111706124818702	0.834873144490475	0.8480422326984834	0.7352297929347912	0.6560968653041608	0.5640249676825297	0.613298875335802	0.5727889678674378	0.6027440288735594	0.753460617629701	0.6875977900821999	0.7240860099131385	0.7104156002829607	0.6689869109041753	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038681		NC_000007.14:45064619:G:A		Ala149Thr																												CCM2_Ala149Thr	7	45064619	G	A	7	allele	445G>A	G01	527_CAVA_Array_P07	N01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064619-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Phe34Cys	7.204566186715207	0.00017742529934530618	-1.9188547732241465	1.0	2025_01_Batch_13-14	0.8930240841096873	0.9110751086339479	0.8882816334753623	0.9395293461461559	0.8243090951965234	0.8539948588305041	0.8535434769328026	0.8550420940281295	0.8552886373350626	0.7965256524057183	0.8735094714700957	0.8823092927833753	0.8716618637517459	0.8974089917406092	0.8104173738011209	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023269		NC_000011.10:112087905:T:G		Phe34Cys																												SDHD_Phe34Cys	11	112087905	T	G	11	allele	101T>G	B11	527_CAVA_Array_P05	C21	B13A7A8P2_R1	B14A7A8P2_R2				11-112087905-T-G	135196	11	112087905	T	G	F	C	rs141802836	11	111958629	11	111463839	34	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.101T>G	p.Phe34Cys	c.101T>G	p.Phe34Cys	principal1	Y	1	YES	Select	+	TTT	2	0	T	./.	./.	./.	./.	0.081	0.78662	T	0.157	0.92967	T	0.953	0.54293	P	0.43	0.45391	B	0.13	0.52324	N	simple_aae	87.0	13.0	2.3	0.65510	M	-0.55	0.96333	N	0.622	0.70120	0.2199	0.86189	D	0.6593	0.88119	D	10	0.53285825	0.62974	D	0.151246	0.83237	D	0.691	0.88724	.	.	.	.	.	0.931227753352	0.92998	0.5560470912091142	0.55343	0.662533756427	0.58709	0.521012783051	0.41709	T	0.32663	0.69546	T	0.127906	0.66920	D	0.251929	0.85611	D	0.116020513204259	0.13859	T	0.860814	0.58949	D	0.08004188	0.18151	0.07223325	0.15552	0.08004188	0.18151	0.07223325	0.15552	-3.982	0.23555	T	0.1996	0.63627	B	0.144711279699783	0.46760	0.99037120	0.96789	0.241	0.51065	.	.	.	.	.	.	3.395206	0.47109	22.4	0.99261210856720172	0.57287	0.736750	0.68100	D	0.209532460011217	0.51422	3.345592	0.250926334821979	0.52455	3.443302	4.81	3.66	0.41042	.	.	2.022	0.40755	5.897000	0.50911	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.939	0.47934	635	0.64545	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	32	264690	1.2089614E-4	segdup	5	109398	4.570470e-05	0	8	208124	3.843860e-05	0	8	236946	3.376300e-05	0	3	7164	4.187600e-04	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	7164	4.187600e-04	0	6	16218	3.699590e-04	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16724	0.000000e+00	0	0	89558	0.000000e+00	0	0	30608	0.000000e+00	0	6	16218	3.699590e-04	0	6	14902	4.026310e-04	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	6	14902	4.026310e-04	0	.	44	1614066	2.726030e-05	0	38	75038	5.064100e-04	0	38	75038	5.064100e-04	0	0	912	0.000000e+00	0	3	60030	4.997500e-05	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179892	0.000000e+00	0	0	91088	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	2	2784	7.183908045977011E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	2	2898	6.901311249137336E-4	0	112	0	2	14050	1.4234875444839857E-4	Conflicting_classifications_of_pathogenicity	not_specified|Paragangliomas_1|not_provided|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|Hereditary_pheochromocytoma-paraganglioma|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112087905T>G	ClinGen:CA016754	CN169374|C3494181|C3661900|C0031511|C1847319|C1868633|CN166604|C1708353|C0027672	168000|171300|606864	29072|29072|97286|201|29072|140162	.	Phe	Cys	138935	single nucleotide variant	NM_003002.4(SDHD):c.101T>G (p.Phe34Cys)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0	Jan 23, 2025	141802836	-	RCV000122008|RCV000569765|RCV001545828|RCV003230259|RCV002228410|RCV003997358|RCV004748588	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|	not specified|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112087905	112087905	11q23.1	criteria provided, conflicting classifications	7	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016754	2	135196	112087905	T	G	-	-	-	-	-	-	SCV000287810|SCV000675108|SCV001765234|SCV003928129|SCV004845023	-	-	101T>G 	Phe34Cys	NM_003002.4	1	3_Conflicting																																																																																																									
SDHD	SDHD_His102Leu	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	0.8313680258033279	0.947252744964598	0.9658088804128862	0.9381400157371114	0.8279097867431578	0.9522927559250102	0.9267390341730586	0.9620227410524386	0.9527092880084899	0.863479764578817	0.891830390864169	0.9369958895688283	0.9639158107326624	0.9454246518728007	0.8456947756609874	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	SDHD	ENSG00000204370	5678	201957	CCSBVarC006160	ALE00006160	NC_000011.10:112089002:A:T	305A>T	His102Leu	CEGS2	CegsMutGDEh1014	D09	GDEhDisVCh_40066	F02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SDHD_His102Leu	11	112089002	A	T	11											11-112089002-A-T	6898	11	112089002	A	T	H	L	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>T	p.His102Leu	c.305A>T	p.His102Leu	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.001	0.91343	D	0.002	0.92967	D	0.999	0.77914	D	0.928	0.66273	D	0.99	0.99291	A	simple_aae	1.0	99.0	3.925	0.96220	H	-10.94	0.99269	D	0.946	0.98282	0.8082	0.94493	D	0.9985	0.99959	D	9	0.99472225	0.99961	D	0.795712	0.98395	D	0.909	0.97545	0.988	0.99876	O14521	H102L	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.994554434502	0.99442	0.9890505541009824	0.98896	0.822681584721	0.67039	0.580342292786	0.50068	T	0.976715	0.99780	D	0.566984	0.96335	D	0.576657	0.96276	D	0.999900341033936	0.99626	D	0.716128	0.45817	T	0.8378367	0.86274	0.7502163	0.85055	0.8351151	0.86080	0.7859342	0.87236	-9.818	0.80483	D	0.8306	0.78714	P	0.996540517566282	0.92238	0.99904233	0.99109	0.983	0.99413	.	.	.	.	.	.	4.855792	0.79446	27.1	0.96663677478836951	0.30834	0.948642	0.96033	D	0.654068949213661	0.76505	6.522557	0.496041743816457	0.67552	5.122925	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>T	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	171300|606864|168000	140162|201|29072|97286|29072	.	His	Leu	21937	single nucleotide variant	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	6392	SDHD	HGNC:10683	Pathogenic	1	Apr 08, 2024	104894302	-	RCV000007307|RCV000566289|RCV002228003	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112089002	112089002	11q23.1	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	3	6898	112089002	A	T	-	-	-	-	-	-	SCV000664577|SCV000762668	-	-	305A>T 	His102Leu	NM_003002.4	2	1_Pathogenic																																																																																																									
SDHD	SDHD_His102Leu	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	0.8313680258033279	0.947252744964598	0.9658088804128862	0.9381400157371114	0.8279097867431578	0.9522927559250102	0.9267390341730586	0.9620227410524386	0.9527092880084899	0.863479764578817	0.891830390864169	0.9369958895688283	0.9639158107326624	0.9454246518728007	0.8456947756609874	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023325		NC_000011.10:112089002:A:T		His102Leu																												SDHD_His102Leu	11	112089002	A	T	11	allele	305A>T	E12	527_CAVA_Array_P05	I23	B13A7A8P2_R1	B14A7A8P2_R2				11-112089002-A-T	6898	11	112089002	A	T	H	L	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>T	p.His102Leu	c.305A>T	p.His102Leu	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.001	0.91343	D	0.002	0.92967	D	0.999	0.77914	D	0.928	0.66273	D	0.99	0.99291	A	simple_aae	1.0	99.0	3.925	0.96220	H	-10.94	0.99269	D	0.946	0.98282	0.8082	0.94493	D	0.9985	0.99959	D	9	0.99472225	0.99961	D	0.795712	0.98395	D	0.909	0.97545	0.988	0.99876	O14521	H102L	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.994554434502	0.99442	0.9890505541009824	0.98896	0.822681584721	0.67039	0.580342292786	0.50068	T	0.976715	0.99780	D	0.566984	0.96335	D	0.576657	0.96276	D	0.999900341033936	0.99626	D	0.716128	0.45817	T	0.8378367	0.86274	0.7502163	0.85055	0.8351151	0.86080	0.7859342	0.87236	-9.818	0.80483	D	0.8306	0.78714	P	0.996540517566282	0.92238	0.99904233	0.99109	0.983	0.99413	.	.	.	.	.	.	4.855792	0.79446	27.1	0.96663677478836951	0.30834	0.948642	0.96033	D	0.654068949213661	0.76505	6.522557	0.496041743816457	0.67552	5.122925	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>T	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	171300|606864|168000	140162|201|29072|97286|29072	.	His	Leu	21937	single nucleotide variant	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	6392	SDHD	HGNC:10683	Pathogenic	1	Apr 08, 2024	104894302	-	RCV000007307|RCV000566289|RCV002228003	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112089002	112089002	11q23.1	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	3	6898	112089002	A	T	-	-	-	-	-	-	SCV000664577|SCV000762668	-	-	305A>T 	His102Leu	NM_003002.4	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Ala405Ser	1.8017483584790188	1.0	9.21150344682097	0.00017255341456105602	2025_01_Batch_13-14	0.8995997094616511	0.9352903375504438	0.9558139965484268	0.9203224490874541	0.8273008676018744	0.7091493441900338	0.8687205527695214	0.9380979818683115	0.8718697911557426	0.6547958003781928	0.8043745268258424	0.9020054451599826	0.9469559892083692	0.8960961201215983	0.7410483339900336	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038824		NC_000007.14:45075935:G:T		Ala405Ser																												CCM2_Ala405Ser	7	45075935	G	T	7	allele	1213G>T	F12	527_CAVA_Array_P07	L23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075935-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser164Phe	3.38195655212955	0.2403649768559846	6.576821629379306	0.03374111932409388	2025_01_Batch_13-14	0.9846004049735231	0.890684087621429	0.86573037123843	0.9205190303733387	0.974059093749872	0.7717946233515673	0.8570462185117425	0.7964820454225408	0.7731140022278594	0.7183497571779979	0.8781975141625452	0.8738651530665857	0.8311062083304854	0.8468165163005991	0.8462044254639349	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038686		NC_000007.14:45068461:C:T		Ser164Phe																												CCM2_Ser164Phe	7	45068461	C	T	7	allele	491C>T	B02	527_CAVA_Array_P07	D03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068461-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Ser68Gly	6.045343083600106	0.0007737129719721013	0.011366001524099723	1.0	2025_01_Batch_13-14	0.81903851669005	0.8837958005716589	0.8233262997117662	0.8905435213901371	0.7668257119115635	0.7747656332563092	0.8149245968509216	0.810321897022911	0.839414790220858	0.6861559920661408	0.7969020749731797	0.8493601987112902	0.8168240983673386	0.8649791558054976	0.7264908519888521	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023282		NC_000011.10:112088899:A:G		Ser68Gly																												SDHD_Ser68Gly	11	112088899	A	G	11	allele	202A>G	E11	527_CAVA_Array_P05	I21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088899-A-G	1692740	11	112088899	A	G	S	G	rs2135269276	11	111959623	11	111464833	68	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.202A>G	p.Ser68Gly	c.202A>G	p.Ser68Gly	principal1	Y	1	YES	Select	+	AGC	1	0	A	./.	./.	./.	./.	0.976	0.05990	T	0.707	0.07740	T	0.001	0.07480	B	0.001	0.04348	B	0.13	0.33788	N	simple_aae	87.0	13.0	0.415	0.12397	N	-1.06	0.30311	N	0.309	0.34641	0.1300	0.84642	D	0.6363	0.87225	D	10	0.27792534	0.44975	D	0.027744	0.50323	D	0.589	0.83500	0.323	0.30252	O14521	S68G	Loss of disorder (P = 0.1141)| Loss of stability (P = 0.2528)| Loss of phosphorylation at S68 (P = 0.2631)| Gain of catalytic residue at T67 (P = 0.2736)| Loss of loop (P = 0.2897)	0.983747050717	0.98339	0.6418887932230426	0.63954	0.171667858329	0.19059	0.347676306963	0.17562	T	0.705796	0.91487	D	0.153806	0.69403	D	-0.016845	0.69011	D	0.118915073573589	0.14142	T	0.819918	0.49610	T	0.04305329	0.06580	0.04685765	0.06638	0.04305329	0.06580	0.04685765	0.06637	-1.587	0.38256	T	0.0495	0.00860	B	0.109295900523767	0.44137	0.97679627	0.95218	0.145	0.37545	.	.	.	.	.	.	1.080037	0.1465	11.19	0.73018468418494142	0.10342	0.321938	0.42266	N	-0.922609032286981	0.10190	0.4922996	-0.794832955240867	0.14373	0.7649354	5.04	-5.0	0.02780	.	.	0.898	0.2813	1.446000	0.26652	0.691	0.84104	0.885	0.31181	0.972000	0.29889	0.998	0.85369	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612668	6.200900e-07	0	1	91012	1.098760e-05	0	0	74984	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29606	0.000000e+00	0	0	44870	0.000000e+00	0	0	64046	0.000000e+00	0	0	4916	0.000000e+00	0	0	1179934	0.000000e+00	0	1	91012	1.098760e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088899A>G	.	C0027672	.	140162	.	Ser	Gly	1685180	single nucleotide variant	NM_003002.4(SDHD):c.202A>G (p.Ser68Gly)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0	Apr 16, 2024	2135269276	-	RCV002257333|RCV004804413	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112088899	112088899	11q23.1	criteria provided, conflicting classifications	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617218	2	1692740	112088899	A	G	-	-	-	-	-	-	SCV002527119|SCV004051962|SCV005424122	-	-	202A>G 	Ser68Gly	NM_003002.4	1	3_Conflicting																																																																																																									
FARS2	FARS2_Ala166Thr	1.7169263893776356	1.0	-1.6391975750498469	0.2876744818638418	2025_01_Batch_13-14	0.4713106607706262	0.6370303960480233	0.6270861144226683	0.6699912261170724	0.41871075186739654	0.630837315503083	0.6479839477667335	0.6696845627362428	0.7365212452649857	0.5198577825811788	0.5510739881368546	0.6425071719073784	0.6483853385794556	0.703256235691029	0.4692842672242876	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011877		NC_000006.12:5369066:G:A		Ala166Thr																												FARS2_Ala166Thr	6	5369066	G	A	6	allele	496G>A	D01	527_CAVA_Array_P03	H01	B13A7A8P1_R1	B14A7A8P1_R2				6-5369066-G-A	214328	6	5369066	G	A	A	T	rs764932724	6	5369299	6	5314298	166	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.496G>A	p.Ala166Thr	c.496G>A	p.Ala166Thr	principal1	Y	1	.	.	+	GCG	1	0	G	G/G	G/G	G/G	G/G	0.349	0.12418	T	0.319	0.19439	T	0.789	0.44584	P	0.273	0.40008	B	0.1	0.28107	N	simple_aae	90.0	10.0	1.57	0.39465	L	-1.32	0.32965	N	0.253	0.28534	-1.0287	0.20841	T	0.0493	0.20874	T	10	0.12830508	0.24112	T	0.014536	0.34468	T	0.060	0.17153	0.351	0.34780	O95363	A166T	Loss of helix (P = 0.0196)| Gain of loop (P = 0.069)| Loss of stability (P = 0.0942)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.3125)	0.653491938199	0.64789	0.5003925295663422	0.49766	0.172407162635	0.19145	0.372067689896	0.21105	T	0.063676	0.31993	T	-0.340643	0.05166	T	-0.55124	0.16906	T	0.152796268463135	0.17108	T	.	0.43452	.	0.06440483	0.13537	0.10302442	0.24659	0.08581967	0.19742	0.10970226	0.26384	-6.934	0.53619	T	0.0898	0.12616	LB	0.20033392600971	0.49936	0.15600365	0.70784	0.037	0.08577	.	.	.	.	.	.	0.792367	0.11648	8.215	0.99410883744534362	0.63313	0.116843	0.22702	N	-0.396344597065005	0.25323	1.390813	-0.454383794869487	0.23109	1.27738	5.68	1.35	0.21027	-0.754	0.16971	0.428	0.2119	2.603000	0.33615	-0.675	0.04283	0.339	0.25753	0.998000	0.34068	0.571	0.30719	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109328	1.829360e-05	0	4	207998	1.923100e-05	0	5	236750	2.111930e-05	0	0	7164	0.000000e+00	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13314	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	2	17112	1.168770e-04	0	0	16210	0.000000e+00	0	2	30522	6.552650e-05	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16654	0.000000e+00	0	2	89522	2.234090e-05	0	0	30606	0.000000e+00	0	2	30522	6.552650e-05	0	0	14902	0.000000e+00	0	2	34260	5.837710e-05	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21552	0.000000e+00	0	3	102636	2.922950e-05	0	0	30526	0.000000e+00	0	2	34260	5.837710e-05	0	.	18	1614038	1.115220e-05	0	3	6062	4.948860e-04	0	0	75018	0.000000e+00	0	0	912	0.000000e+00	0	2	60022	3.332110e-05	0	0	29606	0.000000e+00	0	0	44876	0.000000e+00	0	0	63952	0.000000e+00	0	3	6062	4.948860e-04	0	11	1180016	9.321910e-06	0	1	91064	1.098130e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Combined_oxidative_phosphorylation_defect_type_14|not_specified	criteria_provided,_conflicting_classifications	NC_000006.12:g.5369066G>A	ClinGen:CA322451	C4755312|CN169374	614946	319519	Phenylalanyl-tRNA synthetase	Ala	Thr	211251	single nucleotide variant	NM_006567.5(FARS2):c.496G>A (p.Ala166Thr)	10667	FARS2	HGNC:21062	Conflicting classifications of pathogenicity	0	May 06, 2024	764932724	-	RCV000197977|RCV001853177	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5369066	5369066	6p25.1	criteria provided, conflicting classifications	2	-	N	ClinGen:CA322451	2	214328	5369066	G	A	-	-	-	-	-	-	SCV000251368|SCV002217538	-	-	496G>A 	Ala166Thr	NM_006567.5	1	3_Conflicting																																																																																																									
CCM2	CCM2_Pro165Ala	7.5753372000252694	1.0	14.988397904923183	0.00025427994940822044	2025_01_Batch_13-14	0.7918468416465446	0.9155895305703673	0.9067509825154715	0.9055414988004696	0.7059840702306358	0.7365715492510394	0.8617276628790556	0.9127221942890235	0.8273766065626831	0.7228822061467445	0.764209195448792	0.8886585967247114	0.9097365884022475	0.8664590526815763	0.7144331381886901	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038688		NC_000007.14:45068463:C:G		Pro165Ala																												CCM2_Pro165Ala	7	45068463	C	G	7	allele	493C>G	D02	527_CAVA_Array_P07	H03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068463-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_His135Asp	2.635252319289227	1.0	-1.036882426271927	1.0	2025_01_Batch_13-14	0.7853086066618791	0.6754433308184951	0.664676040723288	0.8122260731565495	0.569307399872398	0.6404895598553311	0.6260270377742088	0.6013170955941902	0.6686704150526575	0.5496618618560352	0.7128990832586051	0.6507351842963519	0.6329965681587391	0.7404482441046034	0.5594846308642165	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011938		NC_000006.12:5368973:C:G		His135Asp																												FARS2_His135Asp	6	5368973	C	G	6	allele	403C>G	H12	527_CAVA_Array_P02	O24	B13A7A8P1_R1	B14A7A8P1_R2				6-5368973-C-G	214339	6	5368973	C	G	H	D	rs1554169353	6	5369206	6	5314205	135	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.403C>G	p.His135Asp	c.403C>G	p.His135Asp	principal1	Y	1	.	.	+	CAC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.485	0.98910	H	-8.41	0.97166	D	0.959	0.96886	0.5303	0.90933	D	0.6251	0.86770	D	10	0.9888847	0.99321	D	0.373027	0.92777	D	0.882	0.96531	0.912	0.98259	O95363	H135D	Gain of ubiquitination at K140 (P = 0.0395)| Gain of methylation at K140 (P = 0.0835)| Gain of phosphorylation at S137 (P = 0.1076)| Gain of disorder (P = 0.1088)| Gain of relative solvent accessibility (P = 0.1571)	0.967068046118	0.96641	0.9676189548153906	0.96731	0.789096686981	0.65457	0.638907074928	0.58343	T	0.608311	0.87433	D	0.392218	0.89385	D	0.325617	0.89250	D	0.999627828598022	0.98192	D	.	0.69489	.	0.9517225	0.96384	0.93154466	0.97160	0.93853235	0.95023	0.92687786	0.96834	-9.08	0.68288	D	0.9357	0.85478	LP	0.999854978671078	0.98365	0.97500426	0.95060	0.978	0.99209	.	.	.	.	.	.	4.904405	0.80679	27.4	0.99386437466063282	0.62166	0.882442	0.80986	D	1.00590361464167	0.95901	14.10817	0.89920352941961	0.95512	13.71825	5.38	5.38	0.77246	.	.	7.564	0.81354	7.594000	0.61402	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.67	0.33292	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5368973C>G	.	C4755312	614946	319519	Phenylalanyl-tRNA synthetase	His	Asp	211250	single nucleotide variant	NM_006567.5(FARS2):c.403C>G (p.His135Asp)	10667	FARS2	HGNC:21062	Likely pathogenic	1	Jun 13, 2018	1554169353	-	RCV000714939	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368973	5368973	6p25.1	criteria provided, single submitter	1	-	N	ClinGen:CA321889	2	214339	5368973	C	G	-	-	-	-	-	-	SCV000845706	-	-	403C>G 	His135Asp	NM_006567.5	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Leu212Val	1.918548300777739	1.0	10.06646402279967	0.05708195474909338	2025_01_Batch_13-14	0.8427635012071999	0.804289138926686	0.8023557956072581	0.8386666802497972	0.7699489795326765	0.7841843355938374	0.8740153386044276	0.821583515535836	0.7649216489107782	0.7648534982654213	0.8134739184005186	0.8391522387655568	0.811969655571547	0.8017941645802877	0.7674012388990489	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038720		NC_000007.14:45069850:C:G		Leu212Val																												CCM2_Leu212Val	7	45069850	C	G	7	allele	634C>G	C05	527_CAVA_Array_P07	F09	B13A7A8P2_R1	B14A7A8P2_R2				7-45069850-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BRIP1	BRIP1_Ser520Thr	0.371993516515847	0.7214710962483611	0.7464293414885849	0.5681293449170272	2025_01_Batch_13-14	0.7296687083203657	0.6929974826337902	0.6576451968220566	0.6362999541312206	0.688999708379693	0.7470475012567772	0.7430743432933519	0.7208467243012086	0.7157303902993957	0.6802472179360314	0.7383581047885714	0.718035912963571	0.6892459605616326	0.6760151722153082	0.6846234631578623	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1		55128		CCSBVarC031368		NC_000017.11:61784339:C:G		Ser520Thr																												BRIP1_Ser520Thr	17	61784339	C	G	17	allele	1559G>C	D12	527_CAVA_Array_P01	G23	B13A7A8P1_R1	B14A7A8P1_R2				17-61784339-C-G	1679010	17	61784339	C	G	S	T	rs757629526	17	59861700	17	57216482	520	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.1559G>C	p.Ser520Thr	principal2	Y	.	.	.	-	AGT	2	0	C	C/C	C/C	C/C	C/C	.	0.35312	.	.	0.25277	.	0.997	0.70687	D	0.985	0.76461	D	.	.	.	.	.	.	2.77	0.80725	M	.	0.47017	.	.	0.33568	0.2150	0.86105	D	0.5977	0.85609	D	9	.	0.52780	.	0.242835	0.88750	D	.	0.70117	0.37	0.37869	Q9BX63	S520T	Gain of loop (P = 0.0435)| Loss of helix (P = 0.079)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.099)| Gain of glycosylation at S520 (P = 0.1371)	.	0.88833	.	0.68862	.	0.43011	0.593239068985	0.51884	T	0.189817	0.54192	T	-0.00666905	0.50407	T	-0.150502	0.58913	T	0.951732993125916	0.63403	D	0.758424	0.38019	T	0.33792168	0.55782	0.27921516	0.53680	0.33792168	0.55782	0.27921516	0.53679	-8.391	0.63781	D	.	0.17342	.	0.273335049405932	0.53188	0.92831135	0.92318	0.238	0.50735	.	.	.	.	.	.	3.879663	0.56457	23.7	0.99605583092882555	0.74486	0.663288	0.63154	D	0.718735528270629	0.80755	7.388994	0.687325371777153	0.81314	7.521477	5.37	5.37	0.76916	.	.	4.902	0.63037	4.818000	0.45172	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	49	0.97674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109392	0.000000e+00	0	1	208056	4.806400e-06	0	1	236844	4.222190e-06	0	0	7160	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89510	0.000000e+00	0	1	30600	3.267970e-05	0	1	30600	3.267970e-05	0	0	14898	0.000000e+00	0	0	34244	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102680	0.000000e+00	0	1	30518	3.276750e-05	0	1	30518	3.276750e-05	0	.	1	1613166	6.198990e-07	0	1	91054	1.098250e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29600	0.000000e+00	0	0	44820	0.000000e+00	0	0	64020	0.000000e+00	0	0	6032	0.000000e+00	0	0	1179258	0.000000e+00	0	1	91054	1.098250e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_breast_ovarian_cancer_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.61784339C>G	.	C0677776	.	145	.	Ser	Thr	1670804	single nucleotide variant	NM_032043.3(BRIP1):c.1559G>C (p.Ser520Thr)	83990	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0	Jan 20, 2025	757629526	-	RCV002226323|RCV005225570	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61784339	61784339	17q23.2	criteria provided, conflicting classifications	2	-	N	ClinGen:CA8690715	2	1679010	61784339	C	G	-	-	-	-	-	-	SCV002505035|SCV005863038	-	-	1559G>C 	Ser520Thr	NM_032043.3	1	3_Conflicting																																																																																																									
CCM2	CCM2_Pro165Thr	1.6879089382785049	1.0	8.76706613087107	1.0	2025_01_Batch_13-14	0.7685940206785458	0.7981126452451881	0.8439093041565969	0.8127488594485652	0.6916817111106012	0.7274774890534288	0.8135256216283786	0.7219224900086136	0.723273541725407	0.6858313429592846	0.7480357548659873	0.8058191334367834	0.7829158970826053	0.7680112005869861	0.688756527034943	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038687		NC_000007.14:45068463:C:A		Pro165Thr																												CCM2_Pro165Thr	7	45068463	C	A	7	allele	493C>A	C02	527_CAVA_Array_P07	F03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068463-C-A	1744254	7	45068463	C	A	P	T	.	7	45108062	7	45074587	165	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.493C>A	p.Pro165Thr	c.493C>A	p.Pro165Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.124	0.54136	T	0.99	0.63438	D	0.858	0.61121	P	0.79	0.86984	D	simple_aae	21.0	79.0	2.43	0.70264	M	-1.64	0.41044	N	0.788	0.88895	-0.6943	0.60539	T	0.2097	0.56771	T	10	0.77626044	0.77262	D	0.036443	0.56828	D	0.221	0.51503	0.472	0.54563	Q9BSQ5	P165T	Loss of phosphorylation at S164 (P = 0.1236)| Loss of loop (P = 0.1258)| Loss of disorder (P = 0.1877)| Loss of glycosylation at P165 (P = 0.1937)| Gain of catalytic residue at S164 (P = 0.2988)	0.62662319709	0.62068	.	0.58154	.	0.75870	0.769790291786	0.77352	T	0.154296	0.49286	T	0.200399	0.73735	D	0.0500834	0.73392	D	0.957652747631073	0.64846	D	0.940956	0.77880	D	0.23243222	0.45704	0.18815462	0.41944	0.23243222	0.45704	0.18815462	0.41943	-3.684	0.19393	T	0.2917	0.61364	B	0.352545047965017	0.56101	0.97508687	0.95068	0.406	0.65085	.	.	.	.	.	.	4.980549	0.8253	27.8	0.99820957980014635	0.90422	0.881441	0.80810	D	0.636695259881321	0.75378	6.318806	0.624734438970673	0.76612	6.547179	4.68	4.68	0.58268	2.68	0.49003	7.162	0.77143	7.505000	0.59604	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1614192	3.717030e-06	0	5	1180040	4.237140e-06	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29608	0.000000e+00	0	0	44876	0.000000e+00	0	0	64030	0.000000e+00	0	0	6060	0.000000e+00	0	5	1180040	4.237140e-06	0	0	91088	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45068463C>A	.	C0950123	.	.	PTB/PI domain	Pro	Thr	1799150	single nucleotide variant	NM_031443.4(CCM2):c.493C>A (p.Pro165Thr)	83605	CCM2	HGNC:21708	Uncertain significance	0	Nov 29, 2021	-1	-	RCV002342672	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45068463	45068463	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367430238	2	1744254	45068463	C	A	-	-	-	-	-	-	SCV002643885	-	-	493C>A 	Pro165Thr	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Ala123Val	0.43185424078754747	1.0	0.372728697534314	1.0	2025_01_Batch_13-14	0.9030213875134377	0.8671395493219555	0.8684333690526072	0.8486867698853856	0.8188734867000954	0.8473120325455243	0.7670917273416421	0.7740618921532129	0.8179150701568323	0.8153595716049051	0.8751667100294811	0.8171156383317988	0.82124763060291	0.833300920021109	0.8171165291525002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038659		NC_000007.14:45064542:C:T		Ala123Val																												CCM2_Ala123Val	7	45064542	C	T	7	allele	368C>T	A12	527_CAVA_Array_P06	A24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064542-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Ile388Ser	1.0162955675066876	1.0	-4.23530096770175	0.007658698829097526	2025_01_Batch_13-14	0.6256694420392738	0.7512853222117405	0.8307693779158166	0.7678373906321424	0.6186307284129027	0.4460281175979493	0.7229202849838836	0.8613571204353483	0.7762661569413991	0.43800721167840495	0.5358487798186116	0.737102803597812	0.8460632491755824	0.7720517737867707	0.5283189700456539	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011922		NC_000006.12:5613266:T:G		Ile388Ser																												FARS2_Ile388Ser	6	5613266	T	G	6	allele	1163T>G	D12	527_CAVA_Array_P02	G24	B13A7A8P1_R1	B14A7A8P1_R2				6-5613266-T-G	488516	6	5613266	T	G	I	S	rs1407198979	6	5613499	6	5558498	388	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1163T>G	p.Ile388Ser	c.1163T>G	p.Ile388Ser	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.002	0.79703	D	0.714	0.42184	P	0.367	0.43429	B	.	.	.	.	.	.	2.125	0.58867	M	-4.96	0.82015	D	0.84	0.83632	-0.4338	0.70810	T	0.2675	0.63745	T	10	0.8248781	0.81483	D	0.051707	0.64640	D	0.511	0.78922	0.559	0.67707	O95363	I388S	Loss of stability (P = 0.0161)| Gain of disorder (P = 0.0363)| Gain of glycosylation at I388 (P = 0.0591)| Gain of helix (P = 0.0854)| Gain of relative solvent accessibility (P = 0.09)	0.935486347505	0.93431	.	0.78077	.	0.44430	0.315835446119	0.12779	T	0.571252	0.85676	D	0.0869603	0.62581	D	-0.112864	0.62116	T	0.979173302650452	0.72507	D	0.978802	0.92613	D	0.7625783	0.81381	0.80076313	0.88169	0.80483794	0.84016	0.7604622	0.85673	-13.402	0.90970	D	0.2564	0.49112	B	0.980686339579557	0.85480	0.83609140	0.89259	0.977	0.99166	.	.	.	.	.	.	4.872277	0.79869	27.2	0.99235441243343336	0.56442	0.866864	0.78564	D	0.407863502934099	0.61656	4.392269	0.462304649405172	0.65325	4.833016	5.53	5.53	0.82506	3.23	0.58548	7.299	0.78213	6.134000	0.54028	0.665	0.62996	0.997	0.40243	0.978000	0.30284	0.903	0.43926	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5613266T>G	ClinGen:CA362736964	C4755312	614946	319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Ile	Ser	481384	single nucleotide variant	NM_006567.5(FARS2):c.1163T>G (p.Ile388Ser)	10667	FARS2	HGNC:21062	Likely pathogenic	1	Nov 15, 2017	1407198979	-	RCV000578458	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613266	5613266	6p25.1	criteria provided, single submitter	1	-	N	ClinGen:CA362736964	2	488516	5613266	T	G	-	-	-	-	-	-	SCV000680228	-	-	1163T>G 	Ile388Ser	NM_006567.5	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Thr222Met	2.385058078762126	1.0	9.484319817457575	0.15120549933460545	2025_01_Batch_13-14	0.8309607874358647	0.8882467254318983	0.8523251527451926	0.8413475636186526	0.7671886101334318	0.8617591997739303	0.8594445670168106	0.8016529909316533	0.7866035556571092	0.821312393409362	0.8463599936048976	0.8738456462243545	0.826989071838423	0.8139755596378808	0.7942505017713969	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038727		NC_000007.14:45069881:C:T		Thr222Met																												CCM2_Thr222Met	7	45069881	C	T	7	allele	665C>T	B06	527_CAVA_Array_P07	D11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069881-C-T	1501181	7	45069881	C	T	T	M	rs370245890	7	45109480	7	45076005	222	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.665C>T	p.Thr222Met	c.665C>T	p.Thr222Met	principal1	Y	1	YES	Select	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.029	0.47069	D	0.048	0.49742	D	1.0	0.90580	D	0.979	0.74458	D	0.7	0.87470	D	simple_aae	30.0	70.0	2.2	0.61826	M	-3.22	0.66580	D	0.877	0.87898	-0.3089	0.74623	T	0.3568	0.71818	T	10	0.7749148	0.77157	D	0.049874	0.63866	D	0.336	0.65636	.	.	.	.	.	0.716792763484	0.71205	.	0.59095	.	0.73591	0.773486018181	0.77907	T	0.418491	0.76916	T	0.115501	0.65674	D	0.131732	0.78850	D	0.677253246307373	0.39359	D	0.987401	0.95725	D	0.24155386	0.46743	0.18725671	0.41802	0.24155386	0.46743	0.18725671	0.41801	-9.519	0.71056	D	0.4439	0.67505	A	0.117593642991584	0.44814	0.97817165	0.95343	0.527	0.73171	.	.	.	.	.	.	5.016553	0.83377	28.0	0.99918125559922299	0.98587	0.880913	0.80719	D	0.790186908833709	0.85407	8.590804	0.75619866640505	0.86547	8.947827	5.32	5.32	0.75341	2.14	0.41296	6.057	0.70813	4.765000	0.44816	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	4	109384	3.656840e-05	0	9	208088	4.325090e-05	0	12	236928	5.064830e-05	0	1	7164	1.395870e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13370	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	1	7164	1.395870e-04	0	1	16218	6.165990e-05	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16710	0.000000e+00	0	8	89536	8.934950e-05	0	0	30608	0.000000e+00	0	8	89536	8.934950e-05	0	1	14902	6.710510e-05	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21606	0.000000e+00	0	11	102752	1.070540e-04	0	0	30526	0.000000e+00	0	11	102752	1.070540e-04	0	.	141	1614084	8.735600e-05	0	131	1180040	1.110130e-04	0	3	74944	4.002990e-05	0	0	912	0.000000e+00	0	1	60006	1.666500e-05	0	0	29606	0.000000e+00	0	0	44900	0.000000e+00	0	0	64012	0.000000e+00	0	0	6084	0.000000e+00	0	131	1180040	1.110130e-04	0	0	91094	0.000000e+00	0	3	42730	7.020828457758016E-5	0	306	0	0	112	0	0	8044	0	0	500	0	0	628	0	0	56	0	0	98	0	0	8296	0	0	8350	0	0	168	0	3	60770	4.9366463715649167E-5	Conflicting_classifications_of_pathogenicity	not_provided|Inborn_genetic_diseases|Cerebral_cavernous_malformation_2	criteria_provided,_conflicting_classifications	NC_000007.14:g.45069881C>T	.	C3661900|C0950123|C1864041	603284	221061	PTB/PI domain	Thr	Met	1401929	single nucleotide variant	NM_031443.4(CCM2):c.665C>T (p.Thr222Met)	83605	CCM2	HGNC:21708	Conflicting classifications of pathogenicity	0	Jul 20, 2023	370245890	-	RCV002017274|RCV002642131|RCV003222377	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Cerebral cavernous malformation 2|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	45069881	45069881	7p13	criteria provided, conflicting classifications	3	-	N	ClinGen:CA4247056	2	1501181	45069881	C	T	-	-	-	-	-	-	SCV002295736|SCV003721183|SCV003918582	-	-	665C>T 	Thr222Met	NM_031443.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Val255Leu	2.017920615951734	1.0	4.967421138462774	1.0	2025_01_Batch_13-14	0.8119463257529808	0.7368137324632159	0.8155076235287987	0.8400451869968067	0.7872185759833883	0.8003595454084994	0.7404185947396771	0.753444414783472	0.7729094621374619	0.800047629298724	0.8061529355807401	0.7386161636014466	0.7844760191561353	0.8064773245671344	0.7936331026410561	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038741		NC_000007.14:45072743:G:T		Val255Leu																												CCM2_Val255Leu	7	45072743	G	T	7	allele	763G>T	G07	527_CAVA_Array_P07	N13	B13A7A8P2_R1	B14A7A8P2_R2				7-45072743-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr394Ser	1.2775621148515899	1.0	5.209646626989591	1.0	2025_01_Batch_13-14	0.9112715825211285	0.9264438959766365	0.9196564678275424	0.9247765392693418	0.8147817109392924	0.7806547585039488	0.8639711382094571	0.8128650729111396	0.852894215104604	0.6815125513986171	0.8459631705125387	0.8952075170930468	0.866260770369341	0.8888353771869728	0.7481471311689547	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038818		NC_000007.14:45075902:A:T		Thr394Ser																												CCM2_Thr394Ser	7	45075902	A	T	7	allele	1180A>T	C12	527_CAVA_Array_P07	F23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075902-A-T	1742095	7	45075902	A	T	T	S	rs368380083	7	45115501	7	45082026	394	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1180A>T	p.Thr394Ser	c.1180A>T	p.Thr394Ser	principal1	Y	1	YES	Select	+	ACC	1	0	A	A/A	A/A	A/A	A/A	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.0	0.01384	B	0.11	0.50204	N	simple_aae	89.0	11.0	-0.635	0.02132	N	0.71	0.02114	N	0.065	0.03720	-0.9691	0.37233	T	0.0136	0.05319	T	10	0.01746577	0.00370	T	0.005406	0.13598	T	0.084	0.24298	0.098	0.01373	Q9BSQ5	T394S	Gain of phosphorylation at T394 (P = 0.0587)| Loss of glycosylation at S393 (P = 0.0641)| Gain of MoRF binding (P = 0.1193)| Gain of catalytic residue at T395 (P = 0.4221)| Gain of methylation at R390 (P = 0.4412)	0.141422826196	0.13382	.	0.21574	.	0.28401	0.341061234474	0.16581	T	0.025502	0.18895	T	-0.455682	0.00977	T	-0.694689	0.05927	T	0.0100869446853163	0.00134	T	0.730727	0.34426	T	0.022190802	0.00862	0.030627562	0.01551	0.022190802	0.00862	0.030627562	0.01551	-2.745	0.07697	T	0.0693	0.04866	B	0.000443722566371579	0.06411	0.46558350	0.81130	0.058	0.15819	.	.	.	.	.	.	1.101111	0.14875	11.38	0.74605043917423208	0.10933	0.334119	0.43109	N	-0.919413008933823	0.10263	0.4961876	-0.696642389463698	0.16764	0.9045113	4.22	3.05	0.34192	-1.91	0.11913	1.104	0.30788	3.317000	0.37593	0.756	0.943	0.995	0.38864	0.991000	0.31563	0.941	0.48226	726	0.54730	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	6	264690	2.2668026E-5	.	5	109348	4.572560e-05	0	11	206826	5.318480e-05	0	9	236698	3.802310e-05	0	0	7154	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13382	0.000000e+00	0	5	42744	1.169750e-04	0	0	15690	0.000000e+00	0	5	42744	1.169750e-04	0	0	16086	0.000000e+00	0	0	30496	0.000000e+00	0	0	6150	0.000000e+00	0	0	13384	0.000000e+00	0	0	16720	0.000000e+00	0	11	88552	1.242210e-04	0	0	30606	0.000000e+00	0	11	88552	1.242210e-04	0	0	14856	0.000000e+00	0	0	34240	0.000000e+00	0	0	9564	0.000000e+00	0	0	17688	0.000000e+00	0	0	21584	0.000000e+00	0	9	102626	8.769710e-05	0	0	30524	0.000000e+00	0	9	102626	8.769710e-05	0	.	45	1613162	2.789550e-05	0	44	1179996	3.728830e-05	0	0	75028	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29606	0.000000e+00	0	0	44884	0.000000e+00	0	0	63074	0.000000e+00	0	0	6062	0.000000e+00	0	44	1179996	3.728830e-05	0	0	91082	0.000000e+00	0	3	32650	9.188361408882082E-5	0	122	0	0	112	0	0	3390	0	0	500	0	0	628	0	0	56	0	0	98	0	0	6864	0	0	3512	0	0	168	0	3	44420	6.75371454299865E-5	Likely_benign	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45075902A>T	.	C0950123	.	.	.	Thr	Ser	1801738	single nucleotide variant	NM_031443.4(CCM2):c.1180A>T (p.Thr394Ser)	83605	CCM2	HGNC:21708	Likely benign	0	Aug 24, 2022	-1	-	RCV002330432	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45075902	45075902	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4247278	2	1742095	45075902	A	T	-	-	-	-	-	-	SCV002633608	-	-	1180A>T 	Thr394Ser	NM_031443.4	1	2_Benign																																																																																																									
CCM2	CCM2_Ser416Ala	0.9702455486405969	1.0	3.015189983682466	1.0	2025_01_Batch_13-14	0.7935438893520864	0.7244320836145838	0.7903098266117028	0.7841266108786552	0.7284781794473857	0.8104563581836616	0.8572258208526399	0.815858946370786	0.7638620207401008	0.7938285593834816	0.802000123767874	0.7908289522336118	0.8030843864912445	0.773994315809378	0.7611533694154337	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038833		NC_000007.14:45075968:T:G		Ser416Ala																												CCM2_Ser416Ala	7	45075968	T	G	7	allele	1246T>G	H01	527_CAVA_Array_P08	P02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075968-T-G	393024	7	45075968	T	G	S	A	rs1057524745	7	45115567	7	45082092	416	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1246T>G	p.Ser416Ala	c.1246T>G	p.Ser416Ala	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.116	0.29959	T	0.097	0.42783	T	0.341	0.33489	B	0.124	0.32549	B	0.23	0.72539	N	simple_aae	77.0	23.0	2.255	0.63995	M	-1.04	0.33171	N	0.532	0.60801	-0.4092	0.71610	T	0.3244	0.69178	T	10	0.39421082	0.54756	D	0.058473	0.67211	D	0.154	0.40121	0.038	0.00025	Q9BSQ5	S416A	Loss of phosphorylation at S416 (P = 0.0075)| Loss of glycosylation at S416 (P = 0.0522)| Gain of methylation at R412 (P = 0.3431)| Loss of helix (P = 0.5774)| Loss of stability (P = 0.6783)	0.696850601288	0.69184	.	0.61589	.	0.54379	0.539842844009	0.44358	T	0.186695	0.53781	T	-0.0554977	0.43265	T	-0.317495	0.42505	T	0.744102299213409	0.42664	D	0.80302	0.44829	T	0.07426937	0.16503	0.07124534	0.15227	0.07426937	0.16502	0.07124534	0.15227	-3.92	0.32069	T	0.0696	0.07733	B	0.0390223430308253	0.35049	0.92350763	0.92113	0.081	0.22877	.	.	.	.	.	.	3.443999	0.48012	22.5	0.98112111729641249	0.38504	0.861462	0.77872	D	0.181778223083209	0.50080	3.223513	0.164994056225379	0.47677	3.017008	4.49	4.49	0.54123	0.365	0.24126	5.895	0.69627	7.779000	0.68678	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.548	0.30173	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1613008	2.479840e-06	0	3	1179990	2.542390e-06	0	0	74986	0.000000e+00	0	0	912	0.000000e+00	0	0	60014	0.000000e+00	0	0	29608	0.000000e+00	0	0	44870	0.000000e+00	0	0	63004	0.000000e+00	0	0	6062	0.000000e+00	0	3	1179990	2.542390e-06	0	0	91074	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000007.14:g.45075968T>G	ClinGen:CA16605225	CN517202	.	.	.	Ser	Ala	369473	single nucleotide variant	NM_031443.4(CCM2):c.1246T>G (p.Ser416Ala)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jan 26, 2017	1057524745	-	RCV000442649	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000007.14	7	45075968	45075968	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA16605225	2	393024	45075968	T	G	-	-	-	-	-	-	SCV000536374	-	-	1246T>G 	Ser416Ala	NM_031443.4	1	4_VUS																																																																																																									
SDHD	SDHD_Glu69Lys	7.232879738605847	0.00017436415792478971	-4.077985550501284	0.2861293525491404	2025_01_Batch_13-14	0.8821027870189919	0.8894584643146449	0.8695156845974097	0.8899949431301525	0.8409505617727295	0.8785284667882032	0.8680985288630207	0.8556173956891031	0.8759832893674684	0.8231562566782767	0.8803156269035975	0.8787784965888328	0.8625665401432564	0.8829891162488104	0.8320534092255032	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023285		NC_000011.10:112088902:G:A		Glu69Lys																												SDHD_Glu69Lys	11	112088902	G	A	11	allele	205G>A	F11	527_CAVA_Array_P05	K21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088902-G-A	156153	11	112088902	G	A	E	K	rs202198133	11	111959626	11	111464836	69	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.205G>A	p.Glu69Lys	c.205G>A	p.Glu69Lys	principal1	Y	1	YES	Select	+	GAG	1	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.004	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.83	0.95555	H	-4.0	0.74082	D	0.996	0.99956	1.0385	0.97876	D	0.9843	0.99522	D	10	0.9897574	0.99448	D	0.760838	0.98097	D	0.991	0.99981	0.955	0.99499	O14521	E69K	Gain of MoRF binding (P = 0.0031)| Gain of methylation at E69 (P = 0.0104)| Gain of ubiquitination at E69 (P = 0.0539)| Gain of relative solvent accessibility (P = 0.0999)| Gain of solvent accessibility (P = 0.1045)	0.972172681102	0.97161	0.9609739073875347	0.96060	0.784672596276	0.65221	0.732807695866	0.71868	T	0.979582	0.99826	D	0.572592	0.96621	D	0.600199	0.96985	D	0.999643564224243	0.98285	D	0.974503	0.92926	D	0.98499125	0.99456	0.95455986	0.98647	0.98053944	0.99136	0.9438836	0.97990	-11.599	0.91228	D	0.8013	0.78519	P	0.996962020332363	0.92637	0.99919051	0.99205	0.997	0.99892	.	.	.	.	.	.	5.407385	0.9054	31.0	0.99935591763030651	0.99579	0.950494	0.96405	D	0.966518903071094	0.94586	12.90049	0.888994358309617	0.95048	13.28898	5.04	5.04	0.67250	.	.	9.348	0.96472	11.792000	0.96405	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.997	0.79771	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109406	9.140270e-06	0	2	208106	9.610490e-06	0	2	236722	8.448730e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	2	89538	2.233690e-05	0	0	30608	0.000000e+00	0	2	89538	2.233690e-05	0	0	14900	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	2	102538	1.950500e-05	0	0	30526	0.000000e+00	0	2	102538	1.950500e-05	0	.	4	1612768	2.480210e-06	0	4	1179938	3.390010e-06	0	0	74996	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44872	0.000000e+00	0	0	64040	0.000000e+00	0	0	5002	0.000000e+00	0	4	1179938	3.390010e-06	0	0	91010	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|not_provided|Mitochondrial_complex_II_deficiency,_nuclear_type_1	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088902G>A	ClinGen:CA016681|OMIM:602690.0029|UniProtKB:O14521#VAR_074105	C0027672|C0031511|C1868633|C1847319|CN166604|C5436934|C3661900|C5700310	171300|606864|619167|252011	140162|29072|97286|201|3208	.	Glu	Lys	165952	single nucleotide variant	NM_003002.4(SDHD):c.205G>A (p.Glu69Lys)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1	Jan 15, 2025	202198133	-	RCV000144171|RCV000484125|RCV001290090|RCV002515941|RCV002415627|RCV004748597	MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MedGen:C3661900|MONDO:MONDO:0100294,MedGen:C5700310,OMIM:252011,Orphanet:3208|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	Mitochondrial complex 2 deficiency, nuclear type 3|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|SDHD-related disorder	germline;inherited	germline	GRCh38	NC_000011.10	11	112088902	112088902	11q23.1	criteria provided, conflicting classifications	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016681,UniProtKB:O14521#VAR_074105,OMIM:602690.0029	3	156153	112088902	G	A	-	-	-	-	-	-	SCV000568557|SCV000825280|SCV002725594	-	-	205G>A 	Glu69Lys	NM_003002.4	1	3_Conflicting																																																																																																									
SDHD	SDHD_Ala90Glu	6.330677185442039	0.0003987614285506209	-0.886732719267612	1.0	2025_01_Batch_13-14	0.8256721732844101	0.8309871723130089	0.7602068186207378	0.823567738429494	0.8256987354575871	0.7882412994273117	0.7970724451402329	0.7961394720416298	0.8272352207088102	0.7379069604992105	0.806956736355861	0.8140298087266209	0.7781731453311838	0.8254014795691521	0.7818028479783987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023305		NC_000011.10:112088966:C:A		Ala90Glu																												SDHD_Ala90Glu	11	112088966	C	A	11	allele	269C>A	H11	527_CAVA_Array_P05	O21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088966-C-A	412512	11	112088966	C	A	A	E	rs200255724	11	111959690	11	111464900	90	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.269C>A	p.Ala90Glu	c.269C>A	p.Ala90Glu	principal1	Y	1	YES	Select	+	GCG	2	0	C	./.	./.	./.	./.	0.007	0.65576	D	0.103	0.52087	T	0.932	0.52003	P	0.57	0.49852	P	.	.	.	.	.	.	2.42	0.69809	M	-3.44	0.67509	D	0.838	0.88119	0.6538	0.92564	D	0.9083	0.96954	D	10	0.71854925	0.73260	D	0.221482	0.87778	D	0.717	0.89925	0.651	0.78770	O14521	A90E	Gain of solvent accessibility (P = 0.1185)| Gain of helix (P = 0.132)| Loss of glycosylation at S94 (P = 0.2235)| Loss of loop (P = 0.2237)| Gain of disorder (P = 0.2283)	0.994050821033	0.99390	0.9025812371913887	0.90169	0.56273454734	0.52443	0.434535443783	0.29793	T	0.882903	0.97538	D	0.147502	0.68809	D	0.344014	0.90010	D	0.429612930299171	0.29737	T	0.662834	0.27239	T	0.5395673	0.69073	0.7364212	0.84234	0.5395673	0.69074	0.7364212	0.84235	-10.123	0.80928	D	0.5246	0.71218	A	0.962673093571584	0.82104	0.99742990	0.98376	0.483	0.70339	.	.	.	.	.	.	2.63182	0.34286	19.57	0.99093711970946219	0.52353	0.646940	0.62094	D	-0.0306763802736097	0.40204	2.403878	-0.139133932962987	0.33519	1.939294	5.04	1.52	0.22101	.	.	0.348	0.19856	-0.210000	0.10908	0.549	0.27038	0.03	0.20497	0.000000	0.08389	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	3	109406	2.742080e-05	0	12	208128	5.765680e-05	0	11	236928	4.642760e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	3	9044	3.317120e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	9044	3.317120e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	12	13414	8.945880e-04	0	0	16734	0.000000e+00	0	0	89554	0.000000e+00	0	0	30608	0.000000e+00	0	12	13414	8.945880e-04	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	11	17690	6.218200e-04	0	0	21632	0.000000e+00	0	0	102728	0.000000e+00	0	0	30526	0.000000e+00	0	11	17690	6.218200e-04	0	.	21	1614014	1.301100e-05	0	21	44888	4.678310e-04	0	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	21	44888	4.678310e-04	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179998	0.000000e+00	0	0	91090	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Microcephaly	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088966C>A	ClinGen:CA070965	C3661900|C0027672|C1868633|C1847319|C0031511|CN166604|C4551563	606864|171300	140162|97286|29072|201	.	Ala	Glu	398391	single nucleotide variant	NM_003002.4(SDHD):c.269C>A (p.Ala90Glu)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0	Oct 26, 2024	200255724	-	RCV001016345|RCV001252746|RCV002230664|RCV003235231	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MONDO:MONDO:0001149,MedGen:C4551563|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Microcephaly|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|not provided	germline	germline	GRCh38	NC_000011.10	11	112088966	112088966	11q23.1	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070965	2	412512	112088966	C	A	-	-	-	-	-	-	SCV000554064|SCV001177292|SCV003933375	-	-	269C>A 	Ala90Glu	NM_003002.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Arg412Trp	1.3974158522924547	1.0	5.98425677134014	0.0017766686481813932	2025_01_Batch_13-14	0.814426359904244	0.8279165404849363	0.8871623927191324	0.8681354772492146	0.7043560502342637	0.7905001990785291	0.8754608927518494	0.9594587921676401	0.8982963614227115	0.7545837999616679	0.8024632794913865	0.8516887166183928	0.9233105924433862	0.883215919335963	0.7294699250979658	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038831		NC_000007.14:45075956:C:T		Arg412Trp																												CCM2_Arg412Trp	7	45075956	C	T	7	allele	1234C>T	F01	527_CAVA_Array_P08	L02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075956-C-T	523540	7	45075956	C	T	R	W	rs544276945	7	45115555	7	45082080	412	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1234C>T	p.Arg412Trp	c.1234C>T	p.Arg412Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.19	0.21415	T	0.188	0.28977	T	0.894	0.49197	P	0.219	0.37735	B	0.24	0.68318	N	simple_aae	76.0	24.0	-0.345	0.03334	N	-0.41	0.26798	N	0.151	0.16766	-0.7107	0.59747	T	0.1533	0.48108	T	10	0.08255631	0.13536	T	0.050408	0.64094	D	0.123	0.33814	.	.	.	.	.	0.633743785003	0.62789	.	0.23162	.	0.53746	0.231473743916	0.02081	T	0.028905	0.20627	T	-0.242853	0.14712	T	-0.404471	0.32504	T	0.106811147834092	0.12924	T	0.957404	0.83947	D	0.08115841	0.18465	0.05431554	0.09331	0.08115841	0.18464	0.05431554	0.09331	-4.346	0.34385	T	0.0884	0.16473	B	0.0248309479233182	0.31236	0.91768926	0.91875	0.101	0.28173	.	.	.	.	.	.	2.82976	0.37377	20.5	0.99861441422960806	0.94006	0.858667	0.77539	D	-0.0225275738762253	0.40572	2.432097	0.02526507791334	0.40601	2.447705	4.49	4.49	0.54123	1.3	0.32045	2.821	0.47864	3.929000	0.40602	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.34	0.25482	726	0.54730	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	8	264690	3.0224035E-5	.	5	109352	4.572390e-05	0	9	206622	4.355780e-05	0	9	236530	3.805010e-05	0	0	7158	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	2	9044	2.211410e-04	0	0	13376	0.000000e+00	0	3	42744	7.018530e-05	0	0	15688	0.000000e+00	0	2	9044	2.211410e-04	0	1	16050	6.230530e-05	0	0	30496	0.000000e+00	0	0	6138	0.000000e+00	0	2	13384	1.494320e-04	0	0	16712	0.000000e+00	0	6	88410	6.786560e-05	0	0	30600	0.000000e+00	0	2	13384	1.494320e-04	0	1	14824	6.745820e-05	0	0	34246	0.000000e+00	0	0	9566	0.000000e+00	0	2	17688	1.130710e-04	0	0	21564	0.000000e+00	0	6	102504	5.853430e-05	0	0	30524	0.000000e+00	0	2	17688	1.130710e-04	0	.	71	1613136	4.401360e-05	0	65	1180008	5.508440e-05	0	2	75036	2.665390e-05	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	2	44882	4.456130e-05	0	0	63032	0.000000e+00	0	0	6062	0.000000e+00	0	65	1180008	5.508440e-05	0	1	91074	1.098010e-05	0	4	42734	9.360228389572705E-5	0	306	0	0	112	0	1	8044	1.2431626056688214E-4	0	498	0	0	628	0	0	56	0	0	98	0	0	8296	0	1	8350	1.1976047904191617E-4	0	168	0	5	60772	8.227473178437438E-5	Uncertain_significance	Vasculitis	criteria_provided,_single_submitter	NC_000007.14:g.45075956C>T	ClinGen:CA4247292	C0042384	.	52759	.	Arg	Trp	513972	single nucleotide variant	NM_031443.4(CCM2):c.1234C>T (p.Arg412Trp)	83605	CCM2	HGNC:21708	Uncertain significance	0	Nov 11, 2024	544276945	-	RCV005091829|RCV000626972	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061|Human Phenotype Ontology:HP:0002633,MONDO:MONDO:0018882,MedGen:C0042384,Orphanet:52759	Cerebral cavernous malformation 2|Vasculitis	germline;unknown	germline	GRCh38	NC_000007.14	7	45075956	45075956	7p13	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA4247292	2	523540	45075956	C	T	-	-	-	-	-	-	SCV000747675|SCV005770328	-	-	1234C>T 	Arg412Trp	NM_031443.4	2	4_VUS																																																																																																									
CCM2	CCM2_Thr74Met	-0.5441236960071251	1.0	4.434255161504939	1.0	2025_01_Batch_13-14	0.8595469299827904	0.8411674093476661	0.8216890070279272	0.7636761617853373	0.8136035663268667	0.886088822357963	0.9242204776685732	0.8376017202167	0.8518714342399316	0.8093725738842193	0.8728178761703766	0.8826939435081196	0.8296453636223136	0.8077737980126345	0.811488070105543	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038629		NC_000007.14:45063934:C:T		Thr74Met																												CCM2_Thr74Met	7	45063934	C	T	7	allele	221C>T	A09	527_CAVA_Array_P06	A18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063934-C-T	1438828	7	45063934	C	T	T	M	rs750771937	7	45103533	7	45070058	74	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.221C>T	p.Thr74Met	c.221C>T	p.Thr74Met	principal1	Y	1	YES	Select	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.088	0.33898	T	0.005	0.72530	D	0.216	0.30179	B	0.021	0.19345	B	0.64	0.79708	D	simple_aae	36.0	64.0	2.475	0.71705	M	-3.8	0.73413	D	0.753	0.75084	-0.7470	0.57916	T	0.2378	0.60359	T	10	0.67108417	0.70452	D	0.032579	0.54184	D	0.189	0.46391	0.475	0.55046	Q9BSQ5	T74M	Loss of loop (P = 0.1242)| Gain of helix (P = 0.2059)| Loss of disorder (P = 0.2147)| Gain of phosphorylation at Y69 (P = 0.2259)| Loss of catalytic residue at T74 (P = 0.2593)	0.614679400128	0.60860	.	0.50283	.	0.73844	0.807355165482	0.83057	D	0.424647	0.77338	T	-0.130345	0.31083	T	-0.25588	0.48905	T	0.970702946186066	0.68841	D	0.953605	0.82472	D	0.11568509	0.27052	0.105642214	0.25347	0.11568509	0.27052	0.105642214	0.25346	-9.777	0.76749	D	0.1759	0.60815	B	0.0483877527405051	0.36896	0.93734294	0.92728	0.399	0.64585	.	.	.	.	.	.	3.707691	0.52996	23.3	0.98943812243424833	0.49091	0.880943	0.80724	D	0.305516568370762	0.56208	3.807819	0.338665363587076	0.57604	3.950114	5.25	3.46	0.38646	2.23	0.42398	7.745	0.83993	5.845000	0.50358	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.98	0.58201	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	109402	9.140600e-06	0	0	208112	0.000000e+00	0	1	236928	4.220690e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13390	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16218	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	0	89544	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21628	0.000000e+00	0	0	102732	0.000000e+00	0	0	30526	0.000000e+00	0	1	17692	5.652270e-05	0	.	12	1611752	7.445310e-06	0	1	63996	1.562600e-05	0	1	74794	1.337010e-05	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29596	0.000000e+00	0	0	44878	0.000000e+00	0	1	63996	1.562600e-05	0	0	6082	0.000000e+00	0	9	1178094	7.639460e-06	0	1	91022	1.098640e-05	0	1	36678	2.726430012541578E-5	0	298	0	0	86	0	0	7458	0	0	500	0	0	628	0	0	26	0	0	98	0	1	6022	1.6605778811026238E-4	0	7756	0	0	112	0	2	51794	3.861451133335908E-5	Uncertain_significance	Cerebral_cavernous_malformation_2	criteria_provided,_single_submitter	NC_000007.14:g.45063934C>T	.	C1864041	603284	221061	PTB/PI domain	Thr	Met	1448553	single nucleotide variant	NM_031443.4(CCM2):c.221C>T (p.Thr74Met)	83605	CCM2	HGNC:21708	Uncertain significance	0	Mar 12, 2023	750771937	-	RCV001949078	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45063934	45063934	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4246917	2	1438828	45063934	C	T	-	-	-	-	-	-	SCV002216207	-	-	221C>T 	Thr74Met	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_His364Tyr	2.699563965306408	1.0	8.52450873881591	0.01556918233463625	2025_01_Batch_13-14	0.863776889785638	0.8342500160070722	0.8294586756427424	0.8499117079455979	0.6639257317021353	0.7922806118419462	0.8557165843055491	0.8146081880103903	0.7938092610625227	0.7526941002310633	0.8280287508137921	0.8449833001563106	0.8220334318265663	0.8218604845040602	0.7083099159665993	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038797		NC_000007.14:45075812:C:T		His364Tyr																												CCM2_His364Tyr	7	45075812	C	T	7	allele	1090C>T	G10	527_CAVA_Array_P07	N19	B13A7A8P2_R1	B14A7A8P2_R2				7-45075812-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_His332Arg	1.0371758478925537	1.0	16.95996108596124	3.3215182898690893e-6	2025_01_Batch_13-14	0.8754586293535896	0.9604484461790194	0.9699820023703456	0.9639786033624907	0.761535961558474	0.7467053978502889	0.9315430892684884	0.9650711890519277	0.913662059654324	0.6938160270736902	0.8110820136019392	0.9459957677237538	0.9675265957111366	0.9388203315084074	0.7276759943160821	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038783		NC_000007.14:45074349:A:G		His332Arg																												CCM2_His332Arg	7	45074349	A	G	7	allele	995A>G	B10	527_CAVA_Array_P07	D19	B13A7A8P2_R1	B14A7A8P2_R2				7-45074349-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gln313Arg	5.063972085080273	1.0	14.551077428869675	0.00014182850206092903	2025_01_Batch_13-14	0.839094825120986	0.8211585340644613	0.8487065735684137	0.8353964957616582	0.7680768407420008	0.8039748940482753	0.8843221659637116	0.8916046091845096	0.8679947528037184	0.7563960766239224	0.8215348595846306	0.8527403500140864	0.8701555913764616	0.8516956242826883	0.7622364586829615	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038774		NC_000007.14:45074292:A:G		Gln313Arg																												CCM2_Gln313Arg	7	45074292	A	G	7	allele	938A>G	G09	527_CAVA_Array_P07	N17	B13A7A8P2_R1	B14A7A8P2_R2				7-45074292-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Phe91Ile	2.179643780523128	1.0	9.171077592509185	0.0005290377188209971	2025_01_Batch_13-14	0.8546500363974195	0.8873846432860389	0.8954448710200689	0.8938281255669883	0.7698303509911392	0.7153949037678612	0.8558736722065605	0.9206026203075317	0.8274147959685801	0.6498333647052776	0.7850224700826404	0.8716291577462998	0.9080237456638003	0.8606214607677842	0.7098318578482083	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038638		NC_000007.14:45063984:T:A		Phe91Ile																												CCM2_Phe91Ile	7	45063984	T	A	7	allele	271T>A	D10	527_CAVA_Array_P06	G20	B13A7A8P2_R1	B14A7A8P2_R2				7-45063984-T-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BRCA1	BRCA1_Ser611Arg	0.9435653387772786	1.0	3.4350690406883606	0.02202146477987949	2025_01_Batch_13-14	0.9553935623214185	0.9507932560196941	0.9084188437682514	0.949490270032494	0.883887929907112	0.9809933121913665	0.9396248586533601	0.9215061440810749	0.9789850450005839	0.889371169243643	0.9681934372563925	0.945209057336527	0.9149624939246632	0.964237657516539	0.8866295495753775	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC011835		NC_000017.11:43063881:G:C		Ser611Arg																												BRCA1_Ser611Arg	17	43063881	G	C	17	allele	1833C>G	F08	527_CAVA_Array_P01	K15	B13A7A8P1_R1	B14A7A8P1_R2				17-43063881-G-C	55418	17	43063881	G	C	S	R	rs80357094	17	41215898	17	38469424	1715	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5145C>G	p.Ser1715Arg	principal2	Y	1	.	.	-	AGC	3	2	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.064	0.90580	B	0.031	0.92348	B	.	0.99291	.	.	.	.	3.09	0.87301	M	.	0.74220	.	.	0.93850	0.3749	0.88675	D	0.6610	0.88183	D	10	.	0.79960	.	0.483874	0.94878	D	.	0.88582	.	.	.	.	.	.	0.91515	.	0.92636	.	0.45682	0.678713917732	0.64025	T	0.249441	0.61729	T	0.397653	0.89708	D	0.333424	0.89578	D	0.98091846704483	0.73434	D	.	0.85294	.	0.9707088	0.98298	0.7604528	0.85672	0.97296304	0.98504	0.7653877	0.85971	-15.775	0.97410	D	.	0.96584	.	0.998593400129946	0.94714	0.99986792	0.99835	0.992	0.99727	.	.	.	.	.	.	3.655532	0.51985	23.2	0.99838730133180587	0.91978	0.429032	0.49057	N	0.670045961903725	0.77549	6.719747	0.654600882003088	0.78837	6.981316	6.04	4.89	0.63341	4.33	0.81833	2.013	0.40665	4.969000	0.46465	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43063881G>C	ClinGen:CA003268|UniProtKB:P38398#VAR_063906	C0027672|C2676676	604370	140162|145	BRCT domain|BRCT domain|BRCT domain	Ser	Arg	70085	single nucleotide variant	NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	672	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1	Oct 16, 2024	80357094	-	RCV000112509|RCV002336193|RCV005089439	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063881	43063881	17q21.31	criteria provided, multiple submitters, no conflicts	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003268,UniProtKB:P38398#VAR_063906	2	55418	43063881	G	C	-	-	-	-	-	-	SCV000326168|SCV002645244|SCV005058237|SCV005812863	-	-	5145C>G 	Ser1715Arg	NM_007294.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Ser611Arg	0.9435653387772786	1.0	3.4350690406883606	0.02202146477987949	2025_01_Batch_13-14	0.9553935623214185	0.9507932560196941	0.9084188437682514	0.949490270032494	0.883887929907112	0.9809933121913665	0.9396248586533601	0.9215061440810749	0.9789850450005839	0.889371169243643	0.9681934372563925	0.945209057336527	0.9149624939246632	0.964237657516539	0.8866295495753775	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC011847		NC_000017.11:43063883:T:G		Ser611Arg																												BRCA1_Ser611Arg	17	43063883	T	G	17	allele	1831A>C	C09	527_CAVA_Array_P01	E17	B13A7A8P1_R1	B14A7A8P1_R2				17-43063883-T-G	55414	17	43063883	T	G	S	R	rs80357222	17	41215900	17	38469426	1715	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5143A>C	p.Ser1715Arg	principal2	Y	.	.	.	-	AGC	1	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	0.064	0.90580	B	0.031	0.92348	B	.	0.99291	.	.	.	.	3.09	0.87301	M	.	0.74220	.	.	0.93850	0.4864	0.90317	D	0.6824	0.88985	D	10	.	0.84119	.	0.614101	0.96634	D	.	0.91164	.	.	.	.	.	.	0.93349	.	0.92636	.	0.45682	0.678713917732	0.64025	T	0.249441	0.61729	T	0.403311	0.90034	D	0.341552	0.89910	D	0.955768585205078	0.64367	D	.	0.85294	.	0.96063316	0.97301	0.7210125	0.83331	0.97296304	0.98504	0.7653877	0.85971	-15.775	0.97410	D	.	0.96584	.	0.998593400129946	0.94714	0.99986720	0.99835	0.992	0.99727	.	.	.	.	.	.	3.966832	0.58299	24.0	0.99856366597217106	0.93553	0.773248	0.70624	D	0.737909246897857	0.82017	7.683752	0.733918080214739	0.84867	8.437762	6.04	6.04	0.98023	.	.	3.389	0.52349	7.850000	0.70966	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.999	0.91597	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43063883T>G	BRCA1-HCI:BRCA1_00051|ClinGen:CA003264|UniProtKB:P38398#VAR_063906	C0677776|C2676676|C3661900	604370	145|145	BRCT domain|BRCT domain|BRCT domain	Ser	Arg	70081	single nucleotide variant	NM_007294.4(BRCA1):c.5143A>C (p.Ser1715Arg)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357222	-	RCV000112505|RCV001383430|RCV002267824	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063883	43063883	17q21.31	reviewed by expert panel	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00051,ClinGen:CA003264,UniProtKB:P38398#VAR_063906	2	55414	43063883	T	G	-	-	-	-	-	-	SCV000244386	-	-	5143A>C 	Ser1715Arg	NM_007294.4	3	1_Pathogenic																																																																																																									
CCM2	CCM2_Asp61Asn	1.6499023780056696	1.0	9.75941246567502	0.00021095811415910938	2025_01_Batch_13-14	0.8351320407238654	0.854072570793857	0.8780335489723825	0.8698441139984657	0.7824573268068287	0.8037680268415629	0.7990431035052253	0.8695852939184937	0.7784942275144039	0.791490256943875	0.8194500337827142	0.8265578371495412	0.8738094214454382	0.8241691707564348	0.7869737918753519	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038625		NC_000007.14:45038403:G:A		Asp61Asn																												CCM2_Asp61Asn	7	45038403	G	A	7	allele	181G>A	D08	527_CAVA_Array_P06	G16	B13A7A8P2_R1	B14A7A8P2_R2				7-45038403-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp126Glu	-0.06413260614422622	1.0	7.164526758732106	0.009282926777094634	2025_01_Batch_13-14	0.8219070190351535	0.8480602048437876	0.8267881907731649	0.8172547660849215	0.7279537797833512	0.8186957923333568	0.8533523864028982	0.8578571226555948	0.8604505384041596	0.7861941572720587	0.8203014056842551	0.8507062956233429	0.8423226567143798	0.8388526522445405	0.7570739685277049	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038660		NC_000007.14:45064552:C:G		Asp126Glu																												CCM2_Asp126Glu	7	45064552	C	G	7	allele	378C>G	B12	527_CAVA_Array_P06	C24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064552-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp411Asn	2.88414384973836	1.0	1.9768166785806034	1.0	2025_01_Batch_13-14	0.810227783274217	0.7159365421976167	0.7708498196288837	0.8067232769299743	0.7168452607983284	0.7673839976458487	0.7049512457413726	0.6834348113400546	0.6957482280746101	0.7165932211861227	0.7888058904600328	0.7104438939694946	0.7271423154844692	0.7512357525022921	0.7167192409922256	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038829		NC_000007.14:45075953:G:A		Asp411Asn																												CCM2_Asp411Asn	7	45075953	G	A	7	allele	1231G>A	D01	527_CAVA_Array_P08	H02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075953-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu433Lys	0.9318755256199559	1.0	5.975328769526697	0.1280846072326264	2025_01_Batch_13-14	0.8532915569097073	0.7519832663415652	0.7814467501873633	0.804486189114671	0.7721764130402354	0.7315532281524928	0.7609296187124927	0.7963476159083437	0.7633410656083409	0.6995529511023179	0.7924223925311	0.7564564425270289	0.7888971830478535	0.7839136273615059	0.7358646820712766	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038847		NC_000007.14:45076019:G:A		Glu433Lys																												CCM2_Glu433Lys	7	45076019	G	A	7	allele	1297G>A	F03	527_CAVA_Array_P08	L06	B13A7A8P2_R1	B14A7A8P2_R2				7-45076019-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Leu139Arg	3.798682331808146	0.014136237819953438	3.6405640563005033	0.05718059390456844	2025_01_Batch_13-14	0.8235345660865708	0.8461560115031072	0.8174137578528592	0.7586154412052757	0.7453884050906837	0.8709498956187064	0.8359888050434786	0.8469426184661639	0.8497719666419139	0.7997680457440315	0.8472422308526386	0.8410724082732929	0.8321781881595116	0.8041937039235948	0.7725782254173577	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023371		NC_000011.10:112094906:T:G		Leu139Arg																												SDHD_Leu139Arg	11	112094906	T	G	11	allele	416T>G	D01	527_CAVA_Array_P06	G02	B13A7A8P2_R1	B14A7A8P2_R2				11-112094906-T-G	573651	11	112094906	T	G	L	R	rs80338847	11	111965630	11	111470840	139	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.416T>G	p.Leu139Arg	c.416T>G	p.Leu139Arg	principal1	Y	1	YES	Select	+	CTT	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	3.855	0.95736	H	-5.45	0.85499	D	0.982	0.99346	1.0402	0.97910	D	0.9834	0.99493	D	10	0.9803145	0.97976	D	0.815524	0.98560	D	0.988	0.99961	0.84	0.94573	O14521	L139R	Gain of methylation at L139 (P = 0.0075)| Gain of sheet (P = 0.1208)| Gain of relative solvent accessibility (P = 0.1259)| Loss of helix (P = 0.1299)| Gain of solvent accessibility (P = 0.1319)	0.983425624168	0.98307	0.9940455699504791	0.99400	0.916340064084	0.71077	0.841523647308	0.88307	D	0.976158	0.99771	D	0.5783	0.96940	D	0.592912	0.96890	D	0.99942147731781	0.97327	D	0.929107	0.73846	D	0.9855054	0.99491	0.9717924	0.99533	0.9855054	0.99491	0.9717924	0.99533	-17.005	0.98918	D	0.9277	0.84786	P	0.999298612534229	0.96182	0.99940443	0.99356	0.994	0.99793	.	.	.	.	.	.	4.963449	0.82116	27.7	0.99757144050314794	0.84785	0.951878	0.96672	D	0.890230994464423	0.91223	10.80072	0.800832412790881	0.89794	10.14829	4.85	4.85	0.62327	.	.	7.682	0.8343	7.853000	0.71102	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.999	0.91597	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Cowden_syndrome_3|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma	criteria_provided,_single_submitter	NC_000011.10:g.112094906T>G	.	CN166604|C1847319|C1868633|C0031511	606864|171300	201|97286|29072	.	Leu	Arg	564429	single nucleotide variant	NM_003002.4(SDHD):c.416T>G (p.Leu139Arg)	6392	SDHD	HGNC:10683	Likely pathogenic	1	Jun 09, 2022	80338847	-	RCV002532294	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss	germline	germline	GRCh38	NC_000011.10	11	112094906	112094906	11q23.1	criteria provided, single submitter	1	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619304	2	573651	112094906	T	G	-	-	-	-	-	-	SCV000823868	-	-	416T>G 	Leu139Arg	NM_003002.4	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Glu108Gly	3.3100828342579693	1.0	4.503070209965064	0.04924231302084627	2025_01_Batch_13-14	0.9174569597555884	0.9112533041377294	0.9109735014254596	0.9245952216174352	0.8771216251262791	0.833438973445534	0.8857604214817404	0.9164943286620595	0.8609807378935155	0.7196013678688795	0.8754479666005612	0.8985068628097349	0.9137339150437596	0.8927879797554754	0.7983614964975794	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038650		NC_000007.14:45064497:A:G		Glu108Gly																												CCM2_Glu108Gly	7	45064497	A	G	7	allele	323A>G	E11	527_CAVA_Array_P06	I22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064497-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Thr491Ile	-3.8359287255680843	0.2755942932717806	2.583864682897168	0.271931931279114	2025_01_Batch_13-14	0.8142078548463358	0.7158286617781157	0.7556981684615444	0.7233804167785814	0.793730906544224	0.7370624431233321	0.6183580755393122	0.608405328162545	0.727770857023925	0.7185682600862653	0.775635148984834	0.6670933686587139	0.6820517483120447	0.7255756369012532	0.7561495833152446	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC003427		NC_000003.12:12585745:G:C		Thr491Ile																												RAF1_Thr491Ile	3	12585745	G	C	3	allele	1472C>T	C04	527_CAVA_Array_P05	E07	B13A7A8P2_R1	B14A7A8P2_R2				3-12585745-G-C	13959	3	12585745	G	C	T	R	rs80338799	3	12627244	3	12602244	491	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1472C>G	p.Thr491Arg	c.1472C>G	p.Thr491Arg	principal3	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.122	0.40143	T	1.0	0.90580	D	0.999	0.92348	D	0.98	0.99291	A	simple_aae	2.0	98.0	0.02	0.07909	N	-5.37	0.84911	D	0.961	0.99191	0.1373	0.84771	D	0.4388	0.77686	T	10	0.899554	0.89196	D	0.235705	0.88439	D	0.786	0.92884	0.752	0.88177	P04049	T491R	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.974052792841	0.97352	.	0.85535	2.53490677304	0.97794	0.845280706882	0.88882	D	0.900422	0.98022	D	0.39866	0.89767	D	0.334871	0.89639	D	0.996480882167816	0.89353	D	.	0.92373	.	0.9571182	0.96940	0.9388268	0.97656	0.9463269	0.95828	0.90921533	0.95572	-12.126	0.85499	D	0.9852	0.92260	P	0.999988562000968	0.99579	0.99762386	0.98444	0.978	0.99209	.	.	.	.	.	.	5.424006	0.90747	31.0	0.99437118353782505	0.64619	0.916990	0.88355	D	0.626065396186754	0.74692	6.199454	0.704879681503555	0.82653	7.84486	5.26	5.26	0.73443	.	.	9.996	0.99292	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy|not_provided|Noonan_syndrome_5	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12585745G>C	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	C5555857|C3661900|C1969057	611553	536391|648	Protein kinase domain|Protein kinase domain|Protein kinase domain	Thr	Arg	28998	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894	RAF1	HGNC:9829	Likely pathogenic	1	Sep 11, 2024	80338799	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745	12585745	3p25.2	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3	13959	12585745	G	C	-	-	-	-	-	-	SCV000808247|SCV001401755	-	-	1472C>G 	Thr491Arg	NM_002880.4	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Glu128Ala	-13.804943620515937	0.0009563572221968623																													true	CCM2		3928		CCSBVarC038663		NC_000007.14:45064557:A:C		Glu128Ala																												CCM2_Glu128Ala	7	45064557	A	C	7	allele	383A>C	D12	527_CAVA_Array_P06	G24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064557-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Leu310Val	-1.2940323675327978	1.0	13.919122067467042	0.0007703464467416449	2025_01_Batch_13-14	0.8453988480555713	0.7537551192060757	0.8362563564721391	0.832369565499119	0.757444416944354	0.7674396034692128	0.8500498165644705	0.9075595908621703	0.8642648167036769	0.7391662577503721	0.8064192257623921	0.8019024678852731	0.8719079736671547	0.848317191101398	0.7483053373473632	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038773		NC_000007.14:45074282:C:G		Leu310Val																												CCM2_Leu310Val	7	45074282	C	G	7	allele	928C>G	F09	527_CAVA_Array_P07	L17	B13A7A8P2_R1	B14A7A8P2_R2				7-45074282-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Met424Ile	-0.9369428043847939	1.0	7.918920942911943	0.003540709076950752	2025_01_Batch_13-14	0.7502595738806016	0.7817295479717677	0.8397940046477453	0.8028101692593124	0.6179011446974038	0.7412140730699955	0.8188121976376993	0.8983969697199078	0.8278111675962068	0.7082330651032557	0.7457368234752986	0.8002708728047335	0.8690954871838266	0.8153106684277596	0.6630671049003297	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038841		NC_000007.14:45075994:G:A		Met424Ile																												CCM2_Met424Ile	7	45075994	G	A	7	allele	1272G>A	G02	527_CAVA_Array_P08	N04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075994-G-A	2503149	7	45075994	G	A	M	I	rs1279003303	7	45115593	7	45082118	424	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1272G>A	p.Met424Ile	c.1272G>A	p.Met424Ile	principal1	Y	1	YES	Select	+	ATG	3	0	G	G/G	G/G	G/G	G/G	0.091	0.33397	T	0.34	0.26042	T	0.106	0.26054	B	0.042	0.24116	B	0.56	0.84487	D	simple_aae	44.0	56.0	1.575	0.39544	L	-1.2	0.30521	N	0.483	0.56699	-0.4751	0.69409	T	0.3139	0.68255	T	10	0.28983635	0.46181	D	0.020286	0.42624	T	0.176	0.44151	0.144	0.04716	Q9BSQ5	M424I	Loss of catalytic residue at M424 (P = 0.0068)| Loss of phosphorylation at S429 (P = 0.2634)| Loss of stability (P = 0.3732)| Gain of glycosylation at S429 (P = 0.4473)| Loss of helix (P = 0.5774)	0.55046033382	0.54368	.	0.63834	.	0.44786	0.766089439392	0.76796	T	0.070837	0.33805	T	-0.0148566	0.49257	T	-0.259117	0.48581	T	0.765931189060211	0.43904	D	0.833717	0.50107	T	0.3195307	0.54268	0.26312292	0.51915	0.3195307	0.54268	0.26312292	0.51914	-8.855	0.68154	D	0.8662	0.83763	P	0.0318715374372303	0.33329	0.95160806	0.93464	0.173	0.42260	.	.	.	.	.	.	3.664011	0.52149	23.2	0.99460342866151275	0.65834	0.852432	0.76849	D	0.348681664157762	0.58456	4.040698	0.405131530709039	0.61679	4.39491	4.49	4.49	0.54123	3.63	0.66478	6.732	0.74658	11.664000	0.94029	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.998	0.85369	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1613018	1.859870e-06	0	3	1180026	2.542320e-06	0	0	74926	0.000000e+00	0	0	912	0.000000e+00	0	0	60002	0.000000e+00	0	0	29608	0.000000e+00	0	0	44896	0.000000e+00	0	0	62994	0.000000e+00	0	0	6084	0.000000e+00	0	3	1180026	2.542320e-06	0	0	91090	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000007.14:g.45075994G>A	.	CN517202	.	.	.	Met	Ile	2668330	single nucleotide variant	NM_031443.4(CCM2):c.1272G>A (p.Met424Ile)	83605	CCM2	HGNC:21708	Uncertain significance	0	Nov 25, 2022	-1	-	RCV003229983	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000007.14	7	45075994	45075994	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367431963	2	2503149	45075994	G	A	-	-	-	-	-	-	SCV003927325	-	-	1272G>A 	Met424Ile	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Gly5Ser	0.22514258662889564	1.0	7.340730388402551	0.03598330023285486	2025_01_Batch_13-14	0.8442754501160411	0.8550074834345051	0.8207270140520254	0.7604764401188558	0.8318422546948819	0.9483763596236284	0.9408029972988242	0.927477030662084	0.9508390337242151	0.8697910667280692	0.8963259048698348	0.8979052403666646	0.8741020223570547	0.8556577369215355	0.8508166607114755	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038604		NC_000007.14:45000346:G:A		Gly5Ser																												CCM2_Gly5Ser	7	45000346	G	A	7	allele	13G>A	A06	527_CAVA_Array_P06	A12	B13A7A8P2_R1	B14A7A8P2_R2				7-45000346-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Arg419Cys	1.6552138932581775	1.0	-1.2823493566133495	1.0	2025_01_Batch_13-14	0.7332088438429117	0.67991349779559	0.6942451587201367	0.6559214897792586	0.6525787544082512	0.6437794517662653	0.7353374141674315	0.7821620174284748	0.7692521210008939	0.45969014996277247	0.6884941478045885	0.7076254559815107	0.7382035880743057	0.7125868053900762	0.5561344521855118	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011932		NC_000006.12:5771328:C:T		Arg419Cys																												FARS2_Arg419Cys	6	5771328	C	T	6	allele	1255C>T	E12	527_CAVA_Array_P02	I24	B13A7A8P1_R1	B14A7A8P1_R2				6-5771328-C-T	214336	6	5771328	C	T	R	C	rs775690041	6	5771561	6	5716560	419	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1255C>T	p.Arg419Cys	c.1255C>T	p.Arg419Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.995	0.83178	D	0.94	0.94378	A	simple_aae	6.0	94.0	3.715	0.94651	H	-7.26	0.94393	D	0.932	0.99026	0.6632	0.92683	D	0.7452	0.91281	D	10	0.928861	0.92141	D	0.349699	0.92219	D	0.945	0.98886	0.723	0.85693	O95363	R419C	Loss of MoRF binding (P = 5e-04)| Loss of disorder (P = 0.0261)| Gain of catalytic residue at E422 (P = 0.0714)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T417 (P = 0.1046)	0.955839850528	0.95499	.	0.77993	.	0.65239	0.68183016777	0.64473	T	0.810547	0.95222	D	0.348511	0.86306	D	0.35969	0.90625	D	0.998910188674927	0.95528	D	0.995867	0.98584	D	0.9438368	0.95571	0.897082	0.94697	0.92678815	0.93825	0.8879299	0.94041	-10.535	0.77122	D	0.2542	0.50506	B	0.98820251721525	0.87710	0.97777240	0.95306	0.994	0.99793	.	.	.	.	.	.	5.901953	0.94011	33.0	0.99937551864799379	0.99661	0.856660	0.77309	D	0.97565369231617	0.94917	13.17435	0.915579723915553	0.96194	14.4338	5.81	5.81	0.92402	.	.	6.805	0.75041	7.527000	0.59919	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	964	0.07711	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	2	109402	1.828120e-05	0	2	207842	9.622690e-06	0	3	236614	1.267890e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	1	89280	1.120070e-05	0	1	30606	3.267330e-05	0	1	30606	3.267330e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	2	102430	1.952550e-05	0	1	30524	3.276110e-05	0	1	30524	3.276110e-05	0	.	33	1614088	2.044500e-05	0	28	1180044	2.372790e-05	0	1	74938	1.334440e-05	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	28	1180044	2.372790e-05	0	2	91084	2.195780e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	Hereditary_spastic_paraplegia_77|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5771328C>T	ClinGen:CA321645|OMIM:611592.0006	C5569007|C3661900|C4755312	617046|614946	466722|319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Arg	Cys	211261	single nucleotide variant	NM_006567.5(FARS2):c.1255C>T (p.Arg419Cys)	10667	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1	Jan 29, 2025	775690041	-	RCV000197201|RCV000578139|RCV001378476	MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5771328	5771328	6p25.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA321645,OMIM:611592.0006	3	214336	5771328	C	T	-	-	-	-	-	-	SCV000251376|SCV000845719|SCV001576048	-	-	1255C>T 	Arg419Cys	NM_006567.5	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Gln72Arg	0.24741655803828166	1.0	4.702104534023035	0.02963822409905847	2025_01_Batch_13-14	0.8404551441656817	0.7754964205830374	0.837775074527558	0.8251264733635165	0.8047790859084806	0.8332409798147502	0.8050645864342636	0.8334475372535564	0.8409806560931491	0.7971694820587821	0.8368480619902159	0.7902805035086504	0.8356113058905572	0.8330535647283328	0.8009742839836314	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038628		NC_000007.14:45063928:A:G		Gln72Arg																												CCM2_Gln72Arg	7	45063928	A	G	7	allele	215A>G	H08	527_CAVA_Array_P06	O16	B13A7A8P2_R1	B14A7A8P2_R2				7-45063928-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Cys95Trp	2.1174108905084634	0.25563446626635816	-1.491000957661587	0.23274383192261294	2025_01_Batch_13-14	0.6617335274570855	0.805767475717292	0.7057777209753036	0.7165035141792934	0.6139034617369616	0.9055479247847438	0.8463627931994039	0.8141494462461819	0.9072275184425841	0.8097659020203224	0.7836407261209146	0.826065134458348	0.7599635836107428	0.8118655163109387	0.7118346818786421	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008910		NC_000003.12:12611985:G:C		Cys95Trp																												RAF1_Cys95Trp	3	12611985	G	C	3	allele	285C>G	A05	527_CAVA_Array_P05	A09	B13A7A8P2_R1	B14A7A8P2_R2				3-12611985-G-C	165011	3	12611985	G	C	C	W	rs727503384	3	12653484	3	12628484	95	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.285C>G	p.Cys95Trp	principal3	Y	.	.	.	-	TGC	3	2	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.38356	.	1.0	0.90580	D	0.996	0.84488	D	.	0.94956	.	.	.	.	2.485	0.72164	M	.	0.79947	.	.	0.79136	0.1432	0.84874	D	0.5496	0.83427	D	10	.	0.89682	.	0.141331	0.82326	D	.	0.91849	0.754	0.88343	P04049	C95W	Gain of MoRF binding (P = 0.0301)| Gain of sheet (P = 0.0827)| Gain of catalytic residue at C96 (P = 0.2212)| Loss of loop (P = 0.2897)| Loss of stability (P = 0.5099)	.	0.87322	.	0.85122	.	0.87009	0.869541406631	0.92491	D	0.903854	0.98115	D	0.365418	0.87570	D	0.287121	0.87410	D	0.994695365428925	0.86028	D	.	0.92203	.	0.87996113	0.89519	0.8072368	0.88581	0.8894862	0.90329	0.8686348	0.92675	-10.122	0.74995	D	.	0.94636	.	0.999741413090409	0.97751	0.95872940	0.93882	0.627	0.79193	.	.	.	.	.	.	4.838956	0.79021	27.0	0.99282249625692609	0.58002	0.756013	0.69429	D	0.698857312374925	0.79444	7.102922	0.676399396255758	0.80484	7.33289	5.77	4.71	0.58959	3.37	0.61085	3.451	0.52821	6.510000	0.55873	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Noonan_syndrome	criteria_provided,_single_submitter	NC_000003.12:g.12611985G>C	ClinGen:CA273221	C0028326	PS163950	648	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	Cys	Trp	173887	single nucleotide variant	NM_002880.4(RAF1):c.285C>G (p.Cys95Trp)	5894	RAF1	HGNC:9829	Likely pathogenic	1	Aug 11, 2014	727503384	-	RCV000151719	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	germline	germline	GRCh38	NC_000003.12	3	12611985	12611985	3p25.2	criteria provided, single submitter	1	-	N	ClinGen:CA273221	2	165011	12611985	G	C	-	-	-	-	-	-	SCV000200051	-	-	285C>G 	Cys95Trp	NM_002880.4	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Leu195Pro	1.3531100919295478	1.0	0.8006088357384732	1.0	2025_01_Batch_13-14	0.8354003129683676	0.8232527101893289	0.8886556725142797	0.840994886058129	0.6689998224134572	0.7987028386476526	0.8344321542990475	0.8558208515792041	0.7709650968107554	0.7390684380135412	0.8170515758080101	0.8288424322441882	0.8722382620467419	0.8059799914344422	0.7040341302134991	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038710		NC_000007.14:45068554:T:C		Leu195Pro																												CCM2_Leu195Pro	7	45068554	T	C	7	allele	584T>C	A04	527_CAVA_Array_P07	B07	B13A7A8P2_R1	B14A7A8P2_R2				7-45068554-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Gly361Ala	1.155499028633321	0.5403518469840319	-8.632887687864956	0.0425849344631385	2025_01_Batch_13-14	0.7595018226539966	0.9272565960609439		0.9780376829289873	0.7507258763780502	0.873767237649067	0.9215944194386212	0.9758176547108324	0.9389494908136753	0.8778551909175832	0.8166345301515319	0.9244255077497825		0.9584935868713313	0.8142905336478168	0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008862		NC_000003.12:12599717:C:G		Gly361Ala																												RAF1_Gly361Ala	3	12599717	C	G	3	allele	1082G>C	B03	527_CAVA_Array_P05	C05	B13A7A8P2_R1	B14A7A8P2_R2				3-12599717-C-G	40613	3	12599717	C	G	G	A	rs397516813	3	12641216	3	12616216	361	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.1082G>C	p.Gly361Ala	principal3	Y	.	.	.	-	GGA	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.51463	.	0.997	0.70687	D	0.977	0.73823	D	.	0.94956	.	.	.	.	1.905	0.50677	L	.	0.87174	.	.	0.97765	0.7110	0.93289	D	0.7939	0.92997	D	10	.	0.98222	.	0.320475	0.91439	D	.	0.97773	0.932	0.98955	P04049	G361A	Gain of glycosylation at T362 (P = 0.0323)| Loss of methylation at K365 (P = 0.0936)| Gain of catalytic residue at G361 (P = 0.1011)| Gain of MoRF binding (P = 0.1018)| Loss of disorder (P = 0.134)	.	0.98954	.	0.94466	.	0.97266	0.90528345108	0.97002	D	0.939635	0.99031	D	0.455678	0.92679	D	0.416773	0.92588	D	0.996657013893127	0.89711	D	.	0.97197	.	0.9621787	0.97458	0.92825574	0.96930	0.9493423	0.96139	0.9189513	0.96273	-12.08	0.85279	D	.	0.96519	.	0.999868252519254	0.98431	0.99697757	0.98223	0.967	0.98682	.	.	.	.	.	.	5.440165	0.9094	32.0	0.99865175337036671	0.94371	0.911494	0.87038	D	0.841710195614201	0.88569	9.651506	0.835976326801195	0.92127	11.27517	5.52	5.52	0.82128	.	.	7.9	0.86061	7.697000	0.66139	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.999	0.91597	677	0.60231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|RASopathy|Noonan_syndrome|Noonan_syndrome_5|LEOPARD_syndrome_2	reviewed_by_expert_panel	NC_000003.12:g.12599717C>G	ClinGen:CA134687	C3661900|C5555857|C0028326|C1969057|C1969056	PS163950|611553|611554	536391|648|648|500	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Ala	49083	single nucleotide variant	NM_002880.4(RAF1):c.1082G>C (p.Gly361Ala)	5894	RAF1	HGNC:9829	Pathogenic	1	Apr 03, 2017	397516813	-	RCV000037671|RCV000159081|RCV000473341|RCV001542563|RCV000987116	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500	Noonan syndrome|not provided|RASopathy|Noonan syndrome 5|LEOPARD syndrome 2	germline;unknown	germline	GRCh38	NC_000003.12	3	12599717	12599717	3p25.2	reviewed by expert panel	8	-	N	ClinGen:CA134687	2	40613	12599717	C	G	-	-	-	-	-	-	SCV000616425	-	-	1082G>C 	Gly361Ala	NM_002880.4	3	1_Pathogenic																																																																																																									
CCM2	CCM2_Ser202Arg	3.624114012303276	1.0	-0.35047675688450103	1.0	2025_01_Batch_13-14	0.7634995525984988	0.7887481705988423	0.8475453720516679	0.8740163601069599	0.7046331571494321	0.7077904334468801	0.6830134825388986	0.7765025778400512	0.7281359243789243	0.6121379344019616	0.7356449930226894	0.7358808265688704	0.8120239749458595	0.8010761422429421	0.6583855457756969	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038715		NC_000007.14:45068576:C:G		Ser202Arg																												CCM2_Ser202Arg	7	45068576	C	G	7	allele	606C>G	F04	527_CAVA_Array_P07	L07	B13A7A8P2_R1	B14A7A8P2_R2				7-45068576-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Val45Gly	1.4672760043934012	1.0	8.752267046181695	0.016063906465168573	2025_01_Batch_13-14	0.7988265669012168	0.7720923237813951	0.8005138997060072	0.8153970754061732	0.7744433989741218	0.8169692149893691	0.8254750022704905	0.870608077345835	0.7883428965892153	0.7917969409187992	0.807897890945293	0.7987836630259428	0.8355609885259211	0.8018699859976943	0.7831201699464605	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038617		NC_000007.14:45038356:T:G		Val45Gly																												CCM2_Val45Gly	7	45038356	T	G	7	allele	134T>G	E07	527_CAVA_Array_P06	I14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038356-T-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr44Ser	3.463290838198223	1.0	10.702721826598802	0.0027162697981598753	2025_01_Batch_13-14	0.8949033676369532	0.9305572000643352	0.8954540004799242	0.8855564049477054	0.7890734202391507	0.8774232829344161	0.9338850836523059	0.9060882479325999	0.8753137336523803	0.8294570903372719	0.8861633252856846	0.9322211418583206	0.900771124206262	0.8804350693000429	0.8092652552882114	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038615		NC_000007.14:45038352:A:T		Thr44Ser																												CCM2_Thr44Ser	7	45038352	A	T	7	allele	130A>T	C07	527_CAVA_Array_P06	E14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038352-A-T	2626151	7	45038352	A	T	T	S	rs746014166	7	45077951	7	45044476	44	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.130A>T	p.Thr44Ser	c.130A>T	p.Thr44Ser	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.787	0.03809	T	0.662	0.10631	T	0.995	0.67505	D	0.852	0.60752	P	0.41	0.76257	N	simple_aae	59.0	41.0	1.32	0.32853	L	0.22	0.09239	N	0.637	0.67054	-0.8767	0.49824	T	0.1993	0.55334	T	10	0.4302671	0.57102	D	0.044131	0.61190	D	0.280	0.59538	0.216	0.13567	Q9BSQ5	T44S	Loss of glycosylation at T44 (P = 0.0422)| Gain of disorder (P = 0.0529)| Gain of loop (P = 0.1081)| Gain of phosphorylation at S48 (P = 0.1245)| Gain of MoRF binding (P = 0.1321)	0.583804852878	0.57737	.	0.36446	.	0.53727	0.679253160954	0.64102	T	0.045314	0.26824	T	-0.014758	0.49270	T	-0.0563213	0.66349	D	0.793019354343414	0.45601	D	0.753825	0.41920	T	0.17064792	0.37350	0.11129751	0.26787	0.17064792	0.37349	0.11129751	0.26786	-7.699	0.62154	D	0.1444	0.44312	B	0.00652528497579297	0.20736	0.94883376	0.93311	0.148	0.38090	.	.	.	.	.	.	2.897406	0.38464	20.7	0.46020110755485649	0.03691	0.924106	0.90125	D	0.469070945522157	0.65113	4.804316	0.526967188486197	0.69646	5.41391	5.36	5.36	0.76590	2.96	0.54135	8.811	0.91595	10.861000	0.84000	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	740	0.53031	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	109388	0.000000e+00	0	3	208106	1.441570e-05	0	3	236920	1.266250e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13374	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16714	0.000000e+00	0	0	89552	0.000000e+00	0	3	30608	9.801360e-05	0	3	30608	9.801360e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21612	0.000000e+00	0	0	102740	0.000000e+00	0	3	30526	9.827690e-05	0	3	30526	9.827690e-05	0	.	9	1614062	5.575990e-06	0	8	91090	8.782520e-05	0	0	74928	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	0	44896	0.000000e+00	0	0	64030	0.000000e+00	0	0	6084	0.000000e+00	0	0	1180022	0.000000e+00	0	8	91090	8.782520e-05	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45038352A>T	.	C0950123	.	.	.	Thr	Ser	2793919	single nucleotide variant	NM_031443.4(CCM2):c.130A>T (p.Thr44Ser)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jul 03, 2023	-1	-	RCV003382131	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45038352	45038352	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4246874	2	2626151	45038352	A	T	-	-	-	-	-	-	SCV004096640	-	-	130A>T 	Thr44Ser	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Glu223Val	2.3355111849529266	1.0	-4.223314854845577	1.0	2025_01_Batch_13-14	0.7855545162898211	0.8560499240032793	0.8629999962820317	0.8371951582814438	0.658751942669772	0.807432384693024	0.8694243338718853	0.9171584988539413	0.8691795527908852	0.7597577262132714	0.7964934504914225	0.8627371289375823	0.8900792475679865	0.8531873555361644	0.7092548344415217	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038728		NC_000007.14:45069884:A:T		Glu223Val																												CCM2_Glu223Val	7	45069884	A	T	7	allele	668A>T	C06	527_CAVA_Array_P07	F11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069884-A-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile372Leu	0.1793990097339774	1.0	16.615937825551054	5.094329318158059e-6	2025_01_Batch_13-14	0.9295370090462484	0.9701572787060849	0.9857683152845063	0.9756459816011422	0.8559786952773459	0.8799481152049031	0.9668975119896513	0.9828244416869643	0.9565150011921029	0.796789036725583	0.9047425621255758	0.9685273953478681	0.9842963784857353	0.9660804913966226	0.8263838660014644	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038801		NC_000007.14:45075836:A:C		Ile372Leu																												CCM2_Ile372Leu	7	45075836	A	C	7	allele	1114A>C	C11	527_CAVA_Array_P07	F21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075836-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Val111Ile	7.7451222208037676	0.00011337695822120214	-1.6891303326515856	1.0	2025_01_Batch_13-14	0.6806283428302172	0.7903913226120411	0.7415580184685204	0.7197309821074369	0.6622642931221312	0.8362832234515796	0.8743478894614917	0.8712212938742474	0.8831303715286605	0.6754168939249733	0.7584557831408985	0.8323696060367665	0.8063896561713839	0.8014306768180487	0.6688405935235522	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023342		NC_000011.10:112094821:G:A		Val111Ile																												SDHD_Val111Ile	11	112094821	G	A	11	allele	331G>A	H12	527_CAVA_Array_P05	O23	B13A7A8P2_R1	B14A7A8P2_R2				11-112094821-G-A	412515	11	112094821	G	A	V	I	rs201869798	11	111965545	11	111470755	111	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.331G>A	p.Val111Ile	c.331G>A	p.Val111Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	./.	./.	./.	./.	0.26	0.16832	T	0.779	0.15871	T	0.104	0.25957	B	0.055	0.25997	B	0.9	0.92786	D	simple_aae	10.0	90.0	.	.	.	-0.14	0.09078	N	0.052	0.11434	0.4711	0.90098	D	0.7829	0.92608	D	10	0.2911021	0.46306	D	0.050089	0.63956	D	0.572	0.82541	0.872	0.96404	O14521	V111I	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Gain of phosphorylation at Y114 (P = 0.2011)| Gain of catalytic residue at V111 (P = 0.4375)| Loss of disorder (P = 0.6326)	0.97911266155	0.97867	0.7076145117288314	0.70553	0.181760226822	0.20157	0.386111408472	0.23094	T	0.505437	0.82256	D	0.180199	0.71854	D	0.246769	0.85364	D	0.826030075550079	0.47946	D	0.852415	0.53609	D	0.023600794	0.01108	0.059936233	0.11338	0.027904507	0.02032	0.051471613	0.08303	-2.495	0.10596	T	0.081	0.08359	B	0.0132951746215333	0.26155	0.98876506	0.96548	0.232	0.50061	.	.	.	.	.	.	2.179907	0.27837	17.58	0.97373826413851394	0.33813	0.151882	0.27431	N	-0.212263563345696	0.32351	1.842281	-0.0625121141246808	0.36653	2.157289	4.85	2.83	0.32068	.	.	1.908	0.39642	3.805000	0.39965	0.672	0.70176	1.0	0.71675	1.000000	0.68239	1.0	0.97202	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	segdup	1	109400	9.140770e-06	0	3	207800	1.443700e-05	0	3	236248	1.269850e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16100	0.000000e+00	0	1	30508	3.277830e-05	0	0	6206	0.000000e+00	0	2	13416	1.490760e-04	0	0	16734	0.000000e+00	0	0	89376	0.000000e+00	0	0	30606	0.000000e+00	0	2	13416	1.490760e-04	0	0	14784	0.000000e+00	0	1	34244	2.920220e-05	0	0	9566	0.000000e+00	0	2	17692	1.130450e-04	0	0	21630	0.000000e+00	0	0	102210	0.000000e+00	0	0	30524	0.000000e+00	0	2	17692	1.130450e-04	0	.	111	1611796	6.886730e-05	0	109	44898	2.427730e-03	0	0	74848	0.000000e+00	0	0	912	0.000000e+00	0	2	59980	3.334440e-05	0	0	29602	0.000000e+00	0	109	44898	2.427730e-03	0	0	64020	0.000000e+00	0	0	4452	0.000000e+00	0	0	1179800	0.000000e+00	0	0	90990	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|Paragangliomas_1	criteria_provided,_conflicting_classifications	NC_000011.10:g.112094821G>A	ClinGen:CA071246	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|C5436934|C3494181	606864|171300|619167|168000	140162|97286|29072|201|29072	.	Val	Ile	398070	single nucleotide variant	NM_003002.4(SDHD):c.331G>A (p.Val111Ile)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0	Jan 21, 2025	201869798	-	RCV002230665|RCV003325203|RCV003476144|RCV000565076|RCV001591105	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1|Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary cancer-predisposing syndrome|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	112094821	112094821	11q23.1	criteria provided, conflicting classifications	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071246	2	412515	112094821	G	A	-	-	-	-	-	-	SCV000554067|SCV000675110|SCV001825380|SCV004031142|SCV004203107	-	-	331G>A 	Val111Ile	NM_003002.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Ile432Thr	1.7440533215258014	1.0	2.684169364071653	1.0	2025_01_Batch_13-14	0.8788018778302455	0.9645305094073611	0.9910946895358806	0.958594833639617	0.988424617250739	0.7364537662324585	0.9554142014836097	0.9881049983215121	0.9415907402739742	0.9789010606822018	0.807627822031352	0.9599723554454853	0.9895998439286964	0.9500927869567956	0.9836628389664704	0.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	true	CCM2		3928		CCSBVarC038846		NC_000007.14:45076017:T:C		Ile432Thr																												CCM2_Ile432Thr	7	45076017	T	C	7	allele	1295T>C	E03	527_CAVA_Array_P08	J06	B13A7A8P2_R1	B14A7A8P2_R2				7-45076017-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Met439Ile	0.8084912339972291	1.0	1.1631840374033022	1.0	2025_01_Batch_13-14	0.9291423796907915	0.9139383777618382	0.941952539301958	0.9409044361064745	0.9040069321648939	0.809586604455384	0.9046180467835087	0.8889886844304904	0.8392179038293791	0.7565603115686406	0.8693644920730877	0.9092782122726735	0.9154706118662241	0.8900611699679268	0.8302836218667673	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038849		NC_000007.14:45076039:G:A		Met439Ile																												CCM2_Met439Ile	7	45076039	G	A	7	allele	1317G>A	H03	527_CAVA_Array_P08	P06	B13A7A8P2_R1	B14A7A8P2_R2				7-45076039-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Leu107Pro	0.2849529271708783	1.0	-2.0252207164999985	1.0	2025_01_Batch_13-14	0.8333986418202681	0.8569743213124418	0.8474656162013808	0.8993651620405937	0.7837756991153474	0.8327255249968093	0.821351088417951	0.8226978236124418	0.8458497429542634	0.7879415508181176	0.8330620834085387	0.8391627048651964	0.8350817199069114	0.8726074524974285	0.7858586249667325	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023335		NC_000011.10:112094810:T:C		Leu107Pro																												SDHD_Leu107Pro	11	112094810	T	C	11	allele	320T>C	G12	527_CAVA_Array_P05	M23	B13A7A8P2_R1	B14A7A8P2_R2				11-112094810-T-C	1728924	11	112094810	T	C	L	P	.	11	111965534	11	111470744	107	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.320T>C	p.Leu107Pro	c.320T>C	p.Leu107Pro	principal1	Y	1	YES	Select	+	CTT	2	0	T	./.	./.	./.	./.	0.002	0.72322	D	0.006	0.74454	D	0.989	0.62839	D	0.926	0.66089	D	0.96	0.95575	D	simple_aae	4.0	96.0	.	.	.	-5.05	0.82724	D	0.769	0.81497	1.0953	0.99459	D	0.9673	0.98959	D	10	0.91400754	0.90660	D	0.636512	0.96886	D	0.920	0.97963	0.667	0.80417	O14521	L107P	Loss of stability (P = 0.0278)| Gain of sheet (P = 0.039)| Loss of helix (P = 0.079)| Loss of catalytic residue at L107 (P = 0.0817)| Gain of loop (P = 0.0851)	0.93826696464	0.93714	0.9866521081126458	0.98654	0.939674812069	0.72002	0.464732289314	0.33914	T	0.966942	0.99610	D	0.510562	0.94567	D	0.49561	0.94487	D	0.983124061519632	0.74730	D	0.839116	0.51220	T	0.9550924	0.96731	0.9385074	0.97635	0.9550924	0.96731	0.9385074	0.97635	-14.207	0.94089	D	0.8325	0.78811	P	0.995669802072404	0.91503	0.99935895	0.99325	0.994	0.99793	.	.	.	.	.	.	4.675112	0.74806	26.2	0.99891369030107691	0.96515	0.966134	0.98849	D	0.781789244315126	0.84870	8.434356	0.709516226177353	0.83010	7.934285	4.53	4.53	0.54956	.	.	7.682	0.8343	7.854000	0.71149	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.999	0.91597	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_cancer-predisposing_syndrome	criteria_provided,_single_submitter	NC_000011.10:g.112094810T>C	.	C0027672	.	140162	.	Leu	Pro	1785214	single nucleotide variant	NM_003002.4(SDHD):c.320T>C (p.Leu107Pro)	6392	SDHD	HGNC:10683	Likely pathogenic	1	May 30, 2024	-1	-	RCV002324587	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000011.10	11	112094810	112094810	11q23.1	criteria provided, single submitter	1	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618744	2	1728924	112094810	T	C	-	-	-	-	-	-	SCV002609368	-	-	320T>C 	Leu107Pro	NM_003002.4	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Tyr261Asp	1.6201311793557214	1.0	4.765518863739097	1.0	2025_01_Batch_13-14	0.9678439433920593	0.9286911345531074	0.9264735966528761	0.9768222528083336	0.9169145487491908	0.9037559616642632	0.8793998921086766	0.7796915285498078	0.8142000128772228	0.800675459141263	0.9357999525281613	0.904045513330892	0.853082562601342	0.8955111328427782	0.8587950039452269	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038744		NC_000007.14:45072761:T:G		Tyr261Asp																												CCM2_Tyr261Asp	7	45072761	T	G	7	allele	781T>G	H07	527_CAVA_Array_P07	P13	B13A7A8P2_R1	B14A7A8P2_R2				7-45072761-T-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Cys211Ser	3.588164196775109	1.0	13.1141756213403	0.0005030101871834164	2025_01_Batch_13-14	0.8406451435026976	0.8635285048844469	0.8630519171957528	0.8647272802068257	0.7496584141372565	0.8149492624052096	0.8902174359428093	0.9232083191683765	0.8601884766072211	0.7699954298287028	0.8277972029539535	0.8768729704136281	0.8931301181820647	0.8624578784070234	0.7598269219829796	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038719		NC_000007.14:45069848:G:C		Cys211Ser																												CCM2_Cys211Ser	7	45069848	G	C	7	allele	632G>C	B05	527_CAVA_Array_P07	D09	B13A7A8P2_R1	B14A7A8P2_R2				7-45069848-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala293Thr	-1.1749111388264553	1.0	12.145225273949288	0.00003302541075621193	2025_01_Batch_13-14	0.8902382525827509	0.8819598074742071	0.9280342793302466	0.9459369734100079	0.8312800849462892	0.8255618671860593	0.8667297878773154	0.9186006563782313	0.8571454162203307	0.8019960695884931	0.8579000598844051	0.8743447976757612	0.923317467854239	0.9015411948151693	0.8166380772673911	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038761		NC_000007.14:45073533:G:A		Ala293Thr																												CCM2_Ala293Thr	7	45073533	G	A	7	allele	877G>A	H08	527_CAVA_Array_P07	P15	B13A7A8P2_R1	B14A7A8P2_R2				7-45073533-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly188Trp	2.1840386741212865	1.0	16.36406377309401	0.00003085660114829828	2025_01_Batch_13-14	0.8654049252398939	0.8380017832806993	0.8992370594724064	0.8576290538176289	0.699830260365007	0.7456634772976611	0.8490020211120746	0.9259156971558442	0.8250373659511073	0.7081429335840672	0.8055342012687775	0.843501902196387	0.9125763783141253	0.8413332098843681	0.7039865969745371	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038706		NC_000007.14:45068532:G:T		Gly188Trp																												CCM2_Gly188Trp	7	45068532	G	T	7	allele	562G>T	F03	527_CAVA_Array_P07	L05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068532-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BRIP1	BRIP1_Thr266Lys	2.4151939589858755	0.10172105859617687	-2.8097461543970716	0.1251885088372282	2025_01_Batch_13-14	0.7205994418325682	0.9278881751694511	0.9779481071676986	0.9367839182156471	0.9552154710492178	0.7507343851230628	0.90745197332534	0.9776304937469608	0.9504104860230399	0.9607925001991933	0.7356669134778155	0.9176700742473956	0.9777893004573297	0.9435972021193435	0.9580039856242055	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	true	BRIP1		55128		CCSBVarC031356		NC_000017.11:61808588:G:T		Thr266Lys																												BRIP1_Thr266Lys	17	61808588	G	T	17	allele	797C>A	C01	527_CAVA_Array_P02	E02	B13A7A8P1_R1	B14A7A8P1_R2				17-61808588-G-T	2445403	17	61808588	G	T	T	K	.	17	59885949	17	57240731	266	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.797C>A	p.Thr266Lys	principal2	Y	.	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.74454	.	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4	0.96696	H	.	0.85874	.	.	0.91621	0.4095	0.89196	D	0.6264	0.86824	D	9	.	0.90945	.	0.281209	0.90215	D	.	0.94975	0.679	0.81610	Q9BX63	T266K	Gain of MoRF binding (P = 0.0353)| Loss of phosphorylation at T266 (P = 0.0447)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1066)| Loss of glycosylation at S269 (P = 0.1314)	.	0.95729	.	0.92109	.	0.62958	0.605375230312	0.53597	T	0.789212	0.94460	D	0.37424	0.88252	D	0.299793	0.88104	D	0.999525785446167	0.97739	D	0.90121	0.65586	D	0.92582095	0.93727	0.89155954	0.94301	0.92582095	0.93728	0.89155954	0.94301	-16.593	0.98525	D	.	0.87809	.	0.982054469378051	0.85829	0.98299720	0.95833	0.767	0.87099	.	.	.	.	.	.	4.777777	0.77458	26.7	0.99354365820043622	0.60794	0.906865	0.85967	D	0.929815744903823	0.93103	11.84782	0.873075489682459	0.94258	12.64629	5.29	5.29	0.74394	.	.	9.212	0.94247	11.864000	0.98400	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.878	0.41977	46	0.97740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Ovarian_cancer	criteria_provided,_single_submitter	NC_000017.11:g.61808588G>T	.	C1140680	167000	213500	.	Thr	Lys	2419129	single nucleotide variant	NM_032043.3(BRIP1):c.797C>A (p.Thr266Lys)	83990	BRIP1	HGNC:20473	Likely pathogenic	1	Jan 01, 2022	-1	-	RCV003154813	MONDO:MONDO:0008170,MedGen:C1140680,OMIM:167000,Orphanet:213500	Ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	61808588	61808588	17q23.2	criteria provided, single submitter	1	-	N	ClinGen:CA400484892	2	2445403	61808588	G	T	-	-	-	-	-	-	SCV003843811	-	-	797C>A 	Thr266Lys	NM_032043.3	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Pro77Ser	1.867044332959628	1.0	1.6006170221595992	1.0	2025_01_Batch_13-14	0.8943227379536757	0.8953139295214269	0.8604831826715592	0.8889470625685826	0.7490518443080005	0.7695670562221745	0.8606794898448754	0.8045953512376132	0.8582184151735334	0.7099210216462059	0.8319448970879251	0.8779967096831511	0.8325392669545861	0.873582738871058	0.7294864329771031	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038631		NC_000007.14:45063942:C:T		Pro77Ser																												CCM2_Pro77Ser	7	45063942	C	T	7	allele	229C>T	C09	527_CAVA_Array_P06	E18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063942-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BRIP1	BRIP1_Leu195Pro	1.2668702182308096	0.2718645879814718	-1.898944257778324	0.3193129417034555	2025_01_Batch_13-14	0.737611718470406	0.6595460545978806	0.6706831149265664	0.6998852237962895	0.6857644396183068	0.663999942831503	0.7121556631762217	0.6922164654476003	0.7070030808612925	0.6409849852160716	0.7008058306509545	0.6858508588870511	0.6814497901870833	0.703444152328791	0.6633747124171891	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1	ENSG00000136492	55128	28906	CCSBVarC002407	ALE00002407	NC_000017.11:61847144:A:G	584T>C	Leu195Pro	RC4	RC4_Mut_GDEh1031	G07	GDEhDisVCh_40040	B12	2	RC4_Mut_GDDh1031	G07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			BRIP1_Leu195Pro	17	61847144	A	G	17											17-61847144-A-G	128193	17	61847144	A	G	L	P	rs4988347	17	59924505	17	57279287	195	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.584T>C	p.Leu195Pro	principal2	Y	.	.	.	-	CTC	2	0	A	A/A	A/A	A/A	A/A	.	0.13823	.	.	0.15573	.	0.0	0.02950	B	0.001	0.04348	B	.	0.37131	.	.	.	.	0.75	0.18917	N	.	0.08443	.	.	0.14123	-0.9191	0.45481	T	0.1553	0.48453	T	9	.	0.00085	.	0.03251	0.54133	D	.	0.29213	.	.	.	.	.	.	0.39799	.	0.47148	.	0.28563	0.3499096632	0.17890	T	0.06698	0.32835	T	-0.505713	0.00508	T	-0.505056	0.21493	T	0.00119638136319552	0.00012	T	.	0.13035	.	0.031770874	0.03049	0.031210301	0.01687	0.029862495	0.02528	0.03966814	0.04125	-4.048	0.24602	T	.	0.00668	.	0.00173275598557616	0.12269	0.23876125	0.74722	0.019	0.02684	.	.	.	.	.	.	0.472332	0.08447	5.175	0.2264141844658854	0.00915	0.039188	0.05557	N	-1.11276007648918	0.06339	0.2952269	-1.00712536356647	0.09467	0.4800915	5.26	-0.0114	0.13280	-1.01	0.15704	0.364	0.20126	3.456000	0.38560	-0.592	0.0465	0.393	0.262	0.999000	0.35501	0.001	0.02614	45	0.97779	4	7.987220447284345E-4	0	0.0	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	2	0.002044989775051125	318	264690	0.0012014054	.	270	109370	2.468680e-03	1	407	208056	1.956200e-03	2	467	236808	1.972060e-03	2	2	7160	2.793300e-04	0	11	17112	6.428240e-04	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	149	13378	1.113770e-02	1	94	42762	2.198210e-03	0	8	15688	5.099440e-04	0	94	42762	2.198210e-03	0	8	16212	4.934620e-04	0	21	30524	6.879830e-04	1	0	6208	0.000000e+00	0	0	13404	0.000000e+00	0	175	16718	1.046780e-02	1	178	89524	1.988290e-03	0	13	30604	4.247810e-04	0	178	89524	1.988290e-03	0	8	14896	5.370570e-04	0	25	34260	7.297140e-04	1	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	197	21616	9.113620e-03	1	211	102658	2.055370e-03	0	13	30522	4.259220e-04	0	211	102658	2.055370e-03	0	.	3615	1613712	2.240180e-03	7	525	64018	8.200820e-03	0	32	75020	4.265530e-04	0	0	912	0.000000e+00	0	56	60024	9.329600e-04	1	0	29594	0.000000e+00	0	0	44838	0.000000e+00	0	525	64018	8.200820e-03	0	0	6056	0.000000e+00	0	2836	1179684	2.404030e-03	5	39	91082	4.281860e-04	1	322	198354	0.001623360254897809	0	360	0	0	2728	0	5	9426	5.304476978569913E-4	0	794	0	0	964	0	0	672	0	0	276	0	28	15672	0.0017866258295048494	5	9786	5.109339873288372E-4	0	3400	0	355	229246	0.0015485548275651483	Benign/Likely_benign	BRIP1-related_disorder|Breast_and/or_ovarian_cancer|Fanconi_anemia_complementation_group_J|not_specified|Ovarian_neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.61847144A>G	ClinGen:CA157725	CN239206|CN221562|C1836860|CN169374|C0919267|C0027672|C0346153|C3661900	609054|114480	84|140162|227535	.	Leu	Pro	133650	single nucleotide variant	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	83990	BRIP1	HGNC:20473	Benign/Likely benign	0	Mar 04, 2025	4988347	-	RCV000120407|RCV000116162|RCV000410203|RCV000411259|RCV000990029|RCV000589840|RCV001798361|RCV004528812|RCV001082551	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J|Ovarian neoplasm|Familial cancer of breast|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Fanconi anemia complementation group J;Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61847144	61847144	17q23.2	criteria provided, multiple submitters, no conflicts	25	-	N	ClinGen:CA157725	2	128193	61847144	A	G	-	-	-	-	-	-	SCV000150071|SCV000166684|SCV000172953|SCV000489853|SCV000489854|SCV000699730|SCV000889221|SCV000910543|SCV001140793|SCV001157291|SCV001287318|SCV002043640|SCV002066143|SCV002533721|SCV002551206|SCV002819151|SCV004016923|SCV004145821|SCV005404126	-	-	584T>C 	Leu195Pro	NM_032043.3	2	2_Benign	17	61847144	A	G	0.00227726																																																																																																				
BRIP1	BRIP1_Leu195Pro	1.2668702182308096	0.2718645879814718	-1.898944257778324	0.3193129417034555	2025_01_Batch_13-14	0.737611718470406	0.6595460545978806	0.6706831149265664	0.6998852237962895	0.6857644396183068	0.663999942831503	0.7121556631762217	0.6922164654476003	0.7070030808612925	0.6409849852160716	0.7008058306509545	0.6858508588870511	0.6814497901870833	0.703444152328791	0.6633747124171891	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1		55128		CCSBVarC002407		NC_000017.11:61847144:A:G		Leu195Pro																												BRIP1_Leu195Pro	17	61847144	A	G	17	allele	584T>C	H12	527_CAVA_Array_P01	O23	B13A7A8P1_R1	B14A7A8P1_R2				17-61847144-A-G	128193	17	61847144	A	G	L	P	rs4988347	17	59924505	17	57279287	195	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.584T>C	p.Leu195Pro	principal2	Y	.	.	.	-	CTC	2	0	A	A/A	A/A	A/A	A/A	.	0.13823	.	.	0.15573	.	0.0	0.02950	B	0.001	0.04348	B	.	0.37131	.	.	.	.	0.75	0.18917	N	.	0.08443	.	.	0.14123	-0.9191	0.45481	T	0.1553	0.48453	T	9	.	0.00085	.	0.03251	0.54133	D	.	0.29213	.	.	.	.	.	.	0.39799	.	0.47148	.	0.28563	0.3499096632	0.17890	T	0.06698	0.32835	T	-0.505713	0.00508	T	-0.505056	0.21493	T	0.00119638136319552	0.00012	T	.	0.13035	.	0.031770874	0.03049	0.031210301	0.01687	0.029862495	0.02528	0.03966814	0.04125	-4.048	0.24602	T	.	0.00668	.	0.00173275598557616	0.12269	0.23876125	0.74722	0.019	0.02684	.	.	.	.	.	.	0.472332	0.08447	5.175	0.2264141844658854	0.00915	0.039188	0.05557	N	-1.11276007648918	0.06339	0.2952269	-1.00712536356647	0.09467	0.4800915	5.26	-0.0114	0.13280	-1.01	0.15704	0.364	0.20126	3.456000	0.38560	-0.592	0.0465	0.393	0.262	0.999000	0.35501	0.001	0.02614	45	0.97779	4	7.987220447284345E-4	0	0.0	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	2	0.002044989775051125	318	264690	0.0012014054	.	270	109370	2.468680e-03	1	407	208056	1.956200e-03	2	467	236808	1.972060e-03	2	2	7160	2.793300e-04	0	11	17112	6.428240e-04	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	149	13378	1.113770e-02	1	94	42762	2.198210e-03	0	8	15688	5.099440e-04	0	94	42762	2.198210e-03	0	8	16212	4.934620e-04	0	21	30524	6.879830e-04	1	0	6208	0.000000e+00	0	0	13404	0.000000e+00	0	175	16718	1.046780e-02	1	178	89524	1.988290e-03	0	13	30604	4.247810e-04	0	178	89524	1.988290e-03	0	8	14896	5.370570e-04	0	25	34260	7.297140e-04	1	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	197	21616	9.113620e-03	1	211	102658	2.055370e-03	0	13	30522	4.259220e-04	0	211	102658	2.055370e-03	0	.	3615	1613712	2.240180e-03	7	525	64018	8.200820e-03	0	32	75020	4.265530e-04	0	0	912	0.000000e+00	0	56	60024	9.329600e-04	1	0	29594	0.000000e+00	0	0	44838	0.000000e+00	0	525	64018	8.200820e-03	0	0	6056	0.000000e+00	0	2836	1179684	2.404030e-03	5	39	91082	4.281860e-04	1	322	198354	0.001623360254897809	0	360	0	0	2728	0	5	9426	5.304476978569913E-4	0	794	0	0	964	0	0	672	0	0	276	0	28	15672	0.0017866258295048494	5	9786	5.109339873288372E-4	0	3400	0	355	229246	0.0015485548275651483	Benign/Likely_benign	BRIP1-related_disorder|Breast_and/or_ovarian_cancer|Fanconi_anemia_complementation_group_J|not_specified|Ovarian_neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.61847144A>G	ClinGen:CA157725	CN239206|CN221562|C1836860|CN169374|C0919267|C0027672|C0346153|C3661900	609054|114480	84|140162|227535	.	Leu	Pro	133650	single nucleotide variant	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	83990	BRIP1	HGNC:20473	Benign/Likely benign	0	Mar 04, 2025	4988347	-	RCV000120407|RCV000116162|RCV000410203|RCV000411259|RCV000990029|RCV000589840|RCV001798361|RCV004528812|RCV001082551	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J|Ovarian neoplasm|Familial cancer of breast|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Fanconi anemia complementation group J;Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61847144	61847144	17q23.2	criteria provided, multiple submitters, no conflicts	25	-	N	ClinGen:CA157725	2	128193	61847144	A	G	-	-	-	-	-	-	SCV000150071|SCV000166684|SCV000172953|SCV000489853|SCV000489854|SCV000699730|SCV000889221|SCV000910543|SCV001140793|SCV001157291|SCV001287318|SCV002043640|SCV002066143|SCV002533721|SCV002551206|SCV002819151|SCV004016923|SCV004145821|SCV005404126	-	-	584T>C 	Leu195Pro	NM_032043.3	2	2_Benign	17	61847144	A	G	0.00227726																																																																																																				
RAF1	RAF1_Pro225Ser	0.045139855443872445	1.0	2.0699418157000897	1.0	2025_01_Batch_13-14	0.6512782784969561	0.7999178543484294	0.8474914559883338	0.7688429176710421	0.6431031842912733	0.5939375746955838	0.7949831825516199	0.8322379078372641	0.7539172573256406	0.5492221396366254	0.62260792659627	0.7974505184500247	0.839864681912799	0.7613800874983414	0.5961626619639493	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
BRIP1	BRIP1_Gln255His	0.732346824162546	0.5112396507139866	-0.835991169340316	1.0	2025_01_Batch_13-14	0.7502156437554369	0.7841145318724635	0.8066482874246345	0.7927843692248923	0.6969966491731286	0.8171288577429179	0.8116297048057426	0.782100385457583	0.8591976244199683	0.7232732673439862	0.7836722507491773	0.7978721183391031	0.7943743364411087	0.8259909968224303	0.7101349582585574	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1		55128		CCSBVarC031354		NC_000017.11:61808620:C:A		Gln255His																												BRIP1_Gln255His	17	61808620	C	A	17	allele	765G>T	B01	527_CAVA_Array_P02	C02	B13A7A8P1_R1	B14A7A8P1_R2				17-61808620-C-A	929523	17	61808620	C	A	Q	H	rs2078111971	17	59885981	17	57240763	255	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.765G>T	p.Gln255His	principal2	Y	.	.	.	-	CAG	3	2	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.76775	.	1.0	0.90580	D	0.999	0.92348	D	.	0.90832	.	.	.	.	4.365	0.98493	H	.	0.79862	.	.	0.99419	0.5765	0.91558	D	0.6879	0.89189	D	9	.	0.98250	.	0.227769	0.88077	D	.	0.93600	0.913	0.98298	Q9BX63	Q255H	Gain of phosphorylation at T252 (P = 0.1383)| Gain of catalytic residue at K254 (P = 0.178)| Loss of methylation at K254 (P = 0.1938)| Loss of disorder (P = 0.2059)| Gain of helix (P = 0.2294)	.	0.97798	.	0.96706	.	0.58020	0.720037281513	0.70000	T	0.799612	0.94832	D	0.393787	0.89480	D	0.327871	0.89348	D	0.999322414398193	0.96939	D	0.918508	0.70644	D	0.92846745	0.93994	0.8937532	0.94458	0.9292196	0.94071	0.88003564	0.93477	-14.306	0.94021	D	.	0.97151	.	0.999870395781411	0.98499	0.98894000	0.96574	0.738	0.85485	.	.	.	.	.	.	4.62463	0.73515	26.0	0.99764672733639892	0.85348	0.713631	0.66516	D	0.878838601052151	0.90632	10.51746	0.789515383178468	0.88995	9.820491	5.29	5.29	0.74394	.	.	4.371	0.5938	5.995000	0.52465	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.999	0.91597	46	0.97740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Fanconi_anemia_complementation_group_J	no_assertion_criteria_provided	NC_000017.11:g.61808620C>A	.	C1836860	609054	84	.	Gln	His	917865	single nucleotide variant	NM_032043.3(BRIP1):c.765G>T (p.Gln255His)	83990	BRIP1	HGNC:20473	Pathogenic	1	Feb 07, 2011	2078111971	-	RCV001194716	MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61808620	61808620	17q23.2	no assertion criteria provided	1	-	N	ClinGen:CA400484955	2	929523	61808620	C	A	-	-	-	-	-	-	SCV001364483	-	-	765G>T 	Gln255His	NM_032043.3		1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	0.6317258544338403	0.7175626828034266	0.7067604538877507	0.7237190711631107	0.6348000809610653	0.7814396132952472	0.8348792037272437	0.8978818081707663	0.8382258310191754	0.7005473768703887	0.7065827338645438	0.7762209432653351	0.8023211310292585	0.7809724510911431	0.6676737289157271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2	ENSG00000126970	4320	215107	CCSBVarC005917	ALE00005917	NC_000023.11:64917857:G:A	601C>T	Pro201Ser	CEGS2	CegsMutGDEh1032	E08	GDEhDisVCh_40034	A12	2	CegsMutGDDh1032	E08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			ZC4H2_Pro201Ser	23	64917857	G	A	X											X-64917857-G-A	50982	X	64917857	G	A	P	S	rs398122939	X	64137737	X	64054462	201	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.601C>T	p.Pro201Ser	c.601C>T	p.Pro201Ser	principal1	Y	1	YES	Select	-	CCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-6.88	0.93237	D	0.933	0.93850	-0.0166	0.81829	T	0.4584	0.78867	T	8	0.9272647	0.91983	D	0.879436	0.99079	D	0.949	0.99024	0.568	0.68924	Q9NQZ6	P201S	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.924160061229	0.92281	0.717222727726295	0.71518	3.14057088863	0.99417	0.90233540535	0.96691	D	0.841119	0.96267	D	0.579811	0.96963	D	0.595082	0.96914	D	0.99885880947113	0.95336	D	0.959004	0.85727	D	0.9243852	0.93582	0.9158107	0.96047	0.90647143	0.91852	0.90109336	0.94986	-12.964	0.90166	D	1.0	0.99952	P	0.999295186201027	0.96182	0.99900264	0.99084	0.997	0.99892	.	.	.	.	.	.	4.866916	0.79733	27.2	0.99923738092883418	0.98918	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	9.224	0.94382	11.614000	0.93576	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Likely_pathogenic	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000023.11:g.64917857G>A	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	C0796200|C1535926	314580	3454|85283	Zinc finger C4H2-type	Pro	Ser	65653	single nucleotide variant	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	55906	ZC4H2	HGNC:24931	Likely pathogenic	1	Jun 24, 2020	398122939	-	RCV000043678|RCV001374903	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Wieacker-Wolff syndrome|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	64917857	64917857	Xq11.2	criteria provided, single submitter	2	-	N	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	3	50982	64917857	G	A	-	-	-	-	-	-	SCV001572190	-	-	601C>T 	Pro201Ser	NM_018684.4	1	1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	0.6317258544338403	0.7175626828034266	0.7067604538877507	0.7237190711631107	0.6348000809610653	0.7814396132952472	0.8348792037272437	0.8978818081707663	0.8382258310191754	0.7005473768703887	0.7065827338645438	0.7762209432653351	0.8023211310292585	0.7809724510911431	0.6676737289157271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC005917		NC_000023.11:64917857:G:A		Pro201Ser																												ZC4H2_Pro201Ser	23	64917857	G	A	X	allele	601C>T	F03	527_CAVA_Array_P06	K06	B13A7A8P2_R1	B14A7A8P2_R2				X-64917857-G-A	50982	X	64917857	G	A	P	S	rs398122939	X	64137737	X	64054462	201	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.601C>T	p.Pro201Ser	c.601C>T	p.Pro201Ser	principal1	Y	1	YES	Select	-	CCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-6.88	0.93237	D	0.933	0.93850	-0.0166	0.81829	T	0.4584	0.78867	T	8	0.9272647	0.91983	D	0.879436	0.99079	D	0.949	0.99024	0.568	0.68924	Q9NQZ6	P201S	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.924160061229	0.92281	0.717222727726295	0.71518	3.14057088863	0.99417	0.90233540535	0.96691	D	0.841119	0.96267	D	0.579811	0.96963	D	0.595082	0.96914	D	0.99885880947113	0.95336	D	0.959004	0.85727	D	0.9243852	0.93582	0.9158107	0.96047	0.90647143	0.91852	0.90109336	0.94986	-12.964	0.90166	D	1.0	0.99952	P	0.999295186201027	0.96182	0.99900264	0.99084	0.997	0.99892	.	.	.	.	.	.	4.866916	0.79733	27.2	0.99923738092883418	0.98918	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	9.224	0.94382	11.614000	0.93576	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Likely_pathogenic	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000023.11:g.64917857G>A	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	C0796200|C1535926	314580	3454|85283	Zinc finger C4H2-type	Pro	Ser	65653	single nucleotide variant	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	55906	ZC4H2	HGNC:24931	Likely pathogenic	1	Jun 24, 2020	398122939	-	RCV000043678|RCV001374903	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Wieacker-Wolff syndrome|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	64917857	64917857	Xq11.2	criteria provided, single submitter	2	-	N	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	3	50982	64917857	G	A	-	-	-	-	-	-	SCV001572190	-	-	601C>T 	Pro201Ser	NM_018684.4	1	1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	0.6317258544338403	0.7175626828034266	0.7067604538877507	0.7237190711631107	0.6348000809610653	0.7814396132952472	0.8348792037272437	0.8978818081707663	0.8382258310191754	0.7005473768703887	0.7065827338645438	0.7762209432653351	0.8023211310292585	0.7809724510911431	0.6676737289157271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC005917		NC_000023.11:64917857:G:A		Pro201Ser																												ZC4H2_Pro201Ser	23	64917857	G	A	X	allele	601C>T	A04	527_CAVA_Array_P06	A08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917857-G-A	50982	X	64917857	G	A	P	S	rs398122939	X	64137737	X	64054462	201	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.601C>T	p.Pro201Ser	c.601C>T	p.Pro201Ser	principal1	Y	1	YES	Select	-	CCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-6.88	0.93237	D	0.933	0.93850	-0.0166	0.81829	T	0.4584	0.78867	T	8	0.9272647	0.91983	D	0.879436	0.99079	D	0.949	0.99024	0.568	0.68924	Q9NQZ6	P201S	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.924160061229	0.92281	0.717222727726295	0.71518	3.14057088863	0.99417	0.90233540535	0.96691	D	0.841119	0.96267	D	0.579811	0.96963	D	0.595082	0.96914	D	0.99885880947113	0.95336	D	0.959004	0.85727	D	0.9243852	0.93582	0.9158107	0.96047	0.90647143	0.91852	0.90109336	0.94986	-12.964	0.90166	D	1.0	0.99952	P	0.999295186201027	0.96182	0.99900264	0.99084	0.997	0.99892	.	.	.	.	.	.	4.866916	0.79733	27.2	0.99923738092883418	0.98918	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	9.224	0.94382	11.614000	0.93576	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Likely_pathogenic	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000023.11:g.64917857G>A	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	C0796200|C1535926	314580	3454|85283	Zinc finger C4H2-type	Pro	Ser	65653	single nucleotide variant	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	55906	ZC4H2	HGNC:24931	Likely pathogenic	1	Jun 24, 2020	398122939	-	RCV000043678|RCV001374903	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Wieacker-Wolff syndrome|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	64917857	64917857	Xq11.2	criteria provided, single submitter	2	-	N	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	3	50982	64917857	G	A	-	-	-	-	-	-	SCV001572190	-	-	601C>T 	Pro201Ser	NM_018684.4	1	1_Pathogenic																																																																																																									
RAF1	RAF1_Asp381Asn	0.5714162180205059	1.0	0.5200707489892997	1.0	2025_01_Batch_13-14	0.5916507293648501	0.554141112266058	0.603505251033311	0.5972816925458017	0.5882689811653663	0.6443114881687294	0.6776240956846027	0.6668260636089396	0.7245594930743811	0.5944293789710839	0.6179811087667897	0.6158826039753303	0.6351656573211253	0.6609205928100914	0.5913491800682251	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008844		NC_000003.12:12591760:C:T		Asp381Asn																												RAF1_Asp381Asn	3	12591760	C	T	3	allele	1141G>A	D03	527_CAVA_Array_P05	G05	B13A7A8P2_R1	B14A7A8P2_R2				3-12591760-C-T	181509	3	12591760	C	T	D	N	rs559632360	3	12633259	3	12608259	381	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1141G>A	p.Asp381Asn	c.1141G>A	p.Asp381Asn	principal3	Y	1	YES	Select	-	GAC	1	0	c	C/C	C/C	C/C	C/C	0.741	0.05469	T	0.631	0.07289	T	0.0	0.02950	B	0.002	0.06938	B	0.09	0.26006	N	simple_aae	91.0	9.0	0.725	0.18664	N	-1.58	0.42002	N	0.141	0.15800	-0.8085	0.54456	T	0.2621	0.63163	T	10	0.012194514	0.00259	T	.	.	.	0.164	0.41991	0.348	0.34294	P04049	D381N	Gain of glycosylation at T383 (P = 0.0563)| Gain of MoRF binding (P = 0.0665)| Gain of methylation at K378 (P = 0.0678)| Gain of ubiquitination at K378 (P = 0.1989)| Gain of phosphorylation at T383 (P = 0.2411)	0.324009150485	0.31597	.	0.71714	1.20632500761	0.80616	0.628370404243	0.56847	T	0.710307	0.91654	D	-0.470963	0.00789	T	-0.45545	0.26743	T	0.0264849085100513	0.01464	T	.	0.37334	.	0.08191876	0.18674	0.063901514	0.12728	0.058604848	0.11702	0.05158828	0.08346	-4.384	0.37036	T	0.096	0.17894	B	0.00775539406038167	0.22004	0.70292550	0.86141	0.31	0.57690	.	.	.	.	.	.	1.897587	0.24145	16.27	0.69381873695721796	0.09095	0.104954	0.20775	N	-0.798101639362588	0.13197	0.6575577	-0.628625637051928	0.18464	1.003532	5.15	2.44	0.28799	0.329	0.23862	2.247	0.42906	2.200000	0.31363	-3.876	0.00054	0.959	0.33632	0.976000	0.30138	0.034	0.13647	685	0.5936	3	5.990415335463259E-4	0	0.0	0	0.0	0	0.0	0	0.0	3	0.003067484662576687	6	264690	2.2668026E-5	.	31	109408	2.833430e-04	0	70	208130	3.363280e-04	0	70	236836	2.955630e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	30	15690	1.912050e-03	0	30	15690	1.912050e-03	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89556	1.116620e-05	0	69	30608	2.254310e-03	0	69	30608	2.254310e-03	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	1	102644	9.742410e-06	0	69	30526	2.260370e-03	0	69	30526	2.260370e-03	0	.	249	1614126	1.542630e-04	4	230	91082	2.525200e-03	4	0	75020	0.000000e+00	0	0	910	0.000000e+00	0	1	60020	1.666110e-05	0	0	29608	0.000000e+00	0	0	44880	0.000000e+00	0	0	64028	0.000000e+00	0	0	6062	0.000000e+00	0	11	1180012	9.321940e-06	0	230	91082	2.525200e-03	4	0	9902	0	0	114	0	0	120	0	1	3266	3.061849357011635E-4	0	146	0	0	610	0	0	26	0	1	104	0.009615384615384616	0	792	0	1	3380	2.958579881656805E-4	0	146	0	2	15080	1.326259946949602E-4	Benign	Cardiovascular_phenotype|RASopathy|not_specified|Noonan_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome	reviewed_by_expert_panel	NC_000003.12:g.12591760C>T	ClinGen:CA297118	CN230736|C5555857|CN169374|C0028326|C0175704|C5681679	PS163950|PS151100	536391|648|500|98733	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	179051	single nucleotide variant	NM_002880.4(RAF1):c.1141G>A (p.Asp381Asn)	5894	RAF1	HGNC:9829	Benign	0	Apr 18, 2017	559632360	-	RCV000159079|RCV000522135|RCV001813412|RCV001261134|RCV002453552	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	not specified|RASopathy|Noonan syndrome and Noonan-related syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000003.12	3	12591760	12591760	3p25.2	reviewed by expert panel	7	-	N	ClinGen:CA297118	2	181509	12591760	C	T	-	-	-	-	-	-	SCV000616485	-	-	1141G>A 	Asp381Asn	NM_002880.4	3	2_Benign																																																																																																									
SDHD	SDHD_His50Arg	3.0284841744564357	0.020352148961914243	1.554229897751678	1.0	2025_01_Batch_13-14	0.8487679862963863	0.8719928321814725	0.8172339674526357	0.8810832625909506	0.8441392336339028	0.7954797741243843	0.8378481675212374	0.7725825389706431	0.8202877514285964	0.7279689661472681	0.8221238802103853	0.8549204998513549	0.7949082532116394	0.8506855070097735	0.7860540998905854	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD	ENSG00000204370	5678	201953	CCSBVarC006156	ALE00006156	NC_000011.10:112087953:A:G	149A>G	His50Arg	CEGS2	CegsMutGDEh1012	G11	GDEhDisVCh_40066	B02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SDHD_His50Arg	11	112087953	A	G	11											11-112087953-A-G	6909	11	112087953	A	G	H	R	rs11214077	11	111958677	11	111463887	50	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.149A>G	p.His50Arg	c.149A>G	p.His50Arg	principal1	Y	1	YES	Select	+	CAC	2	0	A	./.	./.	./.	./.	0.065	0.91343	T	0.133	0.92967	T	0.985	0.61134	D	0.804	0.58344	P	0.63	0.78586	D	simple_aae	37.0	63.0	2.875	0.83215	M	-1.91	0.84629	N	0.533	0.69591	0.6916	0.93046	D	0.7712	0.92199	D	9	0.00989148	0.00218	T	.	.	.	0.681	0.88248	.	.	.	.	.	0.949941544596	0.94900	0.8321952904549407	0.83077	0.366577337986	0.37946	0.511648774147	0.40396	T	0.604841	0.87272	D	0.00267657	0.51703	T	0.244042	0.85234	D	0.0389905626794946	0.03481	T	0.876112	0.58713	D	0.17611195	0.38200	0.159546	0.37087	0.16287881	0.36096	0.17666198	0.40081	-3.62	0.18161	T	0.134	0.49161	B	0.893627502624236	0.75625	0.99399060	0.97449	0.427	0.66558	.	.	.	.	.	.	3.521592	0.49453	22.8	0.99613682030186279	0.75021	0.739987	0.68322	D	0.49081428387198	0.66377	4.96495	0.424179265049854	0.62877	4.534256	4.9	4.9	0.63598	.	.	2.521	0.45325	7.662000	0.64345	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.796	0.37596	635	0.64545	33	0.006589456869009584	0	0.0	17	0.016898608349900597	14	0.020172910662824207	0	0.0	2	0.002044989775051125	2054	264690	0.0077600214	segdup	699	109374	6.390920e-03	4	1314	208100	6.314270e-03	5	1570	236924	6.626600e-03	5	13	7164	1.814630e-03	0	126	17112	7.363250e-03	0	18	2320	7.758620e-03	0	0	9046	0.000000e+00	0	78	13360	5.838320e-03	0	408	42768	9.539840e-03	4	26	15690	1.657110e-03	0	408	42768	9.539840e-03	4	24	16218	1.479840e-03	0	212	30524	6.945350e-03	0	52	6212	8.370900e-03	0	0	13416	0.000000e+00	0	106	16700	6.347310e-03	0	811	89556	9.055790e-03	5	53	30608	1.731570e-03	0	811	89556	9.055790e-03	5	23	14902	1.543420e-03	0	251	34260	7.326330e-03	1	80	9572	8.357710e-03	0	0	17692	0.000000e+00	0	138	21598	6.389480e-03	0	961	102754	9.352430e-03	4	53	30526	1.736220e-03	0	961	102754	9.352430e-03	4	.	11829	1609602	7.349020e-03	54	15	912	1.644740e-02	1	135	74930	1.801680e-03	0	15	912	1.644740e-02	1	607	60020	1.011330e-02	2	260	29574	8.791510e-03	2	0	44866	0.000000e+00	0	430	63988	6.720010e-03	2	39	6058	6.437770e-03	0	9648	1175866	8.205020e-03	43	164	91004	1.802120e-03	3	1800	206608	0.008712150545961434	1	418	0.0023923444976076554	1	4578	2.1843599825251202E-4	21	11044	0.001901484969214053	9	1138	0.007908611599297012	9	1030	0.008737864077669903	1	1858	5.382131324004305E-4	0	326	0	154	20432	0.007537196554424432	22	11462	0.0019193857965451055	2	6436	3.1075201988812925E-4	1996	247432	0.008066862814833974	Benign/Likely_benign	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087953A>G	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	171300|606864|168000|114900	29072|140162|201|97286|29072	.	His	Arg	21948	single nucleotide variant	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	6392	SDHD	HGNC:10683	Benign/Likely benign	0	Mar 04, 2025	11214077	-	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	germline;unknown	germline	GRCh38	NC_000011.10	11	112087953	112087953	11q23.1	criteria provided, multiple submitters, no conflicts	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	3	6909	112087953	A	G	-	-	-	-	-	-	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	-	-	149A>G 	His50Arg	NM_003002.4	2	2_Benign	11	112087953	A	G	0.00740724																																																																																																				
SDHD	SDHD_His50Arg	3.0284841744564357	0.020352148961914243	1.554229897751678	1.0	2025_01_Batch_13-14	0.8487679862963863	0.8719928321814725	0.8172339674526357	0.8810832625909506	0.8441392336339028	0.7954797741243843	0.8378481675212374	0.7725825389706431	0.8202877514285964	0.7279689661472681	0.8221238802103853	0.8549204998513549	0.7949082532116394	0.8506855070097735	0.7860540998905854	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023281		NC_000011.10:112087953:A:G		His50Arg																												SDHD_His50Arg	11	112087953	A	G	11	allele	149A>G	D11	527_CAVA_Array_P05	G21	B13A7A8P2_R1	B14A7A8P2_R2				11-112087953-A-G	6909	11	112087953	A	G	H	R	rs11214077	11	111958677	11	111463887	50	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.149A>G	p.His50Arg	c.149A>G	p.His50Arg	principal1	Y	1	YES	Select	+	CAC	2	0	A	./.	./.	./.	./.	0.065	0.91343	T	0.133	0.92967	T	0.985	0.61134	D	0.804	0.58344	P	0.63	0.78586	D	simple_aae	37.0	63.0	2.875	0.83215	M	-1.91	0.84629	N	0.533	0.69591	0.6916	0.93046	D	0.7712	0.92199	D	9	0.00989148	0.00218	T	.	.	.	0.681	0.88248	.	.	.	.	.	0.949941544596	0.94900	0.8321952904549407	0.83077	0.366577337986	0.37946	0.511648774147	0.40396	T	0.604841	0.87272	D	0.00267657	0.51703	T	0.244042	0.85234	D	0.0389905626794946	0.03481	T	0.876112	0.58713	D	0.17611195	0.38200	0.159546	0.37087	0.16287881	0.36096	0.17666198	0.40081	-3.62	0.18161	T	0.134	0.49161	B	0.893627502624236	0.75625	0.99399060	0.97449	0.427	0.66558	.	.	.	.	.	.	3.521592	0.49453	22.8	0.99613682030186279	0.75021	0.739987	0.68322	D	0.49081428387198	0.66377	4.96495	0.424179265049854	0.62877	4.534256	4.9	4.9	0.63598	.	.	2.521	0.45325	7.662000	0.64345	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.796	0.37596	635	0.64545	33	0.006589456869009584	0	0.0	17	0.016898608349900597	14	0.020172910662824207	0	0.0	2	0.002044989775051125	2054	264690	0.0077600214	segdup	699	109374	6.390920e-03	4	1314	208100	6.314270e-03	5	1570	236924	6.626600e-03	5	13	7164	1.814630e-03	0	126	17112	7.363250e-03	0	18	2320	7.758620e-03	0	0	9046	0.000000e+00	0	78	13360	5.838320e-03	0	408	42768	9.539840e-03	4	26	15690	1.657110e-03	0	408	42768	9.539840e-03	4	24	16218	1.479840e-03	0	212	30524	6.945350e-03	0	52	6212	8.370900e-03	0	0	13416	0.000000e+00	0	106	16700	6.347310e-03	0	811	89556	9.055790e-03	5	53	30608	1.731570e-03	0	811	89556	9.055790e-03	5	23	14902	1.543420e-03	0	251	34260	7.326330e-03	1	80	9572	8.357710e-03	0	0	17692	0.000000e+00	0	138	21598	6.389480e-03	0	961	102754	9.352430e-03	4	53	30526	1.736220e-03	0	961	102754	9.352430e-03	4	.	11829	1609602	7.349020e-03	54	15	912	1.644740e-02	1	135	74930	1.801680e-03	0	15	912	1.644740e-02	1	607	60020	1.011330e-02	2	260	29574	8.791510e-03	2	0	44866	0.000000e+00	0	430	63988	6.720010e-03	2	39	6058	6.437770e-03	0	9648	1175866	8.205020e-03	43	164	91004	1.802120e-03	3	1800	206608	0.008712150545961434	1	418	0.0023923444976076554	1	4578	2.1843599825251202E-4	21	11044	0.001901484969214053	9	1138	0.007908611599297012	9	1030	0.008737864077669903	1	1858	5.382131324004305E-4	0	326	0	154	20432	0.007537196554424432	22	11462	0.0019193857965451055	2	6436	3.1075201988812925E-4	1996	247432	0.008066862814833974	Benign/Likely_benign	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087953A>G	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	171300|606864|168000|114900	29072|140162|201|97286|29072	.	His	Arg	21948	single nucleotide variant	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	6392	SDHD	HGNC:10683	Benign/Likely benign	0	Mar 04, 2025	11214077	-	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	germline;unknown	germline	GRCh38	NC_000011.10	11	112087953	112087953	11q23.1	criteria provided, multiple submitters, no conflicts	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	3	6909	112087953	A	G	-	-	-	-	-	-	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	-	-	149A>G 	His50Arg	NM_003002.4	2	2_Benign	11	112087953	A	G	0.00740724																																																																																																				
BRIP1	BRIP1_Arg848His	2.578571129238601	0.0754963461161795	-3.086811053904651	0.18383040953677723	2025_01_Batch_13-14	0.7587827823803477	0.7491731842366169	0.7311718734894977	0.7446874149976265	0.7116923345130145	0.7877104845651395	0.8487688359703991	0.7814650513637258	0.7920417222770307	0.7490619451894294	0.7732466334727436	0.798971010103508	0.7563184624266117	0.7683645686373286	0.730377139851222	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1		55128		CCSBVarC031388		NC_000017.11:61693462:C:T		Arg848His																												BRIP1_Arg848His	17	61693462	C	T	17	allele	2543G>A	G12	527_CAVA_Array_P01	M23	B13A7A8P1_R1	B14A7A8P1_R2				17-61693462-C-T	141499	17	61693462	C	T	R	H	rs374334794	17	59770823	17	57125605	848	BRIP1	ENSG00000136492	ENST00000259008	ENSP00000259008	Q9BX63	FANCJ_HUMAN	c.2543G>A	p.Arg848His	c.2543G>A	p.Arg848His	principal2	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.78	0.86494	D	simple_aae	22.0	78.0	4.15	0.97531	H	-4.6	0.79008	D	0.857	0.99270	1.0848	0.99040	D	0.9696	0.99037	D	9	0.94317496	0.93570	D	0.469494	0.94645	D	0.932	0.98414	.	.	.	.	.	0.999184905289	0.99916	0.8741008375185114	0.87298	0.750843833719	0.63531	0.644317030907	0.59114	T	0.839083	0.96201	D	0.542959	0.95468	D	0.542146	0.95401	D	0.999659895896912	0.98331	D	.	0.93863	.	0.9493171	0.96137	0.8188024	0.89326	0.9493171	0.96137	0.8188024	0.89327	-11.608	0.82941	D	0.8672	0.83733	P	0.999253341147957	0.96077	0.99724770	0.98313	0.641	0.80003	.	.	.	.	.	.	5.402014	0.90472	31.0	0.99942296316834778	0.99824	0.731722	0.67754	D	0.953849966561016	0.94104	12.5292	0.867844537858018	0.93982	12.44217	5.74	5.74	0.90056	.	.	5.053	0.6417	7.610000	0.61936	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.935	0.4738	139	0.94485	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10	1613508	6.197680e-06	0	3	74880	4.006410e-05	0	3	74880	4.006410e-05	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29590	0.000000e+00	0	0	44854	0.000000e+00	0	0	63978	0.000000e+00	0	0	6082	0.000000e+00	0	6	1179678	5.086130e-06	0	1	91078	1.097960e-05	0	0	19722	0	0	298	0	0	86	0	2	7418	2.6961445133459155E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1922	0	2	7716	2.592016588906169E-4	0	112	0	2	30326	6.595000989250148E-5	Conflicting_classifications_of_pathogenicity	Familial_cancer_of_breast|Neurodevelopmental_delay|Fanconi_anemia_complementation_group_J|Ovarian_neoplasm|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.61693462C>T	ClinGen:CA165626	C0346153|C4022738|C1836860|C0919267|C3661900|C0027672	114480|609054	227535|84|140162	.	Arg	His	151213	single nucleotide variant	NM_032043.3(BRIP1):c.2543G>A (p.Arg848His)	83990	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	1	Dec 22, 2024	374334794	-	RCV000130056|RCV000699539|RCV001194712|RCV000663220|RCV001255230|RCV004760390|RCV002273958|RCV003460909	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided|Ovarian neoplasm;Fanconi anemia complementation group J|Fanconi anemia complementation group J|Hereditary breast ovarian cancer syndrome|Neurodevelopmental delay|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61693462	61693462	17q23.2	criteria provided, conflicting classifications	13	-	N	ClinGen:CA165626	2	141499	61693462	C	T	-	-	-	-	-	-	SCV000184883|SCV000786407|SCV000828254|SCV000896650|SCV000909762|SCV001777038|SCV002558935|SCV004217033|SCV005205363|SCV005373762|SCV005416787	-	-	2543G>A 	Arg848His	NM_032043.3	1	3_Conflicting																																																																																																									
CCM2	CCM2_Arg346Cys	5.147035947739847	1.0	8.711424370271944	0.3199814882035325	2025_01_Batch_13-14	0.9302880907088129	0.8799810006093308	0.877225028841703	0.8715094149958119	0.8111947148746553	0.7395522302981256	0.8289427314681227	0.7827045460629231	0.7992404299276873	0.6595261581130546	0.8349201605034693	0.8544618660387268	0.8299647874523131	0.8353749224617496	0.735360436493855	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038791		NC_000007.14:45074390:C:T		Arg346Cys																												CCM2_Arg346Cys	7	45074390	C	T	7	allele	1036C>T	E10	527_CAVA_Array_P07	J19	B13A7A8P2_R1	B14A7A8P2_R2				7-45074390-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Lys23Arg	0.8875476091261906	1.0	16.33450560415662	0.000012418844908784731	2025_01_Batch_13-14	0.7882377081850236	0.829962249657329	0.9140465243131848	0.8304097881054551	0.7615496937765553	0.8167218330981109	0.8758914269590776	0.9529181456452749	0.8989401159142333	0.7858068154325656	0.8024797706415672	0.8529268383082034	0.9334823349792298	0.8646749520098442	0.7736782546045604	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038609		NC_000007.14:45038290:A:G		Lys23Arg																												CCM2_Lys23Arg	7	45038290	A	G	7	allele	68A>G	E06	527_CAVA_Array_P06	I12	B13A7A8P2_R1	B14A7A8P2_R2				7-45038290-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala140Thr	9.41498605588496	0.09584717719186953	11.278010566745627	0.005810462951101376	2025_01_Batch_13-14	0.8127744146892533	0.8046170013013483	0.859391185834964	0.8673134161036461	0.7557145094242261	0.7782637445169669	0.7591813961469747	0.8528659080051316	0.7693134880204227	0.714088403570882	0.7955190796031101	0.7818991987241615	0.8561285469200478	0.8183134520620343	0.734901456497554	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038671		NC_000007.14:45064592:G:A		Ala140Thr																												CCM2_Ala140Thr	7	45064592	G	A	7	allele	418G>A	D01	527_CAVA_Array_P07	H01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064592-G-A	3057999	7	45064592	G	A	A	T	rs1798682183	7	45104191	7	45070716	140	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.418G>A	p.Ala140Thr	c.418G>A	p.Ala140Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.005	0.76775	D	0.104	0.25957	B	0.017	0.18137	B	0.59	0.76257	D	simple_aae	41.0	59.0	2.62	0.76477	M	-3.11	0.63695	D	0.664	0.67836	-0.4381	0.70663	T	0.3341	0.70000	T	10	0.7002276	0.72142	D	0.041531	0.59821	D	0.340	0.66024	0.644	0.78027	Q9BSQ5	A140T	Loss of catalytic residue at A140 (P = 0.12)| Loss of stability (P = 0.1217)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)| Loss of phosphorylation at S143 (P = 0.5686)	0.689420173014	0.68430	.	0.73892	.	0.68825	0.682202935219	0.64526	T	0.663497	0.89828	D	0.112869	0.65402	D	-0.0756479	0.64972	T	0.954649265445779	0.64092	D	0.843516	0.52293	T	0.5482788	0.69562	0.5192621	0.71967	0.5482788	0.69563	0.5192621	0.71968	-9.771	0.72930	D	0.8803	0.84385	P	0.52483353853229	0.61537	0.98175323	0.95698	0.562	0.75337	.	.	.	.	.	.	5.106587	0.85379	28.6	0.99624864838741412	0.75682	0.875631	0.79842	D	0.266363011543981	0.54221	3.610779	0.25654352259502	0.52776	3.473372	5.42	2.68	0.30757	2.56	0.46987	8.144	0.89567	9.742000	0.81468	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.985	0.61072	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9	1613902	5.576550e-06	0	1	91082	1.097910e-05	0	0	74918	0.000000e+00	0	0	912	0.000000e+00	0	0	60002	0.000000e+00	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64004	0.000000e+00	0	0	5968	0.000000e+00	0	8	1180034	6.779470e-06	0	1	91082	1.097910e-05	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Uncertain_significance	CCM2-related_disorder	criteria_provided,_single_submitter	NC_000007.14:g.45064592G>A	.	.	.	.	PTB/PI domain	Ala	Thr	3193113	single nucleotide variant	NM_031443.4(CCM2):c.418G>A (p.Ala140Thr)	83605	CCM2	HGNC:21708	Uncertain significance	0	Nov 03, 2023	-1	-	RCV003981765	-	CCM2-related disorder	germline	germline	GRCh38	NC_000007.14	7	45064592	45064592	7p13	no assertion criteria provided	1	-	N	ClinGen:CA367430077	2	3057999	45064592	G	A	-	-	-	-	-	-	SCV004795435	-	-	418G>A 	Ala140Thr	NM_031443.4		4_VUS																																																																																																									
RAF1	RAF1_Thr491Arg	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	0.8035216812448265	0.7758778365355458	0.848415594617929	0.7156887829290858	0.7773362432954989	0.7092062608687455	0.6928103537942536	0.7052494097190242	0.7287510440410226	0.7004827463123123	0.756363971056786	0.7343440951648996	0.7768325021684765	0.7222199134850542	0.7389094948039057	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1	ENSG00000132155	732	213823	CCSBVarC003427	ALE00003427	NC_000003.12:12585745:G:C	1472C>G	Thr491Arg	CEGS2	CegsMutGDEh1015	G06	GDEhDisVCh_40029	F08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RAF1_Thr491Arg	3	12585745	G	C	3											3-12585745-G-C	13959	3	12585745	G	C	T	R	rs80338799	3	12627244	3	12602244	491	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1472C>G	p.Thr491Arg	c.1472C>G	p.Thr491Arg	principal3	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.122	0.40143	T	1.0	0.90580	D	0.999	0.92348	D	0.98	0.99291	A	simple_aae	2.0	98.0	0.02	0.07909	N	-5.37	0.84911	D	0.961	0.99191	0.1373	0.84771	D	0.4388	0.77686	T	10	0.899554	0.89196	D	0.235705	0.88439	D	0.786	0.92884	0.752	0.88177	P04049	T491R	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.974052792841	0.97352	.	0.85535	2.53490677304	0.97794	0.845280706882	0.88882	D	0.900422	0.98022	D	0.39866	0.89767	D	0.334871	0.89639	D	0.996480882167816	0.89353	D	.	0.92373	.	0.9571182	0.96940	0.9388268	0.97656	0.9463269	0.95828	0.90921533	0.95572	-12.126	0.85499	D	0.9852	0.92260	P	0.999988562000968	0.99579	0.99762386	0.98444	0.978	0.99209	.	.	.	.	.	.	5.424006	0.90747	31.0	0.99437118353782505	0.64619	0.916990	0.88355	D	0.626065396186754	0.74692	6.199454	0.704879681503555	0.82653	7.84486	5.26	5.26	0.73443	.	.	9.996	0.99292	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy|not_provided|Noonan_syndrome_5	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12585745G>C	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	C5555857|C3661900|C1969057	611553	536391|648	Protein kinase domain|Protein kinase domain|Protein kinase domain	Thr	Arg	28998	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894	RAF1	HGNC:9829	Likely pathogenic	1	Sep 11, 2024	80338799	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745	12585745	3p25.2	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3	13959	12585745	G	C	-	-	-	-	-	-	SCV000808247|SCV001401755	-	-	1472C>G 	Thr491Arg	NM_002880.4	2	1_Pathogenic																																																																																																									
RAF1	RAF1_Thr491Arg	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	0.8035216812448265	0.7758778365355458	0.848415594617929	0.7156887829290858	0.7773362432954989	0.7092062608687455	0.6928103537942536	0.7052494097190242	0.7287510440410226	0.7004827463123123	0.756363971056786	0.7343440951648996	0.7768325021684765	0.7222199134850542	0.7389094948039057	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC003426		NC_000003.12:12585761:C:T		Thr491Arg																												RAF1_Thr491Arg	3	12585761	C	T	3	allele	1472C>G	B04	527_CAVA_Array_P05	C07	B13A7A8P2_R1	B14A7A8P2_R2				3-12585761-C-T	21341	3	12585761	C	T	D	N	rs80338798	3	12627260	3	12602260	486	RAF1	ENSG00000132155	ENST00000685653	ENSP00000509968	P04049	RAF1_HUMAN	.	.	c.1456G>A	p.Asp486Asn	principal3	Y	.	.	.	-	GAT	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.998	0.88579	D	.	0.92286	.	.	.	.	2.89	0.83536	M	.	0.78079	.	.	0.99419	0.9420	0.96265	D	0.9946	0.99877	D	9	.	0.99202	.	0.825636	0.98643	D	.	0.97963	0.968	0.99690	P04049	D486N	Gain of MoRF binding (P = 0.0343)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K483 (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K483 (P = 0.1041)	.	0.95330	.	0.98776	.	0.97323	0.879874408245	0.93935	D	0.949346	0.99250	D	0.270705	0.80361	D	0.151072	0.80106	D	0.998047471046448	0.93025	D	0.9975	0.98985	D	0.94164735	0.95344	0.889279	0.94137	0.94205755	0.95387	0.8781777	0.93345	-14.009	0.93099	D	.	0.98152	.	0.99999342572825	0.99831	0.99668110	0.98129	0.995	0.99826	.	.	.	.	.	.	5.650199	0.92811	33.0	0.99921808742760565	0.98788	0.892841	0.82954	D	1.01881719419438	0.96274	14.52467	0.933976822940601	0.96872	15.28689	5.26	5.26	0.73443	5.35	0.93259	7.9	0.86061	7.684000	0.65502	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Noonan_syndrome_with_multiple_lentigines	no_classification_provided	NC_000003.12:g.12585761C>T	ClinGen:CA341928|UniProtKB:P04049#VAR_037817	C0175704	PS151100	500	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	34193	single nucleotide variant	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)	5894	RAF1	HGNC:9829	not provided	0	-	80338798	-	RCV000020506	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	Noonan syndrome with multiple lentigines	unknown	unknown	GRCh38	NC_000003.12	3	12585761	12585761	3p25.2	no classification provided	1	-	N	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	1	21341	12585761	C	T	-	-	-	-	-	-	SCV000040957	-	-	1456G>A 	Asp486Asn	NM_002880.4		5_Others																																																																																																									
CCM2	CCM2_Ala205Thr	3.9965873729588846	1.0	5.7008264122558385	1.0	2025_01_Batch_13-14	0.875329646744958	0.7654515030641801	0.8459421954921146	0.8144176461830356	0.8249516864183651	0.7320037670867687	0.6889755330713704	0.6612950996574746	0.5907865945615188	0.6786267942090906	0.8036667069158634	0.7272135180677752	0.7536186475747946	0.7026021203722772	0.7517892403137278	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038716		NC_000007.14:45069829:G:A		Ala205Thr																												CCM2_Ala205Thr	7	45069829	G	A	7	allele	613G>A	G04	527_CAVA_Array_P07	N07	B13A7A8P2_R1	B14A7A8P2_R2				7-45069829-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ala237Val	0.9929107646593023	1.0	7.368198369958848	0.27008872163689207	2025_01_Batch_13-14	0.8282324530237556	0.6933062141927505	0.7670906662223262	0.7561866175946094	0.7963261341225514	0.7949294240303343	0.7257644074656598	0.754963843778679	0.718402302492934	0.7827972416226441	0.8115809385270449	0.7095353108292052	0.7610272550005026	0.7372944600437716	0.7895616878725977	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038733		NC_000007.14:45069926:C:T		Ala237Val																												CCM2_Ala237Val	7	45069926	C	T	7	allele	710C>T	G06	527_CAVA_Array_P07	N11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069926-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Pro271Thr	2.6955177736893394	1.0	7.380401132390968	1.0	2025_01_Batch_13-14	0.8351948729456812	0.7392506989699229	0.8044604911994283	0.8449224453958433	0.7286945291040546	0.7162592552071048	0.6414059681611775	0.63635844970179	0.6256675977965191	0.7233946879008228	0.7757270640763929	0.6903283335655501	0.7204094704506092	0.7352950215961812	0.7260446085024388	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038749		NC_000007.14:45073467:C:A		Pro271Thr																												CCM2_Pro271Thr	7	45073467	C	A	7	allele	811C>A	D08	527_CAVA_Array_P07	H15	B13A7A8P2_R1	B14A7A8P2_R2				7-45073467-C-A	2573788	7	45073467	C	A	P	T	rs755763949	7	45113066	7	45079591	271	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.811C>A	p.Pro271Thr	c.811C>A	p.Pro271Thr	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	0.028	0.47480	D	0.188	0.37103	T	0.058	0.22981	B	0.069	0.27759	B	0.15	0.59775	N	simple_aae	85.0	15.0	1.5	0.37685	L	-1.31	0.33375	N	0.222	0.27600	-0.8225	0.53590	T	0.1105	0.39557	T	10	0.09829983	0.17581	T	0.02877	0.51197	D	0.058	0.16509	0.242	0.17431	Q9BSQ5	P271T	Gain of catalytic residue at P271 (P = 0.1139)| Gain of phosphorylation at T267 (P = 0.1628)| Loss of disorder (P = 0.209)| Loss of glycosylation at S273 (P = 0.2703)| Gain of loop (P = 0.4661)	0.489869231792	0.48256	.	0.15936	.	0.36972	0.378016710281	0.21950	T	0.134814	0.46331	T	-0.225968	0.16893	T	-0.431913	0.29358	T	0.137811288237572	0.15883	T	0.89491	0.64215	D	0.06066333	0.12360	0.06425827	0.12852	0.06066333	0.12359	0.06425827	0.12852	-4.311	0.28359	T	0.0749	0.08989	B	0.0880414923591727	0.42173	0.81912374	0.88814	0.033	0.07179	.	.	.	.	.	.	1.929475	0.24549	16.42	0.92415717442620138	0.22083	0.076598	0.15221	N	-0.289446817921241	0.29275	1.640012	-0.303771094532898	0.27659	1.556356	5.11	3.27	0.36504	.	.	0.966	0.29024	0.880000	0.22469	0.599	0.40292	0.348	0.25829	0.461000	0.25082	0.015	0.10508	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	1	109270	9.151640e-06	0	2	207078	9.658200e-06	0	5	236672	2.112630e-05	0	0	7162	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13298	0.000000e+00	0	1	42746	2.339400e-05	0	0	15690	0.000000e+00	0	1	42746	2.339400e-05	0	0	16148	0.000000e+00	0	0	30488	0.000000e+00	0	0	6170	0.000000e+00	0	0	13402	0.000000e+00	0	0	16634	0.000000e+00	0	2	88794	2.252400e-05	0	0	30606	0.000000e+00	0	2	88794	2.252400e-05	0	0	14884	0.000000e+00	0	0	34232	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21522	0.000000e+00	0	5	102632	4.871770e-05	0	0	30526	0.000000e+00	0	5	102632	4.871770e-05	0	.	31	1613220	1.921620e-05	0	30	1179778	2.542850e-05	0	0	74930	0.000000e+00	0	0	910	0.000000e+00	0	0	60002	0.000000e+00	0	0	29602	0.000000e+00	0	0	44896	0.000000e+00	0	1	63458	1.575850e-05	0	0	6082	0.000000e+00	0	30	1179778	2.542850e-05	0	0	91088	0.000000e+00	0	1	17050	5.865102639296188E-5	0	268	0	0	84	0	0	6864	0	0	146	0	0	610	0	0	24	0	0	94	0	0	1898	0	0	7132	0	0	108	0	1	27038	3.698498409645684E-5	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000007.14:g.45073467C>A	.	CN517202	.	.	.	Pro	Thr	2738730	single nucleotide variant	NM_031443.4(CCM2):c.811C>A (p.Pro271Thr)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jan 20, 2023	-1	-	RCV003318124	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000007.14	7	45073467	45073467	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4247159	2	2573788	45073467	C	A	-	-	-	-	-	-	SCV004021491	-	-	811C>A 	Pro271Thr	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Asp301Gly	-0.31200394659064273	1.0	16.102028869529907	8.330794453493742e-6	2025_01_Batch_13-14	0.8151995756822145	0.8952153368229174	0.9614809878108291	0.8985950667090389	0.698389375375725	0.7551056153413951	0.9362647805095579	0.9834731489094243	0.9375446883925206	0.7345413939659213	0.7851525955118048	0.9157400586662376	0.9724770683601267	0.9180698775507797	0.7164653846708231	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038765		NC_000007.14:45073558:A:G		Asp301Gly																												CCM2_Asp301Gly	7	45073558	A	G	7	allele	902A>G	E09	527_CAVA_Array_P07	J17	B13A7A8P2_R1	B14A7A8P2_R2				7-45073558-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Tyr118Phe	2.007338607089666	1.0	4.6139486263198455	1.0	2025_01_Batch_13-14	0.8698492889983992	0.887332693569212	0.8695996145860172	0.8884241685453723	0.7650926919936882	0.7031112068809808	0.6659411622971032	0.6534853291683653	0.7390270298147206	0.635125933757022	0.78648024793969	0.7766369279331575	0.7615424718771913	0.8137255991800465	0.700109312875355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038657		NC_000007.14:45064527:A:T		Tyr118Phe																												CCM2_Tyr118Phe	7	45064527	A	T	7	allele	353A>T	H11	527_CAVA_Array_P06	O22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064527-A-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
RAF1	RAF1_Thr145Pro	-6.387994716345845	0.1333777500132942	3.706074644344897	0.04897839094117087	2025_01_Batch_13-14	0.6948395624861297	0.7812129413187235	0.8303045437251851	0.7411965198648527	0.6776063686022727	0.7787636596227573	0.6949013084563911	0.5345638780487201	0.7831153912329918	0.6637667112505362	0.7368016110544435	0.7380571248875574	0.6824342108869526	0.7621559555489222	0.6706865399264045	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008929		NC_000003.12:12608914:T:G		Thr145Pro																												RAF1_Thr145Pro	3	12608914	T	G	3	allele	433A>C	C05	527_CAVA_Array_P05	E09	B13A7A8P2_R1	B14A7A8P2_R2				3-12608914-T-G	373032	3	12608914	T	G	T	P	rs1057518155	3	12650413	3	12625413	145	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.433A>C	p.Thr145Pro	principal3	Y	.	.	.	-	ACG	1	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.79703	.	0.884	0.48632	P	0.651	0.52493	P	.	0.94378	.	.	.	.	3.94	0.96320	H	.	0.76607	.	.	0.66620	1.0870	0.99121	D	0.9288	0.97644	D	10	.	0.92727	.	0.77786	0.98245	D	.	0.99189	0.737	0.86913	P04049	T145P	Gain of glycosylation at T145 (P = 0.0599)| Gain of methylation at K144 (P = 0.1056)| Loss of MoRF binding (P = 0.1062)| Loss of ubiquitination at K144 (P = 0.1287)| Loss of stability (P = 0.1872)	.	0.96289	.	0.91688	.	0.82338	0.8487200737	0.89403	D	0.964761	0.99568	D	0.532258	0.95160	D	0.526776	0.95088	D	0.999636769294739	0.98238	D	.	0.87265	.	0.9750533	0.98689	0.9437567	0.97981	0.97559345	0.98735	0.95809036	0.98851	-11.037	0.80472	D	.	0.93458	.	0.999952511305676	0.99183	0.98135380	0.95656	0.995	0.99826	.	.	.	.	.	.	5.106479	0.85379	28.6	0.99400133114841904	0.62800	0.965951	0.98828	D	0.899566054000196	0.91692	11.03838	0.836522703996796	0.92161	11.29401	5.62	5.62	0.85695	5.35	0.93259	8.012	0.88241	7.910000	0.74019	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	646	0.63408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.12608914T>G	ClinGen:CA16042457	CN517202	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Pro	359447	single nucleotide variant	NM_002880.4(RAF1):c.433A>C (p.Thr145Pro)	5894	RAF1	HGNC:9829	Likely pathogenic	1	Nov 03, 2016	1057518155	-	RCV000414587	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12608914	12608914	3p25.2	criteria provided, single submitter	1	-	N	ClinGen:CA16042457	2	373032	12608914	T	G	-	-	-	-	-	-	SCV000491591	-	-	433A>C 	Thr145Pro	NM_002880.4	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Gly418Glu	0.4627408980397152	1.0	14.133296821429687	0.00009369888010769736	2025_01_Batch_13-14	0.9816498241302911	0.8614160067689695	0.8974918432011917	0.9113186678554775	0.9728033406133133	0.8131254418407999	0.8596479532307305	0.9384164554484595	0.9074171118925034	0.762973341404375	0.8973876329855455	0.86053197999985	0.9179541493248256	0.9093678898739905	0.8678883410088442	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038835		NC_000007.14:45075975:G:A		Gly418Glu																												CCM2_Gly418Glu	7	45075975	G	A	7	allele	1253G>A	B02	527_CAVA_Array_P08	D04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075975-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser143Phe	5.923681397142574	1.0	6.896860328260646	0.10252881905011228	2025_01_Batch_13-14	0.8481033326306163	0.7625928640047084	0.8084780042766201	0.8355939379019995	0.7831426787783425	0.8083789685814917	0.6716745806129125	0.7442243401316766	0.6545856432191413	0.741247343988533	0.8282411506060541	0.7171337223088105	0.7763511722041483	0.7450897905605705	0.7621950113834377	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038674		NC_000007.14:45064602:C:T		Ser143Phe																												CCM2_Ser143Phe	7	45064602	C	T	7	allele	428C>T	E01	527_CAVA_Array_P07	J01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064602-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile425Thr	-1.7616911075392494	1.0	3.550358664820511	1.0	2025_01_Batch_13-14	0.8898238895183109	0.9645432291218254	0.9923214323713346	0.969573833138002	0.9851018922542364	0.7840173951130098	0.9465642924794032	0.9869917757267576	0.9597634039116089	0.9765937056371431	0.8369206423156603	0.9555537608006144	0.9896566040490461	0.9646686185248055	0.9808477989456897	0.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	true	CCM2		3928		CCSBVarC038842		NC_000007.14:45075996:T:C		Ile425Thr																												CCM2_Ile425Thr	7	45075996	T	C	7	allele	1274T>C	H02	527_CAVA_Array_P08	P04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075996-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Val216Ala	5.289808997722305	1.0	10.015137869340359	1.0	2025_01_Batch_13-14	0.7928879345427876	0.788819346167688	0.8188475995741776	0.8301940983458639	0.7505843086273178	0.7903288409811285	0.6204854800472033	0.697052135404756	0.5974610540555879	0.7821166850761001	0.7916083877619581	0.7046524131074456	0.7579498674894668	0.7138275762007259	0.766350496851709	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038722		NC_000007.14:45069863:T:C		Val216Ala																												CCM2_Val216Ala	7	45069863	T	C	7	allele	647T>C	F05	527_CAVA_Array_P07	L09	B13A7A8P2_R1	B14A7A8P2_R2				7-45069863-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Leu182Pro	1.6556452182622745	1.0	7.950391176574159	0.0026191898739884455	2025_01_Batch_13-14	0.9486209402473725	0.8409723787423813	0.8655487151646919	0.8840965548969967	0.8960327831378686	0.7792985742038097	0.8987672261389532	0.874455982667176	0.8602452672710469	0.6846993855408954	0.863959757225591	0.8698698024406673	0.8700023489159339	0.8721709110840218	0.790366084339382	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038698		NC_000007.14:45068515:T:C		Leu182Pro																												CCM2_Leu182Pro	7	45068515	T	C	7	allele	545T>C	B03	527_CAVA_Array_P07	D05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068515-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Arg412Gln	2.2721779616786506	1.0	8.628778874655586	0.0037335824721142614	2025_01_Batch_13-14	0.7596497452291167	0.7632405416634107	0.8581989506643295	0.7890990076484503	0.7154367073273407	0.7330157049809807	0.7445339075604445	0.7782261197260034	0.7226812192964533	0.6764603944611056	0.7463327251050487	0.7538872246119276	0.8182125351951665	0.7558901134724518	0.6959485508942231	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038832		NC_000007.14:45075957:G:A		Arg412Gln																												CCM2_Arg412Gln	7	45075957	G	A	7	allele	1235G>A	G01	527_CAVA_Array_P08	N02	B13A7A8P2_R1	B14A7A8P2_R2				7-45075957-G-A	3068778	7	45075957	G	A	R	Q	rs139366651	7	45115556	7	45082081	412	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1235G>A	p.Arg412Gln	c.1235G>A	p.Arg412Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.339	0.13557	T	0.319	0.19439	T	0.0	0.02950	B	0.0	0.01384	B	0.05	0.33788	N	simple_aae	95.0	5.0	-1.265	0.00751	N	-0.03	0.07402	N	0.097	0.10867	-1.0123	0.26124	T	0.0346	0.14785	T	10	0.03729564	0.02079	T	0.016743	0.37892	T	0.057	0.16184	.	.	.	.	.	0.367425347029	0.35948	.	0.12827	.	0.35096	0.221242576838	0.01385	T	0.023277	0.17655	T	-0.334845	0.05572	T	-0.536611	0.18319	T	0.0216240980887909	0.00863	T	0.90061	0.65375	D	0.019535111	0.00484	0.024821753	0.00515	0.019535111	0.00484	0.024821753	0.00514	-2.762	0.08994	T	0.0589	0.01513	B	0.000451070617010203	0.06484	0.66120080	0.85265	0.015	0.01656	.	.	.	.	.	.	1.382465	0.17967	13.46	0.95553931016956817	0.27444	0.348277	0.44058	N	-0.905615453130585	0.10580	0.5131168	-0.733285273056631	0.15864	0.852057	4.49	2.31	0.27741	-1.65	0.12897	1.901	0.39574	1.120000	0.24320	0.671	0.69477	1.0	0.71675	0.997000	0.33331	0.2	0.21941	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	11	264690	4.155805E-5	.	2	109350	1.828990e-05	0	3	206622	1.451930e-05	0	4	236528	1.691130e-05	0	1	7160	1.396650e-04	0	1	17108	5.845220e-05	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13378	0.000000e+00	0	0	42740	0.000000e+00	0	0	15686	0.000000e+00	0	1	7160	1.396650e-04	0	1	16060	6.226650e-05	0	2	30494	6.558670e-05	0	0	6138	0.000000e+00	0	0	13388	0.000000e+00	0	0	16716	0.000000e+00	0	0	88396	0.000000e+00	0	0	30598	0.000000e+00	0	2	30494	6.558670e-05	0	1	14834	6.741270e-05	0	2	34244	5.840440e-05	0	0	9570	0.000000e+00	0	0	17690	0.000000e+00	0	0	21578	0.000000e+00	0	1	102478	9.758190e-06	0	0	30522	0.000000e+00	0	1	14834	6.741270e-05	0	.	11	1613036	6.819440e-06	0	3	74916	4.004490e-05	0	3	74916	4.004490e-05	0	0	912	0.000000e+00	0	2	60002	3.333220e-05	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	63034	0.000000e+00	0	0	6084	0.000000e+00	0	6	1180026	5.084630e-06	0	0	91078	0.000000e+00	0	0	19780	0	0	298	0	0	86	0	2	7438	2.6888948642108095E-4	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	1930	0	2	7736	2.585315408479835E-4	0	112	0	3	30412	9.864527160331448E-5	Uncertain_significance	not_specified	criteria_provided,_single_submitter	NC_000007.14:g.45075957G>A	.	CN169374	.	.	.	Arg	Gln	3228104	single nucleotide variant	NM_031443.4(CCM2):c.1235G>A (p.Arg412Gln)	83605	CCM2	HGNC:21708	Uncertain significance	0	Feb 07, 2024	-1	-	RCV003994838	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000007.14	7	45075957	45075957	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4247293	2	3068778	45075957	G	A	-	-	-	-	-	-	SCV004813285	-	-	1235G>A 	Arg412Gln	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Arg346His	3.464063008889011	1.0	11.601204075411482	0.00012870130531115868	2025_01_Batch_13-14	0.9024756044280248	0.8456588966634091	0.87946334701265	0.8726642113439711	0.7754326157659519	0.7329369795853004	0.8081088813144248	0.8789042547089853	0.7520149223954414	0.7156282895269171	0.8177062920066626	0.826883888988917	0.8791838008608177	0.8123395668697062	0.7455304526464346	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038792		NC_000007.14:45074391:G:A		Arg346His																												CCM2_Arg346His	7	45074391	G	A	7	allele	1037G>A	F10	527_CAVA_Array_P07	L19	B13A7A8P2_R1	B14A7A8P2_R2				7-45074391-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly162Glu	0.6315816978272256	1.0	-0.17950052558782836	1.0	2025_01_Batch_13-14	0.7760652662700998	0.7617421773582059	0.8162482069047129	0.7955542597095479	0.6405231053064787	0.6857361934126257	0.7356631654030076	0.7383975588087749	0.7043343771638425	0.652541081022123	0.7309007298413628	0.7487026713806068	0.7773228828567439	0.7499443184366952	0.6465320931643008	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038684		NC_000007.14:45068455:G:A		Gly162Glu																												CCM2_Gly162Glu	7	45068455	G	A	7	allele	485G>A	A02	527_CAVA_Array_P07	B03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068455-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Pro77Gln	1.8772767783612314	1.0	7.066997555849626	1.0	2025_01_Batch_13-14	0.8274745435757648	0.8324352074939475	0.8556247281607878	0.8505864762423195	0.7263204975933214	0.6911764652695146	0.6591404380164556	0.6830169692975356	0.6140702578235324	0.6824018552393657	0.7593255044226397	0.7457878227552015	0.7693208487291617	0.7323283670329259	0.7043611764163435	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038632		NC_000007.14:45063943:C:A		Pro77Gln																												CCM2_Pro77Gln	7	45063943	C	A	7	allele	230C>A	E09	527_CAVA_Array_P06	I18	B13A7A8P2_R1	B14A7A8P2_R2				7-45063943-C-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gln441Arg	0.5701009618403354	1.0	13.187428106244349	1.0	2025_01_Batch_13-14	0.8153407427025723	0.7634871801639825	0.7922495871124408	0.7869411577565119	0.7448546167257436	0.7443237119653978	0.7451633483056205	0.7610762159539827	0.8053367518582791	0.6749461148510347	0.779832227333985	0.7543252642348015	0.7766629015332117	0.7961389548073955	0.7099003657883891	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038851		NC_000007.14:45076044:A:G		Gln441Arg																												CCM2_Gln441Arg	7	45076044	A	G	7	allele	1322A>G	B04	527_CAVA_Array_P08	D08	B13A7A8P2_R1	B14A7A8P2_R2				7-45076044-A-G	2397793	7	45076044	A	G	Q	R	rs769680088	7	45115643	7	45082168	441	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1322A>G	p.Gln441Arg	c.1322A>G	p.Gln441Arg	principal1	Y	1	YES	Select	+	CAG	2	0	A	./.	./.	./.	./.	0.391	0.13121	T	0.307	0.22288	T	0.0	0.02950	B	0.001	0.04348	B	0.17	0.63842	N	simple_aae	83.0	17.0	0.29	0.10037	N	-1.04	0.30521	N	0.024	0.01905	-1.0641	0.10772	T	0.0904	0.34457	T	10	0.05373043	0.05607	T	0.013991	0.33541	T	0.095	0.27216	0.023	0.00001	Q9BSQ5	Q441R	Gain of phosphorylation at S438 (P = 0.113)| Loss of glycosylation at S443 (P = 0.3418)| Loss of stability (P = 0.4094)| Loss of helix (P = 0.5774)| Gain of methylation at Q441 (P = 0.6519)	0.481543764896	0.47417	.	0.40177	.	0.33309	0.334933280945	0.15664	T	0.037311	0.24163	T	-0.163623	0.25861	T	-0.472809	0.24867	T	0.091679273929079	0.11272	T	0.787921	0.42524	T	0.030409923	0.02675	0.049405225	0.07558	0.030409923	0.02674	0.049405225	0.07557	-3.469	0.16953	T	0.0679	0.05824	B	0.00209268325604206	0.13319	0.68705714	0.85805	0.052	0.13809	.	.	.	.	.	.	2.289133	0.29328	18.07	0.97664476359180796	0.35383	0.595406	0.58851	D	-0.454361985019352	0.23325	1.268019	-0.277551781557956	0.28521	1.6111	4.49	3.32	0.37060	.	.	2.129	0.41781	5.170000	0.47900	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.991	0.66489	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	1	109250	9.153320e-06	0	1	205730	4.860740e-06	0	1	235686	4.242930e-06	0	0	7152	0.000000e+00	0	0	17092	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13300	0.000000e+00	0	1	42738	2.339840e-05	0	0	15690	0.000000e+00	0	1	42738	2.339840e-05	0	0	15938	0.000000e+00	0	0	30470	0.000000e+00	0	0	6110	0.000000e+00	0	0	13362	0.000000e+00	0	0	16636	0.000000e+00	0	1	87792	1.139060e-05	0	0	30602	0.000000e+00	0	1	87792	1.139060e-05	0	0	14732	0.000000e+00	0	0	34228	0.000000e+00	0	0	9536	0.000000e+00	0	0	17690	0.000000e+00	0	0	21384	0.000000e+00	0	1	101982	9.805650e-06	0	0	30526	0.000000e+00	0	1	101982	9.805650e-06	0	.	4	1613042	2.479790e-06	0	4	1180028	3.389750e-06	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44874	0.000000e+00	0	0	62896	0.000000e+00	0	0	6062	0.000000e+00	0	4	1180028	3.389750e-06	0	0	91090	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	Cerebral_cavernous_malformation_2|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.45076044A>G	.	C1864041|C0950123	603284	221061	.	Gln	Arg	2386775	single nucleotide variant	NM_031443.4(CCM2):c.1322A>G (p.Gln441Arg)	83605	CCM2	HGNC:21708	Uncertain significance	0	Feb 05, 2024	-1	-	RCV002739119|RCV004560085	MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Inborn genetic diseases|Cerebral cavernous malformation 2	germline;unknown	germline	GRCh38	NC_000007.14	7	45076044	45076044	7p13	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA4247313	2	2397793	45076044	A	G	-	-	-	-	-	-	SCV003739793|SCV005049396	-	-	1322A>G 	Gln441Arg	NM_031443.4	2	4_VUS																																																																																																									
CCM2	CCM2_Thr106Ile	0.9072071889664839	1.0	5.4678560772937965	1.0	2025_01_Batch_13-14	0.9236145874689613	0.949282097822255	0.9387316731379246	0.9485622073973913	0.8330717878790534	0.8681868757860302	0.9100074926498527	0.8433205373236765	0.8615377034841445	0.7784070681982186	0.8959007316274957	0.9296447952360538	0.8910261052308006	0.9050499554407678	0.8057394280386361	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038648		NC_000007.14:45064491:C:T		Thr106Ile																												CCM2_Thr106Ile	7	45064491	C	T	7	allele	317C>T	C11	527_CAVA_Array_P06	E22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064491-C-T	1357239	7	45064491	C	T	T	I	rs1798672293	7	45104090	7	45070615	106	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.317C>T	p.Thr106Ile	c.317C>T	p.Thr106Ile	principal1	Y	1	YES	Select	+	ACT	2	0	C	C/C	C/C	C/C	C/C	0.016	0.53331	D	0.045	0.51463	D	0.041	0.21372	B	0.027	0.21085	B	0.4	0.78586	N	simple_aae	60.0	40.0	2.425	0.70064	M	-4.32	0.76686	D	0.72	0.79621	-0.7204	0.59272	T	0.2151	0.57492	T	10	0.5541794	0.64122	D	0.025372	0.48134	D	0.165	0.42174	0.366	0.37218	Q9BSQ5	T106I	Loss of disorder (P = 0.0253)| Loss of phosphorylation at T106 (P = 0.0891)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2059)| Gain of catalytic residue at A111 (P = 0.2706)	0.533469874242	0.52653	.	0.57349	.	0.72830	0.737774252892	0.72597	T	0.449263	0.78926	T	-0.027726	0.47415	T	-0.277603	0.46713	T	0.99258279800415	0.82968	D	0.965703	0.87314	D	0.5694545	0.70738	0.33054653	0.58693	0.5694545	0.70739	0.33054653	0.58692	-9.023	0.71917	D	0.5876	0.76568	P	0.361184600573507	0.56395	0.96883965	0.94568	0.42	0.66071	.	.	.	.	.	.	3.807707	0.54978	23.5	0.99660397213338248	0.77907	0.584144	0.58161	D	0.264603792232977	0.54134	3.60225	0.307025197446167	0.55718	3.758066	5.32	4.44	0.53107	2.32	0.43525	3.272	0.51414	3.218000	0.36919	0.599	0.40292	0.998	0.41403	0.998000	0.34068	0.998	0.85369	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	1613606	4.338110e-06	0	1	75032	1.332760e-05	0	1	75032	1.332760e-05	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	63992	0.000000e+00	0	0	5762	0.000000e+00	0	6	1179902	5.085170e-06	0	0	91056	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Uncertain_significance	Cerebral_cavernous_malformation_2	criteria_provided,_single_submitter	NC_000007.14:g.45064491C>T	.	C1864041	603284	221061	PTB/PI domain	Thr	Ile	1345215	single nucleotide variant	NM_031443.4(CCM2):c.317C>T (p.Thr106Ile)	83605	CCM2	HGNC:21708	Uncertain significance	0	Dec 02, 2021	1798672293	-	RCV001878260	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45064491	45064491	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367429858	2	1357239	45064491	C	T	-	-	-	-	-	-	SCV002123641	-	-	317C>T 	Thr106Ile	NM_031443.4	1	4_VUS																																																																																																									
RAF1	RAF1_Leu613Val	-5.80016652158815	0.04739521026534352	5.723555823832908	0.0022460511579955496	2025_01_Batch_13-14	0.7624597863846477	0.7364161258611203	0.796199025654295	0.7788606988716829	0.6848428071283864											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008860		NC_000003.12:12584624:G:C		Leu613Val																												RAF1_Leu613Val	3	12584624	G	C	3	allele	1837C>G	F04	527_CAVA_Array_P05	K07	B13A7A8P2_R1	B14A7A8P2_R2				3-12584624-G-C	13960	3	12584624	G	C	L	V	rs80338797	3	12626123	3	12601123	613	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1837C>G	p.Leu613Val	c.1837C>G	p.Leu613Val	principal3	Y	1	YES	Select	-	CTA	1	2	G	G/G	G/G	G/G	G/G	0.019	0.60085	D	0.022	0.57928	D	0.135	0.27320	B	0.252	0.39069	B	0.79	0.86984	A	simple_aae	21.0	79.0	2.485	0.72164	M	-2.57	0.56009	D	0.568	0.59354	-0.0874	0.80297	T	0.4146	0.76085	T	9	0.8424604	0.83230	D	0.082094	0.73737	D	0.579	0.82939	0.809	0.92541	P04049	L613V	Loss of catalytic residue at L613 (P = 0.0273)| Loss of glycosylation at K615 (P = 0.0453)| Gain of methylation at K615 (P = 0.0691)| Gain of ubiquitination at K615 (P = 0.1132)| Loss of stability (P = 0.1352)	0.91975856692	0.91833	.	0.69748	0.394351984474	0.40309	0.81423997879	0.84115	D	0.760318	0.93442	D	0.221088	0.75698	D	0.0798012	0.75382	D	0.969073593616486	0.68255	D	.	0.83110	.	0.5087415	0.67300	0.225398	0.47307	0.5052323	0.67095	0.22544135	0.47312	-9.343	0.70025	D	0.5072	0.64853	A	0.993864972354477	0.90295	0.98658720	0.96257	0.839	0.91143	.	.	.	.	.	.	4.008235	0.59191	24.1	0.99627613236244716	0.75865	0.504613	0.53448	D	0.1905950925256	0.50505	3.261897	0.307022034721395	0.55718	3.75805	5.41	4.46	0.53511	4.17	0.79380	3.761	0.55045	5.815000	0.50112	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hypertrophic_cardiomyopathy_1|Noonan_syndrome|RAF1-related_disorder|Noonan_syndrome_with_multiple_lentigines|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2	reviewed_by_expert_panel	NC_000003.12:g.12584624G>C	ClinGen:CA257066|OMIM:164760.0004|UniProtKB:P04049#VAR_037821	C3661900|C3495498|C0028326|C0175704|C5555857|C1969057|C1969056	192600|PS163950|PS151100|611553|611554	648|500|536391|648|500	.	Leu	Val	28999	single nucleotide variant	NM_002880.4(RAF1):c.1837C>G (p.Leu613Val)	5894	RAF1	HGNC:9829	Pathogenic	1	Apr 03, 2017	80338797	-	RCV000014990|RCV000014989|RCV000020508|RCV000159089|RCV000254689|RCV000440827|RCV000824753|RCV001256891|RCV004532353	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|	Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|RASopathy|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Hypertrophic cardiomyopathy 1|RAF1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	12584624	12584624	3p25.2	reviewed by expert panel	11	-	N	ClinGen:CA257066,UniProtKB:P04049#VAR_037821,OMIM:164760.0004	3	13960	12584624	G	C	-	-	-	-	-	-	SCV000616381	-	-	1837C>G 	Leu613Val	NM_002880.4	3	1_Pathogenic																																																																																																									
CCM2	CCM2_Arg40His	1.292728750213537	1.0	0.5277986072138902	1.0	2025_01_Batch_13-14	0.8802314511665292	0.8442433926906708	0.8360201231337995	0.8860561419954439	0.7530532937042311	0.8098023731791208	0.8386039106830473	0.7834598602080058	0.76807152875711	0.7651998641214792	0.845016912172825	0.8414236516868591	0.8097399916709027	0.8270638353762769	0.7591265789128552	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038614		NC_000007.14:45038341:G:A		Arg40His																												CCM2_Arg40His	7	45038341	G	A	7	allele	119G>A	B07	527_CAVA_Array_P06	C14	B13A7A8P2_R1	B14A7A8P2_R2				7-45038341-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SHOC2	SHOC2_Thr494Asn	-2.46768768795486	0.043748529350086024	6.245201442276201	0.0007634759552907376																											true	SHOC2		11602		CCSBVarC028085		NC_000010.11:111009771:C:A		Thr494Asn																												SHOC2_Thr494Asn	10	111009771	C	A	10	allele	1481C>A	A02	527_CAVA_Array_P06	A04	B13A7A8P2_R1	B14A7A8P2_R2				10-111009771-C-A	845617	10	111009771	C	A	T	N	rs758241851	10	112769529	10	112759519	494	SHOC2	ENSG00000108061	ENST00000689118	ENSP00000510554	Q9UQ13	SHOC2_HUMAN	.	.	c.1481C>A	p.Thr494Asn	principal1	Y	.	.	.	+	ACT	2	0	C	C/C	C/C	C/C	C/C	.	0.28279	.	.	0.43692	.	0.163	0.43673	B	0.157	0.42698	B	.	0.59775	.	.	.	.	1.58	0.39613	L	.	0.40077	.	.	0.50808	-0.9736	0.36287	T	0.1329	0.44354	T	10	.	0.29167	.	0.012795	0.31405	T	.	0.20565	0.321	0.29930	Q9UQ13	T494N	Gain of relative solvent accessibility (P = 0.1259)| Loss of helix (P = 0.1299)| Gain of disorder (P = 0.2132)| Gain of solvent accessibility (P = 0.2346)| Gain of loop (P = 0.2754)	.	0.34965	.	0.54033	.	0.80440	0.850702464581	0.89704	D	0.235199	0.60025	T	-0.31296	0.07289	T	-0.359362	0.37770	T	0.172610089051042	0.18523	T	0.943906	0.78769	D	0.16714135	0.36793	0.14926983	0.35145	0.16714135	0.36792	0.14926983	0.35144	-6.592	0.51057	T	.	0.30427	.	0.880875675876287	0.74823	0.00410146	0.30927	0.089	0.25085	.	.	.	.	.	.	3.225538	0.44047	21.8	0.97401986174303501	0.33955	0.331270	0.42914	N	0.106166022947134	0.46496	2.910648	0.219752477088244	0.50689	3.281369	5.75	4.84	0.62077	2.81	0.51409	3.316	0.51765	4.031000	0.41417	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.992	0.67791	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	7	109390	6.399120e-05	0	14	208064	6.728700e-05	0	14	236856	5.910760e-05	0	0	7162	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42762	0.000000e+00	0	7	15690	4.461440e-04	0	7	15690	4.461440e-04	0	0	16216	0.000000e+00	0	0	30516	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89512	0.000000e+00	0	13	30600	4.248370e-04	0	13	30600	4.248370e-04	0	0	14900	0.000000e+00	0	0	34252	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	0	102688	0.000000e+00	0	13	30518	4.259780e-04	0	13	30518	4.259780e-04	0	.	38	1613356	2.355340e-05	0	37	91068	4.062900e-04	0	0	74886	0.000000e+00	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	0	29586	0.000000e+00	0	0	44814	0.000000e+00	0	0	64022	0.000000e+00	0	0	6078	0.000000e+00	0	0	1179528	0.000000e+00	0	37	91068	4.062900e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_specified|RASopathy	criteria_provided,_conflicting_classifications	NC_000010.11:g.111009771C>A	.	CN169374|C5555857	.	536391	.	Thr	Asn	836647	single nucleotide variant	NM_007373.4(SHOC2):c.1481C>A (p.Thr494Asn)	8036	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0	May 02, 2021	758241851	-	RCV001048720|RCV001420775	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN169374	RASopathy|not specified	germline	germline	GRCh38	NC_000010.11	10	111009771	111009771	10q25.2	criteria provided, conflicting classifications	2	-	N	ClinGen:CA5689787	2	845617	111009771	C	A	-	-	-	-	-	-	SCV001212736|SCV001623128	-	-	1481C>A 	Thr494Asn	NM_007373.4	1	3_Conflicting																																																																																																									
RAF1	RAF1_Ser427Gly	-5.857143473908194	0.08915991405016992	4.645910603471249	0.00992717572430983	2025_01_Batch_13-14	0.7927766062981189	0.8314193235226529	0.8219138734955567	0.8557426612183633	0.7318016857301761	0.8342764973325787	0.8421119023640624	0.7209446777313937	0.842479224161091	0.7298495481880614	0.8135265518153487	0.8367656129433576	0.7714292756134752	0.8491109426897272	0.7308256169591187	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAF1		732		CCSBVarC008846		NC_000003.12:12618597:G:A		Ser427Gly																												RAF1_Ser427Gly	3	12618597	G	A	3	allele	1279A>G	H03	527_CAVA_Array_P05	O05	B13A7A8P2_R1	B14A7A8P2_R2				3-12618597-G-A	343103	3	12618597	G	A	A	V	rs11549992	3	12660096	3	12635096	42	RAF1	ENSG00000132155	ENST00000685653	ENSP00000509968	P04049	RAF1_HUMAN	.	.	c.125C>T	p.Ala42Val	principal3	Y	.	.	.	-	GCA	2	0	G	G/G	G/G	G/G	G/G	.	0.43552	.	.	0.24339	.	0.44	0.35909	B	0.118	0.32091	B	.	0.63842	.	.	.	.	1.245	0.31258	L	.	0.26593	.	.	0.53299	-0.6482	0.62631	T	0.2338	0.59872	T	10	.	0.10650	.	0.030693	0.52764	D	.	0.54847	.	.	.	.	.	.	0.68373	.	0.47139	.	0.49126	0.562870502472	0.47606	T	0.461137	0.79651	T	-0.248036	0.14071	T	-0.277907	0.46682	T	0.0281786238071906	0.01706	T	0.980702	0.93698	D	0.14208941	0.32435	0.16238137	0.37602	0.15703622	0.35113	0.15447487	0.36141	-5.939	0.46894	T	.	0.39554	.	0.93421742321215	0.78789	0.34714562	0.78211	0.176	0.42719	.	.	.	.	.	.	4.404223	0.68134	25.2	0.9983696088703764	0.91806	0.777693	0.70936	D	0.159595556076659	0.49020	3.129022	0.329305395729113	0.57042	3.89199	6.17	5.3	0.74708	.	.	7.408	0.79314	11.846000	0.97942	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	615	0.66487	.	.	.	.	.	.	.	.	.	.	.	.	70	264690	2.644603E-4	.	26	109408	2.376430e-04	0	67	208130	3.219140e-04	0	79	236948	3.334060e-04	0	0	7164	0.000000e+00	0	10	17112	5.843850e-04	0	3	2320	1.293100e-03	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	10	42768	2.338200e-04	0	1	15690	6.373490e-05	0	10	17112	5.843850e-04	0	0	16218	0.000000e+00	0	13	30524	4.258940e-04	0	16	6212	2.575660e-03	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	32	89554	3.573260e-04	0	2	30608	6.534240e-05	0	13	30524	4.258940e-04	0	0	14902	0.000000e+00	0	12	34260	3.502630e-04	0	22	9572	2.298370e-03	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	38	102746	3.698440e-04	0	2	30526	6.551790e-05	0	38	102746	3.698440e-04	0	.	350	1614154	2.168320e-04	0	47	29604	1.587620e-03	0	1	75032	1.332760e-05	0	0	910	0.000000e+00	0	18	60022	2.998900e-04	0	47	29604	1.587620e-03	0	0	44878	0.000000e+00	0	0	64030	0.000000e+00	0	9	6062	1.484660e-03	0	242	1180026	2.050800e-04	0	5	91090	5.489080e-05	0	19	42874	4.431590241171806E-4	0	306	0	0	112	0	1	8092	1.2357884330202668E-4	0	500	0	0	628	0	0	56	0	0	98	0	5	8486	5.892057506481263E-4	1	8398	1.1907597046915932E-4	0	168	0	25	61152	4.088173731030874E-4	Likely_benign	not_provided|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12618597G>A	ClinGen:CA2259832	C3661900|C5681679|C5555857|C1969057|C1969056	611553|611554	98733|536391|648|500	.	Ala	Val	289332	single nucleotide variant	NM_002880.4(RAF1):c.125C>T (p.Ala42Val)	5894	RAF1	HGNC:9829	Likely benign	0	Apr 18, 2017	11549992	-	RCV000290750|RCV000398939|RCV000521407|RCV001813467|RCV004544638|RCV000981698	MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733||MedGen:C3661900	LEOPARD syndrome 2|Noonan syndrome 5|RASopathy|Noonan syndrome and Noonan-related syndrome|RAF1-related disorder|not provided	germline	germline	GRCh38	NC_000003.12	3	12618597	12618597	3p25.2	reviewed by expert panel	8	-	N	ClinGen:CA2259832	2	343103	12618597	G	A	-	-	-	-	-	-	SCV000616490	-	-	125C>T 	Ala42Val	NM_002880.4	3	2_Benign																																																																																																									
CCM2	CCM2_His364Arg	0.3341498401312258	1.0	8.755937261794918	0.0070089928889069545	2025_01_Batch_13-14	0.8708392110244972	0.8223149472595622	0.8516054180412502	0.8767600968708793	0.8174849282677368	0.7758844579392616	0.8444672477957159	0.8095175439511414	0.7908518801358031	0.7209042457412065	0.8233618344818794	0.8333910975276391	0.8305614809961959	0.8338059885033412	0.7691945870044716	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038798		NC_000007.14:45075813:A:G		His364Arg																												CCM2_His364Arg	7	45075813	A	G	7	allele	1091A>G	H10	527_CAVA_Array_P07	P19	B13A7A8P2_R1	B14A7A8P2_R2				7-45075813-A-G	1434843	7	45075813	A	G	H	R	rs201559289	7	45115412	7	45081937	364	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1091A>G	p.His364Arg	c.1091A>G	p.His364Arg	principal1	Y	1	YES	Select	+	CAC	2	0	A	A/A	A/A	A/A	A/A	0.033	0.48345	D	0.037	0.53775	D	0.95	0.53896	P	0.698	0.54094	P	0.8	0.87956	D	simple_aae	20.0	80.0	1.79	0.46598	L	-3.23	0.67161	D	0.649	0.67575	-1.1221	0.02213	T	0.0769	0.30577	T	10	0.4965026	0.60977	D	0.018374	0.40172	T	0.175	0.43974	.	.	.	.	.	0.316788114976	0.30868	.	0.77180	.	0.71142	0.875495910645	0.93335	D	0.291238	0.66212	T	-0.173262	0.24405	T	-0.238346	0.50636	T	0.262962818145752	0.23167	T	0.930707	0.74263	D	0.56539315	0.70513	0.48935696	0.70195	0.56539315	0.70515	0.48935696	0.70196	-10.126	0.76144	D	0.4425	0.66572	A	0.056242476954892	0.38205	0.95668780	0.93757	0.486	0.70536	.	.	.	.	.	.	3.679732	0.52452	23.2	0.99704931544951836	0.80955	0.904961	0.85537	D	0.448173918805115	0.63911	4.657031	0.417233154131103	0.62436	4.482638	4.93	3.75	0.42169	2.86	0.52289	6.099	0.71184	9.147000	0.78966	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	10	109406	9.140270e-05	0	16	207696	7.703570e-05	0	18	236718	7.603980e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13392	7.467140e-05	0	8	42768	1.870560e-04	0	0	15690	0.000000e+00	0	8	42768	1.870560e-04	0	0	16198	0.000000e+00	0	0	30514	0.000000e+00	0	0	6188	0.000000e+00	0	0	13408	0.000000e+00	0	1	16732	5.976570e-05	0	13	89192	1.457530e-04	0	0	30606	0.000000e+00	0	13	89192	1.457530e-04	0	0	14898	0.000000e+00	0	0	34248	0.000000e+00	0	0	9556	0.000000e+00	0	0	17690	0.000000e+00	0	1	21630	4.623210e-05	0	15	102556	1.462620e-04	0	0	30526	0.000000e+00	0	15	102556	1.462620e-04	0	.	160	1613674	9.915260e-05	1	153	1180038	1.296570e-04	1	0	74922	0.000000e+00	0	0	910	0.000000e+00	0	0	60002	0.000000e+00	0	0	29608	0.000000e+00	0	0	44898	0.000000e+00	0	3	63650	4.713280e-05	0	0	6084	0.000000e+00	0	153	1180038	1.296570e-04	1	0	91084	0.000000e+00	0	9	114104	7.887541190492883E-5	0	300	0	0	90	0	0	7616	0	0	506	0	0	650	0	0	52	0	0	98	0	1	12042	8.304268393954493E-5	0	7916	0	0	142	0	10	135458	7.382362060564898E-5	Conflicting_classifications_of_pathogenicity	Inborn_genetic_diseases|Cerebral_cavernous_malformation_2|not_provided	criteria_provided,_conflicting_classifications	NC_000007.14:g.45075813A>G	.	C0950123|C1864041|C3661900	603284	221061	Cerebral cavernous malformations 2, harmonin-homology domain|Cerebral cavernous malformations 2, harmonin-homology domain	His	Arg	1507047	single nucleotide variant	NM_031443.4(CCM2):c.1091A>G (p.His364Arg)	83605	CCM2	HGNC:21708	Conflicting classifications of pathogenicity	0	Aug 14, 2024	201559289	-	RCV001955131|RCV003225207|RCV002442903	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Cerebral cavernous malformation 2|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45075813	45075813	7p13	criteria provided, conflicting classifications	3	-	N	ClinGen:CA4247260	2	1434843	45075813	A	G	-	-	-	-	-	-	SCV002212111|SCV002734892|SCV003921615	-	-	1091A>G 	His364Arg	NM_031443.4	1	3_Conflicting																																																																																																									
CCM2	CCM2_Arg389Trp	2.6873883065270796	1.0	11.853335379545825	0.00006849795811967337	2025_01_Batch_13-14	0.8798879295631522	0.89107260141191	0.9066917614679625	0.9072107473453158	0.7938347021501816	0.6808669525100775	0.8485384680077395	0.8982436736710723	0.8209941964545396	0.5959796832945653	0.7803774410366149	0.8698055347098248	0.9024677175695174	0.8641024718999277	0.6949071927223734	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038811		NC_000007.14:45075887:C:T		Arg389Trp																												CCM2_Arg389Trp	7	45075887	C	T	7	allele	1165C>T	G11	527_CAVA_Array_P07	N21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075887-C-T	3139755	7	45075887	C	T	R	W	rs1413642987	7	45115486	7	45082011	389	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1165C>T	p.Arg389Trp	c.1165C>T	p.Arg389Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	0.998	0.73231	D	0.736	0.55524	P	0.17	0.61445	N	simple_aae	83.0	17.0	1.7	0.43657	L	-2.89	0.71435	D	0.612	0.64896	-0.8659	0.50640	T	0.1600	0.49249	T	10	0.5057714	0.61492	D	0.052756	0.65068	D	0.124	0.34032	0.248	0.18351	Q9BSQ5	R389W	Loss of disorder (P = 0.0129)| Loss of glycosylation at S393 (P = 0.0649)| Loss of phosphorylation at S384 (P = 0.1109)| Loss of loop (P = 0.1258)| Gain of MoRF binding (P = 0.1304)	0.470318359215	0.46285	.	0.69317	.	0.74039	0.534363389015	0.43585	T	0.209298	0.56734	T	-0.0784455	0.39615	T	-0.350458	0.38800	T	0.966519117355347	0.67397	D	0.983702	0.94497	D	0.2062018	0.42466	0.17568137	0.39917	0.2062018	0.42466	0.17568137	0.39916	-11.392	0.87894	D	0.4548	0.62394	A	0.457278165254995	0.59478	0.93032205	0.92406	0.407	0.65156	.	.	.	.	.	.	5.003858	0.83076	27.9	0.99908700437013287	0.97876	0.894827	0.83362	D	0.304223589958751	0.56144	3.801101	0.225139920984399	0.50993	3.30882	4.49	3.59	0.40184	-1.75	0.12510	0.881	0.27905	3.923000	0.40564	0.599	0.40292	0.995	0.38864	1.000000	0.68239	0.876	0.41839	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613234	3.719240e-06	0	1	91092	1.097790e-05	0	0	74926	0.000000e+00	0	0	910	0.000000e+00	0	0	60002	0.000000e+00	0	0	29606	0.000000e+00	0	0	44892	0.000000e+00	0	0	63210	0.000000e+00	0	0	6084	0.000000e+00	0	4	1180034	3.389730e-06	0	1	91092	1.097790e-05	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1930	0	0	7736	0	0	112	0	1	30412	3.288175720110483E-5	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45075887C>T	.	C0950123	.	.	.	Arg	Trp	3292490	single nucleotide variant	NM_031443.4(CCM2):c.1165C>T (p.Arg389Trp)	83605	CCM2	HGNC:21708	Uncertain significance	0	Feb 01, 2023	-1	-	RCV004430579	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45075887	45075887	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367431748	2	3139755	45075887	C	T	-	-	-	-	-	-	SCV004923059	-	-	1165C>T 	Arg389Trp	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Arg423His	1.8709229844308213	1.0	3.6821731667918223	1.0	2025_01_Batch_13-14	0.8060172202396566	0.7908622390987037	0.8281323919548359	0.8085776183268639	0.6665536035614784	0.6401658845271497	0.7205467555692906	0.7473501367986679	0.707878526183809	0.5613091847134358	0.7230915523834032	0.7557044973339971	0.7877412643767518	0.7582280722553365	0.6139313941374571	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038839		NC_000007.14:45075990:G:A		Arg423His																												CCM2_Arg423His	7	45075990	G	A	7	allele	1268G>A	E02	527_CAVA_Array_P08	J04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075990-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Asn280Ser	-1.5655811200139778	1.0	-0.6127928774573419	1.0	2025_01_Batch_13-14	0.7753062704216713	0.8364156324435186	0.7536954439410324	0.7567184616927626	0.7212074588575044	0.8389461083420069	0.769635431082419	0.750969399987519	0.8430121171597668	0.6838882114343465	0.8071261893818391	0.8030255317629689	0.7523324219642757	0.7998652894262647	0.7025478351459254	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011867		NC_000006.12:5431107:A:G		Asn280Ser																												FARS2_Asn280Ser	6	5431107	A	G	6	allele	839A>G	F01	527_CAVA_Array_P03	L01	B13A7A8P1_R1	B14A7A8P1_R2				6-5431107-A-G	137292	6	5431107	A	G	N	S	rs11243011	6	5431340	6	5376339	280	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.839A>G	p.Asn280Ser	c.839A>G	p.Asn280Ser	principal1	Y	1	YES	Select	+	AAC	2	0	A	A/A	A/A	A/A	A/A	0.355	0.12180	T	0.358	0.17298	T	0.001	0.07480	B	0.001	0.04348	B	0.35	0.59775	P	simple_aae	65.0	35.0	-1.405	0.00593	N	-0.85	0.23101	N	0.057	0.02855	-1.0690	0.09648	T	0.0343	0.14655	T	9	0.0024745166	0.00036	T	.	.	.	0.045	0.12154	.	.	.	.	.	.	.	.	0.37527	.	0.13639	0.263113975525	0.05267	T	0.039256	0.24861	T	-0.686866	0.00042	T	-0.615592	0.11282	T	0.00545995115788096	0.00059	T	0.873413	0.59719	D	0.13583922	0.31242	0.081693865	0.18565	0.14538196	0.33047	0.072034046	0.15483	-4.658	0.32930	T	0.071	0.11803	B	0.0760332499692323	0.40859	0.01150617	0.42971	0.104	0.28905	.	.	.	.	.	.	1.830349	0.23297	15.95	0.96326186103365574	0.29640	0.180003	0.30517	N	-0.50634435902713	0.21618	1.164074	-0.278242492394687	0.28498	1.60963	5.5	3.13	0.35013	3.86	0.72457	3.397	0.52411	0.661000	0.20583	0.691	0.84104	1.0	0.71675	0.887000	0.27860	0.997	0.79771	957	0.09723	1178	0.23522364217252395	73	0.05521936459909228	162	0.1610337972166998	163	0.23487031700288186	481	0.4771825396825397	299	0.3057259713701431	45111	264690	0.17042956	.	24540	109368	2.243800e-01	3377	45917	208058	2.206930e-01	6059	52920	236782	2.234970e-01	7082	475	7162	6.632230e-02	25	4417	17098	2.583340e-01	595	655	2320	2.823280e-01	91	4291	9038	4.747730e-01	1044	2111	13394	1.576080e-01	164	7831	42760	1.831380e-01	746	4354	15682	2.776430e-01	667	4291	9038	4.747730e-01	1044	1162	16216	7.165760e-02	53	8147	30502	2.670970e-01	1117	1797	6212	2.892790e-01	257	6295	13402	4.697060e-01	1503	2609	16734	1.559100e-01	200	16375	89532	1.828960e-01	1525	8468	30596	2.767680e-01	1279	6295	13402	4.697060e-01	1503	1054	14900	7.073830e-02	49	8942	34234	2.612020e-01	1211	2718	9568	2.840720e-01	370	8428	17676	4.768050e-01	2039	3422	21632	1.581920e-01	262	18713	102644	1.823100e-01	1743	8452	30514	2.769880e-01	1276	8428	17676	4.768050e-01	2039	.	308230	1613374	1.910470e-01	32055	17868	44846	3.984300e-01	3721	5480	75004	7.306280e-02	224	286	912	3.135960e-01	39	14268	59996	2.378160e-01	1793	8354	29588	2.823440e-01	1158	17868	44846	3.984300e-01	3721	10087	63978	1.576640e-01	749	1150	6058	1.898320e-01	124	213144	1179548	1.807000e-01	19229	24843	90970	2.730900e-01	3623	52614	287826	0.1827979404223385	18	410	0.04390243902439024	2047	4918	0.4162261081740545	734	11560	0.06349480968858132	145	1244	0.11655948553054662	2175	9118	0.23853915332309716	891	1978	0.4504550050556117	1355	5196	0.26077752117013087	4344	18732	0.2319026265214606	752	11970	0.06282372598162071	2938	6896	0.42604408352668216	64323	340982	0.1886404560944566	Benign	not_specified|Hereditary_spastic_paraplegia_77|Combined_oxidative_phosphorylation_defect_type_14|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5431107A>G	ClinGen:CA290845|UniProtKB:O95363#VAR_052643	CN169374|C5569007|C4755312|C3661900	617046|614946	466722|319519	Aminoacyl-tRNA synthetase, class II	Asn	Ser	140995	single nucleotide variant	NM_006567.5(FARS2):c.839A>G (p.Asn280Ser)	10667	FARS2	HGNC:21062	Benign	0	Feb 04, 2025	11243011	-	RCV000124983|RCV000677020|RCV001701760|RCV000714927	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline;unknown	germline	GRCh38	NC_000006.12	6	5431107	5431107	6p25.1	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA290845,UniProtKB:O95363#VAR_052643	2	137292	5431107	A	G	-	-	-	-	-	-	SCV000168423|SCV000311536|SCV000845693|SCV001731157|SCV001933312|SCV001933313|SCV005091750	-	-	839A>G 	Asn280Ser	NM_006567.5	2	2_Benign																																																																																																									
FARS2	FARS2_Leu371Phe	0.24590492354475124	1.0	-2.718592944820778	0.042150746612175535	2025_01_Batch_13-14	0.6725393516295189	0.7424490977972589	0.7699201139117763	0.7909852528347302	0.5574119026468386	0.7225344402022017	0.7924054930913393	0.8017880222938175	0.8413800554305063	0.5634828091724872	0.6975368959158603	0.7674272954442991	0.7858540681027969	0.8161826541326183	0.5604473559096629	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011882		NC_000006.12:5613216:G:T		Leu371Phe																												FARS2_Leu371Phe	6	5613216	G	T	6	allele	1113G>T	C12	527_CAVA_Array_P02	E24	B13A7A8P1_R1	B14A7A8P1_R2				6-5613216-G-T	973745	6	5613216	G	T	L	F	rs1204079767	6	5613449	6	5558448	371	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1113G>T	p.Leu371Phe	c.1113G>T	p.Leu371Phe	principal1	Y	1	YES	Select	+	TTG	3	2	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.005	0.72530	D	0.984	0.60748	D	0.905	0.64254	P	0.98	0.97016	A	simple_aae	2.0	98.0	3.49	0.92559	M	-3.3	0.65888	D	0.828	0.82302	0.0185	0.82548	D	0.5146	0.81736	D	10	0.87487864	0.86629	D	0.114229	0.79238	D	0.721	0.90105	0.653	0.78980	O95363	L371F	Loss of catalytic residue at L371 (P = 0.134)| Gain of sheet (P = 0.1451)| Loss of stability (P = 0.1495)| Gain of loop (P = 0.3485)| Gain of disorder (P = 0.4546)	0.934491293691	0.93330	.	0.75719	.	0.59072	0.566125333309	0.48064	T	0.632922	0.88531	D	0.282506	0.81394	D	0.168024	0.81155	D	0.98774379491806	0.78021	D	0.949505	0.80529	D	0.6913538	0.77328	0.57329565	0.75036	0.6913538	0.77329	0.57329565	0.75036	-9.639	0.71800	D	0.4567	0.62580	A	0.937195805839724	0.79075	0.94634580	0.93179	0.82	0.90063	.	.	.	.	.	.	2.807945	0.37026	20.4	0.99854701034997717	0.93373	0.344351	0.43798	N	0.383302004000591	0.60314	4.241475	0.254276606892227	0.52647	3.461171	5.53	0.378	0.15396	0.251	0.23301	0.161	0.16353	0.741000	0.21243	0.676	0.76753	0.99	0.37076	0.997000	0.33331	0.996	0.76032	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Combined_oxidative_phosphorylation_defect_type_14	no_assertion_criteria_provided	NC_000006.12:g.5613216G>T	.	C4755312	614946	319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Leu	Phe	962037	single nucleotide variant	NM_006567.5(FARS2):c.1113G>T (p.Leu371Phe)	10667	FARS2	HGNC:21062	Pathogenic	1	Dec 12, 2019	1204079767	-	RCV001250395	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613216	5613216	6p25.1	no assertion criteria provided	1	-	N	ClinGen:CA362736853	2	973745	5613216	G	T	-	-	-	-	-	-	SCV001424746	-	-	1113G>T 	Leu371Phe	NM_006567.5		1_Pathogenic																																																																																																									
CCM2	CCM2_Asp431Asn	0.46548433431308583	1.0	17.64224742526064	8.745123146969342e-6	2025_01_Batch_13-14	0.7906154361392503	0.8625515565372214	0.9044548698135432	0.872945970688674	0.6966232011037081	0.7928812340654351	0.8758832688864596	0.911056688200422	0.8936672020071179	0.7334050311792725	0.7917483351023427	0.8692174127118405	0.9077557790069826	0.8833065863478959	0.7150141161414902	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038844		NC_000007.14:45076013:G:A		Asp431Asn																												CCM2_Asp431Asn	7	45076013	G	A	7	allele	1291G>A	B03	527_CAVA_Array_P08	D06	B13A7A8P2_R1	B14A7A8P2_R2				7-45076013-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp442Asn	0.3835624713902172	1.0	18.341956219968797	0.000059097979831986415	2025_01_Batch_13-14	0.8341156705408427	0.880764506356703	0.8823018556123543	0.8901089149557778	0.72898473673462	0.811801751587197	0.9376722083581207	0.9442957671390731	0.880763804558331	0.7748080401278877	0.8229587110640199	0.9092183573574119	0.9132988113757137	0.8854363597570545	0.751896388431254	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038852		NC_000007.14:45076046:G:A		Asp442Asn																												CCM2_Asp442Asn	7	45076046	G	A	7	allele	1324G>A	C04	527_CAVA_Array_P08	F08	B13A7A8P2_R1	B14A7A8P2_R2				7-45076046-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu417Gly	0.8484221594894138	1.0	6.020590579099078	0.09382217075424014	2025_01_Batch_13-14	0.7932078371221892	0.8379398378615028	0.8406876443543577	0.8492722548228495	0.6622072942813907	0.8172102455828051	0.804177421602298	0.8034750077116016	0.8447339721506523	0.7481822222865125	0.8052090413524972	0.8210586297319005	0.8220813260329797	0.8470031134867508	0.7051947582839516	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038834		NC_000007.14:45075972:A:G		Glu417Gly																												CCM2_Glu417Gly	7	45075972	A	G	7	allele	1250A>G	A02	527_CAVA_Array_P08	B04	B13A7A8P2_R1	B14A7A8P2_R2				7-45075972-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile92Thr	3.8098330332429313	1.0	-4.542980501558293	1.0	2025_01_Batch_13-14	0.8654767464076857	0.8426562642092751	0.895816529163012	0.8592856917339328	0.7375058491715504	0.8076070427269313	0.8214671679810304	0.9238226797434462	0.9036843108542638	0.7185836018757698	0.8365418945673084	0.8320617160951527	0.9098196044532292	0.8814850012940982	0.7280447255236601	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038639		NC_000007.14:45063988:T:C		Ile92Thr																												CCM2_Ile92Thr	7	45063988	T	C	7	allele	275T>C	E10	527_CAVA_Array_P06	I20	B13A7A8P2_R1	B14A7A8P2_R2				7-45063988-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile331Phe	1.2039140523185194	1.0	11.601011727286384	0.00002084860580441602	2025_01_Batch_13-14	0.9193463934463844	0.9754595944210599	0.9740397288149305	0.9576081068105008	0.7935848559352578	0.8410970799092449	0.9509539984309182	0.9547197946670523	0.8950532071021983	0.7693831755081613	0.8802217366778147	0.963206796425989	0.9643797617409914	0.9263306569563495	0.7814840157217096	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038782		NC_000007.14:45074345:A:T		Ile331Phe																												CCM2_Ile331Phe	7	45074345	A	T	7	allele	991A>T	A10	527_CAVA_Array_P07	B19	B13A7A8P2_R1	B14A7A8P2_R2				7-45074345-A-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu333Val	5.279406297171225	1.0	10.434616059369231	0.021093005336871726	2025_01_Batch_13-14	0.8788704963554007	0.856993632835979	0.8546179257378195	0.8660216972324427	0.7034505022038425	0.7423465870604722	0.8328617901054775	0.826137376468062	0.7138341059695748	0.7127614277108978	0.8106085417079365	0.8449277114707282	0.8403776511029407	0.7899279016010088	0.7081059649573702	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038785		NC_000007.14:45074352:A:T		Glu333Val																												CCM2_Glu333Val	7	45074352	A	T	7	allele	998A>T	D10	527_CAVA_Array_P07	H19	B13A7A8P2_R1	B14A7A8P2_R2				7-45074352-A-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Asp92Gly	8.432612836805006	0.00007012093234778765	-4.98932153593171	0.027997159194273955	2025_01_Batch_13-14	0.8382648617100562	0.9018121459491316	0.894444117072103	0.9084642845176677	0.7545022585795033	0.8028092439799367	0.8158381311538452	0.8258595362843585	0.7671661805653115	0.7578092573793094	0.8205370528449965	0.8588251385514885	0.8601518266782308	0.8378152325414896	0.7561557579794063	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023312		NC_000011.10:112088972:A:G		Asp92Gly																												SDHD_Asp92Gly	11	112088972	A	G	11	allele	275A>G	B12	527_CAVA_Array_P05	C23	B13A7A8P2_R1	B14A7A8P2_R2				11-112088972-A-G	180590	11	112088972	A	G	D	G	rs786205436	11	111959696	11	111464906	92	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.275A>G	p.Asp92Gly	c.275A>G	p.Asp92Gly	principal1	Y	1	YES	Select	+	GAC	2	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97926	A	simple_aae	2.0	98.0	3.9	0.96054	H	-6.8	0.92923	D	0.998	0.99987	1.0131	0.97405	D	0.9872	0.99622	D	10	0.99263144	0.99798	D	0.822633	0.98618	D	0.976	0.99783	0.96	0.99581	O14521	D92G	Loss of stability (P = 0.0632)| Gain of glycosylation at S89 (P = 0.0743)| Gain of catalytic residue at D92 (P = 0.078)| Gain of helix (P = 0.2294)| Gain of disorder (P = 0.6219)	0.981310432533	0.98091	0.9625151340225994	0.96216	0.852731849783	0.68423	0.656035840511	0.60780	T	0.980289	0.99837	D	0.583575	0.97037	D	0.600488	0.96988	D	0.999705016613007	0.98567	D	0.842116	0.51695	T	0.9904235	0.99782	0.970635	0.99484	0.99101526	0.99812	0.97202027	0.99543	-12.11	0.85423	D	0.8975	0.82539	P	0.993190100922059	0.89912	0.99926764	0.99259	0.997	0.99892	.	.	.	.	.	.	5.193893	0.8714	29.1	0.99866692114947953	0.94461	0.957097	0.97598	D	0.854382185558375	0.89298	9.938285	0.777690480254967	0.88139	9.494944	5.04	5.04	0.67250	.	.	8.791	0.91503	9.300000	0.79897	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.964	0.52647	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Fatal_infantile_mitochondrial_cardiomyopathy|Mitochondrial_complex_2_deficiency,_nuclear_type_3	no_assertion_criteria_provided	NC_000011.10:g.112088972A>G	ClinGen:CA016709|OMIM:602690.0031|UniProtKB:O14521#VAR_074106	C3532243|C5436934	619167	.	.	Asp	Gly	178768	single nucleotide variant	NM_003002.4(SDHD):c.275A>G (p.Asp92Gly)	6392	SDHD	HGNC:10683	Pathogenic	1	May 26, 2015	786205436	-	RCV000171136|RCV000186596	MedGen:C3532243|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167	Fatal infantile mitochondrial cardiomyopathy|Mitochondrial complex 2 deficiency, nuclear type 3	germline	germline	GRCh38	NC_000011.10	11	112088972	112088972	11q23.1	no assertion criteria provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016709,UniProtKB:O14521#VAR_074106,OMIM:602690.0031	3	180590	112088972	A	G	-	-	-	-	-	-	SCV000196921|SCV000240203	-	-	275A>G 	Asp92Gly	NM_003002.4		1_Pathogenic																																																																																																									
CCM2	CCM2_Pro102Leu	-1.1806428464056724	1.0	6.610852885224905	1.0	2025_01_Batch_13-14	0.8868209793695604	0.7994483010607292	0.8059476497200698	0.8044387673107026	0.6933133765582186	0.8898234672058275	0.9139565167248028	0.8354731440039439	0.8151068421159545	0.8182801896953941	0.888322223287694	0.8567024088927659	0.8207103968620069	0.8097728047133286	0.7557967831268063	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038646		NC_000007.14:45064479:C:T		Pro102Leu																												CCM2_Pro102Leu	7	45064479	C	T	7	allele	305C>T	A11	527_CAVA_Array_P06	A22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064479-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Tyr144Cys	-0.31983357585618055	1.0	-0.9424771139167271	1.0	2025_01_Batch_13-14	0.6419072422105627	0.7236909392375388	0.6679936181015709	0.7433070910902596	0.4927485261018876	0.751530142942959	0.6496685603276995	0.6400871597731469	0.782555014921668	0.6363712275656164	0.6967186925767608	0.6866797497826191	0.6540403889373589	0.7629310530059639	0.564559876833752	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011920		NC_000006.12:5369001:A:G		Tyr144Cys																												FARS2_Tyr144Cys	6	5369001	A	G	6	allele	431A>G	C01	527_CAVA_Array_P03	F01	B13A7A8P1_R1	B14A7A8P1_R2				6-5369001-A-G	39824	6	5369001	A	G	Y	C	rs397514610	6	5369234	6	5314233	144	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.431A>G	p.Tyr144Cys	c.431A>G	p.Tyr144Cys	principal1	Y	1	.	.	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.145	0.97505	H	-8.24	0.96895	D	0.886	0.88450	0.1109	0.84306	D	0.4650	0.79239	T	10	0.94212466	0.93464	D	0.137269	0.81925	D	0.703	0.89285	0.815	0.92954	O95363	Y144C	Loss of phosphorylation at Y144 (P = 0.0287)| Loss of methylation at K140 (P = 0.0513)| Loss of disorder (P = 0.0822)| Loss of ubiquitination at K140 (P = 0.0949)| Loss of stability (P = 0.1997)	0.912760158171	0.91122	0.8535715990371623	0.85230	0.75116851782	0.63550	0.795505642891	0.81246	T	0.548925	0.84551	D	0.377045	0.88436	D	0.303823	0.88290	D	0.999801814556122	0.99082	D	.	0.88094	.	0.9363221	0.94794	0.7782626	0.86759	0.9463944	0.95835	0.72315854	0.83457	-11.22	0.80911	D	0.5541	0.66907	A	0.999742363997179	0.97751	0.96441020	0.94252	1	0.99985	.	.	.	.	.	.	4.621909	0.73447	26.0	0.99840462098120319	0.92063	0.879351	0.80452	D	0.824854143750858	0.87566	9.286241	0.715026058591333	0.83429	8.04306	5.38	4.2	0.48755	2.35	0.43917	7.079	0.76566	7.903000	0.73696	0.756	0.943	1.0	0.71675	0.999000	0.35501	0.995	0.73271	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	1614150	4.336650e-06	0	1	6062	1.649620e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29606	0.000000e+00	0	2	44878	4.456530e-05	0	0	64024	0.000000e+00	0	1	6062	1.649620e-04	0	1	1180020	8.474430e-07	0	2	91080	2.195870e-05	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Global_developmental_delay|Mitochondrial_encephalomyopathy|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5369001A>G	ClinGen:CA130596|OMIM:611592.0001|UniProtKB:O95363#VAR_069487	C0557874|C0162666|C3661900|C4755312	614946	319519	Phenylalanyl-tRNA synthetase	Tyr	Cys	48423	single nucleotide variant	NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	10667	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1	Mar 25, 2024	397514610	-	RCV000033044|RCV000497519|RCV000162158	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900|Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,Human Phenotype Ontology:HP:0025356,MedGen:C0557874;MONDO:MONDO:0004675,MedGen:C0162666	Combined oxidative phosphorylation defect type 14|not provided|Global developmental delay;Mitochondrial encephalomyopathy	germline;inherited	germline	GRCh38	NC_000006.12	6	5369001	5369001	6p25.1	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA130596,UniProtKB:O95363#VAR_069487,OMIM:611592.0001	3	39824	5369001	A	G	-	-	-	-	-	-	SCV000589666|SCV000845708|SCV001389842|SCV005038812	-	-	431A>G 	Tyr144Cys	NM_006567.5	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Glu128Lys	0.1580182703471523	1.0	3.735662265216638	1.0	2025_01_Batch_13-14	0.9159925660882982	0.8984970031975678	0.8559220270217875	0.8675892308703715	0.8306411482913152	0.7994207598283963	0.8540135781309961	0.7619292981801536	0.7406074884509616	0.7592940873123305	0.8577066629583472	0.876255290664282	0.8089256626009707	0.8040983596606666	0.7949676178018228	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038662		NC_000007.14:45064556:G:A		Glu128Lys																												CCM2_Glu128Lys	7	45064556	G	A	7	allele	382G>A	C12	527_CAVA_Array_P06	E24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064556-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Gly138Val	4.8838800111042024	0.0027079461804252287	-12.876055682927626	0.00001379787718155587	2025_01_Batch_13-14	0.7797279374041839	0.842939506578824	0.8372653544475047	0.8371611674748377	0.6466604887656755	0.8424335559451765	0.8643440041773732	0.9116431333101943	0.8722665348804463	0.696406868316711	0.8110807466746802	0.8536417553780986	0.8744542438788495	0.854713851177642	0.6715336785411932	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023367		NC_000011.10:112094903:G:T		Gly138Val																												SDHD_Gly138Val	11	112094903	G	T	11	allele	413G>T	C01	527_CAVA_Array_P06	E02	B13A7A8P2_R1	B14A7A8P2_R2				11-112094903-G-T	465238	11	112094903	G	T	G	V	rs1401695686	11	111965627	11	111470837	138	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.413G>T	p.Gly138Val	c.413G>T	p.Gly138Val	principal1	Y	1	YES	Select	+	GGG	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.003	0.76775	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.83	0.95555	H	-7.91	0.96234	D	0.976	0.99026	0.9995	0.97172	D	0.9890	0.99688	D	10	0.98711103	0.99050	D	0.662484	0.97162	D	0.973	0.99718	0.895	0.97537	O14521	G138V	Loss of sheet (P = 0.0315)| Gain of helix (P = 0.062)| Gain of catalytic residue at G138 (P = 0.2062)| Loss of stability (P = 0.6621)| Gain of MoRF binding (P = 0.7378)	0.994972793835	0.99485	0.986906335179873	0.98679	0.842846843757	0.67951	0.839876294136	0.88056	D	0.976803	0.99782	D	0.585153	0.97294	D	0.602755	0.97251	D	0.999767601490021	0.98872	D	0.944306	0.78902	D	0.9838489	0.99378	0.979656	0.99806	0.9838489	0.99378	0.979656	0.99807	-15.193	0.98253	D	0.7584	0.75365	P	0.999416088640572	0.96520	0.99923384	0.99231	0.965	0.98576	.	.	.	.	.	.	4.689578	0.75179	26.3	0.99775908092948307	0.86358	0.951372	0.96574	D	0.993936175157801	0.95530	13.73274	0.911916477651707	0.96049	14.27025	4.85	4.85	0.62327	.	.	9.578	0.97363	11.775000	0.95964	0.672	0.70176	1.0	0.71675	1.000000	0.68239	1.0	0.97202	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_conflicting_classifications	NC_000011.10:g.112094903G>T	ClinGen:CA382619290	C1847319|C0031511|CN166604|C1868633|C1708353	606864|171300	97286|29072|201|29072	.	Gly	Val	461681	single nucleotide variant	NM_003002.4(SDHD):c.413G>T (p.Gly138Val)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1	Nov 24, 2024	1401695686	-	RCV002526127|RCV003999154	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112094903	112094903	11q23.1	criteria provided, conflicting classifications	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619290	2	465238	112094903	G	T	-	-	-	-	-	-	SCV000640163|SCV004830039	-	-	413G>T 	Gly138Val	NM_003002.4	1	3_Conflicting																																																																																																									
FARS2	FARS2_Ile329Thr	-2.2456562230357777	1.0	-2.124393793498326	0.10954203012231531	2025_01_Batch_13-14	0.9497609191467175	0.8479652830539113	0.7922037280296529	0.8337499264828268	0.9429145177669562	0.8527071834718516	0.7411114826400237	0.6796648942929623	0.7992589702340727	0.8377677968078636	0.9012340513092845	0.7945383828469674	0.7359343111613076	0.8165044483584497	0.8903411572874099	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011924		NC_000006.12:5545261:T:C		Ile329Thr																												FARS2_Ile329Thr	6	5545261	T	C	6	allele	986T>C	B02	527_CAVA_Array_P03	D03	B13A7A8P1_R1	B14A7A8P1_R2				6-5545261-T-C	39825	6	5545261	T	C	I	T	rs397514611	6	5545494	6	5490493	329	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.986T>C	p.Ile329Thr	c.986T>C	p.Ile329Thr	principal1	Y	1	YES	Select	+	ATC	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.21	0.97827	H	-4.83	0.80975	D	0.969	0.97975	0.7613	0.93913	D	0.7276	0.90648	D	10	0.9569025	0.95004	D	0.551967	0.95867	D	0.926	0.98190	0.769	0.89555	O95363	I329T	Loss of stability (P = 0.0021)| Gain of phosphorylation at I329 (P = 0.0509)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of loop (P = 0.2754)	0.979357470534	0.97892	.	0.96169	.	0.63719	0.75597679615	0.75288	T	0.633828	0.88570	D	0.383	0.88822	D	0.376023	0.91225	D	0.998961210250854	0.95690	D	0.994531	0.98201	D	0.94993186	0.96200	0.90557504	0.95310	0.9474884	0.95948	0.88929117	0.94138	-13.546	0.91505	D	0.899	0.83150	P	0.999640102774092	0.97310	0.97331387	0.94918	0.992	0.99727	.	.	.	.	.	.	5.001397	0.83025	27.9	0.99868570309340743	0.94641	0.907023	0.86001	D	0.963131837071811	0.94462	12.80027	0.855816931618299	0.93315	11.98561	5.27	5.27	0.73761	3.3	0.59857	7.646	0.82647	7.746000	0.68123	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.99	0.65338	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	3	208122	1.441460e-05	0	3	236776	1.267020e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	3	89552	3.350010e-05	0	0	30608	0.000000e+00	0	3	89552	3.350010e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	3	102598	2.924030e-05	0	0	30526	0.000000e+00	0	3	102598	2.924030e-05	0	.	3	1614088	1.858630e-06	0	1	64042	1.561480e-05	0	0	75056	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29604	0.000000e+00	0	0	44882	0.000000e+00	0	1	64042	1.561480e-05	0	0	6062	0.000000e+00	0	0	1179922	0.000000e+00	0	0	91082	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5545261T>C	ClinGen:CA130597|OMIM:611592.0002|UniProtKB:O95363#VAR_069488	C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Ile	Thr	48424	single nucleotide variant	NM_006567.5(FARS2):c.986T>C (p.Ile329Thr)	10667	FARS2	HGNC:21062	Likely pathogenic	1	Jun 13, 2018	397514611	-	RCV000033045	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545261	5545261	6p25.1	criteria provided, single submitter	2	-	N	ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002	3	39825	5545261	T	C	-	-	-	-	-	-	SCV000845715	-	-	986T>C 	Ile329Thr	NM_006567.5	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Asn94Ser	1.3105150070629392	1.0	8.255768227906172	0.00023445429844438592	2025_01_Batch_13-14	0.8620333821941785	0.8703831554763307	0.900524436527753	0.8924899049491576	0.772874066621402	0.7638374818384226	0.828928019650431	0.8911946089667011	0.8319754123771598	0.6912128506999813	0.8129354320163005	0.8496555875633809	0.895859522747227	0.8622326586631587	0.7320434586606916	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038640		NC_000007.14:45063994:A:G		Asn94Ser																												CCM2_Asn94Ser	7	45063994	A	G	7	allele	281A>G	F10	527_CAVA_Array_P06	K20	B13A7A8P2_R1	B14A7A8P2_R2				7-45063994-A-G	1796412	7	45063994	A	G	N	S	rs1226948316	7	45103593	7	45070118	94	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.281A>G	p.Asn94Ser	c.281A>G	p.Asn94Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.625	0.07567	T	0.123	0.35916	T	0.0	0.02950	B	0.002	0.06938	B	0.17	0.40172	N	simple_aae	83.0	17.0	2.08	0.57221	M	-0.39	0.14516	N	0.161	0.17449	-1.0092	0.27089	T	0.1038	0.37934	T	10	0.17897347	0.32640	T	0.009342	0.24233	T	0.140	0.37378	0.151	0.05407	Q9BSQ5	N94S	Gain of disorder (P = 0.0713)| Gain of ubiquitination at K96 (P = 0.0716)| Gain of loop (P = 0.1069)| Gain of relative solvent accessibility (P = 0.1894)| Loss of helix (P = 0.2022)	0.490419987736	0.48309	.	0.23377	.	0.25879	0.368713527918	0.20626	T	0.057938	0.30464	T	-0.281579	0.10267	T	-0.642245	0.09274	T	0.37363800406456	0.27634	T	0.889511	0.63145	D	0.07888045	0.17824	0.053267125	0.08953	0.07888045	0.17824	0.053267125	0.08952	-9.834	0.74074	D	0.0651	0.12996	B	0.010050685504225	0.23971	0.69786480	0.86033	0.062	0.17126	.	.	.	.	.	.	2.134979	0.27229	17.38	0.98809705125145819	0.46694	0.159385	0.28303	N	-0.216462466136124	0.32180	1.830722	-0.137744386810244	0.33574	1.94299	5.25	1.59	0.22563	-1.33	0.14240	3.409	0.52503	4.001000	0.41153	0.756	0.943	1.0	0.71675	0.997000	0.33331	0.997	0.79771	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	0	109388	0.000000e+00	0	1	208076	4.805940e-06	0	1	236896	4.221260e-06	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13382	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30512	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16722	0.000000e+00	0	1	89530	1.116940e-05	0	0	30608	0.000000e+00	0	1	89530	1.116940e-05	0	0	14902	0.000000e+00	0	0	34248	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21620	0.000000e+00	0	1	102728	9.734440e-06	0	0	30526	0.000000e+00	0	1	102728	9.734440e-06	0	.	7	1609270	4.349800e-06	0	1	6074	1.646360e-04	0	2	74788	2.674230e-05	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29578	0.000000e+00	0	1	44852	2.229550e-05	0	0	64028	0.000000e+00	0	1	6074	1.646360e-04	0	1	1175744	8.505250e-07	0	0	90980	0.000000e+00	0	1	11424	8.753501400560224E-5	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	474	0	0	2294	0	0	108	0	1	15150	6.6006600660066E-5	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45063994A>G	.	C0950123	.	.	PTB/PI domain	Asn	Ser	1852847	single nucleotide variant	NM_031443.4(CCM2):c.281A>G (p.Asn94Ser)	83605	CCM2	HGNC:21708	Uncertain significance	0	Aug 08, 2022	-1	-	RCV002441786	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45063994	45063994	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367429767	2	1796412	45063994	A	G	-	-	-	-	-	-	SCV002749501	-	-	281A>G 	Asn94Ser	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Gly8Ser	-3.5867746402070413	1.0	-1.3830053823176076	1.0	2025_01_Batch_13-14	0.8450903689210616	0.7871604342645121	0.8474810261040182	0.9081256176370985	0.7454997999237096	0.8907233424650599	0.7982233805594415	0.8410102581268828	0.8433618795509398	0.7796016066822608	0.8679068556930607	0.7926919074119768	0.8442456421154505	0.8757437485940192	0.7625507033029852	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038605		NC_000007.14:45000355:G:A		Gly8Ser																												CCM2_Gly8Ser	7	45000355	G	A	7	allele	22G>A	B06	527_CAVA_Array_P06	C12	B13A7A8P2_R1	B14A7A8P2_R2				7-45000355-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_His50Asp	5.2045723369280035	0.003547308842902077	-5.489031542982944	0.11438868033215185	2025_01_Batch_13-14	0.9296084092898396	0.9341050188181299	0.9083678801835474	0.9562213211632515	0.8488139186065639	0.9026523425916128	0.8809122384551284	0.8614696514963278	0.9073025499216885	0.7856244238428094	0.9161303759407262	0.9075086286366292	0.8849187658399376	0.93176193554247	0.8172191712246866	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023279		NC_000011.10:112087952:C:G		His50Asp																												SDHD_His50Asp	11	112087952	C	G	11	allele	148C>G	C11	527_CAVA_Array_P05	E21	B13A7A8P2_R1	B14A7A8P2_R2				11-112087952-C-G	431847	11	112087952	C	G	H	D	rs779249550	11	111958676	11	111463886	50	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.148C>G	p.His50Asp	c.148C>G	p.His50Asp	principal1	Y	1	YES	Select	+	CAC	1	0	C	./.	./.	./.	./.	0.018	0.91343	D	0.008	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	.	.	.	.	.	.	2.875	0.83215	M	-3.14	0.89554	D	0.772	0.76851	0.9245	0.96011	D	0.8997	0.96666	D	10	0.84643626	0.83639	D	0.436238	0.94066	D	0.758	0.91722	0.534	0.64172	O14521	H50D	Loss of glycosylation at P53 (P = 0.0815)| Loss of sheet (P = 0.1398)| Loss of catalytic residue at S54 (P = 0.1704)| Gain of disorder (P = 0.1919)| Gain of relative solvent accessibility (P = 0.2363)	0.957064088694	0.95623	0.9054445795321721	0.90457	0.67055262571	0.59146	0.511507630348	0.40377	T	0.704104	0.91424	D	0.460795	0.92907	D	0.424123	0.92818	D	0.960621476173401	0.65639	D	0.862614	0.55690	D	0.41402334	0.61368	0.35787314	0.61034	0.41402334	0.61369	0.35787314	0.61034	-2.133	0.12713	T	0.3169	0.65739	B	0.974774869969241	0.84170	0.99681085	0.98169	0.574	0.76062	.	.	.	.	.	.	4.177101	0.62924	24.5	0.99032993676936265	0.50938	0.784431	0.71408	D	0.635376796190383	0.75292	6.303636	0.556168196419146	0.71674	5.714621	4.9	4.9	0.63598	.	.	3.351	0.52041	5.674000	0.49343	0.599	0.40292	0.999	0.42732	1.000000	0.68239	0.808	0.38116	635	0.64545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	109370	0.000000e+00	0	1	208096	4.805470e-06	0	0	236920	0.000000e+00	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13356	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16696	0.000000e+00	0	1	89556	1.116620e-05	0	0	30608	0.000000e+00	0	1	89556	1.116620e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21594	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087952C>G	ClinGen:CA382617089	C0027672|C1847319|C0031511|C1868633|CN166604|C3661900|C1708353	606864|171300	140162|97286|29072|201|29072	.	His	Asp	425903	single nucleotide variant	NM_003002.4(SDHD):c.148C>G (p.His50Asp)	6392	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1	Oct 04, 2024	779249550	-	RCV000497964|RCV000505346|RCV000569506|RCV002230973	MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112087952	112087952	11q23.1	criteria provided, conflicting classifications	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617089	2	431847	112087952	C	G	-	-	-	-	-	-	SCV000589392|SCV000664535|SCV000762665|SCV005424120	-	-	148C>G 	His50Asp	NM_003002.4	1	3_Conflicting																																																																																																									
FARS2	FARS2_His84Pro	-0.6685215350519559	1.0	-1.9143491804649417	0.11887068523584414	2025_01_Batch_13-14	0.6909273743374506	0.8085540786477744	0.9130441035248813	0.8066052962232809	0.7564985110978174	0.6083734781712353	0.7207950114303019	0.8816449178809973	0.797309862871002	0.6109844495301832	0.649650426254343	0.7646745450390382	0.8973445107029393	0.8019575795471414	0.6837414803140003	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011910		NC_000006.12:5368821:A:C		His84Pro																												FARS2_His84Pro	6	5368821	A	C	6	allele	251A>C	G12	527_CAVA_Array_P02	M24	B13A7A8P1_R1	B14A7A8P1_R2				6-5368821-A-C	973746	6	5368821	A	C	H	P	rs1758844499	6	5369054	6	5314053	84	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.251A>C	p.His84Pro	c.251A>C	p.His84Pro	principal1	Y	1	YES	Select	+	CAC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.98	0.99849	H	-9.18	0.98237	D	0.929	0.93495	0.5682	0.91447	D	0.6119	0.86217	D	10	0.97114253	0.96682	D	0.337595	0.91908	D	0.841	0.95012	0.815	0.92954	O95363	H84P	Gain of catalytic residue at H84 (P = 0.0281)| Gain of glycosylation at H84 (P = 0.0433)| Loss of MoRF binding (P = 0.0679)| Loss of helix (P = 0.079)| Loss of disorder (P = 0.1597)	0.958043335942	0.95723	.	0.96295	.	0.68072	0.523846149445	0.42108	T	0.640816	0.88872	D	0.362787	0.87376	D	0.283342	0.87214	D	0.999933004379272	0.99780	D	0.922108	0.71602	D	0.9622549	0.97466	0.9041385	0.95204	0.9622549	0.97466	0.9041385	0.95205	-13.227	0.90296	D	0.7894	0.77044	P	0.999515333251888	0.96835	0.96594020	0.94359	0.95	0.97732	.	.	.	.	.	.	4.99072	0.82771	27.9	0.98859005853011162	0.47542	0.956935	0.97572	D	1.04327041522056	0.96912	15.34014	0.934733790292807	0.96898	15.32305	5.33	5.33	0.75646	3.49	0.63201	8.916	0.92352	11.098000	0.86082	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Combined_oxidative_phosphorylation_defect_type_14	no_assertion_criteria_provided	NC_000006.12:g.5368821A>C	.	C4755312	614946	319519	Phenylalanyl-tRNA synthetase	His	Pro	962036	single nucleotide variant	NM_006567.5(FARS2):c.251A>C (p.His84Pro)	10667	FARS2	HGNC:21062	Pathogenic	1	Dec 12, 2019	1758844499	-	RCV001250396	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368821	5368821	6p25.1	no assertion criteria provided	1	-	N	ClinGen:CA362734878	2	973746	5368821	A	C	-	-	-	-	-	-	SCV001424747	-	-	251A>C 	His84Pro	NM_006567.5		1_Pathogenic																																																																																																									
CCM2	CCM2_Pro55Ala	0.6298494544960952	1.0	6.603171703592399	0.001127306671113576	2025_01_Batch_13-14	0.9093936494659077	0.9110882839046249	0.9036920125791285	0.90364368041832	0.770119909508125	0.8520567584254688	0.9082087924438325	0.9079153273195893	0.8338540802862262	0.7880365883840277	0.8807252039456883	0.9096485381742287	0.9058036699493589	0.8687488803522732	0.7790782489460764	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038623		NC_000007.14:45038385:C:G		Pro55Ala																												CCM2_Pro55Ala	7	45038385	C	G	7	allele	163C>G	B08	527_CAVA_Array_P06	C16	B13A7A8P2_R1	B14A7A8P2_R2				7-45038385-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SHOC2	SHOC2_Thr126Ile	-3.8344663468001308	0.010115727076797684	5.1294871749893645	1.0																											true	SHOC2		11602		CCSBVarC028024		NC_000010.11:110964735:C:T		Thr126Ile																												SHOC2_Thr126Ile	10	110964735	C	T	10	allele	377C>T	D02	527_CAVA_Array_P06	G04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964735-C-T	448932	10	110964735	C	T	T	I	rs138375593	10	112724493	10	112714483	126	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.377C>T	p.Thr126Ile	principal1	Y	.	.	.	+	ACA	2	0	C	C/C	C/C	C/C	C/C	.	0.32128	.	.	0.28516	.	0.002	0.30905	B	0.011	0.34016	B	.	0.57141	.	.	.	.	1.445	0.36203	L	.	0.38336	.	.	0.47056	0.1822	0.85548	D	0.6836	0.89030	D	10	.	0.19890	.	0.059523	0.67575	D	.	0.42174	.	.	.	.	.	.	0.49718	.	0.36382	.	0.69312	0.832102060318	0.86861	D	0.185472	0.53617	T	-0.141771	0.29253	T	-0.0327684	0.67954	D	0.0516940710911475	0.05736	T	.	0.76748	.	0.19923036	0.41537	0.18350416	0.41202	0.16773851	0.36888	0.1808663	0.40774	-10.107	0.74628	D	.	0.55823	.	0.861928913801726	0.73739	0.02778220	0.53096	0.332	0.59514	.	.	.	.	.	.	3.985377	0.58691	24.0	0.993162836398918	0.59264	0.754523	0.69326	D	0.173017913604129	0.49661	3.185969	0.331430484968046	0.57169	3.905095	5.99	5.99	0.97294	3.68	0.67565	6.109	0.71273	7.666000	0.64570	0.596	0.33565	1.0	0.71675	1.000000	0.68239	1.0	0.97202	915	0.20912	.	.	.	.	.	.	.	.	.	.	.	.	27	264690	1.0200612E-4	.	6	109374	5.485760e-05	0	12	208042	5.768070e-05	0	9	236444	3.806400e-05	0	5	7162	6.981290e-04	0	1	17098	5.848640e-05	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13392	0.000000e+00	0	0	42760	0.000000e+00	0	0	15690	0.000000e+00	0	5	7162	6.981290e-04	0	11	16212	6.785100e-04	0	1	30490	3.279760e-05	0	0	6210	0.000000e+00	0	0	13408	0.000000e+00	0	0	16730	0.000000e+00	0	0	89526	0.000000e+00	0	0	30606	0.000000e+00	0	11	16212	6.785100e-04	0	8	14898	5.369850e-04	0	1	34222	2.922100e-05	0	0	9560	0.000000e+00	0	0	17684	0.000000e+00	0	0	21628	0.000000e+00	0	0	102336	0.000000e+00	0	0	30524	0.000000e+00	0	8	14898	5.369850e-04	0	.	28	1613964	1.734860e-05	0	26	74908	3.470920e-04	0	26	74908	3.470920e-04	0	0	912	0.000000e+00	0	2	59986	3.334110e-05	0	0	29604	0.000000e+00	0	0	44902	0.000000e+00	0	0	64028	0.000000e+00	0	0	6084	0.000000e+00	0	0	1179980	0.000000e+00	0	0	91078	0.000000e+00	0	0	19808	0	0	298	0	0	120	0	6	7860	7.633587786259542E-4	0	146	0	0	610	0	0	26	0	0	104	0	0	2032	0	6	8158	7.354743809757293E-4	0	146	0	6	31004	1.9352341633337633E-4	Likely_benign	not_specified|Cardiovascular_phenotype|RASopathy	reviewed_by_expert_panel	NC_000010.11:g.110964735C>T	ClinGen:CA5689584	CN169374|CN230736|C5555857	.	536391	.	Thr	Ile	442529	single nucleotide variant	NM_007373.4(SHOC2):c.377C>T (p.Thr126Ile)	8036	SHOC2	HGNC:15454	Likely benign	0	Apr 18, 2017	138375593	-	RCV000523425|RCV001255488|RCV002367725	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN169374|MedGen:CN230736	RASopathy|not specified|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964735	110964735	10q25.2	reviewed by expert panel	4	-	N	ClinGen:CA5689584	2	448932	110964735	C	T	-	-	-	-	-	-	SCV000616494	-	-	377C>T 	Thr126Ile	NM_007373.4	3	2_Benign																																																																																																									
CCM2	CCM2_Arg390Gln	-0.1076141949211975	1.0	4.489720010893765	0.008757692318413139	2025_01_Batch_13-14	0.8664256867715786	0.8491557386704458	0.9370410362877385	0.9156878401723193	0.7923340950463622	0.8503840872196117	0.7326950156411711	0.806408456623837	0.7921384553711912	0.7796663950356023	0.8584048869955951	0.7909253771558085	0.8717247464557878	0.8539131477717552	0.7860002450409822	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038814		NC_000007.14:45075891:G:A		Arg390Gln																												CCM2_Arg390Gln	7	45075891	G	A	7	allele	1169G>A	H11	527_CAVA_Array_P07	P21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075891-G-A	3139756	7	45075891	G	A	R	Q	rs1469968795	7	45115490	7	45082015	390	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1169G>A	p.Arg390Gln	c.1169G>A	p.Arg390Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.078	0.24406	B	0.016	0.17739	B	0.21	0.67594	N	simple_aae	79.0	21.0	2.36	0.67699	M	-2.36	0.54888	N	0.822	0.84989	-0.8054	0.54641	T	0.1731	0.51388	T	10	0.7371825	0.74462	D	0.040824	0.59435	D	0.263	0.57404	0.397	0.42281	Q9BSQ5	R390Q	Loss of MoRF binding (P = 0.0183)| Loss of phosphorylation at S393 (P = 0.0571)| Loss of loop (P = 0.1258)| Loss of glycosylation at T395 (P = 0.1756)| Loss of catalytic residue at R390 (P = 0.2648)	0.394384168047	0.38653	.	0.80391	.	0.76664	0.546910226345	0.45355	T	0.35288	0.71854	T	-0.119751	0.32806	T	-0.227644	0.51679	T	0.791442453861237	0.45497	D	0.962604	0.86045	D	0.3043825	0.52963	0.31058767	0.56848	0.3043825	0.52963	0.31058767	0.56847	-9.488	0.75887	D	0.2517	0.48641	B	0.727503451697525	0.67983	0.94212770	0.92961	0.661	0.81152	.	.	.	.	.	.	3.9422	0.5777	23.9	0.99930792479430941	0.99334	0.916182	0.88159	D	0.286078025062462	0.55215	3.708308	0.244349444002833	0.52079	3.408431	4.49	2.63	0.30339	2.56	0.46987	9.994	0.99269	9.799000	0.81714	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.661	0.33037	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	0	109362	0.000000e+00	0	2	207010	9.661370e-06	0	2	236760	8.447370e-06	0	0	7154	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	0	42748	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	1	16092	6.214270e-05	0	0	30508	0.000000e+00	0	0	6166	0.000000e+00	0	1	13394	7.466030e-05	0	0	16718	0.000000e+00	0	0	88694	0.000000e+00	0	0	30604	0.000000e+00	0	1	13394	7.466030e-05	0	1	14858	6.730380e-05	0	0	34252	0.000000e+00	0	0	9564	0.000000e+00	0	1	17692	5.652270e-05	0	0	21594	0.000000e+00	0	0	102662	0.000000e+00	0	0	30524	0.000000e+00	0	1	14858	6.730380e-05	0	.	15	1613264	9.297920e-06	0	3	44886	6.683600e-05	0	3	75044	3.997650e-05	0	0	910	0.000000e+00	0	0	60018	0.000000e+00	0	0	29608	0.000000e+00	0	3	44886	6.683600e-05	0	0	63140	0.000000e+00	0	0	6062	0.000000e+00	0	9	1180016	7.627020e-06	0	0	91086	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45075891G>A	.	C0950123	.	.	.	Arg	Gln	3292491	single nucleotide variant	NM_031443.4(CCM2):c.1169G>A (p.Arg390Gln)	83605	CCM2	HGNC:21708	Uncertain significance	0	Dec 12, 2023	-1	-	RCV004430580	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45075891	45075891	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367431754	2	3139756	45075891	G	A	-	-	-	-	-	-	SCV004923060	-	-	1169G>A 	Arg390Gln	NM_031443.4	1	4_VUS																																																																																																									
FARS2	FARS2_Asp142Tyr	-2.483576660753394	1.0	0.5392488168522181	1.0	2025_01_Batch_13-14	0.5906016339396648	0.6769868661927881	0.6703108451762275	0.6554205626714743	0.532339517574178	0.5679488323067037	0.6936178877958527	0.6599759572345486	0.7143869657921782	0.5390523075029727	0.5792752331231843	0.6853023769943204	0.6651434012053881	0.6849037642318263	0.5356959125385754	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011914		NC_000006.12:5368994:G:T		Asp142Tyr																												FARS2_Asp142Tyr	6	5368994	G	T	6	allele	424G>T	B01	527_CAVA_Array_P03	D01	B13A7A8P1_R1	B14A7A8P1_R2				6-5368994-G-T	253159	6	5368994	G	T	D	Y	rs145555213	6	5369227	6	5314226	142	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.424G>T	p.Asp142Tyr	c.424G>T	p.Asp142Tyr	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.425	0.98710	H	-8.05	0.96618	D	0.974	0.98479	0.6034	0.91916	D	0.6504	0.87777	D	10	0.93858135	0.93109	D	0.279745	0.90164	D	0.809	0.93796	0.791	0.91245	O95363	D142Y	Loss of solvent accessibility (P = 0.0152)| Loss of relative solvent accessibility (P = 0.0186)| Loss of ubiquitination at K139 (P = 0.0246)| Loss of disorder (P = 0.0373)| Loss of phosphorylation at Y144 (P = 0.0593)	0.952766475807	0.95187	.	0.93477	.	0.62839	0.784124493599	0.79514	T	0.511236	0.82575	D	0.286301	0.81716	D	0.342604	0.89952	D	0.999397754669189	0.97208	D	0.961304	0.85467	D	0.9639511	0.97638	0.8991653	0.94847	0.95198554	0.96412	0.9112432	0.95718	-13.759	0.92263	D	0.6133	0.69372	P	0.998275433556404	0.94209	0.97490570	0.95052	0.995	0.99826	.	.	.	.	.	.	5.212362	0.87485	29.2	0.99564433392369855	0.72048	0.890111	0.82419	D	0.948429081889747	0.93888	12.37248	0.847583306341376	0.92834	11.68468	5.38	4.49	0.54123	2.52	0.46380	9.553	0.97226	9.744000	0.81475	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109406	0.000000e+00	0	0	208056	0.000000e+00	0	1	236838	4.222300e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13406	0.000000e+00	0	0	16734	0.000000e+00	0	0	89506	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	1	17688	5.653550e-05	0	0	21632	0.000000e+00	0	0	102650	0.000000e+00	0	0	30526	0.000000e+00	0	1	17688	5.653550e-05	0	.	1	1614168	6.195140e-07	0	1	44882	2.228060e-05	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	1	44882	2.228060e-05	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180018	0.000000e+00	0	0	91082	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_spastic_paraplegia_77	criteria_provided,_single_submitter	NC_000006.12:g.5368994G>T	ClinGen:CA10586223|OMIM:611592.0005|UniProtKB:O95363#VAR_077044	C5569007	617046	466722	Phenylalanyl-tRNA synthetase	Asp	Tyr	247571	single nucleotide variant	NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	10667	FARS2	HGNC:21062	Pathogenic	1	Jun 13, 2018	145555213	-	RCV000239526	MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	Hereditary spastic paraplegia 77	germline	germline	GRCh38	NC_000006.12	6	5368994	5368994	6p25.1	criteria provided, single submitter	3	-	N	ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005	3	253159	5368994	G	T	-	-	-	-	-	-	SCV000845707	-	-	424G>T 	Asp142Tyr	NM_006567.5	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Ile130Val	0.45171639213158726	1.0	5.439162628403782	0.012786940540413528	2025_01_Batch_13-14	0.8423470573028015	0.8131092098617104	0.8407370460640636	0.7935695693513183	0.800696793712366	0.7418462648382507	0.7773897643941474	0.8408457076739105	0.7348658984263915	0.7337537830061193	0.792096661070526	0.795249487127929	0.8407913768689871	0.7642177338888549	0.7672252883592426	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038666		NC_000007.14:45064562:A:G		Ile130Val																												CCM2_Ile130Val	7	45064562	A	G	7	allele	388A>G	F12	527_CAVA_Array_P06	K24	B13A7A8P2_R1	B14A7A8P2_R2				7-45064562-A-G	3139759	7	45064562	A	G	I	V	rs1418279801	7	45104161	7	45070686	130	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.388A>G	p.Ile130Val	c.388A>G	p.Ile130Val	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.075	0.52650	T	0.09	0.53421	T	0.0	0.02950	B	0.0	0.01384	B	0.16	0.38685	N	simple_aae	84.0	16.0	2.2	0.61826	M	-0.74	0.21585	N	0.078	0.06176	-1.0336	0.19275	T	0.0774	0.30730	T	10	0.106099635	0.19427	T	0.01014	0.26052	T	0.037	0.09373	0.183	0.09077	Q9BSQ5	I130V	Gain of MoRF binding (P = 0.3201)| Loss of helix (P = 0.3949)| Loss of catalytic residue at R133 (P = 0.4695)| Loss of sheet (P = 0.5184)| Gain of methylation at R125 (P = 0.5827)	0.126345400529	0.11878	.	0.13434	.	0.26692	0.252834320068	0.04073	T	0.086636	0.37490	T	-0.1881	0.22210	T	-0.507969	0.21195	T	0.276417495727836	0.23740	T	0.664234	0.37114	T	0.13946559	0.31940	0.1294494	0.31043	0.13946559	0.31940	0.1294494	0.31042	-7.47	0.57865	T	0.0686	0.21982	B	0.0146184716727352	0.26907	0.61943870	0.84400	0.055	0.14822	.	.	.	.	.	.	2.777247	0.36539	20.3	0.99107194200406601	0.52703	0.607321	0.59590	D	-0.231062807699583	0.31586	1.791142	-0.0903090485969588	0.35485	2.074816	5.32	2.9	0.32725	0.106	0.22278	3.382	0.5229	5.868000	0.50577	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1613864	1.858890e-06	0	3	1179974	2.542430e-06	0	0	74920	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29602	0.000000e+00	0	0	44894	0.000000e+00	0	0	64022	0.000000e+00	0	0	5998	0.000000e+00	0	3	1179974	2.542430e-06	0	0	91074	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Uncertain_significance	Inborn_genetic_diseases	criteria_provided,_single_submitter	NC_000007.14:g.45064562A>G	.	C0950123	.	.	PTB/PI domain	Ile	Val	3292494	single nucleotide variant	NM_031443.4(CCM2):c.388A>G (p.Ile130Val)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jan 16, 2024	-1	-	RCV004430583	MeSH:D030342,MedGen:C0950123	Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	45064562	45064562	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367430014	2	3139759	45064562	A	G	-	-	-	-	-	-	SCV004923063	-	-	388A>G 	Ile130Val	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Gly103Arg	3.0521672039265675	1.0	12.013975829235259	0.00008394756798910683	2025_01_Batch_13-14	0.8858190061895638	0.9501630886442195	0.955589982093958	0.9411135036255454	0.7919328513132172	0.7663724785671099	0.9307969544411826	0.9521115348130381	0.8742651870035496	0.6911035267409511	0.8260957423783368	0.940480021542701	0.9538507584534981	0.9076893453145475	0.7415181890270841	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038647		NC_000007.14:45064481:G:C		Gly103Arg																												CCM2_Gly103Arg	7	45064481	G	C	7	allele	307G>C	B11	527_CAVA_Array_P06	C22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064481-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr267Asn	1.573241198287552	1.0	5.725214815133369	1.0	2025_01_Batch_13-14	0.881239356938608	0.8393196943509319	0.8496367867684365	0.8611904969346599	0.7691656202853752	0.7031087459184419	0.6617465125855033	0.6366847920289336	0.6126185877279924	0.6503212550478608	0.7921740514285249	0.7505331034682177	0.743160789398685	0.7369045423313261	0.709743437666618	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038746		NC_000007.14:45072780:C:A		Thr267Asn																												CCM2_Thr267Asn	7	45072780	C	A	7	allele	800C>A	B08	527_CAVA_Array_P07	D15	B13A7A8P2_R1	B14A7A8P2_R2				7-45072780-C-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly188Arg	3.3634491804755045	1.0	3.838276477532764	1.0	2025_01_Batch_13-14	0.8654114254282169	0.73588474026501	0.7871762367273695	0.8285154921519627	0.7223897258255451	0.6899057356199406	0.6427282559636247	0.6255413700664721	0.5851725487470205	0.6326837494637713	0.7776585805240788	0.6893064981143173	0.7063588033969208	0.7068440204494917	0.6775367376446582	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038705		NC_000007.14:45068532:G:C		Gly188Arg																												CCM2_Gly188Arg	7	45068532	G	C	7	allele	562G>C	E03	527_CAVA_Array_P07	J05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068532-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Leu298Met	0.44966287283546497	1.0	3.55457493415078	1.0	2025_01_Batch_13-14	0.8938907672175067	0.870411328187648	0.8609623143013506	0.8866652734134982	0.7562480484950127	0.8479211640917833	0.8727946067517117	0.8325825895189612	0.8773884520555048	0.7946129939873013	0.870905965654645	0.8716029674696799	0.8467724519101559	0.8820268627345015	0.775430521241157	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038764		NC_000007.14:45073548:C:A		Leu298Met																												CCM2_Leu298Met	7	45073548	C	A	7	allele	892C>A	C09	527_CAVA_Array_P07	F17	B13A7A8P2_R1	B14A7A8P2_R2				7-45073548-C-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_Tyr114Cys	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	0.8682120279262553	0.8812581055560494	0.8449747493825295	0.7870337879673006	0.788748895242953	0.7852056285483985	0.8303098099806919	0.7751751237961699	0.7336722800916803	0.7314659348476833	0.8267088282373269	0.8557839577683707	0.8100749365893497	0.7603530340294904	0.7601074150453182	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD	ENSG00000204370	5678	201959	CCSBVarC006161	ALE00006161	NC_000011.10:112094831:A:G	341A>G	Tyr114Cys	CEGS2	CegsMutGDEh1008	F02	GDEhDisVCh_40066	D01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SDHD_Tyr114Cys	11	112094831	A	G	11											11-112094831-A-G	6900	11	112094831	A	G	Y	C	rs104894304	11	111965555	11	111470765	114	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.341A>G	p.Tyr114Cys	c.341A>G	p.Tyr114Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	./.	./.	./.	./.	0.018	0.50835	D	0.065	0.45051	T	0.964	0.55869	D	0.844	0.60367	P	0.87	0.93829	A	simple_aae	13.0	87.0	.	.	.	-7.31	0.94609	D	0.976	0.98669	1.0006	0.97190	D	0.9867	0.99604	D	9	0.9957507	0.99992	D	0.633257	0.96850	D	0.943	0.98815	0.983	0.99835	O14521	Y114C	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.936232506373	0.93507	0.976168329744005	0.97594	0.746907957965	0.63330	0.698327541351	0.66847	T	0.978102	0.99803	D	0.331545	0.85161	D	0.238465	0.84966	D	0.993272423744202	0.83880	D	0.867413	0.57053	D	0.6309356	0.74072	0.5530032	0.73898	0.56750697	0.70631	0.64086455	0.78789	-10.9	0.82441	D	0.6697	0.73951	P	0.99848854137229	0.94531	0.99825233	0.98698	0.801	0.88995	.	.	.	.	.	.	4.453053	0.69299	25.3	0.95053500918197487	0.26304	0.957666	0.97690	D	0.756609150763795	0.83245	7.990596	0.715173977717976	0.83441	8.04602	4.85	4.85	0.62327	.	.	8.931	0.92428	9.292000	0.79831	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.992	0.67791	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094831A>G	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	171300|606864|168000	201|29072|97286|140162|29072|29072	.	Tyr	Cys	21939	single nucleotide variant	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	6392	SDHD	HGNC:10683	Pathogenic	1	Mar 04, 2025	104894304	-	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112094831	112094831	11q23.1	criteria provided, multiple submitters, no conflicts	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	3	6900	112094831	A	G	-	-	-	-	-	-	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	-	-	341A>G 	Tyr114Cys	NM_003002.4	2	1_Pathogenic																																																																																																									
SDHD	SDHD_Tyr114Cys	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	0.8682120279262553	0.8812581055560494	0.8449747493825295	0.7870337879673006	0.788748895242953	0.7852056285483985	0.8303098099806919	0.7751751237961699	0.7336722800916803	0.7314659348476833	0.8267088282373269	0.8557839577683707	0.8100749365893497	0.7603530340294904	0.7601074150453182	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023361		NC_000011.10:112094831:A:G		Tyr114Cys																												SDHD_Tyr114Cys	11	112094831	A	G	11	allele	341A>G	B01	527_CAVA_Array_P06	C02	B13A7A8P2_R1	B14A7A8P2_R2				11-112094831-A-G	6900	11	112094831	A	G	Y	C	rs104894304	11	111965555	11	111470765	114	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.341A>G	p.Tyr114Cys	c.341A>G	p.Tyr114Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	./.	./.	./.	./.	0.018	0.50835	D	0.065	0.45051	T	0.964	0.55869	D	0.844	0.60367	P	0.87	0.93829	A	simple_aae	13.0	87.0	.	.	.	-7.31	0.94609	D	0.976	0.98669	1.0006	0.97190	D	0.9867	0.99604	D	9	0.9957507	0.99992	D	0.633257	0.96850	D	0.943	0.98815	0.983	0.99835	O14521	Y114C	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.936232506373	0.93507	0.976168329744005	0.97594	0.746907957965	0.63330	0.698327541351	0.66847	T	0.978102	0.99803	D	0.331545	0.85161	D	0.238465	0.84966	D	0.993272423744202	0.83880	D	0.867413	0.57053	D	0.6309356	0.74072	0.5530032	0.73898	0.56750697	0.70631	0.64086455	0.78789	-10.9	0.82441	D	0.6697	0.73951	P	0.99848854137229	0.94531	0.99825233	0.98698	0.801	0.88995	.	.	.	.	.	.	4.453053	0.69299	25.3	0.95053500918197487	0.26304	0.957666	0.97690	D	0.756609150763795	0.83245	7.990596	0.715173977717976	0.83441	8.04602	4.85	4.85	0.62327	.	.	8.931	0.92428	9.292000	0.79831	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.992	0.67791	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094831A>G	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	171300|606864|168000	201|29072|97286|140162|29072|29072	.	Tyr	Cys	21939	single nucleotide variant	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	6392	SDHD	HGNC:10683	Pathogenic	1	Mar 04, 2025	104894304	-	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112094831	112094831	11q23.1	criteria provided, multiple submitters, no conflicts	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	3	6900	112094831	A	G	-	-	-	-	-	-	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	-	-	341A>G 	Tyr114Cys	NM_003002.4	2	1_Pathogenic																																																																																																									
CCM2	CCM2_Pro281Ser	-0.2665622917417802	1.0	4.859085689926183	1.0	2025_01_Batch_13-14	0.7993949739146383	0.7007361401975314	0.782060488280349	0.8023933501645102	0.7520401786081942	0.786503386940487	0.7618955356192689	0.7853953564805106	0.7411340863890951	0.7706703079621199	0.7929491804275627	0.7313158379084002	0.7837279223804299	0.7717637182768027	0.761355243285157	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038753		NC_000007.14:45073497:C:T		Pro281Ser																												CCM2_Pro281Ser	7	45073497	C	T	7	allele	841C>T	F08	527_CAVA_Array_P07	L15	B13A7A8P2_R1	B14A7A8P2_R2				7-45073497-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BRIP1	BRIP1_His587Arg	1.584238978026326	0.18073804788590883	0.816068200765392	0.546285500107496	2025_01_Batch_13-14	0.7961700191551921	0.699855795832681	0.7171372516909297	0.6867968081920343	0.7478837190377782	0.6292249630555719	0.7365979805628727	0.7242945676845812	0.7098055259549884	0.6244217867226861	0.712697491105382	0.7182268881977769	0.7207159096877555	0.6983011670735113	0.6861527528802321	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRIP1		55128		CCSBVarC031376		NC_000017.11:61780874:T:C		His587Arg																												BRIP1_His587Arg	17	61780874	T	C	17	allele	1760A>G	E12	527_CAVA_Array_P01	I23	B13A7A8P1_R1	B14A7A8P1_R2				17-61780874-T-C	925546	17	61780874	T	C	H	R	rs876660646	17	59858235	17	57213017	587	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.1760A>G	p.His587Arg	principal2	Y	.	.	.	-	CAT	2	0	T	T/T	T/T	T/T	T/T	.	0.14580	.	.	0.15078	.	0.004	0.12194	B	0.002	0.06938	B	.	.	.	.	.	.	0.935	0.23470	L	.	0.51830	.	.	0.37163	-1.0328	0.19528	T	0.0418	0.17856	T	9	.	0.24312	.	0.004931	0.12152	T	.	0.14866	0.491	0.57600	Q9BX63	H587R	Gain of MoRF binding (P = 0.0125)| Loss of methylation at K583 (P = 0.0639)| Loss of catalytic residue at L589 (P = 0.0953)| Gain of solvent accessibility (P = 0.1133)| Loss of loop (P = 0.1242)	.	0.09769	.	0.48927	.	0.22326	0.250247567892	0.03796	T	0.210366	0.56871	T	-0.251719	0.13623	T	-0.599353	0.12601	T	0.194684848189354	0.19868	T	.	0.24645	.	0.10351601	0.24247	0.11949802	0.28773	0.10351601	0.24247	0.11949802	0.28773	-10.008	0.74039	D	.	0.07115	.	0.00139744306121536	0.11129	0.46835166	0.81192	0.123	0.33205	.	.	.	.	.	.	0.721728	0.10931	7.579	0.77167040114901508	0.11955	0.345304	0.43862	N	-0.689993184120315	0.16104	0.8295734	-0.53367226512072	0.20931	1.148141	5.42	3.2	0.35749	-0.62	0.17698	0.573	0.23486	0.301000	0.17048	-0.118	0.14421	0.958	0.33576	0.991000	0.31563	0.993	0.69292	54	0.97580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614206	6.195000e-07	0	1	1180040	8.474290e-07	0	0	75066	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180040	8.474290e-07	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.61780874T>C	.	C0346153|C0027672	114480	227535|140162	.	His	Arg	914095	single nucleotide variant	NM_032043.3(BRIP1):c.1760A>G (p.His587Arg)	83990	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0	Jan 11, 2024	876660646	-	RCV001187524|RCV004570384	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61780874	61780874	17q23.2	criteria provided, conflicting classifications	3	-	N	ClinGen:CA400480314	2	925546	61780874	T	C	-	-	-	-	-	-	SCV001354344|SCV002716735|SCV005059286	-	-	1760A>G 	His587Arg	NM_032043.3	1	3_Conflicting																																																																																																									
CCM2	CCM2_Tyr221Asp	0.2528543429770164	1.0	3.7874095271616173	1.0	2025_01_Batch_13-14	0.873188448370129	0.8576828644876174	0.81619931584793	0.8415277304835217	0.6979784478719256	0.9343624801948911	0.9151713295516068	0.7943822127565254	0.8855049896581981	0.8388755474651162	0.90377546428251	0.8864270970196122	0.8052907643022278	0.86351636007086	0.768426997668521	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038726		NC_000007.14:45069877:T:G		Tyr221Asp																												CCM2_Tyr221Asp	7	45069877	T	G	7	allele	661T>G	A06	527_CAVA_Array_P07	B11	B13A7A8P2_R1	B14A7A8P2_R2				7-45069877-T-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser408Arg	1.9933578781469432	1.0	8.475015559415091	0.0032392522837595412	2025_01_Batch_13-14	0.9611432179853489	0.9200821054082274	0.8870091518273585	0.8975630432222145	0.8748333906982952	0.8927165837803729	0.9173614056814228	0.8463697655647854	0.8104171706833587	0.8596134825092427	0.9269299008828609	0.918721755544825	0.866689458696072	0.8539901069527867	0.867223436603769	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038826		NC_000007.14:45075944:A:C		Ser408Arg																												CCM2_Ser408Arg	7	45075944	A	C	7	allele	1222A>C	H12	527_CAVA_Array_P07	P23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075944-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly379Ser	0.1376616593465778	1.0	17.572684888751358	2.757598958328647e-6	2025_01_Batch_13-14	0.8624543701798596	0.9430792316631056	0.9695202634344624	0.9436619120919408	0.7717446636278967	0.8757578730431156	0.94410778277032	0.9787326848379077	0.9437731179770669	0.7533384627319554	0.8691061216114876	0.9435935072167128	0.974126474136185	0.9437175150345039	0.762541563179926	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038809		NC_000007.14:45075857:G:A		Gly379Ser																												CCM2_Gly379Ser	7	45075857	G	A	7	allele	1135G>A	F11	527_CAVA_Array_P07	L21	B13A7A8P2_R1	B14A7A8P2_R2				7-45075857-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_His247Asp	0.3592043582227431	1.0	0.1774912811672742	1.0	2025_01_Batch_13-14	0.8606884361786479	0.7830767726255633	0.8164510896187144	0.8279058710801092	0.756793386642374	0.8277012434921748	0.8803463551423013	0.8531302663174437	0.8583975647930066	0.7886928979770894	0.8441948398354113	0.8317115638839323	0.834790677968079	0.8431517179365579	0.7727431423097317	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038737		NC_000007.14:45069955:C:G		His247Asp																												CCM2_His247Asp	7	45069955	C	G	7	allele	739C>G	C07	527_CAVA_Array_P07	F13	B13A7A8P2_R1	B14A7A8P2_R2				7-45069955-C-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Gly436Ser	0.3588722675455493	1.0	6.012964928915924	0.02038604832205987	2025_01_Batch_13-14	0.7913719143981548	0.7688439787628583	0.8475322217993125	0.8075317837355732	0.7232748473565117	0.7095822613603954	0.811742335390312	0.8510910094707897	0.7961425650646584	0.6739811600977276	0.750477087879275	0.7902931570765852	0.8493116156350511	0.8018371744001158	0.6986280037271196	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038848		NC_000007.14:45076028:G:A		Gly436Ser																												CCM2_Gly436Ser	7	45076028	G	A	7	allele	1306G>A	G03	527_CAVA_Array_P08	N06	B13A7A8P2_R1	B14A7A8P2_R2				7-45076028-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Thr395Ile	2.4582754923015417	1.0	16.94679569919871	3.6721483647239333e-6	2025_01_Batch_13-14	0.8402805792646698	0.9228877397045362	0.9309603092565352	0.9205114019985086	0.7492058861524057	0.7074631606004569	0.9094175415561687	0.924819797021109	0.8262420290934381	0.6527588526829795	0.7738718699325633	0.9161526406303524	0.9278900531388221	0.8733767155459733	0.7009823694176927	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038819		NC_000007.14:45075906:C:T		Thr395Ile																												CCM2_Thr395Ile	7	45075906	C	T	7	allele	1184C>T	D12	527_CAVA_Array_P07	H23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075906-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Asp110Asn	3.741067007225478	1.0	7.901917790965315	0.0014689276593815098	2025_01_Batch_13-14	0.8673501503371424	0.8923169569226429	0.9015761614046305	0.9127562838710984	0.7812047303655839	0.8271564542066092	0.839428551238626	0.8627186205518961	0.7785639311866132	0.786553668124283	0.8472533022718758	0.8658727540806345	0.8821473909782633	0.8456601075288558	0.7838791992449334	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038653		NC_000007.14:45064502:G:A		Asp110Asn																												CCM2_Asp110Asn	7	45064502	G	A	7	allele	328G>A	G11	527_CAVA_Array_P06	M22	B13A7A8P2_R1	B14A7A8P2_R2				7-45064502-G-A	650820	7	45064502	G	A	D	N	rs41280666	7	45104101	7	45070626	110	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.059	0.38118	T	0.003	0.76775	D	1.0	0.90580	D	0.998	0.88579	D	0.54	0.75656	D	simple_aae	46.0	54.0	2.62	0.76477	M	-4.05	0.74531	D	0.895	0.89792	-0.2136	0.77217	T	0.3773	0.73387	T	10	0.59236854	0.66162	D	0.047304	0.62720	D	0.538	0.80564	.	.	.	.	.	0.799520260262	0.79605	.	0.64425	.	0.72914	0.750232934952	0.74436	T	0.451981	0.79093	T	-0.26384	0.12202	T	-0.26273	0.48220	T	0.615031957626343	0.36693	D	0.979802	0.93659	D	0.6124884	0.73080	0.26611018	0.52251	0.6124884	0.73081	0.26611018	0.52250	-13.053	0.89948	D	0.6623	0.84811	P	0.97624115375529	0.84471	0.97403955	0.94979	0.586	0.76781	.	.	.	.	.	.	4.302215	0.65763	24.9	0.99812034428324714	0.89628	0.937665	0.93553	D	0.801553480566686	0.86126	8.810653	0.732003520456241	0.84724	8.396553	5.32	5.32	0.75341	.	.	9.953	0.98981	11.585000	0.93377	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.975	0.56052	730	0.54265	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	46	264690	1.7378821E-4	.	34	109282	3.111220e-04	0	54	207850	2.598030e-04	0	72	236556	3.043680e-04	0	0	7130	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	7	13340	5.247380e-04	0	26	42748	6.082160e-04	0	0	15682	0.000000e+00	0	26	42748	6.082160e-04	0	1	16168	6.185060e-05	0	1	30504	3.278260e-05	0	0	6204	0.000000e+00	0	0	13404	0.000000e+00	0	7	16680	4.196640e-04	0	43	89444	4.807480e-04	0	0	30590	0.000000e+00	0	43	89444	4.807480e-04	0	1	14858	6.730380e-05	0	2	34240	5.841120e-05	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	9	21570	4.172460e-04	0	58	102506	5.658210e-04	0	0	30508	0.000000e+00	0	58	102506	5.658210e-04	0	.	684	1613760	4.238550e-04	0	640	1179922	5.424090e-04	0	4	75024	5.331630e-05	0	0	912	0.000000e+00	0	2	60018	3.332330e-05	0	0	29604	0.000000e+00	0	1	44888	2.227770e-05	0	20	63994	3.125290e-04	0	0	5878	0.000000e+00	0	640	1179922	5.424090e-04	0	0	91044	0.000000e+00	0	82	173648	4.722196627660555E-4	0	360	0	0	2708	0	0	9428	0	0	794	0	0	968	0	0	682	0	0	280	0	8	15328	5.219206680584551E-4	0	9788	0	0	3390	0	90	204196	4.407530020176693E-4	Uncertain_significance	Cerebral_cavernous_malformation_2|Vascular_dementia	criteria_provided,_single_submitter	NC_000007.14:g.45064502G>A	.	C1864041|C0011269	603284	221061	PTB/PI domain	Asp	Asn	636171	single nucleotide variant	NM_031443.4(CCM2):c.328G>A (p.Asp110Asn)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jul 15, 2024	41280666	-	RCV000806047|RCV002051726	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061|MONDO:MONDO:0004648,MeSH:D015140,MedGen:C0011269	Cerebral cavernous malformation 2|Vascular dementia	germline	germline	GRCh38	NC_000007.14	7	45064502	45064502	7p13	criteria provided, single submitter	2	-	N	ClinGen:CA4246952	2	650820	45064502	G	A	-	-	-	-	-	-	SCV000946027	-	-	328G>A 	Asp110Asn	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Asp440Asn	0.44155083244914284	1.0	8.095811508016842	1.0	2025_01_Batch_13-14	0.7694847133703173	0.8894226467953913	0.8450292034905144	0.8389139774960984	0.6355865726251425	0.9206350761689625	0.9181722839373495	0.8233937211673572	0.8908293918543126	0.869888719826974	0.8450598947696399	0.9037974653663704	0.8342114623289358	0.8648716846752056	0.7527376462260582	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038850		NC_000007.14:45076040:G:A		Asp440Asn																												CCM2_Asp440Asn	7	45076040	G	A	7	allele	1318G>A	A04	527_CAVA_Array_P08	B08	B13A7A8P2_R1	B14A7A8P2_R2				7-45076040-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Glu201Asp	2.34587535064775	1.0	8.862218845743106	1.0	2025_01_Batch_13-14	0.8257430672344791	0.8112375050167787	0.8180205911466195	0.8083235260424709	0.6509953525356845	0.7730212633503473	0.7959502117141173	0.6610915744393222	0.6468752583143896	0.7160157201302337	0.7993821652924131	0.803593858365448	0.7395560827929708	0.7275993921784303	0.6835055363329592	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038713		NC_000007.14:45068573:G:C		Glu201Asp																												CCM2_Glu201Asp	7	45068573	G	C	7	allele	603G>C	C04	527_CAVA_Array_P07	F07	B13A7A8P2_R1	B14A7A8P2_R2				7-45068573-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ser398Tyr	2.384878539629763	1.0	11.33013663848937	0.00004735898821205099	2025_01_Batch_13-14	0.854876577575595	0.9341162339635604	0.9483088584618516	0.9220658454855952	0.777861671976646	0.7782911768794438	0.8999109040922189	0.9180090898053495	0.8205439346538076	0.669870200270265	0.8165838772275194	0.9170135690278896	0.9331589741336006	0.8713048900697014	0.7238659361234555	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038820		NC_000007.14:45075915:C:A		Ser398Tyr																												CCM2_Ser398Tyr	7	45075915	C	A	7	allele	1193C>A	E12	527_CAVA_Array_P07	J23	B13A7A8P2_R1	B14A7A8P2_R2				7-45075915-C-A	2663568	7	45075915	C	A	S	Y	rs750632206	7	45115514	7	45082039	398	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.1193C>A	p.Ser398Tyr	c.1193C>A	p.Ser398Tyr	principal1	Y	1	YES	Select	+	TCC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.83643	D	0.987	0.61929	D	0.878	0.62305	P	0.35	0.75656	N	simple_aae	65.0	35.0	2.215	0.62356	M	-3.21	0.65425	D	0.706	0.74166	-0.7337	0.58602	T	0.1850	0.53236	T	10	0.54579717	0.63671	D	0.069524	0.70649	D	0.151	0.39545	0.228	0.15323	Q9BSQ5	S398Y	Loss of glycosylation at S398 (P = 0.0039)| Loss of phosphorylation at S396 (P = 0.1217)| Loss of MoRF binding (P = 0.1308)| Loss of catalytic residue at T399 (P = 0.1651)| Loss of disorder (P = 0.4818)	0.464014491786	0.45649	.	0.75745	.	0.76977	0.503599047661	0.39275	T	0.272796	0.64321	T	-0.278602	0.10578	T	-0.321813	0.42030	T	0.528497721074829	0.33367	D	0.967503	0.88252	D	0.43762013	0.62929	0.49733776	0.70675	0.43762013	0.62929	0.49733776	0.70676	-7.752	0.60419	D	0.242	0.57571	B	0.549151110492927	0.62272	0.94224304	0.92967	0.613	0.78377	.	.	.	.	.	.	4.383682	0.67653	25.1	0.99400360089810669	0.62846	0.887154	0.81849	D	0.468948946815275	0.65103	4.803447	0.362969416596286	0.59076	4.10585	4.49	3.6	0.40304	3.42	0.61925	5.811	0.68933	4.818000	0.45172	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.983	0.59808	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	4	109368	3.657380e-05	0	12	206908	5.799680e-05	0	12	236754	5.068550e-05	0	0	7160	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13382	0.000000e+00	0	0	42750	0.000000e+00	0	4	15690	2.549390e-04	0	4	15690	2.549390e-04	0	0	16092	0.000000e+00	0	0	30496	0.000000e+00	0	0	6152	0.000000e+00	0	0	13394	0.000000e+00	0	0	16720	0.000000e+00	0	0	88610	0.000000e+00	0	12	30606	3.920800e-04	0	12	30606	3.920800e-04	0	0	14860	0.000000e+00	0	0	34244	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21598	0.000000e+00	0	0	102648	0.000000e+00	0	12	30524	3.931330e-04	0	12	30524	3.931330e-04	0	.	31	1613238	1.921600e-05	0	27	91086	2.964230e-04	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29608	0.000000e+00	0	0	44876	0.000000e+00	0	0	63088	0.000000e+00	0	1	6062	1.649620e-04	0	1	1180036	8.474320e-07	0	27	91086	2.964230e-04	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000007.14:g.45075915C>A	.	C3661900	.	.	.	Ser	Tyr	2831015	single nucleotide variant	NM_031443.4(CCM2):c.1193C>A (p.Ser398Tyr)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jan 14, 2025	-1	-	RCV003443284|RCV005100090	MedGen:C3661900|MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	not provided|Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45075915	45075915	7p13	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA4247280	2	2663568	45075915	C	A	-	-	-	-	-	-	SCV004168161|SCV005814445	-	-	1193C>A 	Ser398Tyr	NM_031443.4	2	4_VUS																																																																																																									
CCM2	CCM2_Gly176Val	2.2369484936426516	1.0	2.5500254877676345	1.0	2025_01_Batch_13-14	0.8726886643296264	0.762396266453456	0.8118364586723333	0.8554961134111783	0.7295731175947423	0.7643552642596582	0.7985385958195854	0.7411966646371608	0.7903943182451166	0.7201782750906864	0.8185219642946423	0.7804674311365207	0.7765165616547471	0.8229452158281474	0.7248756963427143	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038692		NC_000007.14:45068497:G:T		Gly176Val																												CCM2_Gly176Val	7	45068497	G	T	7	allele	527G>T	G02	527_CAVA_Array_P07	N03	B13A7A8P2_R1	B14A7A8P2_R2				7-45068497-G-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
CCM2	CCM2_Ile432Phe	1.1598695638404908	1.0	16.595821831285754	0.000024154144276845024	2025_01_Batch_13-14	0.8282878694173096	0.8744644422208675	0.916272673423174	0.8814289867729926	0.7679848212610288	0.7371941795749466	0.8577356300274177	0.9512101132920584	0.8804191429712036	0.6868727915825219	0.7827410244961281	0.8661000361241427	0.9337413933576162	0.8809240648720982	0.7274288064217753	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038845		NC_000007.14:45076016:A:T		Ile432Phe																												CCM2_Ile432Phe	7	45076016	A	T	7	allele	1294A>T	D03	527_CAVA_Array_P08	H06	B13A7A8P2_R1	B14A7A8P2_R2				7-45076016-A-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Asp325Tyr	-0.023869672948344745	1.0	-2.2000767192007293	0.07158255080772746	2025_01_Batch_13-14	0.7875315940839283	0.7224129475293346	0.7460618465562038	0.6805454834471193	0.7622528725017358	0.6455699269581425	0.7109054393595837	0.7144464645351264	0.7059632220054508	0.604386213000429	0.7165507605210354	0.7166591934444592	0.7302541555456651	0.6932543527262851	0.6833195427510824	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011942		NC_000006.12:5545248:G:T		Asp325Tyr																												FARS2_Asp325Tyr	6	5545248	G	T	6	allele	973G>T	A02	527_CAVA_Array_P03	B03	B13A7A8P1_R1	B14A7A8P1_R2				6-5545248-G-T	253158	6	5545248	G	T	D	Y	rs764427452	6	5545481	6	5490480	325	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.973G>T	p.Asp325Tyr	c.973G>T	p.Asp325Tyr	principal1	Y	1	.	.	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.019	0.59495	D	0.997	0.70687	D	0.856	0.60995	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.89	0.83536	M	-3.91	0.73078	D	0.892	0.89118	-0.4312	0.70898	T	0.2879	0.65824	T	10	0.8789767	0.87061	D	0.327437	0.91634	D	0.365	0.68327	0.549	0.66319	O95363	D325Y	Loss of sheet (P = 0.0457)| Gain of helix (P = 0.1736)| Loss of relative solvent accessibility (P = 0.1903)| Loss of solvent accessibility (P = 0.2668)| Gain of loop (P = 0.2754)	0.863127915216	0.86073	0.818542452780431	0.81703	0.666257477821	0.58909	0.481479197741	0.36213	T	0.386013	0.74554	T	0.0497619	0.58021	T	-0.166297	0.57486	T	0.969270646572113	0.68326	D	.	0.94767	.	0.7669591	0.81643	0.55408955	0.73958	0.7752676	0.82147	0.51400286	0.71661	-13.746	0.92217	D	0.2762	0.51168	LB	0.927914649263957	0.78214	0.86435160	0.90056	0.613	0.78377	.	.	.	.	.	.	4.293796	0.65565	24.8	0.99486466779059812	0.67222	0.403449	0.47535	N	0.582178761681802	0.71915	5.747102	0.542820554954507	0.70738	5.573649	5.27	4.28	0.50124	2.38	0.44324	2.399	0.4425	2.441000	0.32855	0.676	0.76753	1.0	0.71675	0.995000	0.32549	0.978	0.57275	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5545248G>T	ClinGen:CA10586222|OMIM:611592.0004	C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Asp	Tyr	247570	single nucleotide variant	NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr)	10667	FARS2	HGNC:21062	Likely pathogenic	1	Jun 13, 2018	764427452	-	RCV000239485	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545248	5545248	6p25.1	criteria provided, single submitter	2	-	N	ClinGen:CA10586222,OMIM:611592.0004	3	253158	5545248	G	T	-	-	-	-	-	-	SCV000845714	-	-	973G>T 	Asp325Tyr	NM_006567.5	1	1_Pathogenic																																																																																																									
CCM2	CCM2_His137Arg	1.711493791353999	1.0	4.82310447271788	1.0	2025_01_Batch_13-14	0.8113837994579546	0.7048480446066733	0.7790064565175582	0.7851685039514459	0.7687771682881315	0.7422533820425694	0.6916778580795143	0.6999313197553124	0.6667856855850248	0.7059108509108323	0.776818590750262	0.6982629513430938	0.7394688881364353	0.7259770947682354	0.7373440095994819	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038669		NC_000007.14:45064584:A:G		His137Arg																												CCM2_His137Arg	7	45064584	A	G	7	allele	410A>G	B01	527_CAVA_Array_P07	D01	B13A7A8P2_R1	B14A7A8P2_R2				7-45064584-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
SDHD	SDHD_His102Pro	4.677318243891225	0.0025703667270182804	0.4759440939676418	1.0	2025_01_Batch_13-14	0.9100589801042144	0.911754221775473	0.8796519729598896	0.9480011311043718	0.8233505215836364	0.9006813090782809	0.8844697790259992	0.8803163022913099	0.8962418338637648	0.7880721490532581	0.9053701445912476	0.8981120004007361	0.8799841376255997	0.9221214824840682	0.8057113353184473	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SDHD		6363		CCSBVarC023321		NC_000011.10:112089002:A:C		His102Pro																												SDHD_His102Pro	11	112089002	A	C	11	allele	305A>C	C12	527_CAVA_Array_P05	E23	B13A7A8P2_R1	B14A7A8P2_R2				11-112089002-A-C	950869	11	112089002	A	C	H	P	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>C	p.His102Pro	c.305A>C	p.His102Pro	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.003	0.91343	D	0.006	0.92967	D	0.999	0.77914	D	0.986	0.76920	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.925	0.96220	H	-9.9	0.98744	D	0.974	0.99419	0.8482	0.94990	D	0.9986	0.99961	D	10	0.99432874	0.99941	D	0.720051	0.97730	D	0.929	0.98302	0.983	0.99835	O14521	H102P	Loss of loop (P = 0.2237)| Loss of helix (P = 0.2271)| Loss of catalytic residue at L101 (P = 0.3531)| Loss of stability (P = 0.4934)| Gain of glycosylation at H102 (P = 0.6204)	0.994429284596	0.99430	0.994954265430575	0.99492	0.94536333913	0.72230	0.556130588055	0.46655	T	0.976804	0.99782	D	0.567998	0.96540	D	0.578113	0.96482	D	0.99975723028183	0.98821	D	0.911209	0.68451	D	0.9729964	0.98507	0.93879443	0.97654	0.9567221	0.96900	0.9501346	0.98384	-12.078	0.92404	D	0.7574	0.75321	P	0.999806621831839	0.98063	0.99926025	0.99252	0.984	0.99450	.	.	.	.	.	.	4.880315	0.80073	27.2	0.95460008024022269	0.27217	0.982646	0.99906	D	0.671343308934847	0.77635	6.736192	0.508240574032574	0.68372	5.234679	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	criteria_provided,_single_submitter	NC_000011.10:g.112089002A>C	.	C1847319|CN166604|C0031511|C1868633	606864|171300	97286|201|29072	.	His	Pro	926123	single nucleotide variant	NM_003002.4(SDHD):c.305A>C (p.His102Pro)	6392	SDHD	HGNC:10683	Likely pathogenic	1	May 06, 2021	104894302	-	RCV002241296	MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma	germline	germline	GRCh38	NC_000011.10	11	112089002	112089002	11q23.1	criteria provided, single submitter	1	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617414	2	950869	112089002	A	C	-	-	-	-	-	-	SCV001394789	-	-	305A>C 	His102Pro	NM_003002.4	1	1_Pathogenic																																																																																																									
CCM2	CCM2_Ser183Leu	0.7315072713162686	1.0	13.504377714209364	9.65287470078542e-6	2025_01_Batch_13-14	0.8389335158636837	0.889818080737533	0.9470103683727831	0.9009898968748039	0.7436239509702345	0.7072684516134076	0.9128151430058101	0.9763558494071024	0.9253586648450645	0.6614889313035235	0.7731009837385456	0.9013166118716716	0.9616831088899427	0.9131742808599341	0.702556441136879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038699		NC_000007.14:45068518:C:T		Ser183Leu																												CCM2_Ser183Leu	7	45068518	C	T	7	allele	548C>T	D03	527_CAVA_Array_P07	H05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068518-C-T																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
BAP1	BAP1_Arg59Pro	-2.590423379221777	0.037552604621238606	-6.724527061687109	0.0006642771727354712	2025_01_Batch_13-14	0.5309453839443148	0.7984598136944672	0.8843641487311844	0.8386750927350094	0.5029391190634009	0.7760629629165843	0.8643465275670094	0.9072409208963593	0.9068011608930485	0.6600366828700539	0.6535041734304495	0.8314031706307383	0.8958025348137719	0.872738126814029	0.5814879009667274	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009502		NC_000003.12:52408553:C:G		Arg59Pro																												BAP1_Arg59Pro	3	52408553	C	G	3	allele	176G>C	G02	527_CAVA_Array_P01	M03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408553-C-G	1173080	3	52408553	C	G	R	P	rs1298276806	3	52442569	3	52417609	59	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.176G>C	p.Arg59Pro	c.176G>C	p.Arg59Pro	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.033	0.44516	D	0.019	0.69466	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	2.33	0.66629	M	-6.28	0.91119	D	0.734	0.73344	-0.4620	0.69867	T	0.3193	0.68734	T	10	0.73717695	0.74462	D	0.080609	0.73409	D	0.516	0.79231	0.438	0.49015	Q92560	R59P	Gain of glycosylation at S58 (P = 0.0035)| Loss of MoRF binding (P = 0.0099)| Gain of relative solvent accessibility (P = 0.0166)| Gain of loop (P = 0.0435)| Gain of ubiquitination at K61 (P = 0.0519)	0.836624110132	0.83377	0.8990698988239344	0.89814	3.06138964259	0.99302	0.848732292652	0.89405	D	0.266761	0.63670	T	0.213371	0.74962	D	0.0687164	0.74637	D	0.978495126974096	0.72163	D	0.983202	0.94307	D	0.9713552	0.98358	0.9540301	0.98616	0.9713552	0.98358	0.9540301	0.98617	-16.228	0.98086	D	0.9967	0.96455	P	0.99866373685461	0.94835	0.99953306	0.99461	0.706	0.83697	.	.	.	.	.	.	5.519378	0.91776	32.0	0.99817551053923181	0.90069	0.969708	0.99205	D	0.78803106441148	0.85268	8.550095	0.78537237783733	0.88696	9.704019	5.43	5.43	0.78977	.	.	7.867	0.85526	7.674000	0.64997	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.98	0.58201	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52408553C>G	.	C1535926	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Arg	Pro	1162265	single nucleotide variant	NM_004656.4(BAP1):c.176G>C (p.Arg59Pro)	8314	BAP1	HGNC:950	Pathogenic	1	Jun 22, 2021	1298276806	-	RCV001797186	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Neurodevelopmental disorder	de novo	germline	GRCh38	NC_000003.12	3	52408553	52408553	3p21.1	no assertion criteria provided	1	-	N	ClinGen:CA353113466	2	1173080	52408553	C	G	-	-	-	-	-	-	SCV001738371	-	-	176G>C 	Arg59Pro	NM_004656.4		1_Pathogenic																																																																																																									
CCM2	CCM2_Ile197Leu	2.8278120954517996	1.0	6.186230973186896	1.0	2025_01_Batch_13-14	0.8308913427307281	0.7971432889018938	0.825373308096252	0.8046073131960009	0.7142661477401088	0.8111150154442984	0.7738420935914895	0.6158180938901996	0.6650010561132234	0.7682479023717641	0.8210031790875132	0.7854926912466916	0.7205957009932258	0.7348041846546121	0.7412570250559365	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038711		NC_000007.14:45068559:A:C		Ile197Leu																												CCM2_Ile197Leu	7	45068559	A	C	7	allele	589A>C	B04	527_CAVA_Array_P07	D07	B13A7A8P2_R1	B14A7A8P2_R2				7-45068559-A-C	1407762	7	45068559	A	C	I	L	rs1798899357	7	45108158	7	45074683	197	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.589A>C	p.Ile197Leu	c.589A>C	p.Ile197Leu	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.035	0.43867	D	0.03	0.55281	D	0.028	0.19724	B	0.028	0.21332	B	0.12	0.49097	N	simple_aae	88.0	12.0	2.42	0.69809	M	-1.28	0.32155	N	0.526	0.55661	-0.8418	0.52336	T	0.1132	0.40186	T	10	0.3143459	0.48498	D	0.021922	0.44529	T	0.079	0.22901	0.281	0.23526	Q9BSQ5	I197L	Gain of disorder (P = 0.0724)| Gain of loop (P = 0.1069)| Gain of glycosylation at S202 (P = 0.1496)| Loss of helix (P = 0.2022)| Loss of catalytic residue at L198 (P = 0.5151)	0.595359146566	0.58906	.	0.49897	.	0.32263	0.502148628235	0.39073	T	0.119913	0.43874	T	-0.0560365	0.43181	T	-0.318269	0.42419	T	0.819291234016418	0.47439	D	0.80112	0.44511	T	0.33864504	0.55841	0.15452167	0.36152	0.33864504	0.55841	0.15452167	0.36151	-9.59	0.74829	D	0.3103	0.61097	B	0.0205589016742387	0.29674	0.92206790	0.92054	0.126	0.33835	.	.	.	.	.	.	2.205321	0.28181	17.69	0.97138839779267583	0.32717	0.718403	0.66841	D	-0.099217725050376	0.37154	2.177286	-0.0130415779812954	0.38829	2.315102	4.77	3.61	0.40424	1.69	0.36202	2.006	0.40597	3.463000	0.38608	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1613936	8.054840e-06	0	13	1180020	1.101680e-05	0	0	74906	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29606	0.000000e+00	0	0	44874	0.000000e+00	0	0	63956	0.000000e+00	0	0	6084	0.000000e+00	0	13	1180020	1.101680e-05	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Cerebral_cavernous_malformation_2	criteria_provided,_single_submitter	NC_000007.14:g.45068559A>C	.	C1864041	603284	221061	PTB/PI domain	Ile	Leu	1506641	single nucleotide variant	NM_031443.4(CCM2):c.589A>C (p.Ile197Leu)	83605	CCM2	HGNC:21708	Uncertain significance	0	Jun 11, 2024	1798899357	-	RCV001937873	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45068559	45068559	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA367430432	2	1407762	45068559	A	C	-	-	-	-	-	-	SCV002187196	-	-	589A>C 	Ile197Leu	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Ser330Phe	-1.3651818427582885	1.0	9.7838081956437	0.000046866604428786733	2025_01_Batch_13-14	0.8764207602611824	0.8888641487829053	0.942450527462214	0.9271823648634437	0.858974441069228	0.8178508310560506	0.9143907403141621	0.9661369355942551	0.9062027182084171	0.7993935156447245	0.8471357956586165	0.9016274445485337	0.9542937315282345	0.9166925415359304	0.8291839783569763	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038781		NC_000007.14:45074343:C:T		Ser330Phe																												CCM2_Ser330Phe	7	45074343	C	T	7	allele	989C>T	H09	527_CAVA_Array_P07	P17	B13A7A8P2_R1	B14A7A8P2_R2				7-45074343-C-T	1428114	7	45074343	C	T	S	F	rs779374000	7	45113942	7	45080467	330	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.989C>T	p.Ser330Phe	c.989C>T	p.Ser330Phe	principal1	Y	1	YES	Select	+	TCT	2	0	C	C/C	C/C	C/C	C/C	0.017	0.56615	D	0.009	0.70891	D	1.0	0.90580	D	0.998	0.88579	D	0.8	0.90832	D	simple_aae	20.0	80.0	2.38	0.68363	M	-3.4	0.68090	D	0.912	0.92554	-0.5228	0.67668	T	0.2797	0.65012	T	10	0.82238376	0.81244	D	0.051606	0.64598	D	0.325	0.64541	0.293	0.25438	Q9BSQ5	S330F	Loss of disorder (P = 0.1016)| Loss of methylation at R326 (P = 0.1418)| Loss of catalytic residue at G328 (P = 0.2631)| Loss of helix (P = 0.3949)| Loss of MoRF binding (P = 0.4906)	0.633764036925	0.62791	.	0.74124	.	0.67260	0.551510095596	0.46004	T	0.353695	0.71924	T	0.245525	0.78019	D	0.114903	0.77733	D	0.953262490398696	0.63762	D	0.966403	0.88197	D	0.5352562	0.68829	0.37392393	0.62325	0.5352562	0.68830	0.37392393	0.62325	-11.069	0.83570	D	0.697	0.76048	P	0.514348207532578	0.61220	0.98975104	0.96694	0.488	0.70667	.	.	.	.	.	.	5.03566	0.8381	28.1	0.99843592439588569	0.92408	0.884698	0.81391	D	0.785715234330443	0.85122	8.506917	0.75457620632826	0.86424	8.908673	5.54	5.54	0.82883	3.89	0.73480	6.122	0.71399	7.555000	0.60417	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.96	0.51684	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109344	9.145450e-06	0	2	207270	9.649250e-06	0	1	236792	4.223120e-06	0	0	7152	0.000000e+00	0	0	17094	0.000000e+00	0	0	2318	0.000000e+00	0	0	9044	0.000000e+00	0	0	13382	0.000000e+00	0	1	42754	2.338960e-05	0	0	15686	0.000000e+00	0	1	42754	2.338960e-05	0	0	16114	0.000000e+00	0	0	30488	0.000000e+00	0	0	6174	0.000000e+00	0	0	13404	0.000000e+00	0	0	16718	0.000000e+00	0	2	88932	2.248910e-05	0	0	30600	0.000000e+00	0	2	88932	2.248910e-05	0	0	14854	0.000000e+00	0	0	34228	0.000000e+00	0	0	9568	0.000000e+00	0	0	17690	0.000000e+00	0	0	21612	0.000000e+00	0	1	102700	9.737100e-06	0	0	30520	0.000000e+00	0	1	102700	9.737100e-06	0	.	4	1613820	2.478590e-06	0	4	1180042	3.389710e-06	0	0	75068	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	63626	0.000000e+00	0	0	6062	0.000000e+00	0	4	1180042	3.389710e-06	0	0	91084	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Cerebral_cavernous_malformation_2	criteria_provided,_single_submitter	NC_000007.14:g.45074343C>T	.	C1864041	603284	221061	Cerebral cavernous malformations 2, harmonin-homology domain|Cerebral cavernous malformations 2, harmonin-homology domain	Ser	Phe	1464269	single nucleotide variant	NM_031443.4(CCM2):c.989C>T (p.Ser330Phe)	83605	CCM2	HGNC:21708	Uncertain significance	0	Mar 23, 2024	779374000	-	RCV001964789	MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45074343	45074343	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA4247228	2	1428114	45074343	C	T	-	-	-	-	-	-	SCV002201153	-	-	989C>T 	Ser330Phe	NM_031443.4	1	4_VUS																																																																																																									
CCM2	CCM2_Thr296Ala	1.8273134594689553	1.0	8.622948082988874	0.00033539362888666173	2025_01_Batch_13-14	0.8792537708735053	0.9111369074881778	0.9300871003878449	0.9117535647425442	0.7482091569092971	0.7465494713114046	0.876352833788022	0.8637685637870333	0.7428115360898003	0.7173071909109597	0.8129016210924549	0.8937448706380999	0.8969278320874391	0.8272825504161723	0.7327581739101284	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038763		NC_000007.14:45073542:A:G		Thr296Ala																												CCM2_Thr296Ala	7	45073542	A	G	7	allele	886A>G	B09	527_CAVA_Array_P07	D17	B13A7A8P2_R1	B14A7A8P2_R2				7-45073542-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					
FARS2	FARS2_Thr246Met	-0.10148333665327636	1.0	-2.3538191916275255	0.057290090602365104	2025_01_Batch_13-14	0.6804102176056458	0.7023703706038089	0.7528933762948292	0.7472986977081443	0.6146380679875117	0.6770292548089514	0.7112466396093987	0.7828756750691243	0.8243738879775552	0.4743863958826155	0.6787197362072985	0.7068085051066038	0.7678845256819767	0.7858362928428497	0.5445122319350636	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FARS2		12653		CCSBVarC011873		NC_000006.12:5404666:C:T		Thr246Met																												FARS2_Thr246Met	6	5404666	C	T	6	allele	737C>T	E01	527_CAVA_Array_P03	J01	B13A7A8P1_R1	B14A7A8P1_R2				6-5404666-C-T	137291	6	5404666	C	T	T	M	rs116567033	6	5404899	6	5349898	246	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.737C>T	p.Thr246Met	c.737C>T	p.Thr246Met	principal1	Y	1	.	.	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.027	0.46673	D	0.073	0.48688	T	0.996	0.68795	D	0.913	0.64880	D	0.21	0.45549	N	simple_aae	79.0	21.0	2.83	0.82191	M	-3.55	0.74296	D	0.608	0.62419	-0.7616	0.57140	T	0.2289	0.59266	T	10	0.0118563175	0.00254	T	0.024038	0.46809	T	0.317	0.63716	.	.	.	.	.	0.819830007893	0.81670	0.7281157812391854	0.72612	0.655512290444	0.58315	0.467225492001	0.34256	T	0.297402	0.66816	T	-0.321825	0.06557	T	-0.227665	0.51677	T	0.0169158800264063	0.00441	T	.	0.91526	.	0.26475862	0.49212	0.2838555	0.54171	0.3314129	0.55255	0.26372668	0.51982	-9.33	0.69874	D	0.0974	0.35559	LB	0.64624273715353	0.65262	0.71377310	0.86373	0.195	0.45457	.	.	.	.	.	.	4.289772	0.65479	24.8	0.99768528528554123	0.85678	0.131614	0.24846	N	0.315961225953202	0.56747	3.862512	0.173260709396764	0.48124	3.055297	5.32	4.44	0.53107	2.64	0.48287	3.703	0.54631	3.963000	0.40843	0.596	0.33565	1.0	0.71675	0.999000	0.35501	0.533	0.29823	973	0.05579	16	0.003194888178913738	1	7.564296520423601E-4	6	0.005964214711729622	4	0.005763688760806916	0	0.0	5	0.005112474437627812	1306	264690	0.004934074	.	416	108230	3.843670e-03	2	849	205656	4.128250e-03	6	948	234230	4.047300e-03	5	7	7116	9.836990e-04	0	39	16534	2.358780e-03	0	2	2310	8.658010e-04	0	0	8992	0.000000e+00	0	8	13394	5.972820e-04	0	313	42624	7.343280e-03	2	45	15404	2.921320e-03	0	313	42624	7.343280e-03	2	23	16112	1.427510e-03	0	62	29418	2.107550e-03	0	5	6178	8.093230e-04	0	0	13304	0.000000e+00	0	11	16722	6.578160e-04	0	636	89182	7.131480e-03	4	102	29978	3.402500e-03	2	636	89182	7.131480e-03	4	22	14796	1.486890e-03	0	84	33134	2.535160e-03	0	8	9532	8.392780e-04	0	0	17536	0.000000e+00	0	15	21618	6.938660e-04	0	699	102210	6.838860e-03	3	101	29896	3.378380e-03	2	699	102210	6.838860e-03	3	.	10638	1606620	6.621350e-03	55	9520	1175990	8.095310e-03	43	90	74778	1.203560e-03	0	2	912	2.192980e-03	0	224	59598	3.758520e-03	3	15	29462	5.091300e-04	0	1	44762	2.234040e-05	0	70	63756	1.097940e-03	0	20	5910	3.384090e-03	1	9520	1175990	8.095310e-03	43	320	89360	3.581020e-03	5	1182	178306	0.006629053425010936	0	360	0	0	4502	0	25	9456	0.002643824027072758	3	804	0.0037313432835820895	1	974	0.001026694045174538	0	1850	0	0	280	0	87	17442	0.004987960096319229	25	9816	0.0025468622656886716	0	6352	0	1298	213974	0.006066157570545954	Benign/Likely_benign	not_specified|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5404666C>T	ClinGen:CA290843	CN169374|C3661900|C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Thr	Met	140994	single nucleotide variant	NM_006567.5(FARS2):c.737C>T (p.Thr246Met)	10667	FARS2	HGNC:21062	Benign/Likely benign	0	Jan 30, 2025	116567033	-	RCV000124982|RCV000527403|RCV000677019	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline;unknown	germline	GRCh38	NC_000006.12	6	5404666	5404666	6p25.1	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA290843	2	137291	5404666	C	T	-	-	-	-	-	-	SCV000168422|SCV000652852|SCV000845689|SCV001137051|SCV001154616|SCV005222709|SCV005879797	-	-	737C>T 	Thr246Met	NM_006567.5	2	2_Benign																																																																																																									
CCM2	CCM2_Val190Met	1.6323526946369038	1.0	10.919754886666745	0.00019192500010011863	2025_01_Batch_13-14	0.9514897337877023	0.923468925746669	0.9604190180462885	0.9611874552225396	0.889637972964112	0.8024003346811095	0.9396320522394827	0.9780333393632937	0.9411226254548345	0.7438738159692164	0.8769450342344058	0.9315504889930758	0.9692261787047911	0.951155040338687	0.8167558944666642	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CCM2		3928		CCSBVarC038708		NC_000007.14:45068538:G:A		Val190Met																												CCM2_Val190Met	7	45068538	G	A	7	allele	568G>A	H03	527_CAVA_Array_P07	P05	B13A7A8P2_R1	B14A7A8P2_R2				7-45068538-G-A	590660	7	45068538	G	A	V	M	rs200358025	7	45108137	7	45074662	190	CCM2	ENSG00000136280	ENST00000258781	ENSP00000258781	Q9BSQ5	CCM2_HUMAN	c.568G>A	p.Val190Met	c.568G>A	p.Val190Met	principal1	Y	1	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.227	0.18598	T	0.17	0.30949	T	0.874	0.48061	P	0.199	0.36806	B	0.16	0.71892	N	simple_aae	84.0	16.0	2.3	0.65510	M	-0.14	0.09078	N	0.418	0.47612	-0.8351	0.52781	T	0.1980	0.55149	T	10	0.014697552	0.00305	T	0.023819	0.46582	T	0.116	0.32262	.	.	.	.	.	0.401612077098	0.39379	.	0.40445	.	0.71548	0.507417201996	0.39805	T	0.10057	0.40360	T	-0.311667	0.07399	T	-0.221938	0.52230	T	0.0970213041166988	0.11873	T	0.925008	0.72388	D	0.083722204	0.19170	0.10491934	0.25159	0.083722204	0.19170	0.10491934	0.25158	-4.05	0.24662	T	0.0931	0.20264	B	0.0177600689013469	0.28482	0.93287270	0.92520	0.111	0.30556	.	.	.	.	.	.	3.956456	0.58068	23.9	0.98803927021723148	0.46597	0.771050	0.70472	D	0.22366240293383	0.52111	3.409498	0.220382270230183	0.50726	3.284552	4.74	3.87	0.43756	.	.	4.805	0.62337	6.461000	0.55762	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.784	0.371	730	0.54265	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	19	264690	7.178209E-5	.	29	109354	2.651940e-04	0	32	208058	1.538030e-04	0	55	236872	2.321930e-04	0	0	7160	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	25	9046	2.763650e-03	0	0	13348	0.000000e+00	0	2	42766	4.676610e-05	0	1	15690	6.373490e-05	0	25	9046	2.763650e-03	0	0	16214	0.000000e+00	0	0	30520	0.000000e+00	0	0	6210	0.000000e+00	0	26	13416	1.937980e-03	0	0	16688	0.000000e+00	0	3	89536	3.350610e-05	0	1	30608	3.267120e-05	0	26	13416	1.937980e-03	0	0	14898	0.000000e+00	0	0	34256	0.000000e+00	0	0	9570	0.000000e+00	0	47	17692	2.656570e-03	0	0	21584	0.000000e+00	0	5	102726	4.867320e-05	0	1	30526	3.275900e-05	0	47	17692	2.656570e-03	0	.	86	1614140	5.327910e-05	0	56	44880	1.247770e-03	0	1	75054	1.332370e-05	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29608	0.000000e+00	0	56	44880	1.247770e-03	0	2	63990	3.125490e-05	0	1	6062	1.649620e-04	0	19	1180020	1.610140e-05	0	2	91088	2.195680e-05	0	5	67524	7.404774598661217E-5	0	122	0	0	148	0	0	3868	0	0	498	0	0	650	0	0	56	0	0	102	0	3	7412	4.0474905558553697E-4	0	3990	0	0	204	0	8	80380	9.952724558347848E-5	Conflicting_classifications_of_pathogenicity	not_provided|Cerebral_cavernous_malformation_2	criteria_provided,_conflicting_classifications	NC_000007.14:g.45068538G>A	.	C3661900|C1864041	603284	221061	PTB/PI domain	Val	Met	581327	single nucleotide variant	NM_031443.4(CCM2):c.568G>A (p.Val190Met)	83605	CCM2	HGNC:21708	Conflicting classifications of pathogenicity	0	Jul 17, 2024	200358025	-	RCV000721785|RCV002067077	MedGen:C3661900|MONDO:MONDO:0011304,MedGen:C1864041,OMIM:603284,Orphanet:221061	not provided|Cerebral cavernous malformation 2	germline	germline	GRCh38	NC_000007.14	7	45068538	45068538	7p13	criteria provided, conflicting classifications	3	-	N	ClinGen:CA4247031	2	590660	45068538	G	A	-	-	-	-	-	-	SCV000852924|SCV002476404|SCV004156863	-	-	568G>A 	Val190Met	NM_031443.4	1	3_Conflicting																																																																																																									
BRCA1	BRCA1_Thr581Ala	0.0497091547769512	0.9617428060924307	4.326359069964326	0.003453197422548223	2025_01_Batch_13-14	0.9167490291041218	0.9030116271717452	0.903340193991352	0.9247672489714605	0.8009118765693297	0.8837938926005537	0.8520433324779236	0.8593154762600081	0.9488159897593582	0.7574468749360753	0.9002714608523378	0.8775274798248345	0.8813278351256801	0.9367916193654093	0.7791793757527026	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011843		NC_000017.11:43067629:T:C		Thr581Ala																												BRCA1_Thr581Ala	17	43067629	T	C	17	allele	1741A>G	B09	527_CAVA_Array_P01	C17	B13A7A8P1_R1	B14A7A8P1_R2				17-43067629-T-C	55364	17	43067629	T	C	T	A	rs80356890	17	41219646	17	38473172	1685	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5053A>G	p.Thr1685Ala	c.5053A>G	p.Thr1685Ala	principal2	Y	1	YES	Select	-	ACT	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.53	0.77914	P	0.183	0.88579	B	0.91	0.99291	A	simple_aae	9.0	91.0	3.31	0.90471	M	-0.82	0.74769	N	0.875	0.91505	0.7304	0.93530	D	0.7785	0.92454	D	10	0.8680128	0.85903	D	0.754689	0.98044	D	0.882	0.96531	.	.	.	.	.	0.952919659821	0.95202	.	0.86482	.	0.09116	0.670587182045	0.62862	T	0.403358	0.81781	T	0.418536	0.90878	D	0.363421	0.90764	D	0.970580279827118	0.68797	D	.	0.76208	.	0.96085334	0.97324	0.6886691	0.81474	0.9444927	0.95639	0.6872717	0.81396	-14.503	0.94593	D	0.523	0.76577	A	0.979632873704045	0.85227	0.99986613	0.99835	0.966	0.98629	.	.	.	.	.	.	3.78294	0.54478	23.5	0.99777731049735807	0.86531	0.717269	0.66764	D	0.641941303045784	0.75718	6.379083	0.607013709110586	0.75311	6.31232	5.24	5.24	0.72825	3.42	0.61925	4.786	0.62201	7.873000	0.72109	0.56	0.28431	1.0	0.71675	1.000000	0.68239	0.983	0.59808	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067629T>C	BRCA1-HCI:BRCA1_00042|ClinGen:CA003174|UniProtKB:P38398#VAR_063902	C3661900|C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ala	70031	single nucleotide variant	NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80356890	-	RCV000048749|RCV000112475|RCV000163024|RCV000212192	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067629	43067629	17q21.31	reviewed by expert panel	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902	2	55364	43067629	T	C	-	-	-	-	-	-	SCV000244379	-	-	5053A>G 	Thr1685Ala	NM_007294.4	3	1_Pathogenic																																																																																																									
RET	RET_Thr338Ile	-1.424602819963752	0.19729169514798545	2.2743462514220494	0.05711032904998553	2025_01_Batch_13-14	0.9174918166052234	0.7105123566417155	0.6594978765357586	0.5926499598947482	0.8981003866469992	0.9205314968803489	0.9027881067629824	0.8430259524063524	0.9205832086026784	0.8299564944318886	0.9190116567427862	0.806650231702349	0.7512619144710555	0.7566165842487134	0.8640284405394438	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202954	CCSBVarC006878	ALE00006876	NC_000010.11:43106521:C:T	1013C>T	Thr338Ile	CEGS2	CegsMutGDEh1025	A12	GDEhDisVCh_40066	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Thr338Ile	10	43106521	C	T	10											10-43106521-C-T	38594	10	43106521	C	T	T	I	rs377767433	10	43601969	10	42921975	338	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.1013C>T	p.Thr338Ile	c.1013C>T	p.Thr338Ile	principal4	Y	5	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.478	0.08337	T	0.239	0.24837	T	0.017	0.24484	B	0.007	0.19965	B	0.91	0.92786	D	simple_aae	9.0	91.0	2.135	0.59336	M	-0.16	0.09401	N	0.235	0.30814	-0.8203	0.53729	T	0.2905	0.66078	T	10	0.2821769	0.45410	D	0.028251	0.50756	D	0.410	0.72027	0.755	0.88426	P07949	T338I	Loss of disorder (P = 0.0525)| Gain of catalytic residue at A342 (P = 0.1324)| Gain of sheet (P = 0.1945)| Gain of MoRF binding (P = 0.2848)| Loss of loop (P = 0.2897)	0.981789031089	0.98140	0.6790319585223052	0.67683	0.218286694533	0.24083	0.481091409922	0.36160	T	0.376246	0.73794	T	0.151122	0.69149	D	0.135665	0.79109	D	0.17234893143177	0.18506	T	0.726327	0.33844	T	0.14303645	0.32613	0.08598992	0.19866	0.099525385	0.23277	0.08741958	0.20292	-7.255	0.55945	T	0.3018	0.55809	B	0.094241815648635	0.42787	0.99947983	0.99419	0.065	0.18082	.	.	.	.	.	.	2.501402	0.32347	19.0	0.98805091438726533	0.46629	0.155931	0.27906	N	-0.117237538328119	0.36368	2.120756	0.048901495971743	0.41733	2.534287	5.32	5.32	0.75341	4.24	0.80495	1.993	0.40471	4.824000	0.45219	0.599	0.40292	0.974	0.34718	1.000000	0.68239	0.734	0.35269	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	6	109044	5.502370e-05	0	4	206970	1.932650e-05	0	8	235572	3.395990e-05	0	0	7096	0.000000e+00	0	0	17042	0.000000e+00	0	0	2312	0.000000e+00	0	0	9024	0.000000e+00	0	0	13372	0.000000e+00	0	6	42620	1.407790e-04	0	0	15670	0.000000e+00	0	6	42620	1.407790e-04	0	0	16044	0.000000e+00	0	0	30424	0.000000e+00	0	0	6182	0.000000e+00	0	0	13366	0.000000e+00	0	0	16712	0.000000e+00	0	4	88828	4.503080e-05	0	0	30574	0.000000e+00	0	4	88828	4.503080e-05	0	0	14776	0.000000e+00	0	0	34164	0.000000e+00	0	0	9550	0.000000e+00	0	0	17668	0.000000e+00	0	0	21236	0.000000e+00	0	8	102092	7.836070e-05	0	0	30494	0.000000e+00	0	8	102092	7.836070e-05	0	.	31	1613700	1.921050e-05	0	2	6078	3.290560e-04	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	59994	0.000000e+00	0	0	29596	0.000000e+00	0	0	44888	0.000000e+00	0	0	63946	0.000000e+00	0	2	6078	3.290560e-04	0	28	1179836	2.373210e-05	0	1	91072	1.098030e-05	0	0	26588	0	0	114	0	0	86	0	0	3230	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4640	2.1551724137931034E-4	0	3344	0	0	112	0	1	35910	2.78473962684489E-5	Conflicting_classifications_of_pathogenicity	Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hirschsprung_disease,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106521C>T	ClinGen:CA007399	C4048306|C0027672|C0025268|C0025269|C3888239	171400|162300|142623	653|140162|247698|653|247709|653|388	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Ile	47198	single nucleotide variant	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Jan 28, 2025	377767433	-	RCV000709106|RCV000570795|RCV001046577|RCV001262456|RCV005042101|RCV004566792|RCV004700294	MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106521	43106521	10q11.21	criteria provided, conflicting classifications	7	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007399	2	38594	43106521	C	T	-	-	-	-	-	-	SCV000664515|SCV000838375|SCV001210484|SCV001440343|SCV005054176|SCV005201970|SCV005666584	-	-	1013C>T 	Thr338Ile	NM_020975.6	1	3_Conflicting	10	43106521	C	T	0.000018474																																																																																																				
RET	RET_Thr338Ile	-1.424602819963752	0.19729169514798545	2.2743462514220494	0.05711032904998553	2025_01_Batch_13-14	0.9174918166052234	0.7105123566417155	0.6594978765357586	0.5926499598947482	0.8981003866469992	0.9205314968803489	0.9027881067629824	0.8430259524063524	0.9205832086026784	0.8299564944318886	0.9190116567427862	0.806650231702349	0.7512619144710555	0.7566165842487134	0.8640284405394438	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006878		NC_000010.11:43106521:C:T		Thr338Ile																												RET_Thr338Ile	10	43106521	C	T	10	allele	1013C>T	A08	527_CAVA_Array_P05	A15	B13A7A8P2_R1	B14A7A8P2_R2				10-43106521-C-T	38594	10	43106521	C	T	T	I	rs377767433	10	43601969	10	42921975	338	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.1013C>T	p.Thr338Ile	c.1013C>T	p.Thr338Ile	principal4	Y	5	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.478	0.08337	T	0.239	0.24837	T	0.017	0.24484	B	0.007	0.19965	B	0.91	0.92786	D	simple_aae	9.0	91.0	2.135	0.59336	M	-0.16	0.09401	N	0.235	0.30814	-0.8203	0.53729	T	0.2905	0.66078	T	10	0.2821769	0.45410	D	0.028251	0.50756	D	0.410	0.72027	0.755	0.88426	P07949	T338I	Loss of disorder (P = 0.0525)| Gain of catalytic residue at A342 (P = 0.1324)| Gain of sheet (P = 0.1945)| Gain of MoRF binding (P = 0.2848)| Loss of loop (P = 0.2897)	0.981789031089	0.98140	0.6790319585223052	0.67683	0.218286694533	0.24083	0.481091409922	0.36160	T	0.376246	0.73794	T	0.151122	0.69149	D	0.135665	0.79109	D	0.17234893143177	0.18506	T	0.726327	0.33844	T	0.14303645	0.32613	0.08598992	0.19866	0.099525385	0.23277	0.08741958	0.20292	-7.255	0.55945	T	0.3018	0.55809	B	0.094241815648635	0.42787	0.99947983	0.99419	0.065	0.18082	.	.	.	.	.	.	2.501402	0.32347	19.0	0.98805091438726533	0.46629	0.155931	0.27906	N	-0.117237538328119	0.36368	2.120756	0.048901495971743	0.41733	2.534287	5.32	5.32	0.75341	4.24	0.80495	1.993	0.40471	4.824000	0.45219	0.599	0.40292	0.974	0.34718	1.000000	0.68239	0.734	0.35269	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	6	109044	5.502370e-05	0	4	206970	1.932650e-05	0	8	235572	3.395990e-05	0	0	7096	0.000000e+00	0	0	17042	0.000000e+00	0	0	2312	0.000000e+00	0	0	9024	0.000000e+00	0	0	13372	0.000000e+00	0	6	42620	1.407790e-04	0	0	15670	0.000000e+00	0	6	42620	1.407790e-04	0	0	16044	0.000000e+00	0	0	30424	0.000000e+00	0	0	6182	0.000000e+00	0	0	13366	0.000000e+00	0	0	16712	0.000000e+00	0	4	88828	4.503080e-05	0	0	30574	0.000000e+00	0	4	88828	4.503080e-05	0	0	14776	0.000000e+00	0	0	34164	0.000000e+00	0	0	9550	0.000000e+00	0	0	17668	0.000000e+00	0	0	21236	0.000000e+00	0	8	102092	7.836070e-05	0	0	30494	0.000000e+00	0	8	102092	7.836070e-05	0	.	31	1613700	1.921050e-05	0	2	6078	3.290560e-04	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	59994	0.000000e+00	0	0	29596	0.000000e+00	0	0	44888	0.000000e+00	0	0	63946	0.000000e+00	0	2	6078	3.290560e-04	0	28	1179836	2.373210e-05	0	1	91072	1.098030e-05	0	0	26588	0	0	114	0	0	86	0	0	3230	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4640	2.1551724137931034E-4	0	3344	0	0	112	0	1	35910	2.78473962684489E-5	Conflicting_classifications_of_pathogenicity	Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hirschsprung_disease,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106521C>T	ClinGen:CA007399	C4048306|C0027672|C0025268|C0025269|C3888239	171400|162300|142623	653|140162|247698|653|247709|653|388	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Ile	47198	single nucleotide variant	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Jan 28, 2025	377767433	-	RCV000709106|RCV000570795|RCV001046577|RCV001262456|RCV005042101|RCV004566792|RCV004700294	MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106521	43106521	10q11.21	criteria provided, conflicting classifications	7	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007399	2	38594	43106521	C	T	-	-	-	-	-	-	SCV000664515|SCV000838375|SCV001210484|SCV001440343|SCV005054176|SCV005201970|SCV005666584	-	-	1013C>T 	Thr338Ile	NM_020975.6	1	3_Conflicting	10	43106521	C	T	0.000018474																																																																																																				
RET	RET_Val262Ala	-0.24949633256160386	0.8101398810197044	4.814403588905587	0.0019338869466561507	2025_01_Batch_13-14	0.8362120849218995	0.7781827768721448	0.9195076526268073	0.8840339082178769	0.7887272756339547	0.5811504652840943	0.7363850843844051	0.8692173993816996	0.7323775022120607	0.5632976111910845	0.7086812751029969	0.7572839306282749	0.8943625260042535	0.8082057052149687	0.6760124434125196	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202951	CCSBVarC006876	ALE00006874	NC_000010.11:43105111:T:C	785T>C	Val262Ala	CEGS2	CegsMutGDEh1029	C02	GDEhDisVCh_40066	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Val262Ala	10	43105111	T	C	10											10-43105111-T-C	41845	10	43105111	T	C	V	A	rs139790943	10	43600559	10	42920565	262	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.785T>C	p.Val262Ala	c.785T>C	p.Val262Ala	principal4	Y	5	YES	Select	+	GTG	2	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.011	0.65108	D	0.676	0.41333	P	0.568	0.49805	P	0.6	0.76851	D	simple_aae	40.0	60.0	2.325	0.66439	M	-2.44	0.53442	N	0.4	0.94561	0.2692	0.87004	D	0.6452	0.87575	D	10	0.23900184	0.40642	T	0.269317	0.89793	D	0.748	0.91294	.	.	.	.	.	0.986075961623	0.98577	0.9449520661963712	0.94443	1.39902537186	0.85084	0.654298603535	0.60534	T	0.747582	0.92993	D	0.147568	0.68816	D	0.296161	0.87936	D	0.110290273663753	0.13282	T	0.812119	0.46196	T	0.6398909	0.74551	0.46798772	0.68880	0.7156541	0.78674	0.51304674	0.71604	-11.708	0.84188	D	0.7004	0.80456	P	0.998087980433202	0.93939	0.99988472	0.99849	0.487	0.70601	.	.	.	.	.	.	5.265842	0.88433	29.6	0.99080146142778192	0.52036	0.704574	0.65902	D	0.206366859142037	0.51267	3.331407	0.220349645155146	0.50723	3.284379	4.79	3.64	0.40795	3.23	0.58548	5.516	0.66847	7.817000	0.69666	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.946	0.49004	862	0.33096	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	67	264690	2.531263E-4	.	21	108014	1.944190e-04	0	57	203892	2.795600e-04	0	56	233278	2.400570e-04	0	0	6988	0.000000e+00	0	1	17006	5.880280e-05	0	0	2296	0.000000e+00	0	0	8944	0.000000e+00	0	2	12800	1.562500e-04	0	10	42450	2.355710e-04	0	7	15644	4.474560e-04	0	7	15644	4.474560e-04	0	1	15892	6.292470e-05	0	2	30354	6.588920e-05	0	1	6138	1.629200e-04	0	0	13250	0.000000e+00	0	2	16134	1.239620e-04	0	33	86794	3.802110e-04	0	13	30536	4.257270e-04	0	13	30536	4.257270e-04	0	1	14656	6.823140e-05	0	3	34114	8.794040e-05	0	1	9526	1.049760e-04	0	0	17590	0.000000e+00	0	2	20676	9.673050e-05	0	32	100690	3.178070e-04	0	13	30462	4.267610e-04	0	13	30462	4.267610e-04	0	.	347	1612474	2.151970e-04	2	38	6044	6.287230e-03	2	7	74994	9.334080e-05	0	1	912	1.096490e-03	0	11	59988	1.833700e-04	0	2	29562	6.765440e-05	0	0	44818	0.000000e+00	0	3	62808	4.776460e-05	0	38	6044	6.287230e-03	2	229	1179820	1.940970e-04	0	34	91062	3.733720e-04	0	19	38968	4.87579552453295E-4	0	122	0	0	112	0	1	3452	2.8968713789107763E-4	0	498	0	0	628	0	0	56	0	0	98	0	6	7306	8.212428141253764E-4	1	3574	2.797985450475658E-4	0	168	0	26	51240	5.07416081186573E-4	Conflicting_classifications_of_pathogenicity	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon|RET-related_disorder|not_provided|not_specified|Pheochromocytoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105111T>C	ClinGen:CA009350	C1619700|C0027662|C4048306|C0027672|C0006142|C0025268|C3888239|C0019569|C3661900|CN169374|C0031511	191830|PS131100|171400|142623|PS142623|171300	411709|276161|653|140162|247698|653|388|388|29072	Cadherin-like	Val	Ala	50284	single nucleotide variant	NM_020975.6(RET):c.785T>C (p.Val262Ala)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Feb 04, 2025	139790943	-	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000663296|RCV001103896|RCV001103897|RCV001103898|RCV000573525|RCV001269367|RCV001104177|RCV004528165	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Multiple endocrine neoplasia|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43105111	43105111	10q11.21	criteria provided, conflicting classifications	17	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009350	2	41845	43105111	T	C	-	-	-	-	-	-	SCV000166634|SCV000279597|SCV000540171|SCV000664464|SCV000786544|SCV000822200|SCV000838371|SCV000891636|SCV001260709|SCV001260710|SCV001260711|SCV001261020|SCV002062909|SCV002068400|SCV002527924	-	-	785T>C 	Val262Ala	NM_020975.6	1	3_Conflicting	10	43105111	T	C	0.000210916																																																																																																				
RET	RET_Val262Ala	-0.24949633256160386	0.8101398810197044	4.814403588905587	0.0019338869466561507	2025_01_Batch_13-14	0.8362120849218995	0.7781827768721448	0.9195076526268073	0.8840339082178769	0.7887272756339547	0.5811504652840943	0.7363850843844051	0.8692173993816996	0.7323775022120607	0.5632976111910845	0.7086812751029969	0.7572839306282749	0.8943625260042535	0.8082057052149687	0.6760124434125196	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006876		NC_000010.11:43105111:T:C		Val262Ala																												RET_Val262Ala	10	43105111	T	C	10	allele	785T>C	F08	527_CAVA_Array_P05	K15	B13A7A8P2_R1	B14A7A8P2_R2				10-43105111-T-C	41845	10	43105111	T	C	V	A	rs139790943	10	43600559	10	42920565	262	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.785T>C	p.Val262Ala	c.785T>C	p.Val262Ala	principal4	Y	5	YES	Select	+	GTG	2	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.011	0.65108	D	0.676	0.41333	P	0.568	0.49805	P	0.6	0.76851	D	simple_aae	40.0	60.0	2.325	0.66439	M	-2.44	0.53442	N	0.4	0.94561	0.2692	0.87004	D	0.6452	0.87575	D	10	0.23900184	0.40642	T	0.269317	0.89793	D	0.748	0.91294	.	.	.	.	.	0.986075961623	0.98577	0.9449520661963712	0.94443	1.39902537186	0.85084	0.654298603535	0.60534	T	0.747582	0.92993	D	0.147568	0.68816	D	0.296161	0.87936	D	0.110290273663753	0.13282	T	0.812119	0.46196	T	0.6398909	0.74551	0.46798772	0.68880	0.7156541	0.78674	0.51304674	0.71604	-11.708	0.84188	D	0.7004	0.80456	P	0.998087980433202	0.93939	0.99988472	0.99849	0.487	0.70601	.	.	.	.	.	.	5.265842	0.88433	29.6	0.99080146142778192	0.52036	0.704574	0.65902	D	0.206366859142037	0.51267	3.331407	0.220349645155146	0.50723	3.284379	4.79	3.64	0.40795	3.23	0.58548	5.516	0.66847	7.817000	0.69666	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.946	0.49004	862	0.33096	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	67	264690	2.531263E-4	.	21	108014	1.944190e-04	0	57	203892	2.795600e-04	0	56	233278	2.400570e-04	0	0	6988	0.000000e+00	0	1	17006	5.880280e-05	0	0	2296	0.000000e+00	0	0	8944	0.000000e+00	0	2	12800	1.562500e-04	0	10	42450	2.355710e-04	0	7	15644	4.474560e-04	0	7	15644	4.474560e-04	0	1	15892	6.292470e-05	0	2	30354	6.588920e-05	0	1	6138	1.629200e-04	0	0	13250	0.000000e+00	0	2	16134	1.239620e-04	0	33	86794	3.802110e-04	0	13	30536	4.257270e-04	0	13	30536	4.257270e-04	0	1	14656	6.823140e-05	0	3	34114	8.794040e-05	0	1	9526	1.049760e-04	0	0	17590	0.000000e+00	0	2	20676	9.673050e-05	0	32	100690	3.178070e-04	0	13	30462	4.267610e-04	0	13	30462	4.267610e-04	0	.	347	1612474	2.151970e-04	2	38	6044	6.287230e-03	2	7	74994	9.334080e-05	0	1	912	1.096490e-03	0	11	59988	1.833700e-04	0	2	29562	6.765440e-05	0	0	44818	0.000000e+00	0	3	62808	4.776460e-05	0	38	6044	6.287230e-03	2	229	1179820	1.940970e-04	0	34	91062	3.733720e-04	0	19	38968	4.87579552453295E-4	0	122	0	0	112	0	1	3452	2.8968713789107763E-4	0	498	0	0	628	0	0	56	0	0	98	0	6	7306	8.212428141253764E-4	1	3574	2.797985450475658E-4	0	168	0	26	51240	5.07416081186573E-4	Conflicting_classifications_of_pathogenicity	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon|RET-related_disorder|not_provided|not_specified|Pheochromocytoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105111T>C	ClinGen:CA009350	C1619700|C0027662|C4048306|C0027672|C0006142|C0025268|C3888239|C0019569|C3661900|CN169374|C0031511	191830|PS131100|171400|142623|PS142623|171300	411709|276161|653|140162|247698|653|388|388|29072	Cadherin-like	Val	Ala	50284	single nucleotide variant	NM_020975.6(RET):c.785T>C (p.Val262Ala)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Feb 04, 2025	139790943	-	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000663296|RCV001103896|RCV001103897|RCV001103898|RCV000573525|RCV001269367|RCV001104177|RCV004528165	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Multiple endocrine neoplasia|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43105111	43105111	10q11.21	criteria provided, conflicting classifications	17	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009350	2	41845	43105111	T	C	-	-	-	-	-	-	SCV000166634|SCV000279597|SCV000540171|SCV000664464|SCV000786544|SCV000822200|SCV000838371|SCV000891636|SCV001260709|SCV001260710|SCV001260711|SCV001261020|SCV002062909|SCV002068400|SCV002527924	-	-	785T>C 	Val262Ala	NM_020975.6	1	3_Conflicting	10	43105111	T	C	0.000210916																																																																																																				
SHOC2	SHOC2_Asn527Ser	2.1059774962464166	0.0732220540664537	0.2027614561326523	0.8450890466178025	2025_01_Batch_13-14	0.7940691263031118	0.8460453251256255	0.7756819177936045	0.7627699788022595	0.8104367508868358	0.8093247097913885	0.8177718096284736	0.7630117948880923	0.870882894271203	0.7309035102432322	0.8016969180472502	0.8319085673770495	0.7693468563408484	0.8168264365367313	0.770670130565034	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
BRAF	BRAF_Leu485Phe	-3.8216848768826113	0.006527941362460827	3.8578981633103693	0.006228415739546075	2025_01_Batch_13-14	0.5105169863396426	0.5661450889840837	0.6849601012265331	0.6268169169653752	0.5124263589993301	0.598299584251907	0.5775729635304778	0.6184960341014689	0.6586304615480807	0.5200454290084522	0.5544082852957748	0.5718590262572807	0.6517280676640009	0.642723689256728	0.5162358940038911	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220605	CCSBVarC003163	ALE00003163	NC_000007.14:140778053:C:G	1455G>C	Leu485Phe	CEGS2	CegsMutGDEh1018	H07	GDEhDisVCh_40058	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Leu485Phe	7	140778053	C	G	7											7-140778053-C-G	13975	7	140778053	C	G	L	F	rs180177036	7	140477853	7	140124322	485	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1455G>C	p.Leu485Phe	c.1455G>C	p.Leu485Phe	principal4	Y	.	YES	Select	-	TTG	3	2	C	./.	./.	./.	./.	.	0.20412	.	.	.	.	0.264	0.31620	B	0.309	0.41361	B	.	0.97926	.	.	.	.	1.13	0.28751	L	.	0.43153	.	.	.	-0.7046	0.60048	T	0.1770	0.52004	T	9	0.94275165	0.93527	D	0.08652	0.74669	D	.	0.91679	0.859	0.95694	P15056	L485F	Gain of catalytic residue at L485 (P = 0.046)| Loss of ubiquitination at K483 (P = 0.1322)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.1405)| Loss of glycosylation at P490 (P = 0.2882)	.	0.99026	.	0.81127	.	0.95017	0.899181604385	0.96345	D	0.854571	0.96693	D	0.40148	0.89929	D	0.338922	0.89804	D	0.993222117424011	0.83810	D	0.993067	0.97789	D	0.9472474	0.95923	0.87014675	0.92780	0.94315636	0.95501	0.88148624	0.93580	-10.017	0.74092	D	0.9978	0.97942	P	0.999864334331402	0.98431	0.99597543	0.97927	0.953	0.97907	.	.	.	.	.	.	4.137508	0.6203	24.4	0.99892768971460666	0.96668	0.649139	0.62235	D	0.19994089429288	0.50957	3.302872	0.260588829807926	0.53010	3.495244	5.03	4.14	0.47761	4.1	0.78208	5.0	0.63767	4.860000	0.45538	0.545	0.25635	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	BRAF-related_disorder|Ataxia-telangiectasia_syndrome|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiofaciocutaneous_syndrome_1|Cardiovascular_phenotype|not_provided|RASopathy	reviewed_by_expert_panel	NC_000007.14:g.140778053C>G	ClinGen:CA273414|OMIM:164757.0015|UniProtKB:P15056#VAR_026115	C0004135|C0028326|C1275081|CN029449|CN230736|C3661900|C5555857	208900|PS163950|PS115150|115150	100|648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Leu	Phe	29014	single nucleotide variant	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	673	BRAF	HGNC:1097	Pathogenic	1	Feb 28, 2020	180177036	-	RCV000208764|RCV001172276|RCV003415705|RCV004018629|RCV000680805|RCV000015009|RCV001849264|RCV000211749	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype|not provided|Cardiofaciocutaneous syndrome 1|Ataxia-telangiectasia syndrome|Noonan syndrome;Cardio-facio-cutaneous syndrome	germline	germline	GRCh38	NC_000007.14	7	140778053	140778053	7q34	reviewed by expert panel	13	-	N	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	3	13975	140778053	C	G	-	-	-	-	-	-	SCV001335323	-	-	1455G>C 	Leu485Phe	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Leu485Phe	-3.8216848768826113	0.006527941362460827	3.8578981633103693	0.006228415739546075	2025_01_Batch_13-14	0.5105169863396426	0.5661450889840837	0.6849601012265331	0.6268169169653752	0.5124263589993301	0.598299584251907	0.5775729635304778	0.6184960341014689	0.6586304615480807	0.5200454290084522	0.5544082852957748	0.5718590262572807	0.6517280676640009	0.642723689256728	0.5162358940038911	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003163		NC_000007.14:140778053:C:G		Leu485Phe																												BRAF_Leu485Phe	7	140778053	C	G	7	allele	1455G>C	B04	527_CAVA_Array_P01	C07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778053-C-G	13975	7	140778053	C	G	L	F	rs180177036	7	140477853	7	140124322	485	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1455G>C	p.Leu485Phe	c.1455G>C	p.Leu485Phe	principal4	Y	.	YES	Select	-	TTG	3	2	C	./.	./.	./.	./.	.	0.20412	.	.	.	.	0.264	0.31620	B	0.309	0.41361	B	.	0.97926	.	.	.	.	1.13	0.28751	L	.	0.43153	.	.	.	-0.7046	0.60048	T	0.1770	0.52004	T	9	0.94275165	0.93527	D	0.08652	0.74669	D	.	0.91679	0.859	0.95694	P15056	L485F	Gain of catalytic residue at L485 (P = 0.046)| Loss of ubiquitination at K483 (P = 0.1322)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.1405)| Loss of glycosylation at P490 (P = 0.2882)	.	0.99026	.	0.81127	.	0.95017	0.899181604385	0.96345	D	0.854571	0.96693	D	0.40148	0.89929	D	0.338922	0.89804	D	0.993222117424011	0.83810	D	0.993067	0.97789	D	0.9472474	0.95923	0.87014675	0.92780	0.94315636	0.95501	0.88148624	0.93580	-10.017	0.74092	D	0.9978	0.97942	P	0.999864334331402	0.98431	0.99597543	0.97927	0.953	0.97907	.	.	.	.	.	.	4.137508	0.6203	24.4	0.99892768971460666	0.96668	0.649139	0.62235	D	0.19994089429288	0.50957	3.302872	0.260588829807926	0.53010	3.495244	5.03	4.14	0.47761	4.1	0.78208	5.0	0.63767	4.860000	0.45538	0.545	0.25635	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	BRAF-related_disorder|Ataxia-telangiectasia_syndrome|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiofaciocutaneous_syndrome_1|Cardiovascular_phenotype|not_provided|RASopathy	reviewed_by_expert_panel	NC_000007.14:g.140778053C>G	ClinGen:CA273414|OMIM:164757.0015|UniProtKB:P15056#VAR_026115	C0004135|C0028326|C1275081|CN029449|CN230736|C3661900|C5555857	208900|PS163950|PS115150|115150	100|648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Leu	Phe	29014	single nucleotide variant	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	673	BRAF	HGNC:1097	Pathogenic	1	Feb 28, 2020	180177036	-	RCV000208764|RCV001172276|RCV003415705|RCV004018629|RCV000680805|RCV000015009|RCV001849264|RCV000211749	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype|not provided|Cardiofaciocutaneous syndrome 1|Ataxia-telangiectasia syndrome|Noonan syndrome;Cardio-facio-cutaneous syndrome	germline	germline	GRCh38	NC_000007.14	7	140778053	140778053	7q34	reviewed by expert panel	13	-	N	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	3	13975	140778053	C	G	-	-	-	-	-	-	SCV001335323	-	-	1455G>C 	Leu485Phe	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Gln257Arg	-4.0967768173781565	0.004591621866850185	-0.4372464292354162	0.6751046251185971	2025_01_Batch_13-14	0.7356388350237879	0.7482928419550411	0.8074035000113406	0.7098961831331446	0.614278519703086	0.6803782168890007	0.7208613333729822	0.784087971461417	0.725016897765799	0.6871363480348	0.7080085259563943	0.7345770876640116	0.7957457357363789	0.7174565404494718	0.6507074338689429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220590	CCSBVarC003156	ALE00003156	NC_000007.14:140801502:T:C	770A>G	Gln257Arg	CEGS2	CegsMutGDEh1027	G07	GDEhDisVCh_40058	D10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0		0			0			0			BRAF_Gln257Arg	7	140801502	T	C	7											7-140801502-T-C	13973	7	140801502	T	C	Q	R	rs180177035	7	140501302	7	140147771	257	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.770A>G	p.Gln257Arg	c.770A>G	p.Gln257Arg	principal4	Y	.	YES	Select	-	CAG	2	0	T	./.	./.	./.	./.	.	0.48802	.	.	0.24199	.	0.959	0.55150	D	0.626	0.51596	P	.	0.94956	.	.	.	.	3.07	0.86962	M	.	0.25939	.	.	0.91737	1.0162	0.97459	D	0.8814	0.96054	D	9	0.962993	0.95685	D	0.23991	0.88624	D	.	0.94900	0.914	0.98337	P15056	Q257R	Gain of MoRF binding (P = 0.0136)| Loss of helix (P = 0.0376)| Loss of sheet (P = 0.0457)| Gain of loop (P = 0.0502)| Loss of ubiquitination at K253 (P = 0.0525)	.	0.99132	.	0.99541	.	0.81887	0.876263439655	0.93441	D	0.758931	0.93394	D	0.497157	0.94149	D	0.476355	0.94072	D	0.946888327598572	0.62335	D	0.937906	0.77715	D	0.8394073	0.86387	0.6523551	0.79429	0.8253214	0.85393	0.65886503	0.79796	-13.31	0.90620	D	0.9831	0.93940	P	0.984355110891765	0.86463	0.99508744	0.97698	0.646	0.80291	.	.	.	.	.	.	4.989844	0.82746	27.9	0.99828950546521744	0.91119	0.858490	0.77519	D	0.801626318931521	0.86133	8.812097	0.761899469924724	0.86971	9.087886	5.43	5.43	0.78977	.	.	7.971	0.87647	7.808000	0.69392	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.997	0.79771	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Cardiofaciocutaneous_syndrome_1|Noonan_syndrome_7|LEOPARD_syndrome_3|Cardio-facio-cutaneous_syndrome|Lung_cancer|Colorectal_cancer|Melanoma,_cutaneous_malignant,_susceptibility_to,_1|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801502T>C	ClinGen:CA222583|OMIM:164757.0013|UniProtKB:P15056#VAR_026114	CN029449|C3150970|C3150971|C1275081|C0242379|C0346629|C1835047|C4551602|C5681679|CN230736|C5555857|C3661900	115150|613706|613707|PS115150|211980|114500|155600|163950	1340|648|500|1340|618|648|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Arg	29012	single nucleotide variant	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	673	BRAF	HGNC:1097	Pathogenic	1	Apr 03, 2017	180177035	-	RCV000015007|RCV000033289|RCV000080904|RCV000208766|RCV001027771|RCV001261967|RCV001329219|RCV001813208|RCV001813744|RCV004752707|RCV004018628|RCV003224098	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648||MedGen:CN230736|6 conditions	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3;Noonan syndrome 7;Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|BRAF-related disorder|Cardiovascular phenotype|6 conditions	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801502	140801502	7q34	reviewed by expert panel	33	-	N	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	3	13973	140801502	T	C	-	-	-	-	-	-	SCV000616360	-	-	770A>G 	Gln257Arg	NM_004333.6	3	1_Pathogenic	7	140801502	T	C	6.84148e-7																																																																																																				
BRAF	BRAF_Gln257Arg	-4.0967768173781565	0.004591621866850185	-0.4372464292354162	0.6751046251185971	2025_01_Batch_13-14	0.7356388350237879	0.7482928419550411	0.8074035000113406	0.7098961831331446	0.614278519703086	0.6803782168890007	0.7208613333729822	0.784087971461417	0.725016897765799	0.6871363480348	0.7080085259563943	0.7345770876640116	0.7957457357363789	0.7174565404494718	0.6507074338689429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003156		NC_000007.14:140801502:T:C		Gln257Arg																												BRAF_Gln257Arg	7	140801502	T	C	7	allele	770A>G	G05	527_CAVA_Array_P01	M09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801502-T-C	13973	7	140801502	T	C	Q	R	rs180177035	7	140501302	7	140147771	257	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.770A>G	p.Gln257Arg	c.770A>G	p.Gln257Arg	principal4	Y	.	YES	Select	-	CAG	2	0	T	./.	./.	./.	./.	.	0.48802	.	.	0.24199	.	0.959	0.55150	D	0.626	0.51596	P	.	0.94956	.	.	.	.	3.07	0.86962	M	.	0.25939	.	.	0.91737	1.0162	0.97459	D	0.8814	0.96054	D	9	0.962993	0.95685	D	0.23991	0.88624	D	.	0.94900	0.914	0.98337	P15056	Q257R	Gain of MoRF binding (P = 0.0136)| Loss of helix (P = 0.0376)| Loss of sheet (P = 0.0457)| Gain of loop (P = 0.0502)| Loss of ubiquitination at K253 (P = 0.0525)	.	0.99132	.	0.99541	.	0.81887	0.876263439655	0.93441	D	0.758931	0.93394	D	0.497157	0.94149	D	0.476355	0.94072	D	0.946888327598572	0.62335	D	0.937906	0.77715	D	0.8394073	0.86387	0.6523551	0.79429	0.8253214	0.85393	0.65886503	0.79796	-13.31	0.90620	D	0.9831	0.93940	P	0.984355110891765	0.86463	0.99508744	0.97698	0.646	0.80291	.	.	.	.	.	.	4.989844	0.82746	27.9	0.99828950546521744	0.91119	0.858490	0.77519	D	0.801626318931521	0.86133	8.812097	0.761899469924724	0.86971	9.087886	5.43	5.43	0.78977	.	.	7.971	0.87647	7.808000	0.69392	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.997	0.79771	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Cardiofaciocutaneous_syndrome_1|Noonan_syndrome_7|LEOPARD_syndrome_3|Cardio-facio-cutaneous_syndrome|Lung_cancer|Colorectal_cancer|Melanoma,_cutaneous_malignant,_susceptibility_to,_1|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801502T>C	ClinGen:CA222583|OMIM:164757.0013|UniProtKB:P15056#VAR_026114	CN029449|C3150970|C3150971|C1275081|C0242379|C0346629|C1835047|C4551602|C5681679|CN230736|C5555857|C3661900	115150|613706|613707|PS115150|211980|114500|155600|163950	1340|648|500|1340|618|648|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Arg	29012	single nucleotide variant	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	673	BRAF	HGNC:1097	Pathogenic	1	Apr 03, 2017	180177035	-	RCV000015007|RCV000033289|RCV000080904|RCV000208766|RCV001027771|RCV001261967|RCV001329219|RCV001813208|RCV001813744|RCV004752707|RCV004018628|RCV003224098	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648||MedGen:CN230736|6 conditions	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3;Noonan syndrome 7;Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|BRAF-related disorder|Cardiovascular phenotype|6 conditions	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801502	140801502	7q34	reviewed by expert panel	33	-	N	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	3	13973	140801502	T	C	-	-	-	-	-	-	SCV000616360	-	-	770A>G 	Gln257Arg	NM_004333.6	3	1_Pathogenic	7	140801502	T	C	6.84148e-7																																																																																																				
RAD51D	RAD51D_His23Arg	0.46032392122955723	0.6592416574464562	5.869166706727706	0.0006184625812000529	2025_01_Batch_13-14	0.7620934902533476	0.8807734751440904	0.9570207008826094	0.9040232974436648	0.7157911571535472	0.9203527373439884	0.9262859447299913	0.9635565017088441	0.9542859971134809	0.8925726472694465	0.841223113798668	0.9035297099370408	0.9602886012957268	0.9291546472785729	0.8041819022114969	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024711		NC_000017.11:35119546:T:C		His23Arg																												RAD51D_His23Arg	17	35119546	T	C	17	allele	68A>G	G01	527_CAVA_Array_P05	M01	B13A7A8P2_R1	B14A7A8P2_R2				17-35119546-T-C	418673	17	35119546	T	C	H	R	rs990062370	17	33446565	17	30470678	23	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.68A>G	p.His23Arg	c.68A>G	p.His23Arg	principal1	Y	5	.	.	-	CAC	2	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	0.792	0.05378	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	-2.015	0.00188	N	-0.59	0.18393	N	0.064	0.10018	-0.9955	0.31058	T	0.0244	0.10333	T	10	0.032363117	0.01387	T	0.010514	0.26860	T	0.018	0.03036	0.425	0.46877	O75771	H23R	Loss of sheet (P = 0.003)| Gain of helix (P = 0.0034)| Gain of MoRF binding (P = 0.0286)| Gain of phosphorylation at S22 (P = 0.091)| Loss of ubiquitination at K26 (P = 0.1022)	0.319686207203	0.31162	.	0.34452	.	0.11066	.	.	.	0.115945	0.43190	T	-0.364518	0.03721	T	-0.761382	0.02907	T	0.0475806100992363	0.05021	T	0.0435956	0.00994	T	0.040238965	0.05652	0.052508783	0.08678	0.040238965	0.05652	0.052508783	0.08677	-1.909	0.10376	T	0.0613	0.02261	B	7.77047030966497e-07	0.00398	0.22299655	0.74091	0.028	0.05473	.	.	.	.	.	.	0.56021	0.09313	6.069	0.69154575729474244	0.09022	0.046472	0.07594	N	-1.35012510449794	0.03091	0.1390257	-1.25403651457861	0.04992	0.2407925	4.5	-1.34	0.08645	-3.41	0.07546	-1.008	0.03777	-1.240000	0.05963	-0.173	0.11029	0.0	0.06393	0.000000	0.08389	0.771	0.36593	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	107948	0.000000e+00	0	1	204124	4.898980e-06	0	1	233180	4.288530e-06	0	0	7098	0.000000e+00	0	0	17080	0.000000e+00	0	0	2320	0.000000e+00	0	0	8998	0.000000e+00	0	0	12186	0.000000e+00	0	0	42690	0.000000e+00	0	0	15678	0.000000e+00	0	.	.	.	.	0	16112	0.000000e+00	0	0	30490	0.000000e+00	0	0	6182	0.000000e+00	0	0	13344	0.000000e+00	0	0	15526	0.000000e+00	0	1	87036	1.148950e-05	0	0	30596	0.000000e+00	0	1	87036	1.148950e-05	0	0	14834	0.000000e+00	0	0	34228	0.000000e+00	0	0	9560	0.000000e+00	0	0	17644	0.000000e+00	0	0	20424	0.000000e+00	0	1	100384	9.961750e-06	0	0	30514	0.000000e+00	0	1	100384	9.961750e-06	0	.	1	1612358	6.202100e-07	0	1	1179926	8.475110e-07	0	0	74908	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29596	0.000000e+00	0	0	44882	0.000000e+00	0	0	62504	0.000000e+00	0	0	6084	0.000000e+00	0	1	1179926	8.475110e-07	0	0	91090	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119546T>C	ClinGen:CA16620393	C3280345|C3661900|C0027672	614291	145|140162	RAD51D, N-terminal domain	His	Arg	409908	single nucleotide variant	NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Feb 03, 2024	990062370	-	RCV000485429|RCV000547804|RCV000566071	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35119546	35119546	17q12	criteria provided, conflicting classifications	3	-	N	ClinGen:CA16620393	2	418673	35119546	T	C	-	-	-	-	-	-	SCV000565901|SCV000651772|SCV000663810	-	-	68A>G 	His23Arg	NM_002878.4	1	3_Conflicting						963001	RAD51D_unpublished_var157248	RAD51D_unpublished	RAD51D	9823.0	-1.0		35119546.0	35119546.0		68	A	G	23.0	H	R	c.68A>G	p.His23Arg	missense_variant	-0.0128331		functionally_normal	Yes	6.202096556720033e-7	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Oct 19, 2023	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.018																																																											RAD51D_His23Arg	His23Arg	true
RET	RET_Gly321Arg	1.6968224836440589	0.13354425044658957	6.221935624960898	0.00043585464276858364	2025_01_Batch_13-14	0.977325363031224	0.9133247694306528	0.8509189221520284	0.9512187140707647	0.8969964654655831	0.6741510909770319	0.7575514441441777	0.7529307083998097	0.7488623181549918	0.6210943775883868	0.8257382270041279	0.8354381067874153	0.8019248152759191	0.8500405161128783	0.759045421526985	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202955	CCSBVarC006879	ALE00006877	NC_000010.11:43106469:G:A	961G>A	Gly321Arg	CEGS2	CegsMutGDEh1026	B06	GDEhDisVCh_40066	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Gly321Arg	10	43106469	G	A	10											10-43106469-G-A	24881	10	43106469	G	A	G	R	rs377767388	10	43601917	10	42921923	321	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.961G>A	p.Gly321Arg	c.961G>A	p.Gly321Arg	principal4	Y	5	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.231	0.18346	T	0.565	0.09199	T	0.007	0.16277	B	0.003	0.12129	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.1	0.27864	L	-1.64	0.39308	N	0.222	0.27952	-0.9759	0.35787	T	0.1969	0.54992	T	10	0.103147626	0.18741	T	0.032094	0.53831	D	0.428	0.73376	0.69	0.82670	P07949	G321R	Gain of solvent accessibility (P = 0.019)| Gain of sheet (P = 0.0477)| Gain of MoRF binding (P = 0.0483)| Gain of phosphorylation at T323 (P = 0.1426)| Loss of catalytic residue at W324 (P = 0.1943)	0.940005915424	0.93891	0.6768714346963912	0.67466	0.238921890069	0.26162	0.346982002258	0.17459	T	0.435003	0.78028	T	-0.129129	0.31279	T	-0.186593	0.55604	T	0.0158652041221491	0.00371	T	0.673133	0.27914	T	0.1105618	0.25900	0.06433436	0.12879	0.07723053	0.17355	0.065889634	0.13420	-5.573	0.42597	T	0.0874	0.13936	B	0.0249176742024401	0.31262	0.99895360	0.99055	0.232	0.50061	.	.	.	.	.	.	0.991371	0.1371	10.23	0.90570527367935905	0.20078	0.047661	0.07918	N	-1.07470700909571	0.07027	0.3294123	-1.05180989670877	0.08525	0.4273997	5.32	-1.32	0.08700	-4.57	0.05201	0.268	0.18399	0.913000	0.22725	-0.752	0.03581	0.0	0.06393	0.204000	0.23666	0.251	0.23335	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	9	108388	8.303500e-05	0	14	205672	6.806950e-05	0	18	234342	7.681080e-05	0	0	7006	0.000000e+00	0	1	17008	5.879590e-05	0	0	2296	0.000000e+00	0	2	8970	2.229650e-04	0	0	13298	0.000000e+00	0	6	42326	1.417570e-04	0	0	15586	0.000000e+00	0	2	8970	2.229650e-04	0	1	15894	6.291680e-05	0	1	30330	3.297070e-05	0	0	6148	0.000000e+00	0	1	13284	7.527850e-05	0	0	16620	0.000000e+00	0	11	88210	1.247020e-04	0	0	30384	0.000000e+00	0	11	88210	1.247020e-04	0	0	14646	0.000000e+00	0	1	34086	2.933760e-05	0	0	9534	0.000000e+00	0	2	17588	1.137140e-04	0	0	20960	0.000000e+00	0	15	101642	1.475770e-04	0	0	30312	0.000000e+00	0	15	101642	1.475770e-04	0	.	86	1613150	5.331180e-05	0	8	44842	1.784040e-04	0	7	74884	9.347790e-05	0	0	912	0.000000e+00	0	6	59956	1.000730e-04	0	0	29578	0.000000e+00	0	8	44842	1.784040e-04	0	0	63818	0.000000e+00	0	0	6078	0.000000e+00	0	61	1179700	5.170810e-05	0	1	90932	1.099720e-05	0	5	31942	1.5653371736271994E-4	0	306	0	0	112	0	2	8442	2.3691068467187872E-4	0	146	0	0	610	0	0	56	0	0	98	0	0	4502	0	2	8748	2.2862368541380886E-4	0	168	0	7	46214	1.514692517418964E-4	Conflicting_classifications_of_pathogenicity	RET-related_disorder|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|not_specified|not_provided|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Medullary_thyroid_carcinoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106469G>A	ClinGen:CA009403	C0025268|C3888239|CN169374|C3661900|C4048306|C0027672|C0238462	171400|142623	247698|653|388|653|140162|1332	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Gly	Arg	36222	single nucleotide variant	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Mar 04, 2025	377767388	-	RCV000148776|RCV000679758|RCV000709104|RCV000567555|RCV000231209|RCV001818171|RCV003460487|RCV004528128	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	Medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43106469	43106469	10q11.21	criteria provided, conflicting classifications	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009403	2	24881	43106469	G	A	-	-	-	-	-	-	SCV000190513|SCV000290569|SCV000674744|SCV000807066|SCV000838373|SCV002011439|SCV002069391|SCV002527937|SCV004208632|SCV004243365|SCV004699800|SCV005623126	-	-	961G>A 	Gly321Arg	NM_020975.6	1	3_Conflicting	10	43106469	G	A	0.0000499656																																																																																																				
RET	RET_Gly321Arg	1.6968224836440589	0.13354425044658957	6.221935624960898	0.00043585464276858364	2025_01_Batch_13-14	0.977325363031224	0.9133247694306528	0.8509189221520284	0.9512187140707647	0.8969964654655831	0.6741510909770319	0.7575514441441777	0.7529307083998097	0.7488623181549918	0.6210943775883868	0.8257382270041279	0.8354381067874153	0.8019248152759191	0.8500405161128783	0.759045421526985	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006879		NC_000010.11:43106469:G:A		Gly321Arg																												RET_Gly321Arg	10	43106469	G	A	10	allele	961G>A	B09	527_CAVA_Array_P05	C17	B13A7A8P2_R1	B14A7A8P2_R2				10-43106469-G-A	24881	10	43106469	G	A	G	R	rs377767388	10	43601917	10	42921923	321	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.961G>A	p.Gly321Arg	c.961G>A	p.Gly321Arg	principal4	Y	5	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.231	0.18346	T	0.565	0.09199	T	0.007	0.16277	B	0.003	0.12129	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.1	0.27864	L	-1.64	0.39308	N	0.222	0.27952	-0.9759	0.35787	T	0.1969	0.54992	T	10	0.103147626	0.18741	T	0.032094	0.53831	D	0.428	0.73376	0.69	0.82670	P07949	G321R	Gain of solvent accessibility (P = 0.019)| Gain of sheet (P = 0.0477)| Gain of MoRF binding (P = 0.0483)| Gain of phosphorylation at T323 (P = 0.1426)| Loss of catalytic residue at W324 (P = 0.1943)	0.940005915424	0.93891	0.6768714346963912	0.67466	0.238921890069	0.26162	0.346982002258	0.17459	T	0.435003	0.78028	T	-0.129129	0.31279	T	-0.186593	0.55604	T	0.0158652041221491	0.00371	T	0.673133	0.27914	T	0.1105618	0.25900	0.06433436	0.12879	0.07723053	0.17355	0.065889634	0.13420	-5.573	0.42597	T	0.0874	0.13936	B	0.0249176742024401	0.31262	0.99895360	0.99055	0.232	0.50061	.	.	.	.	.	.	0.991371	0.1371	10.23	0.90570527367935905	0.20078	0.047661	0.07918	N	-1.07470700909571	0.07027	0.3294123	-1.05180989670877	0.08525	0.4273997	5.32	-1.32	0.08700	-4.57	0.05201	0.268	0.18399	0.913000	0.22725	-0.752	0.03581	0.0	0.06393	0.204000	0.23666	0.251	0.23335	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	9	108388	8.303500e-05	0	14	205672	6.806950e-05	0	18	234342	7.681080e-05	0	0	7006	0.000000e+00	0	1	17008	5.879590e-05	0	0	2296	0.000000e+00	0	2	8970	2.229650e-04	0	0	13298	0.000000e+00	0	6	42326	1.417570e-04	0	0	15586	0.000000e+00	0	2	8970	2.229650e-04	0	1	15894	6.291680e-05	0	1	30330	3.297070e-05	0	0	6148	0.000000e+00	0	1	13284	7.527850e-05	0	0	16620	0.000000e+00	0	11	88210	1.247020e-04	0	0	30384	0.000000e+00	0	11	88210	1.247020e-04	0	0	14646	0.000000e+00	0	1	34086	2.933760e-05	0	0	9534	0.000000e+00	0	2	17588	1.137140e-04	0	0	20960	0.000000e+00	0	15	101642	1.475770e-04	0	0	30312	0.000000e+00	0	15	101642	1.475770e-04	0	.	86	1613150	5.331180e-05	0	8	44842	1.784040e-04	0	7	74884	9.347790e-05	0	0	912	0.000000e+00	0	6	59956	1.000730e-04	0	0	29578	0.000000e+00	0	8	44842	1.784040e-04	0	0	63818	0.000000e+00	0	0	6078	0.000000e+00	0	61	1179700	5.170810e-05	0	1	90932	1.099720e-05	0	5	31942	1.5653371736271994E-4	0	306	0	0	112	0	2	8442	2.3691068467187872E-4	0	146	0	0	610	0	0	56	0	0	98	0	0	4502	0	2	8748	2.2862368541380886E-4	0	168	0	7	46214	1.514692517418964E-4	Conflicting_classifications_of_pathogenicity	RET-related_disorder|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|not_specified|not_provided|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Medullary_thyroid_carcinoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106469G>A	ClinGen:CA009403	C0025268|C3888239|CN169374|C3661900|C4048306|C0027672|C0238462	171400|142623	247698|653|388|653|140162|1332	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Gly	Arg	36222	single nucleotide variant	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Mar 04, 2025	377767388	-	RCV000148776|RCV000679758|RCV000709104|RCV000567555|RCV000231209|RCV001818171|RCV003460487|RCV004528128	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	Medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43106469	43106469	10q11.21	criteria provided, conflicting classifications	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009403	2	24881	43106469	G	A	-	-	-	-	-	-	SCV000190513|SCV000290569|SCV000674744|SCV000807066|SCV000838373|SCV002011439|SCV002069391|SCV002527937|SCV004208632|SCV004243365|SCV004699800|SCV005623126	-	-	961G>A 	Gly321Arg	NM_020975.6	1	3_Conflicting	10	43106469	G	A	0.0000499656																																																																																																				
RHO	RHO_Asp190Gly	-2.929431263260496	0.022042111608632748	-16.30915772533287	7.936833693923803e-7	2025_01_Batch_13-14	0.783341073946874	0.973871326723488	0.9993510763772249	0.9976678451985929	0.9739839064032518	0.7636426303341605	0.9795315278480028	0.9995586420580448	0.9983459299136886	0.98020196728197	0.7734918521405172	0.9767014272857454	0.9994548592176349	0.9980068875561408	0.9770929368426109	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	true	RHO		40080645		CCSBVarC013544		NC_000003.12:129532289:A:G		Asp190Gly																												RHO_Asp190Gly	3	129532289	A	G	3	allele	569A>G	F09	527_CAVA_Array_P05	K17	B13A7A8P2_R1	B14A7A8P2_R2				3-129532289-A-G	13026	3	129532289	A	G	D	G	rs104893777	3	129251132	3	130733822	190	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.569A>G	p.Asp190Gly	c.569A>G	p.Asp190Gly	principal1	Y	1	YES	Select	+	GAC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.018	0.60067	D	0.754	0.43372	P	0.826	0.59366	P	0.93	0.93829	A	simple_aae	7.0	93.0	3.785	0.95215	H	-5.64	0.86945	D	0.993	0.99866	-0.0993	0.80024	T	0.3223	0.68995	T	9	0.9891775	0.99365	D	0.192539	0.86214	D	0.664	0.87421	0.937	0.99098	P08100	D190G	Loss of ubiquitination at K195 (P = 0.0596)| Gain of catalytic residue at G188 (P = 0.097)| Loss of stability (P = 0.1082)| Gain of sheet (P = 0.1208)| Gain of methylation at K195 (P = 0.1246)	0.775995073384	0.77216	0.9390784996612188	0.93850	0.888851575013	0.69945	0.75512355566	0.75160	T	0.836933	0.96131	D	0.326972	0.84848	D	0.231896	0.84650	D	0.995872437953949	0.88134	D	0.983802	0.94524	D	0.9865587	0.99559	0.97526824	0.99667	0.9865587	0.99559	0.97526824	0.99668	-13.655	0.91898	D	0.9863	0.92535	P	0.999678264541609	0.97434	0.99981183	0.99752	0.961	0.98360	.	.	.	.	.	.	4.848578	0.79269	27.1	0.99740077491250712	0.83425	0.915171	0.87913	D	0.415179912855261	0.62061	4.438596	0.317870176801044	0.56361	3.822499	5.19	4.02	0.45905	.	.	9.32	0.95493	11.251000	0.90759	-0.083	0.16243	1.0	0.71675	1.000000	0.68239	0.259	0.23539	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	106	0	0	434	0	0	34	0	0	658	0	Pathogenic/Likely_pathogenic	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129532289A>G	ClinGen:CA256673|OMIM:180380.0014|UniProtKB:P08100#VAR_004814	C3661900|C3151001|C0854723	613731	791|71862	GPCR, rhodopsin-like, 7TM	Asp	Gly	28065	single nucleotide variant	NM_000539.3(RHO):c.569A>G (p.Asp190Gly)	6010	RHO	HGNC:10012	Pathogenic/Likely pathogenic	1	Oct 01, 2023	104893777	-	RCV000013900|RCV001386998|RCV003887863	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129532289	129532289	3q22.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA256673,UniProtKB:P08100#VAR_004814,OMIM:180380.0014	3	13026	129532289	A	G	-	-	-	-	-	-	SCV001587465|SCV004705665	-	-	569A>G 	Asp190Gly	NM_000539.3	2	1_Pathogenic						999387	RHO_Wan_2019_var220594	RHO_Wan_2019	RHO	10012.0	1.0		129532289.0	129532289.0		569	A	G	190.0	D	G	c.569A>G	p.Asp190Gly	missense_variant	0.2641042882582283			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Oct 01, 2023	nucleotide	urn:mavedb:00000099-a-1	ENST00000296271.4	NM_000539.3	immortalized human cells	Reporter	Fluorescence	cell surface expression	No	missense_variant		0.664																																																											RHO_Asp190Gly	Asp190Gly	true
KRAS	KRAS_Gly60Arg	-2.525125755633534	0.03951338958819366	5.200356910662419	0.0012525185362658572																											true	KRAS	ENSG00000133703	3084	214488	CCSBVarC006097	ALE00006097	NC_000012.12:25227346:C:G	178G>C	Gly60Arg	CEGS2	CegsMutGDEh1041	E01	GDEhDisVCh_40061	A10	1	CegsMutGDDh1041	E01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly60Arg	12	25227346	C	G	12											12-25227346-C-G	12586	12	25227346	C	G	G	R	rs104894359	12	25380280	12	25271547	60	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>C	p.Gly60Arg	c.178G>C	p.Gly60Arg	alternative1	Y	1	.	Plus_Clinical	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.17	0.97633	H	-7.76	0.95831	D	0.956	0.96546	1.0884	0.99174	D	0.9502	0.98375	D	9	0.96227115	0.95603	D	0.451783	0.94345	D	0.938	0.98634	0.802	0.92046	P01116	G60R	Gain of catalytic residue at L56 (P = 0.1064)| Gain of phosphorylation at T58 (P = 0.1068)| Loss of glycosylation at T58 (P = 0.123)| Gain of solvent accessibility (P = 0.1319)| Gain of loop (P = 0.2045)	0.995530386705	0.99541	0.9776364459571039	0.97742	2.98422368777	0.99182	0.947138845921	0.99682	D	0.960754	0.99490	D	0.541091	0.95437	D	0.539464	0.95369	D	0.999921560287476	0.99730	D	0.89791	0.64215	D	0.9893387	0.99724	0.98382205	0.99902	0.98968154	0.99743	0.9740602	0.99623	-12.016	0.88337	D	0.9998	0.99795	P	0.999979503899075	0.99427	0.99919980	0.99211	1	0.99985	.	.	.	.	.	.	5.208984	0.87425	29.2	0.99936203639780719	0.99621	0.908603	0.86363	D	1.15990254133055	0.99090	20.65427	1.0558655561841	0.99443	22.78603	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|Inborn_genetic_diseases|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_3|not_provided|RASopathy|Noonan_syndrome	reviewed_by_expert_panel	NC_000012.12:g.25227346C>G	ClinGen:CA273416|OMIM:190070.0009|UniProtKB:P01116#VAR_026112	C3809005|C0950123|C1275081|C1860991|C3661900|C5555857|C0028326	615278|PS115150|609942|PS163950	1340|1340|648|536391|648	Small GTP-binding domain	Gly	Arg	27625	single nucleotide variant	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3845	KRAS	HGNC:6407	Pathogenic	1	Apr 03, 2017	104894359	-	RCV000013416|RCV000157935|RCV000521390|RCV000254661|RCV001267316|RCV000844635|RCV003313917	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Cardiofaciocutaneous syndrome 2|RASopathy|Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 3	germline;unknown	germline	GRCh38	NC_000012.12	12	25227346	25227346	12p12.1	reviewed by expert panel	9	-	N	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	3	12586	25227346	C	G	-	-	-	-	-	-	SCV000616370	-	-	178G>C 	Gly60Arg	NM_004985.5	3	1_Pathogenic																																																																																																									
KRAS	KRAS_Gly60Arg	-2.525125755633534	0.03951338958819366	5.200356910662419	0.0012525185362658572																											true	KRAS		3084		CCSBVarC006097		NC_000012.12:25227346:C:G		Gly60Arg																												KRAS_Gly60Arg	12	25227346	C	G	12	allele	178G>C	A08	527_CAVA_Array_P03	B15	B13A7A8P1_R1	B14A7A8P1_R2				12-25227346-C-G	12586	12	25227346	C	G	G	R	rs104894359	12	25380280	12	25271547	60	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>C	p.Gly60Arg	c.178G>C	p.Gly60Arg	alternative1	Y	1	.	Plus_Clinical	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.17	0.97633	H	-7.76	0.95831	D	0.956	0.96546	1.0884	0.99174	D	0.9502	0.98375	D	9	0.96227115	0.95603	D	0.451783	0.94345	D	0.938	0.98634	0.802	0.92046	P01116	G60R	Gain of catalytic residue at L56 (P = 0.1064)| Gain of phosphorylation at T58 (P = 0.1068)| Loss of glycosylation at T58 (P = 0.123)| Gain of solvent accessibility (P = 0.1319)| Gain of loop (P = 0.2045)	0.995530386705	0.99541	0.9776364459571039	0.97742	2.98422368777	0.99182	0.947138845921	0.99682	D	0.960754	0.99490	D	0.541091	0.95437	D	0.539464	0.95369	D	0.999921560287476	0.99730	D	0.89791	0.64215	D	0.9893387	0.99724	0.98382205	0.99902	0.98968154	0.99743	0.9740602	0.99623	-12.016	0.88337	D	0.9998	0.99795	P	0.999979503899075	0.99427	0.99919980	0.99211	1	0.99985	.	.	.	.	.	.	5.208984	0.87425	29.2	0.99936203639780719	0.99621	0.908603	0.86363	D	1.15990254133055	0.99090	20.65427	1.0558655561841	0.99443	22.78603	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|Inborn_genetic_diseases|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_3|not_provided|RASopathy|Noonan_syndrome	reviewed_by_expert_panel	NC_000012.12:g.25227346C>G	ClinGen:CA273416|OMIM:190070.0009|UniProtKB:P01116#VAR_026112	C3809005|C0950123|C1275081|C1860991|C3661900|C5555857|C0028326	615278|PS115150|609942|PS163950	1340|1340|648|536391|648	Small GTP-binding domain	Gly	Arg	27625	single nucleotide variant	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3845	KRAS	HGNC:6407	Pathogenic	1	Apr 03, 2017	104894359	-	RCV000013416|RCV000157935|RCV000521390|RCV000254661|RCV001267316|RCV000844635|RCV003313917	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Cardiofaciocutaneous syndrome 2|RASopathy|Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 3	germline;unknown	germline	GRCh38	NC_000012.12	12	25227346	25227346	12p12.1	reviewed by expert panel	9	-	N	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	3	12586	25227346	C	G	-	-	-	-	-	-	SCV000616370	-	-	178G>C 	Gly60Arg	NM_004985.5	3	1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Arg213Trp	-6.429607337566906	0.00035709788012483603	5.315249216584618	0.001104943707691982	2025_01_Batch_13-14	0.7307104948785454	0.734236566256333	0.7917511009968734	0.725454189582057	0.6164665656785188	0.7638881292976838	0.8631221770602862	0.9279671988362974	0.8745117495247433	0.7049967142868286	0.7472993120881146	0.7986793716583096	0.8598591499165854	0.7999829695534002	0.6607316399826737	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009197		NC_000023.11:64917821:G:A		Arg213Trp																												ZC4H2_Arg213Trp	23	64917821	G	A	X	allele	637C>T	D05	527_CAVA_Array_P06	G10	B13A7A8P2_R1	B14A7A8P2_R2				X-64917821-G-A	50983	X	64917821	G	A	R	W	rs879255236	X	64137701	X	64054426	213	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.637C>T	p.Arg213Trp	c.637C>T	p.Arg213Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.993	0.81117	D	0.92	0.93300	A	simple_aae	8.0	92.0	.	.	.	-6.81	0.92962	D	0.63	0.64382	-0.2160	0.77155	T	0.4185	0.76351	T	8	0.838971	0.82873	D	0.886685	0.99137	D	0.374	0.69109	0.495	0.58232	Q9NQZ6	R213W	Loss of solvent accessibility (P = 0.0036)| Loss of methylation at K209 (P = 0.0666)| Loss of relative solvent accessibility (P = 0.0676)| Gain of glycosylation at S210 (P = 0.1548)| Loss of helix (P = 0.2662)	0.964658073467	0.96396	0.7886100765468459	0.78692	3.13339230401	0.99404	0.893401861191	0.95671	D	0.814106	0.95348	D	0.49627	0.94129	D	0.475081	0.94052	D	0.998362839221954	0.93893	D	0.984002	0.95472	D	0.8943117	0.90750	0.79658544	0.87905	0.8859753	0.90028	0.83650655	0.90487	-12.468	0.87537	D	0.9996	0.99217	P	0.999161681495248	0.95853	0.99830365	0.98720	0.973	0.98982	.	.	.	.	.	.	4.527004	0.71085	25.6	0.99915480374987564	0.98380	.	.	.	.	.	.	.	.	.	5.42	3.58	0.40064	2.53	0.46530	3.404	0.52465	4.548000	0.43870	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome|not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917821G>A	ClinGen:CA10575581|OMIM:300897.0004|UniProtKB:Q9NQZ6#VAR_069624	C0796200|C3661900|C0950123	314580	3454|85283	Zinc finger C4H2-type	Arg	Trp	65654	single nucleotide variant	NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	55906	ZC4H2	HGNC:24931	Pathogenic	1	Feb 14, 2022	879255236	-	RCV000043679|RCV002354226|RCV001384432	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Wieacker-Wolff syndrome|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000023.11	X	64917821	64917821	Xq11.2	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA10575581,UniProtKB:Q9NQZ6#VAR_069624,OMIM:300897.0004	3	50983	64917821	G	A	-	-	-	-	-	-	SCV001583928|SCV002074112|SCV002655406	-	-	637C>T 	Arg213Trp	NM_018684.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Thr587Arg	-0.4548873787721197	0.6629621326061451	7.926953340626399	0.00009664275201696506	2025_01_Batch_13-14	0.9122962314024994	0.914388731015901	0.8807865638647172	0.9193700972050594	0.8179770783922686	0.9243496868775378	0.8900549220076304	0.9045064548376147	0.9357637402398886	0.8313383016906821	0.9183229591400186	0.9022218265117656	0.892646509351166	0.927566918722474	0.8246576900414754	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218425	CCSBVarC003304	ALE00003304	NC_000017.11:43067610:G:C	1760C>G	Thr587Arg	CEGS2	CegsMutGDEh1003	H05	GDEhDisVCh_40059	C01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Thr587Arg	17	43067610	G	C	17											17-43067610-G-C	55373	17	43067610	G	C	T	R	rs80357034	17	41219627	17	38473153	1691	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5072C>G	p.Thr1691Arg	principal2	Y	1	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.585	0.90580	P	0.218	0.92348	B	.	.	.	.	.	.	3.175	0.88626	M	.	0.81626	.	.	0.90585	0.5201	0.90791	D	0.6944	0.89429	D	10	.	0.86953	.	0.786117	0.98314	D	.	0.94900	.	.	.	.	.	.	0.94962	.	0.79901	.	0.15475	0.765162229538	0.76658	T	0.292953	0.76109	T	0.409641	0.90394	D	0.350645	0.90276	D	0.983474791049957	0.74950	D	0.952305	0.85727	D	0.955418	0.96765	0.8308187	0.90111	0.950228	0.96231	0.7571084	0.85471	-6.573	0.63425	T	.	0.88256	.	0.991494696303718	0.89054	0.99986839	0.99835	0.994	0.99793	.	.	.	.	.	.	4.249871	0.64569	24.7	0.99500239805060597	0.68015	0.838290	0.75493	D	0.775208299271413	0.84447	8.314456	0.736429675756228	0.85057	8.492664	5.24	5.24	0.72825	.	.	6.008	0.70468	11.808000	0.96854	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.985	0.61072	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43067610G>C	ClinGen:CA003189	C0346153|C0027672|C2676676	114480|604370	227535|140162|145	BRCT domain|BRCT domain|BRCT domain	Thr	Arg	70040	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672	BRCA1	HGNC:1100	Likely pathogenic	1	Oct 04, 2021	80357034	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610	43067610	17q21.31	criteria provided, multiple submitters, no conflicts	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3	55373	43067610	G	C	-	-	-	-	-	-	SCV002537807|SCV002644099	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Thr587Arg	-0.4548873787721197	0.6629621326061451	7.926953340626399	0.00009664275201696506	2025_01_Batch_13-14	0.9122962314024994	0.914388731015901	0.8807865638647172	0.9193700972050594	0.8179770783922686	0.9243496868775378	0.8900549220076304	0.9045064548376147	0.9357637402398886	0.8313383016906821	0.9183229591400186	0.9022218265117656	0.892646509351166	0.927566918722474	0.8246576900414754	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003304		NC_000017.11:43067610:G:C		Thr587Arg																												BRCA1_Thr587Arg	17	43067610	G	C	17	allele	1760C>G	D07	527_CAVA_Array_P01	G13	B13A7A8P1_R1	B14A7A8P1_R2				17-43067610-G-C	55373	17	43067610	G	C	T	R	rs80357034	17	41219627	17	38473153	1691	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5072C>G	p.Thr1691Arg	principal2	Y	1	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.585	0.90580	P	0.218	0.92348	B	.	.	.	.	.	.	3.175	0.88626	M	.	0.81626	.	.	0.90585	0.5201	0.90791	D	0.6944	0.89429	D	10	.	0.86953	.	0.786117	0.98314	D	.	0.94900	.	.	.	.	.	.	0.94962	.	0.79901	.	0.15475	0.765162229538	0.76658	T	0.292953	0.76109	T	0.409641	0.90394	D	0.350645	0.90276	D	0.983474791049957	0.74950	D	0.952305	0.85727	D	0.955418	0.96765	0.8308187	0.90111	0.950228	0.96231	0.7571084	0.85471	-6.573	0.63425	T	.	0.88256	.	0.991494696303718	0.89054	0.99986839	0.99835	0.994	0.99793	.	.	.	.	.	.	4.249871	0.64569	24.7	0.99500239805060597	0.68015	0.838290	0.75493	D	0.775208299271413	0.84447	8.314456	0.736429675756228	0.85057	8.492664	5.24	5.24	0.72825	.	.	6.008	0.70468	11.808000	0.96854	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.985	0.61072	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43067610G>C	ClinGen:CA003189	C0346153|C0027672|C2676676	114480|604370	227535|140162|145	BRCT domain|BRCT domain|BRCT domain	Thr	Arg	70040	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672	BRCA1	HGNC:1100	Likely pathogenic	1	Oct 04, 2021	80357034	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610	43067610	17q21.31	criteria provided, multiple submitters, no conflicts	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3	55373	43067610	G	C	-	-	-	-	-	-	SCV002537807|SCV002644099	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Ser408Ile	0.010557865224829883	0.9918707968983869	7.590508759060606	0.00012728381971504132	2025_01_Batch_13-14	0.9181762445456895	0.9086261201690247	0.9073856712001231	0.9506161820158945	0.7015349709065566	0.7476501008970957	0.7291219676646428	0.8250321224071917	0.8637183099221826	0.6720566719455782	0.8329131727213925	0.8188740439168337	0.8662088968036574	0.9071672459690385	0.6867958214260674	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011797		NC_000017.11:43074471:C:A		Ser408Ile																												BRCA1_Ser408Ile	17	43074471	C	A	17	allele	1223G>T	B08	527_CAVA_Array_P01	C15	B13A7A8P1_R1	B14A7A8P1_R2				17-43074471-C-A	41826	17	43074471	C	A	S	I	rs1800744	17	41226488	17	38480014	1512	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4535G>T	p.Ser1512Ile	principal2	Y	1	.	.	-	AGT	2	0	c	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.337	0.48353	B	0.133	0.44046	B	.	0.30097	.	.	.	.	1.895	0.50187	L	.	0.69035	.	.	0.51076	-0.1200	0.79542	T	0.6215	0.86620	D	10	.	0.01326	.	0.681988	0.97361	D	.	0.79231	.	.	.	.	.	.	0.85105	.	0.41210	.	0.11066	0.293080568314	0.09368	T	0.248577	0.61629	T	-0.0795722	0.39433	T	0.113053	0.77610	D	0.0327816211501777	0.02419	T	0.844516	0.52040	T	0.08077421	0.18357	0.10349156	0.24785	0.12831177	0.29740	0.1181652	0.28456	-5.059	0.39100	T	.	0.43431	.	0.215013996355067	0.50654	0.99944790	0.99395	0.237	0.50624	.	.	.	.	.	.	2.346036	0.30125	18.32	0.99298489580117766	0.58603	0.255502	0.37258	N	-0.32701834229789	0.27846	1.548759	-0.413545015947272	0.24281	1.347945	4.95	3.98	0.45320	2.01	0.39759	3.214	0.50958	1.912000	0.29737	0.591	0.32125	0.012	0.18747	0.005000	0.19288	0.122	0.19292	534	0.73376	3	5.990415335463259E-4	1	7.564296520423601E-4	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	0	0.0	637	264690	0.0024065888	.	244	109396	2.230430e-03	0	497	208108	2.388180e-03	1	554	236830	2.339230e-03	1	4	7164	5.583470e-04	0	37	17112	2.162230e-03	0	14	2320	6.034480e-03	0	0	9040	0.000000e+00	0	23	13390	1.717700e-03	0	154	42766	3.600990e-03	0	11	15690	7.010830e-04	0	154	42766	3.600990e-03	0	12	16218	7.399190e-04	0	58	30524	1.900140e-03	0	29	6210	4.669890e-03	0	0	13410	0.000000e+00	0	27	16730	1.613870e-03	0	348	89544	3.886360e-03	1	15	30608	4.900680e-04	0	348	89544	3.886360e-03	1	12	14902	8.052610e-04	0	59	34260	1.722120e-03	0	42	9568	4.389630e-03	0	0	17686	0.000000e+00	0	31	21628	1.433330e-03	0	387	102648	3.770170e-03	1	15	30526	4.913840e-04	0	387	102648	3.770170e-03	1	.	4969	1614128	3.078440e-03	17	164	29606	5.539420e-03	2	49	75028	6.530900e-04	1	0	912	0.000000e+00	0	87	60012	1.449710e-03	0	164	29606	5.539420e-03	2	0	44892	0.000000e+00	0	86	64022	1.343290e-03	1	12	6060	1.980200e-03	0	4340	1180008	3.677940e-03	10	61	91076	6.697700e-04	2	833	200638	0.004151755898683201	0	360	0	0	2756	0	12	9432	0.001272264631043257	1	796	0.001256281407035176	3	968	0.0030991735537190084	0	682	0	1	280	0.0035714285714285713	57	15836	0.0035993937863096743	12	9792	0.0012254901960784314	0	3438	0	907	231748	0.003913733883356059	Benign	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43074471C>A	BRCA1-HCI:BRCA1_00016|ClinGen:CA002898|UniProtKB:P38398#VAR_007788	C0346153|C3280442|C2676676|C4554406|CN169374|C3661900|C0027672|C0677776	114480|614320|604370|617883	227535|1333|145|140162|145	.	Ser	Ile	50265	single nucleotide variant	NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	1800744	-	RCV000034752|RCV000112356|RCV000048591|RCV000120258|RCV000162492|RCV004803118|RCV002490467	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0700268,MedGen:CN377757|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|BRCA1-related cancer predisposition|Familial cancer of breast;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000017.11	17	43074471	43074471	17q21.31	reviewed by expert panel	40	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00016,ClinGen:CA002898,UniProtKB:P38398#VAR_007788	2	41826	43074471	C	A	-	-	-	-	-	-	SCV000244362	-	-	4535G>T 	Ser1512Ile	NM_007294.4	3	2_Benign																																																																																																									
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						147114	F9_Popp_2025_carboxy_F9_specific_var229016	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.0066197			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						147114	F9_Popp_2025_carboxy_F9_specific_var229016	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.0066197			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						229662	F9_Popp_2025_light_chain_var248378	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.015139726			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						229662	F9_Popp_2025_light_chain_var248378	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.015139726			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						257178	F9_Popp_2025_strep_2_var267740	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.157050150415891			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						257178	F9_Popp_2025_strep_2_var267740	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.157050150415891			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						202146	F9_Popp_2025_heavy_chain_var238697	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.035248798			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						202146	F9_Popp_2025_heavy_chain_var238697	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.035248798			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						174630	F9_Popp_2025_carboxy_gla_motif_var258059	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.0229803689198257			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
F9	F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic						174630	F9_Popp_2025_carboxy_gla_motif_var258059	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561874.0	139561874.0		1189			397.0	A	P	c.1189G>C	p.Ala397Pro	missense_variant	0.0229803689198257			No		Pathogenic	no assertion criteria provided	May 01, 1998	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.974																																																											F9_Ala397Pro	Ala397Pro	true
BRCA1	BRCA1_Arg595Gln	-1.2480440075438437	0.25214139106590744	6.6623375981816295	0.00028723146358685287	2025_01_Batch_13-14	0.8646854932415327	0.9159245401802051	0.8449567484206457	0.8902121761198842	0.7604411608793911	0.9617129546881413	0.9017882958614198	0.8774439183540166	0.9559417941341498	0.9042748552747004	0.913199223964837	0.9088564180208125	0.8612003333873312	0.9230769851270171	0.8323580080770457	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218429	CCSBVarC003306	ALE00003306	NC_000017.11:43063930:C:T	1784G>A	Arg595Gln	CEGS2	CegsMutGDEh1012	D06	GDEhDisVCh_40059	B04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Arg595Gln	17	43063930	C	T	17											17-43063930-C-T	37636	17	43063930	C	T	R	Q	rs41293459	17	41215947	17	38469473	1699	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5096G>A	p.Arg1699Gln	principal2	Y	1	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.995	0.90580	D	0.454	0.97365	P	.	0.97926	.	.	.	.	3.23	0.89408	M	.	0.63232	.	.	0.96659	0.9361	0.96178	D	0.8732	0.95778	D	10	.	0.83114	.	0.74691	0.97975	D	.	0.92843	.	.	.	.	.	.	0.96647	.	0.87449	.	0.39535	0.661911010742	0.61621	T	0.392783	0.80349	T	0.34877	0.86324	D	0.419574	0.92678	D	0.950455367565155	0.63113	D	.	0.97283	.	0.96523166	0.97765	0.7972393	0.87946	0.9692461	0.98160	0.77520096	0.86571	-11.318	0.81678	D	.	0.82063	.	0.987067707466189	0.87311	0.99990070	0.99879	0.902	0.94843	.	.	.	.	.	.	5.19884	0.87233	29.2	0.99957871779371688	0.99986	0.805899	0.72937	D	0.871042515796463	0.90217	10.32869	0.832238134394619	0.91891	11.14783	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	2	109352	1.828960e-05	0	4	207994	1.923130e-05	0	6	236774	2.534060e-05	0	0	7152	0.000000e+00	0	0	17106	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42748	4.678580e-05	0	0	15686	0.000000e+00	0	2	42748	4.678580e-05	0	0	16198	0.000000e+00	0	0	30512	0.000000e+00	0	0	6206	0.000000e+00	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	4	89478	4.470370e-05	0	0	30598	0.000000e+00	0	4	89478	4.470370e-05	0	0	14886	0.000000e+00	0	0	34248	0.000000e+00	0	0	9556	0.000000e+00	0	0	17686	0.000000e+00	0	0	21630	0.000000e+00	0	6	102642	5.845560e-05	0	0	30516	0.000000e+00	0	6	102642	5.845560e-05	0	.	30	1613816	1.858950e-05	0	3	44856	6.688070e-05	0	0	74854	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29598	0.000000e+00	0	3	44856	6.688070e-05	0	0	64006	0.000000e+00	0	0	6084	0.000000e+00	0	25	1179960	2.118720e-05	0	1	91080	1.097940e-05	0	0	49660	0	0	364	0	0	398	0	0	9488	0	0	498	0	0	802	0	0	62	0	0	146	0	0	2420	0	0	9852	0	0	460	0	0	63838	0	Pathogenic	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43063930C>T	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	114480|614320|604370|617883|613659	227535|1333|145|145|140162	BRCT domain|BRCT domain|BRCT domain	Arg	Gln	46192	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672	BRCA1	HGNC:1100	Pathogenic	1	May 10, 2017	41293459	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930	43063930	17q21.31	reviewed by expert panel	49	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3	37636	43063930	C	T	-	-	-	-	-	-	SCV001156534	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3	1_Pathogenic	17	43063930	C	T	0.0000191545																																																																																																				
BRCA1	BRCA1_Arg595Gln	-1.2480440075438437	0.25214139106590744	6.6623375981816295	0.00028723146358685287	2025_01_Batch_13-14	0.8646854932415327	0.9159245401802051	0.8449567484206457	0.8902121761198842	0.7604411608793911	0.9617129546881413	0.9017882958614198	0.8774439183540166	0.9559417941341498	0.9042748552747004	0.913199223964837	0.9088564180208125	0.8612003333873312	0.9230769851270171	0.8323580080770457	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003306		NC_000017.11:43063930:C:T		Arg595Gln																												BRCA1_Arg595Gln	17	43063930	C	T	17	allele	1784G>A	G07	527_CAVA_Array_P01	M13	B13A7A8P1_R1	B14A7A8P1_R2				17-43063930-C-T	37636	17	43063930	C	T	R	Q	rs41293459	17	41215947	17	38469473	1699	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5096G>A	p.Arg1699Gln	principal2	Y	1	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.995	0.90580	D	0.454	0.97365	P	.	0.97926	.	.	.	.	3.23	0.89408	M	.	0.63232	.	.	0.96659	0.9361	0.96178	D	0.8732	0.95778	D	10	.	0.83114	.	0.74691	0.97975	D	.	0.92843	.	.	.	.	.	.	0.96647	.	0.87449	.	0.39535	0.661911010742	0.61621	T	0.392783	0.80349	T	0.34877	0.86324	D	0.419574	0.92678	D	0.950455367565155	0.63113	D	.	0.97283	.	0.96523166	0.97765	0.7972393	0.87946	0.9692461	0.98160	0.77520096	0.86571	-11.318	0.81678	D	.	0.82063	.	0.987067707466189	0.87311	0.99990070	0.99879	0.902	0.94843	.	.	.	.	.	.	5.19884	0.87233	29.2	0.99957871779371688	0.99986	0.805899	0.72937	D	0.871042515796463	0.90217	10.32869	0.832238134394619	0.91891	11.14783	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	2	109352	1.828960e-05	0	4	207994	1.923130e-05	0	6	236774	2.534060e-05	0	0	7152	0.000000e+00	0	0	17106	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42748	4.678580e-05	0	0	15686	0.000000e+00	0	2	42748	4.678580e-05	0	0	16198	0.000000e+00	0	0	30512	0.000000e+00	0	0	6206	0.000000e+00	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	4	89478	4.470370e-05	0	0	30598	0.000000e+00	0	4	89478	4.470370e-05	0	0	14886	0.000000e+00	0	0	34248	0.000000e+00	0	0	9556	0.000000e+00	0	0	17686	0.000000e+00	0	0	21630	0.000000e+00	0	6	102642	5.845560e-05	0	0	30516	0.000000e+00	0	6	102642	5.845560e-05	0	.	30	1613816	1.858950e-05	0	3	44856	6.688070e-05	0	0	74854	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29598	0.000000e+00	0	3	44856	6.688070e-05	0	0	64006	0.000000e+00	0	0	6084	0.000000e+00	0	25	1179960	2.118720e-05	0	1	91080	1.097940e-05	0	0	49660	0	0	364	0	0	398	0	0	9488	0	0	498	0	0	802	0	0	62	0	0	146	0	0	2420	0	0	9852	0	0	460	0	0	63838	0	Pathogenic	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43063930C>T	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	114480|614320|604370|617883|613659	227535|1333|145|145|140162	BRCT domain|BRCT domain|BRCT domain	Arg	Gln	46192	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672	BRCA1	HGNC:1100	Pathogenic	1	May 10, 2017	41293459	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930	43063930	17q21.31	reviewed by expert panel	49	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3	37636	43063930	C	T	-	-	-	-	-	-	SCV001156534	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3	1_Pathogenic	17	43063930	C	T	0.0000191545																																																																																																				
BRCA1	BRCA1_Gly602Ala	3.458879566726189	0.010563565807662701	0.5419560155120805	0.604663137301014	2025_01_Batch_13-14	0.8899492981161312	0.9204675782920699	0.9160276724904372	0.9268155515133806	0.784515980472033	0.9905934057415613	0.9357264373572229	0.9509726911567646	0.9853495651625582	0.9186595541595897	0.9402713519288463	0.9280970078246464	0.9335001818236008	0.9560825583379694	0.8515877673158113	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013096		NC_000017.11:43063909:C:G		Gly602Ala																												BRCA1_Gly602Ala	17	43063909	C	G	17	allele	1805G>C	E11	527_CAVA_Array_P01	I21	B13A7A8P1_R1	B14A7A8P1_R2				17-43063909-C-G	55406	17	43063909	C	G	G	A	rs80356860	17	41215926	17	38469452	1706	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5117G>C	p.Gly1706Ala	principal2	Y	.	.	.	-	GGA	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.858	0.90580	P	0.415	0.97365	B	.	0.97016	.	.	.	.	1.88	0.49806	L	.	0.77997	.	.	0.83220	-0.0839	0.80378	T	0.4691	0.79463	T	10	.	0.52478	.	0.376865	0.92864	D	.	0.79354	.	.	.	.	.	.	0.85197	.	0.86205	.	0.41014	0.788811266422	0.80226	T	0.144841	0.58712	T	0.220015	0.75596	D	0.234626	0.84783	D	0.174270822478175	0.18632	T	.	0.95417	.	0.7676474	0.81684	0.45108074	0.67803	0.816965	0.84823	0.6340818	0.78412	-8.619	0.65921	D	.	0.77716	.	0.953210802210829	0.80831	0.99961549	0.99542	0.738	0.85485	.	.	.	.	.	.	4.015836	0.59356	24.1	0.99832727521296616	0.91463	0.783255	0.71325	D	0.704029495450117	0.79789	7.175777	0.72533764037511	0.84214	8.254455	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.995	0.73271	549	0.72286	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	25	264690	9.445011E-5	.	4	109376	3.657110e-05	0	11	208038	5.287500e-05	0	10	236838	4.222300e-05	0	0	7158	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	1	13394	7.466030e-05	0	1	42758	2.338740e-05	0	0	15682	0.000000e+00	0	1	42758	2.338740e-05	0	0	16206	0.000000e+00	0	1	30514	3.277180e-05	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16734	5.975860e-05	0	5	89502	5.586470e-05	0	0	30596	0.000000e+00	0	5	89502	5.586470e-05	0	0	14892	0.000000e+00	0	0	34250	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	1	21628	4.623640e-05	0	5	102688	4.869120e-05	0	0	30514	0.000000e+00	0	5	102688	4.869120e-05	0	.	75	1614060	4.646670e-05	0	4	6062	6.598480e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	4	59998	6.666890e-05	0	0	29604	0.000000e+00	0	0	44864	0.000000e+00	0	8	64028	1.249450e-04	0	4	6062	6.598480e-04	0	48	1179976	4.067880e-05	0	0	91072	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4596	2.175805047867711E-4	0	2918	0	0	112	0	3	39902	7.518420129316827E-5	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43063909C>G	BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502	C0027672|CN169374|C3661900|C0677776|C2676676|C0006142	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Gly	Ala	70073	single nucleotide variant	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80356860	-	RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063909	43063909	17q21.31	reviewed by expert panel	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	2	55406	43063909	C	G	-	-	-	-	-	-	SCV000244384	-	-	5117G>C 	Gly1706Ala	NM_007294.4	3	2_Benign						38225	BRCA1_Adamovich_2022_Cisplatin_var6405	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43063909.0	43063909.0		5117			1706.0	G	A	c.5117G>C	p.Gly1706Ala	missense_variant	-0.232512202	-0.234707235;-0.26220853;-0.180041867;-0.253091176		No	0.0000464666741013	Benign	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.518	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Gly1706Ala	Gly1706Ala	true
BRCA1	BRCA1_Gly602Ala	3.458879566726189	0.010563565807662701	0.5419560155120805	0.604663137301014	2025_01_Batch_13-14	0.8899492981161312	0.9204675782920699	0.9160276724904372	0.9268155515133806	0.784515980472033	0.9905934057415613	0.9357264373572229	0.9509726911567646	0.9853495651625582	0.9186595541595897	0.9402713519288463	0.9280970078246464	0.9335001818236008	0.9560825583379694	0.8515877673158113	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013096		NC_000017.11:43063909:C:G		Gly602Ala																												BRCA1_Gly602Ala	17	43063909	C	G	17	allele	1805G>C	E11	527_CAVA_Array_P01	I21	B13A7A8P1_R1	B14A7A8P1_R2				17-43063909-C-G	55406	17	43063909	C	G	G	A	rs80356860	17	41215926	17	38469452	1706	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5117G>C	p.Gly1706Ala	principal2	Y	.	.	.	-	GGA	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.858	0.90580	P	0.415	0.97365	B	.	0.97016	.	.	.	.	1.88	0.49806	L	.	0.77997	.	.	0.83220	-0.0839	0.80378	T	0.4691	0.79463	T	10	.	0.52478	.	0.376865	0.92864	D	.	0.79354	.	.	.	.	.	.	0.85197	.	0.86205	.	0.41014	0.788811266422	0.80226	T	0.144841	0.58712	T	0.220015	0.75596	D	0.234626	0.84783	D	0.174270822478175	0.18632	T	.	0.95417	.	0.7676474	0.81684	0.45108074	0.67803	0.816965	0.84823	0.6340818	0.78412	-8.619	0.65921	D	.	0.77716	.	0.953210802210829	0.80831	0.99961549	0.99542	0.738	0.85485	.	.	.	.	.	.	4.015836	0.59356	24.1	0.99832727521296616	0.91463	0.783255	0.71325	D	0.704029495450117	0.79789	7.175777	0.72533764037511	0.84214	8.254455	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.995	0.73271	549	0.72286	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	25	264690	9.445011E-5	.	4	109376	3.657110e-05	0	11	208038	5.287500e-05	0	10	236838	4.222300e-05	0	0	7158	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	1	13394	7.466030e-05	0	1	42758	2.338740e-05	0	0	15682	0.000000e+00	0	1	42758	2.338740e-05	0	0	16206	0.000000e+00	0	1	30514	3.277180e-05	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16734	5.975860e-05	0	5	89502	5.586470e-05	0	0	30596	0.000000e+00	0	5	89502	5.586470e-05	0	0	14892	0.000000e+00	0	0	34250	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	1	21628	4.623640e-05	0	5	102688	4.869120e-05	0	0	30514	0.000000e+00	0	5	102688	4.869120e-05	0	.	75	1614060	4.646670e-05	0	4	6062	6.598480e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	4	59998	6.666890e-05	0	0	29604	0.000000e+00	0	0	44864	0.000000e+00	0	8	64028	1.249450e-04	0	4	6062	6.598480e-04	0	48	1179976	4.067880e-05	0	0	91072	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4596	2.175805047867711E-4	0	2918	0	0	112	0	3	39902	7.518420129316827E-5	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43063909C>G	BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502	C0027672|CN169374|C3661900|C0677776|C2676676|C0006142	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Gly	Ala	70073	single nucleotide variant	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80356860	-	RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063909	43063909	17q21.31	reviewed by expert panel	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	2	55406	43063909	C	G	-	-	-	-	-	-	SCV000244384	-	-	5117G>C 	Gly1706Ala	NM_007294.4	3	2_Benign						46312	BRCA1_Adamovich_2022_HDR_var4960	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43063909.0	43063909.0		5117			1706.0	G	A	c.5117G>C	p.Gly1706Ala	missense_variant	0.07118251875	-0.229987392;0.333306695;-0.120197644;0.301608415		No	0.0000464666741013	Benign	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.518	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Gly1706Ala	Gly1706Ala	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						185013	F9_Popp_2025_heavy_chain_var232669	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.196362795			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						185013	F9_Popp_2025_heavy_chain_var232669	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.196362795			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						129981	F9_Popp_2025_carboxy_F9_specific_var222988	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.0137861421952827			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						129981	F9_Popp_2025_carboxy_F9_specific_var222988	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.0137861421952827			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						240045	F9_Popp_2025_strep_2_var261712	F9_Popp_2025_strep_2	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.35640675873924			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						240045	F9_Popp_2025_strep_2_var261712	F9_Popp_2025_strep_2	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.35640675873924			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						212529	F9_Popp_2025_light_chain_var242350	F9_Popp_2025_light_chain	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.0519859626998802			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						212529	F9_Popp_2025_light_chain_var242350	F9_Popp_2025_light_chain	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	1.0519859626998802			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						157497	F9_Popp_2025_carboxy_gla_motif_var252031	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	0.6820084491046996			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
F9	F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic						157497	F9_Popp_2025_carboxy_gla_motif_var252031	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139541127.0	139541127.0		329			110.0	D	G	c.329A>G	p.Asp110Gly	missense_variant	0.6820084491046996			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.922																																																											F9_Asp110Gly	Asp110Gly	true
ZC4H2	ZC4H2_Ala162Thr	-4.370447319580962	0.0032722768210010993	8.395631701605742	0.0000668881355903243	2025_01_Batch_13-14	0.6325524172812277	0.7885922907571303	0.8245184478802221	0.7413113322146364	0.6491819734900327	0.8502638266287432	0.8683484509498671	0.9436322625012543	0.9405561133731781	0.7059248170414719	0.7414081219549855	0.8284703708534987	0.8840753551907382	0.8409337227939073	0.6775533952657523	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009153		NC_000023.11:64919119:C:T		Ala162Thr																												ZC4H2_Ala162Thr	23	64919119	C	T	X	allele	484G>A	B04	527_CAVA_Array_P06	C08	B13A7A8P2_R1	B14A7A8P2_R2				X-64919119-C-T	793408	X	64919119	C	T	A	T	rs763229158	X	64138999	X	64055724	162	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.484G>A	p.Ala162Thr	c.484G>A	p.Ala162Thr	principal1	Y	1	YES	Select	-	GCC	1	0	C	C/C	C/C	C/C	C/C	0.585	0.05935	T	0.549	0.09609	T	0.253	0.31264	B	0.042	0.24116	B	0.02	0.13669	N	simple_aae	98.0	2.0	0.975	0.24371	L	-0.73	0.20514	N	0.563	0.59694	-0.9631	0.38422	T	0.1409	0.45885	T	9	0.17710975	0.32362	T	0.276816	0.90062	D	0.118	0.32711	0.433	0.48193	Q9NQZ6	A162T	Gain of glycosylation at A162 (P = 0.048)| Gain of phosphorylation at A162 (P = 0.0546)| Gain of MoRF binding (P = 0.1162)| Loss of stability (P = 0.5478)| Gain of catalytic residue at A162 (P = 0.5863)	0.396617757867	0.38874	0.7068802814843511	0.70480	0.002779115915	0.00229	0.73517537117	0.72215	T	0.364445	0.72831	T	-0.170336	0.24842	T	-0.141903	0.59671	T	0.0535271790125423	0.06045	T	0.921908	0.71557	D	0.39003843	0.59709	0.37242544	0.62207	0.39003843	0.59709	0.37242544	0.62207	-5.158	0.38896	T	0.5862	0.68255	P	0.7151635813138	0.67549	0.89157920	0.90918	0.294	0.56292	.	.	.	.	.	.	3.063865	0.41235	21.3	0.99147030646255208	0.53786	.	.	.	.	.	.	.	.	.	5.4	5.4	0.77927	.	.	7.641	0.82558	7.492000	0.59446	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	12	264690	4.533605E-5	.	9	76130	1.182190e-04	0	24	143121	1.676900e-04	0	23	162094	1.418930e-04	0	0	5609	0.000000e+00	0	6	13184	4.550970e-04	0	0	1586	0.000000e+00	0	0	6756	0.000000e+00	0	0	9673	0.000000e+00	0	1	29040	3.443530e-05	0	0	8936	0.000000e+00	0	6	13184	4.550970e-04	0	0	12852	0.000000e+00	0	18	23519	7.653390e-04	0	0	4116	0.000000e+00	0	0	9768	0.000000e+00	0	0	11828	0.000000e+00	0	1	60750	1.646090e-05	0	0	16908	0.000000e+00	0	18	23519	7.653390e-04	0	0	11779	0.000000e+00	0	17	26098	6.513910e-04	0	0	6264	0.000000e+00	0	0	12772	0.000000e+00	0	0	15504	0.000000e+00	0	1	68992	1.449440e-05	0	0	16843	0.000000e+00	0	17	26098	6.513910e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign/Likely_benign	Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64919119C>T	.	C0950123|C3661900	.	.	.	Ala	Thr	786889	single nucleotide variant	NM_018684.4(ZC4H2):c.484G>A (p.Ala162Thr)	55906	ZC4H2	HGNC:24931	Benign/Likely benign	0	Nov 21, 2024	763229158	-	RCV000976591|RCV002548407	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64919119	64919119	Xq11.2	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA10433399	2	793408	64919119	C	T	-	-	-	-	-	-	SCV001124496|SCV001875100|SCV003704074	-	-	484G>A 	Ala162Thr	NM_018684.4	2	2_Benign																																																																																																									
BRAF	BRAF_Val471Phe	2.3797904528016036	0.04889717181123469	-3.0812311870095046	0.01778459894246216	2025_01_Batch_13-14	0.9613681814926571	0.9661325211342289	0.8996643083809368	0.9590310998708382	0.8605722800791198	0.9842419434621872	0.9649148712016956	0.9721444810468575	0.985021780066256	0.9367247114276722	0.9728050624774222	0.9655236961679623	0.9359043947138972	0.9720264399685471	0.898648495753396	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220601	CCSBVarC003161	ALE00003161	NC_000007.14:140781597:C:A	1411G>T	Val471Phe	CEGS2	CegsMutGDEh1018	F01	GDEhDisVCh_40058	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Val471Phe	7	140781597	C	A	7											7-140781597-C-A	40367	7	140781597	C	A	V	F	rs121913376	7	140481397	7	140127866	471	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1411G>T	p.Val471Phe	c.1411G>T	p.Val471Phe	principal4	Y	.	YES	Select	-	GTC	1	0	C	./.	./.	./.	./.	.	0.78662	.	.	.	.	0.999	0.77914	D	0.978	0.74106	D	.	0.93300	.	.	.	.	3.085	0.87210	M	.	0.75724	.	.	.	0.9449	0.96308	D	0.9940	0.99862	D	10	0.98959863	0.99425	D	0.776752	0.98235	D	.	0.99762	0.928	0.98831	P15056	V471F	Loss of MoRF binding (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of methylation at K473 (P = 0.132)| Gain of ubiquitination at K473 (P = 0.2122)| Gain of phosphorylation at T470 (P = 0.2345)	.	0.99319	.	0.97785	.	0.94779	0.875435829163	0.93326	D	0.969342	0.99654	D	0.565576	0.96310	D	0.574634	0.96250	D	0.997305870056152	0.91167	D	0.994967	0.98313	D	0.97874874	0.98996	0.9485988	0.98289	0.98134124	0.99197	0.94787174	0.98244	-16.156	0.97989	D	0.9991	0.99217	P	0.999981316373626	0.99579	0.99920601	0.99218	0.997	0.99892	.	.	.	.	.	.	5.405591	0.9052	31.0	0.99709975588964905	0.81301	0.888659	0.82134	D	1.04820146480743	0.97030	15.51097	0.96315625170976	0.97767	16.74944	5.62	5.62	0.85695	.	.	7.886	0.85829	7.654000	0.63915	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.994	0.71086	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	RASopathy|Ataxia-telangiectasia_syndrome|Melanoma|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781597C>A	ClinGen:CA281968	C5555857|C0004135|C0025202|C3661900	208900	536391|100	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Val	Phe	48837	single nucleotide variant	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	May 17, 2024	121913376	-	RCV000033308|RCV002051798|RCV000654957	MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Ataxia-telangiectasia syndrome|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140781597	140781597	7q34	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA281968	2	40367	140781597	C	A	-	-	-	-	-	-	SCV000057213|SCV000776865|SCV002318959	-	-	1411G>T 	Val471Phe	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Val471Phe	2.3797904528016036	0.04889717181123469	-3.0812311870095046	0.01778459894246216	2025_01_Batch_13-14	0.9613681814926571	0.9661325211342289	0.8996643083809368	0.9590310998708382	0.8605722800791198	0.9842419434621872	0.9649148712016956	0.9721444810468575	0.985021780066256	0.9367247114276722	0.9728050624774222	0.9655236961679623	0.9359043947138972	0.9720264399685471	0.898648495753396	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003161		NC_000007.14:140781597:C:A		Val471Phe																												BRAF_Val471Phe	7	140781597	C	A	7	allele	1411G>T	A04	527_CAVA_Array_P01	A07	B13A7A8P1_R1	B14A7A8P1_R2				7-140781597-C-A	40367	7	140781597	C	A	V	F	rs121913376	7	140481397	7	140127866	471	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1411G>T	p.Val471Phe	c.1411G>T	p.Val471Phe	principal4	Y	.	YES	Select	-	GTC	1	0	C	./.	./.	./.	./.	.	0.78662	.	.	.	.	0.999	0.77914	D	0.978	0.74106	D	.	0.93300	.	.	.	.	3.085	0.87210	M	.	0.75724	.	.	.	0.9449	0.96308	D	0.9940	0.99862	D	10	0.98959863	0.99425	D	0.776752	0.98235	D	.	0.99762	0.928	0.98831	P15056	V471F	Loss of MoRF binding (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of methylation at K473 (P = 0.132)| Gain of ubiquitination at K473 (P = 0.2122)| Gain of phosphorylation at T470 (P = 0.2345)	.	0.99319	.	0.97785	.	0.94779	0.875435829163	0.93326	D	0.969342	0.99654	D	0.565576	0.96310	D	0.574634	0.96250	D	0.997305870056152	0.91167	D	0.994967	0.98313	D	0.97874874	0.98996	0.9485988	0.98289	0.98134124	0.99197	0.94787174	0.98244	-16.156	0.97989	D	0.9991	0.99217	P	0.999981316373626	0.99579	0.99920601	0.99218	0.997	0.99892	.	.	.	.	.	.	5.405591	0.9052	31.0	0.99709975588964905	0.81301	0.888659	0.82134	D	1.04820146480743	0.97030	15.51097	0.96315625170976	0.97767	16.74944	5.62	5.62	0.85695	.	.	7.886	0.85829	7.654000	0.63915	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.994	0.71086	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	RASopathy|Ataxia-telangiectasia_syndrome|Melanoma|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781597C>A	ClinGen:CA281968	C5555857|C0004135|C0025202|C3661900	208900	536391|100	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Val	Phe	48837	single nucleotide variant	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	May 17, 2024	121913376	-	RCV000033308|RCV002051798|RCV000654957	MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Ataxia-telangiectasia syndrome|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140781597	140781597	7q34	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA281968	2	40367	140781597	C	A	-	-	-	-	-	-	SCV000057213|SCV000776865|SCV002318959	-	-	1411G>T 	Val471Phe	NM_004333.6	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Met1Ile	6.765004300970164	0.0002614050448425321	-8.007642466557492	0.0000905951237529456	2025_01_Batch_13-14	0.965432133065669	0.9708351231137582	0.9923100505613676	0.9890790736252655	0.9369278802773922	0.942537676845391	0.9128446786942379	0.9834795160559991	0.9841944238913661	0.876088559150052	0.95398490495553	0.941839900903998	0.9878947833086833	0.9866367487583159	0.9065082197137221	1.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	true	BRCA1		14613		CCSBVarC003295		NC_000017.11:43124094:C:A		Met1Ile																												BRCA1_Met1Ile	17	43124094	C	A	17	allele	3G>T	E06	527_CAVA_Array_P01	I11	B13A7A8P1_R1	B14A7A8P1_R2				17-43124094-C-A	55072	17	43124094	C	A	M	I	rs80357475	17	41276111	17	38529637	1	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.3G>T	p.Met1?	c.3G>T	p.Met1?	principal2	Y	1	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.92967	D	0.924	0.51298	P	0.878	0.62305	P	.	0.99291	.	.	.	.	.	.	.	-0.56	0.54406	N	.	0.93850	0.5223	0.90822	D	0.7099	0.90000	D	9	0.9873682	0.99089	D	0.932498	0.99511	D	0.696	0.88959	0.996	0.99957	E9PFC7	M1I	Gain of catalytic residue at M1 (P = 0.0314)| Loss of disorder (P = 0.1193)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2684)| Loss of phosphorylation at S4 (P = 0.3332)	0.887736870969	0.88576	.	0.24402	.	.	.	.	.	0.280176	0.65093	T	0.398321	0.89744	D	0.334384	0.89616	D	0.996361911296844	0.89105	D	.	0.64967	.	0.90739095	0.91937	0.707353	0.82542	0.9052275	0.91737	0.64797	0.79185	-12.231	0.90483	D	.	.	.	0.999999926062728	0.99831	0.99954283	0.99470	.	.	.	.	.	.	.	.	4.144486	0.62186	24.4	0.99635003892177543	0.76291	0.062568	0.11864	N	0.34664899273018	0.58348	4.029269	0.312639291828477	0.56049	3.791295	3.83	3.83	0.43219	.	.	3.426	0.52638	3.191000	0.36784	-0.284	0.0639	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612162	6.202850e-07	0	1	1178330	8.486590e-07	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	64006	0.000000e+00	0	0	6024	0.000000e+00	0	1	1178330	8.486590e-07	0	0	91032	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43124094C>A	ClinGen:CA002562	C0027672|C3661900|C0346153|C4554406|C2676676|C3280442|C0677776	114480|617883|604370|614320	140162|227535|145|1333|145	.	Met	Ile	69739	single nucleotide variant	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 18, 2019	80357475	-	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124094	43124094	17q21.31	reviewed by expert panel	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002562	2	55072	43124094	C	A	-	-	-	-	-	-	SCV001161632	-	-	3G>T 	Met1Ile	NM_007294.4	3	1_Pathogenic	17	43124094	C	A	6.84988e-7																																																																																																				
LMNA	LMNA_Arg335Trp	4.583862108039076	0.0025321301333144763	-0.9255931267106533	0.385456246323218	2025_01_Batch_13-14	0.7114896389309981	0.8279131353541587	0.768175515004324	0.6641384677519655	0.6181679353333233	0.5907092384194192	0.6694165414177452	0.7801505531661583	0.7028534388956819	0.5982227051075442	0.6510994386752087	0.748664838385952	0.7741630340852412	0.6834959533238236	0.6081953202204338	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA	ENSG00000160789	3903	201328	CCSBVarC003620	ALE00003620	NC_000001.11:156135967:C:T	1003C>T	Arg335Trp	CEGS2	CegsMutGDEh1047	B06	GDEhDisVCh_40057	G10	1	CegsMutGDDh1047	B06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			LMNA_Arg335Trp	1	156135967	C	T	1											1-156135967-C-T	36473	1	156135967	C	T	R	W	rs386134243	1	156105758	1	154372382	335	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.1003C>T	p.Arg335Trp	c.1003C>T	p.Arg335Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.003	0.92967	D	1.0	0.90580	D	0.964	0.76461	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.775	0.95135	H	-6.78	0.93600	D	0.96	0.97765	0.9382	0.96209	D	0.8766	0.95894	D	10	0.9271074	0.91967	D	0.816539	0.98568	D	0.819	0.94182	0.588	0.71518	P02545	R335W	Loss of solvent accessibility (P = 0.1077)| Gain of MoRF binding (P = 0.1637)| Loss of relative solvent accessibility (P = 0.3219)| Loss of methylation at R331 (P = 0.4354)| Loss of glycosylation at S334 (P = 0.5435)	0.964334009803	0.96363	0.9541123517558469	0.95368	2.09983672442	0.94792	0.747377514839	0.74014	T	0.978141	0.99804	D	0.458005	0.92783	D	0.420116	0.92694	D	0.997435510158539	0.91475	D	0.962604	0.86719	D	0.8800445	0.89526	0.80577844	0.88487	0.8201633	0.85040	0.8051204	0.88446	-12.785	0.89664	D	0.5886	0.68353	P	0.99922285455029	0.96001	0.99997473	0.99978	0.78	0.87822	.	.	.	.	.	.	5.395437	0.90388	31.0	0.99922039172766042	0.98853	0.948098	0.95922	D	0.829224154962615	0.87830	9.3793	0.777752911999856	0.88143	9.496604	5.87	5.87	0.94257	.	.	2.013	0.40665	4.774000	0.44870	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.992	0.67791	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613920	6.196090e-07	0	1	1180030	8.474360e-07	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	63884	0.000000e+00	0	0	6082	0.000000e+00	0	1	1180030	8.474360e-07	0	0	91088	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4588	2.1795989537925023E-4	0	2918	0	0	112	0	2	35432	5.644615037254459E-5	Pathogenic/Likely_pathogenic	LMNA-related_disorder|Cardiovascular_phenotype|Left_ventricular_noncompaction|Cardiomyopathy|Primary_familial_dilated_cardiomyopathy|not_provided|Arrhythmogenic_right_ventricular_cardiomyopathy|Charcot-Marie-Tooth_disease_type_2B1|Emery-Dreifuss_muscular_dystrophy_2,_autosomal_dominant|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Dilated_cardiomyopathy-hypergonadotropic_hypogonadism_syndrome|Dilated_cardiomyopathy_1A|Heart-hand_syndrome,_Slovenian_type|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy_3,_autosomal_recessive|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Familial_partial_lipodystrophy,_Dunnigan_type|Restrictive_dermopathy_2|Primary_dilated_cardiomyopathy|Laminopathy|Charcot-Marie-Tooth_disease_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156135967C>T	ClinGen:CA016426|OMIM:150330.0058	CN230736|C1960469|C0878544|C0340427|C3661900|C0349788|C1854154|C0410190|C5399785|C0796031|C1449563|C1857829|C0033300|C2750035|C2750785|C1720860|C5676942|C0007193|C5392094|C0270914	PS604169|PS115200|605588|181350|248370|212112|115200|610140|176670|616516|613205|151660|619793	54260|167848|217607|247|98856|261|264|2457|90153|2229|300751|168796|740|261|98855|157973|2348|217604|98301|64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Trp	45135	single nucleotide variant	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	4000	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1	Sep 12, 2024	386134243	-	RCV000030145|RCV000182368|RCV000721960|RCV000546102|RCV000852407|RCV003492303|RCV000844672|RCV001196390|RCV003149579|RCV002477025|RCV004532421|RCV000620788|RCV000845456	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|11 conditions||MedGen:CN230736|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260	Primary dilated cardiomyopathy|not provided|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2|Arrhythmogenic right ventricular cardiomyopathy|Primary familial dilated cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|11 conditions|LMNA-related disorder|Cardiovascular phenotype|Left ventricular noncompaction	germline;unknown	germline	GRCh38	NC_000001.11	1	156135967	156135967	1q22	criteria provided, multiple submitters, no conflicts	18	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016426,OMIM:150330.0058	3	36473	156135967	C	T	-	-	-	-	-	-	SCV000052800|SCV000064996|SCV000234691|SCV000611277|SCV000657788|SCV000736761|SCV000927154|SCV000987545|SCV000995090|SCV001366997|SCV001715569|SCV003838810|SCV004112973|SCV004240883|SCV005196726|SCV005427697	-	-	1003C>T 	Arg335Trp	NM_170707.4	2	1_Pathogenic																																																																																																									
LMNA	LMNA_Arg335Trp	4.583862108039076	0.0025321301333144763	-0.9255931267106533	0.385456246323218	2025_01_Batch_13-14	0.7114896389309981	0.8279131353541587	0.768175515004324	0.6641384677519655	0.6181679353333233	0.5907092384194192	0.6694165414177452	0.7801505531661583	0.7028534388956819	0.5982227051075442	0.6510994386752087	0.748664838385952	0.7741630340852412	0.6834959533238236	0.6081953202204338	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA		3903		CCSBVarC003620		NC_000001.11:156135967:C:T		Arg335Trp																												LMNA_Arg335Trp	1	156135967	C	T	1	allele	1003C>T	H12	527_CAVA_Array_P03	P23	B13A7A8P1_R1	B14A7A8P1_R2				1-156135967-C-T	36473	1	156135967	C	T	R	W	rs386134243	1	156105758	1	154372382	335	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.1003C>T	p.Arg335Trp	c.1003C>T	p.Arg335Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.003	0.92967	D	1.0	0.90580	D	0.964	0.76461	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.775	0.95135	H	-6.78	0.93600	D	0.96	0.97765	0.9382	0.96209	D	0.8766	0.95894	D	10	0.9271074	0.91967	D	0.816539	0.98568	D	0.819	0.94182	0.588	0.71518	P02545	R335W	Loss of solvent accessibility (P = 0.1077)| Gain of MoRF binding (P = 0.1637)| Loss of relative solvent accessibility (P = 0.3219)| Loss of methylation at R331 (P = 0.4354)| Loss of glycosylation at S334 (P = 0.5435)	0.964334009803	0.96363	0.9541123517558469	0.95368	2.09983672442	0.94792	0.747377514839	0.74014	T	0.978141	0.99804	D	0.458005	0.92783	D	0.420116	0.92694	D	0.997435510158539	0.91475	D	0.962604	0.86719	D	0.8800445	0.89526	0.80577844	0.88487	0.8201633	0.85040	0.8051204	0.88446	-12.785	0.89664	D	0.5886	0.68353	P	0.99922285455029	0.96001	0.99997473	0.99978	0.78	0.87822	.	.	.	.	.	.	5.395437	0.90388	31.0	0.99922039172766042	0.98853	0.948098	0.95922	D	0.829224154962615	0.87830	9.3793	0.777752911999856	0.88143	9.496604	5.87	5.87	0.94257	.	.	2.013	0.40665	4.774000	0.44870	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.992	0.67791	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613920	6.196090e-07	0	1	1180030	8.474360e-07	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	63884	0.000000e+00	0	0	6082	0.000000e+00	0	1	1180030	8.474360e-07	0	0	91088	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4588	2.1795989537925023E-4	0	2918	0	0	112	0	2	35432	5.644615037254459E-5	Pathogenic/Likely_pathogenic	LMNA-related_disorder|Cardiovascular_phenotype|Left_ventricular_noncompaction|Cardiomyopathy|Primary_familial_dilated_cardiomyopathy|not_provided|Arrhythmogenic_right_ventricular_cardiomyopathy|Charcot-Marie-Tooth_disease_type_2B1|Emery-Dreifuss_muscular_dystrophy_2,_autosomal_dominant|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Dilated_cardiomyopathy-hypergonadotropic_hypogonadism_syndrome|Dilated_cardiomyopathy_1A|Heart-hand_syndrome,_Slovenian_type|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy_3,_autosomal_recessive|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Familial_partial_lipodystrophy,_Dunnigan_type|Restrictive_dermopathy_2|Primary_dilated_cardiomyopathy|Laminopathy|Charcot-Marie-Tooth_disease_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156135967C>T	ClinGen:CA016426|OMIM:150330.0058	CN230736|C1960469|C0878544|C0340427|C3661900|C0349788|C1854154|C0410190|C5399785|C0796031|C1449563|C1857829|C0033300|C2750035|C2750785|C1720860|C5676942|C0007193|C5392094|C0270914	PS604169|PS115200|605588|181350|248370|212112|115200|610140|176670|616516|613205|151660|619793	54260|167848|217607|247|98856|261|264|2457|90153|2229|300751|168796|740|261|98855|157973|2348|217604|98301|64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Trp	45135	single nucleotide variant	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	4000	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1	Sep 12, 2024	386134243	-	RCV000030145|RCV000182368|RCV000721960|RCV000546102|RCV000852407|RCV003492303|RCV000844672|RCV001196390|RCV003149579|RCV002477025|RCV004532421|RCV000620788|RCV000845456	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|11 conditions||MedGen:CN230736|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260	Primary dilated cardiomyopathy|not provided|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2|Arrhythmogenic right ventricular cardiomyopathy|Primary familial dilated cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|11 conditions|LMNA-related disorder|Cardiovascular phenotype|Left ventricular noncompaction	germline;unknown	germline	GRCh38	NC_000001.11	1	156135967	156135967	1q22	criteria provided, multiple submitters, no conflicts	18	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016426,OMIM:150330.0058	3	36473	156135967	C	T	-	-	-	-	-	-	SCV000052800|SCV000064996|SCV000234691|SCV000611277|SCV000657788|SCV000736761|SCV000927154|SCV000987545|SCV000995090|SCV001366997|SCV001715569|SCV003838810|SCV004112973|SCV004240883|SCV005196726|SCV005427697	-	-	1003C>T 	Arg335Trp	NM_170707.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Thr616Ala	-6.233928517816243	0.0004308100442908221	-7.543974029456267	0.00013232858766953467																											true	BRCA1		14613		CCSBVarC013127		NC_000017.11:43063368:T:C		Thr616Ala																												BRCA1_Thr616Ala	17	43063368	T	C	17	allele	1846A>G	A12	527_CAVA_Array_P01	A23	B13A7A8P1_R1	B14A7A8P1_R2				17-43063368-T-C	55438	17	43063368	T	C	T	A	rs56195342	17	41215385	17	38468911	1720	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5158A>G	p.Thr1720Ala	c.5158A>G	p.Thr1720Ala	principal2	Y	1	YES	Select	-	ACC	1	0	T	T/T	T/T	T/T	T/T	0.01	0.56615	D	0.095	0.43880	T	0.021	0.53291	B	0.066	0.48451	B	0.23	0.50204	N	simple_aae	77.0	23.0	2.125	0.58867	M	-0.84	0.52959	N	0.567	0.60461	-0.5013	0.68463	T	0.5083	0.81431	D	10	0.065047204	0.08686	T	0.314787	0.91275	D	0.445	0.74592	.	.	.	.	.	0.789056459329	0.78542	.	0.26244	.	0.22090	0.411568820477	0.26642	T	0.14986	0.48633	T	-0.108625	0.34639	T	-0.000295152	0.70099	D	0.0311792727904229	0.02162	T	.	0.71327	.	0.2736807	0.50103	0.12058569	0.29029	0.48555672	0.65926	0.13745041	0.32761	-9.542	0.73014	D	0.1171	0.49112	B	0.698941713513221	0.66991	0.99886380	0.99003	0.426	0.66488	.	.	.	.	.	.	2.969506	0.39651	21.0	0.96895934447641918	0.31711	0.110795	0.21747	N	-0.126275122101043	0.35976	2.092868	-0.0610072656409511	0.36715	2.161836	5.46	3.16	0.35328	5.1	0.90952	0.492	0.22223	2.751000	0.34617	0.609	0.47831	0.102	0.22913	1.000000	0.68239	0.998	0.85369	549	0.72286	1	1.9968051118210862E-4	0	0.0	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	43	264690	1.6245419E-4	.	20	109126	1.832740e-04	0	39	207770	1.877080e-04	0	43	236492	1.818240e-04	0	1	7160	1.396650e-04	0	17	17104	9.939200e-04	0	0	2320	0.000000e+00	0	0	9032	0.000000e+00	0	0	13176	0.000000e+00	0	2	42744	4.679020e-05	0	0	15684	0.000000e+00	0	17	17104	9.939200e-04	0	1	16208	6.169790e-05	0	28	30508	9.177920e-04	0	0	6210	0.000000e+00	0	0	13392	0.000000e+00	0	0	16516	0.000000e+00	0	7	89490	7.822100e-05	0	0	30596	0.000000e+00	0	28	30508	9.177920e-04	0	1	14894	6.714110e-05	0	31	34242	9.053210e-04	0	0	9568	0.000000e+00	0	0	17668	0.000000e+00	0	0	21410	0.000000e+00	0	8	102598	7.797420e-05	0	0	30514	0.000000e+00	0	31	34242	9.053210e-04	0	.	203	1611752	1.259500e-04	0	51	60008	8.498870e-04	0	1	74974	1.333800e-05	0	0	912	0.000000e+00	0	51	60008	8.498870e-04	0	0	29600	0.000000e+00	0	0	44876	0.000000e+00	0	0	63804	0.000000e+00	0	0	6056	0.000000e+00	0	143	1178052	1.213870e-04	0	0	91026	0.000000e+00	0	12	165778	7.238596194911267E-5	0	350	0	0	2686	0	0	8772	0	0	796	0	0	968	0	0	652	0	0	280	0	1	12714	7.865345288658172E-5	0	9122	0	0	3338	0	13	192996	6.73589089929325E-5	Benign	not_provided|not_specified|Malignant_tumor_of_breast|BRCA1-related_disorder|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43063368T>C	BRCA1-HCI:BRCA1_00093|ClinGen:CA003312|UniProtKB:P38398#VAR_070504	C3661900|CN169374|C0006142|C0677776|CN221562|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Thr	Ala	70105	single nucleotide variant	NM_007294.4(BRCA1):c.5158A>G (p.Thr1720Ala)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	56195342	-	RCV000077605|RCV000175327|RCV000162823|RCV000203648|RCV003149710|RCV003736568|RCV001353742|RCV004554687	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related disorder	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063368	43063368	17q21.31	reviewed by expert panel	22	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00093,ClinGen:CA003312,UniProtKB:P38398#VAR_070504	2	55438	43063368	T	C	-	-	-	-	-	-	SCV000244390	-	-	5158A>G 	Thr1720Ala	NM_007294.4	3	2_Benign																																																																																																									
RAD51D	RAD51D_Val66Met	-0.545546479468292	0.6023201818835449	9.486270453812262	0.000030256308289431174	2025_01_Batch_13-14	0.7562182404004095	0.8179277119701884	0.8685760632494186	0.8268199895224255	0.6855978670709192	0.5251440850520803	0.7154595109435239	0.8414875127860665	0.7385265014914997	0.5175576559932441	0.640681162726245	0.7666936114568561	0.8550317880177425	0.7826732455069626	0.6015777615320816	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024804		NC_000017.11:35118568:C:T		Val66Met																												RAD51D_Val66Met	17	35118568	C	T	17	allele	196G>A	G12	527_CAVA_Array_P04	N24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118568-C-T	141578	17	35118568	C	T	V	M	rs56026142	17	33445587	17	30469700	66	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.196G>A	p.Val66Met	c.196G>A	p.Val66Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.095	0.34240	T	0.066	0.44850	T	0.476	0.36683	P	0.365	0.43339	B	0.05	0.16373	N	simple_aae	95.0	5.0	1.2	0.30152	L	-0.54	0.16529	N	0.358	0.39815	-0.9936	0.31561	T	0.1126	0.40048	T	10	0.010412663	0.00228	T	0.024861	0.47635	T	0.088	0.25383	0.532	0.63879	O75771	V66M	Loss of catalytic residue at V66 (P = 0.1757)| Gain of disorder (P = 0.2016)| Gain of relative solvent accessibility (P = 0.2816)| Loss of glycosylation at S62 (P = 0.3483)| Gain of loop (P = 0.3485)	0.485420873983	0.47807	.	.	.	.	.	.	.	0.159822	0.50082	T	-0.540521	0.00322	T	-0.547555	0.17258	T	0.0349691153311283	0.02783	T	.	0.67135	.	0.085984245	0.19788	0.05022742	0.07854	0.085984245	0.19787	0.05022742	0.07854	-4.122	0.28513	T	0.1196	0.24734	LB	0.000394112558413836	0.06034	0.88900130	0.90830	0.035	0.07875	.	.	.	.	.	.	1.488353	0.19181	14.12	0.85296696707845254	0.16045	0.093680	0.18747	N	-0.868469024722056	0.11459	0.5605822	-0.881724750457004	0.12311	0.6448988	4.79	-0.163	0.12675	-5.85	0.03264	0.004	0.13047	0.681000	0.20762	-1.926	0.00504	0.001	0.13799	0.444000	0.24998	0.443	0.27788	926	0.17784	3	5.990415335463259E-4	1	7.564296520423601E-4	0	0.0	0	0.0	2	0.001984126984126984	0	0.0	53	264690	2.0023424E-4	.	30	109376	2.742830e-04	0	60	208066	2.883700e-04	0	76	236884	3.208320e-04	0	1	7164	1.395870e-04	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	24	9044	2.653690e-03	0	0	13366	0.000000e+00	0	2	42766	4.676610e-05	0	1	15690	6.373490e-05	0	24	9044	2.653690e-03	0	1	16218	6.165990e-05	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	48	13414	3.578350e-03	0	0	16706	0.000000e+00	0	4	89522	4.468180e-05	0	1	30608	3.267120e-05	0	48	13414	3.578350e-03	0	1	14902	6.710510e-05	0	4	34260	1.167540e-04	0	0	9572	0.000000e+00	0	65	17690	3.674390e-03	0	0	21604	0.000000e+00	0	2	102710	1.947230e-05	0	1	30526	3.275900e-05	0	65	17690	3.674390e-03	0	.	420	1614178	2.601940e-04	1	374	44872	8.334820e-03	1	1	75058	1.332300e-05	0	0	912	0.000000e+00	0	5	60016	8.331110e-05	0	1	29608	3.377470e-05	0	374	44872	8.334820e-03	1	0	64024	0.000000e+00	0	1	6062	1.649620e-04	0	9	1180038	7.626870e-06	0	17	91078	1.866530e-04	0	1	153016	6.535264286087729E-6	0	176	0	18	4498	0.004001778568252557	0	4724	0	0	442	0	0	950	0	6	1848	0.003246753246753247	0	280	0	9	11718	7.680491551459293E-4	0	4900	0	24	6346	0.003781909864481563	34	177652	1.9138540517416071E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|RAD51D-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118568C>T	ClinGen:CA165840	C0027672|CN221562|C3661900|C0677776|CN169374|C3280345	614291	140162|145|145	.	Val	Met	151292	single nucleotide variant	NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Mar 04, 2025	56026142	-	RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35118568	35118568	17q12	criteria provided, conflicting classifications	16	-	N	ClinGen:CA165840	2	141578	35118568	C	T	-	-	-	-	-	-	SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299	-	-	196G>A 	Val66Met	NM_002878.4	1	3_Conflicting						962165	RAD51D_unpublished_var156412	RAD51D_unpublished	RAD51D	9823.0	-1.0		35118568.0	35118568.0		196	G	A	66.0	V	M	c.196G>A	p.Val66Met	missense_variant	0.00606963		functionally_normal	Yes	0.0002601943527913	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 28, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.088																																																											RAD51D_Val66Met	Val66Met	true
F9	F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	10601	X	139551238	G	A	A	T	rs387906478	X	138633397	X	138461063	233	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.99893111899062204	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.000000	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	25640	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	387906478	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238	139551238	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255365,OMIM:300746.0042	1	10601	139551238	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic						164785	F9_Popp_2025_carboxy_gla_motif_var254610	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551238.0	139551238.0		697			233.0	A	T	c.697G>A	p.Ala233Thr	missense_variant	0.9277382175294492			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.601																																																											F9_Ala233Thr	Ala233Thr	true
F9	F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	10601	X	139551238	G	A	A	T	rs387906478	X	138633397	X	138461063	233	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.99893111899062204	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.000000	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	25640	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	387906478	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238	139551238	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255365,OMIM:300746.0042	1	10601	139551238	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic						219817	F9_Popp_2025_light_chain_var244929	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551238.0	139551238.0		697			233.0	A	T	c.697G>A	p.Ala233Thr	missense_variant	0.927565455095564			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.601																																																											F9_Ala233Thr	Ala233Thr	true
F9	F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	10601	X	139551238	G	A	A	T	rs387906478	X	138633397	X	138461063	233	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.99893111899062204	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.000000	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	25640	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	387906478	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238	139551238	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255365,OMIM:300746.0042	1	10601	139551238	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic						137269	F9_Popp_2025_carboxy_F9_specific_var225567	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551238.0	139551238.0		697			233.0	A	T	c.697G>A	p.Ala233Thr	missense_variant	0.9147990800527244			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.601																																																											F9_Ala233Thr	Ala233Thr	true
F9	F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	10601	X	139551238	G	A	A	T	rs387906478	X	138633397	X	138461063	233	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.99893111899062204	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.000000	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	25640	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	387906478	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238	139551238	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255365,OMIM:300746.0042	1	10601	139551238	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic						192301	F9_Popp_2025_heavy_chain_var235248	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551238.0	139551238.0		697			233.0	A	T	c.697G>A	p.Ala233Thr	missense_variant	0.8971889490305673			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.601																																																											F9_Ala233Thr	Ala233Thr	true
F9	F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	10601	X	139551238	G	A	A	T	rs387906478	X	138633397	X	138461063	233	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.99893111899062204	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.000000	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	25640	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	387906478	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238	139551238	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255365,OMIM:300746.0042	1	10601	139551238	G	A	-	-	-	-	-	-	SCV000031579	-	-	697G>A 	Ala233Thr	NM_000133.4		1_Pathogenic						247333	F9_Popp_2025_strep_2_var264291	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551238.0	139551238.0		697			233.0	A	T	c.697G>A	p.Ala233Thr	missense_variant	0.9995956496751132			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.601																																																											F9_Ala233Thr	Ala233Thr	true
BRAF	BRAF_Phe468Ser	-5.287701209677223	0.0011384771237647243	2.961834070476631	0.021050194197223714	2025_01_Batch_13-14	0.5879989123605611	0.6842041802629649	0.669575683879428	0.6931227660608306	0.54522477106327	0.5839173406709097	0.695054024771055	0.67664586718096	0.6993882351754044	0.5572598106102404	0.5859581265157354	0.68962910251701	0.6731107755301939	0.6962555006181175	0.5512422908367552	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220599	CCSBVarC003159	ALE00003159	NC_000007.14:140781605:A:G	1403T>C	Phe468Ser	CEGS2	CegsMutGDEh1010	E05	GDEhDisVCh_40058	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Phe468Ser	7	140781605	A	G	7											7-140781605-A-G	40366	7	140781605	A	G	F	S	rs397507473	7	140481405	7	140127874	468	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1403T>C	p.Phe468Ser	c.1403T>C	p.Phe468Ser	principal4	Y	.	YES	Select	-	TTT	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.474	0.36638	P	0.333	0.42166	B	.	0.99291	.	.	.	.	1.375	0.34130	L	.	.	.	.	.	0.2775	0.87139	D	0.6181	0.86478	D	10	0.9654888	0.95979	D	0.370597	0.92721	D	.	0.96308	0.907	0.98057	P15056	F468S	Gain of disorder (P = 0.003)| Gain of catalytic residue at F468 (P = 0.0093)| Gain of glycosylation at F468 (P = 0.0356)| Gain of methylation at K473 (P = 0.0485)| Gain of ubiquitination at K473 (P = 0.0682)	.	0.99561	.	0.93588	.	0.97063	0.896780073643	0.96070	D	0.8689	0.97127	D	0.433457	0.91644	D	0.384855	0.91542	D	0.996321439743042	0.89024	D	0.981002	0.93472	D	0.9767253	0.98831	0.96972746	0.99444	0.9715668	0.98378	0.95852166	0.98875	-13.116	0.89856	D	0.9997	0.99795	P	0.99997234991302	0.99427	0.99889910	0.99026	0.997	0.99892	.	.	.	.	.	.	5.459799	0.91162	32.0	0.99801327173541676	0.88648	0.883596	0.81195	D	0.395979229302215	0.61003	4.318368	0.517485622092491	0.68999	5.32187	5.62	5.62	0.85695	.	.	9.302	0.95273	11.190000	0.88645	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109386	9.141940e-06	0	1	208098	4.805430e-06	0	1	236886	4.221440e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13378	0.000000e+00	0	1	42766	2.338310e-05	0	0	15688	0.000000e+00	0	1	42766	2.338310e-05	0	0	16218	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16718	0.000000e+00	0	1	89544	1.116770e-05	0	0	30604	0.000000e+00	0	1	89544	1.116770e-05	0	0	14902	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21616	0.000000e+00	0	1	102710	9.736150e-06	0	0	30522	0.000000e+00	0	1	102710	9.736150e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	83130	0	0	54	0	0	2596	0	0	1234	0	0	290	0	0	318	0	0	600	0	0	182	0	0	1566	0	0	1288	0	0	3196	0	0	89970	0	Pathogenic/Likely_pathogenic	Cardiofaciocutaneous_syndrome_1|not_provided|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|See_cases|RASopathy|BRAF-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781605A>G	ClinGen:CA280002|UniProtKB:P15056#VAR_035097	CN029449|C3661900|C1275081|C5681679|C5555857	115150|PS115150	1340|1340|98733|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Phe	Ser	48836	single nucleotide variant	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Feb 24, 2023	397507473	-	RCV000033305|RCV000037917|RCV001813222|RCV001293860|RCV000797502|RCV003407389|RCV002251944	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||	not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|RASopathy|BRAF-related disorder|See cases	de novo;germline	germline	GRCh38	NC_000007.14	7	140781605	140781605	7q34	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	2	40366	140781605	A	G	-	-	-	-	-	-	SCV000057210|SCV000061579|SCV000937062|SCV001482525|SCV002060517|SCV002502773|SCV002523369|SCV004110177	-	-	1403T>C 	Phe468Ser	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Phe468Ser	-5.287701209677223	0.0011384771237647243	2.961834070476631	0.021050194197223714	2025_01_Batch_13-14	0.5879989123605611	0.6842041802629649	0.669575683879428	0.6931227660608306	0.54522477106327	0.5839173406709097	0.695054024771055	0.67664586718096	0.6993882351754044	0.5572598106102404	0.5859581265157354	0.68962910251701	0.6731107755301939	0.6962555006181175	0.5512422908367552	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003159		NC_000007.14:140781605:A:G		Phe468Ser																												BRAF_Phe468Ser	7	140781605	A	G	7	allele	1403T>C	G03	527_CAVA_Array_P01	M05	B13A7A8P1_R1	B14A7A8P1_R2				7-140781605-A-G	40366	7	140781605	A	G	F	S	rs397507473	7	140481405	7	140127874	468	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1403T>C	p.Phe468Ser	c.1403T>C	p.Phe468Ser	principal4	Y	.	YES	Select	-	TTT	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.474	0.36638	P	0.333	0.42166	B	.	0.99291	.	.	.	.	1.375	0.34130	L	.	.	.	.	.	0.2775	0.87139	D	0.6181	0.86478	D	10	0.9654888	0.95979	D	0.370597	0.92721	D	.	0.96308	0.907	0.98057	P15056	F468S	Gain of disorder (P = 0.003)| Gain of catalytic residue at F468 (P = 0.0093)| Gain of glycosylation at F468 (P = 0.0356)| Gain of methylation at K473 (P = 0.0485)| Gain of ubiquitination at K473 (P = 0.0682)	.	0.99561	.	0.93588	.	0.97063	0.896780073643	0.96070	D	0.8689	0.97127	D	0.433457	0.91644	D	0.384855	0.91542	D	0.996321439743042	0.89024	D	0.981002	0.93472	D	0.9767253	0.98831	0.96972746	0.99444	0.9715668	0.98378	0.95852166	0.98875	-13.116	0.89856	D	0.9997	0.99795	P	0.99997234991302	0.99427	0.99889910	0.99026	0.997	0.99892	.	.	.	.	.	.	5.459799	0.91162	32.0	0.99801327173541676	0.88648	0.883596	0.81195	D	0.395979229302215	0.61003	4.318368	0.517485622092491	0.68999	5.32187	5.62	5.62	0.85695	.	.	9.302	0.95273	11.190000	0.88645	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109386	9.141940e-06	0	1	208098	4.805430e-06	0	1	236886	4.221440e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13378	0.000000e+00	0	1	42766	2.338310e-05	0	0	15688	0.000000e+00	0	1	42766	2.338310e-05	0	0	16218	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16718	0.000000e+00	0	1	89544	1.116770e-05	0	0	30604	0.000000e+00	0	1	89544	1.116770e-05	0	0	14902	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21616	0.000000e+00	0	1	102710	9.736150e-06	0	0	30522	0.000000e+00	0	1	102710	9.736150e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	83130	0	0	54	0	0	2596	0	0	1234	0	0	290	0	0	318	0	0	600	0	0	182	0	0	1566	0	0	1288	0	0	3196	0	0	89970	0	Pathogenic/Likely_pathogenic	Cardiofaciocutaneous_syndrome_1|not_provided|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|See_cases|RASopathy|BRAF-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781605A>G	ClinGen:CA280002|UniProtKB:P15056#VAR_035097	CN029449|C3661900|C1275081|C5681679|C5555857	115150|PS115150	1340|1340|98733|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Phe	Ser	48836	single nucleotide variant	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Feb 24, 2023	397507473	-	RCV000033305|RCV000037917|RCV001813222|RCV001293860|RCV000797502|RCV003407389|RCV002251944	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||	not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|RASopathy|BRAF-related disorder|See cases	de novo;germline	germline	GRCh38	NC_000007.14	7	140781605	140781605	7q34	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	2	40366	140781605	A	G	-	-	-	-	-	-	SCV000057210|SCV000061579|SCV000937062|SCV001482525|SCV002060517|SCV002502773|SCV002523369|SCV004110177	-	-	1403T>C 	Phe468Ser	NM_004333.6	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Pro533Leu	-0.7528200911783965	0.47610774311243165	5.735636261825845	0.0007088088193576657	2025_01_Batch_13-14	0.8966973181666507	0.9046777827911453	0.8366561191366582	0.8836138891142781	0.846603016213943	0.9912462879532155	0.9120658558726263	0.9363661078945147	0.9848881106736286	0.8643488539991834	0.9439718030599331	0.9083718193318858	0.8865111135155864	0.9342509998939533	0.8554759351065632	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013043		NC_000017.11:43071004:G:A		Pro533Leu																												BRCA1_Pro533Leu	17	43071004	G	A	17	allele	1598C>T	F10	527_CAVA_Array_P01	K19	B13A7A8P1_R1	B14A7A8P1_R2				17-43071004-G-A	55314	17	43071004	G	A	P	L	rs80357048	17	41223021	17	38476547	1637	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.4910C>T	p.Pro1637Leu	principal2	Y	.	.	.	-	CCA	2	0	G	G/G	G/G	G/G	G/G	.	0.58783	.	.	0.79703	.	0.364	0.66535	B	0.057	0.65195	B	.	0.53339	.	.	.	.	1.935	0.51654	L	.	0.81462	.	.	0.43554	0.4923	0.90403	D	0.7232	0.90488	D	10	.	0.62760	.	0.458461	0.94460	D	.	0.82485	.	.	.	.	.	.	0.90380	.	0.27141	.	0.09620	0.296533286572	0.09880	T	0.271505	0.64184	T	0.206619	0.74322	D	0.189468	0.82413	D	0.231254577636719	0.21745	T	.	0.48325	.	0.038577784	0.05118	0.050610814	0.07993	0.046824034	0.07827	0.055308446	0.09687	-3.524	0.18016	T	.	0.23603	.	0.544346036701319	0.62126	0.99945563	0.99403	0.431	0.66835	.	.	.	.	.	.	2.130503	0.27171	17.35	0.98451927561516039	0.41758	0.144722	0.26561	N	0.0679651651785688	0.44715	2.761733	-0.0712680779194096	0.36281	2.130881	4.82	4.82	0.61594	2.66	0.48641	0.768	0.26344	6.732000	0.56527	-0.105	0.15707	0.75	0.29224	1.000000	0.68239	0.031	0.13278	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109402	9.140600e-06	0	7	208052	3.364540e-05	0	5	236818	2.111330e-05	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	7	89482	7.822800e-05	0	0	30608	0.000000e+00	0	7	89482	7.822800e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	5	102628	4.871960e-05	0	0	30526	0.000000e+00	0	5	102628	4.871960e-05	0	.	60	1614068	3.717320e-05	0	57	1180046	4.830320e-05	0	0	74916	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44898	0.000000e+00	0	0	64024	0.000000e+00	0	0	6084	0.000000e+00	0	57	1180046	4.830320e-05	0	0	91086	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	0	8162	0	0	112	0	1	30890	3.237293622531564E-5	Benign	Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|BRCA1-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43071004G>A	BRCA1-HCI:BRCA1_00090|ClinGen:CA003076|UniProtKB:P38398#VAR_007794	C0027672|C0006142|C3661900|C0677776|C2676676|CN169374	604370	140162|145|145	.	Pro	Leu	69981	single nucleotide variant	NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80357048	-	RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43071004	43071004	17q21.31	reviewed by expert panel	15	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794	2	55314	43071004	G	A	-	-	-	-	-	-	SCV000244372	-	-	4910C>T 	Pro1637Leu	NM_007294.4	3	2_Benign																																																																																																									
RAD51D	RAD51D_Val132Ile	1.1951833385138684	0.270931637294705	11.407170550504395	8.926785329176513e-6	2025_01_Batch_13-14	0.852293666669155	0.8857411452603304	0.958227488959117	0.9427350272896435	0.8044850193577774	0.8188471165112827	0.9182389071091395	0.9688289215325073	0.9283992779700836	0.7214189944707794	0.8355703915902188	0.9019900261847349	0.9635282052458122	0.9355671526298636	0.7629520069142783	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024822		NC_000017.11:35107074:C:T		Val132Ile																												RAD51D_Val132Ile	17	35107074	C	T	17	allele	394G>A	C01	527_CAVA_Array_P05	E01	B13A7A8P2_R1	B14A7A8P2_R2				17-35107074-C-T	185178	17	35107074	C	T	V	I	rs201141245	17	33434093	17	30458206	132	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.394G>A	p.Val132Ile	c.394G>A	p.Val132Ile	principal1	Y	5	.	.	-	GTC	1	0	C	C/C	C/C	C/C	C/C	.	0.44188	.	0.039	0.53076	D	0.424	0.35468	B	0.382	0.43907	B	0.05	0.18971	N	simple_aae	95.0	5.0	2.62	0.76477	M	.	0.22672	.	0.216	0.24096	-0.3916	0.72168	T	0.3597	0.72046	T	10	0.109271616	0.20146	T	0.071049	0.71066	D	0.229	0.52699	.	.	.	.	.	0.62430428174	0.61834	.	0.37837	.	0.25574	.	.	.	0.15308	0.49109	T	-0.122049	0.32431	T	-0.107115	0.62576	T	0.0757847073892739	0.09324	T	0.738826	0.35767	T	0.08056444	0.18299	0.09804036	0.23318	0.08056444	0.18299	0.09804036	0.23318	-7.63	0.58592	D	0.1016	0.17936	B	0.000961144535626309	0.09382	0.62951803	0.84609	0.122	0.32993	.	.	.	.	.	.	1.358257	0.17693	13.3	0.72709087620192148	0.10230	0.067676	0.13137	N	-0.614819935582183	0.18271	0.9608728	-0.673516161556329	0.17340	0.9379878	4.65	2.66	0.30590	0.89	0.28255	1.984	0.40383	-0.207000	0.10935	-0.939	0.02107	0.942	0.32811	0.000000	0.08389	0.696	0.34057	921	0.19236	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	30	264690	1.1334013E-4	.	6	109402	5.484360e-05	0	14	208126	6.726690e-05	0	15	236922	6.331200e-05	0	2	7164	2.791740e-04	0	3	17112	1.753160e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13388	7.469380e-05	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	2	7164	2.791740e-04	0	5	16218	3.082990e-04	0	4	30524	1.310440e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	1	16728	5.978000e-05	0	4	89554	4.466580e-05	0	0	30608	0.000000e+00	0	5	16218	3.082990e-04	0	4	14902	2.684200e-04	0	5	34260	1.459430e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	1	21626	4.624060e-05	0	5	102724	4.867410e-05	0	0	30526	0.000000e+00	0	4	14902	2.684200e-04	0	.	72	1614046	4.460840e-05	0	3	6060	4.950500e-04	0	8	74988	1.066840e-04	0	0	912	0.000000e+00	0	7	60010	1.166470e-04	0	0	29606	0.000000e+00	0	4	44860	8.916630e-05	0	1	64012	1.562210e-05	0	3	6060	4.950500e-04	0	42	1180002	3.559320e-05	0	2	91086	2.195730e-05	0	12	179916	6.669779230307477E-5	0	360	0	0	2712	0	1	9384	1.0656436487638534E-4	0	796	0	0	968	0	0	682	0	0	278	0	0	15410	0	1	9744	1.0262725779967159E-4	0	3394	0	13	210506	6.175595945008693E-5	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35107074C>T	ClinGen:CA191240	C3661900|C0027672|C0006142|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Val	Ile	184833	single nucleotide variant	NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Jan 19, 2025	201141245	-	RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	35107074	35107074	17q12	criteria provided, conflicting classifications	15	-	N	ClinGen:CA191240	2	185178	35107074	C	T	-	-	-	-	-	-	SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642	-	-	394G>A 	Val132Ile	NM_002878.4	1	3_Conflicting						961266	RAD51D_unpublished_var155513	RAD51D_unpublished	RAD51D	9823.0	-1.0		35107074.0	35107074.0		394	G	A	132.0	V	I	c.394G>A	p.Val132Ile	missense_variant	0.00161802		functionally_normal	Yes	0.0000446083940606	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	May 13, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.229																																																											RAD51D_Val132Ile	Val132Ile	true
FH	FH_Arg101Pro	4.936823787103087	0.0026122475521523467	-6.3120881858677516	0.00039949333367175175	2025_01_Batch_13-14	0.7591463818735215	0.8801537331098237	0.9445807184794202	0.9219469434032179	0.8487166714701131	0.8144788384306456	0.8936658580417775	0.9547278990487912	0.9332433100380673	0.8970774612096026	0.7868126101520836	0.8869097955758005	0.9496543087641056	0.9275951267206426	0.8728970663398579	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214591	CCSBVarC004047	ALE00004047	NC_000001.11:241513679:C:G	302G>C	Arg101Pro	CEGS2	CegsMutGDEh1039	A01	GDEhDisVCh_40065	B08	1	CegsMutGDDh1039	A01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	2	0			0			0			FH_Arg101Pro	1	241513679	C	G	1											1-241513679-C-G	16238	1	241513679	C	G	R	P	rs75086406	1	241676979	1	239743602	101	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.302G>C	p.Arg101Pro	c.302G>C	p.Arg101Pro	principal1	Y	1	YES	Select	-	CGA	2	0	C	C/C	C/C	C/C	C/C	0.005	0.63383	D	0.005	0.72530	D	0.953	0.54293	P	0.743	0.55796	P	0.87	0.90832	A	simple_aae	13.0	87.0	2.92	0.84163	M	-3.0	0.62369	D	0.956	0.96546	1.0727	0.98661	D	0.9706	0.99071	D	10	0.96818995	0.96307	D	0.570217	0.96104	D	0.900	0.97205	0.787	0.90945	P07954	R101P	Loss of MoRF binding (P = 0.0088)| Loss of methylation at R101 (P = 0.0316)| Gain of glycosylation at K100 (P = 0.1926)| Gain of ubiquitination at K100 (P = 0.3295)| Gain of disorder (P = 0.3433)	0.975473075571	0.97496	0.9653000365510797	0.96498	1.0454015372	0.75799	0.572783589363	0.49004	T	0.987676	0.99933	D	0.506134	0.94418	D	0.48925	0.94338	D	0.986802875995636	0.77268	D	0.984402	0.94657	D	0.98190993	0.99239	0.8988987	0.94827	0.98190993	0.99239	0.8988987	0.94828	-17.284	0.99132	D	0.9862	0.92510	P	0.99935590898668	0.96346	0.91557670	0.91792	0.853	0.91950	.	.	.	.	.	.	4.726614	0.76136	26.4	0.99754957809678579	0.84551	0.799097	0.72445	D	0.524983923222637	0.68407	5.235626	0.513199196236598	0.68706	5.281088	5.85	4.95	0.64849	.	.	1.844	0.39015	4.873000	0.45664	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.852	0.40339	965	0.07233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241513679C>G	ClinGen:CA341389|OMIM:136850.0009	C0027672|C3661900|C1708350	150800	140162|523	Fumarate lyase, N-terminal	Arg	Pro	31277	single nucleotide variant	NM_000143.4(FH):c.302G>C (p.Arg101Pro)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Mar 20, 2024	75086406	-	RCV000017625|RCV002433458|RCV000489422	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000001.11	1	241513679	241513679	1q43	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA341389,OMIM:136850.0009	3	16238	241513679	C	G	-	-	-	-	-	-	SCV000576624|SCV002753171|SCV004292025	-	-	302G>C 	Arg101Pro	NM_000143.4	2	1_Pathogenic																																																																																																									
FH	FH_Arg101Pro	4.936823787103087	0.0026122475521523467	-6.3120881858677516	0.00039949333367175175	2025_01_Batch_13-14	0.7591463818735215	0.8801537331098237	0.9445807184794202	0.9219469434032179	0.8487166714701131	0.8144788384306456	0.8936658580417775	0.9547278990487912	0.9332433100380673	0.8970774612096026	0.7868126101520836	0.8869097955758005	0.9496543087641056	0.9275951267206426	0.8728970663398579	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004047		NC_000001.11:241513679:C:G		Arg101Pro																												FH_Arg101Pro	1	241513679	C	G	1	allele	302G>C	F02	527_CAVA_Array_P03	L03	B13A7A8P1_R1	B14A7A8P1_R2				1-241513679-C-G	16238	1	241513679	C	G	R	P	rs75086406	1	241676979	1	239743602	101	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.302G>C	p.Arg101Pro	c.302G>C	p.Arg101Pro	principal1	Y	1	YES	Select	-	CGA	2	0	C	C/C	C/C	C/C	C/C	0.005	0.63383	D	0.005	0.72530	D	0.953	0.54293	P	0.743	0.55796	P	0.87	0.90832	A	simple_aae	13.0	87.0	2.92	0.84163	M	-3.0	0.62369	D	0.956	0.96546	1.0727	0.98661	D	0.9706	0.99071	D	10	0.96818995	0.96307	D	0.570217	0.96104	D	0.900	0.97205	0.787	0.90945	P07954	R101P	Loss of MoRF binding (P = 0.0088)| Loss of methylation at R101 (P = 0.0316)| Gain of glycosylation at K100 (P = 0.1926)| Gain of ubiquitination at K100 (P = 0.3295)| Gain of disorder (P = 0.3433)	0.975473075571	0.97496	0.9653000365510797	0.96498	1.0454015372	0.75799	0.572783589363	0.49004	T	0.987676	0.99933	D	0.506134	0.94418	D	0.48925	0.94338	D	0.986802875995636	0.77268	D	0.984402	0.94657	D	0.98190993	0.99239	0.8988987	0.94827	0.98190993	0.99239	0.8988987	0.94828	-17.284	0.99132	D	0.9862	0.92510	P	0.99935590898668	0.96346	0.91557670	0.91792	0.853	0.91950	.	.	.	.	.	.	4.726614	0.76136	26.4	0.99754957809678579	0.84551	0.799097	0.72445	D	0.524983923222637	0.68407	5.235626	0.513199196236598	0.68706	5.281088	5.85	4.95	0.64849	.	.	1.844	0.39015	4.873000	0.45664	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.852	0.40339	965	0.07233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241513679C>G	ClinGen:CA341389|OMIM:136850.0009	C0027672|C3661900|C1708350	150800	140162|523	Fumarate lyase, N-terminal	Arg	Pro	31277	single nucleotide variant	NM_000143.4(FH):c.302G>C (p.Arg101Pro)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Mar 20, 2024	75086406	-	RCV000017625|RCV002433458|RCV000489422	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000001.11	1	241513679	241513679	1q43	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA341389,OMIM:136850.0009	3	16238	241513679	C	G	-	-	-	-	-	-	SCV000576624|SCV002753171|SCV004292025	-	-	302G>C 	Arg101Pro	NM_000143.4	2	1_Pathogenic																																																																																																									
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						204898	F9_Popp_2025_heavy_chain_var239643	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9530577974528428			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						204898	F9_Popp_2025_heavy_chain_var239643	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9530577974528428			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						259930	F9_Popp_2025_strep_2_var268686	F9_Popp_2025_strep_2	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	1.2791282997000697			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						259930	F9_Popp_2025_strep_2_var268686	F9_Popp_2025_strep_2	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	1.2791282997000697			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						149866	F9_Popp_2025_carboxy_F9_specific_var229962	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9488668190430832			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						149866	F9_Popp_2025_carboxy_F9_specific_var229962	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9488668190430832			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						232414	F9_Popp_2025_light_chain_var249324	F9_Popp_2025_light_chain	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9706696689975236			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						232414	F9_Popp_2025_light_chain_var249324	F9_Popp_2025_light_chain	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9706696689975236			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						177382	F9_Popp_2025_carboxy_gla_motif_var259005	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9605804541680274			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
F9	F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic						177382	F9_Popp_2025_carboxy_gla_motif_var259005	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139562009.0	139562009.0		1324			442.0	G	R	c.1324G>A	p.Gly442Arg	missense_variant	0.9605804541680274			No		Pathogenic	no assertion criteria provided	Sep 11, 2013	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.933																																																											F9_Gly442Arg	Gly442Arg	true
LMNA	LMNA_Arg349Leu	1.0956468444891008	0.3094917419063528	4.167510144450547	0.00420217915215487	2025_01_Batch_13-14	0.5475822828122247	0.8102874186572842	0.9257224225340441	0.773820649870661	0.6142904451750753	0.5851680566044616	0.7547977913410235	0.8856390686863543	0.8115870574462624	0.583577916705548	0.5663751697083431	0.7825426049991538	0.9056807456101992	0.7927038536584616	0.5989341809403117	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA	ENSG00000160789	3903	201322	CCSBVarC003621	ALE00003621	NC_000001.11:156136010:G:T	1046G>T	Arg349Leu	CEGS2	CegsMutGDEh1042	E02	GDEhDisVCh_40057	B10	1	CegsMutGDDh1042	E02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			LMNA_Arg349Leu	1	156136010	G	T	1											1-156136010-G-T	66763	1	156136010	G	T	R	L	rs58789393	1	156105801	1	154372425	349	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1046G>T	p.Arg349Leu	c.1046G>T	p.Arg349Leu	principal1	Y	5	.	.	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.003	0.79703	D	0.775	0.90580	P	0.896	0.86259	P	0.97	0.97016	D	simple_aae	3.0	97.0	3.8	0.95330	H	-6.56	0.91889	D	0.965	0.98762	0.9518	0.96410	D	0.8633	0.95442	D	10	0.97176325	0.96764	D	0.755624	0.98052	D	0.871	0.96123	0.801	0.91975	P02545	R349L	Loss of MoRF binding (P = 0.0632)| Loss of methylation at R349 (P = 0.2199)| Gain of stability (P = 0.2765)| Loss of catalytic residue at M345 (P = 0.6375)| Loss of solvent accessibility (P = 0.6392)	0.966327329089	0.96566	.	0.98457	.	0.96624	0.813560366631	0.84010	D	0.967344	0.99617	D	0.495723	0.94117	D	0.474295	0.94039	D	0.992853701114655	0.83317	D	.	0.96357	.	0.7229245	0.79081	0.65043724	0.79322	0.6761609	0.76503	0.61561835	0.77388	-8.52	0.71001	D	0.9091	0.83342	LP	0.999839382529083	0.98239	0.99996722	0.99978	0.981	0.99334	.	.	.	.	.	.	5.301637	0.89027	29.8	0.99846690473892685	0.92668	0.974698	0.99573	D	0.899982601079214	0.91714	11.04923	0.832866080674497	0.91933	11.169	5.74	4.83	0.61832	4.47	0.83830	10.003	0.9969	11.671000	0.94110	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.955	0.50625	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156136010G>T	ClinGen:CA016488|UniProtKB:P02545#VAR_039776	C0270914|CN230736|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	77660	single nucleotide variant	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	4000	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1	Sep 27, 2024	58789393	-	RCV000057219|RCV001854172|RCV003343625	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136010	156136010	1q22	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016488,UniProtKB:P02545#VAR_039776	2	66763	156136010	G	T	-	-	-	-	-	-	SCV001715571|SCV002262706|SCV004074698	-	-	1046G>T 	Arg349Leu	NM_170707.4	1	3_Conflicting																																																																																																									
LMNA	LMNA_Arg349Leu	1.0956468444891008	0.3094917419063528	4.167510144450547	0.00420217915215487	2025_01_Batch_13-14	0.5475822828122247	0.8102874186572842	0.9257224225340441	0.773820649870661	0.6142904451750753	0.5851680566044616	0.7547977913410235	0.8856390686863543	0.8115870574462624	0.583577916705548	0.5663751697083431	0.7825426049991538	0.9056807456101992	0.7927038536584616	0.5989341809403117	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA		3903		CCSBVarC003621		NC_000001.11:156136010:G:T		Arg349Leu																												LMNA_Arg349Leu	1	156136010	G	T	1	allele	1046G>T	D12	527_CAVA_Array_P03	H23	B13A7A8P1_R1	B14A7A8P1_R2				1-156136010-G-T	66763	1	156136010	G	T	R	L	rs58789393	1	156105801	1	154372425	349	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1046G>T	p.Arg349Leu	c.1046G>T	p.Arg349Leu	principal1	Y	5	.	.	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.003	0.79703	D	0.775	0.90580	P	0.896	0.86259	P	0.97	0.97016	D	simple_aae	3.0	97.0	3.8	0.95330	H	-6.56	0.91889	D	0.965	0.98762	0.9518	0.96410	D	0.8633	0.95442	D	10	0.97176325	0.96764	D	0.755624	0.98052	D	0.871	0.96123	0.801	0.91975	P02545	R349L	Loss of MoRF binding (P = 0.0632)| Loss of methylation at R349 (P = 0.2199)| Gain of stability (P = 0.2765)| Loss of catalytic residue at M345 (P = 0.6375)| Loss of solvent accessibility (P = 0.6392)	0.966327329089	0.96566	.	0.98457	.	0.96624	0.813560366631	0.84010	D	0.967344	0.99617	D	0.495723	0.94117	D	0.474295	0.94039	D	0.992853701114655	0.83317	D	.	0.96357	.	0.7229245	0.79081	0.65043724	0.79322	0.6761609	0.76503	0.61561835	0.77388	-8.52	0.71001	D	0.9091	0.83342	LP	0.999839382529083	0.98239	0.99996722	0.99978	0.981	0.99334	.	.	.	.	.	.	5.301637	0.89027	29.8	0.99846690473892685	0.92668	0.974698	0.99573	D	0.899982601079214	0.91714	11.04923	0.832866080674497	0.91933	11.169	5.74	4.83	0.61832	4.47	0.83830	10.003	0.9969	11.671000	0.94110	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.955	0.50625	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156136010G>T	ClinGen:CA016488|UniProtKB:P02545#VAR_039776	C0270914|CN230736|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	77660	single nucleotide variant	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	4000	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1	Sep 27, 2024	58789393	-	RCV000057219|RCV001854172|RCV003343625	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136010	156136010	1q22	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016488,UniProtKB:P02545#VAR_039776	2	66763	156136010	G	T	-	-	-	-	-	-	SCV001715571|SCV002262706|SCV004074698	-	-	1046G>T 	Arg349Leu	NM_170707.4	1	3_Conflicting																																																																																																									
F9	F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580312	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.8276646758994048	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	627146	X	139561530	A	G	H	R	rs753654616	X	138643689	X	138471355	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.92464920108666138	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999000	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	615669	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	1	Feb 14, 2024	753654616	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530	139561530	Xq27.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA336143030	2	627146	139561530	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1	3_Conflicting						140280	F9_Popp_2025_carboxy_F9_specific_var226602	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561530.0	139561530.0		845			282.0	H	R	c.845A>G	p.His282Arg	missense_variant	0.8899825362811451			No	0.0000273958501098	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 14, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.707																																																											F9_His282Arg	His282Arg	true
F9	F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580312	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.8276646758994048	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	627146	X	139561530	A	G	H	R	rs753654616	X	138643689	X	138471355	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.92464920108666138	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999000	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	615669	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	1	Feb 14, 2024	753654616	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530	139561530	Xq27.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA336143030	2	627146	139561530	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1	3_Conflicting						250344	F9_Popp_2025_strep_2_var265326	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561530.0	139561530.0		845			282.0	H	R	c.845A>G	p.His282Arg	missense_variant	0.8928388237393353			No	0.0000273958501098	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 14, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.707																																																											F9_His282Arg	His282Arg	true
F9	F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580312	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.8276646758994048	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	627146	X	139561530	A	G	H	R	rs753654616	X	138643689	X	138471355	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.92464920108666138	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999000	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	615669	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	1	Feb 14, 2024	753654616	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530	139561530	Xq27.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA336143030	2	627146	139561530	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1	3_Conflicting						222828	F9_Popp_2025_light_chain_var245964	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561530.0	139561530.0		845			282.0	H	R	c.845A>G	p.His282Arg	missense_variant	0.9118857121513826			No	0.0000273958501098	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 14, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.707																																																											F9_His282Arg	His282Arg	true
F9	F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580312	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.8276646758994048	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	627146	X	139561530	A	G	H	R	rs753654616	X	138643689	X	138471355	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.92464920108666138	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999000	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	615669	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	1	Feb 14, 2024	753654616	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530	139561530	Xq27.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA336143030	2	627146	139561530	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1	3_Conflicting						195312	F9_Popp_2025_heavy_chain_var236283	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561530.0	139561530.0		845			282.0	H	R	c.845A>G	p.His282Arg	missense_variant	0.9055978920969366			No	0.0000273958501098	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 14, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.707																																																											F9_His282Arg	His282Arg	true
F9	F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580312	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.8276646758994048	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	627146	X	139561530	A	G	H	R	rs753654616	X	138643689	X	138471355	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.92464920108666138	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999000	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	615669	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	1	Feb 14, 2024	753654616	-	RCV000851898|RCV004588168	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530	139561530	Xq27.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA336143030	2	627146	139561530	A	G	-	-	-	-	-	-	SCV000899963|SCV005079373|SCV005413446	-	-	845A>G 	His282Arg	NM_000133.4	1	3_Conflicting						167796	F9_Popp_2025_carboxy_gla_motif_var255645	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561530.0	139561530.0		845			282.0	H	R	c.845A>G	p.His282Arg	missense_variant	0.9024192508494696			No	0.0000273958501098	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 14, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.707																																																											F9_His282Arg	His282Arg	true
LMNA	LMNA_Ala43Thr	2.826701345748407	0.02552666596388305	-4.1903998369062005	0.004084025769311878	2025_01_Batch_13-14	0.9215057423653834	0.9396516603326881	0.8710391824484176	0.7509784047159569	0.9010626710007219	0.951718694174347	0.9133695378053251	0.8985854888870367	0.9623449079213537	0.8637866395999324	0.9366122182698652	0.9265105990690066	0.8848123356677271	0.8566616563186553	0.8824246553003272	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	LMNA	ENSG00000160789	3903	201283	CCSBVarC003606	ALE00003606	NC_000001.11:156115045:G:A	127G>A	Ala43Thr	CEGS2	CegsMutGDEh1035	C03	GDEhDisVCh_40057	F08	1	CegsMutGDDh1035	C03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			LMNA_Ala43Thr	1	156115045	G	A	1											1-156115045-G-A	66799	1	156115045	G	A	A	T	rs60446065	1	156084836	1	154351460	43	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.127G>A	p.Ala43Thr	principal1	Y	.	.	.	+	GCG	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.60671	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	4.8	0.99640	H	.	0.67623	.	.	0.97975	1.0724	0.98653	D	0.9299	0.97681	D	10	.	0.99375	.	0.712602	0.97660	D	.	0.99545	0.924	0.98699	P02545	A43T	Gain of phosphorylation at A43 (P = 0.0767)| Gain of disorder (P = 0.0918)| Gain of MoRF binding (P = 0.1749)| Loss of stability (P = 0.302)| Gain of solvent accessibility (P = 0.3819)	.	0.98919	.	0.99215	.	0.94644	0.757743537426	0.75550	T	0.975701	0.99763	D	0.565194	0.96303	D	0.574085	0.96243	D	0.999742329120636	0.98769	D	.	0.97858	.	0.85589856	0.87609	0.7691078	0.86196	0.819483	0.84994	0.751655	0.85142	-10.307	0.75805	D	.	0.95185	.	0.999479217996385	0.96705	0.99996510	0.99965	0.984	0.99450	.	.	.	.	.	.	5.634268	0.92707	32.0	0.99901205079885413	0.97276	0.964074	0.98608	D	0.98056132522041	0.95089	13.32298	0.888889835448083	0.95043	13.28456	4.77	4.77	0.60376	.	.	9.953	0.98981	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.999	0.91597	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1597190	6.261000e-07	0	1	1171998	8.532440e-07	0	0	74668	0.000000e+00	0	0	912	0.000000e+00	0	0	57712	0.000000e+00	0	0	29200	0.000000e+00	0	0	43966	0.000000e+00	0	0	62534	0.000000e+00	0	0	6040	0.000000e+00	0	1	1171998	8.532440e-07	0	0	88354	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156115045G>A	ClinGen:CA016942|UniProtKB:P02545#VAR_039753	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Thr	77696	single nucleotide variant	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	4000	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1	Feb 26, 2024	60446065	-	RCV000057262|RCV001225020	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	not provided|Charcot-Marie-Tooth disease type 2	germline	germline	GRCh38	NC_000001.11	1	156115045	156115045	1q22	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	2	66799	156115045	G	A	-	-	-	-	-	-	SCV000293392|SCV000339872|SCV001397255	-	-	127G>A 	Ala43Thr	NM_170707.4	1	3_Conflicting	1	156115045	G	A	6.92112e-7																																																																																																				
LMNA	LMNA_Ala43Thr	2.826701345748407	0.02552666596388305	-4.1903998369062005	0.004084025769311878	2025_01_Batch_13-14	0.9215057423653834	0.9396516603326881	0.8710391824484176	0.7509784047159569	0.9010626710007219	0.951718694174347	0.9133695378053251	0.8985854888870367	0.9623449079213537	0.8637866395999324	0.9366122182698652	0.9265105990690066	0.8848123356677271	0.8566616563186553	0.8824246553003272	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	LMNA		3903		CCSBVarC003606		NC_000001.11:156115045:G:A		Ala43Thr																												LMNA_Ala43Thr	1	156115045	G	A	1	allele	127G>A	G09	527_CAVA_Array_P03	N17	B13A7A8P1_R1	B14A7A8P1_R2				1-156115045-G-A	66799	1	156115045	G	A	A	T	rs60446065	1	156084836	1	154351460	43	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.127G>A	p.Ala43Thr	principal1	Y	.	.	.	+	GCG	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.60671	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	4.8	0.99640	H	.	0.67623	.	.	0.97975	1.0724	0.98653	D	0.9299	0.97681	D	10	.	0.99375	.	0.712602	0.97660	D	.	0.99545	0.924	0.98699	P02545	A43T	Gain of phosphorylation at A43 (P = 0.0767)| Gain of disorder (P = 0.0918)| Gain of MoRF binding (P = 0.1749)| Loss of stability (P = 0.302)| Gain of solvent accessibility (P = 0.3819)	.	0.98919	.	0.99215	.	0.94644	0.757743537426	0.75550	T	0.975701	0.99763	D	0.565194	0.96303	D	0.574085	0.96243	D	0.999742329120636	0.98769	D	.	0.97858	.	0.85589856	0.87609	0.7691078	0.86196	0.819483	0.84994	0.751655	0.85142	-10.307	0.75805	D	.	0.95185	.	0.999479217996385	0.96705	0.99996510	0.99965	0.984	0.99450	.	.	.	.	.	.	5.634268	0.92707	32.0	0.99901205079885413	0.97276	0.964074	0.98608	D	0.98056132522041	0.95089	13.32298	0.888889835448083	0.95043	13.28456	4.77	4.77	0.60376	.	.	9.953	0.98981	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.999	0.91597	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1597190	6.261000e-07	0	1	1171998	8.532440e-07	0	0	74668	0.000000e+00	0	0	912	0.000000e+00	0	0	57712	0.000000e+00	0	0	29200	0.000000e+00	0	0	43966	0.000000e+00	0	0	62534	0.000000e+00	0	0	6040	0.000000e+00	0	1	1171998	8.532440e-07	0	0	88354	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156115045G>A	ClinGen:CA016942|UniProtKB:P02545#VAR_039753	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Thr	77696	single nucleotide variant	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	4000	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1	Feb 26, 2024	60446065	-	RCV000057262|RCV001225020	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	not provided|Charcot-Marie-Tooth disease type 2	germline	germline	GRCh38	NC_000001.11	1	156115045	156115045	1q22	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	2	66799	156115045	G	A	-	-	-	-	-	-	SCV000293392|SCV000339872|SCV001397255	-	-	127G>A 	Ala43Thr	NM_170707.4	1	3_Conflicting	1	156115045	G	A	6.92112e-7																																																																																																				
KRAS	KRAS_Asp153Val	-0.3822084358919264	0.7136459741761332	1.9062732019056778	0.09829495263619474																											true	KRAS	ENSG00000133703	3084	214494	CCSBVarC006101	ALE00006101	NC_000012.12:25209904:T:A	458A>T	Asp153Val	CEGS2	CegsMutGDEh1042	B12	GDEhDisVCh_40061	E10	1	CegsMutGDDh1042	B12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Asp153Val	12	25209904	T	A	12											12-25209904-T-A	12587	12	25209904	T	A	D	V	rs104894360	12	25362838	12	25254105	128	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.383A>T	p.Asp128Val	.	Y	.	.	.	-	GAT	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	.	0.50195	.	.	0.47676	.	.	0.94378	.	.	.	.	.	.	.	.	0.82015	.	.	0.93732	0.2042	0.85920	D	0.4729	0.79666	T	7	.	0.91672	.	0.435687	0.94056	D	.	0.93084	.	0.87760	.	.	.	.	0.92600	.	.	.	.	.	.	.	.	.	.	0.432327	0.91589	D	0.383231	0.91485	D	0.955039322376251	0.64186	D	.	0.90939	.	.	.	.	.	.	.	.	.	.	0.77191	.	.	0.91639	.	.	.	0.96898425	0.94579	0.991	0.99694	.	.	.	.	.	.	4.964316	0.82142	27.7	0.99233185239291311	0.56347	0.867497	0.78650	D	0.565827697853449	0.70896	5.592508	0.631385021559758	0.77104	6.639681	5.87	5.87	0.94257	.	.	7.628	0.82424	7.901000	0.73593	0.583	0.30331	1.0	0.71675	1.000000	0.68239	0.997	0.79771	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Acute_myeloid_leukemia|Autoimmune_lymphoproliferative_syndrome_type_4|Malignant_tumor_of_urinary_bladder|Lung_carcinoma|Cardiofaciocutaneous_syndrome_2|Carcinoma_of_pancreas|Hereditary_diffuse_gastric_adenocarcinoma|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation|Noonan_syndrome_3|Familial_cancer_of_breast|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|not_provided|Cardiovascular_phenotype|RASopathy|Noonan_syndrome_1|not_specified	reviewed_by_expert_panel	NC_000012.12:g.25209904T>A	ClinGen:CA256478|OMIM:190070.0010|OMIM:190070.0015	C0023467|C2674723|C0005684|C0684249|C3809005|C0235974|C1708349|C4552097|C0917804|C1860991|C0346153|C1275081|C0028326|C3661900|CN230736|C5555857|C4551602|CN169374	601626|614470|109800|615278|137215|163200|108010|609942|114480|PS115150|PS163950|163950	519|268114|157980|1340|1333|217074|26106|2612|46724|648|227535|1340|648|536391|648	.	Asp	Val	27626	single nucleotide variant	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3845	KRAS	HGNC:6407	Pathogenic	1	Nov 15, 2018	104894360	-	RCV000013418|RCV000013417|RCV000157940|RCV000212501|RCV000507330|RCV000763307|RCV000523200|RCV000844634|RCV003450634|RCV004018621	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN169374|11 conditions|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|not specified|11 conditions|Noonan syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25209904	25209904	12p12.1	reviewed by expert panel	16	-	N	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	3	12587	25209904	T	A	-	-	-	-	-	-	SCV000616371	-	-	458A>T 	Asp153Val	NM_004985.5	3	1_Pathogenic																																																																																																									
KRAS	KRAS_Asp153Val	-0.3822084358919264	0.7136459741761332	1.9062732019056778	0.09829495263619474																											true	KRAS		3084		CCSBVarC006101		NC_000012.12:25209904:T:A		Asp153Val																												KRAS_Asp153Val	12	25209904	T	A	12	allele	458A>T	H08	527_CAVA_Array_P03	P15	B13A7A8P1_R1	B14A7A8P1_R2				12-25209904-T-A	12587	12	25209904	T	A	D	V	rs104894360	12	25362838	12	25254105	128	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.383A>T	p.Asp128Val	.	Y	.	.	.	-	GAT	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	.	0.50195	.	.	0.47676	.	.	0.94378	.	.	.	.	.	.	.	.	0.82015	.	.	0.93732	0.2042	0.85920	D	0.4729	0.79666	T	7	.	0.91672	.	0.435687	0.94056	D	.	0.93084	.	0.87760	.	.	.	.	0.92600	.	.	.	.	.	.	.	.	.	.	0.432327	0.91589	D	0.383231	0.91485	D	0.955039322376251	0.64186	D	.	0.90939	.	.	.	.	.	.	.	.	.	.	0.77191	.	.	0.91639	.	.	.	0.96898425	0.94579	0.991	0.99694	.	.	.	.	.	.	4.964316	0.82142	27.7	0.99233185239291311	0.56347	0.867497	0.78650	D	0.565827697853449	0.70896	5.592508	0.631385021559758	0.77104	6.639681	5.87	5.87	0.94257	.	.	7.628	0.82424	7.901000	0.73593	0.583	0.30331	1.0	0.71675	1.000000	0.68239	0.997	0.79771	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Acute_myeloid_leukemia|Autoimmune_lymphoproliferative_syndrome_type_4|Malignant_tumor_of_urinary_bladder|Lung_carcinoma|Cardiofaciocutaneous_syndrome_2|Carcinoma_of_pancreas|Hereditary_diffuse_gastric_adenocarcinoma|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation|Noonan_syndrome_3|Familial_cancer_of_breast|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|not_provided|Cardiovascular_phenotype|RASopathy|Noonan_syndrome_1|not_specified	reviewed_by_expert_panel	NC_000012.12:g.25209904T>A	ClinGen:CA256478|OMIM:190070.0010|OMIM:190070.0015	C0023467|C2674723|C0005684|C0684249|C3809005|C0235974|C1708349|C4552097|C0917804|C1860991|C0346153|C1275081|C0028326|C3661900|CN230736|C5555857|C4551602|CN169374	601626|614470|109800|615278|137215|163200|108010|609942|114480|PS115150|PS163950|163950	519|268114|157980|1340|1333|217074|26106|2612|46724|648|227535|1340|648|536391|648	.	Asp	Val	27626	single nucleotide variant	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3845	KRAS	HGNC:6407	Pathogenic	1	Nov 15, 2018	104894360	-	RCV000013418|RCV000013417|RCV000157940|RCV000212501|RCV000507330|RCV000763307|RCV000523200|RCV000844634|RCV003450634|RCV004018621	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN169374|11 conditions|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|not specified|11 conditions|Noonan syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25209904	25209904	12p12.1	reviewed by expert panel	16	-	N	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	3	12587	25209904	T	A	-	-	-	-	-	-	SCV000616371	-	-	458A>T 	Asp153Val	NM_004985.5	3	1_Pathogenic																																																																																																									
RAD51D	RAD51D_Ile251Val	0.7776406398453396	0.4622488886013073	4.73346535387811	0.0021239643067238714	2025_01_Batch_13-14	0.9995217075101795	0.9534029604719589	0.931935185443018	0.942729026977195	0.9995249189219388	0.8034463122456237	0.9634776583088173	0.9860059425467218	0.9610438469712425	0.6815422778313502	0.9014840098779016	0.9584403093903882	0.9589705639948699	0.9518864369742187	0.8405335983766445	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024857		NC_000017.11:35101353:T:C		Ile251Val																												RAD51D_Ile251Val	17	35101353	T	C	17	allele	751A>G	B02	527_CAVA_Array_P05	C03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101353-T-C	141300	17	35101353	T	C	I	V	rs540273429	17	33428372	17	30452485	251	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.751A>G	p.Ile251Val	c.751A>G	p.Ile251Val	principal1	Y	1	YES	Select	-	ATA	1	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.03926	T	0.0	0.02950	B	0.001	0.04348	B	0.06	0.18971	N	simple_aae	94.0	6.0	-1.04	0.01100	N	0.1	0.05782	N	0.105	0.14965	-0.9577	0.39436	T	0.0599	0.24885	T	10	0.036506176	0.01956	T	0.010139	0.26052	T	0.070	0.20265	0.474	0.54885	O75771	I251V	Gain of phosphorylation at T248 (P = 0.0936)| Gain of disorder (P = 0.0983)| Gain of MoRF binding (P = 0.1184)| Gain of methylation at R255 (P = 0.2396)| Loss of stability (P = 0.2941)	0.388174495139	0.38033	.	0.16030	.	0.31871	.	.	.	0.075571	0.34949	T	-0.130246	0.31098	T	-0.424866	0.30159	T	0.0309130971524996	0.02119	T	.	0.39652	.	0.015923232	0.00166	0.02370252	0.00388	0.015923232	0.00166	0.02370252	0.00387	-0.859	0.00857	T	0.0667	0.04993	LB	1.1537049706086e-05	0.00991	0.23355223	0.74518	0.014	0.01428	.	.	.	.	.	.	-0.048466	0.03972	0.888	0.81310861979149396	0.13840	0.042627	0.06525	N	-1.20699475414867	0.04841	0.2220042	-1.14727300713446	0.06706	0.3294306	4.86	-3.91	0.03894	-5.59	0.03621	0.337	0.19651	-2.070000	0.04280	0.665	0.62996	0.881	0.31099	0.000000	0.08389	0.946	0.49004	911	0.21960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109058	0.000000e+00	0	1	207758	4.813290e-06	0	1	236598	4.226580e-06	0	0	7158	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13062	0.000000e+00	0	0	42762	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16206	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16402	0.000000e+00	0	1	89534	1.116890e-05	0	0	30606	0.000000e+00	0	1	89534	1.116890e-05	0	0	14896	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21300	0.000000e+00	0	1	102740	9.733310e-06	0	0	30524	0.000000e+00	0	1	102740	9.733310e-06	0	.	7	1613900	4.337320e-06	0	1	6060	1.650170e-04	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	63756	0.000000e+00	0	1	6060	1.650170e-04	0	4	1180012	3.389800e-06	0	1	91084	1.097890e-05	0	0	6062	0	0	8	0	0	26	0	0	586	0	0	0	0	0	0	0	0	30	0	0	0	0	1	2276	4.393673110720562E-4	0	594	0	0	56	0	1	8988	1.1125945705384957E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101353T>C	ClinGen:CA165041	C0027672|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Ile	Val	151014	single nucleotide variant	NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Jun 23, 2024	540273429	-	RCV000236753|RCV000542443|RCV000129767	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35101353	35101353	17q12	criteria provided, conflicting classifications	4	-	N	ClinGen:CA165041	2	141300	35101353	T	C	-	-	-	-	-	-	SCV000184576|SCV000293833|SCV000651777|SCV000904087	-	-	751A>G 	Ile251Val	NM_002878.4	1	3_Conflicting						959712	RAD51D_unpublished_var153959	RAD51D_unpublished	RAD51D	9823.0	-1.0		35101353.0	35101353.0		751	A	G	251.0	I	V	c.751A>G	p.Ile251Val	missense_variant	-0.00741379		functionally_normal	Yes	4.3373195365e-6	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 27, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.07																																																											RAD51D_Ile251Val	Ile251Val	true
F9	F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937182	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.5854274236054818	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	225354	X	139560786	G	A	V	I	rs200608775	X	138642945	X	138470611	257	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.8550	0.51428	T	0.2284	0.59203	T	10	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.61038201019498284	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.000000	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	Conflicting_classifications_of_pathogenicity	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	227419	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	0	Aug 18, 2024	200608775	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786	139560786	Xq27.1	criteria provided, conflicting classifications	5	-	N	ClinGen:CA10529834	2	225354	139560786	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1	3_Conflicting						166232	F9_Popp_2025_carboxy_gla_motif_var255107	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139560786.0	139560786.0		769			257.0	V	I	c.769G>A	p.Val257Ile	missense_variant	0.6115191676603379			No	0.0001910529332414	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 12, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.483																																																											F9_Val257Ile	Val257Ile	true
F9	F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937182	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.5854274236054818	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	225354	X	139560786	G	A	V	I	rs200608775	X	138642945	X	138470611	257	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.8550	0.51428	T	0.2284	0.59203	T	10	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.61038201019498284	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.000000	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	Conflicting_classifications_of_pathogenicity	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	227419	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	0	Aug 18, 2024	200608775	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786	139560786	Xq27.1	criteria provided, conflicting classifications	5	-	N	ClinGen:CA10529834	2	225354	139560786	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1	3_Conflicting						248780	F9_Popp_2025_strep_2_var264788	F9_Popp_2025_strep_2	F9	3551.0	1.0		139560786.0	139560786.0		769			257.0	V	I	c.769G>A	p.Val257Ile	missense_variant	0.8844402554633948			No	0.0001910529332414	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 12, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.483																																																											F9_Val257Ile	Val257Ile	true
F9	F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937182	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.5854274236054818	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	225354	X	139560786	G	A	V	I	rs200608775	X	138642945	X	138470611	257	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.8550	0.51428	T	0.2284	0.59203	T	10	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.61038201019498284	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.000000	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	Conflicting_classifications_of_pathogenicity	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	227419	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	0	Aug 18, 2024	200608775	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786	139560786	Xq27.1	criteria provided, conflicting classifications	5	-	N	ClinGen:CA10529834	2	225354	139560786	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1	3_Conflicting						193748	F9_Popp_2025_heavy_chain_var235745	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139560786.0	139560786.0		769			257.0	V	I	c.769G>A	p.Val257Ile	missense_variant	0.6698528286308812			No	0.0001910529332414	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 12, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.483																																																											F9_Val257Ile	Val257Ile	true
F9	F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937182	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.5854274236054818	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	225354	X	139560786	G	A	V	I	rs200608775	X	138642945	X	138470611	257	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.8550	0.51428	T	0.2284	0.59203	T	10	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.61038201019498284	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.000000	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	Conflicting_classifications_of_pathogenicity	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	227419	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	0	Aug 18, 2024	200608775	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786	139560786	Xq27.1	criteria provided, conflicting classifications	5	-	N	ClinGen:CA10529834	2	225354	139560786	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1	3_Conflicting						138716	F9_Popp_2025_carboxy_F9_specific_var226064	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139560786.0	139560786.0		769			257.0	V	I	c.769G>A	p.Val257Ile	missense_variant	0.5834863087702088			No	0.0001910529332414	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 12, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.483																																																											F9_Val257Ile	Val257Ile	true
F9	F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937182	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.5854274236054818	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	225354	X	139560786	G	A	V	I	rs200608775	X	138642945	X	138470611	257	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.8550	0.51428	T	0.2284	0.59203	T	10	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.61038201019498284	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.000000	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	Conflicting_classifications_of_pathogenicity	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	227419	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158	F9	HGNC:3551	Conflicting classifications of pathogenicity	0	Aug 18, 2024	200608775	-	RCV000862519|RCV000490374|RCV003917862	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786	139560786	Xq27.1	criteria provided, conflicting classifications	5	-	N	ClinGen:CA10529834	2	225354	139560786	G	A	-	-	-	-	-	-	SCV000267310|SCV000481885|SCV001003033	-	-	769G>A 	Val257Ile	NM_000133.4	1	3_Conflicting						221264	F9_Popp_2025_light_chain_var245426	F9_Popp_2025_light_chain	F9	3551.0	1.0		139560786.0	139560786.0		769			257.0	V	I	c.769G>A	p.Val257Ile	missense_variant	0.5500069180121129			No	0.0001910529332414	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 12, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.483																																																											F9_Val257Ile	Val257Ile	true
BRCA1	BRCA1_Cys64Ser	-0.5198160846601582	0.619220375890755	-3.278051964362376	0.013523323462305666	2025_01_Batch_13-14	0.509193303597748	0.665192591066776	0.7746920340779846	0.7189477005715086	0.4156154156519475	0.7305620324311284	0.5904017028232041	0.7157838760695898	0.7219623155263104	0.700675173216614	0.6198776680144382	0.6277971469449901	0.7452379550737872	0.7204550080489095	0.5581452944342807	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011841		NC_000017.11:43106477:C:G		Cys64Ser																												BRCA1_Cys64Ser	17	43106477	C	G	17	allele	191G>C	A09	527_CAVA_Array_P01	A17	B13A7A8P1_R1	B14A7A8P1_R2				17-43106477-C-G	462571	17	43106477	C	G	C	S	rs55851803	17	41258494	17	38512020	64	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.191G>C	p.Cys64Ser	c.191G>C	p.Cys64Ser	principal2	Y	1	YES	Select	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.99	0.68795	D	0.903	0.78943	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.99	0.96635	H	-1.45	0.98450	N	0.982	0.99346	0.9381	0.96208	D	0.9931	0.99838	D	10	0.9888865	0.99322	D	0.959083	0.99729	D	0.922	0.98039	0.968	0.99690	E9PFC7	C64S	Gain of disorder (P = 0.0079)| Loss of stability (P = 0.0171)| Gain of phosphorylation at C64 (P = 0.0837)| Gain of glycosylation at P62 (P = 0.1363)| Loss of methylation at K65 (P = 0.1443)	0.999450167335	0.99943	.	0.86148	.	0.40765	0.717033147812	0.69562	T	0.46945	0.92995	T	0.553376	0.95819	D	0.55711	0.95755	D	0.997346639633179	0.91262	D	.	0.80441	.	0.9870781	0.99591	0.88999635	0.94188	0.97642994	0.98806	0.88973695	0.94170	-12.832	0.92342	D	0.9961	0.97310	P	0.999399190328388	0.96461	0.99976617	0.99701	0.964	0.98523	.	.	.	.	.	.	5.090651	0.85032	28.5	0.99110843159672235	0.52805	0.851286	0.76729	D	0.91310061370465	0.92344	11.39386	0.783598264701654	0.88566	9.654935	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.997	0.79771	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.43106477C>G	ClinGen:CA10601786	C2676676|C0677776	604370	145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Ser	468251	single nucleotide variant	NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	672	BRCA1	HGNC:1100	Pathogenic	1	Nov 09, 2022	55851803	-	RCV000559047|RCV001076723	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43106477	43106477	17q21.31	criteria provided, single submitter	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10601786	2	462571	43106477	C	G	-	-	-	-	-	-	SCV000635819	-	-	191G>C 	Cys64Ser	NM_007294.4	1	1_Pathogenic																																																																																																									
CTCF	CTCF_Arg342Cys	4.0251147636350355	0.005026859283026853	3.3465906362055593	0.012308068398097118	2025_01_Batch_13-14	0.7323616410391203	0.7980792108414768	0.7414395687576792	0.6956161388840096	0.7051673427152019	0.6435565938548741	0.6789145506292014	0.686227967227117	0.709388113297629	0.5442509671616682	0.6879591174469972	0.7384968807353391	0.7138337679923981	0.7025021260908193	0.624709154938435	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010851		NC_000016.10:67616816:C:T		Arg342Cys																												CTCF_Arg342Cys	16	67616816	C	T	16	allele	1024C>T	G01	527_CAVA_Array_P02	M02	B13A7A8P1_R1	B14A7A8P1_R2				16-67616816-C-T	429261	16	67616816	C	T	R	C	rs1131691283	16	67650719	16	66208220	342	CTCF	ENSG00000102974	ENST00000642819	ENSP00000494408	P49711	CTCF_HUMAN	c.1024C>T	p.Arg342Cys	c.1024C>T	p.Arg342Cys	principal4	Y	.	.	.	+	CGT	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.996	0.84488	D	.	0.91795	.	.	.	.	2.925	0.84244	M	.	0.94690	.	.	0.66102	-0.5414	0.66965	T	0.2195	0.58068	T	10	0.90816814	0.90073	D	0.072612	0.71478	D	.	0.81796	0.799	0.91830	P49711	R342C	Loss of MoRF binding (P = 0.0286)| Loss of disorder (P = 0.0417)| Gain of methylation at K344 (P = 0.0462)| Loss of loop (P = 0.0804)| Loss of solvent accessibility (P = 0.1077)	.	0.78989	.	0.92611	.	0.99749	0.963747024536	0.99943	D	0.874794	0.97303	D	0.243152	0.77795	D	0.111494	0.77506	D	0.998596012592316	0.94546	D	.	0.91755	.	0.8758145	0.89177	0.75798017	0.85523	0.79036707	0.83088	0.75543875	0.85370	-13.341	0.91976	D	0.9958	0.95928	LP	0.999472519562105	0.96705	0.95648080	0.93745	0.846	0.91546	.	.	.	.	.	.	5.456603	0.91125	32.0	0.99912080062961595	0.98096	0.927208	0.90917	D	0.872885598481848	0.90318	10.37319	0.805277495105465	0.90104	10.28159	4.89	4.89	0.63341	.	.	7.701	0.83585	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614136	6.195260e-07	0	1	1180010	8.474500e-07	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180010	8.474500e-07	0	0	91086	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder	criteria_provided,_conflicting_classifications	NC_000016.10:g.67616816C>T	ClinGen:CA396312251	C3661900|C3809686	615502	363611	.	Arg	Cys	422102	single nucleotide variant	NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys)	10664	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1	Aug 31, 2022	1131691283	-	RCV000494182|RCV001253429|RCV004535549	MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|	not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder	de novo;germline	germline	GRCh38	NC_000016.10	16	67616816	67616816	16q22.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA396312251	2	429261	67616816	C	T	-	-	-	-	-	-	SCV000581783|SCV001429134|SCV001449853|SCV004117060	-	-	1024C>T 	Arg342Cys	NM_006565.4	2	1_Pathogenic						964318	CTCF_unpublished_var158565	CTCF_unpublished	CTCF	13723.0	1.0		67616816.0	67616816.0		1024	C	T	342.0	R	C	c.1024C>T	p.Arg342Cys	missense_variant	0.0968285		functionally_normal	Yes	6.195264835181174e-7	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Aug 31, 2022	nucleotide		ENST00000264010.10	NM_006565.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.559																																																											CTCF_Arg342Cys	Arg342Cys	true
RAD51D	RAD51D_Thr328Ile	0.5151692477436156	0.6222994408448728	18.307890143801554	3.592313339156725e-7	2025_01_Batch_13-14	0.7437025918455917	0.9031293954033862	0.9760822387039301	0.8935058931837492	0.7639484780788016	0.929689903410934	0.9488310980965327	0.9693401858737757	0.9579251898475452	0.9120513828608797	0.8366962476282629	0.9259802467499594	0.9727112122888528	0.9257155415156472	0.8379999304698407	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024896		NC_000017.11:35100957:G:A		Thr328Ile																												RAD51D_Thr328Ile	17	35100957	G	A	17	allele	983C>T	H02	527_CAVA_Array_P05	O03	B13A7A8P2_R1	B14A7A8P2_R2				17-35100957-G-A	141343	17	35100957	G	A	T	I	rs138969595	17	33427976	17	30452089	328	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.983C>T	p.Thr328Ile	c.983C>T	p.Thr328Ile	principal1	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.0	0.02950	B	0.001	0.04348	B	0.0	0.01751	N	simple_aae	100.0	0.0	0.145	0.08752	N	-1.32	0.32965	N	0.053	0.21823	-1.0435	0.16258	T	0.0417	0.17815	T	10	0.009995133	0.00221	T	0.006771	0.17625	T	0.026	0.05575	.	.	.	.	.	0.207176502487	0.19935	.	0.26638	.	0.45724	.	.	.	0.115639	0.43135	T	-0.601611	0.00139	T	-0.677482	0.06933	T	0.075320455379959	0.09265	T	.	0.22097	.	0.08105616	0.18434	0.09681502	0.22979	0.08105616	0.18434	0.09681502	0.22979	-4.387	0.29411	T	0.1002	0.28639	LB	4.77421596645541e-05	0.01873	0.28552076	0.76376	0.032	0.06833	.	.	.	.	.	.	1.075211	0.14598	11.14	0.59940449977036514	0.06433	0.051862	0.09058	N	-1.19812197881439	0.04971	0.2282938	-1.22724989160509	0.05389	0.2610204	5.12	-1.75	0.07582	-1.09	0.15326	-0.5	0.065	-0.087000	0.12155	-0.119	0.14328	0.0	0.06393	0.000000	0.08389	0.07	0.16685	914	0.21043	4	7.987220447284345E-4	4	0.0030257186081694403	0	0.0	0	0.0	0	0.0	0	0.0	76	264690	2.8712835E-4	.	6	109408	5.484060e-05	0	19	208136	9.128650e-05	0	17	236950	7.174510e-05	0	6	7164	8.375210e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	6	7164	8.375210e-04	0	17	16218	1.048220e-03	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89558	0.000000e+00	0	1	30608	3.267120e-05	0	17	16218	1.048220e-03	0	14	14902	9.394710e-04	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102746	0.000000e+00	0	1	30526	3.275900e-05	0	14	14902	9.394710e-04	0	.	96	1611324	5.957830e-05	1	80	74978	1.066980e-03	1	80	74978	1.066980e-03	1	0	912	0.000000e+00	0	4	60018	6.664670e-05	0	0	29586	0.000000e+00	0	0	44862	0.000000e+00	0	0	64034	0.000000e+00	0	2	6032	3.315650e-04	0	0	1177472	0.000000e+00	0	2	91016	2.197420e-05	0	1	163022	6.13414140422765E-6	0	360	0	0	2712	0	9	9362	9.613330484939116E-4	0	442	0	0	950	0	0	682	0	0	280	0	0	11320	0	9	9722	9.257354453816088E-4	0	3394	0	10	189130	5.287368476709142E-5	Conflicting_classifications_of_pathogenicity	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|RAD51D-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35100957G>A	ClinGen:CA294126	C3280345|C0027672|CN169374|C3661900	614291	145|140162	.	Thr	Ile	151057	single nucleotide variant	NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Feb 03, 2025	138969595	-	RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35100957	35100957	17q12	criteria provided, conflicting classifications	11	-	N	ClinGen:CA294126	2	141343	35100957	G	A	-	-	-	-	-	-	SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733	-	-	983C>T 	Thr328Ile	NM_002878.4	1	3_Conflicting						958901	RAD51D_unpublished_var153148	RAD51D_unpublished	RAD51D	9823.0	-1.0		35100957.0	35100957.0		983	C	T	328.0	T	I	c.983C>T	p.Thr328Ile	missense_variant	-0.0127746		functionally_normal	Yes	0.0000595783343387	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 01, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.026																																																											RAD51D_Thr328Ile	Thr328Ile	true
BRCA1	BRCA1_Cys64Tyr	-0.2411116846042154	0.8163785956912686	-2.2694527201623846	0.057523894319769224	2025_01_Batch_13-14	0.8767777326467614	0.9730828220329724	0.8770861220785622	0.7593569849355692	0.6491123281602564	0.984165069167112	0.9493837665828397	0.9688679226686315	0.9870125638742568	0.960958284831255	0.9304714009069367	0.961233294307906	0.9229770223735969	0.873184774404913	0.8050353064957557	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011839		NC_000017.11:43106477:C:T		Cys64Tyr																												BRCA1_Cys64Tyr	17	43106477	C	T	17	allele	191G>A	H08	527_CAVA_Array_P01	O15	B13A7A8P1_R1	B14A7A8P1_R2				17-43106477-C-T	54400	17	43106477	C	T	C	Y	rs55851803	17	41258494	17	38512020	64	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.191G>A	p.Cys64Tyr	c.191G>A	p.Cys64Tyr	principal2	Y	1	.	.	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.972	0.84488	D	.	0.99291	.	.	.	.	4.34	0.98393	H	-2.59	0.99046	D	.	0.97441	0.9543	0.96449	D	0.9922	0.99809	D	10	0.9909615	0.99609	D	0.946477	0.99626	D	0.954	0.99189	0.991	0.99904	E9PFC7	C64Y	Loss of stability (P = 0.0601)| Loss of disorder (P = 0.0647)| Loss of methylation at K65 (P = 0.0701)| Gain of phosphorylation at T69 (P = 0.1857)| Loss of catalytic residue at L63 (P = 0.238)	0.999548998322	0.99953	.	0.88610	.	0.52543	0.801703929901	0.82191	T	0.476203	0.92995	T	0.553373	0.95819	D	0.557106	0.95755	D	0.998311161994934	0.93754	D	.	0.87587	.	0.98057026	0.99138	0.92475754	0.96684	0.9736041	0.98562	0.9065188	0.95378	-12.677	0.94701	D	0.9941	0.96039	LP	0.999711406740052	0.97610	0.99977249	0.99701	0.97	0.98836	.	.	.	.	.	.	5.19196	0.87099	29.1	0.99179197590808121	0.54687	0.851286	0.76729	D	0.880338828138272	0.90713	10.55451	0.762986794469818	0.87052	9.115097	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.997	0.79771	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1601934	1.248490e-06	0	1	1170064	8.546540e-07	0	0	74760	0.000000e+00	0	0	912	0.000000e+00	0	0	59914	0.000000e+00	0	0	29512	0.000000e+00	0	0	44730	0.000000e+00	0	0	63954	0.000000e+00	0	0	5808	0.000000e+00	0	1	1170064	8.546540e-07	0	0	90238	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition	reviewed_by_expert_panel	NC_000017.11:g.43106477C>T	ClinGen:CA001262|UniProtKB:P38398#VAR_007759	C3661900|C0677776|C3280442|C0027672|C2676676|CN377757	614320|604370	145|1333|140162|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	69067	single nucleotide variant	NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 11, 2024	55851803	-	RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;paternal;unknown	germline	GRCh38	NC_000017.11	17	43106477	43106477	17q21.31	reviewed by expert panel	27	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P38398#VAR_007759,ClinGen:CA001262	2	54400	43106477	C	T	-	-	-	-	-	-	SCV004101417	-	-	191G>A 	Cys64Tyr	NM_007294.4	3	1_Pathogenic																																																																																																									
KRAS	KRAS_Phe156Ile	-1.3743464521347168	0.2117183578603233	4.60376764126087	0.0024731315942266253																											true	KRAS		3084		CCSBVarC006102		NC_000012.12:25209896:A:T		Phe156Ile																												KRAS_Phe156Ile	12	25209896	A	T	12	allele	466T>A	A09	527_CAVA_Array_P03	B17	B13A7A8P1_R1	B14A7A8P1_R2				12-25209896-A-T	163758	12	25209896	A	T	F	I	rs397517042	12	25362830	12	25254097	131	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.391T>A	p.Phe131Ile	.	Y	.	.	.	-	TTC	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	.	0.90580	.	.	0.73823	.	.	0.95575	.	.	.	.	.	.	.	.	0.84554	.	.	0.86483	0.5739	0.91524	D	0.7138	0.90143	D	8	.	0.88974	.	0.39769	0.93315	D	.	0.97054	.	0.92541	.	.	.	.	0.98060	.	.	.	.	.	.	.	.	.	.	0.456603	0.92716	D	0.418102	0.92627	D	0.984689116477966	0.75739	D	.	0.88326	.	.	.	.	.	.	.	.	.	.	0.98607	.	.	0.95820	.	.	.	0.98468506	0.96023	0.937	0.96958	.	.	.	.	.	.	4.958659	0.82	27.7	0.98951824215402029	0.49243	0.871179	0.79169	D	0.741140742699006	0.82229	7.73527	0.744583996035912	0.85673	8.675262	5.43	5.43	0.78977	.	.	8.891	0.9215	11.233000	0.90185	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.999	0.91597	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|not_provided|Noonan_syndrome_3	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25209896A>T	ClinGen:CA273160	C0028326|C1275081|CN517202|C1860991	PS163950|PS115150|609942	648|1340|648	.	Phe	Ile	175711	single nucleotide variant	NM_004985.5(KRAS):c.466T>A (p.Phe156Ile)	3845	KRAS	HGNC:6407	Pathogenic	1	Jan 05, 2022	397517042	-	RCV000150884|RCV000493013|RCV001813760	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:CN517202|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Noonan syndrome;Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome 3	germline	germline	GRCh38	NC_000012.12	12	25209896	25209896	12p12.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA273160	2	163758	25209896	A	T	-	-	-	-	-	-	SCV000198458|SCV000582867|SCV002061164	-	-	466T>A 	Phe156Ile	NM_004985.5	2	1_Pathogenic																																																																																																									
FANCC	FANCC_Asp195Val	1.2566203609821562	0.24919974099408038	-11.629347596522699	7.846369178135278e-6	2025_01_Batch_13-14	0.6351832855990385	0.8836968194865118	0.92331818841267	0.8959693048993332	0.8450017977379654	0.48485712487139987	0.8679383114423312	0.940108021231868	0.8875135436883358	0.7647837148139124	0.5600202052352192	0.8758175654644216	0.931713104822269	0.8917414242938345	0.8048927562759389	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FANCC	ENSG00000158169	7699	13987	CCSBVarC001229	ALE00001229	NC_000009.12:95150025:T:A	584A>T	Asp195Val	RC4	RC4_Mut_GDEh1009	B09	GDEhDisVCh_40044	E07	2	RC4_Mut_GDDh1009	B09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FANCC_Asp195Val	9	95150025	T	A	9											9-95150025-T-A	134305	9	95150025	T	A	D	V	rs1800365	9	97912307	9	96952128	195	FANCC	ENSG00000158169	ENST00000375305	ENSP00000364454	Q00597	FANCC_HUMAN	c.584A>T	p.Asp195Val	c.584A>T	p.Asp195Val	principal1	Y	1	.	.	-	GAT	2	0	T	T/T	T/T	T/T	T/T	0.004	0.65576	D	0.002	0.79703	D	0.992	0.64752	D	0.971	0.72446	D	0.04	0.13669	N	simple_aae	96.0	4.0	2.395	0.69015	M	-5.58	0.86481	D	0.83	0.82505	-0.5256	0.67564	T	0.2312	0.59552	T	10	0.027212769	0.00870	T	.	.	.	0.417	0.72559	.	.	.	.	.	0.869862672899	0.86759	.	0.49056	.	0.40953	0.38103300333	0.22378	T	0.508738	0.82439	D	-0.186631	0.22426	T	-0.0371334	0.67662	D	0.028442771770713	0.01743	T	0.893711	0.71646	D	0.4535079	0.63947	0.3693059	0.61960	0.43107343	0.62503	0.41695112	0.65510	-4.396	0.29534	T	0.2603	0.50323	B	0.427087705106892	0.58537	0.48957047	0.81662	0.506	0.71835	.	.	.	.	.	.	3.822049	0.55272	23.6	0.99328517196819688	0.59720	0.471210	0.51517	N	0.491382671950936	0.66409	4.969212	0.405209269013319	0.61683	4.395473	4.77	4.77	0.60376	.	.	4.533	0.60413	5.887000	0.50787	0.665	0.62996	0.999	0.42732	1.000000	0.68239	0.174	0.21152	167	0.93511	13	0.002595846645367412	1	7.564296520423601E-4	12	0.011928429423459244	0	0.0	0	0.0	0	0.0	840	264690	0.0031735238	.	319	109386	2.916280e-03	2	661	208056	3.177030e-03	4	722	236802	3.048960e-03	4	4	7162	5.585030e-04	0	47	17110	2.746930e-03	0	5	2320	2.155170e-03	0	0	9044	0.000000e+00	0	3	13394	2.239810e-04	0	204	42762	4.770590e-03	2	49	15684	3.124200e-03	0	204	42762	4.770590e-03	2	6	16212	3.700960e-04	0	82	30508	2.687820e-03	1	18	6210	2.898550e-03	0	0	13414	0.000000e+00	0	5	16734	2.987930e-04	0	434	89528	4.847650e-03	3	102	30592	3.334210e-03	0	434	89528	4.847650e-03	3	5	14900	3.355700e-04	0	89	34242	2.599150e-03	1	37	9566	3.867870e-03	0	0	17690	0.000000e+00	0	7	21632	3.235950e-04	0	466	102654	4.539520e-03	3	102	30510	3.343170e-03	0	466	102654	4.539520e-03	3	.	6367	1614040	3.944760e-03	26	31	6060	5.115510e-03	0	52	75002	6.933150e-04	0	0	912	0.000000e+00	0	174	60004	2.899810e-03	1	94	29606	3.175030e-03	0	1	44868	2.228760e-05	0	37	64010	5.780350e-04	0	31	6060	5.115510e-03	0	5355	1180010	4.538100e-03	18	308	91058	3.382460e-03	4	442	92472	0.004779825244398304	0	174	0	0	2674	0	6	4186	0.001433349259436216	8	790	0.010126582278481013	2	946	0.0021141649048625794	0	656	0	1	274	0.0036496350364963502	41	8036	0.00510204081632653	6	4360	0.0013761467889908258	0	3330	0	500	110208	0.004536875725900116	Conflicting_classifications_of_pathogenicity	Fanconi_anemia_complementation_group_A|Fanconi_anemia|Malignant_tumor_of_breast|Fanconi_anemia_complementation_group_C|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000009.12:g.95150025T>A	ClinGen:CA247025|UniProtKB:Q00597#VAR_005228	C3469521|C0015625|C0006142|C3468041|C3661900|CN169374|C0027672	227650|PS227650|227645	84|84|84|140162	.	Asp	Val	138044	single nucleotide variant	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	2176	FANCC	HGNC:3584	Conflicting classifications of pathogenicity	0	Jan 29, 2025	1800365	-	RCV000124962|RCV000120978|RCV000179716|RCV001083500|RCV000667368|RCV000988215|RCV001356570	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000009.12	9	95150025	95150025	9q22.32	criteria provided, conflicting classifications	27	-	N	UniProtKB:Q00597#VAR_005228,ClinGen:CA247025	2	134305	95150025	T	A	-	-	-	-	-	-	SCV000168402|SCV000232007|SCV000261219|SCV000267037|SCV000281279|SCV000302521|SCV000539136|SCV000594678|SCV000673285|SCV000791802|SCV000892896|SCV001137852|SCV001329919|SCV001522905|SCV001653385|SCV002010154|SCV002047091|SCV002535110|SCV005875402	-	-	584A>T 	Asp195Val	NM_000136.3	1	3_Conflicting	9	95150025	T	A	0.00405785																																																																																																				
FANCC	FANCC_Asp195Val	1.2566203609821562	0.24919974099408038	-11.629347596522699	7.846369178135278e-6	2025_01_Batch_13-14	0.6351832855990385	0.8836968194865118	0.92331818841267	0.8959693048993332	0.8450017977379654	0.48485712487139987	0.8679383114423312	0.940108021231868	0.8875135436883358	0.7647837148139124	0.5600202052352192	0.8758175654644216	0.931713104822269	0.8917414242938345	0.8048927562759389	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FANCC		7699		CCSBVarC001229		NC_000009.12:95150025:T:A		Asp195Val																												FANCC_Asp195Val	9	95150025	T	A	9	allele	584A>T	G11	527_CAVA_Array_P02	M22	B13A7A8P1_R1	B14A7A8P1_R2				9-95150025-T-A	134305	9	95150025	T	A	D	V	rs1800365	9	97912307	9	96952128	195	FANCC	ENSG00000158169	ENST00000375305	ENSP00000364454	Q00597	FANCC_HUMAN	c.584A>T	p.Asp195Val	c.584A>T	p.Asp195Val	principal1	Y	1	.	.	-	GAT	2	0	T	T/T	T/T	T/T	T/T	0.004	0.65576	D	0.002	0.79703	D	0.992	0.64752	D	0.971	0.72446	D	0.04	0.13669	N	simple_aae	96.0	4.0	2.395	0.69015	M	-5.58	0.86481	D	0.83	0.82505	-0.5256	0.67564	T	0.2312	0.59552	T	10	0.027212769	0.00870	T	.	.	.	0.417	0.72559	.	.	.	.	.	0.869862672899	0.86759	.	0.49056	.	0.40953	0.38103300333	0.22378	T	0.508738	0.82439	D	-0.186631	0.22426	T	-0.0371334	0.67662	D	0.028442771770713	0.01743	T	0.893711	0.71646	D	0.4535079	0.63947	0.3693059	0.61960	0.43107343	0.62503	0.41695112	0.65510	-4.396	0.29534	T	0.2603	0.50323	B	0.427087705106892	0.58537	0.48957047	0.81662	0.506	0.71835	.	.	.	.	.	.	3.822049	0.55272	23.6	0.99328517196819688	0.59720	0.471210	0.51517	N	0.491382671950936	0.66409	4.969212	0.405209269013319	0.61683	4.395473	4.77	4.77	0.60376	.	.	4.533	0.60413	5.887000	0.50787	0.665	0.62996	0.999	0.42732	1.000000	0.68239	0.174	0.21152	167	0.93511	13	0.002595846645367412	1	7.564296520423601E-4	12	0.011928429423459244	0	0.0	0	0.0	0	0.0	840	264690	0.0031735238	.	319	109386	2.916280e-03	2	661	208056	3.177030e-03	4	722	236802	3.048960e-03	4	4	7162	5.585030e-04	0	47	17110	2.746930e-03	0	5	2320	2.155170e-03	0	0	9044	0.000000e+00	0	3	13394	2.239810e-04	0	204	42762	4.770590e-03	2	49	15684	3.124200e-03	0	204	42762	4.770590e-03	2	6	16212	3.700960e-04	0	82	30508	2.687820e-03	1	18	6210	2.898550e-03	0	0	13414	0.000000e+00	0	5	16734	2.987930e-04	0	434	89528	4.847650e-03	3	102	30592	3.334210e-03	0	434	89528	4.847650e-03	3	5	14900	3.355700e-04	0	89	34242	2.599150e-03	1	37	9566	3.867870e-03	0	0	17690	0.000000e+00	0	7	21632	3.235950e-04	0	466	102654	4.539520e-03	3	102	30510	3.343170e-03	0	466	102654	4.539520e-03	3	.	6367	1614040	3.944760e-03	26	31	6060	5.115510e-03	0	52	75002	6.933150e-04	0	0	912	0.000000e+00	0	174	60004	2.899810e-03	1	94	29606	3.175030e-03	0	1	44868	2.228760e-05	0	37	64010	5.780350e-04	0	31	6060	5.115510e-03	0	5355	1180010	4.538100e-03	18	308	91058	3.382460e-03	4	442	92472	0.004779825244398304	0	174	0	0	2674	0	6	4186	0.001433349259436216	8	790	0.010126582278481013	2	946	0.0021141649048625794	0	656	0	1	274	0.0036496350364963502	41	8036	0.00510204081632653	6	4360	0.0013761467889908258	0	3330	0	500	110208	0.004536875725900116	Conflicting_classifications_of_pathogenicity	Fanconi_anemia_complementation_group_A|Fanconi_anemia|Malignant_tumor_of_breast|Fanconi_anemia_complementation_group_C|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000009.12:g.95150025T>A	ClinGen:CA247025|UniProtKB:Q00597#VAR_005228	C3469521|C0015625|C0006142|C3468041|C3661900|CN169374|C0027672	227650|PS227650|227645	84|84|84|140162	.	Asp	Val	138044	single nucleotide variant	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	2176	FANCC	HGNC:3584	Conflicting classifications of pathogenicity	0	Jan 29, 2025	1800365	-	RCV000124962|RCV000120978|RCV000179716|RCV001083500|RCV000667368|RCV000988215|RCV001356570	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000009.12	9	95150025	95150025	9q22.32	criteria provided, conflicting classifications	27	-	N	UniProtKB:Q00597#VAR_005228,ClinGen:CA247025	2	134305	95150025	T	A	-	-	-	-	-	-	SCV000168402|SCV000232007|SCV000261219|SCV000267037|SCV000281279|SCV000302521|SCV000539136|SCV000594678|SCV000673285|SCV000791802|SCV000892896|SCV001137852|SCV001329919|SCV001522905|SCV001653385|SCV002010154|SCV002047091|SCV002535110|SCV005875402	-	-	584A>T 	Asp195Val	NM_000136.3	1	3_Conflicting	9	95150025	T	A	0.00405785																																																																																																				
LMNA	LMNA_Leu162Pro	-3.3189154883621836	0.012784044679513561	-3.875594822687866	0.006087518771187429	2025_01_Batch_13-14	0.8736470722150931	0.8836403304174143	0.9295726105636404	0.88339887378602	0.8122503904346556	0.8129075240942252	0.8733994403773238	0.935861515387595	0.9231694847989189	0.7839253089672528	0.8432772981546591	0.878519885397369	0.9327170629756176	0.9032841792924695	0.7980878497009543	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA	ENSG00000160789	3903	7240	CCSBVarC000579	ALE00000579	NC_000001.11:156130745:T:C	485T>C	Leu162Pro	RC4	RC4_Mut_GDEh1027	A01	GDEhDisVCh_40057	E12	1	RC4_Mut_GDDh1027	A01	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	7	0			0			0			LMNA_Leu162Pro	1	156130745	T	C	1											1-156130745-T-C	48068	1	156130745	T	C	L	P	rs267607594	1	156100536	1	154367160	162	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.485T>C	p.Leu162Pro	c.485T>C	p.Leu162Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.033	0.70891	D	0.899	0.66535	P	0.701	0.71005	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.525	0.92921	H	-4.21	0.78753	D	0.649	0.88009	0.9396	0.96230	D	0.8568	0.95221	D	10	0.98645115	0.98945	D	0.700292	0.97542	D	0.855	0.95533	0.872	0.96404	P02545	L162P	Loss of stability (P = 0.0302)| Loss of catalytic residue at L162 (P = 0.1798)| Loss of MoRF binding (P = 0.2541)| Gain of methylation at R166 (P = 0.2594)| Gain of glycosylation at L162 (P = 0.618)	0.97668052646	0.97620	0.9799140373469903	0.97973	2.28727837	0.96349	0.738907754421	0.72764	T	0.97322	0.99722	D	0.467231	0.93175	D	0.433368	0.93090	D	0.994527041912079	0.85750	D	0.922208	0.75543	D	0.91780204	0.92932	0.88798314	0.94044	0.89284736	0.90622	0.90807116	0.95490	-16.821	0.98755	D	0.9901	0.93613	P	0.996923279603381	0.92597	0.99995673	0.99965	0.965	0.98576	.	.	.	.	.	.	4.84313	0.79131	27.0	0.99902297693059472	0.97352	0.974602	0.99567	D	0.755506102375548	0.83173	7.971851	0.697166544701107	0.82066	7.699593	5.59	5.59	0.84656	5.37	0.93424	6.268	0.72593	7.897000	0.73388	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.286	0.24211	447	0.79601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Primary_dilated_cardiomyopathy	no_assertion_criteria_provided	NC_000001.11:g.156130745T>C	ClinGen:CA018144	C3661900|C0007193	.	217604	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	57232	single nucleotide variant	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)	4000	LMNA	HGNC:6636	Likely pathogenic	1	Apr 02, 2009	267607594	-	RCV000041352|RCV000057410	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	Primary dilated cardiomyopathy|not provided	germline	germline	GRCh38	NC_000001.11	1	156130745	156130745	1q22	no assertion criteria provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018144	2	48068	156130745	T	C	-	-	-	-	-	-	SCV000065045	-	-	485T>C 	Leu162Pro	NM_170707.4		1_Pathogenic																																																																																																									
LMNA	LMNA_Leu162Pro	-3.3189154883621836	0.012784044679513561	-3.875594822687866	0.006087518771187429	2025_01_Batch_13-14	0.8736470722150931	0.8836403304174143	0.9295726105636404	0.88339887378602	0.8122503904346556	0.8129075240942252	0.8733994403773238	0.935861515387595	0.9231694847989189	0.7839253089672528	0.8432772981546591	0.878519885397369	0.9327170629756176	0.9032841792924695	0.7980878497009543	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA		3903		CCSBVarC000579		NC_000001.11:156130745:T:C		Leu162Pro																												LMNA_Leu162Pro	1	156130745	T	C	1	allele	485T>C	E11	527_CAVA_Array_P03	J21	B13A7A8P1_R1	B14A7A8P1_R2				1-156130745-T-C	48068	1	156130745	T	C	L	P	rs267607594	1	156100536	1	154367160	162	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.485T>C	p.Leu162Pro	c.485T>C	p.Leu162Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.033	0.70891	D	0.899	0.66535	P	0.701	0.71005	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.525	0.92921	H	-4.21	0.78753	D	0.649	0.88009	0.9396	0.96230	D	0.8568	0.95221	D	10	0.98645115	0.98945	D	0.700292	0.97542	D	0.855	0.95533	0.872	0.96404	P02545	L162P	Loss of stability (P = 0.0302)| Loss of catalytic residue at L162 (P = 0.1798)| Loss of MoRF binding (P = 0.2541)| Gain of methylation at R166 (P = 0.2594)| Gain of glycosylation at L162 (P = 0.618)	0.97668052646	0.97620	0.9799140373469903	0.97973	2.28727837	0.96349	0.738907754421	0.72764	T	0.97322	0.99722	D	0.467231	0.93175	D	0.433368	0.93090	D	0.994527041912079	0.85750	D	0.922208	0.75543	D	0.91780204	0.92932	0.88798314	0.94044	0.89284736	0.90622	0.90807116	0.95490	-16.821	0.98755	D	0.9901	0.93613	P	0.996923279603381	0.92597	0.99995673	0.99965	0.965	0.98576	.	.	.	.	.	.	4.84313	0.79131	27.0	0.99902297693059472	0.97352	0.974602	0.99567	D	0.755506102375548	0.83173	7.971851	0.697166544701107	0.82066	7.699593	5.59	5.59	0.84656	5.37	0.93424	6.268	0.72593	7.897000	0.73388	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.286	0.24211	447	0.79601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Primary_dilated_cardiomyopathy	no_assertion_criteria_provided	NC_000001.11:g.156130745T>C	ClinGen:CA018144	C3661900|C0007193	.	217604	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	57232	single nucleotide variant	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)	4000	LMNA	HGNC:6636	Likely pathogenic	1	Apr 02, 2009	267607594	-	RCV000041352|RCV000057410	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	Primary dilated cardiomyopathy|not provided	germline	germline	GRCh38	NC_000001.11	1	156130745	156130745	1q22	no assertion criteria provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018144	2	48068	156130745	T	C	-	-	-	-	-	-	SCV000065045	-	-	485T>C 	Leu162Pro	NM_170707.4		1_Pathogenic																																																																																																									
BAP1	BAP1_Arg718Gln	-0.9458164145836372	0.37573764594446835	-3.420989205735933	0.01112045469917	2025_01_Batch_13-14	0.6172341215461942	0.6324678911973177	0.6666082700400914	0.5700899595063859	0.5552474311534583	0.5676986968568678	0.5770429480093268	0.6575517587246613	0.6233743242745674	0.5716707982217748	0.592466409201531	0.6047554196033222	0.6620800143823764	0.5967321418904766	0.5634591146876166	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009488		NC_000003.12:52402325:C:T		Arg718Gln																												BAP1_Arg718Gln	3	52402325	C	T	3	allele	2153G>A	C02	527_CAVA_Array_P01	E03	B13A7A8P1_R1	B14A7A8P1_R2				3-52402325-C-T	1173084	3	52402325	C	T	R	Q	rs1440748203	3	52436341	3	52411381	718	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.2153G>A	p.Arg718Gln	c.2153G>A	p.Arg718Gln	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.029	0.47069	D	0.067	0.63436	T	0.105	0.26009	B	0.013	0.16457	B	0.45	0.67594	N	simple_aae	55.0	45.0	0.695	0.17891	N	-1.06	0.33774	N	0.486	0.51792	-1.0347	0.18929	T	0.0947	0.35615	T	10	0.27956486	0.45144	D	0.017745	0.39328	T	0.076	0.22039	0.284	0.24003	Q92560	R718Q	Gain of glycosylation at S721 (P = 0.0061)| Gain of relative solvent accessibility (P = 0.0999)| Loss of stability (P = 0.1254)| Gain of helix (P = 0.132)| Loss of ubiquitination at K714 (P = 0.1982)	0.666395784662	0.66096	0.9176963108472813	0.91693	1.18041734594	0.79892	0.887522280216	0.94942	D	0.031629	0.21892	T	-0.0791375	0.39503	T	-0.351452	0.38683	T	0.692419946193695	0.40057	D	0.89941	0.65736	D	0.23402792	0.45888	0.15140484	0.35558	0.23402792	0.45888	0.15140484	0.35557	-4.022	0.24154	T	0.9167	0.95515	P	0.894653573905079	0.75692	0.99749726	0.98401	0.514	0.72347	.	.	.	.	.	.	4.896201	0.80464	27.3	0.99844496711451181	0.92495	0.924435	0.90210	D	0.0651513950594368	0.44583	2.750997	0.22881620568532	0.51201	3.327653	5.52	4.64	0.57348	2.61	0.47779	7.848	0.85237	5.982000	0.52258	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	91766	1.089730e-05	0	1	177226	5.642510e-06	0	1	204170	4.897880e-06	0	0	5246	0.000000e+00	0	1	14932	6.697030e-05	0	0	1838	0.000000e+00	0	0	7348	0.000000e+00	0	0	11372	0.000000e+00	0	0	35934	0.000000e+00	0	0	13430	0.000000e+00	0	1	14932	6.697030e-05	0	0	13106	0.000000e+00	0	1	26036	3.840840e-05	0	0	5376	0.000000e+00	0	0	12242	0.000000e+00	0	0	13878	0.000000e+00	0	0	75596	0.000000e+00	0	0	26784	0.000000e+00	0	1	26036	3.840840e-05	0	0	12254	0.000000e+00	0	1	29894	3.345150e-05	0	0	8858	0.000000e+00	0	0	15560	0.000000e+00	0	0	17108	0.000000e+00	0	0	88666	0.000000e+00	0	0	26736	0.000000e+00	0	1	29894	3.345150e-05	0	.	3	1594688	1.881250e-06	0	1	56488	1.770290e-05	0	0	74946	0.000000e+00	0	0	912	0.000000e+00	0	1	56488	1.770290e-05	0	0	29090	0.000000e+00	0	0	44170	0.000000e+00	0	0	61120	0.000000e+00	0	0	6016	0.000000e+00	0	2	1172136	1.706290e-06	0	0	87956	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52402325C>T	.	C0027672|C1535926|C3280492	614327	140162|289539	.	Arg	Gln	1162261	single nucleotide variant	NM_004656.4(BAP1):c.2153G>A (p.Arg718Gln)	8314	BAP1	HGNC:950	Uncertain significance	1	Jul 16, 2024	1440748203	-	RCV001797190|RCV003365424|RCV002568140	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome	de novo;germline;unknown	germline	GRCh38	NC_000003.12	3	52402325	52402325	3p21.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA353094106	2	1173084	52402325	C	T	-	-	-	-	-	-	SCV003284341|SCV004053060|SCV004213163	-	-	2153G>A 	Arg718Gln	NM_004656.4	2	4_VUS																																																																																																									
ZC4H2	ZC4H2_Arg211Trp	-11.187153169578217	0.00001016631686776567	7.731852774534217	0.00011324258461463719	2025_01_Batch_13-14	0.7362756564933739	0.8753523082842992	0.9440339686968097	0.9020731924419153	0.7336457636726176	0.8338733312953966	0.9208244182493037	0.9747809732699688	0.9508706383015921	0.8333377750320684	0.7850744938943852	0.8980883632668015	0.9594074709833893	0.9264719153717538	0.783491769352343	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009207		NC_000023.11:64917827:G:A		Arg211Trp																												ZC4H2_Arg211Trp	23	64917827	G	A	X	allele	631C>T	F05	527_CAVA_Array_P06	K10	B13A7A8P2_R1	B14A7A8P2_R2				X-64917827-G-A	451159	X	64917827	G	A	R	W	rs1555933616	X	64137707	X	64054432	211	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.631C>T	p.Arg211Trp	c.631C>T	p.Arg211Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.993	0.81117	D	0.86	0.90832	A	simple_aae	14.0	86.0	.	.	.	-7.09	0.93964	D	0.739	0.76009	-0.0594	0.80920	T	0.4448	0.78059	T	8	0.9010761	0.89353	D	0.951091	0.99664	D	0.659	0.87175	0.543	0.65470	Q9NQZ6	R211W	Gain of glycosylation at K207 (P = 0.1309)| Gain of methylation at K209 (P = 0.1951)| Loss of MoRF binding (P = 0.2024)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2668)	0.962268395915	0.96153	0.7471255375488876	0.74521	3.13339230401	0.99404	0.906362950802	0.97112	D	0.864508	0.96996	D	0.550822	0.95775	D	0.553441	0.95711	D	0.99964702129364	0.98285	D	0.950905	0.82300	D	0.9233236	0.93476	0.92333007	0.96584	0.92091435	0.93238	0.9177878	0.96190	-14.699	0.95317	D	0.9995	0.99217	P	0.998500480413866	0.94564	0.99873880	0.98937	0.997	0.99892	.	.	.	.	.	.	5.163537	0.86543	28.9	0.99920383742745356	0.98722	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.42	0.61925	7.402	0.79258	6.482000	0.55808	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Wieacker-Wolff_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917827G>A	ClinGen:CA413411099	C3661900|C0796200	314580	3454|85283	Zinc finger C4H2-type	Arg	Trp	446729	single nucleotide variant	NM_018684.4(ZC4H2):c.631C>T (p.Arg211Trp)	55906	ZC4H2	HGNC:24931	Likely pathogenic	1	Feb 27, 2024	1555933616	-	RCV000521213|RCV004758699|RCV001375995	MedGen:C3661900||Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	not provided|ZC4H2-related disorder|Wieacker-Wolff syndrome	germline;maternal	germline	GRCh38	NC_000023.11	X	64917827	64917827	Xq11.2	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA413411099	2	451159	64917827	G	A	-	-	-	-	-	-	SCV000619821|SCV001572998|SCV002581693|SCV005880170	-	-	631C>T 	Arg211Trp	NM_018684.4	2	1_Pathogenic																																																																																																									
SHOC2	SHOC2_Ser403Gly	-3.861317166307788	0.006200919790985726	9.153768286343025	0.00003820144936004182	2025_01_Batch_13-14	0.8598607476040003	0.9190794412170451	0.802151747828081	0.8293676270278348	0.660643654159381	0.8621220845756798	0.8973053296396158	0.8203158873513924	0.8894980577124589	0.7536872859503306	0.8609914160898401	0.9081923854283305	0.8112338175897367	0.8594328423701469	0.7071654700548557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2		11602		CCSBVarC028051		NC_000010.11:111007576:A:G		Ser403Gly																												SHOC2_Ser403Gly	10	111007576	A	G	10	allele	1207A>G	H01	527_CAVA_Array_P06	O02	B13A7A8P2_R1	B14A7A8P2_R2				10-111007576-A-G	981611	10	111007576	A	G	S	G	rs1564730663	10	112767334	10	112757324	403	SHOC2	ENSG00000108061	ENST00000689300	ENSP00000510639	Q9UQ13	SHOC2_HUMAN	.	.	c.1207A>G	p.Ser403Gly	principal1	Y	.	.	.	+	AGT	1	0	A	A/A	A/A	A/A	A/A	.	0.61594	.	.	0.65108	.	0.775	0.47335	P	0.184	0.51811	B	.	.	.	.	.	.	1.495	0.37283	L	.	0.52959	.	.	0.78751	0.3038	0.87567	D	0.6246	0.86749	D	10	.	0.73599	.	0.076346	0.72413	D	.	0.55539	0.484	0.56487	Q9UQ13	S403G	Loss of sheet (P = 0.0817)| Loss of stability (P = 0.1306)| Loss of helix (P = 0.1706)| Gain of catalytic residue at T402 (P = 0.2032)| Loss of solvent accessibility (P = 0.4436)	.	0.74036	.	0.36956	.	0.65897	0.847841501236	0.89271	D	0.621119	0.88010	D	0.15632	0.69638	D	-0.0132338	0.69250	D	0.921698868274689	0.57905	D	.	0.86146	.	0.3641711	0.57823	0.28831485	0.54635	0.3641711	0.57823	0.28831485	0.54634	-5.834	0.44926	T	.	0.24834	.	0.987016332867827	0.87295	0.03628605	0.56043	0.571	0.75882	.	.	.	.	.	.	4.291712	0.65528	24.8	0.99843858264903962	0.92408	0.922270	0.89662	D	0.593668272867563	0.72634	5.859629	0.665622303315765	0.79668	7.154942	5.82	5.82	0.92730	.	.	9.271	0.94934	11.099000	0.86103	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	919	0.19492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Noonan_syndrome	no_assertion_criteria_provided	NC_000010.11:g.111007576A>G	.	C0028326	PS163950	648	.	Ser	Gly	969662	single nucleotide variant	NM_007373.4(SHOC2):c.1207A>G (p.Ser403Gly)	8036	SHOC2	HGNC:15454	Likely benign	0	-	-1	-	RCV001261152	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	paternal	germline	GRCh38	NC_000010.11	10	111007576	111007576	10q25.2	no assertion criteria provided	1	-	N	ClinGen:CA378523403	2	981611	111007576	A	G	-	-	-	-	-	-	SCV001438561	-	-	1207A>G 	Ser403Gly	NM_007373.4		2_Benign																																																																																																									
ZC4H2	ZC4H2_Ile7Val	-1.3973623365001806	0.20499887214456444	6.065888508703813	0.0005079045702971349	2025_01_Batch_13-14	0.7632383538736797	0.8936149046548247	0.8807897003645184	0.8389151966396824	0.6777458244127534	0.7312884995637602	0.9369051568891026	0.9621820633037574	0.8941139976864503	0.7038972819567935	0.7472634267187199	0.9152600307719636	0.9214858818341379	0.8665145971630663	0.6908215531847735	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009155		NC_000023.11:64976359:T:C		Ile7Val																												ZC4H2_Ile7Val	23	64976359	T	C	X	allele	19A>G	C04	527_CAVA_Array_P06	E08	B13A7A8P2_R1	B14A7A8P2_R2				X-64976359-T-C	1204188	X	64976359	T	C	I	V	rs199516840	X	64196239	X	64112964	7	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.19A>G	p.Ile7Val	c.19A>G	p.Ile7Val	principal1	Y	1	YES	Select	-	ATC	1	0	T	T/T	T/T	T/T	T/T	0.351	0.16776	T	0.678	0.12680	T	0.002	0.09864	B	0.001	0.04348	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.32	0.32853	L	-0.26	0.11844	N	0.31	0.34747	-0.9875	0.33106	T	0.1320	0.44177	T	9	0.07205117	0.10648	T	0.006027	0.15489	T	0.095	0.27216	.	.	.	.	.	0.334371577756	0.32629	0.5398168254113483	0.53715	0.722628895279	0.62047	0.768219232559	0.77118	T	0.032331	0.22195	T	-0.305108	0.07976	T	-0.359887	0.37710	T	0.0683943516306379	0.08326	T	0.849515	0.53108	T	0.18977433	0.40220	0.13270241	0.31751	0.18977433	0.40220	0.13270241	0.31750	-3.754	0.20389	T	0.1285	0.50035	B	0.474340545313315	0.60002	0.85911566	0.89902	0.185	0.44051	.	.	.	.	.	.	2.686521	0.35125	19.8	0.96312281054746651	0.29591	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.0	0.76287	5.297	0.65577	7.617000	0.62206	0.609	0.47831	1.0	0.71675	1.000000	0.68239	1.0	0.97202	45	0.97779	.	.	.	.	.	.	.	.	.	.	.	.	46	264690	1.7378821E-4	.	13	80322	1.618490e-04	0	23	151839	1.514760e-04	0	27	172229	1.567680e-04	0	0	5702	0.000000e+00	0	0	13663	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9917	0.000000e+00	0	13	30957	4.199370e-04	0	0	9952	0.000000e+00	0	13	30957	4.199370e-04	0	0	13134	0.000000e+00	0	0	24382	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12175	0.000000e+00	0	22	64678	3.401470e-04	0	0	19070	0.000000e+00	0	22	64678	3.401470e-04	0	0	12064	0.000000e+00	0	0	27160	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15980	0.000000e+00	0	26	73474	3.538670e-04	0	0	19005	0.000000e+00	0	26	73474	3.538670e-04	0	.	657	1210216	5.428780e-04	1	630	895221	7.037370e-04	1	5	57198	8.741560e-05	0	0	685	0.000000e+00	0	0	45866	0.000000e+00	0	0	22034	0.000000e+00	0	0	33739	0.000000e+00	0	0	46687	0.000000e+00	0	0	4373	0.000000e+00	0	630	895221	7.037370e-04	1	0	56809	0.000000e+00	0	161	146822	0.001096565909741047	0	168	0	0	2686	0	0	4124	0	0	442	0	0	950	0	0	652	0	0	280	0	4	7604	5.260389268805891E-4	0	4292	0	0	3338	0	165	163728	0.0010077689827030197	Benign/Likely_benign	Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64976359T>C	.	C0950123|C3661900	.	.	.	Ile	Val	1195793	single nucleotide variant	NM_018684.4(ZC4H2):c.19A>G (p.Ile7Val)	55906	ZC4H2	HGNC:24931	Benign/Likely benign	0	May 31, 2024	199516840	-	RCV001570468|RCV002570776	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64976359	64976359	Xq11.2	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA10433516	2	1204188	64976359	T	C	-	-	-	-	-	-	SCV001794764|SCV003484470|SCV003707394	-	-	19A>G 	Ile7Val	NM_018684.4	2	2_Benign																																																																																																									
FH	FH_Leu507Pro	4.283741584521042	0.005184294876647455	-9.275306049641868	0.000035051027926109044	2025_01_Batch_13-14	0.9233232839906323	0.941708509775386	0.9910505348182328	0.9782635227503732	0.8190445976873685																0.0	0.0		0.0	0.0	true	FH		3408		CCSBVarC000455		NC_000001.11:241497841:A:G		Leu507Pro																												FH_Leu507Pro	1	241497841	A	G	1	allele	1520T>C	H02	527_CAVA_Array_P03	P03	B13A7A8P1_R1	B14A7A8P1_R2				1-241497841-A-G	501651	1	241497841	A	G	L	P	rs1425094515	1	241661141	1	239727764	507	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1520T>C	p.Leu507Pro	c.1520T>C	p.Leu507Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.003	0.76775	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	D	simple_aae	1.0	99.0	4.165	0.97608	H	-6.03	0.89738	D	0.891	0.89007	0.9009	0.95672	D	0.8489	0.94950	D	10	0.9082073	0.90077	D	0.334363	0.91822	D	0.871	0.96123	0.602	0.73245	P07954	L507P	Gain of disorder (P = 0.0241)| Loss of stability (P = 0.0351)| Gain of ubiquitination at K502 (P = 0.0548)| Gain of glycosylation at L507 (P = 0.0656)| Loss of loop (P = 0.1258)	0.957075880139	0.95625	0.994625853800694	0.99458	1.25285983881	0.81756	0.733992934227	0.72042	T	0.828262	0.95840	D	0.476607	0.93531	D	0.446837	0.93451	D	0.999450027942657	0.97447	D	0.984202	0.94624	D	0.9785105	0.98976	0.96005136	0.98958	0.97985315	0.99083	0.9652735	0.99233	-13.176	0.90095	D	0.8863	0.81817	P	0.999840444787748	0.98301	0.92898947	0.92347	0.974	0.99029	.	.	.	.	.	.	5.100479	0.8524	28.5	0.99930446051084221	0.99334	0.972825	0.99451	D	0.97296511661057	0.94822	13.09385	0.931949475285706	0.96802	15.19072	6.02	6.02	0.97555	5.2	0.91904	7.047	0.76373	10.988000	0.84682	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.999	0.91597	973	0.05579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1609240	1.864230e-06	0	3	1178088	2.546500e-06	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59480	0.000000e+00	0	0	29572	0.000000e+00	0	0	44734	0.000000e+00	0	0	63920	0.000000e+00	0	0	4674	0.000000e+00	0	3	1178088	2.546500e-06	0	0	90726	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_conflicting_classifications	NC_000001.11:g.241497841A>G	ClinGen:CA345450002	C0027672|C3661900|C1708350	150800	140162|523	Fumarase C, C-terminal	Leu	Pro	493075	single nucleotide variant	NM_000143.4(FH):c.1520T>C (p.Leu507Pro)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Nov 07, 2023	1425094515	-	RCV000597494|RCV002395536|RCV003336091	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241497841	241497841	1q43	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA345450002	2	501651	241497841	A	G	-	-	-	-	-	-	SCV001577113|SCV002705312|SCV004045439	-	-	1520T>C 	Leu507Pro	NM_000143.4	2	1_Pathogenic	1	241497841	A	G	2.0591e-6																																																																																																				
BRCA1	BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218449	CCSBVarC003309	ALE00003309	NC_000017.11:43051104:A:G	1979T>C	Leu660Pro	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Leu660Pro	17	43051104	A	G	17											17-43051104-A-G	55510	17	43051104	A	G	L	P	rs80357281	17	41203121	17	38456647	1764	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.99898762507631778	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	70177	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357281	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104	43051104	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2	55510	43051104	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3	1_Pathogenic						39822	BRCA1_Adamovich_2022_Cisplatin_var6840	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43051104.0	43051104.0		5291			1764.0	L	P	c.5291T>C	p.Leu1764Pro	missense_variant	-1.1098435	-0.923573456;-1.20864809;-1.418871427;-0.888281028		No		Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.676	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Leu1764Pro	Leu1764Pro	true
BRCA1	BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003309		NC_000017.11:43051104:A:G		Leu660Pro																												BRCA1_Leu660Pro	17	43051104	A	G	17	allele	1979T>C	A08	527_CAVA_Array_P01	A15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051104-A-G	55510	17	43051104	A	G	L	P	rs80357281	17	41203121	17	38456647	1764	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.99898762507631778	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	70177	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357281	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104	43051104	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2	55510	43051104	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3	1_Pathogenic						39822	BRCA1_Adamovich_2022_Cisplatin_var6840	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43051104.0	43051104.0		5291			1764.0	L	P	c.5291T>C	p.Leu1764Pro	missense_variant	-1.1098435	-0.923573456;-1.20864809;-1.418871427;-0.888281028		No		Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.676	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Leu1764Pro	Leu1764Pro	true
BRCA1	BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218449	CCSBVarC003309	ALE00003309	NC_000017.11:43051104:A:G	1979T>C	Leu660Pro	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Leu660Pro	17	43051104	A	G	17											17-43051104-A-G	55510	17	43051104	A	G	L	P	rs80357281	17	41203121	17	38456647	1764	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.99898762507631778	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	70177	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357281	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104	43051104	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2	55510	43051104	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3	1_Pathogenic						48095	BRCA1_Adamovich_2022_HDR_var5452	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43051104.0	43051104.0		5291			1764.0	L	P	c.5291T>C	p.Leu1764Pro	missense_variant	-2.02023185075	-2.021654763;-1.722566836;-2.060424092;-2.276281712		No		Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.676	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Leu1764Pro	Leu1764Pro	true
BRCA1	BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003309		NC_000017.11:43051104:A:G		Leu660Pro																												BRCA1_Leu660Pro	17	43051104	A	G	17	allele	1979T>C	A08	527_CAVA_Array_P01	A15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051104-A-G	55510	17	43051104	A	G	L	P	rs80357281	17	41203121	17	38456647	1764	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.99898762507631778	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	70177	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357281	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104	43051104	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2	55510	43051104	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3	1_Pathogenic						48095	BRCA1_Adamovich_2022_HDR_var5452	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43051104.0	43051104.0		5291			1764.0	L	P	c.5291T>C	p.Leu1764Pro	missense_variant	-2.02023185075	-2.021654763;-1.722566836;-2.060424092;-2.276281712		No		Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.676	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Leu1764Pro	Leu1764Pro	true
FANCC	FANCC_Leu554Pro	-0.3335628604146983	0.7484786135159357	-4.383117084986827	0.0032222333592398064	2025_01_Batch_13-14	0.6828875378307329	0.9185174287367518	0.9441415721015707	0.9271406611938001	0.8591763545189698	0.9600094866432588	0.956978245322388	0.9678296569608629	0.977639538560533	0.9544129144970065	0.8214485122369959	0.9377478370295699	0.9559856145312168	0.9523900998771666	0.9067946345079881	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	FANCC	ENSG00000158169	7699	13991	CCSBVarC001231	ALE00001231	NC_000009.12:95101723:A:G	1661T>C	Leu554Pro	RC4	RC4_Mut_GDEh1009	D09	GDEhDisVCh_40044	G07	2	RC4_Mut_GDDh1009	D09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FANCC_Leu554Pro	9	95101723	A	G	9											9-95101723-A-G	12043	9	95101723	A	G	L	P	rs104886458	9	97864005	9	96903826	554	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1661T>C	p.Leu554Pro	c.1661T>C	p.Leu554Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.3	0.55288	A	simple_aae	70.0	30.0	2.215	0.62356	M	-3.85	0.72390	D	0.896	0.89567	-0.0283	0.81584	T	0.3880	0.74183	T	9	0.9469856	0.93958	D	0.055743	0.66224	D	0.617	0.85019	.	.	.	.	.	0.900282806353	0.89853	0.8253407305087601	0.82387	0.413463600646	0.41766	0.590069651604	0.51437	T	0.473774	0.80403	T	0.271784	0.80457	D	0.216268	0.83872	D	0.949487268924713	0.62897	D	.	0.12239	.	0.90733176	0.91931	0.87151235	0.92876	0.87194806	0.88866	0.8482753	0.91276	-7.71	0.59149	D	0.6917	0.72637	LP	0.921516655278869	0.77669	0.95718740	0.93787	0.731	0.85095	.	.	.	.	.	.	4.178114	0.62948	24.5	0.99839825199499255	0.92063	0.586505	0.58304	D	0.440542923641051	0.63480	4.605117	0.331677567903355	0.57182	3.906634	4.76	4.76	0.60139	.	.	4.529	0.60386	10.861000	0.84000	0.756	0.943	0.99	0.37076	1.000000	0.68239	0.016	0.10745	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109336	1.829220e-05	0	2	207912	9.619450e-06	0	3	236760	1.267110e-05	0	0	7156	0.000000e+00	0	0	17096	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	2	42740	4.679460e-05	0	0	15684	0.000000e+00	0	2	42740	4.679460e-05	0	0	16190	0.000000e+00	0	0	30492	0.000000e+00	0	0	6200	0.000000e+00	0	0	13412	0.000000e+00	0	0	16720	0.000000e+00	0	2	89440	2.236140e-05	0	0	30596	0.000000e+00	0	2	89440	2.236140e-05	0	0	14880	0.000000e+00	0	0	34228	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	3	102652	2.922500e-05	0	0	30514	0.000000e+00	0	3	102652	2.922500e-05	0	.	24	1613908	1.487070e-05	0	24	1180000	2.033900e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29608	0.000000e+00	0	0	44874	0.000000e+00	0	0	63982	0.000000e+00	0	0	6074	0.000000e+00	0	24	1180000	2.033900e-05	0	0	91068	0.000000e+00	0	4	92818	4.3095089314572604E-5	0	168	0	0	2680	0	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	0	4188	0	0	3306	0	4	104018	3.845488280874464E-5	Pathogenic/Likely_pathogenic	Fanconi_anemia_complementation_group_C|not_provided|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|FANCC-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.95101723A>G	ClinGen:CA284829|Genetic_Testing_Registry_(GTR):GTR000603994|OMIM:613899.0001|UniProtKB:Q00597#VAR_005233	C3468041|C3661900|C0027672|C0015625	227645|PS227650	84|140162|84	.	Leu	Pro	27082	single nucleotide variant	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2176	FANCC	HGNC:3584	Pathogenic/Likely pathogenic	1	Nov 18, 2024	104886458	-	RCV000058925|RCV000012823|RCV002399319|RCV001221431|RCV003421917	MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|	not provided|Fanconi anemia complementation group C|Hereditary cancer-predisposing syndrome|Fanconi anemia|FANCC-related disorder	germline;unknown	germline	GRCh38	NC_000009.12	9	95101723	95101723	9q22.32	criteria provided, multiple submitters, no conflicts	15	-	N	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	3	12043	95101723	A	G	-	-	-	-	-	-	SCV000512973|SCV001163619|SCV001363461|SCV001393476|SCV002022325|SCV002707544|SCV002776573|SCV004108354|SCV005625570	-	-	1661T>C 	Leu554Pro	NM_000136.3	2	1_Pathogenic	9	95101723	A	G	0.000014366																																																																																																				
FANCC	FANCC_Leu554Pro	-0.3335628604146983	0.7484786135159357	-4.383117084986827	0.0032222333592398064	2025_01_Batch_13-14	0.6828875378307329	0.9185174287367518	0.9441415721015707	0.9271406611938001	0.8591763545189698	0.9600094866432588	0.956978245322388	0.9678296569608629	0.977639538560533	0.9544129144970065	0.8214485122369959	0.9377478370295699	0.9559856145312168	0.9523900998771666	0.9067946345079881	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	FANCC		7699		CCSBVarC001231		NC_000009.12:95101723:A:G		Leu554Pro																												FANCC_Leu554Pro	9	95101723	A	G	9	allele	1661T>C	A12	527_CAVA_Array_P02	A24	B13A7A8P1_R1	B14A7A8P1_R2				9-95101723-A-G	12043	9	95101723	A	G	L	P	rs104886458	9	97864005	9	96903826	554	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1661T>C	p.Leu554Pro	c.1661T>C	p.Leu554Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.3	0.55288	A	simple_aae	70.0	30.0	2.215	0.62356	M	-3.85	0.72390	D	0.896	0.89567	-0.0283	0.81584	T	0.3880	0.74183	T	9	0.9469856	0.93958	D	0.055743	0.66224	D	0.617	0.85019	.	.	.	.	.	0.900282806353	0.89853	0.8253407305087601	0.82387	0.413463600646	0.41766	0.590069651604	0.51437	T	0.473774	0.80403	T	0.271784	0.80457	D	0.216268	0.83872	D	0.949487268924713	0.62897	D	.	0.12239	.	0.90733176	0.91931	0.87151235	0.92876	0.87194806	0.88866	0.8482753	0.91276	-7.71	0.59149	D	0.6917	0.72637	LP	0.921516655278869	0.77669	0.95718740	0.93787	0.731	0.85095	.	.	.	.	.	.	4.178114	0.62948	24.5	0.99839825199499255	0.92063	0.586505	0.58304	D	0.440542923641051	0.63480	4.605117	0.331677567903355	0.57182	3.906634	4.76	4.76	0.60139	.	.	4.529	0.60386	10.861000	0.84000	0.756	0.943	0.99	0.37076	1.000000	0.68239	0.016	0.10745	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109336	1.829220e-05	0	2	207912	9.619450e-06	0	3	236760	1.267110e-05	0	0	7156	0.000000e+00	0	0	17096	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	2	42740	4.679460e-05	0	0	15684	0.000000e+00	0	2	42740	4.679460e-05	0	0	16190	0.000000e+00	0	0	30492	0.000000e+00	0	0	6200	0.000000e+00	0	0	13412	0.000000e+00	0	0	16720	0.000000e+00	0	2	89440	2.236140e-05	0	0	30596	0.000000e+00	0	2	89440	2.236140e-05	0	0	14880	0.000000e+00	0	0	34228	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	3	102652	2.922500e-05	0	0	30514	0.000000e+00	0	3	102652	2.922500e-05	0	.	24	1613908	1.487070e-05	0	24	1180000	2.033900e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29608	0.000000e+00	0	0	44874	0.000000e+00	0	0	63982	0.000000e+00	0	0	6074	0.000000e+00	0	24	1180000	2.033900e-05	0	0	91068	0.000000e+00	0	4	92818	4.3095089314572604E-5	0	168	0	0	2680	0	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	0	4188	0	0	3306	0	4	104018	3.845488280874464E-5	Pathogenic/Likely_pathogenic	Fanconi_anemia_complementation_group_C|not_provided|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|FANCC-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.95101723A>G	ClinGen:CA284829|Genetic_Testing_Registry_(GTR):GTR000603994|OMIM:613899.0001|UniProtKB:Q00597#VAR_005233	C3468041|C3661900|C0027672|C0015625	227645|PS227650	84|140162|84	.	Leu	Pro	27082	single nucleotide variant	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2176	FANCC	HGNC:3584	Pathogenic/Likely pathogenic	1	Nov 18, 2024	104886458	-	RCV000058925|RCV000012823|RCV002399319|RCV001221431|RCV003421917	MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|	not provided|Fanconi anemia complementation group C|Hereditary cancer-predisposing syndrome|Fanconi anemia|FANCC-related disorder	germline;unknown	germline	GRCh38	NC_000009.12	9	95101723	95101723	9q22.32	criteria provided, multiple submitters, no conflicts	15	-	N	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	3	12043	95101723	A	G	-	-	-	-	-	-	SCV000512973|SCV001163619|SCV001363461|SCV001393476|SCV002022325|SCV002707544|SCV002776573|SCV004108354|SCV005625570	-	-	1661T>C 	Leu554Pro	NM_000136.3	2	1_Pathogenic	9	95101723	A	G	0.000014366																																																																																																				
CTCF	CTCF_Tyr407Cys	2.2604531941423103	0.058292407096491645	5.642049992400373	0.0007809142606724553	2025_01_Batch_13-14	0.5832082165597294	0.8062520727072294	0.6881772674260671	0.6578961621597847	0.5755667279191388	0.7070470110384419	0.6614940913889276	0.6188088807723816	0.7503805460433652	0.6003427425011371	0.6451276137990857	0.7338730820480786	0.6534930740992244	0.704138354101575	0.587954735210138	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010870		NC_000016.10:67621454:A:G		Tyr407Cys																												CTCF_Tyr407Cys	16	67621454	A	G	16	allele	1220A>G	H01	527_CAVA_Array_P02	O02	B13A7A8P1_R1	B14A7A8P1_R2				16-67621454-A-G	265526	16	67621454	A	G	Y	C	rs886039600	16	67655357	16	66212858	407	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.1220A>G	p.Tyr407Cys	c.1220A>G	p.Tyr407Cys	principal4	Y	.	.	.	+	TAT	2	0	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.92967	.	0.914	0.50540	P	0.665	0.52957	P	.	0.86984	.	.	.	.	3.095	0.87372	M	.	0.96158	.	.	0.77038	-0.7497	0.57774	T	0.1518	0.47848	T	10	0.84561706	0.83554	D	0.084978	0.74353	D	.	0.78861	0.615	0.74786	P49711	Y407C	Loss of phosphorylation at Y407 (P = 0.0811)| Gain of ubiquitination at K405 (P = 0.1079)| Gain of disorder (P = 0.1124)| Gain of glycosylation at K405 (P = 0.1594)| Loss of MoRF binding (P = 0.1621)	.	0.78538	.	0.94871	.	0.99706	0.954362869263	0.99834	D	0.875329	0.97318	D	0.258403	0.79229	D	0.133401	0.78960	D	0.997824430465698	0.92450	D	.	0.93500	.	0.8909639	0.90456	0.6975476	0.81981	0.8259339	0.85435	0.7453358	0.84765	-16.773	0.98709	D	.	0.96717	.	0.999749203930458	0.97751	0.97100700	0.94734	0.889	0.94066	.	.	.	.	.	.	5.434312	0.90871	32.0	0.99770787246477033	0.85930	0.932506	0.92271	D	0.717981494107391	0.80704	7.377784	0.688130749716732	0.81373	7.535864	5.83	4.72	0.59198	4.73	0.87084	9.325	0.96016	11.234000	0.90219	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	54	0.97580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67621454A>G	ClinGen:CA10588621	CN517202	.	.	.	Tyr	Cys	260121	single nucleotide variant	NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys)	10664	CTCF	HGNC:13723	Likely pathogenic	1	Jan 06, 2025	886039600	-	RCV000255519	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67621454	67621454	16q22.1	criteria provided, single submitter	1	-	N	ClinGen:CA10588621	2	265526	67621454	A	G	-	-	-	-	-	-	SCV000322502	-	-	1220A>G 	Tyr407Cys	NM_006565.4	1	1_Pathogenic						965455	CTCF_unpublished_var159702	CTCF_unpublished	CTCF	13723.0	1.0		67621454.0	67621454.0		1220	A	G	407.0	Y	C	c.1220A>G	p.Tyr407Cys	missense_variant	0.00170449		functionally_normal	Yes		Likely pathogenic	criteria provided, single submitter	Jan 12, 2016	nucleotide		ENST00000264010.10	NM_006565.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.51																																																											CTCF_Tyr407Cys	Tyr407Cys	true
RPS19	RPS19_Arg62Trp	2.4791241841752996	0.042264292882514945	-2.5644722198235086	0.03730742779147683	2025_01_Batch_13-14	0.7290373796001557	0.5877760909668668	0.7600550019338441	0.5555206693929152	0.74341438863389											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19	ENSG00000105372	3441	6069	CCSBVarC000467	ALE00000467	NC_000019.10:41869042:C:T	184C>T	Arg62Trp	RC4	RC4_Mut_GDEh1010	F11	GDEhDisVCh_40042	C02	2	RC4_Mut_GDDh1010	F11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			RPS19_Arg62Trp	19	41869042	C	T	19											19-41869042-C-T	6314	19	41869042	C	T	R	W	rs104894711	19	42373112	19	47064952	62	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.184C>T	p.Arg62Trp	c.184C>T	p.Arg62Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	./.	./.	./.	./.	.	.	.	0.019	0.60067	D	0.987	0.61929	D	0.679	0.53438	P	0.97	0.96253	A	simple_aae	3.0	97.0	3.89	0.95985	H	.	.	.	0.96	0.96999	0.2823	0.87220	D	0.4950	0.80784	T	9	0.98888874	0.99322	D	0.794641	0.98386	D	.	.	0.982	0.99827	P39019	R62W	Gain of catalytic residue at A61 (P = 0.0262)| Loss of methylation at R67 (P = 0.0445)| Loss of disorder (P = 0.0768)| Loss of phosphorylation at T60 (P = 0.1237)| Loss of MoRF binding (P = 0.1355)	0.969246388482	0.96863	0.9363405839023272	0.93574	1.09019113237	0.77275	0.841621756554	0.88322	D	0.99269	0.99976	D	0.423948	0.91161	D	0.371195	0.91051	D	0.997496426105499	0.91622	D	.	0.75590	.	0.96338874	0.97581	0.87987745	0.93466	0.93570024	0.94732	0.88595665	0.93899	-12.316	0.86392	D	0.9544	0.90441	LP	0.999645938344676	0.97310	0.99993860	0.99939	0.169	0.41634	.	.	.	.	.	.	5.900132	0.94003	33.0	0.99907463222353998	0.97802	0.886495	0.81725	D	0.68503384224157	0.78536	6.914856	0.596564645006298	0.74551	6.180586	4.3	4.3	0.50482	.	.	3.204	0.5088	2.200000	0.31363	0.596	0.33565	0.995	0.38864	0.976000	0.30138	0.996	0.76032	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	RPS19-related_disorder|Diamond-Blackfan_anemia|not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869042C>T	ClinGen:CA130763|OMIM:603474.0002|UniProtKB:P39019#VAR_006924	C1260899|C3661900|C2676137	PS105650|105650	124|124	.	Arg	Trp	21353	single nucleotide variant	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	6223	RPS19	HGNC:10402	Pathogenic	1	Mar 09, 2023	104894711	-	RCV000033183|RCV000497714|RCV001065746|RCV003415668	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	germline	germline	GRCh38	NC_000019.10	19	41869042	41869042	19q13.2	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	3	6314	41869042	C	T	-	-	-	-	-	-	SCV000589354|SCV001230721|SCV002717112|SCV004047404|SCV004112877	-	-	184C>T 	Arg62Trp	NM_001022.4	2	1_Pathogenic																																																																																																									
RPS19	RPS19_Arg62Trp	2.4791241841752996	0.042264292882514945	-2.5644722198235086	0.03730742779147683	2025_01_Batch_13-14	0.7290373796001557	0.5877760909668668	0.7600550019338441	0.5555206693929152	0.74341438863389											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19		3441		CCSBVarC000467		NC_000019.10:41869042:C:T		Arg62Trp																												RPS19_Arg62Trp	19	41869042	C	T	19	allele	184C>T	F10	527_CAVA_Array_P05	K19	B13A7A8P2_R1	B14A7A8P2_R2				19-41869042-C-T	6314	19	41869042	C	T	R	W	rs104894711	19	42373112	19	47064952	62	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.184C>T	p.Arg62Trp	c.184C>T	p.Arg62Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	./.	./.	./.	./.	.	.	.	0.019	0.60067	D	0.987	0.61929	D	0.679	0.53438	P	0.97	0.96253	A	simple_aae	3.0	97.0	3.89	0.95985	H	.	.	.	0.96	0.96999	0.2823	0.87220	D	0.4950	0.80784	T	9	0.98888874	0.99322	D	0.794641	0.98386	D	.	.	0.982	0.99827	P39019	R62W	Gain of catalytic residue at A61 (P = 0.0262)| Loss of methylation at R67 (P = 0.0445)| Loss of disorder (P = 0.0768)| Loss of phosphorylation at T60 (P = 0.1237)| Loss of MoRF binding (P = 0.1355)	0.969246388482	0.96863	0.9363405839023272	0.93574	1.09019113237	0.77275	0.841621756554	0.88322	D	0.99269	0.99976	D	0.423948	0.91161	D	0.371195	0.91051	D	0.997496426105499	0.91622	D	.	0.75590	.	0.96338874	0.97581	0.87987745	0.93466	0.93570024	0.94732	0.88595665	0.93899	-12.316	0.86392	D	0.9544	0.90441	LP	0.999645938344676	0.97310	0.99993860	0.99939	0.169	0.41634	.	.	.	.	.	.	5.900132	0.94003	33.0	0.99907463222353998	0.97802	0.886495	0.81725	D	0.68503384224157	0.78536	6.914856	0.596564645006298	0.74551	6.180586	4.3	4.3	0.50482	.	.	3.204	0.5088	2.200000	0.31363	0.596	0.33565	0.995	0.38864	0.976000	0.30138	0.996	0.76032	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	RPS19-related_disorder|Diamond-Blackfan_anemia|not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869042C>T	ClinGen:CA130763|OMIM:603474.0002|UniProtKB:P39019#VAR_006924	C1260899|C3661900|C2676137	PS105650|105650	124|124	.	Arg	Trp	21353	single nucleotide variant	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	6223	RPS19	HGNC:10402	Pathogenic	1	Mar 09, 2023	104894711	-	RCV000033183|RCV000497714|RCV001065746|RCV003415668	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	germline	germline	GRCh38	NC_000019.10	19	41869042	41869042	19q13.2	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	3	6314	41869042	C	T	-	-	-	-	-	-	SCV000589354|SCV001230721|SCV002717112|SCV004047404|SCV004112877	-	-	184C>T 	Arg62Trp	NM_001022.4	2	1_Pathogenic																																																																																																									
RHO	RHO_Arg135Trp	-17.38033735531913	5.133434051767988e-7	-16.193593012622983	8.332379341880668e-7	2025_01_Batch_13-14	0.8484507787368682	0.9769099185317103	0.9995777144441768	0.997114828657089	0.9830374641219721	0.8289561051564006	0.9837335836904696	0.9998124136089	0.9982673769471616	0.9894353161315496	0.8387034419466344	0.98032175111109	0.9996950640265384	0.9976911028021254	0.9862363901267608	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	true	RHO		40080645		CCSBVarC013570		NC_000003.12:129530917:C:T		Arg135Trp																												RHO_Arg135Trp	3	129530917	C	T	3	allele	403C>T	G09	527_CAVA_Array_P05	M17	B13A7A8P2_R1	B14A7A8P2_R2				3-129530917-C-T	13028	3	129530917	C	T	R	W	rs104893775	3	129249760	3	130732450	135	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.403C>T	p.Arg135Trp	c.403C>T	p.Arg135Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.9	0.92286	A	simple_aae	10.0	90.0	4.615	0.99277	H	-6.98	0.93600	D	0.975	0.98575	1.0760	0.98756	D	0.9723	0.99129	D	9	0.99393994	0.99911	D	0.669966	0.97240	D	0.931	0.98376	0.97	0.99713	P08100	R135W	Loss of sheet (P = 0.3635)| Loss of stability (P = 0.3899)| Loss of helix (P = 0.3949)| Gain of catalytic residue at R135 (P = 0.455)| Loss of MoRF binding (P = 0.548)	0.989048607444	0.98880	0.9895061687762009	0.98942	0.882892313764	0.69650	0.786314368248	0.79846	T	0.923243	0.98626	D	0.558549	0.96030	D	0.56454	0.95966	D	0.99931013584137	0.96902	D	0.911709	0.68570	D	0.98723143	0.99601	0.9844158	0.99913	0.98945296	0.99731	0.9847179	0.99918	-13.703	0.92067	D	0.9939	0.95008	P	0.99932078557985	0.96263	0.99994576	0.99953	0.941	0.97199	.	.	.	.	.	.	5.094248	0.85113	28.5	0.99915472947634709	0.98380	0.715194	0.66623	D	0.650539432728276	0.76276	6.480144	0.469200349890802	0.65773	4.890175	5.26	2.05	0.25790	2.8	0.51230	1.284	0.32959	2.777000	0.34791	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614258	1.238960e-06	0	2	1180052	1.694840e-06	0	0	75066	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29608	0.000000e+00	0	0	44886	0.000000e+00	0	0	64044	0.000000e+00	0	0	6062	0.000000e+00	0	2	1180052	1.694840e-06	0	0	91088	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Retinitis_punctata_albescens|Retinitis_pigmentosa_4|not_provided|Retinitis_pigmentosa|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129530917C>T	ClinGen:CA122819|OMIM:180380.0012|UniProtKB:P08100#VAR_004797	C1405854|C3151001|C3661900|C0035334|C0854723	613731|268000|PS268000	52427|791|791|71862	GPCR, rhodopsin-like, 7TM	Arg	Trp	28067	single nucleotide variant	NM_000539.3(RHO):c.403C>T (p.Arg135Trp)	6010	RHO	HGNC:10012	Pathogenic	1	Feb 12, 2025	104893775	-	RCV000013902|RCV000013903|RCV000413771|RCV000132597|RCV001074272|RCV004755734	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MONDO:MONDO:0018877,MedGen:C1405854,Orphanet:52427|MedGen:C3661900|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|	Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinitis pigmentosa|Retinal dystrophy|RHO-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000003.12	3	129530917	129530917	3q22.1	criteria provided, multiple submitters, no conflicts	14	-	N	ClinGen:CA122819,UniProtKB:P08100#VAR_004797,OMIM:180380.0012	3	13028	129530917	C	T	-	-	-	-	-	-	SCV000490772|SCV001234184|SCV001239845|SCV001443216|SCV002521615|SCV004030293|SCV004705655|SCV005073429|SCV005690572	-	-	403C>T 	Arg135Trp	NM_000539.3	2	1_Pathogenic						999338	RHO_Wan_2019_var220545	RHO_Wan_2019	RHO	10012.0	1.0		129530917.0	129530917.0		403	C	T	135.0	R	W	c.403C>T	p.Arg135Trp	missense_variant	0.3086407787092269			No	1.2389593237e-6	Pathogenic	criteria provided, multiple submitters, no conflicts	Jan 08, 2024	nucleotide	urn:mavedb:00000099-a-1	ENST00000296271.4	NM_000539.3	immortalized human cells	Reporter	Fluorescence	cell surface expression	No	missense_variant		0.931																																																											RHO_Arg135Trp	Arg135Trp	true
KRAS	KRAS_Ile36Met	-3.4018910795778345	0.011413064402871407	6.974814863521124	0.00021634943402749327																											true	KRAS	ENSG00000133703	3084	214479	CCSBVarC006095	ALE00006095	NC_000012.12:25245277:T:C	108A>G	Ile36Met	CEGS2	CegsMutGDEh1040	D09	GDEhDisVCh_40061	G09	1	CegsMutGDDh1040	D09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Ile36Met	12	25245277	T	C	12											12-25245277-T-C	163768	12	25245277	T	C	I	M	rs727503109	12	25398211	12	25289478	36	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.108A>G	p.Ile36Met	c.108A>G	p.Ile36Met	alternative1	Y	1	.	Plus_Clinical	-	ATA	3	3	T	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.92967	D	0.999	0.77914	D	0.982	0.75481	D	0.83	0.88920	A	simple_aae	17.0	83.0	3.16	0.88393	M	-2.35	0.60859	N	0.866	0.95970	0.6818	0.92922	D	0.7745	0.92315	D	10	0.90810716	0.90066	D	0.260605	0.89466	D	0.864	0.95865	0.768	0.89476	P01116	I36M	Gain of catalytic residue at E31 (P = 0.0146)| Gain of disorder (P = 0.0401)| Gain of phosphorylation at Y40 (P = 0.0722)| Gain of glycosylation at T35 (P = 0.271)| Loss of sheet (P = 0.302)	0.957860125292	0.95704	0.8805200537522034	0.87945	2.38980543874	0.97077	0.802328705788	0.82287	T	0.899405	0.97995	D	0.388059	0.89138	D	0.319644	0.89001	D	0.964436054229736	0.66744	D	0.819518	0.90586	T	0.9472728	0.95925	0.8332933	0.90274	0.9514009	0.96352	0.7634177	0.85851	-13.662	0.93015	D	0.9755	0.92907	P	0.999853564238121	0.98365	0.99868040	0.98905	0.979	0.99252	.	.	.	.	.	.	3.518299	0.49383	22.8	0.99539106627103746	0.70435	0.242004	0.36148	N	0.613285447805062	0.73875	6.061257	0.51615875806198	0.68905	5.309093	5.68	4.51	0.54535	1.47	0.33823	0.81	0.26933	2.363000	0.32466	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.998	0.85369	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_1|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245277T>C	ClinGen:CA273162|UniProtKB:P01116#VAR_064854	CN230736|CN029449|C5555857|C3661900|C0028326|C1275081	115150|PS163950|PS115150	1340|536391|648|1340	Small GTP-binding domain	Ile	Met	175716	single nucleotide variant	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	3845	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1	Oct 23, 2024	727503109	-	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	germline;unknown	germline	GRCh38	NC_000012.12	12	25245277	25245277	12p12.1	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA273162,UniProtKB:P01116#VAR_064854	2	163768	25245277	T	C	-	-	-	-	-	-	SCV000198471|SCV000329772|SCV000919564|SCV000927544|SCV000939441|SCV000999274|SCV002733242	-	-	108A>G 	Ile36Met	NM_004985.5	2	1_Pathogenic																																																																																																									
KRAS	KRAS_Ile36Met	-3.4018910795778345	0.011413064402871407	6.974814863521124	0.00021634943402749327																											true	KRAS		3084		CCSBVarC006095		NC_000012.12:25245277:T:C		Ile36Met																												KRAS_Ile36Met	12	25245277	T	C	12	allele	108A>G	D07	527_CAVA_Array_P03	H13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245277-T-C	163768	12	25245277	T	C	I	M	rs727503109	12	25398211	12	25289478	36	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.108A>G	p.Ile36Met	c.108A>G	p.Ile36Met	alternative1	Y	1	.	Plus_Clinical	-	ATA	3	3	T	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.92967	D	0.999	0.77914	D	0.982	0.75481	D	0.83	0.88920	A	simple_aae	17.0	83.0	3.16	0.88393	M	-2.35	0.60859	N	0.866	0.95970	0.6818	0.92922	D	0.7745	0.92315	D	10	0.90810716	0.90066	D	0.260605	0.89466	D	0.864	0.95865	0.768	0.89476	P01116	I36M	Gain of catalytic residue at E31 (P = 0.0146)| Gain of disorder (P = 0.0401)| Gain of phosphorylation at Y40 (P = 0.0722)| Gain of glycosylation at T35 (P = 0.271)| Loss of sheet (P = 0.302)	0.957860125292	0.95704	0.8805200537522034	0.87945	2.38980543874	0.97077	0.802328705788	0.82287	T	0.899405	0.97995	D	0.388059	0.89138	D	0.319644	0.89001	D	0.964436054229736	0.66744	D	0.819518	0.90586	T	0.9472728	0.95925	0.8332933	0.90274	0.9514009	0.96352	0.7634177	0.85851	-13.662	0.93015	D	0.9755	0.92907	P	0.999853564238121	0.98365	0.99868040	0.98905	0.979	0.99252	.	.	.	.	.	.	3.518299	0.49383	22.8	0.99539106627103746	0.70435	0.242004	0.36148	N	0.613285447805062	0.73875	6.061257	0.51615875806198	0.68905	5.309093	5.68	4.51	0.54535	1.47	0.33823	0.81	0.26933	2.363000	0.32466	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.998	0.85369	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_1|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245277T>C	ClinGen:CA273162|UniProtKB:P01116#VAR_064854	CN230736|CN029449|C5555857|C3661900|C0028326|C1275081	115150|PS163950|PS115150	1340|536391|648|1340	Small GTP-binding domain	Ile	Met	175716	single nucleotide variant	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	3845	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1	Oct 23, 2024	727503109	-	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	germline;unknown	germline	GRCh38	NC_000012.12	12	25245277	25245277	12p12.1	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA273162,UniProtKB:P01116#VAR_064854	2	163768	25245277	T	C	-	-	-	-	-	-	SCV000198471|SCV000329772|SCV000919564|SCV000927544|SCV000939441|SCV000999274|SCV002733242	-	-	108A>G 	Ile36Met	NM_004985.5	2	1_Pathogenic																																																																																																									
LMNA	LMNA_Arg386Thr	1.4645911073941391	0.18644784142247456	-8.018250483099878	0.00008983232334729825	2025_01_Batch_13-14	0.7326336048613691	0.9260771229356421	0.9588176831317521	0.8918935283204882	0.7592879376153259	0.8178282772037097	0.895717817000669	0.9703621554708268	0.9530241965268922	0.8607817846899265	0.7752309410325393	0.9108974699681556	0.9645899193012895	0.9224588624236902	0.8100348611526262	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	LMNA		3903		CCSBVarC021208		NC_000001.11:156136121:G:C		Arg386Thr																												LMNA_Arg386Thr	1	156136121	G	C	1	allele	1157G>C	E09	527_CAVA_Array_P03	J17	B13A7A8P1_R1	B14A7A8P1_R2				1-156136121-G-C	264271	1	156136121	G	C	R	T	rs267607545	1	156105912	1	154372536	386	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.1157G>C	p.Arg386Thr	c.1157G>C	p.Arg386Thr	principal1	Y	1	YES	Select	+	AGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.635	0.99325	H	-5.93	0.89056	D	0.857	0.87350	1.1004	0.99677	D	0.9609	0.98739	D	10	0.90525204	0.89777	D	0.91892	0.99400	D	0.936	0.98562	0.661	0.79808	P02545	R386T	Gain of helix (P = 0.0034)| Loss of loop (P = 0.0073)| Gain of phosphorylation at R386 (P = 0.033)| Loss of MoRF binding (P = 0.0798)| Loss of glycosylation at P391 (P = 0.2507)	0.980401155553	0.97999	0.9678116666716702	0.96751	2.52078213034	0.97725	0.751040816307	0.74556	T	0.984156	0.99893	D	0.577996	0.96936	D	0.592475	0.96885	D	0.999515652656555	0.97697	D	0.986101	0.95472	D	0.91762745	0.92915	0.8370971	0.90525	0.9266469	0.93811	0.8441071	0.90994	-14.125	0.93500	D	0.9991	0.98500	P	0.99996834705116	0.99297	0.99997771	0.99989	0.981	0.99334	.	.	.	.	.	.	6.38395	0.95128	34.0	0.98540116954095625	0.42829	0.944311	0.95106	D	1.02757772399496	0.96510	14.80981	0.954406358037594	0.97520	16.2953	5.3	5.3	0.74708	5.54	0.94607	9.957	0.99008	11.529000	0.93089	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiovascular_phenotype	criteria_provided,_single_submitter	NC_000001.11:g.156136121G>C	ClinGen:CA10587419	CN230736	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Thr	257932	single nucleotide variant	NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr)	4000	LMNA	HGNC:6636	Pathogenic	1	Feb 16, 2016	267607545	-	RCV000248263	MedGen:CN230736	Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136121	156136121	1q22	criteria provided, single submitter	1	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587419	2	264271	156136121	G	C	-	-	-	-	-	-	SCV000320081	-	-	1157G>C 	Arg386Thr	NM_170707.4	1	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Glu455Lys	-0.7002018322598149	0.5063990015883388	-8.447337291706042	0.00006429500751423078	2025_01_Batch_13-14	0.8265669894377499	0.9153739121502169	0.9888722334786625	0.9392603930163101	0.9493802375316499	0.665053456627972	0.8656269708209633	0.9909752059810135	0.9331208421321344	0.9317151446696804	0.7458102230328609	0.8905004414855902	0.9899237197298381	0.9361906175742223	0.9405476911006652	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC011868		NC_000017.11:43074331:C:T		Glu455Lys																												BRCA1_Glu455Lys	17	43074331	C	T	17	allele	1363G>A	A10	527_CAVA_Array_P01	A19	B13A7A8P1_R1	B14A7A8P1_R2				17-43074331-C-T	37604	17	43074331	C	T	E	K	rs80356988	17	41226348	17	38479874	1559	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4675G>A	p.Glu1559Lys	principal2	Y	1	.	.	-	GAG	1	0	c	C/C	C/C	C/C	C/C	.	0.68399	.	.	0.74454	.	0.011	0.43580	B	0.006	0.35928	B	.	0.99291	.	.	.	.	1.75	0.45271	L	.	0.37944	.	.	0.78942	-0.0701	0.80692	T	0.5963	0.85548	D	9	.	0.70725	.	0.851739	0.98855	D	.	0.92017	.	.	.	.	.	.	0.80535	.	0.33367	.	0.11248	0.348278313875	0.17650	T	0.166952	0.51091	T	0.26768	0.80087	D	0.146727	0.79829	D	0.861642837524414	0.50935	D	.	0.48225	.	0.16502066	0.36448	0.16464907	0.38009	0.15768379	0.35225	0.16500245	0.38072	-3.995	0.26211	T	.	0.39417	.	0.95000846091201	0.80446	0.99910450	0.99146	0.831	0.90686	.	.	.	.	.	.	6.609515	0.95486	35.0	0.9984248885113004	0.92321	0.733049	0.67845	D	0.189406980124867	0.50447	3.256703	0.339873231586349	0.57676	3.957668	5.54	5.54	0.82883	3.53	0.64053	3.38	0.52274	5.613000	0.49136	0.591	0.32125	0.985	0.36067	1.000000	0.68239	0.995	0.73271	534	0.73376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613716	1.239380e-06	0	1	64026	1.561870e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59978	0.000000e+00	0	0	29604	0.000000e+00	0	0	44886	0.000000e+00	0	1	64026	1.561870e-05	0	0	6080	0.000000e+00	0	1	1179808	8.475960e-07	0	0	91074	0.000000e+00	0	2	20546	9.734254842791784E-5	0	0	0	0	44	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	288	0	0	426	0	0	44	0	2	21304	9.38790837401427E-5	Pathogenic	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43074331C>T	ClinGen:CA002963	C3661900|C0027672|C2676676|C0677776	604370	140162|145|145	.	Glu	Lys	46160	single nucleotide variant	NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 18, 2019	80356988	-	RCV000031185|RCV000131823|RCV000496604|RCV000482921	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43074331	43074331	17q21.31	reviewed by expert panel	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002963	2	37604	43074331	C	T	-	-	-	-	-	-	SCV001161548	-	-	4675G>A 	Glu1559Lys	NM_007294.4	3	1_Pathogenic																																																																																																									
FH	FH_Ser419Pro	1.6917016548170403	0.14165291060128632	-6.746355577654343	0.0002658955188190891	2025_01_Batch_13-14	0.9213201043130435	0.8773370007239154	0.9050679469217979	0.8950052648966569	0.9097442483214611	0.8723439684984999	0.9018804115409382	0.9215463175573746	0.9176128966731075	0.7942962155237551	0.8968320364057717	0.8896087061324268	0.9133071322395863	0.9063090807848821	0.852020231922608	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214603	CCSBVarC004056	ALE00004056	NC_000001.11:241500572:A:G	1255T>C	Ser419Pro	CEGS2	CegsMutGDEh1042	E07	GDEhDisVCh_40065	C09	1	CegsMutGDDh1042	E07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Ser419Pro	1	241500572	A	G	1											1-241500572-A-G	92451	1	241500572	A	G	S	P	rs200004220	1	241663872	1	239730495	419	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1255T>C	p.Ser419Pro	c.1255T>C	p.Ser419Pro	principal1	Y	1	YES	Select	-	TCA	1	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.865	0.99733	H	-4.94	0.81865	D	0.942	0.94916	1.0873	0.99132	D	0.9643	0.98856	D	10	0.9089949	0.90156	D	0.541982	0.95732	D	0.822	0.94297	0.474	0.54885	P07954	S419P	Loss of MoRF binding (P = 0.0866)| Gain of ubiquitination at K414 (P = 0.2044)| Loss of methylation at R421 (P = 0.225)| Loss of catalytic residue at S419 (P = 0.2816)| Loss of disorder (P = 0.2882)	0.988284473714	0.98802	0.9942181623254077	0.99417	1.10507444367	0.77742	0.735592842102	0.72276	T	0.924582	0.98660	D	0.567543	0.96347	D	0.57746	0.96286	D	0.999648451805115	0.98285	D	0.987601	0.95789	D	0.94234765	0.95416	0.89128804	0.94281	0.94234765	0.95417	0.89128804	0.94282	-14.165	0.93593	D	0.9921	0.94292	P	0.999992778285156	0.99831	0.96268230	0.94135	0.992	0.99727	.	.	.	.	.	.	5.38469	0.90245	31.0	0.99890297198214184	0.96438	0.950240	0.96356	D	1.0315813013022	0.96616	14.9433	0.929047610943649	0.96701	15.05383	5.71	5.71	0.89013	5.93	0.96971	7.0	0.76103	11.015000	0.84918	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1598452	1.876820e-06	0	1	72718	1.375180e-05	0	1	72718	1.375180e-05	0	0	886	0.000000e+00	0	0	58902	0.000000e+00	0	0	29280	0.000000e+00	0	0	44352	0.000000e+00	0	0	61956	0.000000e+00	0	0	5882	0.000000e+00	0	1	1171916	8.533030e-07	0	0	90710	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	FH-related_disorder|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241500572A>G	ClinGen:CA285322	C1708350|C0027672|C3661900	150800	523|140162	.	Ser	Pro	98360	single nucleotide variant	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Sep 23, 2024	200004220	-	RCV000078144|RCV000445624|RCV000492881|RCV004555536	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	241500572	241500572	1q43	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA285322	2	92451	241500572	A	G	-	-	-	-	-	-	SCV000109982|SCV000537264|SCV000544243|SCV000581641|SCV002535539|SCV004186966|SCV005414250	-	-	1255T>C 	Ser419Pro	NM_000143.4	2	1_Pathogenic	1	241500572	A	G	1.37695e-6																																																																																																				
FH	FH_Ser419Pro	1.6917016548170403	0.14165291060128632	-6.746355577654343	0.0002658955188190891	2025_01_Batch_13-14	0.9213201043130435	0.8773370007239154	0.9050679469217979	0.8950052648966569	0.9097442483214611	0.8723439684984999	0.9018804115409382	0.9215463175573746	0.9176128966731075	0.7942962155237551	0.8968320364057717	0.8896087061324268	0.9133071322395863	0.9063090807848821	0.852020231922608	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004056		NC_000001.11:241500572:A:G		Ser419Pro																												FH_Ser419Pro	1	241500572	A	G	1	allele	1255T>C	B03	527_CAVA_Array_P03	D05	B13A7A8P1_R1	B14A7A8P1_R2				1-241500572-A-G	92451	1	241500572	A	G	S	P	rs200004220	1	241663872	1	239730495	419	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1255T>C	p.Ser419Pro	c.1255T>C	p.Ser419Pro	principal1	Y	1	YES	Select	-	TCA	1	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.865	0.99733	H	-4.94	0.81865	D	0.942	0.94916	1.0873	0.99132	D	0.9643	0.98856	D	10	0.9089949	0.90156	D	0.541982	0.95732	D	0.822	0.94297	0.474	0.54885	P07954	S419P	Loss of MoRF binding (P = 0.0866)| Gain of ubiquitination at K414 (P = 0.2044)| Loss of methylation at R421 (P = 0.225)| Loss of catalytic residue at S419 (P = 0.2816)| Loss of disorder (P = 0.2882)	0.988284473714	0.98802	0.9942181623254077	0.99417	1.10507444367	0.77742	0.735592842102	0.72276	T	0.924582	0.98660	D	0.567543	0.96347	D	0.57746	0.96286	D	0.999648451805115	0.98285	D	0.987601	0.95789	D	0.94234765	0.95416	0.89128804	0.94281	0.94234765	0.95417	0.89128804	0.94282	-14.165	0.93593	D	0.9921	0.94292	P	0.999992778285156	0.99831	0.96268230	0.94135	0.992	0.99727	.	.	.	.	.	.	5.38469	0.90245	31.0	0.99890297198214184	0.96438	0.950240	0.96356	D	1.0315813013022	0.96616	14.9433	0.929047610943649	0.96701	15.05383	5.71	5.71	0.89013	5.93	0.96971	7.0	0.76103	11.015000	0.84918	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1598452	1.876820e-06	0	1	72718	1.375180e-05	0	1	72718	1.375180e-05	0	0	886	0.000000e+00	0	0	58902	0.000000e+00	0	0	29280	0.000000e+00	0	0	44352	0.000000e+00	0	0	61956	0.000000e+00	0	0	5882	0.000000e+00	0	1	1171916	8.533030e-07	0	0	90710	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	FH-related_disorder|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241500572A>G	ClinGen:CA285322	C1708350|C0027672|C3661900	150800	523|140162	.	Ser	Pro	98360	single nucleotide variant	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Sep 23, 2024	200004220	-	RCV000078144|RCV000445624|RCV000492881|RCV004555536	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	241500572	241500572	1q43	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA285322	2	92451	241500572	A	G	-	-	-	-	-	-	SCV000109982|SCV000537264|SCV000544243|SCV000581641|SCV002535539|SCV004186966|SCV005414250	-	-	1255T>C 	Ser419Pro	NM_000143.4	2	1_Pathogenic	1	241500572	A	G	1.37695e-6																																																																																																				
BRAF	BRAF_Gly469Glu	1.200036246927843	0.2691587309971123	-2.4349535695068565	0.04509157625446467	2025_01_Batch_13-14	0.7584429920405253	0.8194662027841655	0.8675298357279375	0.8787096855905449	0.6660433758168792	0.7701152582755088	0.9455754807623543	0.9343232747882235	0.9098661414429015	0.6535973522883113	0.764279125158017	0.88252084177326	0.9009265552580805	0.8942879135167232	0.6598203640525953	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003160		NC_000007.14:140781602:C:T		Gly469Glu																												BRAF_Gly469Glu	7	140781602	C	T	7	allele	1406G>A	H03	527_CAVA_Array_P01	O05	B13A7A8P1_R1	B14A7A8P1_R2				7-140781602-C-T	13974	7	140781602	C	T	G	E	rs121913355	7	140481402	7	140127871	469	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1406G>A	p.Gly469Glu	c.1406G>A	p.Gly469Glu	principal4	Y	.	YES	Select	-	GGA	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.999	0.92348	D	.	0.95575	.	.	.	.	3.445	0.92067	M	.	.	.	.	.	1.0760	0.98756	D	0.9172	0.97252	D	10	0.992007	0.99733	D	0.612203	0.96612	D	.	0.98001	0.992	0.99914	P15056	G469E	Loss of MoRF binding (P = 0.0591)| Gain of catalytic residue at G469 (P = 0.1084)| Gain of methylation at K473 (P = 0.1128)| Gain of phosphorylation at Y472 (P = 0.1612)| Gain of ubiquitination at K473 (P = 0.1827)	.	0.97730	.	0.97263	.	0.96811	0.941216766834	0.99500	D	0.964899	0.99571	D	0.481639	0.93706	D	0.454064	0.93626	D	0.999017953872681	0.95854	D	0.990601	0.97084	D	0.99422306	0.99940	0.9877916	0.99959	0.9873307	0.99607	0.98307276	0.99888	-13.528	0.91438	D	1.0	0.99952	P	0.999985580220805	0.99579	0.99919707	0.99211	1	0.99985	.	.	.	.	.	.	5.508136	0.91667	32.0	0.99796911589266579	0.88204	0.905235	0.85598	D	1.07569399882665	0.97644	16.51806	0.981768342919213	0.98233	17.76874	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	13024	0	0	92	0	0	110	0	0	3222	0	0	146	0	0	610	0	0	54	0	0	94	0	0	2794	0	0	3314	0	0	164	0	0	20146	0	Pathogenic	not_specified|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Melanoma|Prostate_adenocarcinoma|Neoplasm_of_the_large_intestine|not_provided|Cardio-facio-cutaneous_syndrome|Malignant_melanoma_of_skin|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1|RASopathy|Noonan_syndrome_7|Multiple_myeloma|Squamous_cell_lung_carcinoma	reviewed_by_expert_panel	NC_000007.14:g.140781602C>T	ClinGen:CA279970|OMIM:164757.0014|UniProtKB:P15056#VAR_018621	CN169374|C0553723|C0279680|C0025202|C0007112|C0009404|C3661900|C1275081|C0151779|C4551602|C5681679|C0152013|CN029449|C5555857|C3150970|C0026764|C0149782	PS115150|163950|115150|613706|254500	1340|648|98733|1340|536391|648|29073|85443	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Glu	29013	single nucleotide variant	NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)	673	BRAF	HGNC:1097	Pathogenic	1	Sep 17, 2024	121913355	-	RCV000015008|RCV000033307|RCV000211748|RCV000212152|RCV000506575|RCV002287336|RCV001813209|RCV003450641	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Cardiofaciocutaneous syndrome 1|RASopathy|Cardio-facio-cutaneous syndrome|not provided|not specified|Noonan syndrome 7|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140781602	140781602	7q34	reviewed by expert panel	18	-	N	ClinGen:CA279970,UniProtKB:P15056#VAR_018621,OMIM:164757.0014	3	13974	140781602	C	T	-	-	-	-	-	-	SCV000616361	-	-	1406G>A 	Gly469Glu	NM_004333.6	3	1_Pathogenic	7	140781602	C	T	0.0																																																																																																				
F9	F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288284	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	963994	X	139548453	A	G	Y	C	rs1927768329	X	138630612	X	138458278	161	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.99787297672792052	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	951629	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158	F9	HGNC:3551	Likely pathogenic	1	Sep 09, 2019	1927768329	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453	139548453	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439233	2	963994	139548453	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1	1_Pathogenic						188010	F9_Popp_2025_heavy_chain_var233739	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548453.0	139548453.0		482			161.0	Y	C	c.482A>G	p.Tyr161Cys	missense_variant	-0.005053132			No		Likely pathogenic	criteria provided, single submitter	Sep 09, 2019	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Tyr161Cys	Tyr161Cys	true
F9	F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288284	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	963994	X	139548453	A	G	Y	C	rs1927768329	X	138630612	X	138458278	161	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.99787297672792052	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	951629	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158	F9	HGNC:3551	Likely pathogenic	1	Sep 09, 2019	1927768329	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453	139548453	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439233	2	963994	139548453	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1	1_Pathogenic						215526	F9_Popp_2025_light_chain_var243420	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548453.0	139548453.0		482			161.0	Y	C	c.482A>G	p.Tyr161Cys	missense_variant	0.0167764641005361			No		Likely pathogenic	criteria provided, single submitter	Sep 09, 2019	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Tyr161Cys	Tyr161Cys	true
F9	F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288284	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	963994	X	139548453	A	G	Y	C	rs1927768329	X	138630612	X	138458278	161	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.99787297672792052	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	951629	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158	F9	HGNC:3551	Likely pathogenic	1	Sep 09, 2019	1927768329	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453	139548453	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439233	2	963994	139548453	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1	1_Pathogenic						243042	F9_Popp_2025_strep_2_var262782	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548453.0	139548453.0		482			161.0	Y	C	c.482A>G	p.Tyr161Cys	missense_variant	0.0249196274567227			No		Likely pathogenic	criteria provided, single submitter	Sep 09, 2019	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Tyr161Cys	Tyr161Cys	true
F9	F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288284	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	963994	X	139548453	A	G	Y	C	rs1927768329	X	138630612	X	138458278	161	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.99787297672792052	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	951629	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158	F9	HGNC:3551	Likely pathogenic	1	Sep 09, 2019	1927768329	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453	139548453	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439233	2	963994	139548453	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1	1_Pathogenic						160494	F9_Popp_2025_carboxy_gla_motif_var253101	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548453.0	139548453.0		482			161.0	Y	C	c.482A>G	p.Tyr161Cys	missense_variant	0.0005122839584507			No		Likely pathogenic	criteria provided, single submitter	Sep 09, 2019	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Tyr161Cys	Tyr161Cys	true
F9	F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288284	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	963994	X	139548453	A	G	Y	C	rs1927768329	X	138630612	X	138458278	161	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.99787297672792052	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	951629	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158	F9	HGNC:3551	Likely pathogenic	1	Sep 09, 2019	1927768329	-	RCV001238122	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548453	139548453	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439233	2	963994	139548453	A	G	-	-	-	-	-	-	SCV001410919	-	-	482A>G 	Tyr161Cys	NM_000133.4	1	1_Pathogenic						132978	F9_Popp_2025_carboxy_F9_specific_var224058	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548453.0	139548453.0		482			161.0	Y	C	c.482A>G	p.Tyr161Cys	missense_variant	0.009457715			No		Likely pathogenic	criteria provided, single submitter	Sep 09, 2019	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Tyr161Cys	Tyr161Cys	true
SHOC2	SHOC2_Thr205Ala	-0.7932454090740622	0.45367827402196725	2.8298723604947678	0.025410841904029143	2025_01_Batch_13-14	0.8085083031253772	0.8430397534984986	0.6808613914511137	0.7631580315275811	0.7875180084414044	0.6792168005819562	0.7906335064419769	0.7265913877311805	0.7882655763071058	0.582966710619111	0.7438625518536668	0.8168366299702378	0.7037263895911471	0.7757118039173434	0.6852423595302577	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2		11602		CCSBVarC028039		NC_000010.11:110964971:A:G		Thr205Ala																												SHOC2_Thr205Ala	10	110964971	A	G	10	allele	613A>G	F02	527_CAVA_Array_P06	K04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964971-A-G	448933	10	110964971	A	G	T	A	rs768411950	10	112724729	10	112714719	205	SHOC2	ENSG00000108061	ENST00000691441	ENSP00000509686	Q9UQ13	SHOC2_HUMAN	.	.	c.613A>G	p.Thr205Ala	principal1	Y	.	.	.	+	ACT	1	0	A	A/A	A/A	A/A	A/A	.	0.34240	.	.	0.39834	.	0.485	0.57842	P	0.23	0.72002	B	.	0.60618	.	.	.	.	2.615	0.76302	M	.	0.43722	.	.	0.71096	-0.9193	0.45454	T	0.1724	0.51276	T	10	.	0.48935	.	0.017149	0.38486	T	.	0.57011	0.293	0.25438	Q9UQ13	T205A	Loss of methylation at K209 (P = 0.1135)| Gain of MoRF binding (P = 0.1344)| Loss of disorder (P = 0.1735)| Gain of helix (P = 0.1736)| Gain of ubiquitination at K209 (P = 0.2261)	.	0.40260	.	0.63105	.	0.84207	0.790986120701	0.80559	T	0.271683	0.64203	T	-0.154376	0.27280	T	-0.137561	0.60050	T	0.258627751812722	0.22980	T	.	0.68925	.	0.22402976	0.44711	0.24907	0.50279	0.20188108	0.41895	0.23230855	0.48205	-5.149	0.42680	T	.	0.31635	.	0.875279691495204	0.74491	0.02179968	0.50361	0.554	0.74849	.	.	.	.	.	.	3.467778	0.48451	22.6	0.99717881961411736	0.81861	0.899008	0.84235	D	0.573813009677373	0.71391	5.666972	0.63331388771494	0.77249	6.666899	5.66	5.66	0.87274	.	.	9.325	0.96016	11.226000	0.89948	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	109120	5.498530e-05	0	13	207686	6.259450e-05	0	13	236340	5.500550e-05	0	0	7158	0.000000e+00	0	0	17086	0.000000e+00	0	0	2320	0.000000e+00	0	0	9036	0.000000e+00	0	0	13172	0.000000e+00	0	0	42756	0.000000e+00	0	6	15686	3.825070e-04	0	6	15686	3.825070e-04	0	0	16178	0.000000e+00	0	0	30454	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16512	0.000000e+00	0	1	89492	1.117420e-05	0	12	30600	3.921570e-04	0	12	30600	3.921570e-04	0	0	14862	0.000000e+00	0	0	34190	0.000000e+00	0	0	9564	0.000000e+00	0	0	17678	0.000000e+00	0	0	21384	0.000000e+00	0	1	102560	9.750390e-06	0	12	30518	3.932110e-04	0	12	30518	3.932110e-04	0	.	31	1613690	1.921060e-05	0	30	91078	3.293880e-04	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	63774	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179874	8.475480e-07	0	30	91078	3.293880e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	RASopathy	reviewed_by_expert_panel	NC_000010.11:g.110964971A>G	ClinGen:CA5689601	C5555857	.	536391	.	Thr	Ala	442530	single nucleotide variant	NM_007373.4(SHOC2):c.613A>G (p.Thr205Ala)	8036	SHOC2	HGNC:15454	Likely benign	0	Apr 18, 2017	768411950	-	RCV000521093|RCV004984937	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964971	110964971	10q25.2	reviewed by expert panel	2	-	N	ClinGen:CA5689601	2	448933	110964971	A	G	-	-	-	-	-	-	SCV000616496	-	-	613A>G 	Thr205Ala	NM_007373.4	3	2_Benign																																																																																																									
F9	F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											true	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	618117	X	139537082	A	T	E	V	rs1569481966	X	138619241	X	138446907	54	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.161A>T	p.Glu54Val	c.161A>T	p.Glu54Val	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	0.98	0.97016	A	simple_aae	2.0	98.0	3.39	0.91450	M	-5.93	0.89665	D	0.709	0.71096	1.0533	0.98185	D	0.9830	0.99480	D	10	0.9908852	0.99600	D	0.911935	0.99342	D	0.927	0.98227	0.928	0.98831	P00740	E54V	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.997881643828	0.99783	0.9863972613488678	0.98628	0.432362513328	0.43127	0.516671419144	0.41100	T	0.989494	0.99950	D	0.347386	0.86234	D	0.261219	0.86054	D	0.997980773448944	0.92867	D	0.886711	0.61285	D	0.9502473	0.96232	0.9330192	0.97262	0.94300646	0.95485	0.91379434	0.95902	-12.114	0.87581	D	0.7702	0.75883	P	0.999768326828511	0.97851	0.99998617	0.99996	0.997	0.99892	.	.	.	.	.	.	4.936893	0.81477	27.5	0.99284327618253276	0.58071	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	6.646	0.74266	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.985	0.61072	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.139537082A>T	.	CN517202	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	610192	single nucleotide variant	NM_000133.4(F9):c.161A>T (p.Glu54Val)	2158	F9	HGNC:3551	Likely pathogenic	1	Dec 11, 2017	1569481966	-	RCV000756129	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000023.11	X	139537082	139537082	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414435761	2	618117	139537082	A	T	-	-	-	-	-	-	SCV000883848	-	-	161A>T 	Glu54Val	NM_000133.4	1	1_Pathogenic						209245	F9_Popp_2025_light_chain_var241162	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537082.0	139537082.0		161			54.0	E	V	c.161A>T	p.Glu54Val	missense_variant	0.6207238790209235			No		Likely pathogenic	criteria provided, single submitter	Dec 11, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.927																																																											F9_Glu54Val	Glu54Val	true
F9	F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											true	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	618117	X	139537082	A	T	E	V	rs1569481966	X	138619241	X	138446907	54	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.161A>T	p.Glu54Val	c.161A>T	p.Glu54Val	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	0.98	0.97016	A	simple_aae	2.0	98.0	3.39	0.91450	M	-5.93	0.89665	D	0.709	0.71096	1.0533	0.98185	D	0.9830	0.99480	D	10	0.9908852	0.99600	D	0.911935	0.99342	D	0.927	0.98227	0.928	0.98831	P00740	E54V	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.997881643828	0.99783	0.9863972613488678	0.98628	0.432362513328	0.43127	0.516671419144	0.41100	T	0.989494	0.99950	D	0.347386	0.86234	D	0.261219	0.86054	D	0.997980773448944	0.92867	D	0.886711	0.61285	D	0.9502473	0.96232	0.9330192	0.97262	0.94300646	0.95485	0.91379434	0.95902	-12.114	0.87581	D	0.7702	0.75883	P	0.999768326828511	0.97851	0.99998617	0.99996	0.997	0.99892	.	.	.	.	.	.	4.936893	0.81477	27.5	0.99284327618253276	0.58071	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	6.646	0.74266	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.985	0.61072	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.139537082A>T	.	CN517202	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	610192	single nucleotide variant	NM_000133.4(F9):c.161A>T (p.Glu54Val)	2158	F9	HGNC:3551	Likely pathogenic	1	Dec 11, 2017	1569481966	-	RCV000756129	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000023.11	X	139537082	139537082	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414435761	2	618117	139537082	A	T	-	-	-	-	-	-	SCV000883848	-	-	161A>T 	Glu54Val	NM_000133.4	1	1_Pathogenic						126697	F9_Popp_2025_carboxy_F9_specific_var221800	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537082.0	139537082.0		161			54.0	E	V	c.161A>T	p.Glu54Val	missense_variant	0.0129022316852641			No		Likely pathogenic	criteria provided, single submitter	Dec 11, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.927																																																											F9_Glu54Val	Glu54Val	true
F9	F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											true	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	618117	X	139537082	A	T	E	V	rs1569481966	X	138619241	X	138446907	54	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.161A>T	p.Glu54Val	c.161A>T	p.Glu54Val	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	0.98	0.97016	A	simple_aae	2.0	98.0	3.39	0.91450	M	-5.93	0.89665	D	0.709	0.71096	1.0533	0.98185	D	0.9830	0.99480	D	10	0.9908852	0.99600	D	0.911935	0.99342	D	0.927	0.98227	0.928	0.98831	P00740	E54V	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.997881643828	0.99783	0.9863972613488678	0.98628	0.432362513328	0.43127	0.516671419144	0.41100	T	0.989494	0.99950	D	0.347386	0.86234	D	0.261219	0.86054	D	0.997980773448944	0.92867	D	0.886711	0.61285	D	0.9502473	0.96232	0.9330192	0.97262	0.94300646	0.95485	0.91379434	0.95902	-12.114	0.87581	D	0.7702	0.75883	P	0.999768326828511	0.97851	0.99998617	0.99996	0.997	0.99892	.	.	.	.	.	.	4.936893	0.81477	27.5	0.99284327618253276	0.58071	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	6.646	0.74266	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.985	0.61072	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.139537082A>T	.	CN517202	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	610192	single nucleotide variant	NM_000133.4(F9):c.161A>T (p.Glu54Val)	2158	F9	HGNC:3551	Likely pathogenic	1	Dec 11, 2017	1569481966	-	RCV000756129	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000023.11	X	139537082	139537082	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414435761	2	618117	139537082	A	T	-	-	-	-	-	-	SCV000883848	-	-	161A>T 	Glu54Val	NM_000133.4	1	1_Pathogenic						236761	F9_Popp_2025_strep_2_var260524	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537082.0	139537082.0		161			54.0	E	V	c.161A>T	p.Glu54Val	missense_variant	0.477580849			No		Likely pathogenic	criteria provided, single submitter	Dec 11, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.927																																																											F9_Glu54Val	Glu54Val	true
F9	F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											true	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	618117	X	139537082	A	T	E	V	rs1569481966	X	138619241	X	138446907	54	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.161A>T	p.Glu54Val	c.161A>T	p.Glu54Val	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	0.98	0.97016	A	simple_aae	2.0	98.0	3.39	0.91450	M	-5.93	0.89665	D	0.709	0.71096	1.0533	0.98185	D	0.9830	0.99480	D	10	0.9908852	0.99600	D	0.911935	0.99342	D	0.927	0.98227	0.928	0.98831	P00740	E54V	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.997881643828	0.99783	0.9863972613488678	0.98628	0.432362513328	0.43127	0.516671419144	0.41100	T	0.989494	0.99950	D	0.347386	0.86234	D	0.261219	0.86054	D	0.997980773448944	0.92867	D	0.886711	0.61285	D	0.9502473	0.96232	0.9330192	0.97262	0.94300646	0.95485	0.91379434	0.95902	-12.114	0.87581	D	0.7702	0.75883	P	0.999768326828511	0.97851	0.99998617	0.99996	0.997	0.99892	.	.	.	.	.	.	4.936893	0.81477	27.5	0.99284327618253276	0.58071	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	6.646	0.74266	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.985	0.61072	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.139537082A>T	.	CN517202	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	610192	single nucleotide variant	NM_000133.4(F9):c.161A>T (p.Glu54Val)	2158	F9	HGNC:3551	Likely pathogenic	1	Dec 11, 2017	1569481966	-	RCV000756129	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000023.11	X	139537082	139537082	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414435761	2	618117	139537082	A	T	-	-	-	-	-	-	SCV000883848	-	-	161A>T 	Glu54Val	NM_000133.4	1	1_Pathogenic						181729	F9_Popp_2025_heavy_chain_var231481	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537082.0	139537082.0		161			54.0	E	V	c.161A>T	p.Glu54Val	missense_variant	0.7034075113107217			No		Likely pathogenic	criteria provided, single submitter	Dec 11, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.927																																																											F9_Glu54Val	Glu54Val	true
F9	F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											true	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	618117	X	139537082	A	T	E	V	rs1569481966	X	138619241	X	138446907	54	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.161A>T	p.Glu54Val	c.161A>T	p.Glu54Val	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	0.98	0.97016	A	simple_aae	2.0	98.0	3.39	0.91450	M	-5.93	0.89665	D	0.709	0.71096	1.0533	0.98185	D	0.9830	0.99480	D	10	0.9908852	0.99600	D	0.911935	0.99342	D	0.927	0.98227	0.928	0.98831	P00740	E54V	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.997881643828	0.99783	0.9863972613488678	0.98628	0.432362513328	0.43127	0.516671419144	0.41100	T	0.989494	0.99950	D	0.347386	0.86234	D	0.261219	0.86054	D	0.997980773448944	0.92867	D	0.886711	0.61285	D	0.9502473	0.96232	0.9330192	0.97262	0.94300646	0.95485	0.91379434	0.95902	-12.114	0.87581	D	0.7702	0.75883	P	0.999768326828511	0.97851	0.99998617	0.99996	0.997	0.99892	.	.	.	.	.	.	4.936893	0.81477	27.5	0.99284327618253276	0.58071	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	6.646	0.74266	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.985	0.61072	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.139537082A>T	.	CN517202	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	610192	single nucleotide variant	NM_000133.4(F9):c.161A>T (p.Glu54Val)	2158	F9	HGNC:3551	Likely pathogenic	1	Dec 11, 2017	1569481966	-	RCV000756129	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000023.11	X	139537082	139537082	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414435761	2	618117	139537082	A	T	-	-	-	-	-	-	SCV000883848	-	-	161A>T 	Glu54Val	NM_000133.4	1	1_Pathogenic						154213	F9_Popp_2025_carboxy_gla_motif_var250843	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537082.0	139537082.0		161			54.0	E	V	c.161A>T	p.Glu54Val	missense_variant	0.7650353777003946			No		Likely pathogenic	criteria provided, single submitter	Dec 11, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.927																																																											F9_Glu54Val	Glu54Val	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		248741	F9_Popp_2025_strep_2_var264774	F9_Popp_2025_strep_2	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.2648858589123566			No					aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		248741	F9_Popp_2025_strep_2_var264774	F9_Popp_2025_strep_2	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.2648858589123566			No					aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		138677	F9_Popp_2025_carboxy_F9_specific_var226050	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.0367885946044001			No					aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		138677	F9_Popp_2025_carboxy_F9_specific_var226050	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.0367885946044001			No					aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		221225	F9_Popp_2025_light_chain_var245412	F9_Popp_2025_light_chain	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.038018179			No					aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		221225	F9_Popp_2025_light_chain_var245412	F9_Popp_2025_light_chain	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.038018179			No					aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		193709	F9_Popp_2025_heavy_chain_var235731	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.091556578			No					aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		193709	F9_Popp_2025_heavy_chain_var235731	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.091556578			No					aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		166193	F9_Popp_2025_carboxy_gla_motif_var255093	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.0164006844039541			No					aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
F9	F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											true	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		166193	F9_Popp_2025_carboxy_gla_motif_var255093	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139560784.0	139560784.0		767			256.0	I	T	c.767T>C	p.Ile256Thr	missense_variant	0.0164006844039541			No					aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile256Thr	Ile256Thr	true
BRCA1	BRCA1_Val275Ile	-0.4219542876087648	0.6857151825709713	2.6645481179410244	0.03225365624269281	2025_01_Batch_13-14	0.7971938108459706	0.9154008456443704	0.7399972816189054	0.7702698951602724	0.6222736911823423	0.9934358013689744	0.9575499119286874	0.9609089410020877	0.9940636425450285	0.9210876525622533	0.8953148061074725	0.936475378786529	0.8504531113104965	0.8821667688526504	0.7716806718722978	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013078		NC_000017.11:43090997:C:T		Val275Ile																												BRCA1_Val275Ile	17	43090997	C	T	17	allele	823G>A	H10	527_CAVA_Array_P01	O19	B13A7A8P1_R1	B14A7A8P1_R2				17-43090997-C-T	55111	17	43090997	C	T	V	I	rs28897690	17	41243014	17	38496540	1378	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4132G>A	p.Val1378Ile	c.4132G>A	p.Val1378Ile	principal2	Y	1	YES	Select	-	GTC	1	0	C	C/C	C/C	C/C	C/C	0.214	0.26644	T	0.235	0.32573	T	0.001	0.32504	B	0.0	0.18137	B	0.01	0.13669	N	simple_aae	99.0	1.0	-0.69	0.01960	N	-0.03	0.09903	N	0.195	0.22590	-0.7244	0.59072	T	0.3134	0.68210	T	10	0.012888253	0.00272	T	0.079338	0.73121	D	0.497	0.78048	.	.	.	.	.	0.158396225186	0.15034	.	0.03344	.	0.07277	0.214491963387	0.01019	T	0.079098	0.35782	T	-0.262208	0.12388	T	-0.205768	0.53787	T	0.0166096592434054	0.00420	T	.	0.29041	.	0.019548856	0.00487	0.028340364	0.01070	0.016553821	0.00205	0.02649676	0.00748	-3.941	0.23134	T	0.0686	0.07209	B	0.000385430296663524	0.05956	0.96491360	0.94286	0.084	0.23719	.	.	.	.	.	.	-0.113362	0.03572	0.688	0.76991446859715706	0.11882	0.095446	0.19078	N	-1.3898584281667	0.02705	0.1210794	-1.32035774990261	0.04105	0.1960024	4.66	0.167	0.14242	-6.06	0.02993	-0.366	0.07635	0.284000	0.16868	-2.609	0.00233	0.0	0.06393	0.024000	0.21036	0.529	0.2973	519	0.74474	.	.	.	.	.	.	.	.	.	.	.	.	129	264690	4.873626E-4	.	19	108190	1.756170e-04	0	27	206062	1.310290e-04	0	41	234636	1.747390e-04	1	0	6938	0.000000e+00	0	16	16980	9.422850e-04	0	0	2220	0.000000e+00	0	1	9016	1.109140e-04	0	0	13288	0.000000e+00	0	2	42360	4.721440e-05	0	0	15500	0.000000e+00	0	16	16980	9.422850e-04	0	0	15900	0.000000e+00	0	18	30256	5.949230e-04	0	0	6090	0.000000e+00	0	1	13376	7.476080e-05	0	0	16568	0.000000e+00	0	5	88838	5.628220e-05	0	2	30224	6.617260e-05	0	18	30256	5.949230e-04	0	0	14596	0.000000e+00	0	34	33994	1.000180e-03	1	0	9436	0.000000e+00	0	1	17648	5.666360e-05	0	0	21354	0.000000e+00	0	4	101906	3.925190e-05	0	2	30142	6.635260e-05	0	34	33994	1.000180e-03	1	.	164	1612732	1.016910e-04	1	89	59814	1.487950e-03	1	1	74898	1.335150e-05	0	0	912	0.000000e+00	0	89	59814	1.487950e-03	1	1	29506	3.389140e-05	0	1	44890	2.227670e-05	0	0	63834	0.000000e+00	0	4	6084	6.574620e-04	0	61	1179578	5.171340e-05	0	5	90788	5.507340e-05	0	2	26660	7.501875468867217E-5	0	114	0	0	120	0	0	3236	0	0	498	0	0	628	0	0	26	0	0	104	0	0	4696	0	0	3350	0	0	146	0	2	36082	5.542929992794191E-5	Benign	Malignant_tumor_of_breast|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43090997C>T	ClinGen:CA002653|UniProtKB:P38398#VAR_070487	C0006142|CN169374|C3661900|C0677776|CN221562|C2676676|C0027672	604370	145|145|140162	.	Val	Ile	69778	single nucleotide variant	NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	672	BRCA1	HGNC:1100	Benign	0	Jun 18, 2019	28897690	-	RCV000048456|RCV000112269|RCV000130952|RCV000195345|RCV000735522|RCV000588834|RCV001353555|RCV004803994	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43090997	43090997	17q21.31	reviewed by expert panel	18	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002653,UniProtKB:P38398#VAR_070487	2	55111	43090997	C	T	-	-	-	-	-	-	SCV001161590	-	-	4132G>A 	Val1378Ile	NM_007294.4	3	2_Benign																																																																																																									
KRAS	KRAS_Gly60Ser	-0.09720436679761342	0.9252887309563864	1.0463836155630004	0.3301649148324332																											true	KRAS	ENSG00000133703	3084	214489	CCSBVarC006098	ALE00006098	NC_000012.12:25227346:C:T	178G>A	Gly60Ser	CEGS2	CegsMutGDEh1036	F02	GDEhDisVCh_40061	A09	1	CegsMutGDDh1036	F02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	3	0			0			0			KRAS_Gly60Ser	12	25227346	C	T	12											12-25227346-C-T	12597	12	25227346	C	T	G	S	rs104894359	12	25380280	12	25271547	60	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>A	p.Gly60Ser	c.178G>A	p.Gly60Ser	alternative1	Y	1	.	Plus_Clinical	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.195	0.88911	M	-5.82	0.88318	D	0.958	0.96773	1.0665	0.98496	D	0.9342	0.97828	D	10	0.9487096	0.94136	D	0.407238	0.93510	D	0.943	0.98815	0.776	0.90105	P01116	G60S	Gain of catalytic residue at L56 (P = 0.0034)| Gain of disorder (P = 0.0769)| Gain of phosphorylation at G60 (P = 0.0926)| Loss of sheet (P = 0.1398)| Loss of helix (P = 0.2022)	0.996255802933	0.99616	0.9459025843081321	0.94539	2.69341285729	0.98552	0.926605463028	0.98783	D	0.929646	0.98786	D	0.524795	0.94982	D	0.516055	0.94909	D	0.999157786369324	0.96329	D	0.966103	0.87543	D	0.98016226	0.99107	0.96225566	0.99077	0.9698139	0.98214	0.94146484	0.97832	-12.139	0.87851	D	0.9985	0.98500	P	0.999680939266056	0.97477	0.99929273	0.99274	0.997	0.99892	.	.	.	.	.	.	5.28558	0.88766	29.7	0.9989031345780135	0.96438	0.908603	0.86363	D	1.06893418515311	0.97500	16.26098	0.997770489382923	0.98575	18.70474	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	not_provided|RASopathy|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25227346C>T	ClinGen:CA256484|OMIM:190070.0020|UniProtKB:P01116#VAR_065146	C3661900|C5555857|C1860991|C3809005	609942|615278	536391|648|1340	Small GTP-binding domain	Gly	Ser	27636	single nucleotide variant	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	3845	KRAS	HGNC:6407	Pathogenic	1	Mar 29, 2024	104894359	-	RCV000013428|RCV000157934|RCV000689097|RCV002470709	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	de novo;germline	germline	GRCh38	NC_000012.12	12	25227346	25227346	12p12.1	criteria provided, multiple submitters, no conflicts	6	-	N	OMIM:190070.0020,ClinGen:CA256484,UniProtKB:P01116#VAR_065146	3	12597	25227346	C	T	-	-	-	-	-	-	SCV000207869|SCV000816735|SCV002318974|SCV002768383	-	-	178G>A 	Gly60Ser	NM_033360.4	2	1_Pathogenic																																																																																																									
KRAS	KRAS_Gly60Ser	-0.09720436679761342	0.9252887309563864	1.0463836155630004	0.3301649148324332																											true	KRAS		3084		CCSBVarC006098		NC_000012.12:25227346:C:T		Gly60Ser																												KRAS_Gly60Ser	12	25227346	C	T	12	allele	178G>A	H07	527_CAVA_Array_P03	P13	B13A7A8P1_R1	B14A7A8P1_R2				12-25227346-C-T	12597	12	25227346	C	T	G	S	rs104894359	12	25380280	12	25271547	60	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>A	p.Gly60Ser	c.178G>A	p.Gly60Ser	alternative1	Y	1	.	Plus_Clinical	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.195	0.88911	M	-5.82	0.88318	D	0.958	0.96773	1.0665	0.98496	D	0.9342	0.97828	D	10	0.9487096	0.94136	D	0.407238	0.93510	D	0.943	0.98815	0.776	0.90105	P01116	G60S	Gain of catalytic residue at L56 (P = 0.0034)| Gain of disorder (P = 0.0769)| Gain of phosphorylation at G60 (P = 0.0926)| Loss of sheet (P = 0.1398)| Loss of helix (P = 0.2022)	0.996255802933	0.99616	0.9459025843081321	0.94539	2.69341285729	0.98552	0.926605463028	0.98783	D	0.929646	0.98786	D	0.524795	0.94982	D	0.516055	0.94909	D	0.999157786369324	0.96329	D	0.966103	0.87543	D	0.98016226	0.99107	0.96225566	0.99077	0.9698139	0.98214	0.94146484	0.97832	-12.139	0.87851	D	0.9985	0.98500	P	0.999680939266056	0.97477	0.99929273	0.99274	0.997	0.99892	.	.	.	.	.	.	5.28558	0.88766	29.7	0.9989031345780135	0.96438	0.908603	0.86363	D	1.06893418515311	0.97500	16.26098	0.997770489382923	0.98575	18.70474	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	not_provided|RASopathy|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25227346C>T	ClinGen:CA256484|OMIM:190070.0020|UniProtKB:P01116#VAR_065146	C3661900|C5555857|C1860991|C3809005	609942|615278	536391|648|1340	Small GTP-binding domain	Gly	Ser	27636	single nucleotide variant	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	3845	KRAS	HGNC:6407	Pathogenic	1	Mar 29, 2024	104894359	-	RCV000013428|RCV000157934|RCV000689097|RCV002470709	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	de novo;germline	germline	GRCh38	NC_000012.12	12	25227346	25227346	12p12.1	criteria provided, multiple submitters, no conflicts	6	-	N	OMIM:190070.0020,ClinGen:CA256484,UniProtKB:P01116#VAR_065146	3	12597	25227346	C	T	-	-	-	-	-	-	SCV000207869|SCV000816735|SCV002318974|SCV002768383	-	-	178G>A 	Gly60Ser	NM_033360.4	2	1_Pathogenic																																																																																																									
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						210285	F9_Popp_2025_light_chain_var241561	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.9295306653411096			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						210285	F9_Popp_2025_light_chain_var241561	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.9295306653411096			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						127737	F9_Popp_2025_carboxy_F9_specific_var222199	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.007236438			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						127737	F9_Popp_2025_carboxy_F9_specific_var222199	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.007236438			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						155253	F9_Popp_2025_carboxy_gla_motif_var251242	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.9857232342018252			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						155253	F9_Popp_2025_carboxy_gla_motif_var251242	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.9857232342018252			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						237801	F9_Popp_2025_strep_2_var260923	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	1.190102844703168			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						237801	F9_Popp_2025_strep_2_var260923	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	1.190102844703168			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						182769	F9_Popp_2025_heavy_chain_var231880	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.8639407670617942			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444636	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520081	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic						182769	F9_Popp_2025_heavy_chain_var231880	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537139.0	139537139.0		218			73.0	E	V	c.218A>T	p.Glu73Val	missense_variant	0.8639407670617942			No		Pathogenic	no assertion criteria provided	Feb 19, 1990	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Glu73Val	Glu73Val	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	189871	F9_Popp_2025_heavy_chain_var234373	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	1.0142334797704238			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	189871	F9_Popp_2025_heavy_chain_var234373	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	1.0142334797704238			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	134839	F9_Popp_2025_carboxy_F9_specific_var224692	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.7881751920285752			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	134839	F9_Popp_2025_carboxy_F9_specific_var224692	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.7881751920285752			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	162355	F9_Popp_2025_carboxy_gla_motif_var253735	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.8607407016784892			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	162355	F9_Popp_2025_carboxy_gla_motif_var253735	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.8607407016784892			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	217387	F9_Popp_2025_light_chain_var244054	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.9560010972432093			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	217387	F9_Popp_2025_light_chain_var244054	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.9560010972432093			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	244903	F9_Popp_2025_strep_2_var263416	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.927009116			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
F9	F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	X	139551113	G	A	2.73283e-6	244903	F9_Popp_2025_strep_2_var263416	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551113.0	139551113.0		572			191.0	R	H	c.572G>A	p.Arg191His	missense_variant	0.927009116			No	3.306932985e-6	Pathogenic	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.73																																								10585.0	CA255342	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PM1_Strong,PS4,PP3	PM2,PS3_Supporting,PP1,PM5	The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	779,746,624,759,143	Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab	36190763-aaae-49d3-a95b-1e8f8f6199ab	Pathogenic	PM1_Strong,PS4	F9_Arg191His	Arg191His	true
SHOC2	SHOC2_Ser4Arg	-2.115892778315492	0.07215780633141851	-0.3869856389427146	0.7102627631544374	2025_01_Batch_13-14	0.9179761181055074	0.9180943736465743	0.8794101522916892	0.9142199019956667	0.866539458520815	0.6755180544798177	0.8080985350876836	0.7424990989446605	0.7389737139587964	0.6404521495380249	0.7967470862926626	0.8630964543671289	0.8109546256181748	0.8265968079772316	0.75349580402942	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2		11602		CCSBVarC027999		NC_000010.11:110964368:A:C		Ser4Arg																												SHOC2_Ser4Arg	10	110964368	A	C	10	allele	10A>C	G01	527_CAVA_Array_P06	M02	B13A7A8P2_R1	B14A7A8P2_R2				10-110964368-A-C	40635	10	110964368	A	C	S	R	rs397517231	10	112724126	10	112714116	4	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.10A>C	p.Ser4Arg	principal1	Y	.	.	.	+	AGT	1	0	A	A/A	A/A	A/A	A/A	.	0.56615	.	.	0.41419	.	0.079	0.24484	B	0.023	0.19965	B	.	0.68318	.	.	.	.	1.39	0.34781	L	.	0.27215	.	.	0.39714	-1.0816	0.07056	T	0.0556	0.23288	T	10	.	0.00200	.	0.006028	0.15489	T	.	0.31580	0.368	0.37543	Q9UQ13	S4R	Loss of phosphorylation at S4 (P = 9e-04)| Gain of MoRF binding (P = 0.0056)| Loss of sheet (P = 0.0315)| Gain of loop (P = 0.069)| Loss of ubiquitination at K7 (P = 0.0702)	.	0.13132	.	0.01051	.	0.52424	0.607206702232	0.53855	T	0.200839	0.55638	T	-0.417862	0.01658	T	-0.376684	0.35750	T	0.0736649466610808	0.09046	T	.	0.74124	.	0.267935	0.49535	0.2938221	0.55197	0.32933065	0.55084	0.33612105	0.59185	-3.61	0.18016	T	.	0.64952	.	0.164860101419667	0.48012	0.00392193	0.30410	0.247	0.51713	.	.	.	.	.	.	3.701145	0.52871	23.3	0.99493880126885215	0.67671	0.875239	0.79781	D	-0.0156583439103937	0.40882	2.456036	0.218876124825274	0.50640	3.276892	5.62	5.62	0.85695	.	.	7.104	0.76723	9.339000	0.80231	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	47	264690	1.7756621E-4	.	56	108758	5.149050e-04	0	101	205586	4.912790e-04	0	104	233670	4.450720e-04	0	0	7132	0.000000e+00	0	54	16920	3.191490e-03	0	0	2310	0.000000e+00	0	0	8928	0.000000e+00	0	0	13386	0.000000e+00	0	0	42570	0.000000e+00	0	0	15610	0.000000e+00	0	54	16920	3.191490e-03	0	0	15362	0.000000e+00	0	99	30182	3.280100e-03	0	0	6158	0.000000e+00	0	0	13368	0.000000e+00	0	0	16712	0.000000e+00	0	0	88600	0.000000e+00	0	0	30440	0.000000e+00	0	99	30182	3.280100e-03	0	0	14110	0.000000e+00	0	102	33912	3.007780e-03	0	0	9530	0.000000e+00	0	0	17430	0.000000e+00	0	0	21590	0.000000e+00	0	0	101240	0.000000e+00	0	0	30358	0.000000e+00	0	102	33912	3.007780e-03	0	.	125	1613066	7.749220e-05	0	124	59742	2.075590e-03	0	0	74862	0.000000e+00	0	0	912	0.000000e+00	0	124	59742	2.075590e-03	0	0	29586	0.000000e+00	0	0	44892	0.000000e+00	0	0	63988	0.000000e+00	0	0	6080	0.000000e+00	0	0	1179630	0.000000e+00	0	0	90932	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	2	610	0.003278688524590164	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	2	14710	1.3596193065941537E-4	Benign	SHOC2-related_disorder|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	reviewed_by_expert_panel	NC_000010.11:g.110964368A>C	ClinGen:CA136657	C3661900|C5555857|C4478716|CN169374	607721	536391|2701	.	Ser	Arg	49105	single nucleotide variant	NM_007373.4(SHOC2):c.10A>C (p.Ser4Arg)	8036	SHOC2	HGNC:15454	Benign	0	Sep 17, 2024	397517231	-	RCV000680308|RCV003914899|RCV000038777|RCV000518991|RCV001286384	MedGen:C3661900||MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	not provided|SHOC2-related disorder|not specified|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1	germline;unknown	germline	GRCh38	NC_000010.11	10	110964368	110964368	10q25.2	reviewed by expert panel	8	-	N	ClinGen:CA136657	2	40635	110964368	A	C	-	-	-	-	-	-	SCV000616429	-	-	10A>C 	Ser4Arg	NM_007373.4	3	2_Benign																																																																																																									
RAD51D	RAD51D_Cys9Ser	-0.430044793701963	0.6800918575546037	5.4449101766361565	0.0009611984439907126	2025_01_Batch_13-14	0.6324635710169321	0.8021323314471392	0.887076778154518	0.818850060236358	0.6706305219371522	0.9002881466248781	0.8716861670864113	0.9283657869044879	0.9291992671149147	0.8615728726581611	0.7663758588209051	0.8369092492667753	0.9077212825295029	0.8740246636756364	0.7661016972976566	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024707		NC_000017.11:35119588:C:G		Cys9Ser																												RAD51D_Cys9Ser	17	35119588	C	G	17	allele	26G>C	B01	527_CAVA_Array_P05	C01	B13A7A8P2_R1	B14A7A8P2_R2				17-35119588-C-G	127886	17	35119588	C	G	C	S	rs140825795	17	33446607	17	30470720	9	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.26G>C	p.Cys9Ser	c.26G>C	p.Cys9Ser	principal1	Y	5	.	.	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.005	0.79703	D	0.948	0.77914	P	0.539	0.82066	P	0.0	0.33788	N	simple_aae	100.0	0.0	2.37	0.68084	M	-5.89	0.91889	D	0.767	0.76382	-0.5618	0.66187	T	0.3025	0.67215	T	10	0.23021111	0.39578	T	0.269442	0.89798	D	0.218	0.51046	0.75	0.88011	O75771	C9S	Gain of disorder (P = 0.0024)| Gain of phosphorylation at C9 (P = 0.0829)| Gain of methylation at R5 (P = 0.2031)| Gain of helix (P = 0.2294)| Gain of catalytic residue at G7 (P = 0.288)	0.89673440463	0.89492	.	0.75662	.	0.38233	.	.	.	0.542336	0.84209	D	-0.0621782	0.42220	T	0.0874681	0.75898	D	0.123274603139513	0.14560	T	0.89681	0.63880	D	0.90909326	0.92096	0.91432685	0.95940	0.9053122	0.91745	0.9265354	0.96810	-13.828	0.92500	D	0.7562	0.75474	P	0.0197165020029777	0.29331	0.98283120	0.95814	0.694	0.83023	.	.	.	.	.	.	4.809918	0.78275	26.9	0.99055369264790372	0.51428	0.811646	0.73360	D	0.419960104252545	0.62325	4.469254	0.393835298150661	0.60976	4.315044	4.5	4.5	0.54328	.	.	3.449	0.52806	7.405000	0.58667	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.842	0.39783	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	112	264690	4.231365E-4	.	27	108026	2.499400e-04	1	83	204386	4.060940e-04	1	81	233462	3.469520e-04	1	0	7118	0.000000e+00	0	6	17088	3.511240e-04	1	0	2320	0.000000e+00	0	0	9008	0.000000e+00	0	1	12198	8.198070e-05	0	20	42712	4.682520e-04	0	0	15682	0.000000e+00	0	20	42712	4.682520e-04	0	1	16132	6.198860e-05	0	12	30494	3.935200e-04	1	0	6188	0.000000e+00	0	0	13354	0.000000e+00	0	1	15538	6.435830e-05	0	68	87248	7.793870e-04	0	0	30600	0.000000e+00	0	68	87248	7.793870e-04	0	1	14856	6.731290e-05	0	13	34236	3.797170e-04	1	0	9562	0.000000e+00	0	0	17654	0.000000e+00	0	1	20436	4.893330e-05	0	64	100606	6.361450e-04	0	0	30518	0.000000e+00	0	64	100606	6.361450e-04	0	.	1058	1612440	6.561480e-04	1	980	1179946	8.305460e-04	0	12	75044	1.599060e-04	0	0	912	0.000000e+00	0	15	60030	2.498750e-04	1	0	29602	0.000000e+00	0	0	44872	0.000000e+00	0	2	62412	3.204510e-05	0	0	6062	0.000000e+00	0	980	1179946	8.305460e-04	0	0	91086	0.000000e+00	0	56	93168	6.010647432594882E-4	0	174	0	0	2674	0	0	4182	0	1	772	0.0012953367875647669	0	946	0	0	656	0	0	274	0	3	7122	4.2122999157540015E-4	0	4356	0	0	3330	0	60	109968	5.456132693147098E-4	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|RAD51D-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119588C>G	ClinGen:CA287968	C0006142|CN221562|C3280345|C1333600|CN169374|C0027672|C3661900	614291	145|140162	RAD51D, N-terminal domain	Cys	Ser	133343	single nucleotide variant	NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Mar 04, 2025	140825795	-	RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35119588	35119588	17q12	criteria provided, conflicting classifications	20	-	N	ClinGen:CA287968	2	127886	35119588	C	G	-	-	-	-	-	-	SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788	-	-	26G>C 	Cys9Ser	NM_002878.4	1	3_Conflicting						963127	RAD51D_unpublished_var157374	RAD51D_unpublished	RAD51D	9823.0	-1.0		35119588.0	35119588.0		26	G	C	9.0	C	S	c.26G>C	p.Cys9Ser	missense_variant	-0.00763888		functionally_normal	Yes	0.0006561484458336	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Nov 18, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.218																																																											RAD51D_Cys9Ser	Cys9Ser	true
FH	FH_His318Tyr	3.1703971636548824	0.019309050557584827	-8.740897838119132	0.000051562458963120044	2025_01_Batch_13-14	0.7185095770613064	0.9010962748991456	0.9437543763498761	0.9152637329177788	0.8993966433284734	0.718969205371559	0.8743944008886777	0.9583120119302941	0.9231214824713794	0.9184497594941273	0.7187393912164326	0.8877453378939116	0.9510331941400851	0.9191926076945791	0.9089232014113003	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	true	FH	ENSG00000091483	3408	214597	CCSBVarC004052	ALE00004052	NC_000001.11:241504198:G:A	952C>T	His318Tyr	CEGS2	CegsMutGDEh1041	E03	GDEhDisVCh_40065	G08	1	CegsMutGDDh1041	E03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_His318Tyr	1	241504198	G	A	1											1-241504198-G-A	92458	1	241504198	G	A	H	Y	rs398123168	1	241667498	1	239734121	318	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.952C>T	p.His318Tyr	c.952C>T	p.His318Tyr	principal1	Y	1	YES	Select	-	CAT	1	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.79703	D	0.998	0.73231	D	0.967	0.71532	D	0.51	0.71237	A	simple_aae	49.0	51.0	4.24	0.97965	H	-5.19	0.83652	D	0.855	0.85095	1.0075	0.97307	D	0.9896	0.99711	D	10	0.96449435	0.95861	D	0.783796	0.98295	D	0.981	0.99874	0.748	0.87844	P07954	H318Y	Gain of phosphorylation at H318 (P = 0.111)| Loss of catalytic residue at D319 (P = 0.1709)| Loss of disorder (P = 0.2552)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	0.970197299285	0.96959	0.9644412197578099	0.96411	1.04814267846	0.75889	0.870154500008	0.92578	D	0.96242	0.99523	D	0.580039	0.96967	D	0.595409	0.96917	D	0.998691618442535	0.94843	D	0.990021	0.96938	D	0.95636344	0.96862	0.92381674	0.96618	0.95636344	0.96862	0.92381674	0.96619	-11.478	0.82269	D	0.8651	0.80553	P	0.999672043470544	0.97434	0.96164210	0.94067	0.997	0.99892	.	.	.	.	.	.	4.864406	0.79665	27.1	0.99843370951524324	0.92321	0.934609	0.92797	D	1.05284626535223	0.97140	15.67457	0.99436337600402	0.98507	18.50119	5.73	5.73	0.89714	6.28	0.98834	9.346	0.96466	9.909000	0.82440	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.976	0.56441	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614178	6.195100e-07	0	1	1180018	8.474450e-07	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180018	8.474450e-07	0	0	91080	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_leiomyomatosis_and_renal_cell_cancer|Fumarase_deficiency|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504198G>A	ClinGen:CA285329	C1708350|C0342770|C3661900|C0027672	150800|606812	523|24|140162	Fumarate lyase, N-terminal	His	Tyr	98367	single nucleotide variant	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Mar 04, 2025	398123168	-	RCV000078152|RCV000445608|RCV000762893|RCV003460742|RCV002371923	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241504198	241504198	1q43	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA285329	2	92458	241504198	G	A	-	-	-	-	-	-	SCV000109990|SCV000251474|SCV000537249|SCV000756697|SCV000893293|SCV002580555|SCV002688460|SCV004187986|SCV004197372|SCV005090906|SCV005394266|SCV005625606	-	-	952C>T 	His318Tyr	NM_000143.4	2	1_Pathogenic	1	241504198	G	A	6.84061e-7																																																																																																				
FH	FH_His318Tyr	3.1703971636548824	0.019309050557584827	-8.740897838119132	0.000051562458963120044	2025_01_Batch_13-14	0.7185095770613064	0.9010962748991456	0.9437543763498761	0.9152637329177788	0.8993966433284734	0.718969205371559	0.8743944008886777	0.9583120119302941	0.9231214824713794	0.9184497594941273	0.7187393912164326	0.8877453378939116	0.9510331941400851	0.9191926076945791	0.9089232014113003	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	true	FH		3408		CCSBVarC004052		NC_000001.11:241504198:G:A		His318Tyr																												FH_His318Tyr	1	241504198	G	A	1	allele	952C>T	G03	527_CAVA_Array_P03	N05	B13A7A8P1_R1	B14A7A8P1_R2				1-241504198-G-A	92458	1	241504198	G	A	H	Y	rs398123168	1	241667498	1	239734121	318	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.952C>T	p.His318Tyr	c.952C>T	p.His318Tyr	principal1	Y	1	YES	Select	-	CAT	1	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.79703	D	0.998	0.73231	D	0.967	0.71532	D	0.51	0.71237	A	simple_aae	49.0	51.0	4.24	0.97965	H	-5.19	0.83652	D	0.855	0.85095	1.0075	0.97307	D	0.9896	0.99711	D	10	0.96449435	0.95861	D	0.783796	0.98295	D	0.981	0.99874	0.748	0.87844	P07954	H318Y	Gain of phosphorylation at H318 (P = 0.111)| Loss of catalytic residue at D319 (P = 0.1709)| Loss of disorder (P = 0.2552)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	0.970197299285	0.96959	0.9644412197578099	0.96411	1.04814267846	0.75889	0.870154500008	0.92578	D	0.96242	0.99523	D	0.580039	0.96967	D	0.595409	0.96917	D	0.998691618442535	0.94843	D	0.990021	0.96938	D	0.95636344	0.96862	0.92381674	0.96618	0.95636344	0.96862	0.92381674	0.96619	-11.478	0.82269	D	0.8651	0.80553	P	0.999672043470544	0.97434	0.96164210	0.94067	0.997	0.99892	.	.	.	.	.	.	4.864406	0.79665	27.1	0.99843370951524324	0.92321	0.934609	0.92797	D	1.05284626535223	0.97140	15.67457	0.99436337600402	0.98507	18.50119	5.73	5.73	0.89714	6.28	0.98834	9.346	0.96466	9.909000	0.82440	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.976	0.56441	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614178	6.195100e-07	0	1	1180018	8.474450e-07	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180018	8.474450e-07	0	0	91080	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_leiomyomatosis_and_renal_cell_cancer|Fumarase_deficiency|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504198G>A	ClinGen:CA285329	C1708350|C0342770|C3661900|C0027672	150800|606812	523|24|140162	Fumarate lyase, N-terminal	His	Tyr	98367	single nucleotide variant	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Mar 04, 2025	398123168	-	RCV000078152|RCV000445608|RCV000762893|RCV003460742|RCV002371923	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241504198	241504198	1q43	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA285329	2	92458	241504198	G	A	-	-	-	-	-	-	SCV000109990|SCV000251474|SCV000537249|SCV000756697|SCV000893293|SCV002580555|SCV002688460|SCV004187986|SCV004197372|SCV005090906|SCV005394266|SCV005625606	-	-	952C>T 	His318Tyr	NM_000143.4	2	1_Pathogenic	1	241504198	G	A	6.84061e-7																																																																																																				
FH	FH_Arg233Cys	0.840040754452072	0.4330774414127768	-0.5768098835051846	0.5821337323712967	2025_01_Batch_13-14	0.5681956161990315	0.591142855004605	0.7443955154689178	0.7275652312524326	0.4790616233228787	0.5987548645396555	0.687703462456375	0.7959572347361038	0.7904062805896533	0.5762077703311804	0.5834752403693435	0.6394231587304899	0.7701763751025108	0.7589857559210429	0.5276346968270296	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214594	CCSBVarC004049	ALE00004049	NC_000001.11:241508644:G:A	697C>T	Arg233Cys	CEGS2	CegsMutGDEh1039	B12	GDEhDisVCh_40065	D08	1	CegsMutGDDh1039	B12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Arg233Cys	1	241508644	G	A	1											1-241508644-G-A	141355	1	241508644	G	A	R	C	rs587781682	1	241671944	1	239738567	233	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.697C>T	p.Arg233Cys	c.697C>T	p.Arg233Cys	principal1	Y	1	YES	Select	-	CGT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	5.07	0.99905	H	-7.81	0.95967	D	0.962	0.97221	0.9273	0.96051	D	0.9945	0.99874	D	10	0.9892357	0.99374	D	0.699957	0.97538	D	0.949	0.99024	0.89	0.97304	P07954	R233C	Loss of catalytic residue at R233 (P = 0.0152)| Loss of phosphorylation at T236 (P = 0.0683)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of MoRF binding (P = 0.0767)| Loss of methylation at K230 (P = 0.1519)	0.967472502496	0.96682	0.9655328358886819	0.96521	1.15023203385	0.79062	0.858424127102	0.90864	D	0.994652	0.99988	D	0.592007	0.97345	D	0.612601	0.97303	D	0.999971151351929	0.99958	D	0.994141	0.98073	D	0.97714406	0.98865	0.9070807	0.95418	0.97714406	0.98865	0.9070807	0.95418	-13.351	0.90777	D	0.9741	0.90045	P	0.999896646635663	0.98645	0.93132580	0.92451	1	0.99985	.	.	.	.	.	.	5.655055	0.92846	33.0	0.99925707796903818	0.99043	0.944500	0.95149	D	1.1397818748542	0.98799	19.44741	1.00471014856407	0.98709	19.13286	5.65	5.65	0.86862	5.55	0.94672	9.516	0.97049	8.562000	0.77604	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.947	0.4917	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613696	3.718170e-06	0	1	29598	3.378610e-05	0	1	74894	1.335220e-05	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	1	29598	3.378610e-05	0	0	44874	0.000000e+00	0	0	64016	0.000000e+00	0	0	6080	0.000000e+00	0	3	1179784	2.542840e-06	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508644G>A	ClinGen:CA165194	C0342770|C0027672|C3661900	606812	24|140162	Fumarate lyase, N-terminal	Arg	Cys	151069	single nucleotide variant	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2271	FH	HGNC:3700	Pathogenic	1	Dec 18, 2024	587781682	-	RCV000129845|RCV000153237|RCV000549060	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241508644	241508644	1q43	criteria provided, multiple submitters, no conflicts	10	-	N	ClinGen:CA165194	2	141355	241508644	G	A	-	-	-	-	-	-	SCV000184662|SCV000230852|SCV000251418|SCV000632484|SCV002535569|SCV002544394|SCV004197373|SCV005625599|SCV005727144	-	-	697C>T 	Arg233Cys	NM_000143.4	2	1_Pathogenic	1	241508644	G	A	3.42099e-6																																																																																																				
FH	FH_Arg233Cys	0.840040754452072	0.4330774414127768	-0.5768098835051846	0.5821337323712967	2025_01_Batch_13-14	0.5681956161990315	0.591142855004605	0.7443955154689178	0.7275652312524326	0.4790616233228787	0.5987548645396555	0.687703462456375	0.7959572347361038	0.7904062805896533	0.5762077703311804	0.5834752403693435	0.6394231587304899	0.7701763751025108	0.7589857559210429	0.5276346968270296	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004049		NC_000001.11:241508644:G:A		Arg233Cys																												FH_Arg233Cys	1	241508644	G	A	1	allele	697C>T	D03	527_CAVA_Array_P03	H05	B13A7A8P1_R1	B14A7A8P1_R2				1-241508644-G-A	141355	1	241508644	G	A	R	C	rs587781682	1	241671944	1	239738567	233	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.697C>T	p.Arg233Cys	c.697C>T	p.Arg233Cys	principal1	Y	1	YES	Select	-	CGT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	5.07	0.99905	H	-7.81	0.95967	D	0.962	0.97221	0.9273	0.96051	D	0.9945	0.99874	D	10	0.9892357	0.99374	D	0.699957	0.97538	D	0.949	0.99024	0.89	0.97304	P07954	R233C	Loss of catalytic residue at R233 (P = 0.0152)| Loss of phosphorylation at T236 (P = 0.0683)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of MoRF binding (P = 0.0767)| Loss of methylation at K230 (P = 0.1519)	0.967472502496	0.96682	0.9655328358886819	0.96521	1.15023203385	0.79062	0.858424127102	0.90864	D	0.994652	0.99988	D	0.592007	0.97345	D	0.612601	0.97303	D	0.999971151351929	0.99958	D	0.994141	0.98073	D	0.97714406	0.98865	0.9070807	0.95418	0.97714406	0.98865	0.9070807	0.95418	-13.351	0.90777	D	0.9741	0.90045	P	0.999896646635663	0.98645	0.93132580	0.92451	1	0.99985	.	.	.	.	.	.	5.655055	0.92846	33.0	0.99925707796903818	0.99043	0.944500	0.95149	D	1.1397818748542	0.98799	19.44741	1.00471014856407	0.98709	19.13286	5.65	5.65	0.86862	5.55	0.94672	9.516	0.97049	8.562000	0.77604	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.947	0.4917	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613696	3.718170e-06	0	1	29598	3.378610e-05	0	1	74894	1.335220e-05	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	1	29598	3.378610e-05	0	0	44874	0.000000e+00	0	0	64016	0.000000e+00	0	0	6080	0.000000e+00	0	3	1179784	2.542840e-06	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508644G>A	ClinGen:CA165194	C0342770|C0027672|C3661900	606812	24|140162	Fumarate lyase, N-terminal	Arg	Cys	151069	single nucleotide variant	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2271	FH	HGNC:3700	Pathogenic	1	Dec 18, 2024	587781682	-	RCV000129845|RCV000153237|RCV000549060	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241508644	241508644	1q43	criteria provided, multiple submitters, no conflicts	10	-	N	ClinGen:CA165194	2	141355	241508644	G	A	-	-	-	-	-	-	SCV000184662|SCV000230852|SCV000251418|SCV000632484|SCV002535569|SCV002544394|SCV004197373|SCV005625599|SCV005727144	-	-	697C>T 	Arg233Cys	NM_000143.4	2	1_Pathogenic	1	241508644	G	A	3.42099e-6																																																																																																				
G6PD	G6PD_Ile48Thr	-0.2620179732240577	0.8008506093363101	-5.13568429567412	0.0013451510736389762	2025_01_Batch_13-14	0.498102051673434	0.6773726472083663	0.8752138130416006	0.690890275113418	0.4686694704507386	0.9620209210586805	0.9095239752944728	0.9169525603244141	0.9731303464201745	0.8291248390927711	0.7300614863660573	0.7934483112514196	0.8960831866830073	0.8320103107667962	0.6488971547717548	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	G6PD		4006		CCSBVarC021436		NC_000023.11:154536156:A:G		Ile48Thr																												G6PD_Ile48Thr	23	154536156	A	G	X	allele	143T>C	A05	527_CAVA_Array_P03	B09	B13A7A8P1_R1	B14A7A8P1_R2				X-154536156-A-G	10402	X	154536156	A	G	I	T	rs76645461	X	153764371	X	153417565	48	G6PD	ENSG00000160211	ENST00000393564	ENSP00000377194	P11413	G6PD_HUMAN	c.143T>C	p.Ile48Thr	c.143T>C	p.Ile48Thr	principal4	Y	5	.	.	-	ATC	2	0	A	A/A	A/A	A/A	A/A	1.0	0.06776	T	0.771	0.06347	T	0.985	0.61134	D	0.964	0.71005	D	0.99	0.97926	A	simple_aae	1.0	99.0	1.365	0.34008	L	-3.37	0.66695	D	0.796	0.86268	0.9127	0.95840	D	0.9334	0.97801	D	10	0.9249425	0.91752	D	0.178446	0.85319	D	0.800	0.93443	0.956	0.99517	P11413	I48T	Gain of disorder (P = 0.0198)| Loss of stability (P = 0.024)| Loss of catalytic residue at P50 (P = 0.0321)| Gain of glycosylation at P50 (P = 0.0902)| Loss of methylation at K47 (P = 0.1012)	0.999291972508	0.99927	.	.	.	0.66127	0.810541808605	0.83546	D	0.864655	0.97001	D	0.423939	0.91161	D	0.630861	0.97650	D	0.353604669620596	0.26859	T	.	0.93807	.	0.83749527	0.86250	0.6371406	0.78580	0.7755391	0.82164	0.66341555	0.80049	-5.158	0.46017	T	0.8079	0.82620	P	0.998863967322053	0.95207	0.99580365	0.97879	0.66	0.81095	.	.	.	.	.	.	4.373753	0.67426	25.1	0.87607992308164628	0.17599	.	.	.	.	.	.	.	.	.	5.38	4.19	0.48586	.	.	7.094	0.76658	9.206000	0.79242	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.998	0.85369	80	0.96675	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	4	264690	1.51120175E-5	.	1	80339	1.244730e-05	0	2	151847	1.317120e-05	0	2	172177	1.161600e-05	0	0	5699	0.000000e+00	0	0	13664	0.000000e+00	0	0	1767	0.000000e+00	0	1	6917	1.445710e-04	0	0	9932	0.000000e+00	0	0	30958	0.000000e+00	0	0	9952	0.000000e+00	0	1	6917	1.445710e-04	0	0	13129	0.000000e+00	0	0	24387	0.000000e+00	0	0	4649	0.000000e+00	0	2	10129	1.974530e-04	0	0	12190	0.000000e+00	0	0	64662	0.000000e+00	0	0	19075	0.000000e+00	0	2	10129	1.974530e-04	0	0	12061	0.000000e+00	0	0	27165	0.000000e+00	0	0	7072	0.000000e+00	0	2	13320	1.501500e-04	0	0	15974	0.000000e+00	0	0	73427	0.000000e+00	0	0	19010	0.000000e+00	0	2	13320	1.501500e-04	0	.	17	1209926	1.405040e-05	0	10	4355	2.296210e-03	0	1	57219	1.747670e-05	0	0	678	0.000000e+00	0	0	45816	0.000000e+00	0	0	22029	0.000000e+00	0	2	33749	5.926100e-05	0	0	46637	0.000000e+00	0	10	4355	2.296210e-03	0	0	895021	0.000000e+00	0	0	56799	0.000000e+00	0	0	18236	0	0	122	0	0	342	0	0	3122	0	0	178	0	0	780	0	0	58	0	0	116	0	0	516	0	0	3244	0	0	400	0	0	23470	0	Pathogenic/Likely_pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency|Malaria,_susceptibility_to|G6PD_AURES|G6PD_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154536156A>G	ClinGen:CA121021|OMIM:305900.0043	C2720289|C1970028|C2939465|C3661900	300908|611162	466026|673	Glucose-6-phosphate dehydrogenase, NAD-binding	Ile	Thr	25441	single nucleotide variant	NM_000402.4(G6PD):c.233T>C (p.Ile78Thr)	2539	G6PD	HGNC:4057	Pathogenic/Likely pathogenic	1	Dec 06, 2024	76645461	-	RCV000011145|RCV000704108|RCV001796957|RCV002482854|RCV003466850|RCV004748514|RCV000224890	|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MONDO:MONDO:0005775,MedGen:C2939465|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026;MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673|MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673||MedGen:C3661900	G6PD AURES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154536156	154536156	Xq28	criteria provided, multiple submitters, no conflicts	16	-	N	ClinGen:CA121021,OMIM:305900.0043,ClinVar:1722711,ClinVar:1722739	3	10402	154536156	A	G	-	-	-	-	-	-	SCV000280664|SCV000833043|SCV001142115|SCV001523185|SCV001793238|SCV002025185|SCV002038576|SCV002506148|SCV002599318|SCV002788373|SCV004195384|SCV004805193|SCV005186094|SCV005413462	-	-	233T>C 	Ile78Thr	NM_000402.4	2	1_Pathogenic						274225	G6PD_unpublished_var123133	G6PD_unpublished	G6PD	4057.0	-1.0		154536156.0	154536156.0		143			48.0	I	T	c.143T>C	p.Ile48Thr	missense_variant	0.3329082933240921	0.6796720223346846;-0.3441175263713626;0.6631703840089543		No	0.0000140504460603	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Aug 31, 2024	aa		ENST00000393562.10	NM_001360016.2	immortalized human cells	Reporter	Fluorescence	Protein stability	Yes	missense_variant		0.8																																																											G6PD_Ile48Thr	Ile48Thr	true
F9	F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	1959260	X	139551130	C	T	P	S	rs867548424	X	138633289	X	138460955	197	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.72190	T	0.3717	0.72963	T	10	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002000	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	2009495	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158	F9	HGNC:3551	Likely benign	0	Feb 03, 2024	-1	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130	139551130	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137425	2	1959260	139551130	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1	2_Benign						245239	F9_Popp_2025_strep_2_var263534	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551130.0	139551130.0		589			197.0	P	S	c.589C>T	p.Pro197Ser	missense_variant	0.9948666767593736			No	1.6515644857e-6	Likely benign	criteria provided, single submitter	Aug 30, 2022	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.197																																																											F9_Pro197Ser	Pro197Ser	true
F9	F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	1959260	X	139551130	C	T	P	S	rs867548424	X	138633289	X	138460955	197	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.72190	T	0.3717	0.72963	T	10	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002000	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	2009495	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158	F9	HGNC:3551	Likely benign	0	Feb 03, 2024	-1	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130	139551130	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137425	2	1959260	139551130	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1	2_Benign						162691	F9_Popp_2025_carboxy_gla_motif_var253853	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551130.0	139551130.0		589			197.0	P	S	c.589C>T	p.Pro197Ser	missense_variant	1.0472969167219943			No	1.6515644857e-6	Likely benign	criteria provided, single submitter	Aug 30, 2022	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.197																																																											F9_Pro197Ser	Pro197Ser	true
F9	F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	1959260	X	139551130	C	T	P	S	rs867548424	X	138633289	X	138460955	197	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.72190	T	0.3717	0.72963	T	10	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002000	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	2009495	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158	F9	HGNC:3551	Likely benign	0	Feb 03, 2024	-1	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130	139551130	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137425	2	1959260	139551130	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1	2_Benign						190207	F9_Popp_2025_heavy_chain_var234491	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551130.0	139551130.0		589			197.0	P	S	c.589C>T	p.Pro197Ser	missense_variant	1.042434873347617			No	1.6515644857e-6	Likely benign	criteria provided, single submitter	Aug 30, 2022	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.197																																																											F9_Pro197Ser	Pro197Ser	true
F9	F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	1959260	X	139551130	C	T	P	S	rs867548424	X	138633289	X	138460955	197	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.72190	T	0.3717	0.72963	T	10	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002000	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	2009495	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158	F9	HGNC:3551	Likely benign	0	Feb 03, 2024	-1	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130	139551130	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137425	2	1959260	139551130	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1	2_Benign						217723	F9_Popp_2025_light_chain_var244172	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551130.0	139551130.0		589			197.0	P	S	c.589C>T	p.Pro197Ser	missense_variant	1.0111500373664293			No	1.6515644857e-6	Likely benign	criteria provided, single submitter	Aug 30, 2022	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.197																																																											F9_Pro197Ser	Pro197Ser	true
F9	F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	1959260	X	139551130	C	T	P	S	rs867548424	X	138633289	X	138460955	197	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.72190	T	0.3717	0.72963	T	10	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002000	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	2009495	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158	F9	HGNC:3551	Likely benign	0	Feb 03, 2024	-1	-	RCV002710164	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551130	139551130	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137425	2	1959260	139551130	C	T	-	-	-	-	-	-	SCV002992787	-	-	589C>T 	Pro197Ser	NM_000133.4	1	2_Benign						135175	F9_Popp_2025_carboxy_F9_specific_var224810	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551130.0	139551130.0		589			197.0	P	S	c.589C>T	p.Pro197Ser	missense_variant	1.010689335057021			No	1.6515644857e-6	Likely benign	criteria provided, single submitter	Aug 30, 2022	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.197																																																											F9_Pro197Ser	Pro197Ser	true
RPS19	RPS19_Gly127Glu	-7.707857851852217	0.0001154978914415701	-7.085159878747123	0.00019620691459792407	2025_01_Batch_13-14	0.7881639125929127	0.8742458682336376	0.9556596922239629	0.9121475347492455	0.719791289438861	0.729857031752785	0.8404173017407848	0.9484581259208962	0.8938388316256192	0.7354839190609905	0.7590104721728489	0.8573315849872112	0.9520589090724295	0.9029931831874323	0.7276376042499257	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19	ENSG00000105372	3441	6078	CCSBVarC000469	ALE00000469	NC_000019.10:41869722:G:A	380G>A	Gly127Glu	RC4	RC4_Mut_GDEh1010	H11	GDEhDisVCh_40042	E02	2	RC4_Mut_GDDh1010	H11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0			0			0			RPS19_Gly127Glu	19	41869722	G	A	19											19-41869722-G-A	6320	19	41869722	G	A	G	E	rs786200936	19	42373792	19	47065632	127	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.380G>A	p.Gly127Glu	c.380G>A	p.Gly127Glu	principal1	Y	3	.	.	+	GGA	2	0	G	./.	./.	./.	./.	.	.	.	0.034	0.53076	D	0.988	0.62341	D	0.996	0.84488	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.73	0.79671	M	.	.	.	0.985	0.99419	0.2563	0.86794	D	0.5614	0.83981	D	9	0.9862165	0.98908	D	0.407513	0.93515	D	.	0.91208	0.984	0.99843	P39019	G127E	Loss of MoRF binding (P = 0.0171)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.0971)| Gain of methylation at K122 (P = 0.1056)| Gain of sheet (P = 0.1451)	0.972294440432	0.97173	.	0.99657	.	0.96144	0.76795142889	0.77078	T	0.98826	0.99938	D	0.558625	0.96031	D	0.56465	0.95968	D	0.991606083214429	0.81780	D	0.847515	0.52781	T	0.97176737	0.98397	0.93296444	0.97258	0.9559469	0.96820	0.9024854	0.95086	-13.608	0.91730	D	0.9981	0.97478	P	0.999816468006815	0.98120	0.99993120	0.99924	0.683	0.82402	.	.	.	.	.	.	4.995052	0.82873	27.9	0.99809882945303208	0.89361	0.952808	0.96846	D	0.931537152194926	0.93180	11.89543	0.874714639492237	0.94342	12.711	5.24	5.24	0.72825	.	.	8.506	0.90371	11.829000	0.97469	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	747	0.52199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Diamond-Blackfan_anemia|Diamond-Blackfan_anemia_1	criteria_provided,_single_submitter	NC_000019.10:g.41869722G>A	ClinGen:CA130769|OMIM:603474.0008|UniProtKB:P39019#VAR_055444	C1260899|C2676137	PS105650|105650	124|124	.	Gly	Glu	21359	single nucleotide variant	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	6223	RPS19	HGNC:10402	Likely pathogenic	1	Jan 12, 2022	786200936	-	RCV000033189|RCV002512845	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	germline	germline	GRCh38	NC_000019.10	19	41869722	41869722	19q13.2	criteria provided, single submitter	2	-	N	ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008	3	6320	41869722	G	A	-	-	-	-	-	-	SCV003443917	-	-	380G>A 	Gly127Glu	NM_001022.4	1	1_Pathogenic																																																																																																									
RPS19	RPS19_Gly127Glu	-7.707857851852217	0.0001154978914415701	-7.085159878747123	0.00019620691459792407	2025_01_Batch_13-14	0.7881639125929127	0.8742458682336376	0.9556596922239629	0.9121475347492455	0.719791289438861	0.729857031752785	0.8404173017407848	0.9484581259208962	0.8938388316256192	0.7354839190609905	0.7590104721728489	0.8573315849872112	0.9520589090724295	0.9029931831874323	0.7276376042499257	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19		3441		CCSBVarC000469		NC_000019.10:41869722:G:A		Gly127Glu																												RPS19_Gly127Glu	19	41869722	G	A	19	allele	380G>A	H10	527_CAVA_Array_P05	O19	B13A7A8P2_R1	B14A7A8P2_R2				19-41869722-G-A	6320	19	41869722	G	A	G	E	rs786200936	19	42373792	19	47065632	127	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.380G>A	p.Gly127Glu	c.380G>A	p.Gly127Glu	principal1	Y	3	.	.	+	GGA	2	0	G	./.	./.	./.	./.	.	.	.	0.034	0.53076	D	0.988	0.62341	D	0.996	0.84488	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.73	0.79671	M	.	.	.	0.985	0.99419	0.2563	0.86794	D	0.5614	0.83981	D	9	0.9862165	0.98908	D	0.407513	0.93515	D	.	0.91208	0.984	0.99843	P39019	G127E	Loss of MoRF binding (P = 0.0171)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.0971)| Gain of methylation at K122 (P = 0.1056)| Gain of sheet (P = 0.1451)	0.972294440432	0.97173	.	0.99657	.	0.96144	0.76795142889	0.77078	T	0.98826	0.99938	D	0.558625	0.96031	D	0.56465	0.95968	D	0.991606083214429	0.81780	D	0.847515	0.52781	T	0.97176737	0.98397	0.93296444	0.97258	0.9559469	0.96820	0.9024854	0.95086	-13.608	0.91730	D	0.9981	0.97478	P	0.999816468006815	0.98120	0.99993120	0.99924	0.683	0.82402	.	.	.	.	.	.	4.995052	0.82873	27.9	0.99809882945303208	0.89361	0.952808	0.96846	D	0.931537152194926	0.93180	11.89543	0.874714639492237	0.94342	12.711	5.24	5.24	0.72825	.	.	8.506	0.90371	11.829000	0.97469	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	747	0.52199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Diamond-Blackfan_anemia|Diamond-Blackfan_anemia_1	criteria_provided,_single_submitter	NC_000019.10:g.41869722G>A	ClinGen:CA130769|OMIM:603474.0008|UniProtKB:P39019#VAR_055444	C1260899|C2676137	PS105650|105650	124|124	.	Gly	Glu	21359	single nucleotide variant	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	6223	RPS19	HGNC:10402	Likely pathogenic	1	Jan 12, 2022	786200936	-	RCV000033189|RCV002512845	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	germline	germline	GRCh38	NC_000019.10	19	41869722	41869722	19q13.2	criteria provided, single submitter	2	-	N	ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008	3	6320	41869722	G	A	-	-	-	-	-	-	SCV003443917	-	-	380G>A 	Gly127Glu	NM_001022.4	1	1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Arg198Gln	-4.669579694535985	0.0022886216209041625	7.053550426742774	0.0002017525172681343	2025_01_Batch_13-14	0.6162865094081145	0.8397023423212076	0.8895967094541701	0.7860623351426326	0.5328589394680393	0.7964344290160212	0.8529203727580343	0.9367131200987617	0.9192406604177108	0.632008755500258	0.7063604692120679	0.846311357539621	0.9131549147764659	0.8526514977801717	0.5824338474841486	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009191		NC_000023.11:64917865:C:T		Arg198Gln																												ZC4H2_Arg198Gln	23	64917865	C	T	X	allele	593G>A	B05	527_CAVA_Array_P06	C10	B13A7A8P2_R1	B14A7A8P2_R2				X-64917865-C-T	50981	X	64917865	C	T	R	Q	rs879255235	X	64137745	X	64054470	198	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.593G>A	p.Arg198Gln	c.593G>A	p.Arg198Gln	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.67073	D	0.998	0.73231	D	0.988	0.77983	D	0.93	0.94378	A	simple_aae	7.0	93.0	.	.	.	-3.56	0.68915	D	0.865	0.89118	-0.0594	0.80920	T	0.4448	0.78059	T	8	0.91766816	0.91026	D	0.931883	0.99506	D	0.540	0.80683	0.558	0.67570	Q9NQZ6	R198Q	Loss of MoRF binding (P = 0.0352)| Loss of helix (P = 0.1299)| Gain of relative solvent accessibility (P = 0.1684)| Gain of catalytic residue at R198 (P = 0.2542)| Gain of loop (P = 0.3485)	0.896646558922	0.89483	0.6985962743898447	0.69647	3.04366087562	0.99279	0.863531589508	0.91618	D	0.861236	0.96898	D	0.619807	0.98328	D	0.652534	0.98300	D	0.998395621776581	0.93976	D	0.974003	0.91550	D	0.8665144	0.88431	0.84589994	0.91114	0.8701332	0.88719	0.84851253	0.91292	-14.555	0.95182	D	0.9999	0.99795	P	0.999345122363188	0.96318	0.99758303	0.98429	0.99	0.99661	.	.	.	.	.	.	5.374841	0.90114	31.0	0.99954933178758143	0.99969	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Wieacker-Wolff_syndrome,_female-restricted|Wieacker-Wolff_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917865C>T	ClinGen:CA10575580|OMIM:300897.0002|UniProtKB:Q9NQZ6#VAR_069622	CN517202|C5393303|C0796200	301041|314580	3454|85283	Zinc finger C4H2-type	Arg	Gln	65652	single nucleotide variant	NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	55906	ZC4H2	HGNC:24931	Pathogenic	1	May 27, 2023	879255235	-	RCV000043677|RCV000498696|RCV001770066	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MedGen:C3661900|MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	Wieacker-Wolff syndrome|not provided|Wieacker-Wolff syndrome, female-restricted	germline;unknown	germline	GRCh38	NC_000023.11	X	64917865	64917865	Xq11.2	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA10575580,UniProtKB:Q9NQZ6#VAR_069622,OMIM:300897.0002	3	50981	64917865	C	T	-	-	-	-	-	-	SCV000589376|SCV002011544|SCV002512603|SCV002521347|SCV004040963	-	-	593G>A 	Arg198Gln	NM_018684.4	2	1_Pathogenic																																																																																																									
CTCF	CTCF_Ala697Thr	-1.1232772209850925	0.298362229751802	1.4887201352067425	0.18016786356357115	2025_01_Batch_13-14	0.427811937381813	0.5241640544122318	0.5867910532063902	0.5020659078393217	0.45735774894400333	0.5498372877198431	0.6931457300702335	0.5644693377632063	0.6763488058324778	0.4648068175958196	0.48882461255082804	0.6086548922412327	0.5756301954847982	0.5892073568358998	0.46108228326991146	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010818		NC_000016.10:67637777:G:A		Ala697Thr																												CTCF_Ala697Thr	16	67637777	G	A	16	allele	2089G>A	F02	527_CAVA_Array_P02	K04	B13A7A8P1_R1	B14A7A8P1_R2				16-67637777-G-A	589165	16	67637777	G	A	A	T	rs201916739	16	67671680	16	66229181	697	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.2089G>A	p.Ala697Thr	c.2089G>A	p.Ala697Thr	principal4	Y	1	YES	Select	+	GCA	1	0	G	G/G	G/G	G/G	G/G	0.222	0.23840	T	0.358	0.23039	T	0.0	0.02950	B	0.0	0.01384	B	0.06	0.40172	N	simple_aae	94.0	6.0	0.345	0.11102	N	-0.8	0.23318	N	0.113	0.10018	-0.9502	0.40759	T	0.0130	0.05035	T	10	0.074863106	0.11429	T	0.003775	0.08537	T	0.085	0.24571	0.089	0.00976	P49711	A697T	Gain of phosphorylation at A697 (P = 0.0106)| Gain of glycosylation at A697 (P = 0.0115)| Gain of loop (P = 0.0502)| Gain of solvent accessibility (P = 0.2291)| Gain of helix (P = 0.2684)	0.352914559346	0.34492	.	0.11959	0.580823813372	0.53620	0.28278157115	0.07880	T	0.353355	0.71894	T	-0.426293	0.01463	T	-0.680989	0.06720	T	0.068806566298008	0.08383	T	.	0.24416	.	0.019917462	0.00532	0.048129845	0.07099	0.02436098	0.01251	0.0497265	0.07671	-4.231	0.28985	T	.	0.04616	.	0.0183708095774007	0.28756	0.18858771	0.72542	0.025	0.04491	.	.	.	.	.	.	1.499315	0.19306	14.18	0.90883258671168698	0.20385	0.269145	0.38347	N	-0.557516232399653	0.20004	1.066043	-0.41758376025414	0.24164	1.340807	5.92	2.91	0.32820	1.78	0.37175	3.992	0.56781	1.282000	0.25443	-0.108	0.15302	0.923	0.3214	0.001000	0.17376	0.323	0.25089	50	0.97656	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	109398	9.140930e-06	0	3	208038	1.442040e-05	0	3	236742	1.267200e-05	0	0	7162	0.000000e+00	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15686	0.000000e+00	0	1	17112	5.843850e-05	0	0	16214	0.000000e+00	0	1	30522	3.276330e-05	0	0	6210	0.000000e+00	0	1	13416	7.453790e-05	0	0	16732	0.000000e+00	0	1	89478	1.117590e-05	0	0	30604	0.000000e+00	0	1	13416	7.453790e-05	0	0	14898	0.000000e+00	0	1	34256	2.919200e-05	0	0	9566	0.000000e+00	0	1	17690	5.652910e-05	0	0	21628	0.000000e+00	0	1	102564	9.750010e-06	0	0	30522	0.000000e+00	0	1	17690	5.652910e-05	0	.	36	1613310	2.231440e-05	0	3	44888	6.683300e-05	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	1	59996	1.666780e-05	0	0	29602	0.000000e+00	0	3	44888	6.683300e-05	0	0	64024	0.000000e+00	0	0	5544	0.000000e+00	0	28	1180018	2.372850e-05	0	1	91036	1.098470e-05	0	9	163634	5.5000794455919916E-5	0	176	0	0	2710	0	0	4744	0	0	796	0	1	968	0.0010330578512396695	0	682	0	0	280	0	1	13700	7.299270072992701E-5	0	4920	0	0	3392	0	11	187690	5.860727795833555E-5	Conflicting_classifications_of_pathogenicity	not_specified|CTCF-related_disorder|Inborn_genetic_diseases	criteria_provided,_conflicting_classifications	NC_000016.10:g.67637777G>A	.	CN169374|C0950123	.	.	.	Ala	Thr	580362	single nucleotide variant	NM_006565.4(CTCF):c.2089G>A (p.Ala697Thr)	10664	CTCF	HGNC:13723	Conflicting classifications of pathogenicity	0	Aug 22, 2023	201916739	-	RCV002318105|RCV004535791|RCV003323701	MeSH:D030342,MedGen:C0950123||MedGen:CN169374	Inborn genetic diseases|CTCF-related disorder|not specified	germline	germline	GRCh38	NC_000016.10	16	67637777	67637777	16q22.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA8112854	2	589165	67637777	G	A	-	-	-	-	-	-	SCV000849791|SCV004029010|SCV004113932	-	-	2089G>A 	Ala697Thr	NM_006565.4	1	3_Conflicting																																																																																																									
BRCA1	BRCA1_Arg71Gly	-1.183279693007538	0.275321882540562	5.634491429600972	0.000787086326597669	2025_01_Batch_13-14	0.9304760710892357	0.940321856870626	0.8585648206893093	0.9119236688191354	0.8374062887316356	0.9855224726609189	0.9404281751104907	0.9263130774563206	0.9809606129506918	0.9391781050206498	0.9579992718750773	0.9403750159905584	0.892438949072815	0.9464421408849136	0.8882921968761427	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011856		NC_000017.11:43106457:T:C		Arg71Gly																												BRCA1_Arg71Gly	17	43106457	T	C	17	allele	211A>G	F09	527_CAVA_Array_P01	K17	B13A7A8P1_R1	B14A7A8P1_R2				17-43106457-T-C	17693	17	43106457	T	C	R	G	rs80357382	17	41258474	17	38512000	71	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.211A>G	p.Arg71Gly	principal2	Y	.	.	.	-	AGG	1	2	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	0.956	0.59057	P	0.444	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	.	0.92366	.	.	0.86054	0.8364	0.94843	D	0.8394	0.94619	D	10	.	0.92374	.	0.80066	0.98437	D	.	0.95939	0.809	0.92541	E9PFC7	R71G	Gain of ubiquitination at K70 (P = 0.0519)| Loss of solvent accessibility (P = 0.0807)| Loss of phosphorylation at T69 (P = 0.1027)| Gain of relative solvent accessibility (P = 0.1684)| Loss of disorder (P = 0.1823)	.	0.93459	.	0.57140	.	0.24793	0.550648927689	0.45883	T	0.325403	0.69435	T	0.464929	0.93082	D	0.430062	0.92996	D	0.867488086223602	0.51486	D	.	0.86835	.	0.7237265	0.79126	0.32902288	0.58556	0.63329226	0.74199	0.31909144	0.57647	-13.862	0.93673	D	.	0.89378	.	0.999229197308064	0.96001	0.99944407	0.99387	0.931	0.96596	.	.	.	.	.	.	5.274462	0.88579	29.6	0.99887384451911465	0.96206	0.840976	0.75732	D	0.586117233560111	0.72160	5.78522	0.5471513750929	0.71040	5.618586	4.64	4.64	0.57348	5.61	0.95042	4.16	0.58035	7.857000	0.71293	0.588	0.31377	1.0	0.71675	1.000000	0.68239	0.994	0.71086	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108704	0.000000e+00	0	1	206546	4.841540e-06	0	1	235294	4.250000e-06	0	0	7112	0.000000e+00	0	0	16894	0.000000e+00	0	0	2294	0.000000e+00	0	0	9040	0.000000e+00	0	0	13388	0.000000e+00	0	0	42620	0.000000e+00	0	0	15456	0.000000e+00	0	.	.	.	.	0	16078	0.000000e+00	0	0	30222	0.000000e+00	0	0	6166	0.000000e+00	0	0	13382	0.000000e+00	0	0	16704	0.000000e+00	0	1	89038	1.123120e-05	0	0	30132	0.000000e+00	0	1	89038	1.123120e-05	0	0	14770	0.000000e+00	0	0	33946	0.000000e+00	0	0	9522	0.000000e+00	0	0	17632	0.000000e+00	0	0	21592	0.000000e+00	0	1	102222	9.782630e-06	0	0	30050	0.000000e+00	0	1	102222	9.782630e-06	0	.	2	1580162	1.265690e-06	0	2	1150962	1.737680e-06	0	0	74308	0.000000e+00	0	0	912	0.000000e+00	0	0	59768	0.000000e+00	0	0	29370	0.000000e+00	0	0	44596	0.000000e+00	0	0	63918	0.000000e+00	0	0	5674	0.000000e+00	0	2	1150962	1.737680e-06	0	0	89324	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|not_specified|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|not_provided|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43106457T>C	ClinGen:CA001398|OMIM:113705.0034	C2676676|C0027672|CN169374|C0346153|C3280442|C4554406|C3661900|C0677776	604370|114480|614320|617883	145|140162|227535|1333|145	.	Arg	Gly	32732	single nucleotide variant	NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 18, 2019	80357382	-	RCV000047713|RCV000131899|RCV000195359|RCV000019263|RCV000469732|RCV000763009|RCV000508177|RCV004758595|RCV004802945	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374||MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|not specified|BRCA1-related disorder|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106457	43106457	17q21.31	reviewed by expert panel	33	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001398,OMIM:113705.0034	3	17693	43106457	T	C	-	-	-	-	-	-	SCV001161539	-	-	211A>G 	Arg71Gly	NM_007294.4	3	1_Pathogenic																																																																																																									
KRAS	KRAS_Pro34Arg	-1.8765842108443014	0.10267990481406933	11.210462647469502	0.000010026137401729719																											true	KRAS	ENSG00000133703	3084	214476	CCSBVarC006094	ALE00006094	NC_000012.12:25245284:G:C	101C>G	Pro34Arg	CEGS2	CegsMutGDEh1040	C02	GDEhDisVCh_40061	F09	1	CegsMutGDDh1040	C02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Pro34Arg	12	25245284	G	C	12											12-25245284-G-C	12590	12	25245284	G	C	P	R	rs104894366	12	25398218	12	25289485	34	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>G	p.Pro34Arg	c.101C>G	p.Pro34Arg	alternative1	Y	1	.	Plus_Clinical	-	CCA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.445	0.92067	M	-7.6	0.97924	D	0.961	0.98079	0.8728	0.95298	D	0.8174	0.93837	D	9	0.94139737	0.93391	D	0.322268	0.91490	D	0.905	0.97394	0.79	0.91170	P01116	P34R	Gain of catalytic residue at I36 (P = 0.0042)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.0874)| Gain of solvent accessibility (P = 0.1708)| Loss of disorder (P = 0.1763)	0.993217693452	0.99306	0.9765456698593341	0.97632	2.76950302636	0.98787	0.913441181183	0.97783	D	0.919051	0.98519	D	0.468623	0.93232	D	0.435368	0.93147	D	0.999483346939087	0.97568	D	0.976402	0.92683	D	0.9888393	0.99697	0.96837485	0.99382	0.9863729	0.99547	0.978969	0.99788	-17.558	0.99602	D	0.9972	0.97478	P	0.999953297071636	0.99183	0.99935538	0.99325	0.97	0.98836	.	.	.	.	.	.	5.331179	0.89486	30.0	0.99851702522609986	0.93107	0.907375	0.86082	D	1.08644740414511	0.97862	16.94078	1.01441952461028	0.98880	19.75079	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided|Acute_myeloid_leukemia|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2|Autoimmune_lymphoproliferative_syndrome_type_4	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245284G>C	ClinGen:CA280040|OMIM:190070.0013|UniProtKB:P01116#VAR_026110	C1275081|C0028326|C5555857|C3661900|C0023467|C1860991|C3809005|C2674723	PS115150|PS163950|601626|609942|615278|614470	1340|648|536391|519|648|1340|268114	Small GTP-binding domain	Pro	Arg	27629	single nucleotide variant	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	3845	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1	Jun 14, 2022	104894366	-	RCV000043674|RCV000207495|RCV000211723|RCV000850569|RCV001851825	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardiofaciocutaneous syndrome 2|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Acute myeloid leukemia;Noonan syndrome 3;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2|RASopathy	germline;unknown	germline	GRCh38	NC_000012.12	12	25245284	25245284	12p12.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	3	12590	25245284	G	C	-	-	-	-	-	-	SCV000061924|SCV000263050|SCV000329384|SCV000992785|SCV002159858	-	-	101C>G 	Pro34Arg	NM_004985.5	2	1_Pathogenic																																																																																																									
KRAS	KRAS_Pro34Arg	-1.8765842108443014	0.10267990481406933	11.210462647469502	0.000010026137401729719																											true	KRAS		3084		CCSBVarC006094		NC_000012.12:25245284:G:C		Pro34Arg																												KRAS_Pro34Arg	12	25245284	G	C	12	allele	101C>G	B07	527_CAVA_Array_P03	D13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245284-G-C	12590	12	25245284	G	C	P	R	rs104894366	12	25398218	12	25289485	34	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>G	p.Pro34Arg	c.101C>G	p.Pro34Arg	alternative1	Y	1	.	Plus_Clinical	-	CCA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.445	0.92067	M	-7.6	0.97924	D	0.961	0.98079	0.8728	0.95298	D	0.8174	0.93837	D	9	0.94139737	0.93391	D	0.322268	0.91490	D	0.905	0.97394	0.79	0.91170	P01116	P34R	Gain of catalytic residue at I36 (P = 0.0042)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.0874)| Gain of solvent accessibility (P = 0.1708)| Loss of disorder (P = 0.1763)	0.993217693452	0.99306	0.9765456698593341	0.97632	2.76950302636	0.98787	0.913441181183	0.97783	D	0.919051	0.98519	D	0.468623	0.93232	D	0.435368	0.93147	D	0.999483346939087	0.97568	D	0.976402	0.92683	D	0.9888393	0.99697	0.96837485	0.99382	0.9863729	0.99547	0.978969	0.99788	-17.558	0.99602	D	0.9972	0.97478	P	0.999953297071636	0.99183	0.99935538	0.99325	0.97	0.98836	.	.	.	.	.	.	5.331179	0.89486	30.0	0.99851702522609986	0.93107	0.907375	0.86082	D	1.08644740414511	0.97862	16.94078	1.01441952461028	0.98880	19.75079	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided|Acute_myeloid_leukemia|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2|Autoimmune_lymphoproliferative_syndrome_type_4	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245284G>C	ClinGen:CA280040|OMIM:190070.0013|UniProtKB:P01116#VAR_026110	C1275081|C0028326|C5555857|C3661900|C0023467|C1860991|C3809005|C2674723	PS115150|PS163950|601626|609942|615278|614470	1340|648|536391|519|648|1340|268114	Small GTP-binding domain	Pro	Arg	27629	single nucleotide variant	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	3845	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1	Jun 14, 2022	104894366	-	RCV000043674|RCV000207495|RCV000211723|RCV000850569|RCV001851825	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardiofaciocutaneous syndrome 2|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Acute myeloid leukemia;Noonan syndrome 3;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2|RASopathy	germline;unknown	germline	GRCh38	NC_000012.12	12	25245284	25245284	12p12.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	3	12590	25245284	G	C	-	-	-	-	-	-	SCV000061924|SCV000263050|SCV000329384|SCV000992785|SCV002159858	-	-	101C>G 	Pro34Arg	NM_004985.5	2	1_Pathogenic																																																																																																									
BAP1	BAP1_Cys91Gly	1.5164097053786887	0.17319848524644227	-4.617978065799683	0.0024319418319997716	2025_01_Batch_13-14	0.5863642072617119	0.7187541665516547	0.8351907724968624	0.795822950306513	0.6109290087208261	0.8059496747384488	0.8150315617787417	0.7801839214064152	0.8950993774317042	0.5548470031652829	0.6961569410000803	0.7668928641651982	0.8076873469516388	0.8454611638691085	0.5828880059430546	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009482		NC_000003.12:52408062:A:C		Cys91Gly																												BAP1_Cys91Gly	3	52408062	A	C	3	allele	271T>G	A02	527_CAVA_Array_P01	A03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408062-A-C	1173082	3	52408062	A	C	C	G	rs1705222655	3	52442078	3	52417118	91	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.271T>G	p.Cys91Gly	c.271T>G	p.Cys91Gly	principal1	Y	1	YES	Select	-	TGT	1	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.145	0.97505	H	-11.35	0.99595	D	0.974	0.98575	1.1018	0.99732	D	0.9443	0.98173	D	10	0.99121475	0.99640	D	0.655758	0.97092	D	0.979	0.99840	0.923	0.98665	Q92560	C91G	Loss of stability (P = 0.0176)| Gain of disorder (P = 0.0416)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1299)| Gain of loop (P = 0.2045)	0.981038681151	0.98064	0.9635444637645938	0.96320	2.76950302636	0.98787	0.846445500851	0.89059	D	0.614019	0.87693	D	0.551935	0.95794	D	0.55504	0.95730	D	0.999918460845947	0.99678	D	0.998744	0.99359	D	0.97112095	0.98337	0.9594046	0.98923	0.97112095	0.98337	0.9594046	0.98923	-13.296	0.90565	D	0.9988	0.98152	P	0.999985923692613	0.99579	0.99989021	0.99864	0.951	0.97790	.	.	.	.	.	.	5.258269	0.88304	29.5	0.97870451339973896	0.36682	0.954137	0.97089	D	1.0074398562281	0.95947	14.15777	0.917979903155774	0.96288	14.54242	5.49	5.49	0.80997	3.34	0.60572	9.031	0.93237	11.129000	0.86768	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000003.12:g.52408062A>C	.	C0027672|C1535926	.	140162	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Cys	Gly	1162264	single nucleotide variant	NM_004656.4(BAP1):c.271T>G (p.Cys91Gly)	8314	BAP1	HGNC:950	Uncertain significance	1	Sep 14, 2021	1705222655	-	RCV001797188|RCV002424967	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52408062	52408062	3p21.1	criteria provided, single submitter	2	-	N	ClinGen:CA353112613	2	1173082	52408062	A	C	-	-	-	-	-	-	SCV002743592	-	-	271T>G 	Cys91Gly	NM_004656.4	1	4_VUS																																																																																																									
BRCA1	BRCA1_Cys44Tyr	-0.8137193508629426	0.4426010528135844	5.676268140463764	0.0007536407364486894	2025_01_Batch_13-14	0.831148627985987	0.9066524143661844	0.8216178034576009	0.8244578506765782	0.7124769240548263	0.9441987717219411	0.8729902762931168	0.9135044475399889	0.9649343906044164	0.860136022816206	0.887673699853964	0.8898213453296506	0.8675611254987949	0.8946961206404973	0.7863064734355162	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003296		NC_000017.11:43115729:C:T		Cys44Tyr																												BRCA1_Cys44Tyr	17	43115729	C	T	17	allele	131G>A	G06	527_CAVA_Array_P01	M11	B13A7A8P1_R1	B14A7A8P1_R2				17-43115729-C-T	54199	17	43115729	C	T	C	Y	rs80357446	17	41267746	17	38521272	44	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.131G>A	p.Cys44Tyr	c.131G>A	p.Cys44Tyr	principal2	Y	1	.	.	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.016	0.91343	D	0.0	0.92967	D	0.994	0.66535	D	0.84	0.60164	P	.	0.99291	.	.	.	.	4.005	0.96727	H	-2.52	0.98949	D	.	0.95504	1.0538	0.98195	D	0.9802	0.99389	D	10	0.99267334	0.99802	D	0.72305	0.97758	D	0.853	0.95458	0.99	0.99894	E9PFC7	C44Y	Loss of disorder (P = 0.0407)| Loss of helix (P = 0.1299)| Loss of catalytic residue at I42 (P = 0.1404)| Loss of stability (P = 0.2362)| Loss of ubiquitination at K45 (P = 0.2592)	0.998941922364	0.99891	.	0.91966	.	0.18552	0.729841411114	0.71433	T	0.47499	0.93038	T	0.562886	0.96259	D	0.57077	0.96199	D	0.987259089946747	0.77622	D	.	0.90786	.	0.92106634	0.93252	0.6351263	0.78468	0.91385037	0.92549	0.69650024	0.81922	-13.581	0.94506	D	0.9966	0.97393	LP	0.999496437666765	0.96769	0.99973255	0.99655	0.94	0.97139	.	.	.	.	.	.	5.096311	0.85159	28.5	0.99228087188246783	0.56189	0.829447	0.74743	D	0.895383086000917	0.91485	10.93124	0.837834818254792	0.92242	11.33957	5.97	5.97	0.96929	.	.	3.475	0.52993	7.600000	0.61593	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115729C>T	BRCA1-HCI:BRCA1_00114|ClinGen:CA000861	C3661900|C0027672|C0677776|C2676676	604370	140162|145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	68866	single nucleotide variant	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357446	-	RCV000077486|RCV000235119|RCV000509871|RCV001386839	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115729	43115729	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	2	54199	43115729	C	T	-	-	-	-	-	-	SCV000244299	-	-	131G>A 	Cys44Tyr	NM_007294.4	3	1_Pathogenic																																																																																																									
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						173261	F9_Popp_2025_carboxy_gla_motif_var257567	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.060282288			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						173261	F9_Popp_2025_carboxy_gla_motif_var257567	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.060282288			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						145745	F9_Popp_2025_carboxy_F9_specific_var228524	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.087066694			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						145745	F9_Popp_2025_carboxy_F9_specific_var228524	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.087066694			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						228293	F9_Popp_2025_light_chain_var247886	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.0940726			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						228293	F9_Popp_2025_light_chain_var247886	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.0940726			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						200777	F9_Popp_2025_heavy_chain_var238205	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.096591788			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						200777	F9_Popp_2025_heavy_chain_var238205	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.096591788			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						255809	F9_Popp_2025_strep_2_var267248	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.3805148886610444			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
F9	F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic						255809	F9_Popp_2025_strep_2_var267248	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561805.0	139561805.0		1120			374.0	V	F	c.1120G>T	p.Val374Phe	missense_variant	0.3805148886610444			No		Pathogenic	criteria provided, single submitter	Dec 18, 2018	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.85																																																											F9_Val374Phe	Val374Phe	true
FH	FH_Ala308Thr	-0.7120971186723563	0.5031403010535435	-11.394484282268747	8.993403746646915e-6	2025_01_Batch_13-14	0.752578540982823	0.9337486622872755	0.9810411602833721	0.9518229092496397	0.7970626847446404	0.6025578030294673	0.9278030839343621	0.984147163271062	0.9551586938342534	0.6860769792243886	0.677568172006145	0.9307758731108188	0.982594161777217	0.9534908015419465	0.7415698319845145	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC000454		NC_000001.11:241504228:C:T		Ala308Thr																												FH_Ala308Thr	1	241504228	C	T	1	allele	922G>A	E02	527_CAVA_Array_P03	J03	B13A7A8P1_R1	B14A7A8P1_R2				1-241504228-C-T	1324397	1	241504228	C	T	A	T	rs121913118	1	241667528	1	239734151	308	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.922G>A	p.Ala308Thr	c.922G>A	p.Ala308Thr	principal1	Y	1	YES	Select	-	GCT	1	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	0.996	0.68795	D	0.958	0.70027	D	0.95	0.94956	D	simple_aae	5.0	95.0	3.44	0.92016	M	-3.59	0.69272	D	0.934	0.93968	1.0591	0.98315	D	0.9836	0.99499	D	9	0.9391092	0.93162	D	0.83885	0.98751	D	0.946	0.98921	0.647	0.78347	P07954	A308T	Gain of glycosylation at A308 (P = 0.0142)| Gain of phosphorylation at A308 (P = 0.0426)| Gain of ubiquitination at K311 (P = 0.1092)| Gain of methylation at K311 (P = 0.1332)| Gain of disorder (P = 0.3258)	0.973295160969	0.97274	0.9325441300373446	0.93191	0.952392643853	0.72524	0.740001261234	0.72926	T	0.976808	0.99782	D	0.554402	0.95837	D	0.558584	0.95773	D	0.981637419267628	0.73841	D	0.979469	0.92945	D	0.9160993	0.92765	0.86255217	0.92251	0.9160993	0.92766	0.86255217	0.92252	-12.206	0.85877	D	0.5677	0.67484	P	0.993749286198762	0.90224	0.95155084	0.93461	0.964	0.98523	.	.	.	.	.	.	5.006822	0.83151	28.0	0.99930399122775604	0.99334	0.921872	0.89561	D	0.931844876423458	0.93192	11.90403	0.895432979793859	0.95345	13.55806	5.73	5.73	0.89714	6.28	0.98834	5.666	0.67804	7.627000	0.62620	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000001.11:g.241504228C>T	.	C3661900	.	.	Fumarate lyase, N-terminal	Ala	Thr	1314669	single nucleotide variant	NM_000143.4(FH):c.922G>A (p.Ala308Thr)	2271	FH	HGNC:3700	Pathogenic	1	Sep 24, 2022	121913118	-	RCV001781102	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000001.11	1	241504228	241504228	1q43	criteria provided, single submitter	1	-	N	ClinGen:CA40327917	2	1324397	241504228	C	T	-	-	-	-	-	-	SCV003523960	-	-	922G>A 	Ala308Thr	NM_000143.4	1	1_Pathogenic																																																																																																									
SHOC2	SHOC2_Glu13Ala	-3.1184142906339396	0.01688113056320015	-0.28172720498089704	0.7862994852852396	2025_01_Batch_13-14	0.9758010558329374	0.9675799270557529	0.9190054001628293	0.966785908068938	0.8998938874806812	0.7147733879096405	0.6330256924172691	0.5847508451405554	0.5905716697947689	0.7257046416676216	0.845287221871289	0.800302809736511	0.7518781226516924	0.7786787889318535	0.8127992645741514	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
BRCA1	BRCA1_Ser186Tyr	1.7603534804730556	0.12173945667616726	-2.5675246326680874	0.03714171283359237	2025_01_Batch_13-14	0.9895433550447515	0.9737788841307277	0.9879681792570353	0.9891091271413341	0.9755578642730985	0.9891402010878071	0.9621113636599743	0.9776515180547332	0.9867512743655017	0.9603178873145011	0.9893417780662793	0.9679451238953509	0.9828098486558843	0.9879302007534179	0.9679378757937998	1.0	1.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC013090		NC_000017.11:43097280:G:T		Ser186Tyr																												BRCA1_Ser186Tyr	17	43097280	G	T	17	allele	557C>A	C11	527_CAVA_Array_P01	E21	B13A7A8P1_R1	B14A7A8P1_R2				17-43097280-G-T	55635	17	43097280	G	T	S	Y	rs55688530	17	41249297	17	38502823	186	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.557C>A	p.Ser186Tyr	principal2	Y	1	.	.	-	TCT	2	0	G	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.956	0.80453	D	.	0.23785	.	.	.	.	2.535	0.73728	M	.	0.76284	.	.	0.68711	0.9031	0.95704	D	0.9635	0.98828	D	10	.	0.00228	.	.	.	.	.	0.92474	.	.	.	.	.	.	0.96689	.	0.57312	.	0.47613	0.504873514175	0.39453	T	0.222563	0.58431	T	0.0490491	0.57930	T	0.304786	0.88335	D	0.0335924297408818	0.02552	T	0.962504	0.88031	D	0.47664887	0.65384	0.49632788	0.70615	0.4938498	0.66423	0.5691173	0.74804	-6.751	0.52305	T	.	0.70541	.	0.995660278977707	0.91503	0.99941337	0.99364	0.231	0.49947	.	.	.	.	.	.	5.082168	0.84844	28.4	0.99425264648970257	0.64033	0.805499	0.72908	D	0.703775773492025	0.79770	7.17216	0.670198265778078	0.80013	7.229281	4.96	4.96	0.65108	5.79	0.96129	4.066	0.57326	11.485000	0.92915	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	473	0.77929	15	0.0029952076677316293	15	0.0113464447806354	0	0.0	0	0.0	0	0.0	0	0.0	820	264690	0.0030979638	.	81	109338	7.408220e-04	3	172	207834	8.275840e-04	3	160	236664	6.760640e-04	3	71	7158	9.918970e-03	3	8	17072	4.686040e-04	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42756	2.338850e-05	0	0	15680	0.000000e+00	0	71	7158	9.918970e-03	3	153	16170	9.461970e-03	3	11	30478	3.609160e-04	0	0	6208	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	4	89398	4.474370e-05	0	0	30586	0.000000e+00	0	153	16170	9.461970e-03	3	142	14856	9.558430e-03	3	10	34210	2.923120e-04	0	0	9568	0.000000e+00	0	0	17688	0.000000e+00	0	0	21630	0.000000e+00	0	4	102608	3.898330e-05	0	0	30504	0.000000e+00	0	142	14856	9.558430e-03	3	.	790	1613484	4.896240e-04	5	685	75010	9.132120e-03	5	685	75010	9.132120e-03	5	0	912	0.000000e+00	0	44	60008	7.332360e-04	0	0	29596	0.000000e+00	0	0	44832	0.000000e+00	0	0	64006	0.000000e+00	0	3	6060	4.950500e-04	0	12	1179650	1.017250e-05	0	1	90940	1.099630e-05	0	11	173906	6.325256172875002E-5	0	352	0	0	2654	0	82	8428	0.009729473184622686	2	804	0.0024875621890547263	0	974	0	0	654	0	0	274	0	8	13470	5.939123979213066E-4	82	8780	0.009339407744874715	0	3308	0	103	201516	5.111256674407988E-4	Benign	Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer|not_specified|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43097280G>T	BRCA1-HCI:BRCA1_00057|ClinGen:CA003732|UniProtKB:P38398#VAR_070467	C0006142|C0677776|C0027672|C0346153|C2676676|CN221562|CN169374|C3661900	114480|604370	145|140162|227535|145	.	Ser	Tyr	70302	single nucleotide variant	NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	55688530	-	RCV000049057|RCV000077630|RCV000162532|RCV000120269|RCV000224107|RCV000470710|RCV001170826|RCV001353515	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN221562|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43097280	43097280	17q21.31	reviewed by expert panel	35	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00057,ClinGen:CA003732,UniProtKB:P38398#VAR_070467	2	55635	43097280	G	T	-	-	-	-	-	-	SCV000244407	-	-	557C>A 	Ser186Tyr	NM_007294.4	3	2_Benign																																																																																																									
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						238164	F9_Popp_2025_strep_2_var261066	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.1083447740611316			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						238164	F9_Popp_2025_strep_2_var261066	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.1083447740611316			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						128100	F9_Popp_2025_carboxy_F9_specific_var222342	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.071385309115317			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						128100	F9_Popp_2025_carboxy_F9_specific_var222342	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.071385309115317			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						183132	F9_Popp_2025_heavy_chain_var232023	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.1370137533445022			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						183132	F9_Popp_2025_heavy_chain_var232023	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.1370137533445022			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						210648	F9_Popp_2025_light_chain_var241704	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.1215083178570668			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						210648	F9_Popp_2025_light_chain_var241704	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.1215083178570668			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						155616	F9_Popp_2025_carboxy_gla_motif_var251385	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.2205893016605571			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
F9	F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic						155616	F9_Popp_2025_carboxy_gla_motif_var251385	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537158.0	139537158.0		237			79.0	E	D	c.237A>C	p.Glu79Asp	missense_variant	1.2205893016605571			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																																											F9_Glu79Asp	Glu79Asp	true
KRAS	KRAS_Thr58Ile	-0.39527774123572407	0.7044069422700285	1.3907484853397487	0.20691013190075047																											true	KRAS	ENSG00000133703	3084	214487	CCSBVarC006096	ALE00006096	NC_000012.12:25227351:G:A	173C>T	Thr58Ile	CEGS2	CegsMutGDEh1040	G09	GDEhDisVCh_40061	H09	1	CegsMutGDDh1040	G09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	2	0			0			0			KRAS_Thr58Ile	12	25227351	G	A	12											12-25227351-G-A	12588	12	25227351	G	A	T	I	rs104894364	12	25380285	12	25271552	58	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.173C>T	p.Thr58Ile	c.173C>T	p.Thr58Ile	alternative1	Y	1	.	Plus_Clinical	-	ACA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.87	0.90832	A	simple_aae	13.0	87.0	2.76	0.80456	M	-5.82	0.88318	D	0.985	0.99419	0.9591	0.96522	D	0.8519	0.95052	D	9	0.95001256	0.94271	D	0.262968	0.89556	D	0.921	0.98001	0.826	0.93687	P01116	T58I	Gain of catalytic residue at A59 (P = 0)| Loss of glycosylation at T58 (P = 0.0493)| Loss of disorder (P = 0.0697)| Loss of sheet (P = 0.1398)| Loss of phosphorylation at T58 (P = 0.1979)	0.993069005404	0.99291	0.9692766844020148	0.96898	2.79487049805	0.98863	0.928796410561	0.98917	D	0.892475	0.97806	D	0.461113	0.92920	D	0.42458	0.92832	D	0.997460722923279	0.91549	D	0.931307	0.74400	D	0.98686	0.99577	0.96777624	0.99355	0.98655695	0.99559	0.97297084	0.99581	-12.877	0.90103	D	0.9994	0.99054	P	0.999977356359875	0.99427	0.99922788	0.99231	0.997	0.99892	.	.	.	.	.	.	5.459501	0.91162	32.0	0.99889978765528353	0.96438	0.874898	0.79727	D	0.989759110368124	0.95396	13.60356	0.904634796992952	0.95748	13.95184	5.77	4.87	0.62830	3.17	0.57548	9.985	0.99185	9.977000	0.82927	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613990	6.195830e-07	0	1	64002	1.562450e-05	0	0	75010	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	1	64002	1.562450e-05	0	0	6060	0.000000e+00	0	0	1179936	0.000000e+00	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Noonan_syndrome|RASopathy|Noonan_syndrome_3|not_provided	reviewed_by_expert_panel	NC_000012.12:g.25227351G>A	ClinGen:CA256480|OMIM:190070.0011|UniProtKB:P01116#VAR_026111	C0028326|C5555857|C1860991|C3661900	PS163950|609942	648|536391|648	Small GTP-binding domain	Thr	Ile	27627	single nucleotide variant	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3845	KRAS	HGNC:6407	Pathogenic	1	Apr 03, 2017	104894364	-	RCV000013419|RCV000157933|RCV000211785|RCV000704828	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 3|not provided|Noonan syndrome|RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227351	25227351	12p12.1	reviewed by expert panel	7	-	N	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	3	12588	25227351	G	A	-	-	-	-	-	-	SCV000616369	-	-	173C>T 	Thr58Ile	NM_004985.5	3	1_Pathogenic	12	25227351	G	A	6.8411e-7																																																																																																				
KRAS	KRAS_Thr58Ile	-0.39527774123572407	0.7044069422700285	1.3907484853397487	0.20691013190075047																											true	KRAS		3084		CCSBVarC006096		NC_000012.12:25227351:G:A		Thr58Ile																												KRAS_Thr58Ile	12	25227351	G	A	12	allele	173C>T	G07	527_CAVA_Array_P03	N13	B13A7A8P1_R1	B14A7A8P1_R2				12-25227351-G-A	12588	12	25227351	G	A	T	I	rs104894364	12	25380285	12	25271552	58	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.173C>T	p.Thr58Ile	c.173C>T	p.Thr58Ile	alternative1	Y	1	.	Plus_Clinical	-	ACA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.87	0.90832	A	simple_aae	13.0	87.0	2.76	0.80456	M	-5.82	0.88318	D	0.985	0.99419	0.9591	0.96522	D	0.8519	0.95052	D	9	0.95001256	0.94271	D	0.262968	0.89556	D	0.921	0.98001	0.826	0.93687	P01116	T58I	Gain of catalytic residue at A59 (P = 0)| Loss of glycosylation at T58 (P = 0.0493)| Loss of disorder (P = 0.0697)| Loss of sheet (P = 0.1398)| Loss of phosphorylation at T58 (P = 0.1979)	0.993069005404	0.99291	0.9692766844020148	0.96898	2.79487049805	0.98863	0.928796410561	0.98917	D	0.892475	0.97806	D	0.461113	0.92920	D	0.42458	0.92832	D	0.997460722923279	0.91549	D	0.931307	0.74400	D	0.98686	0.99577	0.96777624	0.99355	0.98655695	0.99559	0.97297084	0.99581	-12.877	0.90103	D	0.9994	0.99054	P	0.999977356359875	0.99427	0.99922788	0.99231	0.997	0.99892	.	.	.	.	.	.	5.459501	0.91162	32.0	0.99889978765528353	0.96438	0.874898	0.79727	D	0.989759110368124	0.95396	13.60356	0.904634796992952	0.95748	13.95184	5.77	4.87	0.62830	3.17	0.57548	9.985	0.99185	9.977000	0.82927	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613990	6.195830e-07	0	1	64002	1.562450e-05	0	0	75010	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	1	64002	1.562450e-05	0	0	6060	0.000000e+00	0	0	1179936	0.000000e+00	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Noonan_syndrome|RASopathy|Noonan_syndrome_3|not_provided	reviewed_by_expert_panel	NC_000012.12:g.25227351G>A	ClinGen:CA256480|OMIM:190070.0011|UniProtKB:P01116#VAR_026111	C0028326|C5555857|C1860991|C3661900	PS163950|609942	648|536391|648	Small GTP-binding domain	Thr	Ile	27627	single nucleotide variant	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3845	KRAS	HGNC:6407	Pathogenic	1	Apr 03, 2017	104894364	-	RCV000013419|RCV000157933|RCV000211785|RCV000704828	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 3|not provided|Noonan syndrome|RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227351	25227351	12p12.1	reviewed by expert panel	7	-	N	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	3	12588	25227351	G	A	-	-	-	-	-	-	SCV000616369	-	-	173C>T 	Thr58Ile	NM_004985.5	3	1_Pathogenic	12	25227351	G	A	6.8411e-7																																																																																																				
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						178054	F9_Popp_2025_carboxy_gla_motif_var259236	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.005097503			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						178054	F9_Popp_2025_carboxy_gla_motif_var259236	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.005097503			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						150538	F9_Popp_2025_carboxy_F9_specific_var230193	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.010689583			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						150538	F9_Popp_2025_carboxy_F9_specific_var230193	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.010689583			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						260602	F9_Popp_2025_strep_2_var268917	F9_Popp_2025_strep_2	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.005218656			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						260602	F9_Popp_2025_strep_2_var268917	F9_Popp_2025_strep_2	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.005218656			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						233086	F9_Popp_2025_light_chain_var249555	F9_Popp_2025_light_chain	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.005952112			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						233086	F9_Popp_2025_light_chain_var249555	F9_Popp_2025_light_chain	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.005952112			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						205570	F9_Popp_2025_heavy_chain_var239874	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.043974252			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic						205570	F9_Popp_2025_heavy_chain_var239874	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139562042.0	139562042.0		1357			453.0	W	R	c.1357T>C	p.Trp453Arg	missense_variant	0.043974252			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.984																																																											F9_Trp453Arg	Trp453Arg	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						198263	F9_Popp_2025_heavy_chain_var237342	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.016075737			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						198263	F9_Popp_2025_heavy_chain_var237342	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.016075737			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						170747	F9_Popp_2025_carboxy_gla_motif_var256704	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.0144597012858405			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						170747	F9_Popp_2025_carboxy_gla_motif_var256704	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.0144597012858405			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						143231	F9_Popp_2025_carboxy_F9_specific_var227661	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.002747442			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						143231	F9_Popp_2025_carboxy_F9_specific_var227661	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.002747442			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						225779	F9_Popp_2025_light_chain_var247023	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.009126677			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						225779	F9_Popp_2025_light_chain_var247023	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.009126677			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						253295	F9_Popp_2025_strep_2_var266385	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.0257791412491283			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
F9	F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	true	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic						253295	F9_Popp_2025_strep_2_var266385	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561683.0	139561683.0		998			333.0	P	L	c.998C>T	p.Pro333Leu	missense_variant	0.0257791412491283			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.92																																																											F9_Pro333Leu	Pro333Leu	true
RAD51D	RAD51D_Val28Leu	-0.90363915640805	0.3962182548910523	11.911894475594517	6.680577611790535e-6	2025_01_Batch_13-14	0.8519265761309345	0.8839725446363323	0.9382073875115703	0.9477089800607024	0.7668278317963809	0.9488692246219802	0.9229132976854257	0.9568895776594537	0.9680219306510565	0.8853726734734867	0.9003979003764573	0.903442921160879	0.947548482585512	0.9578654553558794	0.8261002526349338	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024750		NC_000017.11:35119532:C:G		Val28Leu																												RAD51D_Val28Leu	17	35119532	C	G	17	allele	82G>C	C02	527_CAVA_Array_P05	E03	B13A7A8P2_R1	B14A7A8P2_R2				17-35119532-C-G	1762829	17	35119532	C	G	V	L	rs2142480064	17	33446551	17	30470664	28	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.82G>C	p.Val28Leu	c.82G>C	p.Val28Leu	principal1	Y	5	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.106	0.92967	T	1.0	0.90580	D	0.996	0.84488	D	.	.	.	.	.	.	2.71	0.79120	M	-2.45	0.56973	N	0.495	0.55314	-0.3621	0.73082	T	0.3608	0.72130	T	9	0.57687366	0.65335	D	0.226204	0.88003	D	0.229	0.52699	0.463	0.53105	O75771	V28L	Loss of sheet (P = 0.0126)| Gain of helix (P = 0.027)| Gain of loop (P = 0.0851)| Gain of ubiquitination at K26 (P = 0.1504)| Loss of phosphorylation at T27 (P = 0.2477)	0.834963111294	0.83208	.	0.68920	.	0.39860	.	.	.	0.485341	0.81083	T	0.0746214	0.61132	D	-0.130588	0.60646	T	0.984222710132599	0.75431	D	0.90461	0.67517	D	0.593787	0.72069	0.3945471	0.63896	0.593787	0.72070	0.3945471	0.63896	-8.931	0.67329	D	0.7085	0.75430	P	0.00939506599652921	0.23451	0.90928640	0.91550	0.676	0.82005	.	.	.	.	.	.	7.247327	0.96318	36.0	0.99800754297607808	0.88559	0.836844	0.75365	D	0.678883385112307	0.78132	6.833586	0.616344378564284	0.75995	6.433988	4.5	4.5	0.54328	.	.	3.379	0.52266	7.344000	0.58328	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.947	0.4917	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119532C>G	.	C0027672|C3280345	614291	140162|145	RAD51D, N-terminal domain	Val	Leu	1813922	single nucleotide variant	NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	1	Nov 06, 2023	-1	-	RCV002430340|RCV003454215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	germline;unknown	germline	GRCh38	NC_000017.11	17	35119532	35119532	17q12	criteria provided, conflicting classifications	2	-	N	ClinGen:CA399092236	2	1762829	35119532	C	G	-	-	-	-	-	-	SCV002681932|SCV004189682	-	-	82G>C 	Val28Leu	NM_002878.4	1	3_Conflicting						962965	RAD51D_unpublished_var157212	RAD51D_unpublished	RAD51D	9823.0	-1.0		35119532.0	35119532.0		82	G	C	28.0	V	L	c.82G>C	p.Val28Leu	missense_variant,splice_region_variant	-0.191517		functionally_abnormal	Yes		Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Nov 06, 2023	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.229																																																											RAD51D_Val28Leu	Val28Leu	true
BRCA1	BRCA1_Cys39Arg	0.8472010433103342	0.4248979667525149	4.1294175576416	0.004407203445207837	2025_01_Batch_13-14	0.911336485197664	0.9137217340058423	0.9073086621204074	0.9371120204690024	0.7799000081227152	0.9652418848774538	0.9170687102373754	0.9237966176939698	0.9615767892708877	0.9409877921854897	0.9382891850375589	0.9153952221216088	0.9155526399071886	0.9493444048699451	0.8604439001541024	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011862		NC_000017.11:43115745:A:G		Cys39Arg																												BRCA1_Cys39Arg	17	43115745	A	G	17	allele	115T>C	G09	527_CAVA_Array_P01	M17	B13A7A8P1_R1	B14A7A8P1_R2				17-43115745-A-G	54152	17	43115745	A	G	C	R	rs80357164	17	41267762	17	38521288	39	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.115T>C	p.Cys39Arg	principal2	Y	.	.	.	-	TGT	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.987	0.90580	D	0.879	0.92348	P	.	0.99291	.	.	.	.	4.355	0.98454	H	.	0.99400	.	.	0.97441	0.9518	0.96410	D	0.9931	0.99838	D	10	.	0.99503	.	0.908305	0.99312	D	.	0.98488	0.996	0.99957	E9PFC7	C39R	Gain of catalytic residue at C39 (P = 0.0465)| Gain of phosphorylation at T37 (P = 0.077)| Gain of helix (P = 0.132)| Gain of MoRF binding (P = 0.136)| Gain of glycosylation at T37 (P = 0.1377)	.	0.99932	.	0.93989	.	0.50598	0.773955702782	0.77978	T	0.409909	0.93004	T	0.564887	0.96297	D	0.573645	0.96237	D	0.998840510845184	0.95303	D	.	0.97903	.	0.98947704	0.99732	0.93276787	0.97245	0.97528833	0.98709	0.93651694	0.97501	-13.367	0.98539	D	.	0.97565	.	0.999949474096148	0.99079	0.99980813	0.99752	0.992	0.99727	.	.	.	.	.	.	4.933548	0.81398	27.5	0.99705377574859155	0.80955	0.797421	0.72325	D	0.971278320987367	0.94761	13.04323	0.87581144299615	0.94398	12.75438	5.97	5.97	0.96929	3.64	0.66725	4.109	0.57651	11.102000	0.86162	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613730	6.196820e-07	0	1	1179810	8.475940e-07	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	59942	0.000000e+00	0	0	29584	0.000000e+00	0	0	44862	0.000000e+00	0	0	64014	0.000000e+00	0	0	6060	0.000000e+00	0	1	1179810	8.475940e-07	0	0	91016	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43115745A>G	BRCA1-HCI:BRCA1_00113|ClinGen:CA000766	C0677776|CN221562|C3661900|C2676676|C0027672	604370	145|145|140162	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Arg	68819	single nucleotide variant	NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357164	-	RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115745	43115745	17q21.31	reviewed by expert panel	18	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00113,ClinGen:CA000766	2	54152	43115745	A	G	-	-	-	-	-	-	SCV000244296	-	-	115T>C 	Cys39Arg	NM_007294.4	3	1_Pathogenic																																																																																																									
SHOC2	SHOC2_Met173Val	-0.3926407601204963	0.7062668529828494	5.87423967430277	0.0006152936639761048	2025_01_Batch_13-14	0.9420425639126733	0.9443311232849014	0.8642483312693653	0.9191645209764896	0.8315313073499484	0.7559028152029459	0.842184246675346	0.734967436996238	0.7478020295372072	0.6343408282006262	0.8489726895578096	0.8932576849801237	0.7996078841328016	0.8334832752568484	0.7329360677752873	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2		11602		CCSBVarC028030		NC_000010.11:110964875:A:G		Met173Val																												SHOC2_Met173Val	10	110964875	A	G	10	allele	517A>G	E02	527_CAVA_Array_P06	I04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964875-A-G	373090	10	110964875	A	G	M	V	rs1057518206	10	112724633	10	112714623	173	SHOC2	ENSG00000108061	ENST00000369452	ENSP00000358464	Q9UQ13	SHOC2_HUMAN	c.517A>G	p.Met173Val	c.517A>G	p.Met173Val	principal1	Y	1	YES	Select	+	ATG	1	0	A	A/A	A/A	A/A	A/A	0.877	0.02574	T	0.71	0.05615	T	0.001	0.22981	B	0.002	0.23834	B	0.17	0.49097	A	simple_aae	83.0	17.0	-0.795	0.01632	N	0.96	0.01825	N	0.72	0.76196	-1.0948	0.04794	T	0.0449	0.19131	T	10	0.2705949	0.44206	D	0.099806	0.77096	D	0.428	0.73376	0.322	0.30091	Q9UQ13	M173V	Loss of catalytic residue at M173 (P = 0.0099)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K170 (P = 0.0863)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.0906)	0.660270521957	0.65475	0.6131685434429178	0.61071	0.514162079924	0.49084	0.843939304352	0.88676	D	0.106314	0.41460	T	-0.000997988	0.51194	T	-0.23921	0.50551	T	0.874729037284851	0.52197	D	.	0.77035	.	0.08041208	0.18257	0.10913989	0.26242	0.06424035	0.13484	0.11111266	0.26739	-7.545	0.57998	D	0.2724	0.59484	B	0.973092210519985	0.83842	0.00909550	0.40214	0.251	0.52136	.	.	.	.	.	.	2.561362	0.33237	19.26	0.30135072733151308	0.01631	0.893472	0.83085	D	-0.639719032405484	0.17541	0.9166258	-0.425424558940744	0.23937	1.327136	5.79	3.44	0.38414	.	.	9.325	0.96016	11.206000	0.89238	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.997	0.79771	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|SHOC2-related_disorder|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964875A>G	ClinGen:CA16042684	C3661900|C4478716|C1843181|C5555857	607721|PS607721	2701|2701|536391	.	Met	Val	359795	single nucleotide variant	NM_007373.4(SHOC2):c.517A>G (p.Met173Val)	8036	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	1	Jun 12, 2024	1057518206	-	RCV000413825|RCV002272224|RCV001584108|RCV003539878|RCV003922677	MedGen:C3661900|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	not provided|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome-like disorder with loose anagen hair|RASopathy|SHOC2-related disorder	de novo;germline	germline	GRCh38	NC_000010.11	10	110964875	110964875	10q25.2	criteria provided, conflicting classifications	7	-	N	ClinGen:CA16042684	2	373090	110964875	A	G	-	-	-	-	-	-	SCV000491653|SCV001821436|SCV002073493|SCV002581433|SCV004267682|SCV005086295	-	-	517A>G 	Met173Val	NM_007373.4	1	3_Conflicting																																																																																																									
F9	F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		true	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	811502	X	139561632	T	C	I	T	rs1603267344	X	138643791	X	138471457	316	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.95690	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.99859680176771604	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	800240	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Nov 13, 2023	1603267344	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632	139561632	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA414444900	2	811502	139561632	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2	1_Pathogenic						197239	F9_Popp_2025_heavy_chain_var236991	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561632.0	139561632.0		947			316.0	I	T	c.947T>C	p.Ile316Thr	missense_variant	0.049148476			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Nov 13, 2023	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Ile316Thr	Ile316Thr	true
F9	F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		true	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	811502	X	139561632	T	C	I	T	rs1603267344	X	138643791	X	138471457	316	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.95690	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.99859680176771604	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	800240	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Nov 13, 2023	1603267344	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632	139561632	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA414444900	2	811502	139561632	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2	1_Pathogenic						224755	F9_Popp_2025_light_chain_var246672	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561632.0	139561632.0		947			316.0	I	T	c.947T>C	p.Ile316Thr	missense_variant	0.006403476			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Nov 13, 2023	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Ile316Thr	Ile316Thr	true
F9	F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		true	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	811502	X	139561632	T	C	I	T	rs1603267344	X	138643791	X	138471457	316	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.95690	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.99859680176771604	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	800240	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Nov 13, 2023	1603267344	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632	139561632	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA414444900	2	811502	139561632	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2	1_Pathogenic						142207	F9_Popp_2025_carboxy_F9_specific_var227310	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561632.0	139561632.0		947			316.0	I	T	c.947T>C	p.Ile316Thr	missense_variant	0.008825945			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Nov 13, 2023	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Ile316Thr	Ile316Thr	true
F9	F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		true	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	811502	X	139561632	T	C	I	T	rs1603267344	X	138643791	X	138471457	316	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.95690	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.99859680176771604	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	800240	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Nov 13, 2023	1603267344	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632	139561632	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA414444900	2	811502	139561632	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2	1_Pathogenic						252271	F9_Popp_2025_strep_2_var266034	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561632.0	139561632.0		947			316.0	I	T	c.947T>C	p.Ile316Thr	missense_variant	0.037217651			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Nov 13, 2023	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Ile316Thr	Ile316Thr	true
F9	F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		true	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	811502	X	139561632	T	C	I	T	rs1603267344	X	138643791	X	138471457	316	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.95690	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.99859680176771604	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	800240	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Nov 13, 2023	1603267344	-	RCV001001414|RCV003769385|RCV004792605	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline	germline	GRCh38	NC_000023.11	X	139561632	139561632	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA414444900	2	811502	139561632	T	C	-	-	-	-	-	-	SCV001158649|SCV004571525|SCV005413449	-	-	947T>C 	Ile316Thr	NM_000133.4	2	1_Pathogenic						169723	F9_Popp_2025_carboxy_gla_motif_var256353	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561632.0	139561632.0		947			316.0	I	T	c.947T>C	p.Ile316Thr	missense_variant	0.0233977835246009			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Nov 13, 2023	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.976																																																											F9_Ile316Thr	Ile316Thr	true
RAD51D	RAD51D_Glu307Lys	-3.404294044082903	0.011375795993745073	0.8497515553009464	0.4235704158061365	2025_01_Batch_13-14	0.9947048700755531	0.9590398418311258	0.9502312770001002	0.9765785759640803	0.9819097374301679	0.9298728681393036	0.9693014477509644	0.9842264895359032	0.9824305982077703	0.8783337045721995	0.9622888691074283	0.9641706447910451	0.9672288832680017	0.9795045870859254	0.9301217210011836	1.0	1.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	true	RAD51D		7201		CCSBVarC024889		NC_000017.11:35101021:C:T		Glu307Lys																												RAD51D_Glu307Lys	17	35101021	C	T	17	allele	919G>A	F02	527_CAVA_Array_P05	K03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101021-C-T	127895	17	35101021	C	T	E	K	rs115031549	17	33428040	17	30452153	307	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.919G>A	p.Glu307Lys	c.919G>A	p.Glu307Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.178	0.22252	T	1.0	0.28071	T	0.001	0.15546	B	0.003	0.17739	B	0.04	0.16373	N	simple_aae	96.0	4.0	0.975	0.24371	L	-1.37	0.33974	N	0.183	0.40913	-1.0750	0.08363	T	0.0695	0.28228	T	10	0.005851954	0.00128	T	0.009794	0.25268	T	0.146	0.38573	.	.	.	.	.	0.607307720492	0.60114	.	0.58340	.	0.10516	.	.	.	0.12397	0.44563	T	-0.436555	0.01267	T	-0.402908	0.32684	T	0.0220424253485093	0.00910	T	.	0.44143	.	0.06279154	0.13032	0.07841017	0.17544	0.06279154	0.13031	0.07841017	0.17544	-3.296	0.19068	T	0.2196	0.48302	LB	0.00210343958860793	0.13347	0.64807075	0.84992	0.024	0.04173	.	.	.	.	.	.	2.74903	0.36098	20.1	0.95388473665255458	0.27048	0.227759	0.34944	N	-0.451516097100692	0.23421	1.273859	-0.296002730575465	0.27912	1.572344	5.16	4.19	0.48586	1.06	0.29739	2.03	0.40832	4.830000	0.45268	-0.187	0.09644	1.0	0.71675	1.000000	0.68239	0.789	0.37304	913	0.21155	3	5.990415335463259E-4	3	0.0022692889561270802	0	0.0	0	0.0	0	0.0	0	0.0	238	264690	8.9916505E-4	.	20	109408	1.828020e-04	0	55	208134	2.642530e-04	0	56	236948	2.363390e-04	0	17	7164	2.372980e-03	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	17	7164	2.372980e-03	0	46	16218	2.836350e-03	0	8	30524	2.620890e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89556	0.000000e+00	0	0	30608	0.000000e+00	0	46	16218	2.836350e-03	0	45	14902	3.019730e-03	0	9	34260	2.626970e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102744	0.000000e+00	0	0	30526	0.000000e+00	0	45	14902	3.019730e-03	0	.	251	1613792	1.555340e-04	2	217	75054	2.891250e-03	2	217	75054	2.891250e-03	2	0	912	0.000000e+00	0	20	60010	3.332780e-04	0	0	29602	0.000000e+00	0	0	44888	0.000000e+00	0	0	64046	0.000000e+00	0	0	6062	0.000000e+00	0	3	1179658	2.543110e-06	0	0	91070	0.000000e+00	0	1	167370	5.9747864013861505E-6	3	362	0.008287292817679558	0	4488	0	28	8974	0.0031201248049922	0	460	0	0	1024	0	0	1820	0	0	296	0	0	11378	0	31	9336	0.0033204798628963155	0	6308	0	32	196172	1.6312215810615173E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|RAD51D-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101021C>T	ClinGen:CA287990	C0027672|CN169374|C3661900|C3280345|C0006142|CN221562	614291	140162|145	.	Glu	Lys	133352	single nucleotide variant	NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Feb 02, 2025	115031549	-	RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35101021	35101021	17q12	criteria provided, conflicting classifications	12	-	N	ClinGen:CA287990	2	127895	35101021	C	T	-	-	-	-	-	-	SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853	-	-	919G>A 	Glu307Lys	NM_002878.4	1	3_Conflicting						959089	RAD51D_unpublished_var153336	RAD51D_unpublished	RAD51D	9823.0	-1.0		35101021.0	35101021.0		919	G	A	307.0	E	K	c.919G>A	p.Glu307Lys	missense_variant	-0.0106997		functionally_normal	Yes	0.0001555342943824	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Sep 11, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.146																																																											RAD51D_Glu307Lys	Glu307Lys	true
RHO	RHO_Pro267Thr	-6.437157064447852	0.0003545519851312502	-11.95420622579369	6.523550915399581e-6	2025_01_Batch_13-14	0.8513456128397525	0.9025171263040506	0.994589753999556	0.9802752080130739	0.9175107261259643	0.9556344726701156	0.9715736384186505	0.998483276351947	0.9941971552212685	0.9456879602265387	0.903490042754934	0.9370453823613505	0.9965365151757515	0.9872361816171712	0.9315993431762515	0.0	0.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	true	RHO		40080645		CCSBVarC013575		NC_000003.12:129532635:C:A		Pro267Thr																												RHO_Pro267Thr	3	129532635	C	A	3	allele	799C>A	A10	527_CAVA_Array_P05	A19	B13A7A8P2_R1	B14A7A8P2_R2				3-129532635-C-A	853413	3	129532635	C	A	P	T	rs2084789550	3	129251478	3	130734168	267	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.799C>A	p.Pro267Thr	c.799C>A	p.Pro267Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	4.65	0.99359	H	-7.12	0.94038	D	0.965	0.97550	0.9999	0.97178	D	0.8404	0.94654	D	10	0.99142945	0.99666	D	0.443179	0.94193	D	0.946	0.98921	0.926	0.98766	P08100	P267T	Loss of glycosylation at S270 (P = 0.1504)| Gain of helix (P = 0.1736)| Gain of catalytic residue at P267 (P = 0.1854)| Loss of loop (P = 0.2897)| Loss of sheet (P = 0.302)	0.990985566321	0.99077	0.9222913745428601	0.92157	0.915089302012	0.71030	0.700365960598	0.67140	T	0.905498	0.98159	D	0.464614	0.93069	D	0.429609	0.92983	D	0.999821364879608	0.99193	D	0.989501	0.96561	D	0.9601639	0.97253	0.9319166	0.97186	0.9601639	0.97253	0.9319166	0.97186	-13.396	0.90947	D	0.9653	0.88720	P	0.999611079235613	0.97193	0.99991560	0.99909	0.995	0.99826	.	.	.	.	.	.	4.83405	0.78897	27.0	0.99803833658587948	0.88826	0.897847	0.83988	D	1.09702721159454	0.98067	17.37958	0.975528194122127	0.98084	17.41673	5.51	5.51	0.81744	.	.	7.9	0.86061	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.798	0.37682	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.129532635C>A	.	C3661900	.	.	GPCR, rhodopsin-like, 7TM	Pro	Thr	827539	single nucleotide variant	NM_000539.3(RHO):c.799C>A (p.Pro267Thr)	6010	RHO	HGNC:10012	Pathogenic	1	Nov 18, 2024	2084789550	-	RCV001058214	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000003.12	3	129532635	129532635	3q22.1	criteria provided, single submitter	1	-	N	ClinGen:CA354470391	2	853413	129532635	C	A	-	-	-	-	-	-	SCV001222770	-	-	799C>A 	Pro267Thr	NM_000539.3	1	1_Pathogenic																																																																																																									
F9	F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.702938843132956	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	2184672	X	139551125	T	G	V	G	rs374674030	X	138633284	X	138460950	195	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258000	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	1921180	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158	F9	HGNC:3551	Likely benign	0	Aug 23, 2023	-1	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125	139551125	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137420	2	2184672	139551125	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1	2_Benign						162585	F9_Popp_2025_carboxy_gla_motif_var253816	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551125.0	139551125.0		584			195.0	V	G	c.584T>G	p.Val195Gly	missense_variant	1.072928962725921			No	3.3068591699e-6	Likely benign	criteria provided, single submitter	Aug 23, 2023	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.301																																																											F9_Val195Gly	Val195Gly	true
F9	F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.702938843132956	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	2184672	X	139551125	T	G	V	G	rs374674030	X	138633284	X	138460950	195	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258000	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	1921180	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158	F9	HGNC:3551	Likely benign	0	Aug 23, 2023	-1	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125	139551125	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137420	2	2184672	139551125	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1	2_Benign						217617	F9_Popp_2025_light_chain_var244135	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551125.0	139551125.0		584			195.0	V	G	c.584T>G	p.Val195Gly	missense_variant	1.090559473007268			No	3.3068591699e-6	Likely benign	criteria provided, single submitter	Aug 23, 2023	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.301																																																											F9_Val195Gly	Val195Gly	true
F9	F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.702938843132956	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	2184672	X	139551125	T	G	V	G	rs374674030	X	138633284	X	138460950	195	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258000	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	1921180	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158	F9	HGNC:3551	Likely benign	0	Aug 23, 2023	-1	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125	139551125	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137420	2	2184672	139551125	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1	2_Benign						135069	F9_Popp_2025_carboxy_F9_specific_var224773	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551125.0	139551125.0		584			195.0	V	G	c.584T>G	p.Val195Gly	missense_variant	1.0683572142925006			No	3.3068591699e-6	Likely benign	criteria provided, single submitter	Aug 23, 2023	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.301																																																											F9_Val195Gly	Val195Gly	true
F9	F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.702938843132956	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	2184672	X	139551125	T	G	V	G	rs374674030	X	138633284	X	138460950	195	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258000	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	1921180	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158	F9	HGNC:3551	Likely benign	0	Aug 23, 2023	-1	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125	139551125	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137420	2	2184672	139551125	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1	2_Benign						190101	F9_Popp_2025_heavy_chain_var234454	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551125.0	139551125.0		584			195.0	V	G	c.584T>G	p.Val195Gly	missense_variant	1.045738961249948			No	3.3068591699e-6	Likely benign	criteria provided, single submitter	Aug 23, 2023	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.301																																																											F9_Val195Gly	Val195Gly	true
F9	F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.702938843132956	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	2184672	X	139551125	T	G	V	G	rs374674030	X	138633284	X	138460950	195	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258000	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	1921180	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158	F9	HGNC:3551	Likely benign	0	Aug 23, 2023	-1	-	RCV002632292	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551125	139551125	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA336137420	2	2184672	139551125	T	G	-	-	-	-	-	-	SCV003501528	-	-	584T>G 	Val195Gly	NM_000133.4	1	2_Benign						245133	F9_Popp_2025_strep_2_var263497	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551125.0	139551125.0		584			195.0	V	G	c.584T>G	p.Val195Gly	missense_variant	1.095708345689263			No	3.3068591699e-6	Likely benign	criteria provided, single submitter	Aug 23, 2023	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.301																																																											F9_Val195Gly	Val195Gly	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						147033	F9_Popp_2025_carboxy_F9_specific_var228989	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.038667062366221			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						147033	F9_Popp_2025_carboxy_F9_specific_var228989	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.038667062366221			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						229581	F9_Popp_2025_light_chain_var248351	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.025590107			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						229581	F9_Popp_2025_light_chain_var248351	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.025590107			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						257097	F9_Popp_2025_strep_2_var267713	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.14033838			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						257097	F9_Popp_2025_strep_2_var267713	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.14033838			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						202065	F9_Popp_2025_heavy_chain_var238670	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.038435796			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						202065	F9_Popp_2025_heavy_chain_var238670	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.038435796			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						174549	F9_Popp_2025_carboxy_gla_motif_var258032	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.0244746370917692			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
F9	F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic						174549	F9_Popp_2025_carboxy_gla_motif_var258032	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561872.0	139561872.0		1187			396.0	C	S	c.1187G>C	p.Cys396Ser	missense_variant	0.0244746370917692			No		Pathogenic	no assertion criteria provided	Jan 01, 1991	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys396Ser	Cys396Ser	true
RET	RET_Arg330Gln	-1.7958396916116608	0.11558602092288398	12.792825715139873	4.1342425315877565e-6	2025_01_Batch_13-14	0.9939309951224155	0.9707838684532181	0.9702720270096226	0.9826078401369326	0.9759573065456218	0.8106779897676171	0.9131511378755663	0.9477362189792289	0.8397761269106413	0.7493257015759742	0.9023044924450163	0.9419675031643922	0.9590041229944257	0.9111919835237869	0.862641504060798	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202957	CCSBVarC006881	ALE00006879	NC_000010.11:43106497:G:A	989G>A	Arg330Gln	CEGS2	CegsMutGDEh1026	D12	GDEhDisVCh_40066	F05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Arg330Gln	10	43106497	G	A	10											10-43106497-G-A	13926	10	43106497	G	A	R	Q	rs80236571	10	43601945	10	42921951	330	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.989G>A	p.Arg330Gln	c.989G>A	p.Arg330Gln	principal4	Y	5	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.241	0.17740	T	0.612	0.07765	T	0.997	0.73231	D	0.775	0.63015	P	0.58	0.75656	D	simple_aae	42.0	58.0	2.585	0.75368	M	-0.99	0.26154	N	0.607	0.62248	-0.0406	0.81321	T	0.5279	0.82381	D	10	0.85925674	0.84978	D	0.089999	0.75354	D	0.569	0.82371	0.757	0.88590	P07949	R330Q	Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.1985)| Gain of loop (P = 0.2045)| Loss of catalytic residue at R330 (P = 0.2566)| Loss of MoRF binding (P = 0.3113)	0.965051945311	0.96435	0.6768372825309222	0.67462	0.826949697597	0.67244	0.388616234064	0.23448	T	0.474583	0.80450	T	0.330437	0.85088	D	0.236874	0.84893	D	0.956602513790131	0.64578	D	0.819018	0.47499	T	0.24423973	0.47042	0.1090586	0.26223	0.21209615	0.43230	0.109657414	0.26374	-3.803	0.21738	T	0.1014	0.27073	B	0.758352146287697	0.69115	0.99982280	0.99765	0.47	0.69480	.	.	.	.	.	.	4.587702	0.72592	25.8	0.99947467890025776	0.99913	0.525698	0.54678	D	0.535811506893486	0.69059	5.326549	0.557793047773544	0.71788	5.732199	5.32	5.32	0.75341	4.38	0.82553	4.133	0.57831	8.604000	0.77773	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.976	0.56441	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613734	6.196810e-07	0	1	1179844	8.475700e-07	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29592	0.000000e+00	0	0	44862	0.000000e+00	0	0	63922	0.000000e+00	0	0	6056	0.000000e+00	0	1	1179844	8.475700e-07	0	0	91026	0.000000e+00	0	1	23858	4.191466174867969E-5	0	84	0	0	84	0	0	2230	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4558	0	0	2314	0	0	108	0	1	32060	3.1191515907673116E-5	Conflicting_classifications_of_pathogenicity	Hirschsprung_disease,_susceptibility_to,_1|not_provided|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106497G>A	ClinGen:CA009415|OMIM:164761.0022|UniProtKB:P07949#VAR_006302	C3888239|C3661900|C4048306	142623	388|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	28965	single nucleotide variant	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	1	Jun 22, 2023	80236571	-	RCV000014951|RCV004696636|RCV001379274	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43106497	43106497	10q11.21	criteria provided, conflicting classifications	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009415,UniProtKB:P07949#VAR_006302,OMIM:164761.0022	3	13926	43106497	G	A	-	-	-	-	-	-	SCV001577045|SCV004817287|SCV005198055|SCV005849412	-	-	989G>A 	Arg330Gln	NM_020975.6	1	3_Conflicting	10	43106497	G	A	6.84263e-7																																																																																																				
RET	RET_Arg330Gln	-1.7958396916116608	0.11558602092288398	12.792825715139873	4.1342425315877565e-6	2025_01_Batch_13-14	0.9939309951224155	0.9707838684532181	0.9702720270096226	0.9826078401369326	0.9759573065456218	0.8106779897676171	0.9131511378755663	0.9477362189792289	0.8397761269106413	0.7493257015759742	0.9023044924450163	0.9419675031643922	0.9590041229944257	0.9111919835237869	0.862641504060798	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006881		NC_000010.11:43106497:G:A		Arg330Gln																												RET_Arg330Gln	10	43106497	G	A	10	allele	989G>A	C09	527_CAVA_Array_P05	E17	B13A7A8P2_R1	B14A7A8P2_R2				10-43106497-G-A	13926	10	43106497	G	A	R	Q	rs80236571	10	43601945	10	42921951	330	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.989G>A	p.Arg330Gln	c.989G>A	p.Arg330Gln	principal4	Y	5	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.241	0.17740	T	0.612	0.07765	T	0.997	0.73231	D	0.775	0.63015	P	0.58	0.75656	D	simple_aae	42.0	58.0	2.585	0.75368	M	-0.99	0.26154	N	0.607	0.62248	-0.0406	0.81321	T	0.5279	0.82381	D	10	0.85925674	0.84978	D	0.089999	0.75354	D	0.569	0.82371	0.757	0.88590	P07949	R330Q	Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.1985)| Gain of loop (P = 0.2045)| Loss of catalytic residue at R330 (P = 0.2566)| Loss of MoRF binding (P = 0.3113)	0.965051945311	0.96435	0.6768372825309222	0.67462	0.826949697597	0.67244	0.388616234064	0.23448	T	0.474583	0.80450	T	0.330437	0.85088	D	0.236874	0.84893	D	0.956602513790131	0.64578	D	0.819018	0.47499	T	0.24423973	0.47042	0.1090586	0.26223	0.21209615	0.43230	0.109657414	0.26374	-3.803	0.21738	T	0.1014	0.27073	B	0.758352146287697	0.69115	0.99982280	0.99765	0.47	0.69480	.	.	.	.	.	.	4.587702	0.72592	25.8	0.99947467890025776	0.99913	0.525698	0.54678	D	0.535811506893486	0.69059	5.326549	0.557793047773544	0.71788	5.732199	5.32	5.32	0.75341	4.38	0.82553	4.133	0.57831	8.604000	0.77773	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.976	0.56441	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613734	6.196810e-07	0	1	1179844	8.475700e-07	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29592	0.000000e+00	0	0	44862	0.000000e+00	0	0	63922	0.000000e+00	0	0	6056	0.000000e+00	0	1	1179844	8.475700e-07	0	0	91026	0.000000e+00	0	1	23858	4.191466174867969E-5	0	84	0	0	84	0	0	2230	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4558	0	0	2314	0	0	108	0	1	32060	3.1191515907673116E-5	Conflicting_classifications_of_pathogenicity	Hirschsprung_disease,_susceptibility_to,_1|not_provided|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106497G>A	ClinGen:CA009415|OMIM:164761.0022|UniProtKB:P07949#VAR_006302	C3888239|C3661900|C4048306	142623	388|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	28965	single nucleotide variant	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	1	Jun 22, 2023	80236571	-	RCV000014951|RCV004696636|RCV001379274	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43106497	43106497	10q11.21	criteria provided, conflicting classifications	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009415,UniProtKB:P07949#VAR_006302,OMIM:164761.0022	3	13926	43106497	G	A	-	-	-	-	-	-	SCV001577045|SCV004817287|SCV005198055|SCV005849412	-	-	989G>A 	Arg330Gln	NM_020975.6	1	3_Conflicting	10	43106497	G	A	6.84263e-7																																																																																																				
RAD51D	RAD51D_Gly289Ser	7.092665294834583	0.00019491549970907673	4.4242509106705175	0.0030654811896686784	2025_01_Batch_13-14	0.9505417159707915	0.8848897946836229	0.8829042769396422	0.8825882918074114	0.9324648798930826	0.9297212965001249	0.9409617617917445	0.9349827186011955	0.9512940765792127	0.8214073716130127	0.9401315062354583	0.9129257782376837	0.9089434977704189	0.916941184193312	0.8769361257530477	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024877		NC_000017.11:35101239:C:T		Gly289Ser																												RAD51D_Gly289Ser	17	35101239	C	T	17	allele	865G>A	D02	527_CAVA_Array_P05	G03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101239-C-T	141945	17	35101239	C	T	G	S	rs587782129	17	33428258	17	30452371	289	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.865G>A	p.Gly289Ser	c.865G>A	p.Gly289Ser	principal1	Y	5	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	.	0.00968	.	1.0	0.10481	T	0.008	0.20016	B	0.008	0.16009	B	0.06	0.18971	N	simple_aae	94.0	6.0	-0.395	0.03015	N	.	0.02351	.	0.225	0.25080	-1.0152	0.25206	T	0.1048	0.38180	T	10	0.047472775	0.04072	T	0.015582	0.36140	T	0.030	0.06938	0.393	0.41625	O75771	G289S	Gain of phosphorylation at G289 (P = 0.0191)| Gain of glycosylation at G289 (P = 0.0564)| Loss of methylation at R290 (P = 0.0588)| Gain of disorder (P = 0.0724)| Gain of MoRF binding (P = 0.1175)	0.0762999501168	0.06748	.	0.22253	.	0.36811	.	.	.	0.105892	0.41382	T	-0.28641	0.09770	T	-0.55233	0.16804	T	0.0316729542490267	0.02239	T	0.675032	0.28091	T	0.018450681	0.00366	0.023860626	0.00404	0.018450681	0.00366	0.023860626	0.00404	-2.752	0.11831	T	0.0718	0.06786	B	2.70558370001736e-05	0.01340	0.14648667	0.70195	0.008	0.00393	.	.	.	.	.	.	-0.012147	0.0421	1.022	0.74482722392783784	0.10886	0.042395	0.06461	N	-1.33388171991115	0.03260	0.1469401	-1.31009436204477	0.04234	0.2024671	4.86	0.314	0.15050	-1.35	0.14151	0.155	0.16235	-0.662000	0.08011	-0.181	0.10317	0.037	0.20898	0.000000	0.08389	0.001	0.02614	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	2	208106	9.610490e-06	0	3	236918	1.266260e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16214	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	1	89538	1.116840e-05	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	1	102720	9.735200e-06	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	11	1614202	6.814510e-06	0	1	91088	1.097840e-05	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	0	44874	0.000000e+00	0	0	64048	0.000000e+00	0	0	6062	0.000000e+00	0	9	1180036	7.626890e-06	0	1	91088	1.097840e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_specified	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101239C>T	ClinGen:CA166871	C3661900|C0027672|C3280345|CN169374	614291	140162|145	DNA repair protein RAD51 homolog 4, C-terminal	Gly	Ser	151659	single nucleotide variant	NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Nov 29, 2024	587782129	-	RCV000130672|RCV000462688|RCV000480701|RCV001194378	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline	germline	GRCh38	NC_000017.11	17	35101239	35101239	17q12	criteria provided, conflicting classifications	5	-	N	ClinGen:CA166871	2	141945	35101239	C	T	-	-	-	-	-	-	SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870	-	-	865G>A 	Gly289Ser	NM_002878.4	1	3_Conflicting						959383	RAD51D_unpublished_var153630	RAD51D_unpublished	RAD51D	9823.0	-1.0		35101239.0	35101239.0		865	G	A	289.0	G	S	c.865G>A	p.Gly289Ser	missense_variant	-0.00125449		functionally_normal	Yes	6.8145126818e-6	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	May 29, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.03																																																											RAD51D_Gly289Ser	Gly289Ser	true
BRCA1	BRCA1_Met671Lys	2.267013845164269	0.05773114204962296	0.8349415031917329	0.43132063358320427	2025_01_Batch_13-14	0.9704484609385355	0.9116781681071608	0.9469280859184088	0.9403527782700145	0.9102883342188165	0.9505938449333811	0.8635539212999332	0.8959331127479064	0.9408515549566256	0.7977029247017272	0.9605211529359583	0.887616044703547	0.9214305993331576	0.9406021666133201	0.8539956294602719	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011871		NC_000017.11:43051071:A:T		Met671Lys																												BRCA1_Met671Lys	17	43051071	A	T	17	allele	2012T>A	B10	527_CAVA_Array_P01	C19	B13A7A8P1_R1	B14A7A8P1_R2				17-43051071-A-T	17695	17	43051071	A	T	M	K	rs41293463	17	41203088	17	38456614	1775	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5324T>A	p.Met1775Lys	c.5324T>A	p.Met1775Lys	principal2	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.99	0.90580	D	0.798	0.86259	P	0.95	0.99291	A	simple_aae	5.0	95.0	2.33	0.66629	M	-1.1	0.77340	N	0.878	0.98669	0.6922	0.93053	D	0.7837	0.92637	D	10	0.8988125	0.89121	D	0.804846	0.98472	D	0.734	0.90683	.	.	.	.	.	0.963482532597	0.96276	.	0.86847	.	0.52277	0.562978863716	0.47621	T	0.234774	0.59973	T	0.436191	0.91778	D	0.388781	0.91677	D	0.990923941135406	0.81018	D	.	0.83947	.	0.9531011	0.96527	0.80974793	0.88742	0.9654434	0.97787	0.735878	0.84203	-12.423	0.89812	D	0.8787	0.86232	P	0.996656271029341	0.92339	0.99989700	0.99879	0.957	0.98136	.	.	.	.	.	.	3.769401	0.54208	23.4	0.98558459070339721	0.43068	0.719653	0.66927	D	0.693440170392724	0.79088	7.028289	0.666244745644706	0.79713	7.165023	5.21	5.21	0.71966	.	.	5.026	0.63961	11.142000	0.87118	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43051071A>T	BRCA1-HCI:BRCA1_00110|ClinGen:CA003476|OMIM:113705.0036|UniProtKB:P38398#VAR_063212	C2676676|C0027672|C0677776	604370	145|140162|145	.	Met	Lys	32734	single nucleotide variant	NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	41293463	-	RCV000019265|RCV000496817|RCV001526335	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43051071	43051071	17q21.31	reviewed by expert panel	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036	3	17695	43051071	A	T	-	-	-	-	-	-	SCV000244397	-	-	5324T>A 	Met1775Lys	NM_007294.4	3	1_Pathogenic																																																																																																									
CTCF	CTCF_His455Gln	3.8257806455949326	0.006493290691325369	-3.9544631677107454	0.00550049482130096	2025_01_Batch_13-14	0.9144240132292991	0.9697413493209072	0.8484144726341254	0.8540200173951931	0.8175221726722572	0.8970715001416794	0.8606907982883133	0.7778673713016637	0.8237783231600767	0.8122234796292092	0.9057477566854892	0.9152160738046102	0.8131409219678946	0.8388991702776349	0.8148728261507332	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010858		NC_000016.10:67626562:C:G		His455Gln																												CTCF_His455Gln	16	67626562	C	G	16	allele	1365C>G	A02	527_CAVA_Array_P02	A04	B13A7A8P1_R1	B14A7A8P1_R2				16-67626562-C-G	812003	16	67626562	C	G	H	Q	rs1597725291	16	67660465	16	66217966	455	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.1365C>G	p.His455Gln	c.1365C>G	p.His455Gln	principal4	Y	1	YES	Select	+	CAC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.992	0.80453	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.485	0.98910	H	-7.51	0.95091	D	0.92	0.92320	-0.2605	0.75966	T	0.3925	0.74513	T	10	0.8887602	0.88083	D	0.149609	0.83093	D	0.579	0.82939	0.748	0.87844	P49711	H455Q	Gain of MoRF binding (P = 0.0878)| Loss of helix (P = 0.1706)| Gain of disorder (P = 0.19)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2629)	0.949006423897	0.94804	.	0.97634	3.03790854674	0.99266	0.889497578144	0.95192	D	0.917886	0.98488	D	0.309664	0.83603	D	0.207035	0.83391	D	0.989961684048839	0.80030	D	.	0.80399	.	0.969477	0.98182	0.83204865	0.90192	0.969477	0.98182	0.83204865	0.90192	-13.14	0.89952	D	.	0.99795	.	0.99981684735099	0.98120	0.98982334	0.96704	0.864	0.92591	.	.	.	.	.	.	3.86468	0.56146	23.7	0.99143631297156454	0.53677	0.530946	0.54986	D	0.449511622968474	0.63986	4.666273	0.33042528030055	0.57107	3.898847	5.48	1.99	0.25354	2.62	0.47948	2.183	0.42298	0.800000	0.21732	-0.182	0.10118	1.0	0.71675	0.999000	0.35501	0.99	0.65338	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	criteria_provided,_single_submitter	NC_000016.10:g.67626562C>G	.	C3809686	615502	363611	.	His	Gln	799962	single nucleotide variant	NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	10664	CTCF	HGNC:13723	Likely pathogenic	1	Jun 10, 2019	1597725291	-	RCV001002552	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	germline	germline	GRCh38	NC_000016.10	16	67626562	67626562	16q22.1	criteria provided, single submitter	1	-	N	ClinGen:CA396317165	2	812003	67626562	C	G	-	-	-	-	-	-	SCV001160523	-	-	1365C>G 	His455Gln	NM_006565.4	1	1_Pathogenic						966000	CTCF_unpublished_var160247	CTCF_unpublished	CTCF	13723.0	1.0		67626562.0	67626562.0		1365	C	G	455.0	H	Q	c.1365C>G	p.His455Gln	missense_variant	-0.295056		functionally_abnormal	Yes		Likely pathogenic	criteria provided, single submitter	Jun 10, 2019	nucleotide		ENST00000264010.10	NM_006565.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.579																																																											CTCF_His455Gln	His455Gln	true
F9	F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811218	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	973811	X	139561690	C	G	C	W	rs1928110579	X	138643849	X	138471515	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.95810	D	0.9301	0.97688	D	10	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.99364900823550439	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001000	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	962089	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158	F9	HGNC:3551	Likely pathogenic	1	Jun 01, 2019	1928110579	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690	139561690	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414445330	2	973811	139561690	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic						170878	F9_Popp_2025_carboxy_gla_motif_var256750	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561690.0	139561690.0		1005			335.0	C	W	c.1005C>G	p.Cys335Trp	missense_variant	-0.002064131			No		Likely pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.874																																																											F9_Cys335Trp	Cys335Trp	true
F9	F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811218	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	973811	X	139561690	C	G	C	W	rs1928110579	X	138643849	X	138471515	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.95810	D	0.9301	0.97688	D	10	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.99364900823550439	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001000	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	962089	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158	F9	HGNC:3551	Likely pathogenic	1	Jun 01, 2019	1928110579	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690	139561690	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414445330	2	973811	139561690	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic						225910	F9_Popp_2025_light_chain_var247069	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561690.0	139561690.0		1005			335.0	C	W	c.1005C>G	p.Cys335Trp	missense_variant	-0.001194971			No		Likely pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.874																																																											F9_Cys335Trp	Cys335Trp	true
F9	F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811218	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	973811	X	139561690	C	G	C	W	rs1928110579	X	138643849	X	138471515	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.95810	D	0.9301	0.97688	D	10	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.99364900823550439	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001000	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	962089	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158	F9	HGNC:3551	Likely pathogenic	1	Jun 01, 2019	1928110579	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690	139561690	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414445330	2	973811	139561690	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic						198394	F9_Popp_2025_heavy_chain_var237388	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561690.0	139561690.0		1005			335.0	C	W	c.1005C>G	p.Cys335Trp	missense_variant	0.016996726			No		Likely pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.874																																																											F9_Cys335Trp	Cys335Trp	true
F9	F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811218	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	973811	X	139561690	C	G	C	W	rs1928110579	X	138643849	X	138471515	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.95810	D	0.9301	0.97688	D	10	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.99364900823550439	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001000	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	962089	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158	F9	HGNC:3551	Likely pathogenic	1	Jun 01, 2019	1928110579	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690	139561690	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414445330	2	973811	139561690	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic						253426	F9_Popp_2025_strep_2_var266431	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561690.0	139561690.0		1005			335.0	C	W	c.1005C>G	p.Cys335Trp	missense_variant	0.0161410384652565			No		Likely pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.874																																																											F9_Cys335Trp	Cys335Trp	true
F9	F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811218	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	973811	X	139561690	C	G	C	W	rs1928110579	X	138643849	X	138471515	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.95810	D	0.9301	0.97688	D	10	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.99364900823550439	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001000	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	962089	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158	F9	HGNC:3551	Likely pathogenic	1	Jun 01, 2019	1928110579	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690	139561690	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414445330	2	973811	139561690	C	G	-	-	-	-	-	-	SCV001424890	-	-	1005C>G 	Cys335Trp	NM_000133.4		1_Pathogenic						143362	F9_Popp_2025_carboxy_F9_specific_var227707	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561690.0	139561690.0		1005			335.0	C	W	c.1005C>G	p.Cys335Trp	missense_variant	0.005012777			No		Likely pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.874																																																											F9_Cys335Trp	Cys335Trp	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						175458	F9_Popp_2025_carboxy_gla_motif_var258341	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.0822136685510857			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						175458	F9_Popp_2025_carboxy_gla_motif_var258341	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.0822136685510857			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						202974	F9_Popp_2025_heavy_chain_var238979	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	0.9778487977783746			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						202974	F9_Popp_2025_heavy_chain_var238979	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	0.9778487977783746			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						147942	F9_Popp_2025_carboxy_F9_specific_var229298	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.1096005759589982			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						147942	F9_Popp_2025_carboxy_F9_specific_var229298	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.1096005759589982			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						258006	F9_Popp_2025_strep_2_var268022	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.0706452008237304			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						258006	F9_Popp_2025_strep_2_var268022	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.0706452008237304			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						230490	F9_Popp_2025_light_chain_var248660	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.0517157228317906			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic						230490	F9_Popp_2025_light_chain_var248660	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561917.0	139561917.0		1232			411.0	S	I	c.1232G>T	p.Ser411Ile	missense_variant	1.0517157228317906			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.975																																																											F9_Ser411Ile	Ser411Ile	true
F9	F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890914	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648655	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									
RAD51D	RAD51D_Val56Gly	1.9985217593357885	0.08580618781279473	6.150467942611997	0.00046732469968957475	2025_01_Batch_13-14	0.68541614335651	0.7903470561584305	0.8642881205783758	0.8287716597985677	0.6506081281818463	0.43725980088048955	0.6049024150896948	0.7474274935923941	0.6306652566123854	0.427543295429101	0.5613379721184998	0.6976247356240626	0.805857807085385	0.7297184582054765	0.5390757118054736	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024801		NC_000017.11:35118597:A:C		Val56Gly																												RAD51D_Val56Gly	17	35118597	A	C	17	allele	167T>G	F12	527_CAVA_Array_P04	L24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118597-A-C	1098881	17	35118597	A	C	V	G	rs745307359	17	33445616	17	30469729	56	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.167T>G	p.Val56Gly	c.167T>G	p.Val56Gly	principal1	Y	5	.	.	-	GTG	2	0	A	A/A	A/A	A/A	A/A	.	0.31374	.	0.002	0.79703	D	0.722	0.42404	P	0.488	0.47286	P	.	.	.	.	.	.	1.795	0.47093	L	.	0.62039	.	0.721	0.72170	-0.8783	0.49699	T	0.1726	0.51308	T	10	0.03294766	0.01460	T	0.089068	0.75174	D	.	0.75010	0.613	0.74554	O75771	V56G	Loss of stability (P = 2e-04)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0804)| Gain of relative solvent accessibility (P = 0.1066)| Loss of MoRF binding (P = 0.1311)	0.776739155903	0.77291	.	.	.	.	.	.	.	0.488934	0.81292	T	0.239419	0.77440	D	0.106132	0.77147	D	0.0787749525895067	0.09708	T	0.559044	0.19237	T	0.33676666	0.55690	0.3519664	0.60545	0.33676666	0.55690	0.3519664	0.60544	-8.078	0.61675	D	0.5902	0.68420	P	0.0493707858960898	0.37072	0.99278045	0.97206	0.385	0.63571	.	.	.	.	.	.	5.133939	0.85944	28.7	0.99732360981923829	0.82849	0.946436	0.95573	D	0.430607372517603	0.62920	4.538864	0.465062733801357	0.65503	4.855777	4.79	4.79	0.60860	.	.	7.519	0.80763	11.047000	0.85271	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.989	0.64309	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	108972	6.423670e-05	0	8	207056	3.863690e-05	0	82	235244	3.485740e-04	0	0	7146	0.000000e+00	0	0	17078	0.000000e+00	0	0	2320	0.000000e+00	0	3	9000	3.333330e-04	0	1	13178	7.588400e-05	0	2	42660	4.688230e-05	0	1	15678	6.378360e-05	0	3	9000	3.333330e-04	0	1	16102	6.210410e-05	0	0	30476	0.000000e+00	0	0	6194	0.000000e+00	0	3	13346	2.247860e-04	0	1	16510	6.056940e-05	0	2	88982	2.247650e-05	0	1	30596	3.268400e-05	0	3	13346	2.247860e-04	0	1	14812	6.751280e-05	0	0	34214	0.000000e+00	0	0	9556	0.000000e+00	0	3	17638	1.700870e-04	0	39	20808	1.874280e-03	0	36	102102	3.525890e-04	0	1	30514	3.277180e-05	0	36	102102	3.525890e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118597A>C	.	CN221562|C3280345	614291	145	RAD51D, N-terminal domain	Val	Gly	1087626	single nucleotide variant	NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	May 03, 2021	745307359	-	RCV001779181|RCV001799083	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	35118597	35118597	17q12	criteria provided, conflicting classifications	2	-	N	ClinGen:CA8499636	2	1098881	35118597	A	C	-	-	-	-	-	-	SCV001623514|SCV002043212	-	-	167T>G 	Val56Gly	NM_002878.4	1	3_Conflicting						962248	RAD51D_unpublished_var156495	RAD51D_unpublished	RAD51D	9823.0	-1.0		35118597.0	35118597.0		167	T	G	56.0	V	G	c.167T>G	p.Val56Gly	missense_variant	-0.0642389		functionally_normal	Yes		Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	May 03, 2021	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.451																																																											RAD51D_Val56Gly	Val56Gly	true
F9	F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.6835627637597309	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	10588	X	139551121	A	G	T	A	rs6048	X	138633280	X	138460946	194	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.0530	0.13578	T	0.0001	0.00038	T	9	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.00020	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.000000	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	25627	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	6048	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121	139551121	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3	10588	139551121	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3	2_Benign						190001	F9_Popp_2025_heavy_chain_var234420	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551121.0	139551121.0		580			194.0	T	A	c.580A>G	p.Thr194Ala	missense_variant	0.9966376032652992			No	0.2680851451013608	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.255																																								10588.0	CA121125	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BP4,BA1		The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9	3b7d37ef-41c7-478a-a6de-0913aa2c42d9	VUS	BA1	F9_Thr194Ala	Thr194Ala	true
F9	F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.6835627637597309	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	10588	X	139551121	A	G	T	A	rs6048	X	138633280	X	138460946	194	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.0530	0.13578	T	0.0001	0.00038	T	9	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.00020	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.000000	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	25627	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	6048	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121	139551121	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3	10588	139551121	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3	2_Benign						245033	F9_Popp_2025_strep_2_var263463	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551121.0	139551121.0		580			194.0	T	A	c.580A>G	p.Thr194Ala	missense_variant	0.904152746			No	0.2680851451013608	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.255																																								10588.0	CA121125	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BP4,BA1		The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9	3b7d37ef-41c7-478a-a6de-0913aa2c42d9	VUS	BA1	F9_Thr194Ala	Thr194Ala	true
F9	F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.6835627637597309	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	10588	X	139551121	A	G	T	A	rs6048	X	138633280	X	138460946	194	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.0530	0.13578	T	0.0001	0.00038	T	9	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.00020	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.000000	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	25627	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	6048	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121	139551121	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3	10588	139551121	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3	2_Benign						134969	F9_Popp_2025_carboxy_F9_specific_var224739	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551121.0	139551121.0		580			194.0	T	A	c.580A>G	p.Thr194Ala	missense_variant	1.0363504808988786			No	0.2680851451013608	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.255																																								10588.0	CA121125	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BP4,BA1		The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9	3b7d37ef-41c7-478a-a6de-0913aa2c42d9	VUS	BA1	F9_Thr194Ala	Thr194Ala	true
F9	F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.6835627637597309	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	10588	X	139551121	A	G	T	A	rs6048	X	138633280	X	138460946	194	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.0530	0.13578	T	0.0001	0.00038	T	9	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.00020	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.000000	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	25627	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	6048	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121	139551121	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3	10588	139551121	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3	2_Benign						162485	F9_Popp_2025_carboxy_gla_motif_var253782	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551121.0	139551121.0		580			194.0	T	A	c.580A>G	p.Thr194Ala	missense_variant	1.0287167291236163			No	0.2680851451013608	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.255																																								10588.0	CA121125	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BP4,BA1		The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9	3b7d37ef-41c7-478a-a6de-0913aa2c42d9	VUS	BA1	F9_Thr194Ala	Thr194Ala	true
F9	F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.6835627637597309	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	10588	X	139551121	A	G	T	A	rs6048	X	138633280	X	138460946	194	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.0530	0.13578	T	0.0001	0.00038	T	9	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.00020	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.000000	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	25627	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	6048	-	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551121	139551121	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3	10588	139551121	A	G	-	-	-	-	-	-	SCV004363688	-	-	580A>G 	Thr194Ala	NM_000133.4	3	2_Benign						217517	F9_Popp_2025_light_chain_var244101	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551121.0	139551121.0		580			194.0	T	A	c.580A>G	p.Thr194Ala	missense_variant	1.0709261690420655			No	0.2680851451013608	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.255																																								10588.0	CA121125	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BP4,BA1		The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9	3b7d37ef-41c7-478a-a6de-0913aa2c42d9	VUS	BA1	F9_Thr194Ala	Thr194Ala	true
RAD51D	RAD51D_Ser46Cys	0.7829957094149949	0.4592952894564183	2.61629208398007	0.03459523845265817	2025_01_Batch_13-14	0.4904067758180217	0.646948468082983	0.6251686851710547	0.5838162373290128	0.4417403194913215	0.5648243070034515	0.6555887017994018	0.704324560526074	0.6506322595267637	0.5392594278649514	0.5276155414107366	0.6512685849411923	0.6647466228485643	0.6172242484278883	0.4904998736781364	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024795		NC_000017.11:35119118:G:C		Ser46Cys																												RAD51D_Ser46Cys	17	35119118	G	C	17	allele	137C>G	D12	527_CAVA_Array_P04	H24	B13A7A8P1_R1	B14A7A8P1_R2				17-35119118-G-C	127882	17	35119118	G	C	S	C	rs587780102	17	33446137	17	30470250	46	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.137C>G	p.Ser46Cys	c.137C>G	p.Ser46Cys	principal1	Y	5	.	.	-	TCT	2	0	G	G/G	G/G	G/G	G/G	0.007	0.63383	D	0.023	0.79703	D	1.0	0.90580	D	0.956	0.86259	D	.	0.68318	.	.	.	.	2.72	0.79369	M	-3.45	0.72035	D	0.683	0.70828	-0.3645	0.73009	T	0.3321	0.69833	T	10	0.7786217	0.77446	D	0.048765	0.63381	D	0.456	0.75352	.	.	.	.	.	0.947946397878	0.94697	.	0.54121	.	0.43501	.	.	.	0.683251	0.90627	D	-0.0213529	0.48331	T	-0.0134026	0.69239	D	0.823957562446594	0.47789	D	0.883212	0.68570	D	0.53418267	0.68768	0.28243348	0.54022	0.5920361	0.71975	0.31285465	0.57062	-10.77	0.78452	D	0.2118	0.50240	B	0.0651732501033949	0.39495	0.96507460	0.94298	0.545	0.74295	.	.	.	.	.	.	5.349603	0.89758	31.0	0.99138447258004703	0.53541	0.928860	0.91342	D	0.802452879217227	0.86184	8.828211	0.769679193341177	0.87549	9.284908	5.02	5.02	0.66699	.	.	5.745	0.68382	11.447000	0.92795	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.96	0.51684	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	8	109378	7.314090e-05	0	16	208038	7.690900e-05	0	18	236818	7.600770e-05	0	0	7160	0.000000e+00	0	1	17104	5.846590e-05	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	7	42754	1.637270e-04	0	0	15690	0.000000e+00	0	7	42754	1.637270e-04	0	0	16198	0.000000e+00	0	3	30514	9.831550e-05	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	12	89498	1.340810e-04	0	0	30608	0.000000e+00	0	12	89498	1.340810e-04	0	0	14886	0.000000e+00	0	4	34250	1.167880e-04	0	0	9572	0.000000e+00	0	0	17688	0.000000e+00	0	0	21562	0.000000e+00	0	13	102716	1.265630e-04	0	0	30526	0.000000e+00	0	13	102716	1.265630e-04	0	.	169	1613388	1.047490e-04	0	9	59998	1.500050e-04	0	0	74900	0.000000e+00	0	0	912	0.000000e+00	0	9	59998	1.500050e-04	0	0	29604	0.000000e+00	0	0	44884	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	155	1179426	1.314200e-04	0	0	91082	0.000000e+00	0	13	32650	3.9816232771822357E-4	0	122	0	0	112	0	0	3390	0	1	500	0.002	0	628	0	0	56	0	0	98	0	0	6864	0	0	3512	0	0	168	0	14	44420	3.1517334533993696E-4	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119118G>C	ClinGen:CA287956	C0006142|CN221562|C0027672|C3280345|C1333600|CN169374|C3661900	614291	140162|145	RAD51D, N-terminal domain	Ser	Cys	133339	single nucleotide variant	NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Mar 04, 2025	587780102	-	RCV000115808|RCV000212953|RCV000228533|RCV000656964|RCV003492493|RCV001354278|RCV001798341	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:C1333600|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer|Malignant tumor of breast|Breast and/or ovarian cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35119118	35119118	17q12	criteria provided, conflicting classifications	18	-	N	ClinGen:CA287956	2	127882	35119118	G	C	-	-	-	-	-	-	SCV000149717|SCV000185614|SCV000287698|SCV000604997|SCV000686419|SCV000784997|SCV000839197|SCV002043210|SCV002534771|SCV002760915|SCV002819352|SCV004017757|SCV004208087|SCV004220162|SCV005641839	-	-	137C>G 	Ser46Cys	NM_002878.4	1	3_Conflicting						962534	RAD51D_unpublished_var156781	RAD51D_unpublished	RAD51D	9823.0	-1.0		35119118.0	35119118.0		137	C	G	46.0	S	C	c.137C>G	p.Ser46Cys	missense_variant	-0.0108749		functionally_normal	Yes	0.0001047485167857	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Mar 19, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.456																																																											RAD51D_Ser46Cys	Ser46Cys	true
RAD51D	RAD51D_Phe305Leu	0.583403789039403	0.6005843938160091	3.733061609886038	0.033504115466645654	2025_01_Batch_13-14						0.899373938602152	0.9326561923583545	0.9572311202580884	0.9425515409215897	0.7934838271957201										0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024886		NC_000017.11:35101025:G:C		Phe305Leu																												RAD51D_Phe305Leu	17	35101025	G	C	17	allele	915C>G	E02	527_CAVA_Array_P05	I03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101025-G-C	480950	17	35101025	G	C	F	L	rs1316114457	17	33428044	17	30452157	305	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.915C>G	p.Phe305Leu	c.915C>G	p.Phe305Leu	principal1	Y	1	YES	Select	-	TTC	3	2	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.05249	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	0.83	0.20850	L	0.13	0.05476	N	0.053	0.11150	-1.0215	0.23176	T	0.1042	0.38033	T	10	0.040840566	0.02691	T	0.009973	0.25673	T	0.024	0.04912	0.301	0.26717	O75771	F305L	Gain of disorder (P = 0.0917)| Gain of MoRF binding (P = 0.1056)| Loss of phosphorylation at T303 (P = 0.1899)| Gain of relative solvent accessibility (P = 0.2629)| Loss of sheet (P = 0.302)	0.444807159249	0.43722	.	0.23376	.	0.10592	.	.	.	0.051884	0.28757	T	-0.259589	0.12690	T	-0.610658	0.11674	T	0.0400510121688084	0.03670	T	.	0.18007	.	0.045180835	0.07283	0.032197934	0.01928	0.045180835	0.07282	0.032197934	0.01928	-2.604	0.08768	T	0.3499	0.57023	A	4.50213563311964e-06	0.00398	0.25410953	0.75297	0.005	0.00124	.	.	.	.	.	.	1.205182	0.15999	12.23	0.83537688913623076	0.15012	0.108385	0.21352	N	-1.04489556684859	0.07596	0.357995	-0.957731270841975	0.10562	0.543092	5.16	1.6	0.22627	1.17	0.30762	-0.02	0.12505	1.312000	0.25630	-0.105	0.15707	0.788	0.29661	1.000000	0.68239	0.621	0.31965	913	0.21155	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613800	1.239310e-06	0	2	1179680	1.695380e-06	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44886	0.000000e+00	0	0	64040	0.000000e+00	0	0	6062	0.000000e+00	0	2	1179680	1.695380e-06	0	0	91072	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101025G>C	ClinGen:CA399086171	C0027672|C3280345	614291	140162|145	.	Phe	Leu	478443	single nucleotide variant	NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Apr 20, 2024	1316114457	-	RCV001040689|RCV000568982|RCV004760603	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	35101025	35101025	17q12	criteria provided, conflicting classifications	4	-	N	ClinGen:CA399086171	2	480950	35101025	G	C	-	-	-	-	-	-	SCV000664927|SCV000911553|SCV001204278|SCV005369137	-	-	915C>G 	Phe305Leu	NM_002878.4	1	3_Conflicting						959097	RAD51D_unpublished_var153344	RAD51D_unpublished	RAD51D	9823.0	-1.0		35101025.0	35101025.0		915	C	G	305.0	F	L	c.915C>G	p.Phe305Leu	missense_variant	0.00648996		functionally_normal	Yes	1.2393109431e-6	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Apr 01, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.024																																																											RAD51D_Phe305Leu	Phe305Leu	true
RAD51D	RAD51D_Val66Leu	3.332290913702663	0.01255158257903223	1.740539247119287	0.1253102833057257	2025_01_Batch_13-14	0.7368980398348188	0.8389360038622496	0.7995719693817023	0.8769572018758964	0.6571225292527669	0.4735135380022462	0.6069124412868073	0.6694074919314468	0.6884580734740696	0.49921612075738153	0.6052057889185325	0.7229242225745285	0.7344897306565745	0.7827076376749831	0.5781693250050742	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024807		NC_000017.11:35118568:C:A		Val66Leu																												RAD51D_Val66Leu	17	35118568	C	A	17	allele	196G>T	H12	527_CAVA_Array_P04	P24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118568-C-A	419663	17	35118568	C	A	V	L	rs56026142	17	33445587	17	30469700	66	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.196G>T	p.Val66Leu	c.196G>T	p.Val66Leu	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.831	0.13644	T	0.486	0.11871	T	0.0	0.02950	B	0.004	0.10086	B	0.06	0.18971	N	simple_aae	94.0	6.0	-0.185	0.04240	N	0.04	0.06455	N	0.164	0.17177	-1.0483	0.14873	T	0.0520	0.21919	T	10	0.057495058	0.06602	T	0.008992	0.23404	T	0.048	0.13183	0.513	0.61027	O75771	V66L	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Loss of catalytic residue at V66 (P = 0.2378)| Gain of disorder (P = 0.3398)| Gain of loop (P = 0.3485)	0.394990421082	0.38713	.	.	.	.	.	.	.	0.112411	0.42566	T	-0.25802	0.12873	T	-0.608404	0.11857	T	0.170912176370621	0.18410	T	.	0.24645	.	0.08530245	0.19601	0.0358917	0.02939	0.08530245	0.19601	0.0358917	0.02939	-4.193	0.26677	T	0.1367	0.29891	LB	1.88384050960672e-05	0.00991	0.78514117	0.87977	0.009	0.00522	.	.	.	.	.	.	0.314705	0.06924	3.434	0.81722106588712895	0.14047	0.088102	0.17661	N	-1.34751807488594	0.03118	0.1402777	-1.22328831331821	0.05450	0.2641167	4.79	-0.163	0.12675	-5.85	0.03264	0.004	0.13047	0.681000	0.20762	-1.926	0.00504	0.001	0.13799	0.444000	0.24998	0.443	0.27788	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614178	1.239020e-06	0	1	75058	1.332300e-05	0	1	75058	1.332300e-05	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180038	0.000000e+00	0	0	91078	0.000000e+00	0	0	153016	0	0	176	0	0	4498	0	0	4724	0	0	442	0	0	950	0	0	1848	0	0	280	0	0	11718	0	0	4900	0	0	6346	0	0	177652	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118568C>A	ClinGen:CA16620388	C3661900|C0027672|C3280345	614291	140162|145	.	Val	Leu	409903	single nucleotide variant	NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Oct 24, 2024	56026142	-	RCV000484401|RCV001373871|RCV001524373	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35118568	35118568	17q12	criteria provided, conflicting classifications	5	-	N	ClinGen:CA16620388	2	419663	35118568	C	A	-	-	-	-	-	-	SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837	-	-	196G>T 	Val66Leu	NM_002878.4	1	3_Conflicting						962163	RAD51D_unpublished_var156410	RAD51D_unpublished	RAD51D	9823.0	-1.0		35118568.0	35118568.0		196	G	T	66.0	V	L	c.196G>T	p.Val66Leu	missense_variant	0.0187496		functionally_normal	Yes	1.2390207275e-6	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Aug 10, 2023	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.048																																																											RAD51D_Val66Leu	Val66Leu	true
FH	FH_Pro174Arg	10.162270857596216	0.000052836229120136614	-7.281739576538825	0.00016533890191996532	2025_01_Batch_13-14	0.6762706853155396	0.7848065989828991	0.8607648878207168	0.8843137993744704	0.5720850641276243											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004048		NC_000001.11:241512001:G:C		Pro174Arg																												FH_Pro174Arg	1	241512001	G	C	1	allele	521C>G	A03	527_CAVA_Array_P03	B05	B13A7A8P1_R1	B14A7A8P1_R2				1-241512001-G-C	29705	1	241512001	G	C	P	R	rs199822819	1	241675301	1	239741924	174	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.521C>G	p.Pro174Arg	c.521C>G	p.Pro174Arg	principal1	Y	1	YES	Select	-	CCT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.016	0.61305	D	0.999	0.77914	D	0.981	0.75172	D	0.6	0.76851	A	simple_aae	40.0	60.0	2.505	0.72748	M	-7.67	0.95559	D	0.969	0.97975	1.0331	0.97771	D	0.9867	0.99604	D	10	0.9749284	0.97191	D	0.717923	0.97710	D	0.961	0.99405	.	.	.	.	.	0.987495772737	0.98721	0.8682662705529591	0.86710	0.978554424983	0.73484	0.763472080231	0.76405	T	0.951848	0.99304	D	0.469226	0.93253	D	0.566685	0.96142	D	0.918809771537781	0.57480	D	0.976702	0.91928	D	0.8966469	0.90957	0.89710534	0.94698	0.8966469	0.90959	0.89710534	0.94699	-13.629	0.91805	D	0.8317	0.78770	P	0.969616269158006	0.83212	0.92770165	0.92291	0.975	0.99076	.	.	.	.	.	.	5.112622	0.85504	28.6	0.9981003855289049	0.89450	0.904483	0.85431	D	0.949310228068722	0.93923	12.39802	0.89439856430428	0.95298	13.5147	5.24	5.24	0.72825	.	.	9.079	0.9345	11.757000	0.95546	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	968	0.07020	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	3	109368	2.743030e-05	0	3	208072	1.441810e-05	0	5	236768	2.111770e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13354	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16694	0.000000e+00	0	3	89538	3.350530e-05	0	0	30608	0.000000e+00	0	3	89538	3.350530e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21592	0.000000e+00	0	5	102618	4.872440e-05	0	0	30526	0.000000e+00	0	5	102618	4.872440e-05	0	.	234	1613826	1.449970e-04	0	230	1179928	1.949270e-04	0	0	74900	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	0	63972	0.000000e+00	0	0	6082	0.000000e+00	0	230	1179928	1.949270e-04	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	1	2784	3.5919540229885057E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	1	2898	3.450655624568668E-4	0	112	0	1	14050	7.117437722419929E-5	Pathogenic/Likely_pathogenic	Fumarase_deficiency|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|FH-related_disorder|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241512001G>C	ClinGen:CA220381|OMIM:136850.0010	C0342770|C1708350|C0027672|C3661900	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Pro	Arg	38660	single nucleotide variant	NM_000143.4(FH):c.521C>G (p.Pro174Arg)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Jan 13, 2025	199822819	-	RCV000022554|RCV000078149|RCV000492836|RCV003335052|RCV003483435	MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523;MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome|FH-related disorder|Hereditary leiomyomatosis and renal cell cancer;Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241512001	241512001	1q43	criteria provided, multiple submitters, no conflicts	19	-	N	ClinGen:CA220381,OMIM:136850.0010	3	29705	241512001	G	C	-	-	-	-	-	-	SCV000109987|SCV000283674|SCV000356713|SCV000516751|SCV000581681|SCV000992190|SCV002012378|SCV002048740|SCV004046437|SCV004197294|SCV004218884|SCV005184523|SCV005874269	-	-	521C>G 	Pro174Arg	NM_000143.4	2	1_Pathogenic	1	241512001	G	C	0.000157353																																																																																																				
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	195915	F9_Popp_2025_heavy_chain_var236531	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.059427999			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	195915	F9_Popp_2025_heavy_chain_var236531	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.059427999			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	223431	F9_Popp_2025_light_chain_var246212	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.094617019			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	223431	F9_Popp_2025_light_chain_var246212	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.094617019			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	140883	F9_Popp_2025_carboxy_F9_specific_var226850	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.057010278			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	140883	F9_Popp_2025_carboxy_F9_specific_var226850	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.057010278			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	250947	F9_Popp_2025_strep_2_var265574	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.1320033759338407			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	250947	F9_Popp_2025_strep_2_var265574	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.1320033759338407			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	168399	F9_Popp_2025_carboxy_gla_motif_var255893	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.067749693			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
F9	F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	X	139561566	G	A	1.82809e-6	168399	F9_Popp_2025_carboxy_gla_motif_var255893	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561566.0	139561566.0		881			294.0	R	Q	c.881G>A	p.Arg294Gln	missense_variant	0.067749693			No	1.6561213141e-6	Pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.576																																								10602.0	CA255368	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	PP3,PM5	The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	317fdec6-df8d-4c37-90c0-0c5ae79cb5ad	Likely Pathogenic	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	F9_Arg294Gln	Arg294Gln	true
RAD51D	RAD51D_Arg165Gln	2.2867183231461263	0.05607812764399085	7.454881373375606	0.0001426289433675745	2025_01_Batch_13-14	0.8167428149144145	0.8087444747462854	0.9222728431096141	0.8498909586148119	0.8059725835278194	0.9315934600653433	0.9206384594597057	0.9609246328766348	0.9448715878739475	0.8724392445842243	0.8741681374898789	0.8646914671029955	0.9415987379931244	0.8973812732443798	0.8392059140560219	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D	ENSG00000185379	7201	900197	CCSBVarC002917	ALE00002917	NC_000017.11:35106468:C:T	494G>A	Arg165Gln	RC4	NatVar_GDE_001	F05	GDEhDisVCh_40046	E03	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	G01	VUSmut_GDEh12	E02	1	1	0		0			1	1	1	1	1	1	RAD51D_Arg165Gln	17	35106468	C	T	17											17-35106468-C-T	142159	17	35106468	C	T	R	Q	rs4796033	17	33433487	17	30457600	165	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.494G>A	p.Arg165Gln	c.494G>A	p.Arg165Gln	principal1	Y	5	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	1.0	0.01173	T	0.0	0.14667	B	0.001	0.04348	B	0.01	0.13669	P	simple_aae	99.0	1.0	-1.43	0.00575	N	-3.12	0.63808	D	0.019	0.15800	-1.0318	0.19845	T	0.0001	0.00038	T	9	0.0022848845	0.00033	T	.	.	.	0.127	0.34681	.	.	.	.	.	.	.	.	0.04975	.	0.41278	.	.	.	0.074496	0.34695	T	-0.647874	0.00072	T	-0.559582	0.16122	T	0.00742585393685776	0.00085	T	0.740726	0.35767	T	0.029415702	0.02411	0.048267353	0.07149	0.029415702	0.02411	0.048267353	0.07148	3.206	0.12431	T	0.057	0.00818	B	2.61638337411342e-05	0.01340	0.02316738	0.51051	0.078	0.22017	.	.	.	.	.	.	1.452401	0.18765	13.9	0.91470505594779028	0.20995	0.077101	0.15335	N	-1.06674822980265	0.07176	0.3368571	-0.830017416971714	0.13532	0.7160679	4.96	0.253	0.14768	1.12	0.30289	1.179	0.31705	0.032000	0.13801	-0.169	0.1135	1.0	0.71675	0.963000	0.29478	0.96	0.51684	917	0.20141	476	0.0950479233226837	18	0.01361573373676248	130	0.12922465208747516	153	0.22046109510086456	41	0.040674603174603176	134	0.13701431492842536	31713	264690	0.119811855	.	17045	107270	1.588980e-01	1699	31945	204674	1.560770e-01	3152	36543	232850	1.569380e-01	3557	180	6652	2.705950e-02	1	5012	16850	2.974480e-01	784	395	2196	1.798720e-01	42	413	9024	4.576680e-02	8	2281	13332	1.710920e-01	204	6003	41956	1.430780e-01	432	2481	15384	1.612710e-01	210	5012	16850	2.974480e-01	784	458	15532	2.948750e-02	12	9035	30024	3.009260e-01	1451	1134	6024	1.882470e-01	111	564	13384	4.213990e-02	6	2827	16654	1.697490e-01	255	12341	88222	1.398860e-01	860	4896	30022	1.630800e-01	411	9035	30024	3.009260e-01	1451	409	14258	2.868570e-02	9	9971	33746	2.954720e-01	1567	1778	9368	1.897950e-01	174	815	17666	4.613380e-02	15	3630	21494	1.688840e-01	330	14237	100834	1.411920e-01	990	4879	29942	1.629480e-01	407	9971	33746	2.954720e-01	1567	.	223574	1611192	1.387630e-01	17336	15964	59646	2.676460e-01	2333	2280	74974	3.041050e-02	55	100	912	1.096490e-01	6	15964	59646	2.676460e-01	2333	5762	29446	1.956800e-01	582	1940	44876	4.323020e-02	36	10732	63890	1.679760e-01	897	779	6052	1.287180e-01	57	162928	1178350	1.382680e-01	11455	14721	90614	1.624580e-01	1305	47230	333254	0.14172373024779897	6	594	0.010101010101010102	215	5014	0.04287993617869964	636	15964	0.03983963918817339	182	1488	0.12231182795698925	1955	7246	0.2698040298095501	99	1968	0.05030487804878049	864	5226	0.1653272101033295	3257	24004	0.13568571904682553	642	16558	0.03877279864717961	314	6982	0.04497278716700086	54444	394758	0.1379174076269512	Benign	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35106468C>T	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	CN169374|C3661900|C3280345|C0027672	614291	145|140162	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Arg	Gln	151873	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892	RAD51D	HGNC:9823	Benign	0	Feb 04, 2025	4796033	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468	35106468	17q12	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2	142159	35106468	C	T	-	-	-	-	-	-	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	-	-	494G>A 	Arg165Gln	NM_002878.4	2	2_Benign	17	35106468	C	T	0.14061																																																																																																				
RAD51D	RAD51D_Arg165Gln	2.2867183231461263	0.05607812764399085	7.454881373375606	0.0001426289433675745	2025_01_Batch_13-14	0.8167428149144145	0.8087444747462854	0.9222728431096141	0.8498909586148119	0.8059725835278194	0.9315934600653433	0.9206384594597057	0.9609246328766348	0.9448715878739475	0.8724392445842243	0.8741681374898789	0.8646914671029955	0.9415987379931244	0.8973812732443798	0.8392059140560219	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC002917		NC_000017.11:35106468:C:T		Arg165Gln																												RAD51D_Arg165Gln	17	35106468	C	T	17	allele	494G>A	E01	527_CAVA_Array_P05	I01	B13A7A8P2_R1	B14A7A8P2_R2				17-35106468-C-T	142159	17	35106468	C	T	R	Q	rs4796033	17	33433487	17	30457600	165	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.494G>A	p.Arg165Gln	c.494G>A	p.Arg165Gln	principal1	Y	5	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	1.0	0.01173	T	0.0	0.14667	B	0.001	0.04348	B	0.01	0.13669	P	simple_aae	99.0	1.0	-1.43	0.00575	N	-3.12	0.63808	D	0.019	0.15800	-1.0318	0.19845	T	0.0001	0.00038	T	9	0.0022848845	0.00033	T	.	.	.	0.127	0.34681	.	.	.	.	.	.	.	.	0.04975	.	0.41278	.	.	.	0.074496	0.34695	T	-0.647874	0.00072	T	-0.559582	0.16122	T	0.00742585393685776	0.00085	T	0.740726	0.35767	T	0.029415702	0.02411	0.048267353	0.07149	0.029415702	0.02411	0.048267353	0.07148	3.206	0.12431	T	0.057	0.00818	B	2.61638337411342e-05	0.01340	0.02316738	0.51051	0.078	0.22017	.	.	.	.	.	.	1.452401	0.18765	13.9	0.91470505594779028	0.20995	0.077101	0.15335	N	-1.06674822980265	0.07176	0.3368571	-0.830017416971714	0.13532	0.7160679	4.96	0.253	0.14768	1.12	0.30289	1.179	0.31705	0.032000	0.13801	-0.169	0.1135	1.0	0.71675	0.963000	0.29478	0.96	0.51684	917	0.20141	476	0.0950479233226837	18	0.01361573373676248	130	0.12922465208747516	153	0.22046109510086456	41	0.040674603174603176	134	0.13701431492842536	31713	264690	0.119811855	.	17045	107270	1.588980e-01	1699	31945	204674	1.560770e-01	3152	36543	232850	1.569380e-01	3557	180	6652	2.705950e-02	1	5012	16850	2.974480e-01	784	395	2196	1.798720e-01	42	413	9024	4.576680e-02	8	2281	13332	1.710920e-01	204	6003	41956	1.430780e-01	432	2481	15384	1.612710e-01	210	5012	16850	2.974480e-01	784	458	15532	2.948750e-02	12	9035	30024	3.009260e-01	1451	1134	6024	1.882470e-01	111	564	13384	4.213990e-02	6	2827	16654	1.697490e-01	255	12341	88222	1.398860e-01	860	4896	30022	1.630800e-01	411	9035	30024	3.009260e-01	1451	409	14258	2.868570e-02	9	9971	33746	2.954720e-01	1567	1778	9368	1.897950e-01	174	815	17666	4.613380e-02	15	3630	21494	1.688840e-01	330	14237	100834	1.411920e-01	990	4879	29942	1.629480e-01	407	9971	33746	2.954720e-01	1567	.	223574	1611192	1.387630e-01	17336	15964	59646	2.676460e-01	2333	2280	74974	3.041050e-02	55	100	912	1.096490e-01	6	15964	59646	2.676460e-01	2333	5762	29446	1.956800e-01	582	1940	44876	4.323020e-02	36	10732	63890	1.679760e-01	897	779	6052	1.287180e-01	57	162928	1178350	1.382680e-01	11455	14721	90614	1.624580e-01	1305	47230	333254	0.14172373024779897	6	594	0.010101010101010102	215	5014	0.04287993617869964	636	15964	0.03983963918817339	182	1488	0.12231182795698925	1955	7246	0.2698040298095501	99	1968	0.05030487804878049	864	5226	0.1653272101033295	3257	24004	0.13568571904682553	642	16558	0.03877279864717961	314	6982	0.04497278716700086	54444	394758	0.1379174076269512	Benign	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35106468C>T	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	CN169374|C3661900|C3280345|C0027672	614291	145|140162	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Arg	Gln	151873	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892	RAD51D	HGNC:9823	Benign	0	Feb 04, 2025	4796033	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468	35106468	17q12	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2	142159	35106468	C	T	-	-	-	-	-	-	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	-	-	494G>A 	Arg165Gln	NM_002878.4	2	2_Benign	17	35106468	C	T	0.14061																																																																																																				
KRAS	KRAS_Gly12Val	-5.955690773263131	0.0005668221876575696	7.386569839087916	0.00015114042618877112																											true	KRAS	ENSG00000133703	3084	214485	CCSBVarC006089	ALE00006089	NC_000012.12:25245350:C:A	35G>T	Gly12Val	CEGS2	CegsMutGDEh1035	A04	GDEhDisVCh_40061	G08	1	CegsMutGDDh1035	A04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly12Val	12	25245350	C	A	12											12-25245350-C-A	12583	12	25245350	C	A	G	V	rs121913529	12	25398284	12	25289551	12	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>T	p.Gly12Val	c.35G>T	p.Gly12Val	alternative1	Y	1	.	Plus_Clinical	-	GGT	2	0	C	./.	./.	./.	./.	0.008	0.60085	D	0.001	0.83643	D	0.999	0.77914	D	0.978	0.74106	D	1.0	0.99291	A	simple_aae	0.0	100.0	1.84	0.48108	L	-7.11	0.97229	D	0.939	0.94561	0.5429	0.91106	D	0.6987	0.89587	D	10	0.9236257	0.91620	D	0.181073	0.85494	D	0.910	0.97583	0.767	0.89397	P01116	G12V	Gain of catalytic residue at V14 (P = 0)| Loss of ubiquitination at K16 (P = 0.1037)| Loss of methylation at K16 (P = 0.1785)| Loss of disorder (P = 0.1841)| Loss of sheet (P = 0.302)	0.988619423247	0.98836	0.9781072363123009	0.97790	2.35052041495	0.96801	0.898488461971	0.96267	D	0.843047	0.96328	D	0.385769	0.88997	D	0.316354	0.88859	D	0.990357935428619	0.80423	D	0.366763	0.56662	T	0.96866757	0.98104	0.9503655	0.98397	0.9776439	0.98906	0.9436424	0.97974	-15.17	0.98083	D	0.9949	0.96393	P	0.999985518475673	0.99579	0.99924910	0.99245	0.997	0.99892	.	.	.	.	.	.	4.859019	0.79528	27.1	0.99792542458718392	0.87849	0.919073	0.88866	D	0.947784823501693	0.93861	12.35383	0.901530992395951	0.95614	13.81752	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612866	6.200140e-07	0	1	1179302	8.479590e-07	0	0	75026	0.000000e+00	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29524	0.000000e+00	0	0	44856	0.000000e+00	0	0	63988	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179302	8.479590e-07	0	0	90794	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Linear_nevus_sebaceous_syndrome|Nevus_sebaceous|not_provided|Non-small_cell_lung_carcinoma|Chronic_myelogenous_leukemia,_BCR-ABL1_positive|Carcinoma_of_pancreas|Lung_sarcomatoid_carcinoma|Acute_myeloid_leukemia|Juvenile_myelomonocytic_leukemia|Cerebral_arteriovenous_malformation|Thyroid_tumor|Ovarian_neoplasm|RASopathy|Neoplasm_of_the_large_intestine	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>A	COSMIC:520|ClinGen:CA122540|OMIM:190070.0006|OMIM:190070.0026|UniProtKB:P01116#VAR_006840	C4552097|C3854181|C3661900|C0007131|C0279543|C0235974|C1708781|C0023467|C0349639|C0917804|C0040136|C0919267|C5555857|C0009404	163200|608232|601626|607785|108010	2612|521|1333|217074|519|86834|46724|100087|536391	Small GTP-binding domain	Gly	Val	27622	single nucleotide variant	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	3845	KRAS	HGNC:6407	Pathogenic	1	Oct 13, 2023	121913529	-	RCV000013413|RCV000157944|RCV000585801|RCV003322589|RCV003539760|RCV000029216|RCV003455987|RCV000150895|RCV000154262|RCV004668725|RCV002291496	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521	Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Neoplasm|Chronic myelogenous leukemia, BCR-ABL1 positive	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350	25245350	12p12.1	criteria provided, multiple submitters, no conflicts	12	-	N	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	3	12583	25245350	C	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000198477|SCV000203917|SCV000207879|SCV001746133|SCV004176921|SCV004295856	-	SCV005094259	35G>T 	Gly12Val	NM_004985.5	2	1_Pathogenic	12	25245350	C	A	6.84666e-7																																																																																																				
KRAS	KRAS_Gly12Val	-5.955690773263131	0.0005668221876575696	7.386569839087916	0.00015114042618877112																											true	KRAS		3084		CCSBVarC006089		NC_000012.12:25245350:C:A		Gly12Val																												KRAS_Gly12Val	12	25245350	C	A	12	allele	35G>T	F08	527_CAVA_Array_P03	L15	B13A7A8P1_R1	B14A7A8P1_R2				12-25245350-C-A	12583	12	25245350	C	A	G	V	rs121913529	12	25398284	12	25289551	12	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>T	p.Gly12Val	c.35G>T	p.Gly12Val	alternative1	Y	1	.	Plus_Clinical	-	GGT	2	0	C	./.	./.	./.	./.	0.008	0.60085	D	0.001	0.83643	D	0.999	0.77914	D	0.978	0.74106	D	1.0	0.99291	A	simple_aae	0.0	100.0	1.84	0.48108	L	-7.11	0.97229	D	0.939	0.94561	0.5429	0.91106	D	0.6987	0.89587	D	10	0.9236257	0.91620	D	0.181073	0.85494	D	0.910	0.97583	0.767	0.89397	P01116	G12V	Gain of catalytic residue at V14 (P = 0)| Loss of ubiquitination at K16 (P = 0.1037)| Loss of methylation at K16 (P = 0.1785)| Loss of disorder (P = 0.1841)| Loss of sheet (P = 0.302)	0.988619423247	0.98836	0.9781072363123009	0.97790	2.35052041495	0.96801	0.898488461971	0.96267	D	0.843047	0.96328	D	0.385769	0.88997	D	0.316354	0.88859	D	0.990357935428619	0.80423	D	0.366763	0.56662	T	0.96866757	0.98104	0.9503655	0.98397	0.9776439	0.98906	0.9436424	0.97974	-15.17	0.98083	D	0.9949	0.96393	P	0.999985518475673	0.99579	0.99924910	0.99245	0.997	0.99892	.	.	.	.	.	.	4.859019	0.79528	27.1	0.99792542458718392	0.87849	0.919073	0.88866	D	0.947784823501693	0.93861	12.35383	0.901530992395951	0.95614	13.81752	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612866	6.200140e-07	0	1	1179302	8.479590e-07	0	0	75026	0.000000e+00	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29524	0.000000e+00	0	0	44856	0.000000e+00	0	0	63988	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179302	8.479590e-07	0	0	90794	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Linear_nevus_sebaceous_syndrome|Nevus_sebaceous|not_provided|Non-small_cell_lung_carcinoma|Chronic_myelogenous_leukemia,_BCR-ABL1_positive|Carcinoma_of_pancreas|Lung_sarcomatoid_carcinoma|Acute_myeloid_leukemia|Juvenile_myelomonocytic_leukemia|Cerebral_arteriovenous_malformation|Thyroid_tumor|Ovarian_neoplasm|RASopathy|Neoplasm_of_the_large_intestine	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>A	COSMIC:520|ClinGen:CA122540|OMIM:190070.0006|OMIM:190070.0026|UniProtKB:P01116#VAR_006840	C4552097|C3854181|C3661900|C0007131|C0279543|C0235974|C1708781|C0023467|C0349639|C0917804|C0040136|C0919267|C5555857|C0009404	163200|608232|601626|607785|108010	2612|521|1333|217074|519|86834|46724|100087|536391	Small GTP-binding domain	Gly	Val	27622	single nucleotide variant	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	3845	KRAS	HGNC:6407	Pathogenic	1	Oct 13, 2023	121913529	-	RCV000013413|RCV000157944|RCV000585801|RCV003322589|RCV003539760|RCV000029216|RCV003455987|RCV000150895|RCV000154262|RCV004668725|RCV002291496	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521	Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Neoplasm|Chronic myelogenous leukemia, BCR-ABL1 positive	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350	25245350	12p12.1	criteria provided, multiple submitters, no conflicts	12	-	N	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	3	12583	25245350	C	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000198477|SCV000203917|SCV000207879|SCV001746133|SCV004176921|SCV004295856	-	SCV005094259	35G>T 	Gly12Val	NM_004985.5	2	1_Pathogenic	12	25245350	C	A	6.84666e-7																																																																																																				
RET	RET_Leu56Met	2.070499399299519	0.07715984473902697	4.176807048731463	0.004153743658106803	2025_01_Batch_13-14	0.9547018505169517	0.8922386929915563	0.8183809072225747	0.9252820879349938	0.8460785661873986	0.6442601120187283	0.7139921804489365	0.7069766295923227	0.7212286329031747	0.6685173300236056	0.7994809812678401	0.8031154367202464	0.7626787684074487	0.8232553604190842	0.7572979481055021	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202944	CCSBVarC006872	ALE00006870	NC_000010.11:43100551:C:A	166C>A	Leu56Met	CEGS2	CegsMutGDEh1027	G04	GDEhDisVCh_40066	G05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Leu56Met	10	43100551	C	A	10											10-43100551-C-A	36723	10	43100551	C	A	L	M	rs145633958	10	43595999	10	42916005	56	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.166C>A	p.Leu56Met	c.166C>A	p.Leu56Met	principal4	Y	5	YES	Select	+	CTG	1	2	C	C/C	C/C	C/C	C/C	0.393	0.11116	T	0.37	0.92967	T	0.558	0.44790	P	0.207	0.43709	B	0.08	0.23785	N	simple_aae	92.0	8.0	1.74	0.44959	L	-0.71	0.20082	N	0.234	0.27835	-0.4197	0.71275	T	0.2838	0.65421	T	10	0.01373741	0.00287	T	0.038562	0.58137	D	0.506	0.78612	.	.	.	.	.	0.965681725857	0.96499	0.5310686656002561	0.52839	0.936903531846	0.71884	0.436104416847	0.30008	T	0.443185	0.78547	T	-0.161264	0.26220	T	-0.00332951	0.69900	D	0.00669683503352234	0.00074	T	0.677732	0.28414	T	0.13296163	0.30675	0.057930265	0.10627	0.15338261	0.34482	0.070077136	0.14837	-5.112	0.38089	T	0.2222	0.51413	B	0.420929723777606	0.58343	0.99925655	0.99252	0.115	0.31465	.	.	.	.	.	.	0.98931	0.13688	10.21	0.97808508319477172	0.36268	0.071078	0.13951	N	-0.303488539195444	0.28736	1.605345	-0.361080103655587	0.25850	1.44365	5.51	3.41	0.38072	1.56	0.34791	0.376	0.2034	0.096000	0.14644	0.599	0.40292	0.307	0.25474	0.003000	0.18726	0.004	0.06081	862	0.33096	6	0.0011980830670926517	1	7.564296520423601E-4	4	0.003976143141153081	1	0.001440922190201729	0	0.0	0	0.0	779	264690	0.0029430655	.	289	109366	2.642500e-03	1	564	207736	2.714980e-03	1	625	236592	2.641680e-03	1	4	7148	5.595970e-04	0	27	17110	1.578020e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	35	13384	2.615060e-03	0	217	42756	5.075310e-03	1	0	15688	0.000000e+00	0	217	42756	5.075310e-03	1	11	16174	6.801040e-04	0	40	30516	1.310790e-03	0	0	6206	0.000000e+00	0	1	13410	7.457120e-05	0	44	16724	2.630950e-03	0	454	89240	5.087400e-03	1	0	30606	0.000000e+00	0	454	89240	5.087400e-03	1	9	14876	6.050010e-04	0	53	34256	1.547170e-03	0	0	9564	0.000000e+00	0	1	17692	5.652270e-05	0	49	21620	2.266420e-03	0	498	102440	4.861380e-03	1	0	30524	0.000000e+00	0	498	102440	4.861380e-03	1	.	7763	1613938	4.809970e-03	25	7135	1180022	6.046500e-03	24	54	75056	7.194630e-04	0	0	912	0.000000e+00	0	109	60026	1.815880e-03	0	1	29608	3.377470e-05	0	1	44880	2.228160e-05	0	194	63782	3.041610e-03	1	0	6060	0.000000e+00	0	7135	1180022	6.046500e-03	24	2	91090	2.195630e-05	0	981	198634	0.0049387315363935685	1	360	0.002777777777777778	0	4532	0	5	9432	5.301102629346904E-4	5	796	0.00628140703517588	0	966	0	0	1842	0	0	280	0	54	17500	0.003085714285714286	6	9792	6.127450980392157E-4	0	6374	0	1046	234342	0.004463561802835173	Conflicting_classifications_of_pathogenicity	not_specified|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon	criteria_provided,_conflicting_classifications	NC_000010.11:g.43100551C>A	ClinGen:CA007702	CN169374|C1619700|C0027662|C3661900|C0031511|C0027672|C4048306|C0025268|C3888239|C0019569	191830|PS131100|171300|171400|142623|PS142623	411709|276161|29072|140162|653|247698|653|388|388	Ret, cadherin like domain 1	Leu	Met	45384	single nucleotide variant	NM_020975.6(RET):c.166C>A (p.Leu56Met)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Mar 04, 2025	145633958	-	RCV000121985|RCV000202649|RCV000034766|RCV000030402|RCV000163266|RCV001108850|RCV000148768|RCV001082759|RCV001108849|RCV001108851	MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388	not specified|Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000010.11	10	43100551	43100551	10q11.21	criteria provided, conflicting classifications	26	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007702	2	36723	43100551	C	A	-	-	-	-	-	-	SCV000113984|SCV000213794|SCV000258169|SCV000261742|SCV000514406|SCV000711342|SCV000807009|SCV001138019|SCV001147859|SCV001158030|SCV001266132|SCV001266133|SCV001266134|SCV001266135|SCV002011461|SCV002067079|SCV002529940|SCV002550377|SCV002774043|SCV004357214|SCV004838625	-	-	166C>A 	Leu56Met	NM_020975.6	1	3_Conflicting	10	43100551	C	A	0.00499724																																																																																																				
RET	RET_Leu56Met	2.070499399299519	0.07715984473902697	4.176807048731463	0.004153743658106803	2025_01_Batch_13-14	0.9547018505169517	0.8922386929915563	0.8183809072225747	0.9252820879349938	0.8460785661873986	0.6442601120187283	0.7139921804489365	0.7069766295923227	0.7212286329031747	0.6685173300236056	0.7994809812678401	0.8031154367202464	0.7626787684074487	0.8232553604190842	0.7572979481055021	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006872		NC_000010.11:43100551:C:A		Leu56Met																												RET_Leu56Met	10	43100551	C	A	10	allele	166C>A	B08	527_CAVA_Array_P05	C15	B13A7A8P2_R1	B14A7A8P2_R2				10-43100551-C-A	36723	10	43100551	C	A	L	M	rs145633958	10	43595999	10	42916005	56	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.166C>A	p.Leu56Met	c.166C>A	p.Leu56Met	principal4	Y	5	YES	Select	+	CTG	1	2	C	C/C	C/C	C/C	C/C	0.393	0.11116	T	0.37	0.92967	T	0.558	0.44790	P	0.207	0.43709	B	0.08	0.23785	N	simple_aae	92.0	8.0	1.74	0.44959	L	-0.71	0.20082	N	0.234	0.27835	-0.4197	0.71275	T	0.2838	0.65421	T	10	0.01373741	0.00287	T	0.038562	0.58137	D	0.506	0.78612	.	.	.	.	.	0.965681725857	0.96499	0.5310686656002561	0.52839	0.936903531846	0.71884	0.436104416847	0.30008	T	0.443185	0.78547	T	-0.161264	0.26220	T	-0.00332951	0.69900	D	0.00669683503352234	0.00074	T	0.677732	0.28414	T	0.13296163	0.30675	0.057930265	0.10627	0.15338261	0.34482	0.070077136	0.14837	-5.112	0.38089	T	0.2222	0.51413	B	0.420929723777606	0.58343	0.99925655	0.99252	0.115	0.31465	.	.	.	.	.	.	0.98931	0.13688	10.21	0.97808508319477172	0.36268	0.071078	0.13951	N	-0.303488539195444	0.28736	1.605345	-0.361080103655587	0.25850	1.44365	5.51	3.41	0.38072	1.56	0.34791	0.376	0.2034	0.096000	0.14644	0.599	0.40292	0.307	0.25474	0.003000	0.18726	0.004	0.06081	862	0.33096	6	0.0011980830670926517	1	7.564296520423601E-4	4	0.003976143141153081	1	0.001440922190201729	0	0.0	0	0.0	779	264690	0.0029430655	.	289	109366	2.642500e-03	1	564	207736	2.714980e-03	1	625	236592	2.641680e-03	1	4	7148	5.595970e-04	0	27	17110	1.578020e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	35	13384	2.615060e-03	0	217	42756	5.075310e-03	1	0	15688	0.000000e+00	0	217	42756	5.075310e-03	1	11	16174	6.801040e-04	0	40	30516	1.310790e-03	0	0	6206	0.000000e+00	0	1	13410	7.457120e-05	0	44	16724	2.630950e-03	0	454	89240	5.087400e-03	1	0	30606	0.000000e+00	0	454	89240	5.087400e-03	1	9	14876	6.050010e-04	0	53	34256	1.547170e-03	0	0	9564	0.000000e+00	0	1	17692	5.652270e-05	0	49	21620	2.266420e-03	0	498	102440	4.861380e-03	1	0	30524	0.000000e+00	0	498	102440	4.861380e-03	1	.	7763	1613938	4.809970e-03	25	7135	1180022	6.046500e-03	24	54	75056	7.194630e-04	0	0	912	0.000000e+00	0	109	60026	1.815880e-03	0	1	29608	3.377470e-05	0	1	44880	2.228160e-05	0	194	63782	3.041610e-03	1	0	6060	0.000000e+00	0	7135	1180022	6.046500e-03	24	2	91090	2.195630e-05	0	981	198634	0.0049387315363935685	1	360	0.002777777777777778	0	4532	0	5	9432	5.301102629346904E-4	5	796	0.00628140703517588	0	966	0	0	1842	0	0	280	0	54	17500	0.003085714285714286	6	9792	6.127450980392157E-4	0	6374	0	1046	234342	0.004463561802835173	Conflicting_classifications_of_pathogenicity	not_specified|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon	criteria_provided,_conflicting_classifications	NC_000010.11:g.43100551C>A	ClinGen:CA007702	CN169374|C1619700|C0027662|C3661900|C0031511|C0027672|C4048306|C0025268|C3888239|C0019569	191830|PS131100|171300|171400|142623|PS142623	411709|276161|29072|140162|653|247698|653|388|388	Ret, cadherin like domain 1	Leu	Met	45384	single nucleotide variant	NM_020975.6(RET):c.166C>A (p.Leu56Met)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Mar 04, 2025	145633958	-	RCV000121985|RCV000202649|RCV000034766|RCV000030402|RCV000163266|RCV001108850|RCV000148768|RCV001082759|RCV001108849|RCV001108851	MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388	not specified|Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	germline;unknown	germline	GRCh38	NC_000010.11	10	43100551	43100551	10q11.21	criteria provided, conflicting classifications	26	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007702	2	36723	43100551	C	A	-	-	-	-	-	-	SCV000113984|SCV000213794|SCV000258169|SCV000261742|SCV000514406|SCV000711342|SCV000807009|SCV001138019|SCV001147859|SCV001158030|SCV001266132|SCV001266133|SCV001266134|SCV001266135|SCV002011461|SCV002067079|SCV002529940|SCV002550377|SCV002774043|SCV004357214|SCV004838625	-	-	166C>A 	Leu56Met	NM_020975.6	1	3_Conflicting	10	43100551	C	A	0.00499724																																																																																																				
RET	RET_Val292Met	-6.302622328210597	0.00040314669841361	5.126137385468295	0.0013594595445485806	2025_01_Batch_13-14	0.5597747988299054	0.7418593421567587	0.8696012586804667	0.8053184200824319	0.6489271164433885	0.6522687131589785	0.7182645813064765	0.8402332581550437	0.7615852880624969	0.6873326960557387	0.606021755994442	0.7300619617316176	0.8549172584177551	0.7834518540724644	0.6681299062495636	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202956	CCSBVarC006880	ALE00006878	NC_000010.11:43106382:G:A	874G>A	Val292Met	CEGS2	CegsMutGDEh1026	H07	GDEhDisVCh_40066	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Val292Met	10	43106382	G	A	10											10-43106382-G-A	24880	10	43106382	G	A	V	M	rs34682185	10	43601830	10	42921836	292	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.874G>A	p.Val292Met	c.874G>A	p.Val292Met	principal4	Y	5	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.032	0.53775	D	1.0	0.90580	D	0.935	0.73565	D	0.12	0.31989	N	simple_aae	88.0	12.0	2.615	0.76302	M	-1.09	0.28250	N	0.558	0.60971	0.4163	0.89300	D	0.5416	0.83044	D	10	0.010467678	0.00229	T	.	.	.	0.409	0.71949	.	.	.	.	.	0.888871705788	0.88692	0.788903358267811	0.78722	1.83343156079	0.92045	0.564820885658	0.47880	T	0.467186	0.80012	T	-0.0978649	0.36423	T	0.0917746	0.76187	D	0.0599002876036932	0.07075	T	0.681032	0.28743	T	0.17939073	0.38700	0.13158411	0.31509	0.22824927	0.45215	0.13554715	0.32360	-8.694	0.65784	D	0.1243	0.33824	B	0.936206762942958	0.78979	0.99984658	0.99806	0.706	0.83697	.	.	.	.	.	.	4.280368	0.6527	24.8	0.99748410528429388	0.84091	0.558315	0.56606	D	0.404318965602062	0.61459	4.370004	0.288787131538424	0.54646	3.6522	4.86	4.86	0.62577	2.99	0.54692	6.727	0.74634	6.639000	0.56245	-0.168	0.1142	0.998	0.41403	1.000000	0.68239	0.08	0.17286	862	0.33096	19	0.0037939297124600637	0	0.0	1	9.940357852882703E-4	0	0.0	17	0.016865079365079364	1	0.0010224948875255625	81	264690	3.0601837E-4	.	78	107468	7.257970e-04	0	120	203952	5.883740e-04	0	149	233194	6.389530e-04	0	2	7086	2.822470e-04	0	2	17040	1.173710e-04	0	0	2316	0.000000e+00	0	65	9000	7.222220e-03	0	0	11960	0.000000e+00	0	3	42544	7.051520e-05	0	6	15632	3.838280e-04	0	65	9000	7.222220e-03	0	2	15900	1.257860e-04	0	4	30412	1.315270e-04	0	0	6136	0.000000e+00	0	95	13298	7.143930e-03	0	0	15296	0.000000e+00	0	5	87600	5.707760e-05	0	11	30514	3.604900e-04	0	95	13298	7.143930e-03	0	2	14664	1.363880e-04	0	4	34166	1.170750e-04	0	0	9544	0.000000e+00	0	123	17646	6.970420e-03	0	0	19796	0.000000e+00	0	6	101376	5.918560e-05	0	11	30434	3.614380e-04	0	123	17646	6.970420e-03	0	.	365	1610770	2.266000e-04	5	199	44880	4.434050e-03	2	7	75016	9.331340e-05	0	0	912	0.000000e+00	0	4	60016	6.664890e-05	0	2	29608	6.754930e-05	0	199	44880	4.434050e-03	2	1	61774	1.618800e-05	0	1	5300	1.886790e-04	0	73	1179870	6.187120e-05	0	39	91004	4.285530e-04	3	15	159894	9.381215054973921E-5	0	242	0	21	4726	0.004443504020313161	0	5982	0	0	1146	0	0	1160	0	5	1878	0.0026624068157614484	0	322	0	10	15512	6.446621970087674E-4	0	6224	0	26	6604	0.003937007874015748	51	190862	2.6720876863912143E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer|Multiple_endocrine_neoplasia,_type_2|Hirschsprung_disease,_susceptibility_to,_1|not_provided|not_specified|Multiple_endocrine_neoplasia_type_2B|Pheochromocytoma|Multiple_endocrine_neoplasia|Hereditary_cancer-predisposing_syndrome|Renal_hypodysplasia/aplasia_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106382G>A	ClinGen:CA009374|UniProtKB:P07949#VAR_041764	C1333600|C4048306|C3888239|C3661900|CN169374|C0025269|C0031511|C0027662|C0027672|C1619700	142623|162300|171300|PS131100|191830	653|388|247709|653|29072|276161|140162|411709	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Val	Met	36221	single nucleotide variant	NM_020975.6(RET):c.874G>A (p.Val292Met)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Jan 30, 2025	34682185	-	RCV000034779|RCV000121992|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000367517|RCV000565970|RCV001083006|RCV003492298	MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	not provided|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000010.11	10	43106382	43106382	10q11.21	criteria provided, conflicting classifications	15	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	2	24880	43106382	G	A	-	-	-	-	-	-	SCV000218577|SCV000362271|SCV000362272|SCV000362273|SCV000362274|SCV000609569|SCV000616852|SCV000674801|SCV000692679|SCV000807063|SCV000838372|SCV000883098|SCV002011440|SCV002527933|SCV002572022|SCV004220049	-	-	874G>A 	Val292Met	NM_020975.6	1	3_Conflicting	10	43106382	G	A	0.000211869																																																																																																				
RET	RET_Val292Met	-6.302622328210597	0.00040314669841361	5.126137385468295	0.0013594595445485806	2025_01_Batch_13-14	0.5597747988299054	0.7418593421567587	0.8696012586804667	0.8053184200824319	0.6489271164433885	0.6522687131589785	0.7182645813064765	0.8402332581550437	0.7615852880624969	0.6873326960557387	0.606021755994442	0.7300619617316176	0.8549172584177551	0.7834518540724644	0.6681299062495636	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006880		NC_000010.11:43106382:G:A		Val292Met																												RET_Val292Met	10	43106382	G	A	10	allele	874G>A	H08	527_CAVA_Array_P05	O15	B13A7A8P2_R1	B14A7A8P2_R2				10-43106382-G-A	24880	10	43106382	G	A	V	M	rs34682185	10	43601830	10	42921836	292	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.874G>A	p.Val292Met	c.874G>A	p.Val292Met	principal4	Y	5	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.032	0.53775	D	1.0	0.90580	D	0.935	0.73565	D	0.12	0.31989	N	simple_aae	88.0	12.0	2.615	0.76302	M	-1.09	0.28250	N	0.558	0.60971	0.4163	0.89300	D	0.5416	0.83044	D	10	0.010467678	0.00229	T	.	.	.	0.409	0.71949	.	.	.	.	.	0.888871705788	0.88692	0.788903358267811	0.78722	1.83343156079	0.92045	0.564820885658	0.47880	T	0.467186	0.80012	T	-0.0978649	0.36423	T	0.0917746	0.76187	D	0.0599002876036932	0.07075	T	0.681032	0.28743	T	0.17939073	0.38700	0.13158411	0.31509	0.22824927	0.45215	0.13554715	0.32360	-8.694	0.65784	D	0.1243	0.33824	B	0.936206762942958	0.78979	0.99984658	0.99806	0.706	0.83697	.	.	.	.	.	.	4.280368	0.6527	24.8	0.99748410528429388	0.84091	0.558315	0.56606	D	0.404318965602062	0.61459	4.370004	0.288787131538424	0.54646	3.6522	4.86	4.86	0.62577	2.99	0.54692	6.727	0.74634	6.639000	0.56245	-0.168	0.1142	0.998	0.41403	1.000000	0.68239	0.08	0.17286	862	0.33096	19	0.0037939297124600637	0	0.0	1	9.940357852882703E-4	0	0.0	17	0.016865079365079364	1	0.0010224948875255625	81	264690	3.0601837E-4	.	78	107468	7.257970e-04	0	120	203952	5.883740e-04	0	149	233194	6.389530e-04	0	2	7086	2.822470e-04	0	2	17040	1.173710e-04	0	0	2316	0.000000e+00	0	65	9000	7.222220e-03	0	0	11960	0.000000e+00	0	3	42544	7.051520e-05	0	6	15632	3.838280e-04	0	65	9000	7.222220e-03	0	2	15900	1.257860e-04	0	4	30412	1.315270e-04	0	0	6136	0.000000e+00	0	95	13298	7.143930e-03	0	0	15296	0.000000e+00	0	5	87600	5.707760e-05	0	11	30514	3.604900e-04	0	95	13298	7.143930e-03	0	2	14664	1.363880e-04	0	4	34166	1.170750e-04	0	0	9544	0.000000e+00	0	123	17646	6.970420e-03	0	0	19796	0.000000e+00	0	6	101376	5.918560e-05	0	11	30434	3.614380e-04	0	123	17646	6.970420e-03	0	.	365	1610770	2.266000e-04	5	199	44880	4.434050e-03	2	7	75016	9.331340e-05	0	0	912	0.000000e+00	0	4	60016	6.664890e-05	0	2	29608	6.754930e-05	0	199	44880	4.434050e-03	2	1	61774	1.618800e-05	0	1	5300	1.886790e-04	0	73	1179870	6.187120e-05	0	39	91004	4.285530e-04	3	15	159894	9.381215054973921E-5	0	242	0	21	4726	0.004443504020313161	0	5982	0	0	1146	0	0	1160	0	5	1878	0.0026624068157614484	0	322	0	10	15512	6.446621970087674E-4	0	6224	0	26	6604	0.003937007874015748	51	190862	2.6720876863912143E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer|Multiple_endocrine_neoplasia,_type_2|Hirschsprung_disease,_susceptibility_to,_1|not_provided|not_specified|Multiple_endocrine_neoplasia_type_2B|Pheochromocytoma|Multiple_endocrine_neoplasia|Hereditary_cancer-predisposing_syndrome|Renal_hypodysplasia/aplasia_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106382G>A	ClinGen:CA009374|UniProtKB:P07949#VAR_041764	C1333600|C4048306|C3888239|C3661900|CN169374|C0025269|C0031511|C0027662|C0027672|C1619700	142623|162300|171300|PS131100|191830	653|388|247709|653|29072|276161|140162|411709	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Val	Met	36221	single nucleotide variant	NM_020975.6(RET):c.874G>A (p.Val292Met)	5979	RET	HGNC:9967	Conflicting classifications of pathogenicity	0	Jan 30, 2025	34682185	-	RCV000034779|RCV000121992|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000367517|RCV000565970|RCV001083006|RCV003492298	MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	not provided|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000010.11	10	43106382	43106382	10q11.21	criteria provided, conflicting classifications	15	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	2	24880	43106382	G	A	-	-	-	-	-	-	SCV000218577|SCV000362271|SCV000362272|SCV000362273|SCV000362274|SCV000609569|SCV000616852|SCV000674801|SCV000692679|SCV000807063|SCV000838372|SCV000883098|SCV002011440|SCV002527933|SCV002572022|SCV004220049	-	-	874G>A 	Val292Met	NM_020975.6	1	3_Conflicting	10	43106382	G	A	0.000211869																																																																																																				
BRAF	BRAF_Val487Gly	-6.116199946608242	0.00048331137760885195	3.8723574361118165	0.006113032285350252	2025_01_Batch_13-14	0.5407661447805905	0.6765742692118035	0.7522435543255914	0.6841347854488865	0.507385551881682	0.7776936183988863	0.7968696578257537	0.7144309182995557	0.7060995616659878	0.6554421850724196	0.6592298815897384	0.7367219635187786	0.7333372363125736	0.6951171735574371	0.5814138684770508	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220606	CCSBVarC003164	ALE00003164	NC_000007.14:140778048:A:C	1460T>G	Val487Gly	CEGS2	CegsMutGDEh1011	H06	GDEhDisVCh_40058	E03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Val487Gly	7	140778048	A	C	7											7-140778048-A-C	44806	7	140778048	A	C	V	G	rs397516893	7	140477848	7	140124317	487	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1460T>G	p.Val487Gly	c.1460T>G	p.Val487Gly	principal4	Y	.	YES	Select	-	GTG	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.478	0.36724	P	0.148	0.34068	B	.	0.99291	.	.	.	.	0.895	0.22286	L	.	.	.	.	.	-0.8552	0.51413	T	0.1922	0.54309	T	10	0.9420905	0.93461	D	0.174902	0.85076	D	.	0.96086	0.828	0.93817	P15056	V487G	Gain of disorder (P = 0.0281)| Loss of stability (P = 0.0406)| Gain of ubiquitination at K483 (P = 0.0985)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.2005)	.	0.98130	.	0.92090	.	0.93269	0.828899681568	0.86370	D	0.848438	0.96500	D	0.417248	0.90811	D	0.361572	0.90697	D	0.99738210439682	0.91358	D	0.946505	0.79494	D	0.9640127	0.97644	0.93370944	0.97310	0.948537	0.96056	0.9274714	0.96876	-13.971	0.92975	D	0.9903	0.95874	P	0.999977702097208	0.99427	0.99449290	0.97559	0.997	0.99892	.	.	.	.	.	.	5.288129	0.8881	29.7	0.99591389096133687	0.73662	0.903643	0.85245	D	0.341902369550804	0.58100	4.002832	0.436077121338009	0.63630	4.624474	4.96	4.96	0.65108	.	.	9.289	0.95099	11.177000	0.88188	0.686	0.82694	1.0	0.71675	1.000000	0.68239	0.997	0.79771	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided|Inborn_genetic_diseases|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778048A>C	ClinGen:CA280007	C1275081|C3661900|C0950123|C5555857	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	53973	single nucleotide variant	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Jul 21, 2021	397516893	-	RCV000788814|RCV000037922|RCV000622585|RCV001852794	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Cardio-facio-cutaneous syndrome|Inborn genetic diseases|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140778048	140778048	7q34	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA280007	2	44806	140778048	A	C	-	-	-	-	-	-	SCV000061585|SCV000740925|SCV000928070|SCV002008924|SCV002196994	-	-	1460T>G 	Val487Gly	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Val487Gly	-6.116199946608242	0.00048331137760885195	3.8723574361118165	0.006113032285350252	2025_01_Batch_13-14	0.5407661447805905	0.6765742692118035	0.7522435543255914	0.6841347854488865	0.507385551881682	0.7776936183988863	0.7968696578257537	0.7144309182995557	0.7060995616659878	0.6554421850724196	0.6592298815897384	0.7367219635187786	0.7333372363125736	0.6951171735574371	0.5814138684770508	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003164		NC_000007.14:140778048:A:C		Val487Gly																												BRAF_Val487Gly	7	140778048	A	C	7	allele	1460T>G	C04	527_CAVA_Array_P01	E07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778048-A-C	44806	7	140778048	A	C	V	G	rs397516893	7	140477848	7	140124317	487	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1460T>G	p.Val487Gly	c.1460T>G	p.Val487Gly	principal4	Y	.	YES	Select	-	GTG	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.478	0.36724	P	0.148	0.34068	B	.	0.99291	.	.	.	.	0.895	0.22286	L	.	.	.	.	.	-0.8552	0.51413	T	0.1922	0.54309	T	10	0.9420905	0.93461	D	0.174902	0.85076	D	.	0.96086	0.828	0.93817	P15056	V487G	Gain of disorder (P = 0.0281)| Loss of stability (P = 0.0406)| Gain of ubiquitination at K483 (P = 0.0985)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.2005)	.	0.98130	.	0.92090	.	0.93269	0.828899681568	0.86370	D	0.848438	0.96500	D	0.417248	0.90811	D	0.361572	0.90697	D	0.99738210439682	0.91358	D	0.946505	0.79494	D	0.9640127	0.97644	0.93370944	0.97310	0.948537	0.96056	0.9274714	0.96876	-13.971	0.92975	D	0.9903	0.95874	P	0.999977702097208	0.99427	0.99449290	0.97559	0.997	0.99892	.	.	.	.	.	.	5.288129	0.8881	29.7	0.99591389096133687	0.73662	0.903643	0.85245	D	0.341902369550804	0.58100	4.002832	0.436077121338009	0.63630	4.624474	4.96	4.96	0.65108	.	.	9.289	0.95099	11.177000	0.88188	0.686	0.82694	1.0	0.71675	1.000000	0.68239	0.997	0.79771	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided|Inborn_genetic_diseases|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778048A>C	ClinGen:CA280007	C1275081|C3661900|C0950123|C5555857	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	53973	single nucleotide variant	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Jul 21, 2021	397516893	-	RCV000788814|RCV000037922|RCV000622585|RCV001852794	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Cardio-facio-cutaneous syndrome|Inborn genetic diseases|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140778048	140778048	7q34	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA280007	2	44806	140778048	A	C	-	-	-	-	-	-	SCV000061585|SCV000740925|SCV000928070|SCV002008924|SCV002196994	-	-	1460T>G 	Val487Gly	NM_004333.6	2	1_Pathogenic																																																																																																									
F9	F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079176	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.693389980645856	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	10573	X	139537145	G	A	R	Q	rs137852228	X	138619304	X	138446970	75	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.99953252965582506	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	25612	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158	F9	HGNC:3551	Pathogenic	1	Oct 11, 2024	137852228	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145	139537145	Xq27.1	reviewed by expert panel	9	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3	10573	139537145	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3	1_Pathogenic						210375	F9_Popp_2025_light_chain_var241613	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537145.0	139537145.0		224			75.0	R	Q	c.224G>A	p.Arg75Gln	missense_variant	0.7745385738532904			No	3.3027716859e-6	Pathogenic	reviewed by expert panel	Oct 11, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																								10573.0	CA255318	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PP3	PM1	NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	10/11/24	1/7/25	false	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02	178efdc9-7922-4e7d-8479-352a42eedd02	VUS	PS4_Very,PM2_Supporting	F9_Arg75Gln	Arg75Gln	true
F9	F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079176	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.693389980645856	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	10573	X	139537145	G	A	R	Q	rs137852228	X	138619304	X	138446970	75	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.99953252965582506	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	25612	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158	F9	HGNC:3551	Pathogenic	1	Oct 11, 2024	137852228	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145	139537145	Xq27.1	reviewed by expert panel	9	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3	10573	139537145	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3	1_Pathogenic						155343	F9_Popp_2025_carboxy_gla_motif_var251294	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537145.0	139537145.0		224			75.0	R	Q	c.224G>A	p.Arg75Gln	missense_variant	0.9527583231469484			No	3.3027716859e-6	Pathogenic	reviewed by expert panel	Oct 11, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																								10573.0	CA255318	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PP3	PM1	NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	10/11/24	1/7/25	false	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02	178efdc9-7922-4e7d-8479-352a42eedd02	VUS	PS4_Very,PM2_Supporting	F9_Arg75Gln	Arg75Gln	true
F9	F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079176	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.693389980645856	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	10573	X	139537145	G	A	R	Q	rs137852228	X	138619304	X	138446970	75	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.99953252965582506	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	25612	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158	F9	HGNC:3551	Pathogenic	1	Oct 11, 2024	137852228	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145	139537145	Xq27.1	reviewed by expert panel	9	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3	10573	139537145	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3	1_Pathogenic						182859	F9_Popp_2025_heavy_chain_var231932	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537145.0	139537145.0		224			75.0	R	Q	c.224G>A	p.Arg75Gln	missense_variant	0.8204446127049808			No	3.3027716859e-6	Pathogenic	reviewed by expert panel	Oct 11, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																								10573.0	CA255318	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PP3	PM1	NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	10/11/24	1/7/25	false	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02	178efdc9-7922-4e7d-8479-352a42eedd02	VUS	PS4_Very,PM2_Supporting	F9_Arg75Gln	Arg75Gln	true
F9	F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079176	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.693389980645856	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	10573	X	139537145	G	A	R	Q	rs137852228	X	138619304	X	138446970	75	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.99953252965582506	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	25612	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158	F9	HGNC:3551	Pathogenic	1	Oct 11, 2024	137852228	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145	139537145	Xq27.1	reviewed by expert panel	9	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3	10573	139537145	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3	1_Pathogenic						127827	F9_Popp_2025_carboxy_F9_specific_var222251	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537145.0	139537145.0		224			75.0	R	Q	c.224G>A	p.Arg75Gln	missense_variant	0.8265238286063324			No	3.3027716859e-6	Pathogenic	reviewed by expert panel	Oct 11, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																								10573.0	CA255318	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PP3	PM1	NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	10/11/24	1/7/25	false	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02	178efdc9-7922-4e7d-8479-352a42eedd02	VUS	PS4_Very,PM2_Supporting	F9_Arg75Gln	Arg75Gln	true
F9	F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079176	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.693389980645856	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	10573	X	139537145	G	A	R	Q	rs137852228	X	138619304	X	138446970	75	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.99953252965582506	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	25612	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158	F9	HGNC:3551	Pathogenic	1	Oct 11, 2024	137852228	-	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145	139537145	Xq27.1	reviewed by expert panel	9	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3	10573	139537145	G	A	-	-	-	-	-	-	SCV005437139	-	-	224G>A 	Arg75Gln	NM_000133.4	3	1_Pathogenic						237891	F9_Popp_2025_strep_2_var260975	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537145.0	139537145.0		224			75.0	R	Q	c.224G>A	p.Arg75Gln	missense_variant	0.6763994715577879			No	3.3027716859e-6	Pathogenic	reviewed by expert panel	Oct 11, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.904																																								10573.0	CA255318	hemophilia B	MONDO:0010604	X-linked inheritance	Pathogenic	PP4_Moderate,PS4_Very,PM2_Supporting,PP3	PM1	NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	10/11/24	1/7/25	false	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02	178efdc9-7922-4e7d-8479-352a42eedd02	VUS	PS4_Very,PM2_Supporting	F9_Arg75Gln	Arg75Gln	true
BAP1	BAP1_Leu49Pro	1.5336173628501408	0.16899235826402517	-3.5941090630658135	0.008808725066084462	2025_01_Batch_13-14	0.6714650514021713	0.7249915388752513	0.7211160899220241	0.7357994038965971	0.6612148620052707	0.5927178557285544	0.6573221090769205	0.7233256814860385	0.7226002686637022	0.5611411472899007	0.6320914535653628	0.6911568239760859	0.7222208857040313	0.7291998362801497	0.6111780046475856	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009492		NC_000003.12:52408583:A:G		Leu49Pro																												BAP1_Leu49Pro	3	52408583	A	G	3	allele	146T>C	D02	527_CAVA_Array_P01	G03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408583-A-G	1173079	3	52408583	A	G	L	P	rs2153228340	3	52442599	3	52417639	49	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.146T>C	p.Leu49Pro	c.146T>C	p.Leu49Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.14	0.97479	H	-6.34	0.91806	D	0.964	0.97441	0.4731	0.90127	D	0.5835	0.84984	D	10	0.9803013	0.97974	D	0.465198	0.94573	D	0.830	0.94600	0.911	0.98220	Q92560	L49P	Loss of stability (P = 0.0111)| Gain of sheet (P = 0.0477)| Loss of MoRF binding (P = 0.0633)| Gain of disorder (P = 0.1336)| Gain of glycosylation at Y44 (P = 0.1882)	0.919171306595	0.91774	0.9942708640742988	0.99423	3.28525368344	0.99563	0.917951464653	0.98162	D	0.61312	0.87653	D	0.399268	0.89798	D	0.335745	0.89671	D	0.999857425689697	0.99358	D	0.998712	0.99310	D	0.98750603	0.99618	0.97671837	0.99717	0.98750603	0.99618	0.97671837	0.99718	-17.779	0.99425	D	0.9998	0.99584	P	0.999944798679913	0.99079	0.99983054	0.99778	0.979	0.99252	.	.	.	.	.	.	5.605936	0.92502	32.0	0.99900871002661273	0.97276	0.961659	0.98292	D	1.02132438138349	0.96342	14.6051	0.93110546969636	0.96774	15.15042	5.43	5.43	0.78977	3.34	0.60572	9.279	0.94993	9.358000	0.80383	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Neurodevelopmental_disorder|not_provided	criteria_provided,_single_submitter	NC_000003.12:g.52408583A>G	.	C1535926|C3661900	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Leu	Pro	1162266	single nucleotide variant	NM_004656.4(BAP1):c.146T>C (p.Leu49Pro)	8314	BAP1	HGNC:950	Likely pathogenic	1	Sep 28, 2022	2153228340	-	RCV001797185|RCV003161062	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408583	52408583	3p21.1	criteria provided, single submitter	2	-	N	ClinGen:CA353113658	2	1173079	52408583	A	G	-	-	-	-	-	-	SCV003915265	-	-	146T>C 	Leu49Pro	NM_004656.4	1	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Ala102Gly	-1.4050219512461604	0.20280504742642533	-6.386066195669309	0.00037218712893209217	2025_01_Batch_13-14	0.87910947777377	0.9080614217344603	0.9790875484839284	0.9649037055693481	0.8255454760853147	0.7179899562352263	0.8008915564922798	0.9556453157602098	0.9172671299391097	0.7462918151419493	0.7985497170044982	0.85447648911337	0.9673664321220692	0.9410854177542289	0.785918645613632	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013080		NC_000017.11:43104258:G:C		Ala102Gly																												BRCA1_Ala102Gly	17	43104258	G	C	17	allele	305C>G	A11	527_CAVA_Array_P01	A21	B13A7A8P1_R1	B14A7A8P1_R2				17-43104258-G-C	37505	17	43104258	G	C	A	G	rs80357190	17	41256275	17	38509801	102	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.305C>G	p.Ala102Gly	c.305C>G	p.Ala102Gly	principal2	Y	1	.	.	-	GCA	2	0	G	G/G	G/G	G/G	G/G	0.006	0.68399	D	0.065	0.48945	T	0.057	0.44237	B	0.023	0.42592	B	.	0.61445	.	.	.	.	2.24	0.63167	M	-0.52	0.48535	N	.	0.53827	-0.8845	0.49200	T	0.1938	0.54543	T	10	0.33566126	0.50348	D	0.118185	0.79755	D	0.606	0.84430	0.48	0.55849	E9PFC7	A102G	Loss of stability (P = 0.0442)| Gain of relative solvent accessibility (P = 0.0999)| Gain of disorder (P = 0.157)| Gain of catalytic residue at S104 (P = 0.1636)| Loss of phosphorylation at Y101 (P = 0.2814)	0.947690629548	0.94671	.	0.33795	.	0.20076	0.312466681004	0.12270	T	0.212967	0.57203	T	0.262764	0.79636	D	0.139666	0.79372	D	0.518966853618622	0.33015	D	.	0.80632	.	0.12579814	0.29224	0.06543072	0.13260	0.12579814	0.29224	0.06543072	0.13260	-4.128	0.40366	T	0.1268	0.35034	LB	0.485608964919914	0.60346	0.99054370	0.96816	0.105	0.29145	.	.	.	.	.	.	2.791559	0.36769	20.3	0.99356524987265227	0.60877	0.328409	0.42717	N	0.0961423372559193	0.46027	2.871031	0.125822333913209	0.45602	2.842934	5.32	3.24	0.36180	4.41	0.82967	1.516	0.35569	6.237000	0.55333	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.968	0.53734	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1609246	2.485640e-06	0	1	74900	1.335110e-05	0	1	74900	1.335110e-05	0	0	912	0.000000e+00	0	0	59924	0.000000e+00	0	0	29582	0.000000e+00	0	0	44828	0.000000e+00	0	0	63826	0.000000e+00	0	0	6050	0.000000e+00	0	0	1176114	0.000000e+00	0	0	90756	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	1	24	0.041666666666666664	0	94	0	0	466	0	0	2294	0	1	108	0.009259259259259259	1	10680	9.363295880149813E-5	Benign	not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43104258G>C	ClinGen:CA002009	CN169374|C0677776|C3661900|C2676676|CN377757|C0027672	604370	145|145|140162	.	Ala	Gly	46061	single nucleotide variant	NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	672	BRCA1	HGNC:1100	Benign	0	Jun 11, 2024	80357190	-	RCV004566761|RCV001353922|RCV000166160|RCV000203639|RCV000031086|RCV000048062	MONDO:MONDO:0700268,MedGen:CN377757|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374	BRCA1-related cancer predisposition|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43104258	43104258	17q21.31	reviewed by expert panel	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002009	2	37505	43104258	G	C	-	-	-	-	-	-	SCV004101421	-	-	305C>G 	Ala102Gly	NM_007294.4	3	2_Benign																																																																																																									
SHOC2	SHOC2_Gln269Arg	-1.8731767698109718	0.10319517574123058	4.883717454830403	0.001786015443663744	2025_01_Batch_13-14	0.6157670407013233	0.7034325372287237	0.6721865775921672	0.5990108450587132	0.5973191878592183	0.6764018619453296	0.5925631045270634	0.67241443224796	0.5574465641286752	0.6788020234629276	0.6460844513233264	0.6479978208778936	0.6723005049200637	0.5782287045936942	0.6380606056610729	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
CTCF	CTCF_Arg342Gly	6.0220837101592055	0.0005304623673855454	1.3306764800790363	0.22500413846281694	2025_01_Batch_13-14	0.6738743571694991	0.8386015774173865	0.9362891247658401	0.823922261253352	0.7704360005544952	0.6082543794760712	0.7681794064875938	0.9202075187399034	0.8076678706202	0.7252917962726947	0.6410643683227851	0.8033904919524901	0.9282483217528718	0.815795065936776	0.747863898413595	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010867		NC_000016.10:67616816:C:G		Arg342Gly																												CTCF_Arg342Gly	16	67616816	C	G	16	allele	1024C>G	F01	527_CAVA_Array_P02	K02	B13A7A8P1_R1	B14A7A8P1_R2				16-67616816-C-G	1176667	16	67616816	C	G	R	G	rs1131691283	16	67650719	16	66208220	342	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.1024C>G	p.Arg342Gly	c.1024C>G	p.Arg342Gly	principal4	Y	.	.	.	+	CGT	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	0.997	0.70687	D	0.993	0.81117	D	.	0.93829	.	.	.	.	2.485	0.72164	M	.	0.91330	.	.	0.79815	-0.8813	0.49460	T	0.1541	0.48246	T	10	0.8994916	0.89190	D	0.046837	0.62502	D	.	0.85178	0.787	0.90945	P49711	R342G	Loss of stability (P = 0.0064)| Loss of MoRF binding (P = 0.0492)| Gain of methylation at K344 (P = 0.0961)| Gain of phosphorylation at Y343 (P = 0.1164)| Loss of disorder (P = 0.1303)	.	0.90579	.	0.96335	.	0.99365	0.949047386646	0.99729	D	0.857179	0.96774	D	0.260551	0.79429	D	0.136487	0.79163	D	0.986837384407801	0.77291	D	.	0.80202	.	0.9000301	0.91262	0.84071624	0.90766	0.9000301	0.91263	0.84071624	0.90766	-15.136	0.96171	D	.	0.97655	.	0.999648397760086	0.97310	0.96604900	0.94367	0.857	0.92182	.	.	.	.	.	.	4.995947	0.82886	27.9	0.99693360905744033	0.80133	0.947897	0.95882	D	0.75661128044812	0.83245	7.990627	0.730908088587966	0.84641	8.37291	4.89	4.89	0.63341	.	.	7.701	0.83585	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67616816C>G	.	C3661900	.	.	.	Arg	Gly	1166187	single nucleotide variant	NM_006565.4(CTCF):c.1024C>G (p.Arg342Gly)	10664	CTCF	HGNC:13723	Likely pathogenic	1	Feb 01, 2021	1131691283	-	RCV001532325	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67616816	67616816	16q22.1	criteria provided, single submitter	1	-	N	ClinGen:CA396312242	2	1176667	67616816	C	G	-	-	-	-	-	-	SCV001747837	-	-	1024C>G 	Arg342Gly	NM_006565.4	1	1_Pathogenic						964317	CTCF_unpublished_var158564	CTCF_unpublished	CTCF	13723.0	1.0		67616816.0	67616816.0		1024	C	G	342.0	R	G	c.1024C>G	p.Arg342Gly	missense_variant	0.0775292		functionally_normal	Yes		Likely pathogenic	criteria provided, single submitter	Feb 01, 2021	nucleotide		ENST00000264010.10	NM_006565.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.62																																																											CTCF_Arg342Gly	Arg342Gly	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						169108	F9_Popp_2025_carboxy_gla_motif_var256142	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.4440151418526494			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						169108	F9_Popp_2025_carboxy_gla_motif_var256142	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.4440151418526494			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						141592	F9_Popp_2025_carboxy_F9_specific_var227099	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.5514024847166168			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						141592	F9_Popp_2025_carboxy_F9_specific_var227099	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.5514024847166168			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						224140	F9_Popp_2025_light_chain_var246461	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.5262446676818676			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						224140	F9_Popp_2025_light_chain_var246461	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.5262446676818676			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						196624	F9_Popp_2025_heavy_chain_var236780	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.6069392182469997			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						196624	F9_Popp_2025_heavy_chain_var236780	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.6069392182469997			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						251656	F9_Popp_2025_strep_2_var265823	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.9838242373602404			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
F9	F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											true	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic						251656	F9_Popp_2025_strep_2_var265823	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561602.0	139561602.0		917			306.0	N	S	c.917A>G	p.Asn306Ser	missense_variant	0.9838242373602404			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.578																																																											F9_Asn306Ser	Asn306Ser	true
KRAS	KRAS_Gly13Asp	-1.6558698671862377	0.1417194965294439	2.6206139205304035	0.03437849113816																											true	KRAS	ENSG00000133703	3084	214486	CCSBVarC006091	ALE00006091	NC_000012.12:25245347:C:T	38G>A	Gly13Asp	CEGS2	CegsMutGDEh1039	E06	GDEhDisVCh_40061	E09	1	CegsMutGDDh1039	E06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly13Asp	12	25245347	C	T	12											12-25245347-C-T	12580	12	25245347	C	T	G	D	rs112445441	12	25398281	12	25289548	13	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.38G>A	p.Gly13Asp	c.38G>A	p.Gly13Asp	alternative1	Y	1	.	Plus_Clinical	-	GGC	2	0	C	./.	./.	./.	./.	0.032	0.54841	D	0.023	0.60671	D	0.803	0.45147	P	0.506	0.47822	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.025	0.86187	M	-5.4	0.92581	D	0.977	0.98762	0.5692	0.91461	D	0.6901	0.89270	D	10	0.9007832	0.89322	D	0.225927	0.87991	D	0.832	0.94675	0.722	0.85604	P01116	G13D	Gain of catalytic residue at A11 (P = 0)| Gain of solvent accessibility (P = 0.0648)| Loss of ubiquitination at K16 (P = 0.1191)| Loss of methylation at K16 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1684)	0.974405323578	0.97388	0.9548591274127232	0.95442	2.43727951051	0.97301	0.92631560564	0.98765	D	0.897336	0.97939	D	0.43077	0.91511	D	0.380995	0.91406	D	0.993683218955994	0.84461	D	0.853715	0.56129	D	0.91416115	0.92578	0.8911059	0.94268	0.90101796	0.91352	0.8511729	0.91471	-9.831	0.73003	D	0.998	0.98262	P	0.999983137957112	0.99579	0.99862206	0.98875	0.995	0.99826	.	.	.	.	.	.	4.988767	0.82721	27.9	0.99835685265907259	0.91720	0.894850	0.83365	D	0.645709001054705	0.75963	6.423009	0.687742056596172	0.81343	7.528909	5.68	5.68	0.88004	.	.	7.892	0.85894	5.998000	0.52513	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.999	0.91597	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	1612796	3.100210e-06	0	5	1179366	4.239570e-06	0	0	74896	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29526	0.000000e+00	0	0	44868	0.000000e+00	0	0	63986	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179366	4.239570e-06	0	0	90796	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Juvenile_myelomonocytic_leukemia|OCULOECTODERMAL_SYNDROME,_SOMATIC|Noonan_syndrome_and_Noonan-related_syndrome|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Inborn_genetic_diseases|Acute_myeloid_leukemia|not_provided|RASopathy|Breast_adenocarcinoma|Ovarian_neoplasm|Non-small_cell_lung_carcinoma|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|KRAS-related_disorder	criteria_provided,_conflicting_classifications	NC_000012.12:g.25245347C>T	ClinGen:CA122534|OMIM:190070.0003|UniProtKB:P01116#VAR_016029	C0349639|C5681679|C0406612|C0009404|C0040136|C0950123|C0023467|C3661900|C5555857|C0858252|C0919267|C0007131|C2674723|C3854181	607785|613001|601626|614470	86834|98733|2396|100087|519|536391|268114	Small GTP-binding domain	Gly	Asp	27619	single nucleotide variant	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	3845	KRAS	HGNC:6407	Pathogenic	1	Dec 18, 2024	112445441	-	RCV000013409|RCV000791297|RCV001526657|RCV004668723|RCV001857340|RCV004813034|RCV000038269|RCV000144967|RCV000144968|RCV004549358|RCV001092389|RCV001266168|RCV001813183|RCV001839444	MONDO:MONDO:0004988,MedGen:C0858252||Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114||MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396	Breast adenocarcinoma|OCULOECTODERMAL SYNDROME, SOMATIC|Nevus sebaceous|Neoplasm|RASopathy|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|KRAS-related disorder|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245347	25245347	12p12.1	criteria provided, multiple submitters, no conflicts	15	-	N	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	3	12580	25245347	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000061938|SCV001248878|SCV001444340|SCV001737088|SCV002016398|SCV002060774|SCV002117438|SCV005438357	-	SCV005094256	38G>A 	Gly13Asp	NM_004985.5	2	1_Pathogenic	12	25245347	C	T	1.36928e-6																																																																																																				
KRAS	KRAS_Gly13Asp	-1.6558698671862377	0.1417194965294439	2.6206139205304035	0.03437849113816																											true	KRAS		3084		CCSBVarC006091		NC_000012.12:25245347:C:T		Gly13Asp																												KRAS_Gly13Asp	12	25245347	C	T	12	allele	38G>A	G08	527_CAVA_Array_P03	N15	B13A7A8P1_R1	B14A7A8P1_R2				12-25245347-C-T	12580	12	25245347	C	T	G	D	rs112445441	12	25398281	12	25289548	13	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.38G>A	p.Gly13Asp	c.38G>A	p.Gly13Asp	alternative1	Y	1	.	Plus_Clinical	-	GGC	2	0	C	./.	./.	./.	./.	0.032	0.54841	D	0.023	0.60671	D	0.803	0.45147	P	0.506	0.47822	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.025	0.86187	M	-5.4	0.92581	D	0.977	0.98762	0.5692	0.91461	D	0.6901	0.89270	D	10	0.9007832	0.89322	D	0.225927	0.87991	D	0.832	0.94675	0.722	0.85604	P01116	G13D	Gain of catalytic residue at A11 (P = 0)| Gain of solvent accessibility (P = 0.0648)| Loss of ubiquitination at K16 (P = 0.1191)| Loss of methylation at K16 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1684)	0.974405323578	0.97388	0.9548591274127232	0.95442	2.43727951051	0.97301	0.92631560564	0.98765	D	0.897336	0.97939	D	0.43077	0.91511	D	0.380995	0.91406	D	0.993683218955994	0.84461	D	0.853715	0.56129	D	0.91416115	0.92578	0.8911059	0.94268	0.90101796	0.91352	0.8511729	0.91471	-9.831	0.73003	D	0.998	0.98262	P	0.999983137957112	0.99579	0.99862206	0.98875	0.995	0.99826	.	.	.	.	.	.	4.988767	0.82721	27.9	0.99835685265907259	0.91720	0.894850	0.83365	D	0.645709001054705	0.75963	6.423009	0.687742056596172	0.81343	7.528909	5.68	5.68	0.88004	.	.	7.892	0.85894	5.998000	0.52513	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.999	0.91597	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	1612796	3.100210e-06	0	5	1179366	4.239570e-06	0	0	74896	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29526	0.000000e+00	0	0	44868	0.000000e+00	0	0	63986	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179366	4.239570e-06	0	0	90796	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Conflicting_classifications_of_pathogenicity	Juvenile_myelomonocytic_leukemia|OCULOECTODERMAL_SYNDROME,_SOMATIC|Noonan_syndrome_and_Noonan-related_syndrome|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Inborn_genetic_diseases|Acute_myeloid_leukemia|not_provided|RASopathy|Breast_adenocarcinoma|Ovarian_neoplasm|Non-small_cell_lung_carcinoma|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|KRAS-related_disorder	criteria_provided,_conflicting_classifications	NC_000012.12:g.25245347C>T	ClinGen:CA122534|OMIM:190070.0003|UniProtKB:P01116#VAR_016029	C0349639|C5681679|C0406612|C0009404|C0040136|C0950123|C0023467|C3661900|C5555857|C0858252|C0919267|C0007131|C2674723|C3854181	607785|613001|601626|614470	86834|98733|2396|100087|519|536391|268114	Small GTP-binding domain	Gly	Asp	27619	single nucleotide variant	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	3845	KRAS	HGNC:6407	Pathogenic	1	Dec 18, 2024	112445441	-	RCV000013409|RCV000791297|RCV001526657|RCV004668723|RCV001857340|RCV004813034|RCV000038269|RCV000144967|RCV000144968|RCV004549358|RCV001092389|RCV001266168|RCV001813183|RCV001839444	MONDO:MONDO:0004988,MedGen:C0858252||Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114||MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396	Breast adenocarcinoma|OCULOECTODERMAL SYNDROME, SOMATIC|Nevus sebaceous|Neoplasm|RASopathy|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|KRAS-related disorder|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245347	25245347	12p12.1	criteria provided, multiple submitters, no conflicts	15	-	N	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	3	12580	25245347	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000061938|SCV001248878|SCV001444340|SCV001737088|SCV002016398|SCV002060774|SCV002117438|SCV005438357	-	SCV005094256	38G>A 	Gly13Asp	NM_004985.5	2	1_Pathogenic	12	25245347	C	T	1.36928e-6																																																																																																				
F9	F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	368001	X	139551199	T	A	S	T	rs777361659	X	138633358	X	138461024	220	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.02660	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.53336181712178654	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Benign/Likely_benign	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	352093	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Nov 26, 2024	777361659	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199	139551199	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA10529817	2	368001	139551199	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2	2_Benign						191500	F9_Popp_2025_heavy_chain_var234975	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551199.0	139551199.0		658			220.0	S	T	c.658T>A	p.Ser220Thr	missense_variant	0.985123728674622			No	0.0000611805869037	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 27, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.12																																																											F9_Ser220Thr	Ser220Thr	true
F9	F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	368001	X	139551199	T	A	S	T	rs777361659	X	138633358	X	138461024	220	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.02660	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.53336181712178654	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Benign/Likely_benign	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	352093	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Nov 26, 2024	777361659	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199	139551199	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA10529817	2	368001	139551199	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2	2_Benign						219016	F9_Popp_2025_light_chain_var244656	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551199.0	139551199.0		658			220.0	S	T	c.658T>A	p.Ser220Thr	missense_variant	0.9359157740770834			No	0.0000611805869037	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 27, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.12																																																											F9_Ser220Thr	Ser220Thr	true
F9	F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	368001	X	139551199	T	A	S	T	rs777361659	X	138633358	X	138461024	220	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.02660	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.53336181712178654	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Benign/Likely_benign	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	352093	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Nov 26, 2024	777361659	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199	139551199	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA10529817	2	368001	139551199	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2	2_Benign						136468	F9_Popp_2025_carboxy_F9_specific_var225294	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551199.0	139551199.0		658			220.0	S	T	c.658T>A	p.Ser220Thr	missense_variant	0.9827713024496731			No	0.0000611805869037	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 27, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.12																																																											F9_Ser220Thr	Ser220Thr	true
F9	F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	368001	X	139551199	T	A	S	T	rs777361659	X	138633358	X	138461024	220	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.02660	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.53336181712178654	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Benign/Likely_benign	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	352093	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Nov 26, 2024	777361659	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199	139551199	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA10529817	2	368001	139551199	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2	2_Benign						163984	F9_Popp_2025_carboxy_gla_motif_var254337	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551199.0	139551199.0		658			220.0	S	T	c.658T>A	p.Ser220Thr	missense_variant	0.9422268415037416			No	0.0000611805869037	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 27, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.12																																																											F9_Ser220Thr	Ser220Thr	true
F9	F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	368001	X	139551199	T	A	S	T	rs777361659	X	138633358	X	138461024	220	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.02660	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.53336181712178654	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Benign/Likely_benign	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	352093	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Nov 26, 2024	777361659	-	RCV000279243|RCV000862176|RCV002502409|RCV003950311	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199	139551199	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA10529817	2	368001	139551199	T	A	-	-	-	-	-	-	SCV000481884|SCV001002642|SCV002806336	-	-	658T>A 	Ser220Thr	NM_000133.4	2	2_Benign						246532	F9_Popp_2025_strep_2_var264018	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551199.0	139551199.0		658			220.0	S	T	c.658T>A	p.Ser220Thr	missense_variant	0.9920700972578148			No	0.0000611805869037	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 27, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.12																																																											F9_Ser220Thr	Ser220Thr	true
RAD51D	RAD51D_Met308Val	-1.5191507364824384	0.17252213344359443	14.967472002836823	1.4261030216509061e-6	2025_01_Batch_13-14	0.8740166193615837	0.9519753630441335	0.9903938708502005	0.9746801363316713	0.8196698329128753	0.960538673330112	0.9782166968374082	0.9876383851038141	0.987975692054751	0.9316261742150724	0.9172776463458479	0.9650960299407709	0.9890161279770073	0.9813279141932112	0.8756480035639739	0.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024892		NC_000017.11:35101018:T:C		Met308Val																												RAD51D_Met308Val	17	35101018	T	C	17	allele	922A>G	G02	527_CAVA_Array_P05	M03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101018-T-C	185144	17	35101018	T	C	M	V	rs786201961	17	33428037	17	30452150	308	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.922A>G	p.Met308Val	c.922A>G	p.Met308Val	principal1	Y	1	YES	Select	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.274	0.15912	T	0.326	0.19266	T	0.0	0.09864	B	0.0	0.06938	B	0.04	0.13669	N	simple_aae	96.0	4.0	0.72	0.18616	N	-0.61	0.17975	N	0.017	0.04065	-0.9351	0.43192	T	0.0836	0.32564	T	10	0.091109514	0.15785	T	0.00703	0.18349	T	0.046	0.12499	0.368	0.37543	O75771	M308V	Loss of disorder (P = 0.066)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T303 (P = 0.2109)| Loss of MoRF binding (P = 0.2269)| Gain of glycosylation at T313 (P = 0.247)	0.445711490874	0.43808	.	0.24814	.	0.09186	.	.	.	0.090794	0.38381	T	-0.22766	0.16671	T	-0.564795	0.15640	T	0.04466512799263	0.04499	T	.	0.22727	.	0.09098598	0.21114	0.08494699	0.19556	0.09098598	0.21113	0.08494699	0.19555	-2.125	0.04505	T	0.0668	0.03206	LB	0.000116984907820501	0.03146	0.33311860	0.77819	0.031	0.06489	.	.	.	.	.	.	0.745387	0.11172	7.79	0.84883383379766109	0.15792	0.063394	0.12075	N	-1.10219193532207	0.06526	0.304481	-1.00842900774596	0.09439	0.4784977	5.16	-1.59	0.07985	0.883	0.28197	-0.196	0.09562	-0.511000	0.08784	0.665	0.62996	0.007	0.17722	0.000000	0.08389	0.941	0.48226	913	0.21155	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8	1613598	4.957860e-06	0	3	74880	4.006410e-05	0	3	74880	4.006410e-05	0	0	910	0.000000e+00	0	0	59998	0.000000e+00	0	0	29602	0.000000e+00	0	0	44890	0.000000e+00	0	0	64022	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179678	4.238440e-06	0	0	91062	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	1	35432	2.8223075186272295E-5	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101018T>C	ClinGen:CA191144	C0027672|C3280345	614291	140162|145	.	Met	Val	184803	single nucleotide variant	NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Sep 23, 2024	786201961	-	RCV000164512|RCV004782268|RCV000649679	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	germline	germline	GRCh38	NC_000017.11	17	35101018	35101018	17q12	criteria provided, conflicting classifications	4	-	N	ClinGen:CA191144	2	185144	35101018	T	C	-	-	-	-	-	-	SCV000215164|SCV000771511|SCV000911462|SCV005394802	-	-	922A>G 	Met308Val	NM_002878.4	1	3_Conflicting						959082	RAD51D_unpublished_var153329	RAD51D_unpublished	RAD51D	9823.0	-1.0		35101018.0	35101018.0		922	A	G	308.0	M	V	c.922A>G	p.Met308Val	missense_variant	0.0243469		functionally_normal	Yes	4.9578643503e-6	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Sep 23, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.046																																																											RAD51D_Met308Val	Met308Val	true
KRAS	KRAS_Tyr71His	-4.892479479558333	0.001768232186353	6.312032320641843	0.0003995147857415345																											true	KRAS	ENSG00000133703	3084	214490	CCSBVarC006099	ALE00006099	NC_000012.12:25227313:A:G	211T>C	Tyr71His	CEGS2	CegsMutGDEh1036	F03	GDEhDisVCh_40061	B09	1	CegsMutGDDh1036	F03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Tyr71His	12	25227313	A	G	12											12-25227313-A-G	31940	12	25227313	A	G	Y	H	rs387907205	12	25380247	12	25271514	71	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.211T>C	p.Tyr71His	c.211T>C	p.Tyr71His	alternative1	Y	1	.	Plus_Clinical	-	TAC	1	0	A	A/A	A/A	A/A	A/A	0.025	0.48345	D	0.061	0.45880	T	0.919	0.50939	P	0.913	0.64880	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.48	0.71880	M	-4.45	0.77749	D	0.968	0.97870	0.6011	0.91886	D	0.7268	0.90619	D	10	0.88397557	0.87583	D	0.096778	0.76586	D	0.895	0.97016	0.693	0.82954	P01116	Y71H	Gain of catalytic residue at T74 (P = 0.0026)| Gain of disorder (P = 0.029)| Loss of phosphorylation at Y71 (P = 0.0387)| Loss of stability (P = 0.1315)| Loss of helix (P = 0.1706)	0.967032760806	0.96637	0.9119234105740558	0.91111	3.04366087562	0.99279	0.940733075142	0.99483	D	0.901474	0.98050	D	0.41344	0.90604	D	0.356102	0.90487	D	0.988144636154175	0.78358	D	0.884911	0.60851	D	0.93090373	0.94241	0.9041667	0.95206	0.927135	0.93859	0.8970921	0.94698	-12.052	0.85144	D	0.9986	0.98903	P	0.999975559545648	0.99427	0.99871314	0.98921	0.987	0.99559	.	.	.	.	.	.	5.005977	0.83126	28.0	0.99860396733546142	0.93915	0.873516	0.79516	D	0.756487767865435	0.83238	7.988538	0.776357426611185	0.88040	9.459321	5.77	5.77	0.91065	3.95	0.75212	9.309	0.95324	11.259000	0.91022	0.731	0.85655	1.0	0.71675	1.000000	0.68239	0.998	0.85369	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Cardiofaciocutaneous_syndrome_2	no_assertion_criteria_provided	NC_000012.12:g.25227313A>G	ClinGen:CA279983|OMIM:190070.0021|UniProtKB:P01116#VAR_069784	C3809005	615278	1340	Small GTP-binding domain	Tyr	His	40605	single nucleotide variant	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	3845	KRAS	HGNC:6407	Pathogenic	1	Jan 15, 2013	387907205	-	RCV000024617	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Cardiofaciocutaneous syndrome 2	germline	germline	GRCh38	NC_000012.12	12	25227313	25227313	12p12.1	no assertion criteria provided	1	-	N	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	1	31940	25227313	A	G	-	-	-	-	-	-	SCV000050483	-	-	211T>C 	Tyr71His	NM_033360.4		1_Pathogenic																																																																																																									
KRAS	KRAS_Tyr71His	-4.892479479558333	0.001768232186353	6.312032320641843	0.0003995147857415345																											true	KRAS		3084		CCSBVarC006099		NC_000012.12:25227313:A:G		Tyr71His																												KRAS_Tyr71His	12	25227313	A	G	12	allele	211T>C	B08	527_CAVA_Array_P03	D15	B13A7A8P1_R1	B14A7A8P1_R2				12-25227313-A-G	31940	12	25227313	A	G	Y	H	rs387907205	12	25380247	12	25271514	71	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.211T>C	p.Tyr71His	c.211T>C	p.Tyr71His	alternative1	Y	1	.	Plus_Clinical	-	TAC	1	0	A	A/A	A/A	A/A	A/A	0.025	0.48345	D	0.061	0.45880	T	0.919	0.50939	P	0.913	0.64880	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.48	0.71880	M	-4.45	0.77749	D	0.968	0.97870	0.6011	0.91886	D	0.7268	0.90619	D	10	0.88397557	0.87583	D	0.096778	0.76586	D	0.895	0.97016	0.693	0.82954	P01116	Y71H	Gain of catalytic residue at T74 (P = 0.0026)| Gain of disorder (P = 0.029)| Loss of phosphorylation at Y71 (P = 0.0387)| Loss of stability (P = 0.1315)| Loss of helix (P = 0.1706)	0.967032760806	0.96637	0.9119234105740558	0.91111	3.04366087562	0.99279	0.940733075142	0.99483	D	0.901474	0.98050	D	0.41344	0.90604	D	0.356102	0.90487	D	0.988144636154175	0.78358	D	0.884911	0.60851	D	0.93090373	0.94241	0.9041667	0.95206	0.927135	0.93859	0.8970921	0.94698	-12.052	0.85144	D	0.9986	0.98903	P	0.999975559545648	0.99427	0.99871314	0.98921	0.987	0.99559	.	.	.	.	.	.	5.005977	0.83126	28.0	0.99860396733546142	0.93915	0.873516	0.79516	D	0.756487767865435	0.83238	7.988538	0.776357426611185	0.88040	9.459321	5.77	5.77	0.91065	3.95	0.75212	9.309	0.95324	11.259000	0.91022	0.731	0.85655	1.0	0.71675	1.000000	0.68239	0.998	0.85369	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Cardiofaciocutaneous_syndrome_2	no_assertion_criteria_provided	NC_000012.12:g.25227313A>G	ClinGen:CA279983|OMIM:190070.0021|UniProtKB:P01116#VAR_069784	C3809005	615278	1340	Small GTP-binding domain	Tyr	His	40605	single nucleotide variant	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	3845	KRAS	HGNC:6407	Pathogenic	1	Jan 15, 2013	387907205	-	RCV000024617	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Cardiofaciocutaneous syndrome 2	germline	germline	GRCh38	NC_000012.12	12	25227313	25227313	12p12.1	no assertion criteria provided	1	-	N	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	1	31940	25227313	A	G	-	-	-	-	-	-	SCV000050483	-	-	211T>C 	Tyr71His	NM_033360.4		1_Pathogenic																																																																																																									
F9	F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	973818	X	139548372	G	C	C	S	rs1927764839	X	138630531	X	138458197	134	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.96610	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.98390809585124928	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	962086	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jun 01, 2019	1927764839	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372	139548372	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414438797	2	973818	139548372	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic						131369	F9_Popp_2025_carboxy_F9_specific_var223487	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548372.0	139548372.0		401			134.0	C	S	c.401G>C	p.Cys134Ser	missense_variant	0.287122221128485			No		Pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.936																																																											F9_Cys134Ser	Cys134Ser	true
F9	F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	973818	X	139548372	G	C	C	S	rs1927764839	X	138630531	X	138458197	134	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.96610	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.98390809585124928	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	962086	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jun 01, 2019	1927764839	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372	139548372	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414438797	2	973818	139548372	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic						158885	F9_Popp_2025_carboxy_gla_motif_var252530	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548372.0	139548372.0		401			134.0	C	S	c.401G>C	p.Cys134Ser	missense_variant	0.082006696			No		Pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.936																																																											F9_Cys134Ser	Cys134Ser	true
F9	F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	973818	X	139548372	G	C	C	S	rs1927764839	X	138630531	X	138458197	134	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.96610	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.98390809585124928	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	962086	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jun 01, 2019	1927764839	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372	139548372	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414438797	2	973818	139548372	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic						186401	F9_Popp_2025_heavy_chain_var233168	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548372.0	139548372.0		401			134.0	C	S	c.401G>C	p.Cys134Ser	missense_variant	0.3701647117442558			No		Pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.936																																																											F9_Cys134Ser	Cys134Ser	true
F9	F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	973818	X	139548372	G	C	C	S	rs1927764839	X	138630531	X	138458197	134	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.96610	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.98390809585124928	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	962086	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jun 01, 2019	1927764839	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372	139548372	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414438797	2	973818	139548372	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic						241433	F9_Popp_2025_strep_2_var262211	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548372.0	139548372.0		401			134.0	C	S	c.401G>C	p.Cys134Ser	missense_variant	0.4047348077825853			No		Pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.936																																																											F9_Cys134Ser	Cys134Ser	true
F9	F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	973818	X	139548372	G	C	C	S	rs1927764839	X	138630531	X	138458197	134	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.96610	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.98390809585124928	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	962086	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jun 01, 2019	1927764839	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372	139548372	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA414438797	2	973818	139548372	G	C	-	-	-	-	-	-	SCV001424902	-	-	401G>C 	Cys134Ser	NM_000133.4		1_Pathogenic						213917	F9_Popp_2025_light_chain_var242849	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548372.0	139548372.0		401			134.0	C	S	c.401G>C	p.Cys134Ser	missense_variant	0.3291742709468179			No		Pathogenic	no assertion criteria provided	Jun 01, 2019	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.936																																																											F9_Cys134Ser	Cys134Ser	true
CTCF	CTCF_Pro643Ser	-1.7124595339057247	0.13054179486316442	1.7682708607040438	0.1203399615971312	2025_01_Batch_13-14	0.5445619721105004	0.6598887700312495	0.600793935814599	0.6456517057217984	0.47991567103928157	0.6683800679644131	0.7041990439999969	0.5319774876104315	0.5987681854550634	0.6621843567519261	0.6064710200374568	0.6820439070156232	0.5663857117125153	0.6222099455884309	0.5710500138956038	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010816		NC_000016.10:67636779:C:T		Pro643Ser																												CTCF_Pro643Ser	16	67636779	C	T	16	allele	1927C>T	E02	527_CAVA_Array_P02	I04	B13A7A8P1_R1	B14A7A8P1_R2				16-67636779-C-T	210800	16	67636779	C	T	P	S	rs145727304	16	67670682	16	66228183	643	CTCF	ENSG00000102974	ENST00000646076	ENSP00000494538	P49711	CTCF_HUMAN	c.1927C>T	p.Pro643Ser	c.1927C>T	p.Pro643Ser	principal4	Y	.	.	.	+	CCA	1	0	C	C/C	C/C	C/C	C/C	.	0.36067	.	.	0.43323	.	0.993	0.65587	D	0.968	0.71743	D	.	0.81345	.	.	.	.	1.75	0.45271	L	.	0.13539	.	.	0.50538	-1.1289	0.01844	T	0.0334	0.14266	T	10	0.008668512	0.00193	T	0.022134	0.44775	T	.	0.47884	.	.	.	.	.	.	0.36087	0.4567110836694177	0.45390	.	0.88493	0.604438900948	0.53464	T	0.358122	0.72301	T	-0.428226	0.01423	T	-0.387077	0.34534	T	0.0343362705906861	0.02675	T	.	0.58028	.	0.048771452	0.08473	0.12885952	0.30913	0.057762917	0.11430	0.12383783	0.29781	-5.595	0.42817	T	.	0.19907	.	0.950983739944161	0.80561	0.51967055	0.82312	0.169	0.41634	.	.	.	.	.	.	4.725224	0.76095	26.4	0.99909288397707574	0.97950	0.770006	0.70400	D	0.635361922304199	0.75292	6.303452	0.69695071304512	0.82049	7.695614	6.03	6.03	0.97795	.	.	6.114	0.71317	7.668000	0.64675	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	50	0.97656	1	1.9968051118210862E-4	0	0.0	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	780	264690	0.0029468434	.	221	106748	2.070300e-03	2	481	202560	2.374610e-03	1	511	231178	2.210420e-03	2	4	7038	5.683430e-04	0	9	16122	5.582430e-04	0	0	2306	0.000000e+00	0	0	8772	0.000000e+00	0	0	13394	0.000000e+00	0	205	42284	4.848170e-03	2	0	15048	0.000000e+00	0	205	42284	4.848170e-03	2	14	15880	8.816120e-04	0	21	28602	7.342140e-04	0	0	6170	0.000000e+00	0	0	12828	0.000000e+00	0	3	16706	1.795760e-04	0	434	88384	4.910390e-03	1	0	29358	0.000000e+00	0	434	88384	4.910390e-03	1	11	14564	7.552870e-04	0	21	32292	6.503160e-04	0	0	9506	0.000000e+00	0	0	17100	0.000000e+00	0	7	21596	3.241340e-04	0	457	101466	4.503970e-03	2	0	29276	0.000000e+00	0	457	101466	4.503970e-03	2	.	7521	1605712	4.683900e-03	22	7107	1176036	6.043180e-03	20	71	74680	9.507230e-04	0	0	912	0.000000e+00	0	54	58944	9.161240e-04	0	2	29508	6.777820e-05	0	0	44268	0.000000e+00	0	26	63952	4.065550e-04	0	0	6046	0.000000e+00	0	7107	1176036	6.043180e-03	20	4	89172	4.485710e-05	0	992	194484	0.005100676662347545	0	360	0	0	4546	0	11	9432	0.001166242578456319	0	796	0	2	968	0.002066115702479339	0	1848	0	0	280	0	70	17414	0.004019754220741932	11	9792	0.0011233660130718953	0	6394	0	1075	230128	0.004671313356045331	Benign/Likely_benign	not_specified|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder|not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67636779C>T	ClinGen:CA207677	CN169374|C3809686|C3661900|C0950123	615502	363611	.	Pro	Ser	208297	single nucleotide variant	NM_006565.4(CTCF):c.1927C>T (p.Pro643Ser)	10664	CTCF	HGNC:13723	Benign/Likely benign	0	Nov 01, 2024	145727304	-	RCV000193895|RCV000427860|RCV000989613|RCV002314799|RCV004530110	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MeSH:D030342,MedGen:C0950123|	not specified|not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|Inborn genetic diseases|CTCF-related disorder	germline;unknown	germline	GRCh38	NC_000016.10	16	67636779	67636779	16q22.1	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA207677	2	210800	67636779	C	T	-	-	-	-	-	-	SCV000247133|SCV000511014|SCV000706245|SCV000847384|SCV001096543|SCV001140120|SCV001855650|SCV002497922|SCV005218571	-	-	1927C>T 	Pro643Ser	NM_006565.4	2	2_Benign																																																																																																									
F9	F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	1596936	X	139551220	G	A	V	I	rs137852242	X	138633379	X	138461045	227	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.000000	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	1602531	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158	F9	HGNC:3551	Benign	0	Nov 02, 2020	137852242	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220	139551220	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529819	2	1596936	139551220	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1	2_Benign						191910	F9_Popp_2025_heavy_chain_var235115	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551220.0	139551220.0		679			227.0	V	I	c.679G>A	p.Val227Ile	missense_variant	1.029189915641788			No	0.0000123826537182	Benign	criteria provided, single submitter	Nov 02, 2020	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.26																																																											F9_Val227Ile	Val227Ile	true
F9	F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	1596936	X	139551220	G	A	V	I	rs137852242	X	138633379	X	138461045	227	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.000000	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	1602531	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158	F9	HGNC:3551	Benign	0	Nov 02, 2020	137852242	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220	139551220	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529819	2	1596936	139551220	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1	2_Benign						219426	F9_Popp_2025_light_chain_var244796	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551220.0	139551220.0		679			227.0	V	I	c.679G>A	p.Val227Ile	missense_variant	1.037087801312708			No	0.0000123826537182	Benign	criteria provided, single submitter	Nov 02, 2020	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.26																																																											F9_Val227Ile	Val227Ile	true
F9	F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	1596936	X	139551220	G	A	V	I	rs137852242	X	138633379	X	138461045	227	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.000000	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	1602531	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158	F9	HGNC:3551	Benign	0	Nov 02, 2020	137852242	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220	139551220	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529819	2	1596936	139551220	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1	2_Benign						246942	F9_Popp_2025_strep_2_var264158	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551220.0	139551220.0		679			227.0	V	I	c.679G>A	p.Val227Ile	missense_variant	1.0140900236697072			No	0.0000123826537182	Benign	criteria provided, single submitter	Nov 02, 2020	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.26																																																											F9_Val227Ile	Val227Ile	true
F9	F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	1596936	X	139551220	G	A	V	I	rs137852242	X	138633379	X	138461045	227	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.000000	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	1602531	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158	F9	HGNC:3551	Benign	0	Nov 02, 2020	137852242	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220	139551220	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529819	2	1596936	139551220	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1	2_Benign						136878	F9_Popp_2025_carboxy_F9_specific_var225434	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551220.0	139551220.0		679			227.0	V	I	c.679G>A	p.Val227Ile	missense_variant	1.024657254936364			No	0.0000123826537182	Benign	criteria provided, single submitter	Nov 02, 2020	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.26																																																											F9_Val227Ile	Val227Ile	true
F9	F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	1596936	X	139551220	G	A	V	I	rs137852242	X	138633379	X	138461045	227	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.000000	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	1602531	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158	F9	HGNC:3551	Benign	0	Nov 02, 2020	137852242	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220	139551220	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529819	2	1596936	139551220	G	A	-	-	-	-	-	-	SCV002408526	-	-	679G>A 	Val227Ile	NM_000133.4	1	2_Benign						164394	F9_Popp_2025_carboxy_gla_motif_var254477	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551220.0	139551220.0		679			227.0	V	I	c.679G>A	p.Val227Ile	missense_variant	1.0573560919262863			No	0.0000123826537182	Benign	criteria provided, single submitter	Nov 02, 2020	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.26																																																											F9_Val227Ile	Val227Ile	true
F9	F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											true	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	811518	X	139551074	G	T	C	F	rs1603265779	X	138633233	X	138460899	178	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.533G>T	p.Cys178Phe	c.533G>T	p.Cys178Phe	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.175	0.60790	M	-8.86	0.97951	D	0.831	0.87788	1.0280	0.97673	D	0.9025	0.96759	D	10	0.98915994	0.99362	D	0.411263	0.93590	D	0.934	0.98488	0.96	0.99581	P00740	C178F	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.998265984387	0.99822	0.9987586514114085	0.99874	2.03962625952	0.94194	0.488848567009	0.37228	T	0.902337	0.98074	D	0.596124	0.97612	D	0.618514	0.97575	D	0.960028551474682	0.65474	D	0.89971	0.64775	D	0.9723726	0.98452	0.9668715	0.99311	0.97047687	0.98276	0.9649957	0.99219	-15.016	0.96719	D	0.9469	0.86554	P	0.999894557545851	0.98645	0.99999130	0.99996	0.971	0.98885	.	.	.	.	.	.	4.97306	0.82349	27.8	0.98977113623540003	0.49751	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	4.7	0.86749	5.955	0.70098	11.785000	0.96219	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139551074G>T	.	CN169374	.	.	.	Cys	Phe	800233	single nucleotide variant	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	2158	F9	HGNC:3551	Pathogenic	1	May 26, 2019	1603265779	-	RCV001001433	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139551074	139551074	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414440306	2	811518	139551074	G	T	-	-	-	-	-	-	SCV001158669	-	-	533G>T 	Cys178Phe	NM_000133.4	1	1_Pathogenic						134008	F9_Popp_2025_carboxy_F9_specific_var224408	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551074.0	139551074.0		533			178.0	C	F	c.533G>T	p.Cys178Phe	missense_variant	0.027478519932592			No		Pathogenic	criteria provided, single submitter	May 26, 2019	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.934																																																											F9_Cys178Phe	Cys178Phe	true
F9	F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											true	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	811518	X	139551074	G	T	C	F	rs1603265779	X	138633233	X	138460899	178	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.533G>T	p.Cys178Phe	c.533G>T	p.Cys178Phe	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.175	0.60790	M	-8.86	0.97951	D	0.831	0.87788	1.0280	0.97673	D	0.9025	0.96759	D	10	0.98915994	0.99362	D	0.411263	0.93590	D	0.934	0.98488	0.96	0.99581	P00740	C178F	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.998265984387	0.99822	0.9987586514114085	0.99874	2.03962625952	0.94194	0.488848567009	0.37228	T	0.902337	0.98074	D	0.596124	0.97612	D	0.618514	0.97575	D	0.960028551474682	0.65474	D	0.89971	0.64775	D	0.9723726	0.98452	0.9668715	0.99311	0.97047687	0.98276	0.9649957	0.99219	-15.016	0.96719	D	0.9469	0.86554	P	0.999894557545851	0.98645	0.99999130	0.99996	0.971	0.98885	.	.	.	.	.	.	4.97306	0.82349	27.8	0.98977113623540003	0.49751	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	4.7	0.86749	5.955	0.70098	11.785000	0.96219	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139551074G>T	.	CN169374	.	.	.	Cys	Phe	800233	single nucleotide variant	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	2158	F9	HGNC:3551	Pathogenic	1	May 26, 2019	1603265779	-	RCV001001433	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139551074	139551074	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414440306	2	811518	139551074	G	T	-	-	-	-	-	-	SCV001158669	-	-	533G>T 	Cys178Phe	NM_000133.4	1	1_Pathogenic						189040	F9_Popp_2025_heavy_chain_var234089	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551074.0	139551074.0		533			178.0	C	F	c.533G>T	p.Cys178Phe	missense_variant	0.0137137661184121			No		Pathogenic	criteria provided, single submitter	May 26, 2019	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.934																																																											F9_Cys178Phe	Cys178Phe	true
F9	F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											true	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	811518	X	139551074	G	T	C	F	rs1603265779	X	138633233	X	138460899	178	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.533G>T	p.Cys178Phe	c.533G>T	p.Cys178Phe	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.175	0.60790	M	-8.86	0.97951	D	0.831	0.87788	1.0280	0.97673	D	0.9025	0.96759	D	10	0.98915994	0.99362	D	0.411263	0.93590	D	0.934	0.98488	0.96	0.99581	P00740	C178F	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.998265984387	0.99822	0.9987586514114085	0.99874	2.03962625952	0.94194	0.488848567009	0.37228	T	0.902337	0.98074	D	0.596124	0.97612	D	0.618514	0.97575	D	0.960028551474682	0.65474	D	0.89971	0.64775	D	0.9723726	0.98452	0.9668715	0.99311	0.97047687	0.98276	0.9649957	0.99219	-15.016	0.96719	D	0.9469	0.86554	P	0.999894557545851	0.98645	0.99999130	0.99996	0.971	0.98885	.	.	.	.	.	.	4.97306	0.82349	27.8	0.98977113623540003	0.49751	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	4.7	0.86749	5.955	0.70098	11.785000	0.96219	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139551074G>T	.	CN169374	.	.	.	Cys	Phe	800233	single nucleotide variant	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	2158	F9	HGNC:3551	Pathogenic	1	May 26, 2019	1603265779	-	RCV001001433	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139551074	139551074	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414440306	2	811518	139551074	G	T	-	-	-	-	-	-	SCV001158669	-	-	533G>T 	Cys178Phe	NM_000133.4	1	1_Pathogenic						161524	F9_Popp_2025_carboxy_gla_motif_var253451	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551074.0	139551074.0		533			178.0	C	F	c.533G>T	p.Cys178Phe	missense_variant	0.0129147483513136			No		Pathogenic	criteria provided, single submitter	May 26, 2019	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.934																																																											F9_Cys178Phe	Cys178Phe	true
F9	F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											true	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	811518	X	139551074	G	T	C	F	rs1603265779	X	138633233	X	138460899	178	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.533G>T	p.Cys178Phe	c.533G>T	p.Cys178Phe	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.175	0.60790	M	-8.86	0.97951	D	0.831	0.87788	1.0280	0.97673	D	0.9025	0.96759	D	10	0.98915994	0.99362	D	0.411263	0.93590	D	0.934	0.98488	0.96	0.99581	P00740	C178F	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.998265984387	0.99822	0.9987586514114085	0.99874	2.03962625952	0.94194	0.488848567009	0.37228	T	0.902337	0.98074	D	0.596124	0.97612	D	0.618514	0.97575	D	0.960028551474682	0.65474	D	0.89971	0.64775	D	0.9723726	0.98452	0.9668715	0.99311	0.97047687	0.98276	0.9649957	0.99219	-15.016	0.96719	D	0.9469	0.86554	P	0.999894557545851	0.98645	0.99999130	0.99996	0.971	0.98885	.	.	.	.	.	.	4.97306	0.82349	27.8	0.98977113623540003	0.49751	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	4.7	0.86749	5.955	0.70098	11.785000	0.96219	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139551074G>T	.	CN169374	.	.	.	Cys	Phe	800233	single nucleotide variant	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	2158	F9	HGNC:3551	Pathogenic	1	May 26, 2019	1603265779	-	RCV001001433	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139551074	139551074	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414440306	2	811518	139551074	G	T	-	-	-	-	-	-	SCV001158669	-	-	533G>T 	Cys178Phe	NM_000133.4	1	1_Pathogenic						244072	F9_Popp_2025_strep_2_var263132	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551074.0	139551074.0		533			178.0	C	F	c.533G>T	p.Cys178Phe	missense_variant	0.030263747			No		Pathogenic	criteria provided, single submitter	May 26, 2019	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.934																																																											F9_Cys178Phe	Cys178Phe	true
F9	F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											true	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	811518	X	139551074	G	T	C	F	rs1603265779	X	138633233	X	138460899	178	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.533G>T	p.Cys178Phe	c.533G>T	p.Cys178Phe	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.175	0.60790	M	-8.86	0.97951	D	0.831	0.87788	1.0280	0.97673	D	0.9025	0.96759	D	10	0.98915994	0.99362	D	0.411263	0.93590	D	0.934	0.98488	0.96	0.99581	P00740	C178F	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.998265984387	0.99822	0.9987586514114085	0.99874	2.03962625952	0.94194	0.488848567009	0.37228	T	0.902337	0.98074	D	0.596124	0.97612	D	0.618514	0.97575	D	0.960028551474682	0.65474	D	0.89971	0.64775	D	0.9723726	0.98452	0.9668715	0.99311	0.97047687	0.98276	0.9649957	0.99219	-15.016	0.96719	D	0.9469	0.86554	P	0.999894557545851	0.98645	0.99999130	0.99996	0.971	0.98885	.	.	.	.	.	.	4.97306	0.82349	27.8	0.98977113623540003	0.49751	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	4.7	0.86749	5.955	0.70098	11.785000	0.96219	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139551074G>T	.	CN169374	.	.	.	Cys	Phe	800233	single nucleotide variant	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	2158	F9	HGNC:3551	Pathogenic	1	May 26, 2019	1603265779	-	RCV001001433	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139551074	139551074	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414440306	2	811518	139551074	G	T	-	-	-	-	-	-	SCV001158669	-	-	533G>T 	Cys178Phe	NM_000133.4	1	1_Pathogenic						216556	F9_Popp_2025_light_chain_var243770	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551074.0	139551074.0		533			178.0	C	F	c.533G>T	p.Cys178Phe	missense_variant	0.013786189047073			No		Pathogenic	criteria provided, single submitter	May 26, 2019	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.934																																																											F9_Cys178Phe	Cys178Phe	true
G6PD	G6PD_Gly378Ser	0.44980261220938383	0.6664511291342612	-4.885624293312452	0.001782128546597905	2025_01_Batch_13-14	0.40905820693214356	0.5162071505102306	0.6487625345346948	0.5846796562437677	0.4342564757227669	0.5350994019317835	0.604818612219922	0.7438736509912314	0.6463048748584876	0.5446064429274138	0.47207880443196354	0.5605128813650763	0.6963180927629631	0.6154922655511277	0.48943145932509036	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	G6PD		4006		CCSBVarC021515		NC_000023.11:154532722:C:T		Gly378Ser																												G6PD_Gly378Ser	23	154532722	C	T	X	allele	1132G>A	G04	527_CAVA_Array_P03	N07	B13A7A8P1_R1	B14A7A8P1_R2				X-154532722-C-T	1722614	X	154532722	C	T	G	S	rs371489738	X	153760937	X	153414131	378	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1132G>A	p.Gly378Ser	principal4	Y	.	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	.	0.20791	.	.	0.31345	.	1.0	0.90580	D	0.983	0.75798	D	.	0.95575	.	.	.	.	1.855	0.48991	L	.	0.80118	.	.	0.69502	1.0912	0.99286	D	0.9601	0.98711	D	10	.	0.90197	.	0.683657	0.97378	D	.	0.92639	.	.	.	.	.	.	0.98330	.	.	.	0.94444	0.661729335785	0.61595	T	0.964038	0.99554	D	0.491478	0.93997	D	0.520035	0.94954	D	0.929728746414185	0.59158	D	0.913609	0.69172	D	0.86035365	0.87950	0.81130373	0.88841	0.857077	0.87700	0.76723653	0.86083	-8.453	0.67258	D	.	0.57080	.	0.987461282210342	0.87449	0.99859923	0.98864	0.905	0.95023	.	.	.	.	.	.	3.113311	0.42085	21.5	0.99607459962891864	0.74605	.	.	.	.	.	.	.	.	.	5.82	5.82	0.92730	4.13	0.78719	7.406	0.79294	3.963000	0.40843	0.585	0.3052	1.0	0.71675	0.999000	0.35501	0.232	0.22834	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	79875	0.000000e+00	0	2	150869	1.325650e-05	0	1	171104	5.844400e-06	0	0	5668	0.000000e+00	0	0	13617	0.000000e+00	0	0	1760	0.000000e+00	0	0	6853	0.000000e+00	0	0	9912	0.000000e+00	0	0	30728	0.000000e+00	0	0	9893	0.000000e+00	0	.	.	.	.	0	13060	0.000000e+00	0	0	24309	0.000000e+00	0	0	4622	0.000000e+00	0	0	10047	0.000000e+00	0	0	12156	0.000000e+00	0	2	64114	3.119440e-05	0	0	18959	0.000000e+00	0	2	64114	3.119440e-05	0	0	12003	0.000000e+00	0	0	27090	0.000000e+00	0	0	7058	0.000000e+00	0	0	13231	0.000000e+00	0	0	15912	0.000000e+00	0	1	72783	1.373950e-05	0	0	18893	0.000000e+00	0	1	72783	1.373950e-05	0	.	12	1210896	9.910020e-06	0	1	46682	2.142150e-05	0	0	57586	0.000000e+00	0	0	683	0.000000e+00	0	0	45931	0.000000e+00	0	0	22045	0.000000e+00	0	0	33786	0.000000e+00	0	1	46682	2.142150e-05	0	0	4374	0.000000e+00	0	11	895342	1.228580e-05	0	0	56870	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_conflicting_classifications	NC_000023.11:g.154532722C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Gly	Ser	1780130	single nucleotide variant	NM_001360016.2(G6PD):c.1132G>A (p.Gly378Ser)	2539	G6PD	HGNC:4057	Conflicting classifications of pathogenicity	1	Jan 16, 2025	-1	-	RCV002305724|RCV004700721	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MedGen:C3661900	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154532722	154532722	Xq28	criteria provided, conflicting classifications	3	-	N	ClinGen:CA10566075	2	1722614	154532722	C	T	-	-	-	-	-	-	SCV002599268|SCV004299708|SCV005201601	-	-	1132G>A 	Gly378Ser	NM_001360016.2	1	3_Conflicting																																																																																																									
RET	RET_Thr278Asn	-0.6907675516055969	0.5119595315860082	6.503086124471587	0.00033316518625512326	2025_01_Batch_13-14	0.8320212540974146	0.8256731724420541	0.8831043347292347	0.8885259291901384	0.7689220201987548	0.5357371563328672	0.6689644492275445	0.8046262801654496	0.701802033042142	0.5392557432710541	0.6838792052151409	0.7473188108347992	0.8438653074473421	0.7951639811161402	0.6540888817349044	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202952	CCSBVarC006877	ALE00006875	NC_000010.11:43105159:C:A	833C>A	Thr278Asn	CEGS2	CegsMutGDEh1029	D06	GDEhDisVCh_40066	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Thr278Asn	10	43105159	C	A	10											10-43105159-C-A	41846	10	43105159	C	A	T	N	rs35118262	10	43600607	10	42920613	278	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.833C>A	p.Thr278Asn	c.833C>A	p.Thr278Asn	principal4	Y	5	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.035	0.43867	D	0.194	0.28427	T	0.001	0.12194	B	0.004	0.16860	B	0.05	0.16373	N	simple_aae	95.0	5.0	2.595	0.75684	M	-1.04	0.27215	N	0.317	0.79815	-0.5698	0.65873	T	0.2726	0.64282	T	10	0.0058131814	0.00127	T	.	.	.	0.180	0.44851	.	.	.	.	.	0.764498015703	0.76048	0.8788456336718098	0.87776	0.869349038865	0.69149	0.447220146656	0.31525	T	0.476434	0.80560	T	-0.352383	0.04410	T	-0.258001	0.48694	T	0.0540457288643749	0.06132	T	0.865113	0.56224	D	0.48162338	0.65687	0.3053008	0.56338	0.48379323	0.65819	0.30986196	0.56777	-2.309	0.07193	T	0.1721	0.44951	B	0.723577208028241	0.67844	0.99777067	0.98500	0.561	0.75276	.	.	.	.	.	.	3.2057	0.43694	21.8	0.97103921571150231	0.32564	0.489384	0.52567	N	-0.160029608786539	0.34534	1.991452	-0.0125543226448844	0.38851	2.316717	4.73	3.82	0.43085	1.81	0.37505	3.421	0.52594	3.421000	0.38332	0.597	0.3436	0.996	0.3946	0.998000	0.34068	0.997	0.79771	862	0.33096	20	0.003993610223642172	0	0.0	0	0.0	0	0.0	19	0.018849206349206348	1	0.0010224948875255625	328	264690	0.0012391855	.	268	108738	2.464640e-03	5	382	203268	1.879290e-03	6	541	233088	2.321010e-03	7	0	7086	0.000000e+00	0	0	17050	0.000000e+00	0	0	2308	0.000000e+00	0	255	8972	2.842180e-02	5	0	13120	0.000000e+00	0	2	42634	4.691090e-05	0	10	15664	6.384070e-04	0	255	8972	2.842180e-02	5	0	15770	0.000000e+00	0	1	30418	3.287530e-05	0	0	6120	0.000000e+00	0	353	13264	2.661340e-02	6	0	16456	0.000000e+00	0	7	85866	8.152240e-05	0	18	30570	5.888130e-04	0	353	13264	2.661340e-02	6	0	14546	0.000000e+00	0	2	34182	5.851030e-05	0	0	9522	0.000000e+00	0	509	17618	2.889090e-02	7	0	21196	0.000000e+00	0	10	99950	1.000500e-04	0	18	30494	5.902800e-04	0	509	17618	2.889090e-02	7	.	1119	1612876	6.937920e-04	14	938	44842	2.091790e-02	13	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	4	60014	6.665110e-05	0	0	29582	0.000000e+00	0	938	44842	2.091790e-02	13	0	62980	0.000000e+00	0	1	6044	1.654530e-04	0	35	1179890	2.966380e-05	0	75	91072	8.235240e-04	1	7	170470	4.1062943626444535E-5	0	176	0	104	4426	0.02349751468594668	0	4788	0	0	794	0	0	968	0	31	1788	0.017337807606263984	0	280	0	48	15660	0.0030651340996168583	0	4964	0	135	6214	0.021725136787898294	190	199350	9.530975670930524E-4	Conflicting_classifications_of_pathogenicity	Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia_type_2A|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105159C>A	ClinGen:CA009353|UniProtKB:P07949#VAR_041763	C0027662|C3661900|C0031511|C1619700|C4048306|C0027672|C3888239|C0025268|CN169374	PS131100|171300|191830|142623|171400	276161|29072|411709|653|140162|388|247698|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Asn	50285	single nucleotide variant	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	5979	RET	HGNC:9967	Benign/Likely benign	0	Mar 04, 2025	35118262	-	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104178|RCV001104180|RCV001104179|RCV001083124	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	germline;unknown	germline	GRCh38	NC_000010.11	10	43105159	43105159	10q11.21	criteria provided, multiple submitters, no conflicts	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	2	41846	43105159	C	A	-	-	-	-	-	-	SCV000213991|SCV000261217|SCV000267474|SCV000362270|SCV000540167|SCV000729739|SCV000807061|SCV001138021|SCV001261021|SCV001261022|SCV001261023|SCV002527928|SCV004127589|SCV004220048|SCV004243364|SCV004357223|SCV004564906	-	-	833C>A 	Thr278Asn	NM_020975.6	2	2_Benign	10	43105159	C	A	0.000677802																																																																																																				
RET	RET_Thr278Asn	-0.6907675516055969	0.5119595315860082	6.503086124471587	0.00033316518625512326	2025_01_Batch_13-14	0.8320212540974146	0.8256731724420541	0.8831043347292347	0.8885259291901384	0.7689220201987548	0.5357371563328672	0.6689644492275445	0.8046262801654496	0.701802033042142	0.5392557432710541	0.6838792052151409	0.7473188108347992	0.8438653074473421	0.7951639811161402	0.6540888817349044	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006877		NC_000010.11:43105159:C:A		Thr278Asn																												RET_Thr278Asn	10	43105159	C	A	10	allele	833C>A	G08	527_CAVA_Array_P05	M15	B13A7A8P2_R1	B14A7A8P2_R2				10-43105159-C-A	41846	10	43105159	C	A	T	N	rs35118262	10	43600607	10	42920613	278	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.833C>A	p.Thr278Asn	c.833C>A	p.Thr278Asn	principal4	Y	5	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.035	0.43867	D	0.194	0.28427	T	0.001	0.12194	B	0.004	0.16860	B	0.05	0.16373	N	simple_aae	95.0	5.0	2.595	0.75684	M	-1.04	0.27215	N	0.317	0.79815	-0.5698	0.65873	T	0.2726	0.64282	T	10	0.0058131814	0.00127	T	.	.	.	0.180	0.44851	.	.	.	.	.	0.764498015703	0.76048	0.8788456336718098	0.87776	0.869349038865	0.69149	0.447220146656	0.31525	T	0.476434	0.80560	T	-0.352383	0.04410	T	-0.258001	0.48694	T	0.0540457288643749	0.06132	T	0.865113	0.56224	D	0.48162338	0.65687	0.3053008	0.56338	0.48379323	0.65819	0.30986196	0.56777	-2.309	0.07193	T	0.1721	0.44951	B	0.723577208028241	0.67844	0.99777067	0.98500	0.561	0.75276	.	.	.	.	.	.	3.2057	0.43694	21.8	0.97103921571150231	0.32564	0.489384	0.52567	N	-0.160029608786539	0.34534	1.991452	-0.0125543226448844	0.38851	2.316717	4.73	3.82	0.43085	1.81	0.37505	3.421	0.52594	3.421000	0.38332	0.597	0.3436	0.996	0.3946	0.998000	0.34068	0.997	0.79771	862	0.33096	20	0.003993610223642172	0	0.0	0	0.0	0	0.0	19	0.018849206349206348	1	0.0010224948875255625	328	264690	0.0012391855	.	268	108738	2.464640e-03	5	382	203268	1.879290e-03	6	541	233088	2.321010e-03	7	0	7086	0.000000e+00	0	0	17050	0.000000e+00	0	0	2308	0.000000e+00	0	255	8972	2.842180e-02	5	0	13120	0.000000e+00	0	2	42634	4.691090e-05	0	10	15664	6.384070e-04	0	255	8972	2.842180e-02	5	0	15770	0.000000e+00	0	1	30418	3.287530e-05	0	0	6120	0.000000e+00	0	353	13264	2.661340e-02	6	0	16456	0.000000e+00	0	7	85866	8.152240e-05	0	18	30570	5.888130e-04	0	353	13264	2.661340e-02	6	0	14546	0.000000e+00	0	2	34182	5.851030e-05	0	0	9522	0.000000e+00	0	509	17618	2.889090e-02	7	0	21196	0.000000e+00	0	10	99950	1.000500e-04	0	18	30494	5.902800e-04	0	509	17618	2.889090e-02	7	.	1119	1612876	6.937920e-04	14	938	44842	2.091790e-02	13	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	4	60014	6.665110e-05	0	0	29582	0.000000e+00	0	938	44842	2.091790e-02	13	0	62980	0.000000e+00	0	1	6044	1.654530e-04	0	35	1179890	2.966380e-05	0	75	91072	8.235240e-04	1	7	170470	4.1062943626444535E-5	0	176	0	104	4426	0.02349751468594668	0	4788	0	0	794	0	0	968	0	31	1788	0.017337807606263984	0	280	0	48	15660	0.0030651340996168583	0	4964	0	135	6214	0.021725136787898294	190	199350	9.530975670930524E-4	Conflicting_classifications_of_pathogenicity	Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia_type_2A|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105159C>A	ClinGen:CA009353|UniProtKB:P07949#VAR_041763	C0027662|C3661900|C0031511|C1619700|C4048306|C0027672|C3888239|C0025268|CN169374	PS131100|171300|191830|142623|171400	276161|29072|411709|653|140162|388|247698|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Asn	50285	single nucleotide variant	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	5979	RET	HGNC:9967	Benign/Likely benign	0	Mar 04, 2025	35118262	-	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104178|RCV001104180|RCV001104179|RCV001083124	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	germline;unknown	germline	GRCh38	NC_000010.11	10	43105159	43105159	10q11.21	criteria provided, multiple submitters, no conflicts	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	2	41846	43105159	C	A	-	-	-	-	-	-	SCV000213991|SCV000261217|SCV000267474|SCV000362270|SCV000540167|SCV000729739|SCV000807061|SCV001138021|SCV001261021|SCV001261022|SCV001261023|SCV002527928|SCV004127589|SCV004220048|SCV004243364|SCV004357223|SCV004564906	-	-	833C>A 	Thr278Asn	NM_020975.6	2	2_Benign	10	43105159	C	A	0.000677802																																																																																																				
ZC4H2	ZC4H2_Leu66His	-6.503081082564646	0.0003331667654269905	5.090199097323906	0.0014148589207405259	2025_01_Batch_13-14	0.8522655514090403	0.9633536275335962	0.9804984863300853	0.9752995486173831	0.9748941121269308	0.9542813202282818	0.9690505195896728	0.9833910565904622	0.9883638761388648	0.9641545542687115	0.903273435818661	0.9662020735616346	0.9819447714602738	0.9818317123781239	0.9695243331978212	0.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	true	ZC4H2		4320		CCSBVarC009188		NC_000023.11:64921845:A:T		Leu66His																												ZC4H2_Leu66His	23	64921845	A	T	X	allele	197T>A	A05	527_CAVA_Array_P06	A10	B13A7A8P2_R1	B14A7A8P2_R2				X-64921845-A-T	378042	X	64921845	A	T	L	H	rs1057520297	X	64141725	X	64058450	66	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.197T>A	p.Leu66His	c.197T>A	p.Leu66His	principal1	Y	1	YES	Select	-	CTC	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.94	0.94378	A	simple_aae	6.0	94.0	2.58	0.75182	M	-6.17	0.90790	D	0.966	0.97658	-0.4130	0.71488	T	0.3407	0.70541	T	9	0.91775376	0.91035	D	0.110217	0.78686	D	0.673	0.87862	0.827	0.93752	Q9NQZ6	L66H	Loss of stability (P = 0.0086)| Gain of disorder (P = 0.0553)| Loss of helix (P = 0.079)| Gain of catalytic residue at L68 (P = 0.0857)| Loss of MoRF binding (P = 0.5018)	0.958049427582	0.95723	0.9684491553990456	0.96815	2.23748090164	0.95976	0.934989273548	0.99245	D	0.857357	0.96779	D	0.55841	0.96027	D	0.564341	0.95964	D	0.997178673744202	0.90862	D	0.950605	0.87028	D	0.9276844	0.93915	0.8559096	0.91794	0.9275634	0.93903	0.858151	0.91947	-11.957	0.85475	D	1.0	0.99952	P	0.99974676713688	0.97751	0.99785450	0.98531	0.994	0.99793	.	.	.	.	.	.	4.36859	0.67299	25.1	0.98348546103222834	0.40650	.	.	.	.	.	.	.	.	.	5.7	4.54	0.55168	.	.	9.008	0.9315	11.114000	0.86409	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921845A>T	ClinGen:CA16609220|OMIM:300897.0005	C0796200	314580	3454|85283	.	Leu	His	380135	single nucleotide variant	NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)	55906	ZC4H2	HGNC:24931	Pathogenic	1	Mar 02, 2017	1057520297	-	RCV000425925	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921845	64921845	Xq11.2	no assertion criteria provided	1	-	N	ClinGen:CA16609220,OMIM:300897.0005	1	378042	64921845	A	T	-	-	-	-	-	-	SCV000513395	-	-	197T>A 	Leu66His	NM_018684.4		1_Pathogenic																																																																																																									
SHOC2	SHOC2_Thr321Ala	-3.868653257477352	0.006142367602687363	0.8489421917934488	0.4239913700374366	2025_01_Batch_13-14	0.9944865255095497	0.9769409488992881	0.9579636104033097	0.984332074949247	0.9610009395064388	0.9226336864782333	0.6990133106060262	0.7001475754549954	0.7779270847526419	0.7449061871908219	0.9585601059938915	0.8379771297526571	0.8290555929291525	0.8811295798509444	0.8529535633486304	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
BAP1	BAP1_Glu31Lys	0.06824504354142172	0.9474990528833314	-2.0298025778770206	0.08193664202063412	2025_01_Batch_13-14	0.5646853145735389	0.5190594261515206	0.4923047687112512	0.5492657033647534	0.5517911511141563	0.7117206420996531	0.6011434644920295	0.5648586555852341	0.6718865866645662	0.6450377460662851	0.638202978336596	0.560101445321775	0.5285817121482426	0.6105761450146598	0.5984144485902207	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009499		NC_000003.12:52409585:C:T		Glu31Lys																												BAP1_Glu31Lys	3	52409585	C	T	3	allele	91G>A	F02	527_CAVA_Array_P01	K03	B13A7A8P1_R1	B14A7A8P1_R2				3-52409585-C-T	1173078	3	52409585	C	T	E	K	rs2153228535	3	52443601	3	52418641	31	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.91G>A	p.Glu31Lys	c.91G>A	p.Glu31Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.045	0.96963	H	-3.77	0.72856	D	0.925	0.93495	0.4363	0.89592	D	0.5505	0.83470	D	10	0.9600752	0.95355	D	0.307408	0.91057	D	0.692	0.88771	0.866	0.96082	Q92560	E31K	Gain of glycosylation at Y33 (P = 0.0136)| Gain of ubiquitination at E31 (P = 0.0238)| Gain of methylation at E31 (P = 0.1374)| Loss of stability (P = 0.1598)| Loss of catalytic residue at E31 (P = 0.2264)	0.862246886347	0.85983	0.9484795993003543	0.94798	2.56847412068	0.97995	0.905887842178	0.97064	D	0.595912	0.86858	D	0.379185	0.88575	D	0.306897	0.88431	D	0.999779880046844	0.98923	D	0.989034	0.96357	D	0.95834297	0.97067	0.9142625	0.95935	0.95834297	0.97067	0.9142625	0.95936	-18.084	0.99558	D	0.9998	0.99584	P	0.986962859459876	0.87278	0.99976045	0.99689	0.896	0.94485	.	.	.	.	.	.	5.710604	0.93179	33.0	0.99932207852356958	0.99439	0.929216	0.91432	D	0.986620787527088	0.95291	13.50747	0.884071350561727	0.94811	13.08669	4.97	4.97	0.65374	2.7	0.49372	7.695	0.83532	7.645000	0.63450	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.999	0.91597	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Neurodevelopmental_disorder|not_provided|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_conflicting_classifications	NC_000003.12:g.52409585C>T	.	C1535926|C3661900|C3280492	614327	289539	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Glu	Lys	1162267	single nucleotide variant	NM_004656.4(BAP1):c.91G>A (p.Glu31Lys)	8314	BAP1	HGNC:950	Conflicting classifications of pathogenicity	1	Jan 21, 2024	2153228535	-	RCV001797184|RCV002305612|RCV002568139	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|not provided|BAP1-related tumor predisposition syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409585	52409585	3p21.1	criteria provided, conflicting classifications	3	-	N	ClinGen:CA353114656	2	1173078	52409585	C	T	-	-	-	-	-	-	SCV002599838|SCV003525331	-	-	91G>A 	Glu31Lys	NM_004656.4	1	3_Conflicting																																																																																																									
RAD51D	RAD51D_Glu233Gly	2.0151388056522266	0.08372864851161924	-22.26053493041938	9.334055407083976e-8	2025_01_Batch_13-14	0.6523177668682895	0.8737579764020821	0.9617439699350335	0.9066849961213046	0.7123528900241779	0.6967076010813679	0.8967476179637639	0.9669006250473935	0.9315224387652209	0.6991962903503816	0.6745126839748287	0.8852527971829229	0.9643222974912136	0.9191037174432628	0.7057745901872797	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D	ENSG00000185379	7201	12776	CCSBVarC001140	ALE00001140	NC_000017.11:35103294:T:C	698A>G	Glu233Gly	RC4	RC4_Mut_GDEh1002	C07	GDEhDisVCh_40046	H04	2	RC4_Mut_GDDh1002	C07	NULL	NULL	VUSMutpDEST2_06	F01	VUSmut_GDEh12	G05	1	2	1	1	0			1	1	1	1	1	1	RAD51D_Glu233Gly	17	35103294	T	C	17											17-35103294-T-C	138873	17	35103294	T	C	E	G	rs28363284	17	33430313	17	30454426	233	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.698A>G	p.Glu233Gly	c.698A>G	p.Glu233Gly	principal1	Y	5	.	.	-	GAG	2	0	T	T/T	T/T	T/T	T/T	.	0.36459	.	0.451	0.68204	T	0.973	0.90580	D	0.785	0.86259	P	0.01	0.13669	N	simple_aae	99.0	1.0	1.85	0.48914	L	.	0.66695	.	0.562	0.63954	-0.5609	0.66221	T	0.2448	0.61193	T	10	0.012577295	0.00266	T	.	.	.	0.189	0.46391	.	.	.	.	.	0.911308683432	0.90975	.	0.64516	.	0.41897	.	.	.	0.290868	0.66175	T	-0.22489	0.17038	T	-0.07823	0.64785	T	0.021744398197262	0.00877	T	0.918208	0.70530	D	0.46690348	0.64786	0.5062009	0.71202	0.46690348	0.64786	0.5062009	0.71203	-7.244	0.74324	T	0.4981	0.71170	A	0.0150280587944397	0.27128	0.89164200	0.90920	0.292	0.56112	.	.	.	.	.	.	4.817542	0.78468	26.9	0.97842595494901574	0.36495	0.450689	0.50327	N	0.408714271726761	0.61704	4.397588	0.40833569100615	0.61877	4.417963	4.92	4.92	0.64102	.	.	2.999	0.49258	7.756000	0.68269	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.998	0.85369	908	0.22602	22	0.00439297124600639	0	0.0	11	0.010934393638170975	9	0.012968299711815562	0	0.0	2	0.002044989775051125	2903	264690	0.010967547	.	877	106826	8.209610e-03	7	1989	203334	9.781940e-03	19	2153	232226	9.271140e-03	19	17	6852	2.481030e-03	0	139	16760	8.293560e-03	0	2	2226	8.984730e-04	0	0	8848	0.000000e+00	0	19	13238	1.435260e-03	0	642	41754	1.537580e-02	7	46	15266	3.013230e-03	0	642	41754	1.537580e-02	7	54	15672	3.445640e-03	0	220	29852	7.369690e-03	0	11	6048	1.818780e-03	0	0	13294	0.000000e+00	0	21	16462	1.275670e-03	0	1541	87382	1.763520e-02	18	94	29872	3.146760e-03	0	1541	87382	1.763520e-02	18	44	14468	3.041190e-03	0	242	33624	7.197240e-03	0	16	9428	1.697070e-03	0	0	17460	0.000000e+00	0	25	21078	1.186070e-03	0	1672	100816	1.658470e-02	18	94	29798	3.154570e-03	0	1672	100816	1.658470e-02	18	.	27113	1611638	1.682330e-02	297	24903	1179112	2.112010e-02	286	234	74922	3.123250e-03	0	10	912	1.096490e-02	0	477	59646	7.997180e-03	0	54	29510	1.829890e-03	0	1	44820	2.231150e-05	0	106	63816	1.661030e-03	0	43	6018	7.145230e-03	1	24903	1179112	2.112010e-02	286	335	90476	3.702640e-03	3	3387	201918	0.016774136035420318	0	358	0	0	4530	0	38	9444	0.004023718763235917	6	800	0.0075	12	974	0.012320328542094456	1	1850	5.405405405405405E-4	0	282	0	223	18644	0.011960952585282129	38	9802	0.0038767598449296063	1	6380	1.5673981191222572E-4	3667	238800	0.015355946398659967	Benign/Likely_benign	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35103294T>C	ClinGen:CA293923|UniProtKB:O75771#VAR_020564	C3661900|C0027672|CN169374|C0677776|C3280345|C0006142	614291	140162|145|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Glu	Gly	142576	single nucleotide variant	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	5892	RAD51D	HGNC:9823	Benign/Likely benign	0	Mar 04, 2025	28363284	-	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35103294	35103294	17q12	criteria provided, multiple submitters, no conflicts	20	-	N	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	2	138873	35103294	T	C	-	-	-	-	-	-	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	-	-	698A>G 	Glu233Gly	NM_002878.4	2	2_Benign	17	35103294	T	C	0.0174388	960095	RAD51D_unpublished_var154342	RAD51D_unpublished	RAD51D	9823.0	-1.0		35103294.0	35103294.0		698	A	G	233.0	E	G	c.698A>G	p.Glu233Gly	missense_variant	0.018394		functionally_normal	Yes	0.0168232568355921	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Feb 01, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.189																																																											RAD51D_Glu233Gly	Glu233Gly	true
RAD51D	RAD51D_Glu233Gly	2.0151388056522266	0.08372864851161924	-22.26053493041938	9.334055407083976e-8	2025_01_Batch_13-14	0.6523177668682895	0.8737579764020821	0.9617439699350335	0.9066849961213046	0.7123528900241779	0.6967076010813679	0.8967476179637639	0.9669006250473935	0.9315224387652209	0.6991962903503816	0.6745126839748287	0.8852527971829229	0.9643222974912136	0.9191037174432628	0.7057745901872797	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC001140		NC_000017.11:35103294:T:C		Glu233Gly																												RAD51D_Glu233Gly	17	35103294	T	C	17	allele	698A>G	A02	527_CAVA_Array_P05	A03	B13A7A8P2_R1	B14A7A8P2_R2				17-35103294-T-C	138873	17	35103294	T	C	E	G	rs28363284	17	33430313	17	30454426	233	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.698A>G	p.Glu233Gly	c.698A>G	p.Glu233Gly	principal1	Y	5	.	.	-	GAG	2	0	T	T/T	T/T	T/T	T/T	.	0.36459	.	0.451	0.68204	T	0.973	0.90580	D	0.785	0.86259	P	0.01	0.13669	N	simple_aae	99.0	1.0	1.85	0.48914	L	.	0.66695	.	0.562	0.63954	-0.5609	0.66221	T	0.2448	0.61193	T	10	0.012577295	0.00266	T	.	.	.	0.189	0.46391	.	.	.	.	.	0.911308683432	0.90975	.	0.64516	.	0.41897	.	.	.	0.290868	0.66175	T	-0.22489	0.17038	T	-0.07823	0.64785	T	0.021744398197262	0.00877	T	0.918208	0.70530	D	0.46690348	0.64786	0.5062009	0.71202	0.46690348	0.64786	0.5062009	0.71203	-7.244	0.74324	T	0.4981	0.71170	A	0.0150280587944397	0.27128	0.89164200	0.90920	0.292	0.56112	.	.	.	.	.	.	4.817542	0.78468	26.9	0.97842595494901574	0.36495	0.450689	0.50327	N	0.408714271726761	0.61704	4.397588	0.40833569100615	0.61877	4.417963	4.92	4.92	0.64102	.	.	2.999	0.49258	7.756000	0.68269	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.998	0.85369	908	0.22602	22	0.00439297124600639	0	0.0	11	0.010934393638170975	9	0.012968299711815562	0	0.0	2	0.002044989775051125	2903	264690	0.010967547	.	877	106826	8.209610e-03	7	1989	203334	9.781940e-03	19	2153	232226	9.271140e-03	19	17	6852	2.481030e-03	0	139	16760	8.293560e-03	0	2	2226	8.984730e-04	0	0	8848	0.000000e+00	0	19	13238	1.435260e-03	0	642	41754	1.537580e-02	7	46	15266	3.013230e-03	0	642	41754	1.537580e-02	7	54	15672	3.445640e-03	0	220	29852	7.369690e-03	0	11	6048	1.818780e-03	0	0	13294	0.000000e+00	0	21	16462	1.275670e-03	0	1541	87382	1.763520e-02	18	94	29872	3.146760e-03	0	1541	87382	1.763520e-02	18	44	14468	3.041190e-03	0	242	33624	7.197240e-03	0	16	9428	1.697070e-03	0	0	17460	0.000000e+00	0	25	21078	1.186070e-03	0	1672	100816	1.658470e-02	18	94	29798	3.154570e-03	0	1672	100816	1.658470e-02	18	.	27113	1611638	1.682330e-02	297	24903	1179112	2.112010e-02	286	234	74922	3.123250e-03	0	10	912	1.096490e-02	0	477	59646	7.997180e-03	0	54	29510	1.829890e-03	0	1	44820	2.231150e-05	0	106	63816	1.661030e-03	0	43	6018	7.145230e-03	1	24903	1179112	2.112010e-02	286	335	90476	3.702640e-03	3	3387	201918	0.016774136035420318	0	358	0	0	4530	0	38	9444	0.004023718763235917	6	800	0.0075	12	974	0.012320328542094456	1	1850	5.405405405405405E-4	0	282	0	223	18644	0.011960952585282129	38	9802	0.0038767598449296063	1	6380	1.5673981191222572E-4	3667	238800	0.015355946398659967	Benign/Likely_benign	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35103294T>C	ClinGen:CA293923|UniProtKB:O75771#VAR_020564	C3661900|C0027672|CN169374|C0677776|C3280345|C0006142	614291	140162|145|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Glu	Gly	142576	single nucleotide variant	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	5892	RAD51D	HGNC:9823	Benign/Likely benign	0	Mar 04, 2025	28363284	-	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35103294	35103294	17q12	criteria provided, multiple submitters, no conflicts	20	-	N	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	2	138873	35103294	T	C	-	-	-	-	-	-	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	-	-	698A>G 	Glu233Gly	NM_002878.4	2	2_Benign	17	35103294	T	C	0.0174388	960095	RAD51D_unpublished_var154342	RAD51D_unpublished	RAD51D	9823.0	-1.0		35103294.0	35103294.0		698	A	G	233.0	E	G	c.698A>G	p.Glu233Gly	missense_variant	0.018394		functionally_normal	Yes	0.0168232568355921	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Feb 01, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.189																																																											RAD51D_Glu233Gly	Glu233Gly	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						136845	F9_Popp_2025_carboxy_F9_specific_var225422	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	1.078825764535242			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						136845	F9_Popp_2025_carboxy_F9_specific_var225422	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	1.078825764535242			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						246909	F9_Popp_2025_strep_2_var264146	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	0.757955943			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						246909	F9_Popp_2025_strep_2_var264146	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	0.757955943			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						164361	F9_Popp_2025_carboxy_gla_motif_var254465	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	1.0671888984333089			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						164361	F9_Popp_2025_carboxy_gla_motif_var254465	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	1.0671888984333089			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						219393	F9_Popp_2025_light_chain_var244784	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	1.0828234546833777			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						219393	F9_Popp_2025_light_chain_var244784	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	1.0828234546833777			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						191877	F9_Popp_2025_heavy_chain_var235103	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	0.943706481718542			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
F9	F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic						191877	F9_Popp_2025_heavy_chain_var235103	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551218.0	139551218.0		677			226.0	R	Q	c.677G>A	p.Arg226Gln	missense_variant	0.943706481718542			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 21, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.793																																																											F9_Arg226Gln	Arg226Gln	true
BRCA1	BRCA1_Lys502Glu	0.8105603126478718	0.44429777323077857	4.989655621459293	0.0015836344442593491	2025_01_Batch_13-14	0.8872472228434505	0.8853565853297606	0.883380119926835	0.940891248085023	0.7309200947844363	0.8760282906814943	0.834676051235093	0.8217419276734688	0.8994130753199278	0.762667311487012	0.8816377567624725	0.8600163182824268	0.8525610238001519	0.9201521617024754	0.7467937031357241	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218418	CCSBVarC003301	ALE00003301	NC_000017.11:43071098:T:C	1504A>G	Lys502Glu	CEGS2	CegsMutGDEh1026	D01	GDEhDisVCh_40059	H08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Lys502Glu	17	43071098	T	C	17											17-43071098-T-C	37612	17	43071098	T	C	K	E	rs80356943	17	41223115	17	38476641	1606	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4816A>G	p.Lys1606Glu	principal2	Y	1	.	.	-	AAA	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.49207	.	0.0	0.02950	B	0.0	0.01384	B	.	0.99291	.	.	.	.	0	0.06502	N	.	0.10767	.	.	0.28302	-0.5432	0.66897	T	0.4017	0.75178	T	10	.	0.37017	.	0.227152	0.88048	D	.	0.75894	.	.	.	.	.	.	0.58443	.	0.16602	.	0.12617	0.260015904903	0.04893	T	0.098826	0.40015	T	0.0938011	0.63355	D	0.0772584	0.75211	D	0.106747360008648	0.12918	T	0.852615	0.53662	D	0.096304744	0.22477	0.09333296	0.22003	0.09800102	0.22901	0.07730816	0.17192	-3.059	0.10842	T	.	0.04993	.	0.00105470856972761	0.09785	0.99718000	0.98290	0.042	0.10339	.	.	.	.	.	.	1.918289	0.24404	16.37	0.91817812478712357	0.21378	0.169829	0.29455	N	-0.929974890242364	0.10024	0.4834715	-0.879878298600479	0.12355	0.6474283	4.92	2.88	0.32534	3.03	0.55386	2.465	0.44835	6.225000	0.55234	-0.114	0.14662	0.492	0.26984	1.000000	0.68239	0.007	0.07843	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	3	109406	2.742080e-05	0	5	208130	2.402340e-05	0	7	236868	2.955230e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89554	5.583220e-05	0	0	30608	0.000000e+00	0	5	89554	5.583220e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	7	102672	6.817830e-05	0	0	30526	0.000000e+00	0	7	102672	6.817830e-05	0	.	50	1613986	3.097920e-05	0	45	1180018	3.813500e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	0	64032	0.000000e+00	0	0	6084	0.000000e+00	0	45	1180018	3.813500e-05	0	0	91082	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	1	7864	1.271617497456765E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	1	8162	1.2251899044351874E-4	0	112	0	2	30890	6.474587245063128E-5	Benign	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43071098T>C	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	604370	145|140162|145	.	Lys	Glu	46168	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672	BRCA1	HGNC:1100	Benign	0	Jun 18, 2019	80356943	-	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098	43071098	17q21.31	reviewed by expert panel	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2	37612	43071098	T	C	-	-	-	-	-	-	SCV001161595	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3	2_Benign	17	43071098	T	C	0.0000321515																																																																																																				
BRCA1	BRCA1_Lys502Glu	0.8105603126478718	0.44429777323077857	4.989655621459293	0.0015836344442593491	2025_01_Batch_13-14	0.8872472228434505	0.8853565853297606	0.883380119926835	0.940891248085023	0.7309200947844363	0.8760282906814943	0.834676051235093	0.8217419276734688	0.8994130753199278	0.762667311487012	0.8816377567624725	0.8600163182824268	0.8525610238001519	0.9201521617024754	0.7467937031357241	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003301		NC_000017.11:43071098:T:C		Lys502Glu																												BRCA1_Lys502Glu	17	43071098	T	C	17	allele	1504A>G	B07	527_CAVA_Array_P01	C13	B13A7A8P1_R1	B14A7A8P1_R2				17-43071098-T-C	37612	17	43071098	T	C	K	E	rs80356943	17	41223115	17	38476641	1606	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4816A>G	p.Lys1606Glu	principal2	Y	1	.	.	-	AAA	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.49207	.	0.0	0.02950	B	0.0	0.01384	B	.	0.99291	.	.	.	.	0	0.06502	N	.	0.10767	.	.	0.28302	-0.5432	0.66897	T	0.4017	0.75178	T	10	.	0.37017	.	0.227152	0.88048	D	.	0.75894	.	.	.	.	.	.	0.58443	.	0.16602	.	0.12617	0.260015904903	0.04893	T	0.098826	0.40015	T	0.0938011	0.63355	D	0.0772584	0.75211	D	0.106747360008648	0.12918	T	0.852615	0.53662	D	0.096304744	0.22477	0.09333296	0.22003	0.09800102	0.22901	0.07730816	0.17192	-3.059	0.10842	T	.	0.04993	.	0.00105470856972761	0.09785	0.99718000	0.98290	0.042	0.10339	.	.	.	.	.	.	1.918289	0.24404	16.37	0.91817812478712357	0.21378	0.169829	0.29455	N	-0.929974890242364	0.10024	0.4834715	-0.879878298600479	0.12355	0.6474283	4.92	2.88	0.32534	3.03	0.55386	2.465	0.44835	6.225000	0.55234	-0.114	0.14662	0.492	0.26984	1.000000	0.68239	0.007	0.07843	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	3	109406	2.742080e-05	0	5	208130	2.402340e-05	0	7	236868	2.955230e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89554	5.583220e-05	0	0	30608	0.000000e+00	0	5	89554	5.583220e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	7	102672	6.817830e-05	0	0	30526	0.000000e+00	0	7	102672	6.817830e-05	0	.	50	1613986	3.097920e-05	0	45	1180018	3.813500e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	0	64032	0.000000e+00	0	0	6084	0.000000e+00	0	45	1180018	3.813500e-05	0	0	91082	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	1	7864	1.271617497456765E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	1	8162	1.2251899044351874E-4	0	112	0	2	30890	6.474587245063128E-5	Benign	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43071098T>C	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	604370	145|140162|145	.	Lys	Glu	46168	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672	BRCA1	HGNC:1100	Benign	0	Jun 18, 2019	80356943	-	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098	43071098	17q21.31	reviewed by expert panel	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2	37612	43071098	T	C	-	-	-	-	-	-	SCV001161595	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3	2_Benign	17	43071098	T	C	0.0000321515																																																																																																				
FH	FH_Gln376Pro	4.964945865150239	0.0025396516076362347	-7.121042736745749	0.00019011851741779218	2025_01_Batch_13-14	0.4809332923956441	0.8970850884189809	0.9509859139522358	0.9209322629506538	0.7859056690255877	0.6954918151638652	0.8891893934119484	0.9588243952495716	0.9546566583557993	0.8556528408751934	0.5882125537797547	0.8931372409154646	0.9549051546009037	0.9377944606532265	0.8207792549503905	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214601	CCSBVarC004055	ALE00004055	NC_000001.11:241502552:T:G	1127A>C	Gln376Pro	CEGS2	CegsMutGDEh1042	C05	GDEhDisVCh_40065	B09	1	CegsMutGDDh1042	C05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Gln376Pro	1	241502552	T	G	1											1-241502552-T-G	42094	1	241502552	T	G	Q	P	rs200796606	1	241665852	1	239732475	376	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1127A>C	p.Gln376Pro	c.1127A>C	p.Gln376Pro	principal1	Y	1	YES	Select	-	CAG	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.55	0.99107	H	-5.97	0.89297	D	0.588	0.60631	0.9801	0.96852	D	0.9899	0.99722	D	10	0.89965594	0.89206	D	0.783004	0.98288	D	0.970	0.99647	.	.	.	.	.	0.988874007372	0.98862	0.9931077487324933	0.99305	1.08544749973	0.77132	0.73917901516	0.72804	T	0.978282	0.99806	D	0.409114	0.90364	D	0.565222	0.95975	D	0.996202170848846	0.88780	D	0.989101	0.96387	D	0.99478674	0.99956	0.97383636	0.99614	0.99478674	0.99956	0.97383636	0.99615	-15.301	0.96526	D	0.89	0.82051	P	0.999990050804425	0.99831	0.96386050	0.94214	0.995	0.99826	.	.	.	.	.	.	4.747101	0.76664	26.5	0.99695009503082266	0.80201	0.750574	0.69053	D	0.94256199435676	0.93648	12.20484	0.851050495351092	0.93038	11.80997	5.96	5.96	0.96689	.	.	2.556	0.45625	7.892000	0.73146	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	segdup	7	109398	6.398650e-05	0	12	208098	5.766510e-05	0	15	236884	6.332210e-05	0	1	7164	1.395870e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	1	13394	7.466030e-05	0	5	42768	1.169100e-04	0	0	15688	0.000000e+00	0	1	7164	1.395870e-04	0	1	16218	6.165990e-05	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	1	16734	5.975860e-05	0	10	89552	1.116670e-04	0	0	30606	0.000000e+00	0	10	89552	1.116670e-04	0	1	14902	6.710510e-05	0	0	34238	0.000000e+00	0	0	9570	0.000000e+00	0	0	17688	0.000000e+00	0	2	21632	9.245560e-05	0	12	102714	1.168290e-04	0	0	30524	0.000000e+00	0	12	102714	1.168290e-04	0	.	75	1614038	4.646730e-05	0	10	64034	1.561670e-04	0	2	74940	2.668800e-05	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44886	0.000000e+00	0	10	64034	1.561670e-04	0	0	6084	0.000000e+00	0	62	1180012	5.254180e-05	0	0	91086	0.000000e+00	0	18	178358	1.0092062032541293E-4	0	352	0	0	2686	0	1	8798	1.1366219595362583E-4	0	796	0	0	968	0	0	652	0	0	280	0	1	13144	7.608034083992696E-5	1	9150	1.092896174863388E-4	0	3338	0	20	206034	9.707135715464438E-5	Conflicting_classifications_of_pathogenicity	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_conflicting_classifications	NC_000001.11:g.241502552T>G	ClinGen:CA189211	C3661900|C0342770|C0027672|C2239176|C1708350	606812|114550|150800	24|140162|88673|523	Fumarate lyase, N-terminal	Gln	Pro	51260	single nucleotide variant	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	2271	FH	HGNC:3700	Conflicting classifications of pathogenicity	1	Jan 29, 2025	200796606	-	RCV000163798|RCV000199873|RCV002280864|RCV000034920|RCV004595492	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241502552	241502552	1q43	criteria provided, conflicting classifications	12	-	N	ClinGen:CA189211	3	42094	241502552	T	G	-	-	-	-	-	-	SCV000214379|SCV000251429|SCV000632435|SCV001428576|SCV002022985|SCV003928116|SCV004197296|SCV005640073	-	-	1127A>C 	Gln376Pro	NM_000143.4	1	3_Conflicting	1	241502552	T	G	0.0000465174																																																																																																				
FH	FH_Gln376Pro	4.964945865150239	0.0025396516076362347	-7.121042736745749	0.00019011851741779218	2025_01_Batch_13-14	0.4809332923956441	0.8970850884189809	0.9509859139522358	0.9209322629506538	0.7859056690255877	0.6954918151638652	0.8891893934119484	0.9588243952495716	0.9546566583557993	0.8556528408751934	0.5882125537797547	0.8931372409154646	0.9549051546009037	0.9377944606532265	0.8207792549503905	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004055		NC_000001.11:241502552:T:G		Gln376Pro																												FH_Gln376Pro	1	241502552	T	G	1	allele	1127A>C	G02	527_CAVA_Array_P03	N03	B13A7A8P1_R1	B14A7A8P1_R2				1-241502552-T-G	42094	1	241502552	T	G	Q	P	rs200796606	1	241665852	1	239732475	376	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1127A>C	p.Gln376Pro	c.1127A>C	p.Gln376Pro	principal1	Y	1	YES	Select	-	CAG	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.55	0.99107	H	-5.97	0.89297	D	0.588	0.60631	0.9801	0.96852	D	0.9899	0.99722	D	10	0.89965594	0.89206	D	0.783004	0.98288	D	0.970	0.99647	.	.	.	.	.	0.988874007372	0.98862	0.9931077487324933	0.99305	1.08544749973	0.77132	0.73917901516	0.72804	T	0.978282	0.99806	D	0.409114	0.90364	D	0.565222	0.95975	D	0.996202170848846	0.88780	D	0.989101	0.96387	D	0.99478674	0.99956	0.97383636	0.99614	0.99478674	0.99956	0.97383636	0.99615	-15.301	0.96526	D	0.89	0.82051	P	0.999990050804425	0.99831	0.96386050	0.94214	0.995	0.99826	.	.	.	.	.	.	4.747101	0.76664	26.5	0.99695009503082266	0.80201	0.750574	0.69053	D	0.94256199435676	0.93648	12.20484	0.851050495351092	0.93038	11.80997	5.96	5.96	0.96689	.	.	2.556	0.45625	7.892000	0.73146	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	segdup	7	109398	6.398650e-05	0	12	208098	5.766510e-05	0	15	236884	6.332210e-05	0	1	7164	1.395870e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	1	13394	7.466030e-05	0	5	42768	1.169100e-04	0	0	15688	0.000000e+00	0	1	7164	1.395870e-04	0	1	16218	6.165990e-05	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	1	16734	5.975860e-05	0	10	89552	1.116670e-04	0	0	30606	0.000000e+00	0	10	89552	1.116670e-04	0	1	14902	6.710510e-05	0	0	34238	0.000000e+00	0	0	9570	0.000000e+00	0	0	17688	0.000000e+00	0	2	21632	9.245560e-05	0	12	102714	1.168290e-04	0	0	30524	0.000000e+00	0	12	102714	1.168290e-04	0	.	75	1614038	4.646730e-05	0	10	64034	1.561670e-04	0	2	74940	2.668800e-05	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44886	0.000000e+00	0	10	64034	1.561670e-04	0	0	6084	0.000000e+00	0	62	1180012	5.254180e-05	0	0	91086	0.000000e+00	0	18	178358	1.0092062032541293E-4	0	352	0	0	2686	0	1	8798	1.1366219595362583E-4	0	796	0	0	968	0	0	652	0	0	280	0	1	13144	7.608034083992696E-5	1	9150	1.092896174863388E-4	0	3338	0	20	206034	9.707135715464438E-5	Conflicting_classifications_of_pathogenicity	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_conflicting_classifications	NC_000001.11:g.241502552T>G	ClinGen:CA189211	C3661900|C0342770|C0027672|C2239176|C1708350	606812|114550|150800	24|140162|88673|523	Fumarate lyase, N-terminal	Gln	Pro	51260	single nucleotide variant	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	2271	FH	HGNC:3700	Conflicting classifications of pathogenicity	1	Jan 29, 2025	200796606	-	RCV000163798|RCV000199873|RCV002280864|RCV000034920|RCV004595492	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241502552	241502552	1q43	criteria provided, conflicting classifications	12	-	N	ClinGen:CA189211	3	42094	241502552	T	G	-	-	-	-	-	-	SCV000214379|SCV000251429|SCV000632435|SCV001428576|SCV002022985|SCV003928116|SCV004197296|SCV005640073	-	-	1127A>C 	Gln376Pro	NM_000143.4	1	3_Conflicting	1	241502552	T	G	0.0000465174																																																																																																				
LMNA	LMNA_Arg377Leu	0.8303741991373911	0.4337309726645242	-1.7547994394249709	0.12273046621541059	2025_01_Batch_13-14	0.732651144476482	0.9809019974562119	0.9985181048778051	0.9899325537451653	0.9821100560733841	0.6803825019777638	0.9825461087800901	0.9985531629178768	0.992536651994558	0.989151297345318	0.706516823227123	0.981724053118151	0.998535633897841	0.9912346028698616	0.985630676709351	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	true	LMNA	ENSG00000160789	3903	7292	CCSBVarC000580	ALE00000580	NC_000001.11:156136094:G:T	1130G>T	Arg377Leu	RC4	RC4_Mut_GDEh1027	B01	GDEhDisVCh_40057	F12	1	RC4_Mut_GDDh1027	B01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	99	0			0			0			LMNA_Arg377Leu	1	156136094	G	T	1											1-156136094-G-T	66778	1	156136094	G	T	R	L	rs61672878	1	156105885	1	154372509	377	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1130G>T	p.Arg377Leu	c.1130G>T	p.Arg377Leu	principal1	Y	5	.	.	+	CGC	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.715	0.94651	H	-6.93	0.93423	D	0.951	0.99270	1.0722	0.98647	D	0.9311	0.97722	D	10	0.9717735	0.96765	D	0.774445	0.98215	D	0.971	0.99671	0.839	0.94511	P02545	R377L	Gain of helix (P = 0.2059)| Loss of MoRF binding (P = 0.211)| Gain of ubiquitination at K378 (P = 0.2392)| Gain of phosphorylation at Y376 (P = 0.2452)| Loss of methylation at K378 (P = 0.3112)	0.987595316139	0.98732	.	0.98530	.	0.96642	0.850583195686	0.89686	D	0.98346	0.99884	D	0.551552	0.95787	D	0.55449	0.95724	D	0.998611927032471	0.94603	D	.	0.68071	.	0.95186484	0.96399	0.92578965	0.96757	0.9515742	0.96369	0.8996569	0.94882	-9.847	0.73069	D	0.9926	0.94839	LP	0.999965529954525	0.99297	0.99997818	0.99989	0.996	0.99859	.	.	.	.	.	.	5.27379	0.8857	29.6	0.99871771175567314	0.94906	0.977482	0.99724	D	0.966889726849636	0.94600	12.91139	0.89589923552897	0.95367	13.57775	5.3	5.3	0.74708	5.54	0.94607	8.119	0.8947	11.663000	0.94018	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614014	1.239150e-06	0	1	59978	1.667280e-05	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	1	59978	1.667280e-05	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	63898	0.000000e+00	0	0	6054	0.000000e+00	0	1	1180036	8.474320e-07	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|Primary_dilated_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156136094G>T	ClinGen:CA016657|UniProtKB:P02545#VAR_039777	C3661900|C2750785|C0270914|CN230736|C0007193	613205	157973|64746|217604	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	77675	single nucleotide variant	NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	4000	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1	Nov 11, 2024	61672878	-	RCV000057236|RCV001237945|RCV002321554|RCV003448256|RCV003996497	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736|MONDO:MONDO:0013178,MedGen:C2750785,OMIM:613205,Orphanet:157973|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Primary dilated cardiomyopathy	germline	germline	GRCh38	NC_000001.11	1	156136094	156136094	1q22	criteria provided, multiple submitters, no conflicts	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016657,UniProtKB:P02545#VAR_039777	2	66778	156136094	G	T	-	-	-	-	-	-	SCV000271921|SCV001410737|SCV002610638|SCV004176574|SCV004825165	-	-	1130G>T 	Arg377Leu	NM_170707.4	2	1_Pathogenic	1	156136094	G	T	1.36824e-6																																																																																																				
LMNA	LMNA_Arg377Leu	0.8303741991373911	0.4337309726645242	-1.7547994394249709	0.12273046621541059	2025_01_Batch_13-14	0.732651144476482	0.9809019974562119	0.9985181048778051	0.9899325537451653	0.9821100560733841	0.6803825019777638	0.9825461087800901	0.9985531629178768	0.992536651994558	0.989151297345318	0.706516823227123	0.981724053118151	0.998535633897841	0.9912346028698616	0.985630676709351	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	true	LMNA		3903		CCSBVarC000580		NC_000001.11:156136094:G:T		Arg377Leu																												LMNA_Arg377Leu	1	156136094	G	T	1	allele	1130G>T	G12	527_CAVA_Array_P03	N23	B13A7A8P1_R1	B14A7A8P1_R2				1-156136094-G-T	66778	1	156136094	G	T	R	L	rs61672878	1	156105885	1	154372509	377	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1130G>T	p.Arg377Leu	c.1130G>T	p.Arg377Leu	principal1	Y	5	.	.	+	CGC	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.715	0.94651	H	-6.93	0.93423	D	0.951	0.99270	1.0722	0.98647	D	0.9311	0.97722	D	10	0.9717735	0.96765	D	0.774445	0.98215	D	0.971	0.99671	0.839	0.94511	P02545	R377L	Gain of helix (P = 0.2059)| Loss of MoRF binding (P = 0.211)| Gain of ubiquitination at K378 (P = 0.2392)| Gain of phosphorylation at Y376 (P = 0.2452)| Loss of methylation at K378 (P = 0.3112)	0.987595316139	0.98732	.	0.98530	.	0.96642	0.850583195686	0.89686	D	0.98346	0.99884	D	0.551552	0.95787	D	0.55449	0.95724	D	0.998611927032471	0.94603	D	.	0.68071	.	0.95186484	0.96399	0.92578965	0.96757	0.9515742	0.96369	0.8996569	0.94882	-9.847	0.73069	D	0.9926	0.94839	LP	0.999965529954525	0.99297	0.99997818	0.99989	0.996	0.99859	.	.	.	.	.	.	5.27379	0.8857	29.6	0.99871771175567314	0.94906	0.977482	0.99724	D	0.966889726849636	0.94600	12.91139	0.89589923552897	0.95367	13.57775	5.3	5.3	0.74708	5.54	0.94607	8.119	0.8947	11.663000	0.94018	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614014	1.239150e-06	0	1	59978	1.667280e-05	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	1	59978	1.667280e-05	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	63898	0.000000e+00	0	0	6054	0.000000e+00	0	1	1180036	8.474320e-07	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|Primary_dilated_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156136094G>T	ClinGen:CA016657|UniProtKB:P02545#VAR_039777	C3661900|C2750785|C0270914|CN230736|C0007193	613205	157973|64746|217604	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	77675	single nucleotide variant	NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	4000	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1	Nov 11, 2024	61672878	-	RCV000057236|RCV001237945|RCV002321554|RCV003448256|RCV003996497	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736|MONDO:MONDO:0013178,MedGen:C2750785,OMIM:613205,Orphanet:157973|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Primary dilated cardiomyopathy	germline	germline	GRCh38	NC_000001.11	1	156136094	156136094	1q22	criteria provided, multiple submitters, no conflicts	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016657,UniProtKB:P02545#VAR_039777	2	66778	156136094	G	T	-	-	-	-	-	-	SCV000271921|SCV001410737|SCV002610638|SCV004176574|SCV004825165	-	-	1130G>T 	Arg377Leu	NM_170707.4	2	1_Pathogenic	1	156136094	G	T	1.36824e-6																																																																																																				
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						230185	F9_Popp_2025_light_chain_var248556	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0735200136724985			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						230185	F9_Popp_2025_light_chain_var248556	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0735200136724985			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						175153	F9_Popp_2025_carboxy_gla_motif_var258237	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0662084564629408			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						175153	F9_Popp_2025_carboxy_gla_motif_var258237	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0662084564629408			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						202669	F9_Popp_2025_heavy_chain_var238875	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0917705378443288			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						202669	F9_Popp_2025_heavy_chain_var238875	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0917705378443288			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						147637	F9_Popp_2025_carboxy_F9_specific_var229194	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0629815468074084			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						147637	F9_Popp_2025_carboxy_F9_specific_var229194	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.0629815468074084			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						257701	F9_Popp_2025_strep_2_var267918	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.1617170228965867			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
F9	F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic						257701	F9_Popp_2025_strep_2_var267918	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561902.0	139561902.0		1217			406.0	S	L	c.1217C>T	p.Ser406Leu	missense_variant	1.1617170228965867			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.86																																																											F9_Ser406Leu	Ser406Leu	true
BRAF	BRAF_Glu501Lys	0.6633972900818994	0.528310912774345	-0.6694140404872534	0.5246885914445109	2025_01_Batch_13-14	0.5795877855320548	0.7519196371322805	0.7961102983764758	0.7376978443703014	0.4759953809032452	0.5613240661661344	0.8224787036917817	0.8169991370326886	0.7926714600855322	0.5109504785266199	0.5704559258490947	0.7871991704120311	0.8065547177045822	0.7651846522279169	0.49347292971493256	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003167		NC_000007.14:140778007:C:T		Glu501Lys																												BRAF_Glu501Lys	7	140778007	C	T	7	allele	1501G>A	F04	527_CAVA_Array_P01	K07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778007-C-T	13977	7	140778007	C	T	E	K	rs180177038	7	140477807	7	140124276	501	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1501G>A	p.Glu501Lys	c.1501G>A	p.Glu501Lys	principal4	Y	.	YES	Select	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.96253	.	.	.	.	2.92	0.84163	M	.	.	.	.	.	0.5272	0.90891	D	0.6189	0.86511	D	9	0.98748183	0.99108	D	0.412682	0.93618	D	.	0.99740	0.984	0.99843	P15056	E501K	Gain of MoRF binding (P = 0.0045)| Gain of methylation at E501 (P = 0.0827)| Loss of ubiquitination at K499 (P = 0.1356)| Loss of stability (P = 0.2896)| Gain of catalytic residue at K499 (P = 0.3037)	.	0.99090	.	0.99420	.	0.95797	0.938608407974	0.99402	D	0.958012	0.99434	D	0.554969	0.95963	D	0.559398	0.95900	D	0.99942809343338	0.97327	D	0.959604	0.84795	D	0.9500797	0.96215	0.8697107	0.92749	0.96031433	0.97269	0.83118904	0.90135	-12.836	0.88701	D	0.9999	0.99795	P	0.999976740337915	0.99427	0.99923956	0.99238	0.995	0.99826	.	.	.	.	.	.	5.637157	0.92725	32.0	0.99903041562417938	0.97428	0.904129	0.85351	D	0.639137191857678	0.75537	6.346777	0.630565185681596	0.77043	6.628201	4.96	4.96	0.65108	6.58	0.99812	7.869	0.85551	7.641000	0.63257	0.545	0.25635	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic/Likely_pathogenic	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiovascular_phenotype|not_provided|Cardiofaciocutaneous_syndrome_1|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778007C>T	ClinGen:CA273130|OMIM:164757.0017|UniProtKB:P15056#VAR_026118	C0028326|C1275081|CN230736|C3661900|CN029449|C5555857	PS163950|PS115150|115150	648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Lys	29016	single nucleotide variant	NM_004333.6(BRAF):c.1501G>A (p.Glu501Lys)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Jan 29, 2025	180177038	-	RCV000015011|RCV000207513|RCV000033315|RCV000844616|RCV004018630	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	Cardiofaciocutaneous syndrome 1|not provided|RASopathy|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000007.14	7	140778007	140778007	7q34	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA273130,UniProtKB:P15056#VAR_026118,OMIM:164757.0017	3	13977	140778007	C	T	-	-	-	-	-	-	SCV000263065|SCV000338452|SCV000948576|SCV002767018|SCV003610904	-	-	1501G>A 	Glu501Lys	NM_004333.6	2	1_Pathogenic																																																																																																									
SHOC2	SHOC2_Glu25Gly	-1.292301105093803	0.23727522836829176	4.4494150343610945	0.002973737450232932	2025_01_Batch_13-14	0.6433044032860071	0.7750878643601726	0.6371818379286176	0.6228404341855232	0.5403685906557271	0.6224070740030938	0.7418334256889555	0.6435865191916832	0.7761029737935217	0.53295432120808	0.6328557386445505	0.7584606450245641	0.6403841785601504	0.6994717039895224	0.5366614559319035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
BRCA1	BRCA1_Gly666Val	0.8111849338867764	0.4439619283781052	3.5112350638164833	0.009843009152846182	2025_01_Batch_13-14	0.8413339729777471	0.905374571810571	0.8714205125345021	0.9150813611590665	0.6980768194668904	0.9221979106285213	0.8248239232178372	0.8489993684039382	0.9412095699512582	0.7681921894318554	0.8817659418031343	0.8650992475142041	0.8602099404692202	0.9281454655551623	0.7331345044493729	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011818		NC_000017.11:43051086:C:A		Gly666Val																												BRCA1_Gly666Val	17	43051086	C	A	17	allele	1997G>T	D08	527_CAVA_Array_P01	G15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051086-C-A	417832	17	43051086	C	A	G	V	rs863224765	17	41203103	17	38456629	1770	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.5309G>T	p.Gly1770Val	principal2	Y	1	.	.	-	GGG	2	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.583	0.77914	P	0.055	0.73565	B	.	0.99291	.	.	.	.	2.215	0.62356	M	.	0.90790	.	.	0.94206	0.6824	0.92930	D	0.7985	0.93160	D	10	.	0.91415	.	0.786529	0.98318	D	.	0.94788	.	.	.	.	.	.	0.93785	.	0.83211	.	0.40658	0.485455960035	0.36760	T	0.327304	0.69606	T	0.420504	0.90984	D	0.366249	0.90872	D	0.977009236812592	0.71446	D	.	0.91429	.	0.58132803	0.71391	0.22660044	0.47467	0.58380777	0.71528	0.32384387	0.58085	-9.173	0.85385	D	.	0.77473	.	0.994521859597463	0.90703	0.99981505	0.99752	0.916	0.95687	.	.	.	.	.	.	3.272588	0.44882	22.0	0.99741871120433134	0.83570	0.471283	0.51522	N	0.484917239323781	0.66032	4.920639	0.444495820101055	0.64170	4.689884	5.06	4.09	0.46976	4.36	0.82260	2.72	0.47021	4.864000	0.45576	0.599	0.40292	0.981	0.35482	1.000000	0.68239	0.98	0.58201	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613796	1.239310e-06	0	1	91068	1.098080e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	63966	0.000000e+00	0	0	6056	0.000000e+00	0	0	1179952	0.000000e+00	0	1	91068	1.098080e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051086C>A	ClinGen:CA10590929	C0006142|C0027672|C0677776|C3661900|C2676676	604370	140162|145|145	.	Gly	Val	404710	single nucleotide variant	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	672	BRCA1	HGNC:1100	Pathogenic	1	Jul 18, 2018	863224765	-	RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421	MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051086	43051086	17q21.31	reviewed by expert panel	13	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10590929	2	417832	43051086	C	A	-	-	-	-	-	-	SCV001161716	-	-	5309G>T 	Gly1770Val	NM_007294.4	3	1_Pathogenic						48348	BRCA1_Adamovich_2022_HDR_var5517	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43051086.0	43051086.0		5309			1770.0	G	V	c.5309G>T	p.Gly1770Val	missense_variant	-0.5585491575	-0.282751458;-0.705049372;-0.792067657;-0.454328143		No	1.2393140149e-6	Pathogenic	reviewed by expert panel	Jul 18, 2018	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.835	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Gly1770Val	Gly1770Val	true
BRCA1	BRCA1_Gly666Val	0.8111849338867764	0.4439619283781052	3.5112350638164833	0.009843009152846182	2025_01_Batch_13-14	0.8413339729777471	0.905374571810571	0.8714205125345021	0.9150813611590665	0.6980768194668904	0.9221979106285213	0.8248239232178372	0.8489993684039382	0.9412095699512582	0.7681921894318554	0.8817659418031343	0.8650992475142041	0.8602099404692202	0.9281454655551623	0.7331345044493729	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011818		NC_000017.11:43051086:C:A		Gly666Val																												BRCA1_Gly666Val	17	43051086	C	A	17	allele	1997G>T	D08	527_CAVA_Array_P01	G15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051086-C-A	417832	17	43051086	C	A	G	V	rs863224765	17	41203103	17	38456629	1770	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.5309G>T	p.Gly1770Val	principal2	Y	1	.	.	-	GGG	2	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.583	0.77914	P	0.055	0.73565	B	.	0.99291	.	.	.	.	2.215	0.62356	M	.	0.90790	.	.	0.94206	0.6824	0.92930	D	0.7985	0.93160	D	10	.	0.91415	.	0.786529	0.98318	D	.	0.94788	.	.	.	.	.	.	0.93785	.	0.83211	.	0.40658	0.485455960035	0.36760	T	0.327304	0.69606	T	0.420504	0.90984	D	0.366249	0.90872	D	0.977009236812592	0.71446	D	.	0.91429	.	0.58132803	0.71391	0.22660044	0.47467	0.58380777	0.71528	0.32384387	0.58085	-9.173	0.85385	D	.	0.77473	.	0.994521859597463	0.90703	0.99981505	0.99752	0.916	0.95687	.	.	.	.	.	.	3.272588	0.44882	22.0	0.99741871120433134	0.83570	0.471283	0.51522	N	0.484917239323781	0.66032	4.920639	0.444495820101055	0.64170	4.689884	5.06	4.09	0.46976	4.36	0.82260	2.72	0.47021	4.864000	0.45576	0.599	0.40292	0.981	0.35482	1.000000	0.68239	0.98	0.58201	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613796	1.239310e-06	0	1	91068	1.098080e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	63966	0.000000e+00	0	0	6056	0.000000e+00	0	0	1179952	0.000000e+00	0	1	91068	1.098080e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051086C>A	ClinGen:CA10590929	C0006142|C0027672|C0677776|C3661900|C2676676	604370	140162|145|145	.	Gly	Val	404710	single nucleotide variant	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	672	BRCA1	HGNC:1100	Pathogenic	1	Jul 18, 2018	863224765	-	RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421	MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051086	43051086	17q21.31	reviewed by expert panel	13	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10590929	2	417832	43051086	C	A	-	-	-	-	-	-	SCV001161716	-	-	5309G>T 	Gly1770Val	NM_007294.4	3	1_Pathogenic						40086	BRCA1_Adamovich_2022_Cisplatin_var6912	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43051086.0	43051086.0		5309			1770.0	G	V	c.5309G>T	p.Gly1770Val	missense_variant	-0.9230767545	-1.290499945;-0.697451801;-0.828356624;-0.875998648		No	1.2393140149e-6	Pathogenic	reviewed by expert panel	Jul 18, 2018	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.835	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Gly1770Val	Gly1770Val	true
CTCF	CTCF_Arg567Trp	-2.2467893963047323	0.05947914658227662	4.260796641789189	0.0037429098147742346	2025_01_Batch_13-14	0.845062424909783	0.9353934882605206	0.9929235469435809	0.98291111648267	0.958814571357891	0.8577022478605604	0.925778215348259	0.9961799374689079	0.9836805419035566	0.9789552684935916	0.8513823363851717	0.9305858518043898	0.9945517422062444	0.9832958291931133	0.9688849199257413	0.0	0.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	true	CTCF		6173		CCSBVarC010838		NC_000016.10:67628550:C:T		Arg567Trp																												CTCF_Arg567Trp	16	67628550	C	T	16	allele	1699C>T	C02	527_CAVA_Array_P02	E04	B13A7A8P1_R1	B14A7A8P1_R2				16-67628550-C-T	88638	16	67628550	C	T	R	W	rs879255516	16	67662453	16	66219954	567	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.1699C>T	p.Arg567Trp	c.1699C>T	p.Arg567Trp	principal4	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.272	0.16020	T	0.032	0.53775	D	1.0	0.90580	D	0.996	0.84488	D	0.9	0.92286	A	simple_aae	10.0	90.0	0.975	0.24371	L	3.81	0.00067	N	0.871	0.86807	-0.1910	0.77803	T	0.4630	0.79128	T	10	0.45562387	0.58637	D	0.259847	0.89437	D	0.467	0.76095	0.505	0.59796	P49711	R567W	Loss of disorder (P = 0.0022)| Gain of catalytic residue at M570 (P = 0.0054)| Loss of ubiquitination at K562 (P = 0.0595)| Loss of glycosylation at T565 (P = 0.062)| Gain of MoRF binding (P = 0.0672)	0.924862249397	0.92352	.	0.85423	1.77042804158	0.91237	0.938079476357	0.99381	D	0.337032	0.70472	T	0.299086	0.82769	D	0.19184	0.82547	D	0.758090436458588	0.43448	D	.	0.72299	.	0.34531498	0.56370	0.20212594	0.44068	0.21461935	0.43549	0.19353762	0.42778	-8.437	0.81389	D	.	0.88398	.	0.977421928894321	0.84724	0.93024755	0.92403	0.348	0.60781	.	.	.	.	.	.	5.827689	0.93734	33.0	0.99912878870036514	0.98168	0.650883	0.62348	D	0.233022080859582	0.52570	3.452482	0.364610182935106	0.59176	4.116707	5.72	5.72	0.89363	2.48	0.45773	3.487	0.53079	3.253000	0.37120	0.599	0.40292	0.997	0.40243	0.999000	0.35501	0.998	0.85369	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Inborn_genetic_diseases|CTCF-related_syndromic_intellectual_disability|not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67628550C>T	ClinGen:CA10575614|OMIM:604167.0003|UniProtKB:P49711#VAR_070776	C0950123|C3661900|C3809686	615502	363611	.	Arg	Trp	94227	single nucleotide variant	NM_006565.4(CTCF):c.1699C>T (p.Arg567Trp)	10664	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1	Oct 04, 2024	879255516	-	RCV000074335|RCV000413282|RCV002260512|RCV002399425|RCV004798770	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900||MeSH:D030342,MedGen:C0950123|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided|CTCF-related syndromic intellectual disability|Inborn genetic diseases|Intellectual disability	de novo;germline;unknown	germline	GRCh38	NC_000016.10	16	67628550	67628550	16q22.1	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA10575614,UniProtKB:P49711#VAR_070776,OMIM:604167.0003	3	88638	67628550	C	T	-	-	-	-	-	-	SCV000491326|SCV001140119|SCV001763559|SCV002026307|SCV002540226|SCV002712444|SCV004012893|SCV005418082|SCV005420471	-	-	1699C>T 	Arg567Trp	NM_006565.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Asp67Tyr	2.5125896208651195	0.04024421782312692	-0.9756740391325569	0.3617299832806894	2025_01_Batch_13-14	0.9909520492431141	0.9587707827180625	0.975413541128114	0.9870750278331963	0.9642158549481505	0.9162230980428752	0.8907745672989336	0.9196469894768488	0.9442195653598557	0.7599903085066182	0.9535875736429946	0.924772675008498	0.9475302653024813	0.965647296596526	0.8621030817273844	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013083		NC_000017.11:43106469:C:A		Asp67Tyr																												BRCA1_Asp67Tyr	17	43106469	C	A	17	allele	199G>T	B11	527_CAVA_Array_P01	C21	B13A7A8P1_R1	B14A7A8P1_R2				17-43106469-C-A	54431	17	43106469	C	A	D	Y	rs80357102	17	41258486	17	38512012	67	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.199G>T	p.Asp67Tyr	principal2	Y	.	.	.	-	GAT	1	0	C	C/C	C/C	C/C	C/C	.	0.72322	.	.	0.79703	.	0.868	0.47756	P	0.24	0.38861	B	.	0.51279	.	.	.	.	1.25	0.31597	L	.	0.75325	.	.	0.67836	-0.0620	0.80864	T	0.6621	0.88225	D	10	.	0.34335	.	0.282437	0.90256	D	.	0.87125	.	.	.	.	.	.	0.86240	.	0.43573	.	0.11448	0.42940607667	0.29092	T	0.14757	0.48293	T	0.108459	0.64942	D	0.173063	0.81457	D	0.0394584648311138	0.03564	T	.	0.83345	.	0.28895706	0.51563	0.10798522	0.25949	0.378384	0.58872	0.13106883	0.31396	-6.164	0.51688	T	.	0.56478	.	0.956250935363193	0.81217	0.99734180	0.98344	0.64	0.79945	.	.	.	.	.	.	2.280806	0.29216	18.03	0.99318147251181976	0.59339	0.233566	0.35440	N	-0.260466381601807	0.30407	1.713454	-0.295009425429782	0.27944	1.574398	4.64	-1.4	0.08479	1.19	0.30954	0.033	0.13684	-0.025000	0.12924	0.531	0.24877	0.943	0.32853	0.000000	0.08389	0.993	0.69292	459	0.78836	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	10	264690	3.7780046E-5	.	8	109008	7.338910e-05	0	14	207104	6.759890e-05	0	17	235908	7.206200e-05	0	0	7140	0.000000e+00	0	1	16978	5.889980e-05	0	0	2308	0.000000e+00	0	0	9042	0.000000e+00	0	0	13390	0.000000e+00	0	7	42690	1.639730e-04	0	0	15548	0.000000e+00	0	7	42690	1.639730e-04	0	0	16118	0.000000e+00	0	2	30338	6.592390e-05	0	0	6186	0.000000e+00	0	0	13394	0.000000e+00	0	0	16710	0.000000e+00	0	12	89212	1.345110e-04	0	0	30298	0.000000e+00	0	12	89212	1.345110e-04	0	0	14808	0.000000e+00	0	2	34062	5.871650e-05	0	0	9548	0.000000e+00	0	0	17668	0.000000e+00	0	0	21604	0.000000e+00	0	15	102410	1.464700e-04	0	0	30216	0.000000e+00	0	15	102410	1.464700e-04	0	.	132	1596780	8.266640e-05	0	126	1165696	1.080900e-04	0	1	74666	1.339300e-05	0	0	912	0.000000e+00	0	2	59860	3.341130e-05	0	0	29466	0.000000e+00	0	0	44696	0.000000e+00	0	0	63924	0.000000e+00	0	0	5778	0.000000e+00	0	126	1165696	1.080900e-04	0	0	89912	0.000000e+00	0	12	129722	9.250551178674396E-5	0	352	0	0	2726	0	0	8264	0	0	790	0	0	946	0	0	626	0	0	280	0	0	7514	0	0	8616	0	0	3352	0	12	151220	7.935458272715249E-5	Benign	Malignant_tumor_of_breast|not_provided|not_specified|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43106469C>A	BRCA1-HCI:BRCA1_00052|ClinGen:CA001328|UniProtKB:P38398#VAR_070460	C0006142|C3661900|CN169374|CN221562|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	114480|617883|604370|614320	145|227535|145|1333|140162	.	Asp	Tyr	69098	single nucleotide variant	NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80357102	-	RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106469	43106469	17q21.31	reviewed by expert panel	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460	2	54431	43106469	C	A	-	-	-	-	-	-	SCV000244311	-	-	199G>T 	Asp67Tyr	NM_007294.4	3	2_Benign																																																																																																									
LMNA	LMNA_Arg41His	4.266345707886469	0.0037173824125443845	-7.249892521424595	0.00016994557101229237	2025_01_Batch_13-14	0.9685184608031403	0.9546879748106982	0.9518480534400747	0.9287920510754318	0.9546152002699522	0.9361856833297664	0.9459083085923632	0.965736028721621	0.9723880485089806	0.9082688556380418	0.9523520720664533	0.9502981417015307	0.9587920410808479	0.9505900497922062	0.931442027953997	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	true	LMNA		3903		CCSBVarC021100		NC_000001.11:156115040:G:A		Arg41His																												LMNA_Arg41His	1	156115040	G	A	1	allele	122G>A	F09	527_CAVA_Array_P03	L17	B13A7A8P1_R1	B14A7A8P1_R2				1-156115040-G-A	408994	1	156115040	G	A	R	H	rs1060502215	1	156084831	1	154351455	41	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.122G>A	p.Arg41His	principal1	Y	.	.	.	+	CGC	2	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.997	0.86259	D	.	0.99291	.	.	.	.	3.65	0.94095	H	.	0.76931	.	.	0.94442	1.0096	0.97344	D	0.8998	0.96669	D	10	.	0.95527	.	0.697456	0.97514	D	.	0.98921	0.839	0.94511	P02545	R41H	Loss of disorder (P = 0.0408)| Loss of MoRF binding (P = 0.0657)| Loss of stability (P = 0.0853)| Gain of catalytic residue at Y45 (P = 0.2364)| Gain of phosphorylation at Y45 (P = 0.3525)	.	0.98195	.	0.99019	.	0.96618	0.826536655426	0.86008	D	0.981432	0.99855	D	0.543151	0.95472	D	0.542423	0.95404	D	0.998799562454224	0.95146	D	.	0.60605	.	0.8277698	0.85561	0.67164475	0.80513	0.7031715	0.77980	0.6304929	0.78213	-11.691	0.83363	D	.	0.93873	.	0.999670505958946	0.97434	0.99995460	0.99953	0.989	0.99628	.	.	.	.	.	.	5.697397	0.93103	33.0	0.99939450855587175	0.99734	0.969077	0.99147	D	0.920677880494411	0.92694	11.59756	0.8501245464411	0.92984	11.77651	4.77	4.77	0.60376	5.21	0.92006	9.725	0.9802	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.996	0.76032	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156115040G>A	ClinGen:CA16609885	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	His	390827	single nucleotide variant	NM_170707.4(LMNA):c.122G>A (p.Arg41His)	4000	LMNA	HGNC:6636	Pathogenic	1	Mar 14, 2023	1060502215	-	RCV000457713|RCV000994129	MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:C3661900	Charcot-Marie-Tooth disease type 2|not provided	germline	germline	GRCh38	NC_000001.11	1	156115040	156115040	1q22	criteria provided, multiple submitters, no conflicts	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16609885	2	408994	156115040	G	A	-	-	-	-	-	-	SCV000548863|SCV001147454	-	-	122G>A 	Arg41His	NM_170707.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_His41Arg	-0.7905479031010616	0.45515193572773704	2.625988804254552	0.03411090005792832	2025_01_Batch_13-14	0.7635952103109366	0.9180190411090324	0.6955686537564537	0.6385853229034477	0.5758214868863146	0.9836352860827905	0.9407984783796364	0.9415830691802393	0.9804317122724854	0.9444769747268804	0.8736152481968635	0.9294087597443343	0.8185758614683465	0.8095085175879666	0.7601492308065976	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011865		NC_000017.11:43115738:T:C		His41Arg																												BRCA1_His41Arg	17	43115738	T	C	17	allele	122A>G	H09	527_CAVA_Array_P01	O17	B13A7A8P1_R1	B14A7A8P1_R2				17-43115738-T-C	54166	17	43115738	T	C	H	R	rs80357276	17	41267755	17	38521281	41	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.122A>G	p.His41Arg	principal2	Y	1	.	.	-	CAC	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	0.959	0.90580	D	0.542	0.92348	P	.	0.99291	.	.	.	.	3.995	0.96666	H	.	0.95148	.	.	0.88119	0.9682	0.96663	D	0.9917	0.99792	D	10	.	0.99449	.	0.885446	0.99127	D	.	0.99491	0.966	0.99665	E9PFC7	H41R	Gain of MoRF binding (P = 0.0172)| Loss of catalytic residue at D40 (P = 0.0761)| Gain of disorder (P = 0.0885)| Gain of helix (P = 0.132)| Gain of phosphorylation at T37 (P = 0.2265)	.	0.99628	.	0.94303	.	0.46401	0.697537183762	0.66732	T	0.460215	0.93020	T	0.562828	0.96258	D	0.570687	0.96198	D	0.998141407966614	0.93292	D	0.955504	0.83052	D	0.9505324	0.96261	0.6308536	0.78232	0.9015565	0.91402	0.6761325	0.80766	-13.38	0.93979	D	.	0.95417	.	0.999422575166627	0.96550	0.99957854	0.99505	0.964	0.98523	.	.	.	.	.	.	4.490848	0.70206	25.5	0.99650553719529922	0.77280	0.750685	0.69060	D	0.939969350591933	0.93540	12.13134	0.850731219321243	0.93019	11.79838	5.97	5.97	0.96929	.	.	3.518	0.533	7.815000	0.69605	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115738T>C	BRCA1-HCI:BRCA1_00130|ClinGen:CA000805	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	His	Arg	68833	single nucleotide variant	NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357276	-	RCV000047383|RCV000111820|RCV000484980|RCV000569789	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115738	43115738	17q21.31	reviewed by expert panel	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00130,ClinGen:CA000805	2	54166	43115738	T	C	-	-	-	-	-	-	SCV000244297	-	-	122A>G 	His41Arg	NM_007294.4	3	1_Pathogenic																																																																																																									
RET	RET_Pro64Leu	-1.201347931595469	0.2686812116504655	8.469985626960886	0.00006319510150519935	2025_01_Batch_13-14	0.9804880815822493	0.9530161642274781	0.9435651694351904	0.9760410272134588	0.9326239165240031	0.658728523687184	0.8366351888408243	0.8457080164261688	0.7596773926946224	0.6324477076733983	0.8196083026347167	0.8948256765341512	0.8946365929306797	0.8678592099540405	0.7825358120987007	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202947	CCSBVarC006874	ALE00006872	NC_000010.11:43100576:C:T	191C>T	Pro64Leu	CEGS2	CegsMutGDEh1028	E01	GDEhDisVCh_40066	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Pro64Leu	10	43100576	C	T	10											10-43100576-C-T	13924	10	43100576	C	T	P	L	rs77596424	10	43596024	10	42916030	64	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.191C>T	p.Pro64Leu	c.191C>T	p.Pro64Leu	principal4	Y	5	YES	Select	+	CCC	2	0	C	C/C	C/C	C/C	C/C	0.004	0.65576	D	0.004	0.74454	D	0.959	0.58322	D	0.411	0.51228	B	0.76	0.87470	D	simple_aae	24.0	76.0	2.67	0.77975	M	-3.22	0.64967	D	0.536	0.85733	0.0771	0.83683	D	0.5121	0.81614	D	10	0.89362335	0.88586	D	0.118491	0.79794	D	0.672	0.87814	0.818	0.93158	P07949	P64L	Loss of disorder (P = 0.0168)| Gain of sheet (P = 0.0266)| Loss of loop (P = 0.0374)| Loss of catalytic residue at P64 (P = 0.301)| Gain of stability (P = 0.3098)	0.926320950286	0.92500	0.9054588325528415	0.90458	0.905716289001	0.70658	0.415368586779	0.27167	T	0.721132	0.92046	D	0.22536	0.76106	D	0.0859375	0.75795	D	0.963108539581299	0.66346	D	0.863614	0.55862	D	0.24177787	0.46769	0.1777569	0.40264	0.2933445	0.51970	0.190038	0.42237	-3.563	0.17366	T	0.2	0.49988	B	0.356992193338291	0.56253	0.99964368	0.99561	0.512	0.72220	.	.	.	.	.	.	3.585512	0.50649	23.0	0.99877806916319922	0.95413	0.312706	0.41613	N	0.524681360864973	0.68387	5.233171	0.540917518592382	0.70609	5.553941	5.51	5.51	0.81744	3.8	0.70283	2.831	0.47943	4.843000	0.45380	0.599	0.40292	1.0	0.71675	0.996000	0.32869	0.839	0.39622	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100576C>T	ClinGen:CA008426|OMIM:164761.0019|UniProtKB:P07949#VAR_006296	C3888239|C4048306	142623	388|653	Ret, cadherin like domain 1	Pro	Leu	28963	single nucleotide variant	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	5979	RET	HGNC:9967	Uncertain significance	0	Apr 09, 2024	77596424	-	RCV000014949|RCV003531901	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43100576	43100576	10q11.21	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	3	13924	43100576	C	T	-	-	-	-	-	-	SCV004294349|SCV004831371	-	-	191C>T 	Pro64Leu	NM_020975.6	2	4_VUS																																																																																																									
RET	RET_Pro64Leu	-1.201347931595469	0.2686812116504655	8.469985626960886	0.00006319510150519935	2025_01_Batch_13-14	0.9804880815822493	0.9530161642274781	0.9435651694351904	0.9760410272134588	0.9326239165240031	0.658728523687184	0.8366351888408243	0.8457080164261688	0.7596773926946224	0.6324477076733983	0.8196083026347167	0.8948256765341512	0.8946365929306797	0.8678592099540405	0.7825358120987007	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006874		NC_000010.11:43100576:C:T		Pro64Leu																												RET_Pro64Leu	10	43100576	C	T	10	allele	191C>T	C08	527_CAVA_Array_P05	E15	B13A7A8P2_R1	B14A7A8P2_R2				10-43100576-C-T	13924	10	43100576	C	T	P	L	rs77596424	10	43596024	10	42916030	64	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.191C>T	p.Pro64Leu	c.191C>T	p.Pro64Leu	principal4	Y	5	YES	Select	+	CCC	2	0	C	C/C	C/C	C/C	C/C	0.004	0.65576	D	0.004	0.74454	D	0.959	0.58322	D	0.411	0.51228	B	0.76	0.87470	D	simple_aae	24.0	76.0	2.67	0.77975	M	-3.22	0.64967	D	0.536	0.85733	0.0771	0.83683	D	0.5121	0.81614	D	10	0.89362335	0.88586	D	0.118491	0.79794	D	0.672	0.87814	0.818	0.93158	P07949	P64L	Loss of disorder (P = 0.0168)| Gain of sheet (P = 0.0266)| Loss of loop (P = 0.0374)| Loss of catalytic residue at P64 (P = 0.301)| Gain of stability (P = 0.3098)	0.926320950286	0.92500	0.9054588325528415	0.90458	0.905716289001	0.70658	0.415368586779	0.27167	T	0.721132	0.92046	D	0.22536	0.76106	D	0.0859375	0.75795	D	0.963108539581299	0.66346	D	0.863614	0.55862	D	0.24177787	0.46769	0.1777569	0.40264	0.2933445	0.51970	0.190038	0.42237	-3.563	0.17366	T	0.2	0.49988	B	0.356992193338291	0.56253	0.99964368	0.99561	0.512	0.72220	.	.	.	.	.	.	3.585512	0.50649	23.0	0.99877806916319922	0.95413	0.312706	0.41613	N	0.524681360864973	0.68387	5.233171	0.540917518592382	0.70609	5.553941	5.51	5.51	0.81744	3.8	0.70283	2.831	0.47943	4.843000	0.45380	0.599	0.40292	1.0	0.71675	0.996000	0.32869	0.839	0.39622	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100576C>T	ClinGen:CA008426|OMIM:164761.0019|UniProtKB:P07949#VAR_006296	C3888239|C4048306	142623	388|653	Ret, cadherin like domain 1	Pro	Leu	28963	single nucleotide variant	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	5979	RET	HGNC:9967	Uncertain significance	0	Apr 09, 2024	77596424	-	RCV000014949|RCV003531901	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43100576	43100576	10q11.21	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	3	13924	43100576	C	T	-	-	-	-	-	-	SCV004294349|SCV004831371	-	-	191C>T 	Pro64Leu	NM_020975.6	2	4_VUS																																																																																																									
BRCA1	BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321133	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604405	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.9555780160962769	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218422	CCSBVarC003303	ALE00003303	NC_000017.11:43067628:G:A	1742C>T	Thr581Ile	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Thr581Ile	17	43067628	G	A	17											17-43067628-G-A	55365	17	43067628	G	A	T	I	rs80357043	17	41219645	17	38473171	1685	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.7600	0.93898	D	0.7898	0.92853	D	10	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.74950	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.99904362282002479	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	70032	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357043	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628	43067628	17q21.31	reviewed by expert panel	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2	55365	43067628	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3	1_Pathogenic	17	43067628	G	A	1.36983e-6	45752	BRCA1_Adamovich_2022_HDR_var4810	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43067628.0	43067628.0		5054			1685.0	T	I	c.5054C>T	p.Thr1685Ile	missense_variant	-1.6102287575	-1.749740061;-1.61491971;-1.600068476;-1.476186784		No	1.8608736429e-6	Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.88	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Thr1685Ile	Thr1685Ile	true
BRCA1	BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321133	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604405	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.9555780160962769	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003303		NC_000017.11:43067628:G:A		Thr581Ile																												BRCA1_Thr581Ile	17	43067628	G	A	17	allele	1742C>T	C07	527_CAVA_Array_P01	E13	B13A7A8P1_R1	B14A7A8P1_R2				17-43067628-G-A	55365	17	43067628	G	A	T	I	rs80357043	17	41219645	17	38473171	1685	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.7600	0.93898	D	0.7898	0.92853	D	10	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.74950	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.99904362282002479	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	70032	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357043	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628	43067628	17q21.31	reviewed by expert panel	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2	55365	43067628	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3	1_Pathogenic	17	43067628	G	A	1.36983e-6	45752	BRCA1_Adamovich_2022_HDR_var4810	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43067628.0	43067628.0		5054			1685.0	T	I	c.5054C>T	p.Thr1685Ile	missense_variant	-1.6102287575	-1.749740061;-1.61491971;-1.600068476;-1.476186784		No	1.8608736429e-6	Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.88	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Thr1685Ile	Thr1685Ile	true
BRCA1	BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321133	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604405	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.9555780160962769	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218422	CCSBVarC003303	ALE00003303	NC_000017.11:43067628:G:A	1742C>T	Thr581Ile	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Thr581Ile	17	43067628	G	A	17											17-43067628-G-A	55365	17	43067628	G	A	T	I	rs80357043	17	41219645	17	38473171	1685	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.7600	0.93898	D	0.7898	0.92853	D	10	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.74950	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.99904362282002479	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	70032	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357043	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628	43067628	17q21.31	reviewed by expert panel	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2	55365	43067628	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3	1_Pathogenic	17	43067628	G	A	1.36983e-6	37742	BRCA1_Adamovich_2022_Cisplatin_var6277	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43067628.0	43067628.0		5054			1685.0	T	I	c.5054C>T	p.Thr1685Ile	missense_variant	-1.03350250925	-1.321210618;-1.433452633;-0.670731515;-0.708615272		No	1.8608736429e-6	Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.88	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Thr1685Ile	Thr1685Ile	true
BRCA1	BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321133	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604405	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.9555780160962769	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003303		NC_000017.11:43067628:G:A		Thr581Ile																												BRCA1_Thr581Ile	17	43067628	G	A	17	allele	1742C>T	C07	527_CAVA_Array_P01	E13	B13A7A8P1_R1	B14A7A8P1_R2				17-43067628-G-A	55365	17	43067628	G	A	T	I	rs80357043	17	41219645	17	38473171	1685	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.7600	0.93898	D	0.7898	0.92853	D	10	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.74950	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.99904362282002479	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	70032	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357043	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628	43067628	17q21.31	reviewed by expert panel	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2	55365	43067628	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3	1_Pathogenic	17	43067628	G	A	1.36983e-6	37742	BRCA1_Adamovich_2022_Cisplatin_var6277	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43067628.0	43067628.0		5054			1685.0	T	I	c.5054C>T	p.Thr1685Ile	missense_variant	-1.03350250925	-1.321210618;-1.433452633;-0.670731515;-0.708615272		No	1.8608736429e-6	Pathogenic	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.88	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Thr1685Ile	Thr1685Ile	true
KRAS	KRAS_Pro34Leu	-1.422648105997645	0.1978359955775831	4.762868314287779	0.002052621330944476																											true	KRAS	ENSG00000133703	3084	214481	CCSBVarC006093	ALE00006093	NC_000012.12:25245284:G:A	101C>T	Pro34Leu	CEGS2	CegsMutGDEh1035	F07	GDEhDisVCh_40061	H08	1	CegsMutGDDh1035	F07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Pro34Leu	12	25245284	G	A	12											12-25245284-G-A	40454	12	25245284	G	A	P	L	rs104894366	12	25398218	12	25289485	34	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>T	p.Pro34Leu	c.101C>T	p.Pro34Leu	alternative1	Y	1	.	Plus_Clinical	-	CCA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.155	0.88323	M	-8.45	0.98724	D	0.966	0.97658	0.8491	0.95002	D	0.8110	0.93606	D	10	0.9343852	0.92690	D	0.2884	0.90456	D	0.867	0.95976	0.768	0.89476	P01116	P34L	Gain of catalytic residue at I36 (P = 0.0054)| Loss of disorder (P = 0.0163)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.1364)| Loss of relative solvent accessibility (P = 0.1807)	0.993019268771	0.99286	0.9624586865523342	0.96210	2.72839044085	0.98645	0.913879752159	0.97821	D	0.916481	0.98452	D	0.461598	0.92940	D	0.425277	0.92852	D	0.999580919742584	0.98005	D	0.906909	0.69125	D	0.9735194	0.98554	0.9422203	0.97882	0.96042603	0.97281	0.9655402	0.99246	-15.775	0.98455	D	0.9976	0.97942	P	0.999893295116841	0.98645	0.99935130	0.99318	0.997	0.99892	.	.	.	.	.	.	5.430283	0.90819	31.0	0.99866189682566164	0.94461	0.907536	0.86118	D	1.07681546054986	0.97667	16.56095	1.0082682822431	0.98773	19.35518	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Noonan_syndrome|RASopathy|Noonan_syndrome_1|not_provided|Noonan_syndrome_3	reviewed_by_expert_panel	NC_000012.12:g.25245284G>A	ClinGen:CA235301|UniProtKB:P01116#VAR_064852	C0028326|C5555857|C4551602|C3661900|C1860991	PS163950|163950|609942	648|536391|648|648	Small GTP-binding domain	Pro	Leu	48924	single nucleotide variant	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3845	KRAS	HGNC:6407	Pathogenic	1	Sep 17, 2024	104894366	-	RCV000150892|RCV000232330|RCV003152670|RCV000157668|RCV003450654	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Noonan syndrome|RASopathy|Noonan syndrome 3|not provided|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25245284	25245284	12p12.1	reviewed by expert panel	7	-	N	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	2	40454	25245284	G	A	-	-	-	-	-	-	SCV000616368	-	-	101C>T 	Pro34Leu	NM_004985.5	3	1_Pathogenic																																																																																																									
KRAS	KRAS_Pro34Leu	-1.422648105997645	0.1978359955775831	4.762868314287779	0.002052621330944476																											true	KRAS		3084		CCSBVarC006093		NC_000012.12:25245284:G:A		Pro34Leu																												KRAS_Pro34Leu	12	25245284	G	A	12	allele	101C>T	C07	527_CAVA_Array_P03	F13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245284-G-A	40454	12	25245284	G	A	P	L	rs104894366	12	25398218	12	25289485	34	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>T	p.Pro34Leu	c.101C>T	p.Pro34Leu	alternative1	Y	1	.	Plus_Clinical	-	CCA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.155	0.88323	M	-8.45	0.98724	D	0.966	0.97658	0.8491	0.95002	D	0.8110	0.93606	D	10	0.9343852	0.92690	D	0.2884	0.90456	D	0.867	0.95976	0.768	0.89476	P01116	P34L	Gain of catalytic residue at I36 (P = 0.0054)| Loss of disorder (P = 0.0163)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.1364)| Loss of relative solvent accessibility (P = 0.1807)	0.993019268771	0.99286	0.9624586865523342	0.96210	2.72839044085	0.98645	0.913879752159	0.97821	D	0.916481	0.98452	D	0.461598	0.92940	D	0.425277	0.92852	D	0.999580919742584	0.98005	D	0.906909	0.69125	D	0.9735194	0.98554	0.9422203	0.97882	0.96042603	0.97281	0.9655402	0.99246	-15.775	0.98455	D	0.9976	0.97942	P	0.999893295116841	0.98645	0.99935130	0.99318	0.997	0.99892	.	.	.	.	.	.	5.430283	0.90819	31.0	0.99866189682566164	0.94461	0.907536	0.86118	D	1.07681546054986	0.97667	16.56095	1.0082682822431	0.98773	19.35518	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Noonan_syndrome|RASopathy|Noonan_syndrome_1|not_provided|Noonan_syndrome_3	reviewed_by_expert_panel	NC_000012.12:g.25245284G>A	ClinGen:CA235301|UniProtKB:P01116#VAR_064852	C0028326|C5555857|C4551602|C3661900|C1860991	PS163950|163950|609942	648|536391|648|648	Small GTP-binding domain	Pro	Leu	48924	single nucleotide variant	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3845	KRAS	HGNC:6407	Pathogenic	1	Sep 17, 2024	104894366	-	RCV000150892|RCV000232330|RCV003152670|RCV000157668|RCV003450654	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Noonan syndrome|RASopathy|Noonan syndrome 3|not provided|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25245284	25245284	12p12.1	reviewed by expert panel	7	-	N	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	2	40454	25245284	G	A	-	-	-	-	-	-	SCV000616368	-	-	101C>T 	Pro34Leu	NM_004985.5	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Thr241Arg	-8.877044476380464	0.0000466454663945854	6.127715259649578	0.000477871903155989	2025_01_Batch_13-14	0.8299258911292273	0.7721124795906301	0.8035507867832169	0.7584846614033833	0.7485082955646319											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220596	CCSBVarC003154	ALE00003154	NC_000007.14:140801550:G:C	722C>G	Thr241Arg	CEGS2	CegsMutGDEh1016	G06	GDEhDisVCh_40058	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Thr241Arg	7	140801550	G	C	7											7-140801550-G-C	29806	7	140801550	G	C	T	R	rs387906660	7	140501350	7	140147819	241	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.722C>G	p.Thr241Arg	c.722C>G	p.Thr241Arg	principal4	Y	.	YES	Select	-	ACG	2	0	G	./.	./.	./.	./.	.	0.91343	.	.	0.53421	.	1.0	0.90580	D	0.998	0.88579	D	.	0.86984	.	.	.	.	3.175	0.88626	M	.	0.77586	.	.	0.96886	0.9426	0.96274	D	0.8732	0.95778	D	10	0.9803134	0.97976	D	0.440713	0.94148	D	.	0.99124	0.93	0.98894	P15056	T241R	Gain of solvent accessibility (P = 0.008)| Gain of relative solvent accessibility (P = 0.0289)| Gain of MoRF binding (P = 0.033)| Gain of methylation at T241 (P = 0.0391)| Loss of ubiquitination at K240 (P = 0.0594)	.	0.98932	.	0.97131	.	0.95664	0.916709661484	0.98061	D	0.89813	0.97961	D	0.503099	0.94327	D	0.484891	0.94248	D	0.998121440410614	0.93238	D	0.983902	0.95725	D	0.94158983	0.95338	0.8970028	0.94691	0.92752135	0.93899	0.90271693	0.95103	-14.509	0.94604	D	0.9977	0.98500	P	0.999963000543786	0.99297	0.99600226	0.97933	0.973	0.98982	.	.	.	.	.	.	5.408322	0.90554	31.0	0.99652661569364764	0.77405	0.880398	0.80631	D	0.884148484170867	0.90911	10.64868	0.845660358607975	0.92720	11.61548	5.17	5.17	0.70808	.	.	9.943	0.9894	11.755000	0.95501	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.94	0.48078	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Inborn_genetic_diseases|RASopathy|not_provided|Noonan_syndrome_7|Noonan_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801550G>C	ClinGen:CA259663|OMIM:164757.0023|UniProtKB:P15056#VAR_058622	C0950123|C5555857|C3661900|C3150970|C4551602	613706|163950	536391|648|648	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Arg	38761	single nucleotide variant	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	673	BRAF	HGNC:1097	Pathogenic	1	Feb 01, 2023	387906660	-	RCV000022679|RCV000208548|RCV002513171|RCV000624512|RCV001703420	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Noonan syndrome 7|Noonan syndrome 1|RASopathy|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	140801550	140801550	7q34	criteria provided, multiple submitters, no conflicts	5	-	N	UniProtKB:P15056#VAR_058622,OMIM:164757.0023,ClinGen:CA259663	3	29806	140801550	G	C	-	-	-	-	-	-	SCV000057185|SCV000743069|SCV003440618	-	-	722C>G 	Thr241Arg	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Thr241Arg	-8.877044476380464	0.0000466454663945854	6.127715259649578	0.000477871903155989	2025_01_Batch_13-14	0.8299258911292273	0.7721124795906301	0.8035507867832169	0.7584846614033833	0.7485082955646319											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003154		NC_000007.14:140801550:G:C		Thr241Arg																												BRAF_Thr241Arg	7	140801550	G	C	7	allele	722C>G	D05	527_CAVA_Array_P01	G09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801550-G-C	29806	7	140801550	G	C	T	R	rs387906660	7	140501350	7	140147819	241	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.722C>G	p.Thr241Arg	c.722C>G	p.Thr241Arg	principal4	Y	.	YES	Select	-	ACG	2	0	G	./.	./.	./.	./.	.	0.91343	.	.	0.53421	.	1.0	0.90580	D	0.998	0.88579	D	.	0.86984	.	.	.	.	3.175	0.88626	M	.	0.77586	.	.	0.96886	0.9426	0.96274	D	0.8732	0.95778	D	10	0.9803134	0.97976	D	0.440713	0.94148	D	.	0.99124	0.93	0.98894	P15056	T241R	Gain of solvent accessibility (P = 0.008)| Gain of relative solvent accessibility (P = 0.0289)| Gain of MoRF binding (P = 0.033)| Gain of methylation at T241 (P = 0.0391)| Loss of ubiquitination at K240 (P = 0.0594)	.	0.98932	.	0.97131	.	0.95664	0.916709661484	0.98061	D	0.89813	0.97961	D	0.503099	0.94327	D	0.484891	0.94248	D	0.998121440410614	0.93238	D	0.983902	0.95725	D	0.94158983	0.95338	0.8970028	0.94691	0.92752135	0.93899	0.90271693	0.95103	-14.509	0.94604	D	0.9977	0.98500	P	0.999963000543786	0.99297	0.99600226	0.97933	0.973	0.98982	.	.	.	.	.	.	5.408322	0.90554	31.0	0.99652661569364764	0.77405	0.880398	0.80631	D	0.884148484170867	0.90911	10.64868	0.845660358607975	0.92720	11.61548	5.17	5.17	0.70808	.	.	9.943	0.9894	11.755000	0.95501	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.94	0.48078	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Inborn_genetic_diseases|RASopathy|not_provided|Noonan_syndrome_7|Noonan_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801550G>C	ClinGen:CA259663|OMIM:164757.0023|UniProtKB:P15056#VAR_058622	C0950123|C5555857|C3661900|C3150970|C4551602	613706|163950	536391|648|648	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Arg	38761	single nucleotide variant	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	673	BRAF	HGNC:1097	Pathogenic	1	Feb 01, 2023	387906660	-	RCV000022679|RCV000208548|RCV002513171|RCV000624512|RCV001703420	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Noonan syndrome 7|Noonan syndrome 1|RASopathy|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000007.14	7	140801550	140801550	7q34	criteria provided, multiple submitters, no conflicts	5	-	N	UniProtKB:P15056#VAR_058622,OMIM:164757.0023,ClinGen:CA259663	3	29806	140801550	G	C	-	-	-	-	-	-	SCV000057185|SCV000743069|SCV003440618	-	-	722C>G 	Thr241Arg	NM_004333.6	2	1_Pathogenic																																																																																																									
FH	FH_Arg160Gly	7.053545849662073	0.00040631942806925705	-6.7751149070571115	0.0002590061663729525	2025_01_Batch_13-14	0.9376294565533879	0.9837924347182717	0.9975807407127623	0.9927809552237875	0.993994406740671																					true	FH		3408		CCSBVarC000453		NC_000001.11:241512044:T:C		Arg160Gly																												FH_Arg160Gly	1	241512044	T	C	1	allele	478A>G	A04	527_CAVA_Array_P03	B07	B13A7A8P1_R1	B14A7A8P1_R2				1-241512044-T-C	237116	1	241512044	T	C	R	G	rs878853694	1	241675344	1	239741967	160	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.478A>G	p.Arg160Gly	c.478A>G	p.Arg160Gly	principal1	Y	1	YES	Select	-	AGA	1	2	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.0	0.92967	D	0.998	0.73231	D	0.975	0.73364	D	0.71	0.82936	A	simple_aae	29.0	71.0	4.81	0.99656	H	-6.64	0.92238	D	0.943	0.95034	0.9804	0.96857	D	0.9928	0.99829	D	10	0.9792192	0.97811	D	0.851385	0.98852	D	0.920	0.97963	0.813	0.92818	P07954	R160G	Loss of catalytic residue at R160 (P = 0.0886)| Gain of loop (P = 0.1069)| Loss of stability (P = 0.1215)| Gain of disorder (P = 0.1881)| Loss of helix (P = 0.2022)	0.979233309591	0.97880	0.9654764021894513	0.96515	1.07981011161	0.76970	0.771721363068	0.77643	T	0.98538	0.99908	D	0.550818	0.95775	D	0.553435	0.95711	D	0.998749494552612	0.94994	D	0.991801	0.97448	D	0.975441	0.98723	0.9348335	0.97387	0.975441	0.98723	0.9348335	0.97387	-13.725	0.92144	D	0.982	0.91531	P	0.999915695951876	0.98806	0.93021200	0.92401	0.976	0.99121	.	.	.	.	.	.	4.663639	0.74516	26.2	0.99852011306919974	0.93107	0.644088	0.61910	D	0.765365713599	0.83814	8.140567	0.616020889310283	0.75972	6.42976	5.24	4.1	0.47135	4.75	0.87304	2.846	0.4806	3.698000	0.39597	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	968	0.07020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613996	6.195800e-07	0	1	1179892	8.475350e-07	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60028	0.000000e+00	0	0	29596	0.000000e+00	0	0	44868	0.000000e+00	0	0	64008	0.000000e+00	0	0	6060	0.000000e+00	0	1	1179892	8.475350e-07	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241512044T>C	ClinGen:CA10581784	C0027672|C3661900	.	140162	Fumarate lyase, N-terminal	Arg	Gly	238260	single nucleotide variant	NM_000143.4(FH):c.478A>G (p.Arg160Gly)	2271	FH	HGNC:3700	Pathogenic	1	Nov 16, 2023	878853694	-	RCV001782719|RCV001023046	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000001.11	1	241512044	241512044	1q43	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA10581784	2	237116	241512044	T	C	-	-	-	-	-	-	SCV000283673|SCV001184862	-	-	478A>G 	Arg160Gly	NM_000143.4	2	1_Pathogenic	1	241512044	T	C	6.84158e-7																																																																																																				
BRAF	BRAF_Lys499Asn	-4.944762682826767	0.0016661142958100037	5.574798126697147	0.0008377883870810507	2025_01_Batch_13-14	0.6633039561986507	0.6996246581318293	0.7713521227339928	0.7623872845325846	0.5442598720342052	0.6615102294809463	0.7097992368420202	0.7316570262664239	0.6880806223967423	0.5794403314132704	0.6624070928397985	0.7047119474869248	0.7515045745002084	0.7252339534646635	0.5618501017237378	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003166		NC_000007.14:140778011:T:G		Lys499Asn																												BRAF_Lys499Asn	7	140778011	T	G	7	allele	1497A>C	E04	527_CAVA_Array_P01	I07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778011-T-G	40371	7	140778011	T	G	K	N	rs397507476	7	140477811	7	140124280	499	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1497A>C	p.Lys499Asn	c.1497A>C	p.Lys499Asn	principal4	Y	.	YES	Select	-	AAA	3	2	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	0.947	0.53490	P	0.688	0.53696	P	.	0.97926	.	.	.	.	0.965	0.23851	L	.	.	.	.	.	0.1071	0.84236	D	0.5198	0.81988	D	10	0.9434156	0.93596	D	0.1256	0.80658	D	.	0.88818	0.889	0.97257	P15056	K499N	Loss of methylation at K499 (P = 0.0305)| Loss of MoRF binding (P = 0.0517)| Loss of ubiquitination at K499 (P = 0.0546)| Gain of helix (P = 0.2059)| Gain of disorder (P = 0.292)	.	0.81448	.	0.87500	.	0.95599	0.913059830666	0.97749	D	0.824469	0.95710	D	0.110668	0.65175	D	-0.078809	0.64743	T	0.9956134557724	0.87648	D	0.958804	0.84469	D	0.97060555	0.98288	0.9186677	0.96252	0.9693646	0.98171	0.9186677	0.96252	-12.924	0.89071	D	0.9993	0.99393	P	0.999246574469187	0.96052	0.99575126	0.97865	0.98	0.99294	.	.	.	.	.	.	4.441576	0.69029	25.3	0.99865938726691972	0.94371	0.620121	0.60389	D	0.22632943565752	0.52240	3.421713	0.30192289424299	0.55416	3.728117	4.96	4.96	0.65108	4.21	0.80015	3.119	0.50212	4.195000	0.42508	0.605	0.46302	1.0	0.71675	1.000000	0.68239	1.0	0.97202	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778011T>G	ClinGen:CA281974|UniProtKB:P15056#VAR_058625	C1275081|C3661900	PS115150	1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Lys	Asn	48841	single nucleotide variant	NM_004333.6(BRAF):c.1497A>C (p.Lys499Asn)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Jul 23, 2015	397507476	-	RCV000207509|RCV001814021	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	not provided|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140778011	140778011	7q34	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA281974,UniProtKB:P15056#VAR_058625	2	40371	140778011	T	G	-	-	-	-	-	-	SCV000057218|SCV000263064	-	-	1497A>C 	Lys499Asn	NM_004333.6	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Glu116Lys	-0.5233944689523996	0.6168548518585896	-8.233502008527779	0.00007581852114808089	2025_01_Batch_13-14	0.5045541015624009	0.8997581228520514	0.9684817915298322	0.9519226502253639	0.53067015370023	0.47863625149603095	0.8685349197079164	0.9460941132888923	0.8720732274871875	0.5636348664071934	0.4915951765292159	0.8841465212799839	0.9572879524093623	0.9119979388562758	0.5471525100537117	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218399	CCSBVarC003298	ALE00003298	NC_000017.11:43104217:C:T	346G>A	Glu116Lys	CEGS2	CegsMutGDEh1028	G06	GDEhDisVCh_40059	G09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Glu116Lys	17	43104217	C	T	17											17-43104217-C-T	54893	17	43104217	C	T	E	K	rs397509071	17	41256234	17	38509760	116	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.346G>A	p.Glu116Lys	c.346G>A	p.Glu116Lys	principal2	Y	1	YES	Select	-	GAA	1	0	C	./.	./.	./.	./.	0.001	0.78662	D	0.015	0.61973	D	0.956	0.54679	P	0.275	0.40079	B	0.99	0.97926	D	simple_aae	1.0	99.0	2.455	0.71058	M	-0.56	0.54726	N	0.665	0.73073	1.0626	0.98399	D	0.9333	0.97797	D	10	0.75375986	0.75596	D	0.687104	0.97412	D	0.698	0.89052	.	.	.	.	.	0.936910906656	0.93576	.	0.48618	.	0.25914	0.455957233906	0.32716	T	0.167623	0.51184	T	0.458962	0.92824	D	0.42149	0.92735	D	0.960671126842499	0.65652	D	.	0.90678	.	0.30580968	0.53088	0.31052214	0.56841	0.29307255	0.51944	0.32331142	0.58036	-4.132	0.26444	T	0.103	0.24020	B	0.315487270864402	0.54793	0.99916387	0.99185	0.137	0.36038	.	.	.	.	.	.	3.863469	0.56124	23.7	0.99917023792078985	0.98450	0.588432	0.58423	D	0.519732155081613	0.68091	5.192408	0.544271718873321	0.70840	5.588604	5.32	5.32	0.75341	.	.	2.768	0.47428	3.839000	0.40112	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	17708	0	0	292	0	0	84	0	2	7360	2.717391304347826E-4	0	146	0	0	610	0	0	24	0	0	94	0	0	1904	0	2	7652	2.6136957658128593E-4	0	108	0	2	28222	7.086669973779322E-5	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast	criteria_provided,_single_submitter	NC_000017.11:g.43104217C>T	ClinGen:CA002236	C0027672|C0346153	114480	140162|227535	.	Glu	Lys	69560	single nucleotide variant	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	672	BRCA1	HGNC:1100	Uncertain significance	0	Jan 25, 2022	397509071	-	RCV000577079|RCV002453364	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43104217	43104217	17q21.31	criteria provided, single submitter	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002236	3	54893	43104217	C	T	-	-	-	-	-	-	SCV002612990	-	-	346G>A 	Glu116Lys	NM_007294.4	1	4_VUS																																																																																																									
BRCA1	BRCA1_Glu116Lys	-0.5233944689523996	0.6168548518585896	-8.233502008527779	0.00007581852114808089	2025_01_Batch_13-14	0.5045541015624009	0.8997581228520514	0.9684817915298322	0.9519226502253639	0.53067015370023	0.47863625149603095	0.8685349197079164	0.9460941132888923	0.8720732274871875	0.5636348664071934	0.4915951765292159	0.8841465212799839	0.9572879524093623	0.9119979388562758	0.5471525100537117	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003298		NC_000017.11:43104217:C:T		Glu116Lys																												BRCA1_Glu116Lys	17	43104217	C	T	17	allele	346G>A	A07	527_CAVA_Array_P01	A13	B13A7A8P1_R1	B14A7A8P1_R2				17-43104217-C-T	54893	17	43104217	C	T	E	K	rs397509071	17	41256234	17	38509760	116	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.346G>A	p.Glu116Lys	c.346G>A	p.Glu116Lys	principal2	Y	1	YES	Select	-	GAA	1	0	C	./.	./.	./.	./.	0.001	0.78662	D	0.015	0.61973	D	0.956	0.54679	P	0.275	0.40079	B	0.99	0.97926	D	simple_aae	1.0	99.0	2.455	0.71058	M	-0.56	0.54726	N	0.665	0.73073	1.0626	0.98399	D	0.9333	0.97797	D	10	0.75375986	0.75596	D	0.687104	0.97412	D	0.698	0.89052	.	.	.	.	.	0.936910906656	0.93576	.	0.48618	.	0.25914	0.455957233906	0.32716	T	0.167623	0.51184	T	0.458962	0.92824	D	0.42149	0.92735	D	0.960671126842499	0.65652	D	.	0.90678	.	0.30580968	0.53088	0.31052214	0.56841	0.29307255	0.51944	0.32331142	0.58036	-4.132	0.26444	T	0.103	0.24020	B	0.315487270864402	0.54793	0.99916387	0.99185	0.137	0.36038	.	.	.	.	.	.	3.863469	0.56124	23.7	0.99917023792078985	0.98450	0.588432	0.58423	D	0.519732155081613	0.68091	5.192408	0.544271718873321	0.70840	5.588604	5.32	5.32	0.75341	.	.	2.768	0.47428	3.839000	0.40112	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	17708	0	0	292	0	0	84	0	2	7360	2.717391304347826E-4	0	146	0	0	610	0	0	24	0	0	94	0	0	1904	0	2	7652	2.6136957658128593E-4	0	108	0	2	28222	7.086669973779322E-5	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast	criteria_provided,_single_submitter	NC_000017.11:g.43104217C>T	ClinGen:CA002236	C0027672|C0346153	114480	140162|227535	.	Glu	Lys	69560	single nucleotide variant	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	672	BRCA1	HGNC:1100	Uncertain significance	0	Jan 25, 2022	397509071	-	RCV000577079|RCV002453364	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43104217	43104217	17q21.31	criteria provided, single submitter	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002236	3	54893	43104217	C	T	-	-	-	-	-	-	SCV002612990	-	-	346G>A 	Glu116Lys	NM_007294.4	1	4_VUS																																																																																																									
FH	FH_Ser334Arg	0.5356287401458311	0.6114778201904933	-5.513451391166578	0.0008937233895488164	2025_01_Batch_13-14	0.8007347478615932	0.8589931606726063	0.8978571531593534	0.9153387714918513	0.7111055567943652	0.8033091007193875	0.838310274110057	0.9268423305735295	0.8967450792009897	0.7993948760244484	0.8020219242904904	0.8486517173913317	0.9123497418664415	0.9060419253464205	0.7552502164094068	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214599	CCSBVarC004053	ALE00004053	NC_000001.11:241504148:A:C	1002T>G	Ser334Arg	CEGS2	CegsMutGDEh1041	C09	GDEhDisVCh_40065	H08	1	CegsMutGDDh1041	C09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Ser334Arg	1	241504148	A	C	1											1-241504148-A-C	2506143	1	241504148	A	C	S	R	rs2147916185	1	241667448	1	239734071	334	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1002T>G	p.Ser334Arg	c.1002T>G	p.Ser334Arg	principal1	Y	1	YES	Select	-	AGT	3	2	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.55	0.93172	H	-4.9	0.81545	D	0.983	0.99270	1.0955	0.99468	D	0.9817	0.99438	D	10	0.96632713	0.96080	D	0.928795	0.99481	D	0.902	0.97281	0.765	0.89238	P07954	S334R	Gain of MoRF binding (P = 0.012)| Gain of methylation at S334 (P = 0.1999)| Gain of catalytic residue at S334 (P = 0.2478)| Gain of ubiquitination at K337 (P = 0.2694)| Loss of helix (P = 0.3949)	0.986805441107	0.98651	0.991474710610662	0.99141	1.03551510566	0.75429	0.77938503027	0.78796	T	0.968915	0.99646	D	0.540935	0.95434	D	0.539239	0.95366	D	0.996222853660583	0.88820	D	0.991801	0.97448	D	0.988074	0.99652	0.94546735	0.98092	0.988074	0.99652	0.94546735	0.98092	-15.188	0.96286	D	0.9943	0.95185	P	0.999937025252751	0.98982	0.96908960	0.94587	0.973	0.98982	.	.	.	.	.	.	3.81089	0.55043	23.6	0.99825879520171334	0.90858	0.530379	0.54952	D	0.60202261948517	0.73159	5.94406	0.506605376223128	0.68262	5.219445	5.73	3.45	0.38530	2.53	0.46530	1.348	0.33697	1.133000	0.24427	0.756	0.943	1.0	0.71675	0.994000	0.32271	0.999	0.91597	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_single_submitter	NC_000001.11:g.241504148A>C	.	C1708350	150800	523	Fumarate lyase, N-terminal	Ser	Arg	1314676	single nucleotide variant	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	2271	FH	HGNC:3700	Likely pathogenic	1	May 22, 2023	2147916185	-	RCV003236374	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary leiomyomatosis and renal cell cancer	germline	germline	GRCh38	NC_000001.11	1	241504148	241504148	1q43	criteria provided, single submitter	1	-	N	ClinGen:CA345438245	2	2506143	241504148	A	C	-	-	-	-	-	-	SCV003934314	-	-	1002T>G 	Ser334Arg	NM_000143.4	1	1_Pathogenic																																																																																																									
FH	FH_Ser334Arg	0.5356287401458311	0.6114778201904933	-5.513451391166578	0.0008937233895488164	2025_01_Batch_13-14	0.8007347478615932	0.8589931606726063	0.8978571531593534	0.9153387714918513	0.7111055567943652	0.8033091007193875	0.838310274110057	0.9268423305735295	0.8967450792009897	0.7993948760244484	0.8020219242904904	0.8486517173913317	0.9123497418664415	0.9060419253464205	0.7552502164094068	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004053		NC_000001.11:241504148:A:C		Ser334Arg																												FH_Ser334Arg	1	241504148	A	C	1	allele	1002T>G	H03	527_CAVA_Array_P03	P05	B13A7A8P1_R1	B14A7A8P1_R2				1-241504148-A-C	2506143	1	241504148	A	C	S	R	rs2147916185	1	241667448	1	239734071	334	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1002T>G	p.Ser334Arg	c.1002T>G	p.Ser334Arg	principal1	Y	1	YES	Select	-	AGT	3	2	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.55	0.93172	H	-4.9	0.81545	D	0.983	0.99270	1.0955	0.99468	D	0.9817	0.99438	D	10	0.96632713	0.96080	D	0.928795	0.99481	D	0.902	0.97281	0.765	0.89238	P07954	S334R	Gain of MoRF binding (P = 0.012)| Gain of methylation at S334 (P = 0.1999)| Gain of catalytic residue at S334 (P = 0.2478)| Gain of ubiquitination at K337 (P = 0.2694)| Loss of helix (P = 0.3949)	0.986805441107	0.98651	0.991474710610662	0.99141	1.03551510566	0.75429	0.77938503027	0.78796	T	0.968915	0.99646	D	0.540935	0.95434	D	0.539239	0.95366	D	0.996222853660583	0.88820	D	0.991801	0.97448	D	0.988074	0.99652	0.94546735	0.98092	0.988074	0.99652	0.94546735	0.98092	-15.188	0.96286	D	0.9943	0.95185	P	0.999937025252751	0.98982	0.96908960	0.94587	0.973	0.98982	.	.	.	.	.	.	3.81089	0.55043	23.6	0.99825879520171334	0.90858	0.530379	0.54952	D	0.60202261948517	0.73159	5.94406	0.506605376223128	0.68262	5.219445	5.73	3.45	0.38530	2.53	0.46530	1.348	0.33697	1.133000	0.24427	0.756	0.943	1.0	0.71675	0.994000	0.32271	0.999	0.91597	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_single_submitter	NC_000001.11:g.241504148A>C	.	C1708350	150800	523	Fumarate lyase, N-terminal	Ser	Arg	1314676	single nucleotide variant	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	2271	FH	HGNC:3700	Likely pathogenic	1	May 22, 2023	2147916185	-	RCV003236374	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary leiomyomatosis and renal cell cancer	germline	germline	GRCh38	NC_000001.11	1	241504148	241504148	1q43	criteria provided, single submitter	1	-	N	ClinGen:CA345438245	2	2506143	241504148	A	C	-	-	-	-	-	-	SCV003934314	-	-	1002T>G 	Ser334Arg	NM_000143.4	1	1_Pathogenic																																																																																																									
FH	FH_Leu303Ser	4.116431421416617	0.006241164929272879	-6.345032355574454	0.00038706498420756636	2025_01_Batch_13-14	0.8505563411567992	0.859268928404852	0.8885463987713997	0.9118880825508586	0.7094237006526922	0.6280580150688557	0.8204002263080932	0.8932375913349474	0.7610136797967357	0.60468249164271	0.7393071781128275	0.8398345773564726	0.8908919950531735	0.8364508811737972	0.6570530961477011	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214596	CCSBVarC004051	ALE00004051	NC_000001.11:241504242:A:G	908T>C	Leu303Ser	CEGS2	CegsMutGDEh1040	C11	GDEhDisVCh_40065	F08	1	CegsMutGDDh1040	C11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Leu303Ser	1	241504242	A	G	1											1-241504242-A-G	41584	1	241504242	A	G	L	S	rs201502246	1	241667542	1	239734165	303	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.908T>C	p.Leu303Ser	c.908T>C	p.Leu303Ser	principal1	Y	1	YES	Select	-	TTG	2	0	A	./.	./.	./.	./.	0.011	0.55689	D	0.023	0.57446	D	1.0	0.90580	D	0.987	0.77493	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.44	0.92016	M	-4.68	0.79692	D	0.874	0.87133	0.9670	0.96644	D	0.9919	0.99799	D	10	0.9618218	0.95552	D	0.846144	0.98810	D	0.946	0.98921	0.745	0.87592	P07954	L303S	Loss of stability (P = 0.0343)| Gain of glycosylation at L303 (P = 0.0808)| Gain of disorder (P = 0.2233)| Gain of phosphorylation at T301 (P = 0.2914)| Gain of MoRF binding (P = 0.2989)	0.993238567584	0.99308	0.9823634086207722	0.98220	0.74807911618	0.63377	0.741951107979	0.73213	T	0.984249	0.99894	D	0.547779	0.95628	D	0.564556	0.95967	D	0.981520354747772	0.73778	D	0.970103	0.89232	D	0.72908586	0.79431	0.67910284	0.80933	0.72908586	0.79432	0.67910284	0.80934	-11.157	0.80574	D	0.7218	0.73810	P	0.993515370856004	0.90091	0.94387890	0.93050	0.8	0.88939	.	.	.	.	.	.	4.874147	0.7991	27.2	0.99846162936952287	0.92581	0.938010	0.93635	D	1.02294957323601	0.96387	14.65791	0.942700215822651	0.97163	15.70981	5.73	5.73	0.89714	6.28	0.98834	8.711	0.91115	11.145000	0.87201	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.992	0.67791	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	0	109296	0.000000e+00	0	2	207286	9.648500e-06	0	1	235642	4.243730e-06	0	0	7160	0.000000e+00	0	0	17080	0.000000e+00	0	0	2318	0.000000e+00	0	0	9036	0.000000e+00	0	0	13390	0.000000e+00	0	0	42732	0.000000e+00	0	0	15672	0.000000e+00	0	.	.	.	.	0	15810	0.000000e+00	0	0	30442	0.000000e+00	0	0	6202	0.000000e+00	0	0	13406	0.000000e+00	0	0	16720	0.000000e+00	0	2	89310	2.239390e-05	0	0	30572	0.000000e+00	0	2	89310	2.239390e-05	0	0	14502	0.000000e+00	0	0	34174	0.000000e+00	0	0	9556	0.000000e+00	0	0	17666	0.000000e+00	0	0	21616	0.000000e+00	0	1	102080	9.796240e-06	0	0	30490	0.000000e+00	0	1	102080	9.796240e-06	0	.	65	1613904	4.027500e-05	0	65	1179950	5.508710e-05	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44900	0.000000e+00	0	0	64028	0.000000e+00	0	0	6030	0.000000e+00	0	65	1179950	5.508710e-05	0	0	91074	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency	criteria_provided,_conflicting_classifications	NC_000001.11:g.241504242A>G	ClinGen:CA215563	C3661900|C0027672|C0342770	606812	140162|24	Fumarate lyase, N-terminal	Leu	Ser	50023	single nucleotide variant	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	2271	FH	HGNC:3700	Conflicting classifications of pathogenicity	1	Jan 08, 2025	201502246	-	RCV000568576|RCV004767031|RCV000034486|RCV000471678	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not specified|not provided|Fumarase deficiency	germline	germline	GRCh38	NC_000001.11	1	241504242	241504242	1q43	criteria provided, conflicting classifications	8	-	N	ClinGen:CA215563	2	41584	241504242	A	G	-	-	-	-	-	-	SCV000544239|SCV000673377|SCV001986003|SCV002535579|SCV004224834|SCV005381789	-	-	908T>C 	Leu303Ser	NM_000143.4	1	3_Conflicting	1	241504242	A	G	0.0000437859																																																																																																				
FH	FH_Leu303Ser	4.116431421416617	0.006241164929272879	-6.345032355574454	0.00038706498420756636	2025_01_Batch_13-14	0.8505563411567992	0.859268928404852	0.8885463987713997	0.9118880825508586	0.7094237006526922	0.6280580150688557	0.8204002263080932	0.8932375913349474	0.7610136797967357	0.60468249164271	0.7393071781128275	0.8398345773564726	0.8908919950531735	0.8364508811737972	0.6570530961477011	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004051		NC_000001.11:241504242:A:G		Leu303Ser																												FH_Leu303Ser	1	241504242	A	G	1	allele	908T>C	F03	527_CAVA_Array_P03	L05	B13A7A8P1_R1	B14A7A8P1_R2				1-241504242-A-G	41584	1	241504242	A	G	L	S	rs201502246	1	241667542	1	239734165	303	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.908T>C	p.Leu303Ser	c.908T>C	p.Leu303Ser	principal1	Y	1	YES	Select	-	TTG	2	0	A	./.	./.	./.	./.	0.011	0.55689	D	0.023	0.57446	D	1.0	0.90580	D	0.987	0.77493	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.44	0.92016	M	-4.68	0.79692	D	0.874	0.87133	0.9670	0.96644	D	0.9919	0.99799	D	10	0.9618218	0.95552	D	0.846144	0.98810	D	0.946	0.98921	0.745	0.87592	P07954	L303S	Loss of stability (P = 0.0343)| Gain of glycosylation at L303 (P = 0.0808)| Gain of disorder (P = 0.2233)| Gain of phosphorylation at T301 (P = 0.2914)| Gain of MoRF binding (P = 0.2989)	0.993238567584	0.99308	0.9823634086207722	0.98220	0.74807911618	0.63377	0.741951107979	0.73213	T	0.984249	0.99894	D	0.547779	0.95628	D	0.564556	0.95967	D	0.981520354747772	0.73778	D	0.970103	0.89232	D	0.72908586	0.79431	0.67910284	0.80933	0.72908586	0.79432	0.67910284	0.80934	-11.157	0.80574	D	0.7218	0.73810	P	0.993515370856004	0.90091	0.94387890	0.93050	0.8	0.88939	.	.	.	.	.	.	4.874147	0.7991	27.2	0.99846162936952287	0.92581	0.938010	0.93635	D	1.02294957323601	0.96387	14.65791	0.942700215822651	0.97163	15.70981	5.73	5.73	0.89714	6.28	0.98834	8.711	0.91115	11.145000	0.87201	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.992	0.67791	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	0	109296	0.000000e+00	0	2	207286	9.648500e-06	0	1	235642	4.243730e-06	0	0	7160	0.000000e+00	0	0	17080	0.000000e+00	0	0	2318	0.000000e+00	0	0	9036	0.000000e+00	0	0	13390	0.000000e+00	0	0	42732	0.000000e+00	0	0	15672	0.000000e+00	0	.	.	.	.	0	15810	0.000000e+00	0	0	30442	0.000000e+00	0	0	6202	0.000000e+00	0	0	13406	0.000000e+00	0	0	16720	0.000000e+00	0	2	89310	2.239390e-05	0	0	30572	0.000000e+00	0	2	89310	2.239390e-05	0	0	14502	0.000000e+00	0	0	34174	0.000000e+00	0	0	9556	0.000000e+00	0	0	17666	0.000000e+00	0	0	21616	0.000000e+00	0	1	102080	9.796240e-06	0	0	30490	0.000000e+00	0	1	102080	9.796240e-06	0	.	65	1613904	4.027500e-05	0	65	1179950	5.508710e-05	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44900	0.000000e+00	0	0	64028	0.000000e+00	0	0	6030	0.000000e+00	0	65	1179950	5.508710e-05	0	0	91074	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency	criteria_provided,_conflicting_classifications	NC_000001.11:g.241504242A>G	ClinGen:CA215563	C3661900|C0027672|C0342770	606812	140162|24	Fumarate lyase, N-terminal	Leu	Ser	50023	single nucleotide variant	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	2271	FH	HGNC:3700	Conflicting classifications of pathogenicity	1	Jan 08, 2025	201502246	-	RCV000568576|RCV004767031|RCV000034486|RCV000471678	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not specified|not provided|Fumarase deficiency	germline	germline	GRCh38	NC_000001.11	1	241504242	241504242	1q43	criteria provided, conflicting classifications	8	-	N	ClinGen:CA215563	2	41584	241504242	A	G	-	-	-	-	-	-	SCV000544239|SCV000673377|SCV001986003|SCV002535579|SCV004224834|SCV005381789	-	-	908T>C 	Leu303Ser	NM_000143.4	1	3_Conflicting	1	241504242	A	G	0.0000437859																																																																																																				
ABCD1	ABCD1_Arg518Trp	8.231574645280068	0.00007593249847055185	-2.9770111643332635	0.020601941044853928																											true	ABCD1		100008637		CCSBVarC007022		NC_000023.11:153740155:C:T		Arg518Trp																												ABCD1_Arg518Trp	23	153740155	C	T	X	allele	1552C>T	B01	527_CAVA_Array_P01	C01	B13A7A8P1_R1	B14A7A8P1_R2				X-153740155-C-T	11307	X	153740155	C	T	R	W	rs128624224	X	153005609	X	152658803	518	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1552C>T	p.Arg518Trp	c.1552C>T	p.Arg518Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.0	0.92967	D	0.9	0.49610	P	0.635	0.51905	P	0.93	0.93829	A	simple_aae	7.0	93.0	3.32	0.90595	M	-7.19	0.94211	D	0.914	0.91621	1.0183	0.97497	D	0.9928	0.99829	D	9	0.9946109	0.99953	D	0.948221	0.99641	D	0.844	0.95124	0.968	0.99690	P33897	R518W	Gain of catalytic residue at L516 (P = 0.0119)| Gain of methylation at K513 (P = 0.0313)| Loss of MoRF binding (P = 0.1001)| Loss of ubiquitination at K513 (P = 0.1202)| Loss of disorder (P = 0.1253)	0.99953428563	0.99951	0.9495563564850404	0.94907	1.28273602722	0.82497	0.730939924717	0.71594	T	0.990187	0.99956	D	0.634204	0.99871	D	0.673213	0.99870	D	0.978487551212311	0.72158	D	0.976102	0.91686	D	0.84760565	0.86987	0.8724228	0.92940	0.84760565	0.86989	0.8724228	0.92940	-15.212	0.96338	D	0.9663	0.88858	P	0.999868428588881	0.98431	0.99881697	0.98981	0.966	0.98629	.	.	.	.	.	.	4.573317	0.72229	25.8	0.99908012509830546	0.97802	.	.	.	.	.	.	.	.	.	4.93	4.06	0.46510	.	.	0.985	0.29273	.	.	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.929	0.46613	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic/Likely_pathogenic	X-linked_spondyloepimetaphyseal_dysplasia|Adrenoleukodystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153740155C>T	ClinGen:CA278115|OMIM:300371.0016|UniProtKB:P33897#VAR_000071	C1848097|C0162309|C3661900	300106|300100	93349|43	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	Arg	Trp	26346	single nucleotide variant	NM_000033.4(ABCD1):c.1552C>T (p.Arg518Trp)	215	ABCD1	HGNC:61	Pathogenic/Likely pathogenic	1	Oct 05, 2022	128624224	-	RCV000012059|RCV001358358|RCV000723537	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MONDO:MONDO:0010248,MedGen:C1848097,OMIM:300106,Orphanet:93349|MedGen:C3661900	Adrenoleukodystrophy|X-linked spondyloepimetaphyseal dysplasia|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	153740155	153740155	Xq28	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA278115,UniProtKB:P33897#VAR_000071,OMIM:300371.0016	3	11307	153740155	C	T	-	-	-	-	-	-	SCV000109783|SCV000918373|SCV001249771|SCV001592684|SCV002045831|SCV003920874|SCV005418162	-	-	1552C>T 	Arg518Trp	NM_000033.4	2	1_Pathogenic																																																																																																									
F9	F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	2444124	X	139561689	G	A	C	Y	.	X	138643848	X	138471514	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.97780	D	10	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.99785198512514828	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	2417857	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158	F9	HGNC:3551	Likely pathogenic	1	Feb 23, 2023	-1	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689	139561689	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414445316	2	2444124	139561689	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1	1_Pathogenic						143361	F9_Popp_2025_carboxy_F9_specific_var227706	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561689.0	139561689.0		1004			335.0	C	Y	c.1004G>A	p.Cys335Tyr	missense_variant	0.002802343			No		Likely pathogenic	criteria provided, single submitter	Feb 23, 2023	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.959																																																											F9_Cys335Tyr	Cys335Tyr	true
F9	F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	2444124	X	139561689	G	A	C	Y	.	X	138643848	X	138471514	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.97780	D	10	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.99785198512514828	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	2417857	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158	F9	HGNC:3551	Likely pathogenic	1	Feb 23, 2023	-1	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689	139561689	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414445316	2	2444124	139561689	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1	1_Pathogenic						198393	F9_Popp_2025_heavy_chain_var237387	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561689.0	139561689.0		1004			335.0	C	Y	c.1004G>A	p.Cys335Tyr	missense_variant	0.065910745			No		Likely pathogenic	criteria provided, single submitter	Feb 23, 2023	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.959																																																											F9_Cys335Tyr	Cys335Tyr	true
F9	F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	2444124	X	139561689	G	A	C	Y	.	X	138643848	X	138471514	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.97780	D	10	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.99785198512514828	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	2417857	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158	F9	HGNC:3551	Likely pathogenic	1	Feb 23, 2023	-1	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689	139561689	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414445316	2	2444124	139561689	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1	1_Pathogenic						253425	F9_Popp_2025_strep_2_var266430	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561689.0	139561689.0		1004			335.0	C	Y	c.1004G>A	p.Cys335Tyr	missense_variant	0.048180928625395			No		Likely pathogenic	criteria provided, single submitter	Feb 23, 2023	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.959																																																											F9_Cys335Tyr	Cys335Tyr	true
F9	F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	2444124	X	139561689	G	A	C	Y	.	X	138643848	X	138471514	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.97780	D	10	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.99785198512514828	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	2417857	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158	F9	HGNC:3551	Likely pathogenic	1	Feb 23, 2023	-1	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689	139561689	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414445316	2	2444124	139561689	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1	1_Pathogenic						225909	F9_Popp_2025_light_chain_var247068	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561689.0	139561689.0		1004			335.0	C	Y	c.1004G>A	p.Cys335Tyr	missense_variant	0.004308598			No		Likely pathogenic	criteria provided, single submitter	Feb 23, 2023	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.959																																																											F9_Cys335Tyr	Cys335Tyr	true
F9	F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	2444124	X	139561689	G	A	C	Y	.	X	138643848	X	138471514	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.97780	D	10	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.99785198512514828	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	2417857	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158	F9	HGNC:3551	Likely pathogenic	1	Feb 23, 2023	-1	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689	139561689	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414445316	2	2444124	139561689	G	A	-	-	-	-	-	-	SCV003841472	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1	1_Pathogenic						170877	F9_Popp_2025_carboxy_gla_motif_var256749	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561689.0	139561689.0		1004			335.0	C	Y	c.1004G>A	p.Cys335Tyr	missense_variant	0.003812298			No		Likely pathogenic	criteria provided, single submitter	Feb 23, 2023	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.959																																																											F9_Cys335Tyr	Cys335Tyr	true
BAP1	BAP1_Ser596Gly	0.351957833731541	0.7352272520962135	0.8767858936876382	0.40968206922602535	2025_01_Batch_13-14	0.5532073414376034	0.6796596792339478	0.5646293238417727	0.5627001908311333	0.5423182660052609	0.48790658287507727	0.5160948709558142	0.48137670979594915	0.4605114732564167	0.5044037424813426	0.5205569621563404	0.597877275094881	0.5230030168188609	0.5116058320437751	0.5233610042433017	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009473		NC_000003.12:52403242:T:C		Ser596Gly																												BAP1_Ser596Gly	3	52403242	T	C	3	allele	1786A>G	F01	527_CAVA_Array_P01	K01	B13A7A8P1_R1	B14A7A8P1_R2				3-52403242-T-C	133664	3	52403242	T	C	S	G	rs79014342	3	52437258	3	52412298	596	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.1786A>G	p.Ser596Gly	c.1786A>G	p.Ser596Gly	principal1	Y	1	YES	Select	-	AGC	1	0	T	T/T	T/T	T/T	T/T	0.393	0.10794	T	0.485	0.14890	T	0.0	0.02950	B	0.0	0.01384	B	0.02	0.08015	P	simple_aae	98.0	2.0	1.39	0.34781	L	0.01	0.15507	N	0.119	0.10867	-1.0601	0.11740	T	0.0022	0.00700	T	10	0.0015929043	0.00018	T	.	.	.	0.046	0.12499	.	.	.	.	.	0.40146981186	0.39360	0.27734753240827054	0.27451	0.342242573836	0.35868	0.283363044262	0.07963	T	0.019939	0.15680	T	-0.690695	0.00040	T	-0.70984	0.05120	T	0.000335560480817249	0.00003	T	0.556544	0.19051	T	0.023078172	0.01012	0.035254005	0.02755	0.030649683	0.02742	0.042524464	0.05097	-4.038	0.24393	T	0.0674	0.02645	B	0.0411517187189644	0.35503	0.98504820	0.96067	0.024	0.04173	.	.	.	.	.	.	0.911982	0.12883	9.376	0.77187842073536805	0.11964	0.066346	0.12810	N	-1.03807936463251	0.07730	0.3647541	-0.89131888610997	0.12086	0.6318495	5.94	-0.682	0.10740	0.733	0.26955	0.015	0.13291	0.443000	0.18516	-0.12	0.14111	0.001	0.13799	0.545000	0.25517	0.339	0.25458	68	0.97129	135	0.026956869009584664	132	0.09984871406959153	1	9.940357852882703E-4	2	0.002881844380403458	0	0.0	0	0.0	6540	264690	0.02470815	.	683	109386	6.243940e-03	18	1445	208072	6.944710e-03	43	1393	236900	5.880120e-03	40	535	7164	7.467900e-02	18	122	17112	7.129500e-03	0	3	2320	1.293100e-03	0	0	9046	0.000000e+00	0	0	13372	0.000000e+00	0	20	42768	4.676390e-04	0	0	15690	0.000000e+00	0	535	7164	7.467900e-02	18	1203	16216	7.418600e-02	43	175	30514	5.735070e-03	0	7	6210	1.127210e-03	0	0	13416	0.000000e+00	0	0	16712	0.000000e+00	0	42	89532	4.691060e-04	0	2	30608	6.534240e-05	0	1203	16216	7.418600e-02	43	1108	14902	7.435240e-02	40	203	34250	5.927010e-03	0	15	9572	1.567070e-03	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	50	102730	4.867130e-04	0	2	30526	6.551790e-05	0	1108	14902	7.435240e-02	40	.	7156	1614170	4.433240e-03	250	5750	75034	7.663190e-02	242	5750	75034	7.663190e-02	242	0	912	0.000000e+00	0	419	60032	6.979610e-03	1	32	29608	1.080790e-03	0	1	44884	2.227970e-05	0	0	64004	0.000000e+00	0	36	6062	5.938630e-03	0	484	1180040	4.101560e-04	1	15	91084	1.646830e-04	0	75	190482	3.937379909912748E-4	29	370	0.07837837837837838	0	4510	0	681	9628	0.07073120066472788	21	812	0.02586206896551724	9	1042	0.008637236084452975	0	1850	0	0	296	0	79	17940	0.004403567447045708	710	9998	0.07101420284056811	0	6360	0	894	226930	0.0039395408275679725	Benign	not_specified|Hereditary_cancer-predisposing_syndrome|BAP1-related_tumor_predisposition_syndrome|Melanoma,_uveal,_susceptibility_to,_2|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52403242T>C	ClinGen:CA157253	CN169374|C0027672|C3280492|C1847723|C3661900	614327|606661	140162|289539|39044	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Ser	Gly	137403	single nucleotide variant	NM_004656.4(BAP1):c.1786A>G (p.Ser596Gly)	8314	BAP1	HGNC:950	Benign	0	Mar 04, 2025	79014342	-	RCV000120192|RCV000569518|RCV003315731|RCV000396271|RCV003654201	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900	not specified|Hereditary cancer-predisposing syndrome|Melanoma, uveal, susceptibility to, 2|BAP1-related tumor predisposition syndrome|not provided	germline;unknown	germline	GRCh38	NC_000003.12	3	52403242	52403242	3p21.1	criteria provided, multiple submitters, no conflicts	14	-	N	ClinGen:CA157253	2	133664	52403242	T	C	-	-	-	-	-	-	SCV000310599|SCV000445464|SCV000518938|SCV000563727|SCV000602623|SCV000664595|SCV000682598|SCV002046889|SCV002537267|SCV002550709|SCV004016329|SCV005306435|SCV005404611	-	-	1786A>G 	Ser596Gly	NM_004656.4	2	2_Benign																																																																																																									
ZC4H2	ZC4H2_Ala157Thr	-10.081278927908906	0.00002028191414801023	9.593570090277995	0.000028105857841895354	2025_01_Batch_13-14	0.8225176987191085	0.8795583823130079	0.9207357200542785	0.9021636911526654	0.7383830096110535	0.7120837534108332	0.920207730610582	0.9760120806025069	0.9466316452432798	0.7105962662307128	0.7673007260649709	0.899883056461795	0.9483739003283926	0.9243976681979726	0.7244896379208832	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009160		NC_000023.11:64919134:C:T		Ala157Thr																												ZC4H2_Ala157Thr	23	64919134	C	T	X	allele	469G>A	E04	527_CAVA_Array_P06	I08	B13A7A8P2_R1	B14A7A8P2_R2				X-64919134-C-T	1205492	X	64919134	C	T	A	T	rs756615930	X	64139014	X	64055739	157	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.469G>A	p.Ala157Thr	c.469G>A	p.Ala157Thr	principal1	Y	1	YES	Select	-	GCT	1	0	C	./.	./.	./.	./.	0.345	0.12584	T	0.671	0.08074	T	0.999	0.77914	D	0.994	0.82066	D	0.07	0.44282	N	simple_aae	93.0	7.0	1.59	0.40152	L	-0.2	0.10073	N	0.56	0.58756	-0.5882	0.65140	T	0.3458	0.70954	T	9	0.355225	0.51923	D	0.179905	0.85417	D	0.212	0.50121	.	.	.	.	.	0.496162226526	0.48888	0.696682045515307	0.69455	0.00654792661685	0.00552	0.645161211491	0.59234	T	0.270772	0.64106	T	0.0837489	0.62210	D	-0.117477	0.61741	T	0.376825159565334	0.27756	T	0.927207	0.73106	D	0.30280557	0.52822	0.3234439	0.58049	0.30280557	0.52822	0.3234439	0.58048	-5.678	0.44103	T	0.4207	0.60657	A	0.690180673695841	0.66695	0.97556907	0.95109	0.138	0.36230	.	.	.	.	.	.	3.698819	0.52818	23.3	0.99793533325966355	0.87938	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	.	.	7.638	0.82522	7.554000	0.60397	0.595	0.32887	1.0	0.71675	0.999000	0.35501	0.966	0.53174	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	4	77492	5.161820e-05	0	4	145397	2.751090e-05	0	4	164610	2.429990e-05	0	0	5627	0.000000e+00	0	1	13221	7.563720e-05	0	0	1650	0.000000e+00	0	1	6793	1.472100e-04	0	0	9769	0.000000e+00	0	2	29771	6.717950e-05	0	0	9288	0.000000e+00	0	1	6793	1.472100e-04	0	0	12905	0.000000e+00	0	1	23514	4.252790e-05	0	0	4286	0.000000e+00	0	1	9851	1.015130e-04	0	0	11944	0.000000e+00	0	2	61889	3.231590e-05	0	0	17571	0.000000e+00	0	1	9851	1.015130e-04	0	0	11834	0.000000e+00	0	1	26175	3.820440e-05	0	0	6515	0.000000e+00	0	1	12811	7.805790e-05	0	0	15672	0.000000e+00	0	2	70182	2.849730e-05	0	0	17506	0.000000e+00	0	1	12811	7.805790e-05	0	.	14	1205217	1.161620e-05	0	3	45240	6.631300e-05	0	3	57025	5.260850e-05	0	0	685	0.000000e+00	0	3	45240	6.631300e-05	0	0	21757	0.000000e+00	0	1	33605	2.975750e-05	0	0	46483	0.000000e+00	0	0	4345	0.000000e+00	0	6	892775	6.720620e-06	0	0	55969	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.64919134C>T	.	C3661900	.	.	.	Ala	Thr	1195791	single nucleotide variant	NM_018684.4(ZC4H2):c.469G>A (p.Ala157Thr)	55906	ZC4H2	HGNC:24931	Conflicting classifications of pathogenicity	0	Mar 01, 2023	756615930	-	RCV001572168	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	64919134	64919134	Xq11.2	criteria provided, conflicting classifications	2	-	N	ClinGen:CA10433405	2	1205492	64919134	C	T	-	-	-	-	-	-	SCV001796760|SCV004674635	-	-	469G>A 	Ala157Thr	NM_018684.4	1	3_Conflicting																																																																																																									
BRCA1	BRCA1_Val632Ala	2.1490587662768768	0.06870905490576534	3.81823247434967	0.006557305473716378	2025_01_Batch_13-14	0.8813107186301907	0.8772968783547237	0.8683821066344395	0.905743118181431	0.7797971771542498	0.9800312051341327	0.9247600758234454	0.9297751709075213	0.9743619796830157	0.9522056147366262	0.9306709618821617	0.9010284770890846	0.8990786387709804	0.9400525489322233	0.866001395945438	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011853		NC_000017.11:43057122:A:G		Val632Ala																												BRCA1_Val632Ala	17	43057122	A	G	17	allele	1895T>C	E09	527_CAVA_Array_P01	I17	B13A7A8P1_R1	B14A7A8P1_R2				17-43057122-A-G	37648	17	43057122	A	G	V	A	rs45553935	17	41209139	17	38462665	1736	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5207T>C	p.Val1736Ala	principal2	Y	.	.	.	-	GTC	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.802	0.90580	P	0.38	0.92348	B	.	0.99291	.	.	.	.	3.265	0.89891	M	.	0.66695	.	.	0.89680	0.8523	0.95041	D	0.8418	0.94704	D	10	.	0.91075	.	0.753957	0.98037	D	.	0.94487	.	.	.	.	.	.	0.89179	.	0.79043	.	0.13518	0.580183625221	0.50045	T	0.137814	0.46804	T	0.456703	0.92720	D	0.418246	0.92630	D	0.982382714748383	0.74278	D	.	0.83839	.	0.64500636	0.74826	0.18117532	0.40826	0.56882757	0.70704	0.19759434	0.43395	-8.463	0.64259	D	.	0.87654	.	0.989452318288449	0.88181	0.99978083	0.99714	0.81	0.89500	.	.	.	.	.	.	4.681403	0.74972	26.2	0.99880114867489878	0.95656	0.684452	0.64551	D	0.735250864207851	0.81845	7.641852	0.688539164513861	0.81406	7.543151	5.07	5.07	0.68064	.	.	5.554	0.67074	10.840000	0.83929	0.748	0.86774	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1613984	8.054600e-06	0	12	1179920	1.017020e-05	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	64010	0.000000e+00	0	0	6056	0.000000e+00	0	12	1179920	1.017020e-05	0	0	91084	0.000000e+00	0	1	24506	4.080633314290378E-5	0	84	0	0	84	0	0	2656	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4632	0	0	2740	0	0	108	0	1	33208	3.0113225728740063E-5	Pathogenic	not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43057122A>G	ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506	C3661900|C4554406|C0027672|C2676676|C0677776	617883|604370	140162|145|145	BRCT domain	Val	Ala	46204	single nucleotide variant	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 25, 2019	45553935	-	RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43057122	43057122	17q21.31	reviewed by expert panel	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	3	37648	43057122	A	G	-	-	-	-	-	-	SCV001161713	-	-	5207T>C 	Val1736Ala	NM_007294.4	3	1_Pathogenic						47114	BRCA1_Adamovich_2022_HDR_var5176	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43057122.0	43057122.0		5207			1736.0	V	A	c.5207T>C	p.Val1736Ala	missense_variant	-0.3849073175	-0.931080134;0.251635;-0.708107784;-0.152076352		No	8.0546027717e-6	Pathogenic	reviewed by expert panel	Jun 25, 2019	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.827	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Val1736Ala	Val1736Ala	true
BRCA1	BRCA1_Val632Ala	2.1490587662768768	0.06870905490576534	3.81823247434967	0.006557305473716378	2025_01_Batch_13-14	0.8813107186301907	0.8772968783547237	0.8683821066344395	0.905743118181431	0.7797971771542498	0.9800312051341327	0.9247600758234454	0.9297751709075213	0.9743619796830157	0.9522056147366262	0.9306709618821617	0.9010284770890846	0.8990786387709804	0.9400525489322233	0.866001395945438	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011853		NC_000017.11:43057122:A:G		Val632Ala																												BRCA1_Val632Ala	17	43057122	A	G	17	allele	1895T>C	E09	527_CAVA_Array_P01	I17	B13A7A8P1_R1	B14A7A8P1_R2				17-43057122-A-G	37648	17	43057122	A	G	V	A	rs45553935	17	41209139	17	38462665	1736	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5207T>C	p.Val1736Ala	principal2	Y	.	.	.	-	GTC	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.802	0.90580	P	0.38	0.92348	B	.	0.99291	.	.	.	.	3.265	0.89891	M	.	0.66695	.	.	0.89680	0.8523	0.95041	D	0.8418	0.94704	D	10	.	0.91075	.	0.753957	0.98037	D	.	0.94487	.	.	.	.	.	.	0.89179	.	0.79043	.	0.13518	0.580183625221	0.50045	T	0.137814	0.46804	T	0.456703	0.92720	D	0.418246	0.92630	D	0.982382714748383	0.74278	D	.	0.83839	.	0.64500636	0.74826	0.18117532	0.40826	0.56882757	0.70704	0.19759434	0.43395	-8.463	0.64259	D	.	0.87654	.	0.989452318288449	0.88181	0.99978083	0.99714	0.81	0.89500	.	.	.	.	.	.	4.681403	0.74972	26.2	0.99880114867489878	0.95656	0.684452	0.64551	D	0.735250864207851	0.81845	7.641852	0.688539164513861	0.81406	7.543151	5.07	5.07	0.68064	.	.	5.554	0.67074	10.840000	0.83929	0.748	0.86774	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1613984	8.054600e-06	0	12	1179920	1.017020e-05	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	64010	0.000000e+00	0	0	6056	0.000000e+00	0	12	1179920	1.017020e-05	0	0	91084	0.000000e+00	0	1	24506	4.080633314290378E-5	0	84	0	0	84	0	0	2656	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4632	0	0	2740	0	0	108	0	1	33208	3.0113225728740063E-5	Pathogenic	not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43057122A>G	ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506	C3661900|C4554406|C0027672|C2676676|C0677776	617883|604370	140162|145|145	BRCT domain	Val	Ala	46204	single nucleotide variant	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 25, 2019	45553935	-	RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43057122	43057122	17q21.31	reviewed by expert panel	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	3	37648	43057122	A	G	-	-	-	-	-	-	SCV001161713	-	-	5207T>C 	Val1736Ala	NM_007294.4	3	1_Pathogenic						38923	BRCA1_Adamovich_2022_Cisplatin_var6590	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43057122.0	43057122.0		5207			1736.0	V	A	c.5207T>C	p.Val1736Ala	missense_variant	-0.55257940575	-0.503452878;-0.197632461;-0.259319621;-1.249912663		No	8.0546027717e-6	Pathogenic	reviewed by expert panel	Jun 25, 2019	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant		0.827	Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified																																																		BRCA1_Val1736Ala	Val1736Ala	true
BRCA1	BRCA1_His299Tyr	-2.033763125966286	0.08145918034371533	6.185243760707367	0.00045170431666583454	2025_01_Batch_13-14	0.9752599466533105	0.9407185611386177	0.9348006054634483	0.9749079994982701	0.8284316359193244	0.9839165423156767	0.9528075263033645	0.9500261278288228	0.9865447508415817	0.9324547560605925	0.9795882444844937	0.9467630437209911	0.9424133666461356	0.9807263751699259	0.8804431959899585	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011806		NC_000017.11:43082557:G:A		His299Tyr																												BRCA1_His299Tyr	17	43082557	G	A	17	allele	895C>T	C08	527_CAVA_Array_P01	E15	B13A7A8P1_R1	B14A7A8P1_R2				17-43082557-G-A	55140	17	43082557	G	A	H	Y	rs80357365	17	41234574	17	38488100	1402	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.4204C>T	p.His1402Tyr	principal2	Y	1	.	.	-	CAT	1	0	C	G/G	G/G	G/G	G/G	.	0.27673	.	.	0.37649	.	0.019	0.18002	B	0.023	0.19965	B	.	0.21442	.	.	.	.	-0.345	0.03334	N	.	0.40464	.	.	0.37578	-0.7649	0.56959	T	0.3229	0.69047	T	10	.	0.14597	.	0.075011	0.72087	D	.	0.70364	0.173	0.07846	E9PFC7	H1402Y	Loss of catalytic residue at L1404 (P = 0.0693)| Loss of ubiquitination at K1406 (P = 0.071)| Gain of methylation at K1406 (P = 0.1374)| Loss of disorder (P = 0.146)| Loss of phosphorylation at T1399 (P = 0.2256)	.	0.55302	.	0.05014	.	0.12517	0.428560256958	0.28977	T	0.086384	0.37435	T	0.0446199	0.57354	T	-0.173683	0.56807	T	0.169085681438446	0.18287	T	.	0.31359	.	0.035931196	0.04282	0.049696308	0.07661	0.032783277	0.03337	0.04356669	0.05464	-4.172	0.39583	T	.	0.23217	.	0.00428760772610033	0.17785	0.96681190	0.94420	0.22	0.48657	.	.	.	.	.	.	3.245445	0.44401	21.9	0.97578969279789363	0.34893	0.283041	0.39425	N	-0.564913128253644	0.19776	1.052213	-0.336469916680358	0.26612	1.490904	5.35	4.38	0.51962	3.41	0.61757	1.739	0.37947	2.733000	0.34485	-0.805	0.03126	0.996	0.3946	1.000000	0.68239	0.79	0.37345	520	0.74375	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	1	109398	9.140930e-06	0	1	208096	4.805470e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13388	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16728	0.000000e+00	0	0	89540	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	0	21626	0.000000e+00	0	0	102644	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	45	1614020	2.788070e-05	0	41	1180040	3.474460e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	1	29606	3.377690e-05	0	0	44900	0.000000e+00	0	0	63994	0.000000e+00	0	0	6084	0.000000e+00	0	41	1180040	3.474460e-05	0	0	91084	0.000000e+00	0	1	24490	4.083299305839118E-5	0	108	0	0	84	0	0	2728	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4552	0	0	2836	0	0	108	0	1	33208	3.0113225728740063E-5	Benign	Hereditary_cancer-predisposing_syndrome|BRCA1-related_disorder|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43082557G>A	BRCA1-HCI:BRCA1_00085|ClinGen:CA002707	C0027672|C0677776|C3661900|C2676676|CN169374	604370	140162|145|145	.	His	Tyr	69807	single nucleotide variant	NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80357365	-	RCV000048486|RCV000083205|RCV000162983|RCV000254639|RCV001087632|RCV004803996|RCV004554674	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43082557	43082557	17q21.31	reviewed by expert panel	15	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00085,ClinGen:CA002707	2	55140	43082557	G	A	-	-	-	-	-	-	SCV000244356	-	-	4204C>T 	His1402Tyr	NM_007294.4	3	2_Benign																																																																																																									
BRCA1	BRCA1_Arg391Met	0.12346703943560886	0.9052076336151375	-6.583652048919766	0.00030897140928174853	2025_01_Batch_13-14	0.9299075772210593	0.9497984108090004	0.9853237433825538	0.9866899917271708	0.7585291153116679	0.9306585284304988	0.9019704211817761	0.97806231864069	0.9773906371032913	0.7791421211298803	0.930283052825779	0.9258844159953883	0.9816930310116219	0.982040314415231	0.7688356182207741	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC002123		NC_000017.11:43076488:C:A		Arg391Met																												BRCA1_Arg391Met	17	43076488	C	A	17	allele	1172G>T	C06	527_CAVA_Array_P01	E11	B13A7A8P1_R1	B14A7A8P1_R2				17-43076488-C-A	37598	17	43076488	C	A	R	M	rs80357389	17	41228505	17	38482031	1495	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4484G>T	p.Arg1495Met	principal2	Y	1	.	.	-	AGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.69466	.	0.468	0.63438	P	0.215	0.73159	B	.	0.99291	.	.	.	.	1.895	0.50187	L	.	0.58927	.	.	0.80306	0.5123	0.90684	D	0.7437	0.91227	D	9	.	0.65625	.	0.825771	0.98644	D	.	0.89238	.	.	.	.	.	.	0.88343	.	0.29073	.	0.18057	0.296483755112	0.09873	T	0.157106	0.49694	T	0.355325	0.86796	D	0.272623	0.86624	D	0.845764636993408	0.49533	D	.	0.55938	.	0.11150219	0.26113	0.10292555	0.24633	0.13314977	0.30712	0.09751014	0.23171	-3.944	0.23826	T	.	0.37685	.	0.925453315994447	0.78001	0.99961948	0.99542	0.915	0.95626	.	.	.	.	.	.	5.032274	0.83736	28.1	0.95831755947551867	0.28156	0.813047	0.73465	D	0.417212491786565	0.62173	4.451626	0.412864384325496	0.62163	4.450753	4.97	4.97	0.65374	5.07	0.90660	3.879	0.55941	5.667000	0.49316	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.977	0.56847	527	0.73883	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	1	109282	9.150640e-06	0	1	207956	4.808710e-06	0	1	236646	4.225720e-06	0	0	7160	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13292	0.000000e+00	0	1	42760	2.338630e-05	0	0	15688	0.000000e+00	0	1	42760	2.338630e-05	0	0	16212	0.000000e+00	0	0	30518	0.000000e+00	0	0	6210	0.000000e+00	0	0	13408	0.000000e+00	0	0	16632	0.000000e+00	0	1	89510	1.117190e-05	0	0	30604	0.000000e+00	0	1	89510	1.117190e-05	0	0	14896	0.000000e+00	0	0	34254	0.000000e+00	0	0	9564	0.000000e+00	0	0	17684	0.000000e+00	0	0	21528	0.000000e+00	0	1	102588	9.747730e-06	0	0	30522	0.000000e+00	0	1	102588	9.747730e-06	0	.	4	1613516	2.479060e-06	0	4	1179796	3.390420e-06	0	0	74976	0.000000e+00	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	63812	0.000000e+00	0	0	6058	0.000000e+00	0	4	1179796	3.390420e-06	0	0	91068	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43076488C>A	Breast_Cancer_Information_Core_(BIC)_(BRCA1):4603&base_change%3DG_to_T|ClinGen:CA002876|UniProtKB:P38398#VAR_063900	C0346153|CN169374|CN221562|C3661900|C2676676|C0677776|C0027672	114480|604370	227535|145|145|140162	.	Arg	Met	46154	single nucleotide variant	NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	672	BRCA1	HGNC:1100	Pathogenic	1	Jan 23, 2025	80357389	-	RCV000131886|RCV000159992|RCV000770739|RCV005016310|RCV000031179|RCV000048576|RCV000462940|RCV001171414|RCV000238601	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Hereditary breast ovarian cancer syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43076488	43076488	17q21.31	criteria provided, multiple submitters, no conflicts	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	Breast Cancer Information Core (BIC) (BRCA1):4603&base_change=G to T,ClinGen:CA002876,UniProtKB:P38398#VAR_063900	2	37598	43076488	C	A	-	-	-	-	-	-	SCV000076589|SCV000186941|SCV000210177|SCV000223754|SCV000296380|SCV000296803|SCV000325979|SCV000537652|SCV000540946|SCV000605750|SCV000699152|SCV000902222|SCV001140523|SCV002512513|SCV002515213|SCV002537753|SCV004215024|SCV004817666|SCV005647134	-	-	4484G>T 	Arg1495Met	NM_007294.4	2	1_Pathogenic	17	43076488	C	A	2.7372e-6																																																																																																				
BRCA1	BRCA1_Glu631Lys	1.0983392108185215	0.30839265196900983	1.9419342156297021	0.09326896956291159	2025_01_Batch_13-14	0.8653114532543542	0.8609513783183007	0.6786680870186188	0.7122638775895174	0.8390927652271518	0.9766476325556214	0.9213786545766204	0.9381547758252562	0.9808460116119835	0.9233140844072092	0.9209795429049878	0.8911650164474605	0.8084114314219375	0.8465549446007504	0.8812034248171805	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218448	CCSBVarC003307	ALE00003307	NC_000017.11:43057126:C:T	1891G>A	Glu631Lys	CEGS2	CegsMutGDEh1026	D09	GDEhDisVCh_40059	A09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Glu631Lys	17	43057126	C	T	17											17-43057126-C-T	55455	17	43057126	C	T	E	K	rs397509238	17	41209143	17	38462669	1735	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5203G>A	p.Glu1735Lys	principal2	Y	1	.	.	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.904	0.90580	P	0.17	0.88579	B	.	.	.	.	.	.	3.64	0.94011	H	.	0.66115	.	.	0.97441	1.0854	0.99062	D	0.9540	0.98504	D	10	.	0.91685	.	0.776902	0.98236	D	.	0.94374	.	.	.	.	.	.	0.94343	.	0.86555	.	0.10057	0.611799120903	0.54504	T	0.384042	0.81335	T	0.454957	0.92647	D	0.415738	0.92557	D	0.99232280254364	0.82639	D	.	0.97033	.	0.87069577	0.88763	0.49804372	0.70717	0.8283224	0.85601	0.4636008	0.68604	-14.271	0.93916	D	.	0.86411	.	0.997865992856704	0.93647	0.99988377	0.99849	0.931	0.96596	.	.	.	.	.	.	4.661471	0.74461	26.2	0.99903481763990787	0.97503	0.684509	0.64555	D	0.813291850711605	0.86860	9.046169	0.751252984158328	0.86175	8.829661	5.07	5.07	0.68064	3.31	0.60027	4.681	0.61438	7.412000	0.58717	0.593	0.32293	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	no_classification_provided	NC_000017.11:g.43057126C>T	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	C0346153|C2676676	114480|604370	227535|145	BRCT domain	Glu	Lys	70122	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672	BRCA1	HGNC:1100	not provided	0	-	397509238	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126	43057126	17q21.31	no classification provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3	55455	43057126	C	T	-	-	-	-	-	-	SCV000679293|SCV001237915	-	-	5203G>A 	Glu1735Lys	NM_007294.4		5_Others																																																																																																									
BRCA1	BRCA1_Glu631Lys	1.0983392108185215	0.30839265196900983	1.9419342156297021	0.09326896956291159	2025_01_Batch_13-14	0.8653114532543542	0.8609513783183007	0.6786680870186188	0.7122638775895174	0.8390927652271518	0.9766476325556214	0.9213786545766204	0.9381547758252562	0.9808460116119835	0.9233140844072092	0.9209795429049878	0.8911650164474605	0.8084114314219375	0.8465549446007504	0.8812034248171805	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003307		NC_000017.11:43057126:C:T		Glu631Lys																												BRCA1_Glu631Lys	17	43057126	C	T	17	allele	1891G>A	H07	527_CAVA_Array_P01	O13	B13A7A8P1_R1	B14A7A8P1_R2				17-43057126-C-T	55455	17	43057126	C	T	E	K	rs397509238	17	41209143	17	38462669	1735	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5203G>A	p.Glu1735Lys	principal2	Y	1	.	.	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.904	0.90580	P	0.17	0.88579	B	.	.	.	.	.	.	3.64	0.94011	H	.	0.66115	.	.	0.97441	1.0854	0.99062	D	0.9540	0.98504	D	10	.	0.91685	.	0.776902	0.98236	D	.	0.94374	.	.	.	.	.	.	0.94343	.	0.86555	.	0.10057	0.611799120903	0.54504	T	0.384042	0.81335	T	0.454957	0.92647	D	0.415738	0.92557	D	0.99232280254364	0.82639	D	.	0.97033	.	0.87069577	0.88763	0.49804372	0.70717	0.8283224	0.85601	0.4636008	0.68604	-14.271	0.93916	D	.	0.86411	.	0.997865992856704	0.93647	0.99988377	0.99849	0.931	0.96596	.	.	.	.	.	.	4.661471	0.74461	26.2	0.99903481763990787	0.97503	0.684509	0.64555	D	0.813291850711605	0.86860	9.046169	0.751252984158328	0.86175	8.829661	5.07	5.07	0.68064	3.31	0.60027	4.681	0.61438	7.412000	0.58717	0.593	0.32293	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	no_classification_provided	NC_000017.11:g.43057126C>T	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	C0346153|C2676676	114480|604370	227535|145	BRCT domain	Glu	Lys	70122	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672	BRCA1	HGNC:1100	not provided	0	-	397509238	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126	43057126	17q21.31	no classification provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3	55455	43057126	C	T	-	-	-	-	-	-	SCV000679293|SCV001237915	-	-	5203G>A 	Glu1735Lys	NM_007294.4		5_Others																																																																																																									
F9	F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	700019	X	139551064	C	T	P	S	rs762986355	X	138633223	X	138460889	175	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.8690	0.95250	D	0.8615	0.95381	D	10	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.99894604001216725	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	689353	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158	F9	HGNC:3551	Benign	0	Dec 27, 2024	762986355	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064	139551064	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA10529810	2	700019	139551064	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1	2_Benign						216377	F9_Popp_2025_light_chain_var243710	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551064.0	139551064.0		523			175.0	P	S	c.523C>T	p.Pro175Ser	missense_variant,splice_region_variant	1.0088200544671224			No	0.000010769711264	Benign	criteria provided, single submitter	Jan 19, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.756																																																											F9_Pro175Ser	Pro175Ser	true
F9	F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	700019	X	139551064	C	T	P	S	rs762986355	X	138633223	X	138460889	175	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.8690	0.95250	D	0.8615	0.95381	D	10	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.99894604001216725	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	689353	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158	F9	HGNC:3551	Benign	0	Dec 27, 2024	762986355	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064	139551064	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA10529810	2	700019	139551064	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1	2_Benign						161345	F9_Popp_2025_carboxy_gla_motif_var253391	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551064.0	139551064.0		523			175.0	P	S	c.523C>T	p.Pro175Ser	missense_variant,splice_region_variant	0.9867402763044592			No	0.000010769711264	Benign	criteria provided, single submitter	Jan 19, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.756																																																											F9_Pro175Ser	Pro175Ser	true
F9	F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	700019	X	139551064	C	T	P	S	rs762986355	X	138633223	X	138460889	175	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.8690	0.95250	D	0.8615	0.95381	D	10	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.99894604001216725	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	689353	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158	F9	HGNC:3551	Benign	0	Dec 27, 2024	762986355	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064	139551064	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA10529810	2	700019	139551064	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1	2_Benign						243893	F9_Popp_2025_strep_2_var263072	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551064.0	139551064.0		523			175.0	P	S	c.523C>T	p.Pro175Ser	missense_variant,splice_region_variant	1.0487967880316358			No	0.000010769711264	Benign	criteria provided, single submitter	Jan 19, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.756																																																											F9_Pro175Ser	Pro175Ser	true
F9	F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	700019	X	139551064	C	T	P	S	rs762986355	X	138633223	X	138460889	175	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.8690	0.95250	D	0.8615	0.95381	D	10	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.99894604001216725	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	689353	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158	F9	HGNC:3551	Benign	0	Dec 27, 2024	762986355	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064	139551064	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA10529810	2	700019	139551064	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1	2_Benign						133829	F9_Popp_2025_carboxy_F9_specific_var224348	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551064.0	139551064.0		523			175.0	P	S	c.523C>T	p.Pro175Ser	missense_variant,splice_region_variant	0.9735976624606066			No	0.000010769711264	Benign	criteria provided, single submitter	Jan 19, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.756																																																											F9_Pro175Ser	Pro175Ser	true
F9	F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	700019	X	139551064	C	T	P	S	rs762986355	X	138633223	X	138460889	175	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.8690	0.95250	D	0.8615	0.95381	D	10	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.99894604001216725	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	689353	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158	F9	HGNC:3551	Benign	0	Dec 27, 2024	762986355	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064	139551064	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA10529810	2	700019	139551064	C	T	-	-	-	-	-	-	SCV001009324	-	-	523C>T 	Pro175Ser	NM_000133.4	1	2_Benign						188861	F9_Popp_2025_heavy_chain_var234029	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551064.0	139551064.0		523			175.0	P	S	c.523C>T	p.Pro175Ser	missense_variant,splice_region_variant	0.9909768733771436			No	0.000010769711264	Benign	criteria provided, single submitter	Jan 19, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.756																																																											F9_Pro175Ser	Pro175Ser	true
G6PD	G6PD_Arg365His	-0.12537883577312148	0.9037485339254261	-0.030512229050507184	0.9765102707417327	2025_01_Batch_13-14	0.5453099664505856	0.740656644322949	0.6136202157862378	0.6880198318154094	0.49923219256387213	0.5049687799684487	0.504684733769262	0.5665028575772248	0.5254002764427956	0.5171809644275656	0.5251393732095171	0.6226706890461056	0.5900615366817313	0.6067100541291025	0.5082065784957188	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	G6PD		4006		CCSBVarC021512		NC_000023.11:154532760:C:T		Arg365His																												G6PD_Arg365His	23	154532760	C	T	X	allele	1094G>A	F04	527_CAVA_Array_P03	L07	B13A7A8P1_R1	B14A7A8P1_R2				X-154532760-C-T	1722612	X	154532760	C	T	R	H	rs781967767	X	153760975	X	153414169	365	G6PD	ENSG00000160211	ENST00000393562	ENSP00000377192	P11413	G6PD_HUMAN	c.1094G>A	p.Arg365His	c.1094G>A	p.Arg365His	principal4	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.48345	.	.	0.52739	.	0.535	0.37823	P	0.12	0.32232	B	0.87	0.91311	D	simple_aae	13.0	87.0	3.26	0.89820	M	.	0.75883	.	.	0.68273	1.0246	0.97612	D	0.9807	0.99405	D	10	0.8802651	0.87196	D	0.613028	0.96622	D	0.798	0.93363	0.603	0.73365	P11413	R365H	Loss of solvent accessibility (P = 0.0364)| Loss of stability (P = 0.0369)| Gain of ubiquitination at K360 (P = 0.0542)| Loss of MoRF binding (P = 0.0803)| Loss of methylation at K360 (P = 0.1029)	0.998371958706	0.99832	.	.	1.20514760124	0.80587	0.833622932434	0.87096	D	0.967016	0.99611	D	0.594247	0.97356	D	0.615818	0.97313	D	0.961354553699493	0.65842	D	.	0.95367	.	0.8231586	0.85244	0.6705637	0.80452	0.8231586	0.85245	0.6705637	0.80453	-9.6	0.75018	D	0.5174	0.69466	A	0.997402931741911	0.93099	0.99792010	0.98559	0.947	0.97555	.	.	.	.	.	.	3.345784	0.46204	22.2	0.99806085228496089	0.89004	.	.	.	.	.	.	.	.	.	5.73	4.87	0.62830	.	.	5.68	0.67905	3.272000	0.37248	0.535	0.24985	1.0	0.71675	1.000000	0.68239	0.906	0.44196	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210393	8.261780e-07	0	1	45926	2.177420e-05	0	0	57896	0.000000e+00	0	0	686	0.000000e+00	0	1	45926	2.177420e-05	0	0	22013	0.000000e+00	0	0	33766	0.000000e+00	0	0	46693	0.000000e+00	0	0	4352	0.000000e+00	0	0	894734	0.000000e+00	0	0	56740	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.154532760C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Arg	His	1780128	single nucleotide variant	NM_001360016.2(G6PD):c.1094G>A (p.Arg365His)	2539	G6PD	HGNC:4057	Likely pathogenic	1	Aug 12, 2022	-1	-	RCV002305722	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	unknown	unknown	GRCh38	NC_000023.11	X	154532760	154532760	Xq28	criteria provided, single submitter	1	-	N	ClinGen:CA10566079	2	1722612	154532760	C	T	-	-	-	-	-	-	SCV002599266	-	-	1094G>A 	Arg365His	NM_001360016.2	1	1_Pathogenic						285730	G6PD_unpublished_var126900	G6PD_unpublished	G6PD	4057.0	-1.0		154532760.0	154532760.0		1094			365.0	R	H	c.1094G>A	p.Arg365His	missense_variant	0.95310181152785	0.993865394126386;0.898221796809856;0.9672182436473086		No	8.26177943857904e-7	Likely pathogenic	criteria provided, single submitter	Aug 12, 2022	aa		ENST00000393562.10	NM_001360016.2	immortalized human cells	Reporter	Fluorescence	Protein stability	Yes	missense_variant		0.798																																																											G6PD_Arg365His	Arg365His	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						125155	F9_Popp_2025_carboxy_F9_specific_var221268	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.2435717878896782			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						125155	F9_Popp_2025_carboxy_F9_specific_var221268	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.2435717878896782			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						180187	F9_Popp_2025_heavy_chain_var230949	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.048946376			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						180187	F9_Popp_2025_heavy_chain_var230949	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.048946376			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						207703	F9_Popp_2025_light_chain_var240630	F9_Popp_2025_light_chain	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.3029369390680045			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						207703	F9_Popp_2025_light_chain_var240630	F9_Popp_2025_light_chain	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.3029369390680045			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						235219	F9_Popp_2025_strep_2_var259992	F9_Popp_2025_strep_2	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.030553486554471			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						235219	F9_Popp_2025_strep_2_var259992	F9_Popp_2025_strep_2	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.030553486554471			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						152671	F9_Popp_2025_carboxy_gla_motif_var250311	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.087257991			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
F9	F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic						152671	F9_Popp_2025_carboxy_gla_motif_var250311	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139530846.0	139530846.0		82			28.0	C	R	c.82T>C	p.Cys28Arg	missense_variant	0.087257991			No		Pathogenic	criteria provided, single submitter	Feb 02, 2021	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.621																																																											F9_Cys28Arg	Cys28Arg	true
RAD51D	RAD51D_Ala231Ser	0.24888080055203415	0.8105973795143	15.706224815942015	1.0267282885890921e-6	2025_01_Batch_13-14	0.6124205899357343	0.7948659978902257	0.9617142773847289	0.779002624690744	0.6826065995404491	0.8818606767782569	0.9009835130033984	0.9606344086250178	0.9370644171431224	0.8438134656424551	0.7471406333569957	0.8479247554468121	0.9611743430048734	0.8580335209169332	0.7632100325914521	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024850		NC_000017.11:35103301:C:A		Ala231Ser																												RAD51D_Ala231Ser	17	35103301	C	A	17	allele	691G>T	H01	527_CAVA_Array_P05	O01	B13A7A8P2_R1	B14A7A8P2_R2				17-35103301-C-A	480531	17	35103301	C	A	A	S	rs772135704	17	33430320	17	30454433	231	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.691G>T	p.Ala231Ser	c.691G>T	p.Ala231Ser	principal1	Y	5	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	.	0.39016	.	0.148	0.35663	T	0.68	0.53374	P	0.562	0.49607	P	0.18	0.50204	N	simple_aae	82.0	18.0	1.42	0.35528	L	.	0.43338	.	0.222	0.39513	-0.6345	0.63221	T	0.2791	0.64952	T	10	0.45145473	0.58389	D	0.066725	0.69852	D	0.162	0.41623	0.644	0.78027	O75771	A231S	Gain of phosphorylation at A231 (P = 0.0655)| Gain of disorder (P = 0.0844)| Gain of MoRF binding (P = 0.1284)| Loss of ubiquitination at K235 (P = 0.2243)| Loss of methylation at R232 (P = 0.3779)	0.942670400808	0.94162	.	0.52746	.	0.36618	.	.	.	0.169282	0.51414	T	-0.0747325	0.40218	T	-0.00673246	0.69677	D	0.217512117147641	0.21078	T	0.864413	0.57408	D	0.5926053	0.72005	0.42019272	0.65736	0.5926053	0.72007	0.42019272	0.65736	-7.695	0.62579	D	0.116	0.32008	B	0.000766225569270482	0.08395	0.93499870	0.92618	0.232	0.50061	.	.	.	.	.	.	3.594988	0.50833	23.0	0.96226307501413078	0.29313	0.620192	0.60393	D	0.387026469158641	0.60517	4.263942	0.432911172391861	0.63430	4.600281	4.92	4.92	0.64102	3.22	0.58372	4.112	0.57674	2.653000	0.33911	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	908	0.22602	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	8	106972	7.478590e-05	0	15	203574	7.368330e-05	0	15	232448	6.453060e-05	0	0	6872	0.000000e+00	0	0	16800	0.000000e+00	0	0	2230	0.000000e+00	0	0	8846	0.000000e+00	0	0	13256	0.000000e+00	0	0	41826	0.000000e+00	0	8	15260	5.242460e-04	0	8	15260	5.242460e-04	0	0	15702	0.000000e+00	0	0	29908	0.000000e+00	0	0	6046	0.000000e+00	0	0	13302	0.000000e+00	0	0	16488	0.000000e+00	0	0	87500	0.000000e+00	0	15	29876	5.020750e-04	0	15	29876	5.020750e-04	0	0	14484	0.000000e+00	0	0	33672	0.000000e+00	0	0	9430	0.000000e+00	0	0	17458	0.000000e+00	0	0	21108	0.000000e+00	0	0	100948	0.000000e+00	0	15	29796	5.034230e-04	0	15	29796	5.034230e-04	0	.	47	1611894	2.915820e-05	0	46	90536	5.080850e-04	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	0	59658	0.000000e+00	0	0	29510	0.000000e+00	0	0	44848	0.000000e+00	0	0	63892	0.000000e+00	0	0	6052	0.000000e+00	0	0	1179196	0.000000e+00	0	46	90536	5.080850e-04	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35103301C>A	ClinGen:CA8499378	C0027672|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Ala	Ser	478474	single nucleotide variant	NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Jan 14, 2025	772135704	-	RCV000575670|RCV001351481|RCV001764647	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35103301	35103301	17q12	criteria provided, conflicting classifications	5	-	N	ClinGen:CA8499378	2	480531	35103301	C	A	-	-	-	-	-	-	SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079	-	-	691G>T 	Ala231Ser	NM_002878.4	1	3_Conflicting						960115	RAD51D_unpublished_var154362	RAD51D_unpublished	RAD51D	9823.0	-1.0		35103301.0	35103301.0		691	G	T	231.0	A	S	c.691G>T	p.Ala231Ser	missense_variant	0.0141602		functionally_normal	Yes	0.0000291582448969	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Mar 21, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.162																																																											RAD51D_Ala231Ser	Ala231Ser	true
BRAF	BRAF_Gln262Lys	-3.3290490377403623	0.012607505897050326	1.4713633473538252	0.18466553940209554	2025_01_Batch_13-14	0.7673606758750543	0.7418021366726815	0.7824119719135454	0.8146385969778781	0.656309645689469	0.44257125389276825	0.5478799800519032	0.6121320145426549	0.6069403394663526	0.4351602513534001	0.6049659648839113	0.6448410583622923	0.6972719932281002	0.7107894682221154	0.5457349485214346	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220594	CCSBVarC003157	ALE00003157	NC_000007.14:140801488:G:T	784C>A	Gln262Lys	CEGS2	CegsMutGDEh1017	C07	GDEhDisVCh_40058	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0		0			0			0			BRAF_Gln262Lys	7	140801488	G	T	7											7-140801488-G-T	40352	7	140801488	G	T	Q	K	rs397507470	7	140501288	7	140147757	262	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.784C>A	p.Gln262Lys	c.784C>A	p.Gln262Lys	principal4	Y	.	YES	Select	-	CAA	1	0	G	./.	./.	./.	./.	.	0.31974	.	.	0.25963	.	0.476	0.36683	P	0.145	0.33873	B	.	0.92786	.	.	.	.	0.335	0.10354	N	.	0.39882	.	.	0.92789	0.1437	0.84883	D	0.5754	0.84624	D	10	0.9098774	0.90245	D	0.119437	0.79914	D	.	0.88724	0.854	0.95408	P15056	Q262K	Gain of methylation at Q262 (P = 0.0013)| Gain of MoRF binding (P = 0.034)| Loss of sheet (P = 0.0457)| Gain of catalytic residue at Q262 (P = 0.0492)| Gain of helix (P = 0.0854)	.	0.99108	.	0.89159	.	0.83165	0.890452325344	0.95311	D	0.767013	0.93678	D	0.433189	0.91632	D	0.384469	0.91529	D	0.877448976039886	0.52474	D	0.972478	0.90100	D	0.7150027	0.78637	0.36088184	0.61282	0.69711965	0.77646	0.29162404	0.54973	-8.711	0.65895	D	0.9841	0.91998	P	0.999639817524742	0.97271	0.98278390	0.95809	0.783	0.87990	.	.	.	.	.	.	4.792683	0.77833	26.8	0.99520084160858091	0.69200	0.875019	0.79748	D	0.229428578319334	0.52393	3.435949	0.399610595300935	0.61333	4.355617	5.21	5.21	0.71966	5.79	0.96129	9.943	0.9894	11.707000	0.94599	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.996	0.76032	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801488G>T	ClinGen:CA281957|UniProtKB:P15056#VAR_065172	CN517202|C5555857	.	536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Lys	48822	single nucleotide variant	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Nov 22, 2024	397507470	-	RCV000033290|RCV001193980	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140801488	140801488	7q34	criteria provided, multiple submitters, no conflicts	2	-	N	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	2	40352	140801488	G	T	-	-	-	-	-	-	SCV000057195|SCV001363182	-	-	784C>A 	Gln262Lys	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Gln262Lys	-3.3290490377403623	0.012607505897050326	1.4713633473538252	0.18466553940209554	2025_01_Batch_13-14	0.7673606758750543	0.7418021366726815	0.7824119719135454	0.8146385969778781	0.656309645689469	0.44257125389276825	0.5478799800519032	0.6121320145426549	0.6069403394663526	0.4351602513534001	0.6049659648839113	0.6448410583622923	0.6972719932281002	0.7107894682221154	0.5457349485214346	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003157		NC_000007.14:140801488:G:T		Gln262Lys																												BRAF_Gln262Lys	7	140801488	G	T	7	allele	784C>A	H05	527_CAVA_Array_P01	O09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801488-G-T	40352	7	140801488	G	T	Q	K	rs397507470	7	140501288	7	140147757	262	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.784C>A	p.Gln262Lys	c.784C>A	p.Gln262Lys	principal4	Y	.	YES	Select	-	CAA	1	0	G	./.	./.	./.	./.	.	0.31974	.	.	0.25963	.	0.476	0.36683	P	0.145	0.33873	B	.	0.92786	.	.	.	.	0.335	0.10354	N	.	0.39882	.	.	0.92789	0.1437	0.84883	D	0.5754	0.84624	D	10	0.9098774	0.90245	D	0.119437	0.79914	D	.	0.88724	0.854	0.95408	P15056	Q262K	Gain of methylation at Q262 (P = 0.0013)| Gain of MoRF binding (P = 0.034)| Loss of sheet (P = 0.0457)| Gain of catalytic residue at Q262 (P = 0.0492)| Gain of helix (P = 0.0854)	.	0.99108	.	0.89159	.	0.83165	0.890452325344	0.95311	D	0.767013	0.93678	D	0.433189	0.91632	D	0.384469	0.91529	D	0.877448976039886	0.52474	D	0.972478	0.90100	D	0.7150027	0.78637	0.36088184	0.61282	0.69711965	0.77646	0.29162404	0.54973	-8.711	0.65895	D	0.9841	0.91998	P	0.999639817524742	0.97271	0.98278390	0.95809	0.783	0.87990	.	.	.	.	.	.	4.792683	0.77833	26.8	0.99520084160858091	0.69200	0.875019	0.79748	D	0.229428578319334	0.52393	3.435949	0.399610595300935	0.61333	4.355617	5.21	5.21	0.71966	5.79	0.96129	9.943	0.9894	11.707000	0.94599	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.996	0.76032	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801488G>T	ClinGen:CA281957|UniProtKB:P15056#VAR_065172	CN517202|C5555857	.	536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Lys	48822	single nucleotide variant	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Nov 22, 2024	397507470	-	RCV000033290|RCV001193980	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140801488	140801488	7q34	criteria provided, multiple submitters, no conflicts	2	-	N	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	2	40352	140801488	G	T	-	-	-	-	-	-	SCV000057195|SCV001363182	-	-	784C>A 	Gln262Lys	NM_004333.6	2	1_Pathogenic																																																																																																									
SHOC2	SHOC2_Leu174Phe	1.1759562196714102	0.2780523239715201	-1.9936040449264232	0.08643071743388651	2025_01_Batch_13-14	0.9295363964837904	0.9520932679612392	0.8115757110971933	0.9278015806273477	0.8310827847603361	0.9381013085387566	0.8911017667912078	0.8714141234060793	0.8963413969822411	0.9398888078018313	0.9338188525112735	0.9215975173762234	0.8414949172516363	0.9120714888047945	0.8854857962810837	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
F9	F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	1364269	X	139561868	T	A	F	I	rs1175050951	X	138644027	X	138471693	395	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.99205605394600549	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	1386208	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158	F9	HGNC:3551	Pathogenic	1	Apr 18, 2021	1175050951	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868	139561868	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414446355	2	1364269	139561868	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1	1_Pathogenic						146958	F9_Popp_2025_carboxy_F9_specific_var228962	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561868.0	139561868.0		1183			395.0	F	I	c.1183T>A	p.Phe395Ile	missense_variant	0.0292381837381701			No		Pathogenic	criteria provided, single submitter	Apr 18, 2021	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.891																																																											F9_Phe395Ile	Phe395Ile	true
F9	F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	1364269	X	139561868	T	A	F	I	rs1175050951	X	138644027	X	138471693	395	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.99205605394600549	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	1386208	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158	F9	HGNC:3551	Pathogenic	1	Apr 18, 2021	1175050951	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868	139561868	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414446355	2	1364269	139561868	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1	1_Pathogenic						257022	F9_Popp_2025_strep_2_var267686	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561868.0	139561868.0		1183			395.0	F	I	c.1183T>A	p.Phe395Ile	missense_variant	0.2464381922978602			No		Pathogenic	criteria provided, single submitter	Apr 18, 2021	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.891																																																											F9_Phe395Ile	Phe395Ile	true
F9	F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	1364269	X	139561868	T	A	F	I	rs1175050951	X	138644027	X	138471693	395	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.99205605394600549	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	1386208	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158	F9	HGNC:3551	Pathogenic	1	Apr 18, 2021	1175050951	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868	139561868	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414446355	2	1364269	139561868	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1	1_Pathogenic						174474	F9_Popp_2025_carboxy_gla_motif_var258005	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561868.0	139561868.0		1183			395.0	F	I	c.1183T>A	p.Phe395Ile	missense_variant	0.0142730601583807			No		Pathogenic	criteria provided, single submitter	Apr 18, 2021	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.891																																																											F9_Phe395Ile	Phe395Ile	true
F9	F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	1364269	X	139561868	T	A	F	I	rs1175050951	X	138644027	X	138471693	395	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.99205605394600549	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	1386208	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158	F9	HGNC:3551	Pathogenic	1	Apr 18, 2021	1175050951	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868	139561868	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414446355	2	1364269	139561868	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1	1_Pathogenic						229506	F9_Popp_2025_light_chain_var248324	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561868.0	139561868.0		1183			395.0	F	I	c.1183T>A	p.Phe395Ile	missense_variant	0.0209959529538574			No		Pathogenic	criteria provided, single submitter	Apr 18, 2021	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.891																																																											F9_Phe395Ile	Phe395Ile	true
F9	F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	1364269	X	139561868	T	A	F	I	rs1175050951	X	138644027	X	138471693	395	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.99205605394600549	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	1386208	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158	F9	HGNC:3551	Pathogenic	1	Apr 18, 2021	1175050951	-	RCV001905309	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561868	139561868	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414446355	2	1364269	139561868	T	A	-	-	-	-	-	-	SCV002132959	-	-	1183T>A 	Phe395Ile	NM_000133.4	1	1_Pathogenic						201990	F9_Popp_2025_heavy_chain_var238643	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561868.0	139561868.0		1183			395.0	F	I	c.1183T>A	p.Phe395Ile	missense_variant	0.054036665			No		Pathogenic	criteria provided, single submitter	Apr 18, 2021	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.891																																																											F9_Phe395Ile	Phe395Ile	true
RAD51D	RAD51D_Asn138His	1.6166526065546751	0.14998682499991292	10.652301864900743	0.000014084472813108453	2025_01_Batch_13-14	0.7661350354466943	0.8948077182600973	0.9743968861454785	0.9276685729320928	0.7468842806042563	0.9312611228377888	0.9490494215219716	0.9775521749267864	0.9623249119764552	0.8647562969491779	0.8486980791422416	0.9219285698910344	0.9759745305361325	0.944996742454274	0.8058202887767171	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024825		NC_000017.11:35107056:T:G		Asn138His																												RAD51D_Asn138His	17	35107056	T	G	17	allele	412A>C	D01	527_CAVA_Array_P05	G01	B13A7A8P2_R1	B14A7A8P2_R2				17-35107056-T-G	127888	17	35107056	T	G	N	H	rs141690729	17	33434075	17	30458188	138	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.412A>C	p.Asn138His	c.412A>C	p.Asn138His	principal1	Y	5	.	.	-	AAT	1	0	T	T/T	T/T	T/T	T/T	.	0.28402	.	0.1	0.56982	T	0.395	0.34741	B	0.591	0.50477	P	0.06	0.18971	N	simple_aae	94.0	6.0	2.35	0.67323	M	.	0.48032	.	0.307	0.34427	-0.4330	0.70838	T	0.3126	0.68139	T	10	0.45225775	0.58437	D	0.154917	0.83550	D	0.281	0.59659	0.625	0.75933	O75771	N138H	Gain of sheet (P = 0.1945)| Gain of disorder (P = 0.2095)| Loss of stability (P = 0.211)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2953)	0.920393908519	0.91898	.	0.26696	.	0.40252	.	.	.	0.188245	0.53985	T	-0.0652968	0.41729	T	-0.127971	0.60868	T	0.542844533920288	0.33898	D	0.843016	0.51848	T	0.14909644	0.33722	0.17573822	0.39925	0.14909644	0.33722	0.17573822	0.39925	-6.785	0.53382	T	0.1649	0.36807	B	0.00403443879358769	0.17381	0.62988700	0.84616	0.079	0.22306	.	.	.	.	.	.	4.260774	0.64815	24.7	0.51412546772186041	0.04613	0.615052	0.60072	D	0.261244387338902	0.53967	3.585971	0.218849069588625	0.50637	3.276757	4.65	3.52	0.39345	2.95	0.53955	4.397	0.59537	6.109000	0.53713	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.885	0.42478	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	2	109408	1.828020e-05	0	1	208132	4.804640e-06	0	11	236936	4.642600e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89554	1.116640e-05	0	0	30608	0.000000e+00	0	1	89554	1.116640e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	11	102732	1.070750e-04	0	0	30526	0.000000e+00	0	11	102732	1.070750e-04	0	.	22	1613968	1.363100e-05	0	21	1180018	1.779630e-05	0	0	74892	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64026	0.000000e+00	0	0	6084	0.000000e+00	0	21	1180018	1.779630e-05	0	0	91090	0.000000e+00	0	1	32854	3.0437694040299505E-5	0	114	0	0	86	0	0	2852	0	0	500	0	0	628	0	0	26	0	0	98	0	0	5026	0	0	2966	0	0	112	0	1	42184	2.370567039635881E-5	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35107056T>G	ClinGen:CA287974	C0027672|CN169374|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Asn	His	133345	single nucleotide variant	NM_002878.4(RAD51D):c.412A>C (p.Asn138His)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Mar 04, 2025	141690729	-	RCV000572128|RCV003321505|RCV000649680|RCV000760062	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35107056	35107056	17q12	criteria provided, conflicting classifications	11	-	N	ClinGen:CA287974	2	127888	35107056	T	G	-	-	-	-	-	-	SCV000149723|SCV000674693|SCV000686451|SCV000771512|SCV000822178|SCV000889821|SCV001472084|SCV002563404|SCV002579319|SCV004026736|SCV004208088	-	-	412A>C 	Asn138His	NM_002878.4	1	3_Conflicting						961212	RAD51D_unpublished_var155459	RAD51D_unpublished	RAD51D	9823.0	-1.0		35107056.0	35107056.0		412	A	C	138.0	N	H	c.412A>C	p.Asn138His	missense_variant	0.00946169		functionally_normal	Yes	0.0000136310013581	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Feb 22, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.281																																																											RAD51D_Asn138His	Asn138His	true
BRCA1	BRCA1_Met1Thr	2.6505609192138624	0.03291488248938516	-5.415058354854697	0.000992346045870956	2025_01_Batch_13-14	0.9188140326650334	0.9527153734968281	0.9840460552581236	0.984750990435898	0.793637090171406	0.8536066331104628	0.8623721456022353	0.9654591126834374	0.9354789732760659	0.8121469904325598	0.8862103328877481	0.9075437595495317	0.9747525839707805	0.960114981855982	0.8028920403019829	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218377	CCSBVarC003294	ALE00003294	NC_000017.11:43124095:A:G	2T>C	Met1Thr	CEGS2	CegsMutGDEh1015	F12	GDEhDisVCh_40059	F04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Met1Thr	17	43124095	A	G	17											17-43124095-A-G	54745	17	43124095	A	G	M	T	rs80357111	17	41276112	17	38529638	1	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	c.2T>C	p.Met1?	c.2T>C	p.Met1?	principal2	Y	1	.	.	-	ATG	2	0	A	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	0.967	0.56423	D	0.916	0.65195	D	.	0.99291	.	.	.	.	.	.	.	.	0.71435	.	.	0.96886	0.4652	0.90013	D	0.7036	0.89769	D	9	0.98665875	0.98978	D	0.950787	0.99662	D	.	0.89789	0.987	0.99867	E9PFC7	M1T	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.883389812914	0.88134	.	0.29790	.	.	.	.	.	0.298644	0.66936	T	0.3844	0.88912	D	0.314388	0.88772	D	0.991858303546906	0.82073	D	0.9	0.64967	D	0.9435044	0.95537	0.71842754	0.83181	0.9426614	0.95450	0.7257	0.83606	-9.871	0.82067	D	.	.	.	0.999999935724936	0.99831	0.99948680	0.99428	.	.	.	.	.	.	.	.	3.997208	0.58947	24.0	0.97714747887968068	0.35682	0.056815	0.10376	N	0.358832926107613	0.58998	4.098281	0.311400030491244	0.55978	3.783919	3.83	3.83	0.43219	2.37	0.44186	4.168	0.58094	11.022000	0.84990	0.634	0.51995	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43124095A>G	ClinGen:CA001954	C0677776|C0027672|C2676676	604370	145|140162|145	.	Met	Thr	69412	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1	May 05, 2024	80357111	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095	43124095	17q21.31	criteria provided, multiple submitters, no conflicts	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2	54745	43124095	A	G	-	-	-	-	-	-	SCV000325520|SCV000785479|SCV001179120|SCV001587504	-	-	2T>C 	Met1Thr	NM_007294.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Met1Thr	2.6505609192138624	0.03291488248938516	-5.415058354854697	0.000992346045870956	2025_01_Batch_13-14	0.9188140326650334	0.9527153734968281	0.9840460552581236	0.984750990435898	0.793637090171406	0.8536066331104628	0.8623721456022353	0.9654591126834374	0.9354789732760659	0.8121469904325598	0.8862103328877481	0.9075437595495317	0.9747525839707805	0.960114981855982	0.8028920403019829	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003294		NC_000017.11:43124095:A:G		Met1Thr																												BRCA1_Met1Thr	17	43124095	A	G	17	allele	2T>C	D06	527_CAVA_Array_P01	G11	B13A7A8P1_R1	B14A7A8P1_R2				17-43124095-A-G	54745	17	43124095	A	G	M	T	rs80357111	17	41276112	17	38529638	1	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	c.2T>C	p.Met1?	c.2T>C	p.Met1?	principal2	Y	1	.	.	-	ATG	2	0	A	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	0.967	0.56423	D	0.916	0.65195	D	.	0.99291	.	.	.	.	.	.	.	.	0.71435	.	.	0.96886	0.4652	0.90013	D	0.7036	0.89769	D	9	0.98665875	0.98978	D	0.950787	0.99662	D	.	0.89789	0.987	0.99867	E9PFC7	M1T	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.883389812914	0.88134	.	0.29790	.	.	.	.	.	0.298644	0.66936	T	0.3844	0.88912	D	0.314388	0.88772	D	0.991858303546906	0.82073	D	0.9	0.64967	D	0.9435044	0.95537	0.71842754	0.83181	0.9426614	0.95450	0.7257	0.83606	-9.871	0.82067	D	.	.	.	0.999999935724936	0.99831	0.99948680	0.99428	.	.	.	.	.	.	.	.	3.997208	0.58947	24.0	0.97714747887968068	0.35682	0.056815	0.10376	N	0.358832926107613	0.58998	4.098281	0.311400030491244	0.55978	3.783919	3.83	3.83	0.43219	2.37	0.44186	4.168	0.58094	11.022000	0.84990	0.634	0.51995	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43124095A>G	ClinGen:CA001954	C0677776|C0027672|C2676676	604370	145|140162|145	.	Met	Thr	69412	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1	May 05, 2024	80357111	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095	43124095	17q21.31	criteria provided, multiple submitters, no conflicts	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2	54745	43124095	A	G	-	-	-	-	-	-	SCV000325520|SCV000785479|SCV001179120|SCV001587504	-	-	2T>C 	Met1Thr	NM_007294.4	2	1_Pathogenic																																																																																																									
F9	F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	10627	X	139562013	T	C	I	T	rs137852268	X	138644172	X	138471838	443	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	25666	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Aug 21, 2024	137852268	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013	139562013	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3	10627	139562013	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2	1_Pathogenic						177426	F9_Popp_2025_carboxy_gla_motif_var259020	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139562013.0	139562013.0		1328			443.0	I	T	c.1328T>C	p.Ile443Thr	missense_variant	0.8460506942392463			No	8.258081565071619e-7	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 27, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile443Thr	Ile443Thr	true
F9	F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	10627	X	139562013	T	C	I	T	rs137852268	X	138644172	X	138471838	443	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	25666	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Aug 21, 2024	137852268	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013	139562013	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3	10627	139562013	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2	1_Pathogenic						232458	F9_Popp_2025_light_chain_var249339	F9_Popp_2025_light_chain	F9	3551.0	1.0		139562013.0	139562013.0		1328			443.0	I	T	c.1328T>C	p.Ile443Thr	missense_variant	0.8181587757660991			No	8.258081565071619e-7	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 27, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile443Thr	Ile443Thr	true
F9	F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	10627	X	139562013	T	C	I	T	rs137852268	X	138644172	X	138471838	443	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	25666	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Aug 21, 2024	137852268	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013	139562013	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3	10627	139562013	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2	1_Pathogenic						149910	F9_Popp_2025_carboxy_F9_specific_var229977	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139562013.0	139562013.0		1328			443.0	I	T	c.1328T>C	p.Ile443Thr	missense_variant	0.7664048975098552			No	8.258081565071619e-7	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 27, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile443Thr	Ile443Thr	true
F9	F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	10627	X	139562013	T	C	I	T	rs137852268	X	138644172	X	138471838	443	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	25666	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Aug 21, 2024	137852268	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013	139562013	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3	10627	139562013	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2	1_Pathogenic						259974	F9_Popp_2025_strep_2_var268701	F9_Popp_2025_strep_2	F9	3551.0	1.0		139562013.0	139562013.0		1328			443.0	I	T	c.1328T>C	p.Ile443Thr	missense_variant	1.067409682132013			No	8.258081565071619e-7	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 27, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile443Thr	Ile443Thr	true
F9	F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	10627	X	139562013	T	C	I	T	rs137852268	X	138644172	X	138471838	443	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	25666	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Aug 21, 2024	137852268	-	RCV000011371|RCV001810850|RCV005042032|RCV001382695	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562013	139562013	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3	10627	139562013	T	C	-	-	-	-	-	-	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	-	-	1328T>C 	Ile443Thr	NM_000133.4	2	1_Pathogenic						204942	F9_Popp_2025_heavy_chain_var239658	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139562013.0	139562013.0		1328			443.0	I	T	c.1328T>C	p.Ile443Thr	missense_variant	0.9483916253669096			No	8.258081565071619e-7	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 27, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.905																																																											F9_Ile443Thr	Ile443Thr	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						144738	F9_Popp_2025_carboxy_F9_specific_var228177	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.092139475			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						144738	F9_Popp_2025_carboxy_F9_specific_var228177	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.092139475			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						227286	F9_Popp_2025_light_chain_var247539	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.0929588609411258			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						227286	F9_Popp_2025_light_chain_var247539	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.0929588609411258			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						172254	F9_Popp_2025_carboxy_gla_motif_var257220	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.090086830285221			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						172254	F9_Popp_2025_carboxy_gla_motif_var257220	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.090086830285221			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						199770	F9_Popp_2025_heavy_chain_var237858	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.0398613047454082			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						199770	F9_Popp_2025_heavy_chain_var237858	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	1.0398613047454082			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						254802	F9_Popp_2025_strep_2_var266901	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	0.929428832801446			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic						254802	F9_Popp_2025_strep_2_var266901	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561754.0	139561754.0		1069			357.0	G	R	c.1069G>A	p.Gly357Arg	missense_variant	0.929428832801446			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Sep 01, 2022	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.953																																																											F9_Gly357Arg	Gly357Arg	true
F9	F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	10584	X	139551112	C	T	R	C	rs137852237	X	138633271	X	138460937	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.8340	0.94814	D	0.8689	0.95632	D	10	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.99835540160048397	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.46200	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.000000	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Pathogenic/Likely_pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	25623	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Mar 11, 2024	137852237	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112	139551112	Xq27.1	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3	10584	139551112	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2	1_Pathogenic						189855	F9_Popp_2025_heavy_chain_var234369	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139551112.0	139551112.0		571			191.0	R	C	c.571C>T	p.Arg191Cys	missense_variant	0.7279694452442058			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 23, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.808																																																											F9_Arg191Cys	Arg191Cys	true
F9	F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	10584	X	139551112	C	T	R	C	rs137852237	X	138633271	X	138460937	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.8340	0.94814	D	0.8689	0.95632	D	10	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.99835540160048397	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.46200	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.000000	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Pathogenic/Likely_pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	25623	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Mar 11, 2024	137852237	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112	139551112	Xq27.1	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3	10584	139551112	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2	1_Pathogenic						134823	F9_Popp_2025_carboxy_F9_specific_var224688	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139551112.0	139551112.0		571			191.0	R	C	c.571C>T	p.Arg191Cys	missense_variant	0.707286787			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 23, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.808																																																											F9_Arg191Cys	Arg191Cys	true
F9	F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	10584	X	139551112	C	T	R	C	rs137852237	X	138633271	X	138460937	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.8340	0.94814	D	0.8689	0.95632	D	10	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.99835540160048397	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.46200	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.000000	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Pathogenic/Likely_pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	25623	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Mar 11, 2024	137852237	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112	139551112	Xq27.1	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3	10584	139551112	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2	1_Pathogenic						162339	F9_Popp_2025_carboxy_gla_motif_var253731	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139551112.0	139551112.0		571			191.0	R	C	c.571C>T	p.Arg191Cys	missense_variant	0.6328657420181729			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 23, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.808																																																											F9_Arg191Cys	Arg191Cys	true
F9	F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	10584	X	139551112	C	T	R	C	rs137852237	X	138633271	X	138460937	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.8340	0.94814	D	0.8689	0.95632	D	10	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.99835540160048397	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.46200	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.000000	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Pathogenic/Likely_pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	25623	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Mar 11, 2024	137852237	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112	139551112	Xq27.1	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3	10584	139551112	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2	1_Pathogenic						244887	F9_Popp_2025_strep_2_var263412	F9_Popp_2025_strep_2	F9	3551.0	1.0		139551112.0	139551112.0		571			191.0	R	C	c.571C>T	p.Arg191Cys	missense_variant	1.1185310922702083			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 23, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.808																																																											F9_Arg191Cys	Arg191Cys	true
F9	F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	10584	X	139551112	C	T	R	C	rs137852237	X	138633271	X	138460937	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.8340	0.94814	D	0.8689	0.95632	D	10	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.99835540160048397	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.46200	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.000000	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Pathogenic/Likely_pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	25623	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Mar 11, 2024	137852237	-	RCV004700216|RCV005042030|RCV000011330|RCV001390295	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112	139551112	Xq27.1	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3	10584	139551112	C	T	-	-	-	-	-	-	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	-	-	571C>T 	Arg191Cys	NM_000133.4	2	1_Pathogenic						217371	F9_Popp_2025_light_chain_var244050	F9_Popp_2025_light_chain	F9	3551.0	1.0		139551112.0	139551112.0		571			191.0	R	C	c.571C>T	p.Arg191Cys	missense_variant	0.7229880596910316			No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Feb 23, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.808																																																											F9_Arg191Cys	Arg191Cys	true
KRAS	KRAS_Phe156Leu	-2.8937598314972	0.023191472239177145	0.615722224711817	0.5575590131675932																											true	KRAS	ENSG00000133703	3084	214497	CCSBVarC006103	ALE00006103	NC_000012.12:25209894:G:C	468C>G	Phe156Leu	CEGS2	CegsMutGDEh1042	A06	GDEhDisVCh_40061	D10	1	CegsMutGDDh1042	A06	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0			0			0			KRAS_Phe156Leu	12	25209894	G	C	12											12-25209894-G-C	12595	12	25209894	G	C	F	L	rs104894362	12	25362828	12	25254095	131	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.393C>G	p.Phe131Leu	.	Y	.	.	.	-	TTC	3	2	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.83643	.	.	0.55569	.	.	0.53661	.	.	0.90354	.	.	.	.	.	.	.	.	0.84554	.	.	0.87459	0.4565	0.89890	D	0.5849	0.85046	D	7	.	0.94504	.	0.338981	0.91944	D	.	0.94600	.	0.93225	.	.	.	.	0.97133	.	.	.	.	.	.	.	.	.	.	0.427055	0.91321	D	0.375659	0.91214	D	0.960605561733246	0.65634	D	.	0.72066	.	.	.	.	.	.	.	.	.	.	0.95241	.	.	0.98903	.	.	.	0.97816370	0.95342	0.965	0.98576	.	.	.	.	.	.	4.89283	0.80384	27.3	0.9950134605667188	0.68072	0.705408	0.65957	D	0.603185148433657	0.73232	5.956009	0.626658052516122	0.76756	6.573638	5.43	4.53	0.54956	.	.	6.216	0.72225	6.589000	0.56088	0.591	0.32125	1.0	0.71675	1.000000	0.68239	0.999	0.91597	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|not_provided|RASopathy|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25209894G>C	ClinGen:CA279964|OMIM:190070.0018	C3809005|C3661900|C5555857	615278	1340|536391	.	Phe	Leu	27634	single nucleotide variant	NM_033360.4(KRAS):c.*22C>G	3845	KRAS	HGNC:6407	Pathogenic	1	Mar 29, 2023	104894362	-	RCV000013426|RCV000157942|RCV001205658|RCV004549359	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder	germline	germline	GRCh38	NC_000012.12	12	25209894	25209894	12p12.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA279964,OMIM:190070.0018	3	12595	25209894	G	C	-	-	-	-	-	-	SCV000207877|SCV001376927|SCV004121369	-	-	*22C>G		NM_033360.4	2	1_Pathogenic																																																																																																									
KRAS	KRAS_Phe156Leu	-2.8937598314972	0.023191472239177145	0.615722224711817	0.5575590131675932																											true	KRAS		3084		CCSBVarC006103		NC_000012.12:25209894:G:C		Phe156Leu																												KRAS_Phe156Leu	12	25209894	G	C	12	allele	468C>G	B09	527_CAVA_Array_P03	D17	B13A7A8P1_R1	B14A7A8P1_R2				12-25209894-G-C	12595	12	25209894	G	C	F	L	rs104894362	12	25362828	12	25254095	131	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.393C>G	p.Phe131Leu	.	Y	.	.	.	-	TTC	3	2	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.83643	.	.	0.55569	.	.	0.53661	.	.	0.90354	.	.	.	.	.	.	.	.	0.84554	.	.	0.87459	0.4565	0.89890	D	0.5849	0.85046	D	7	.	0.94504	.	0.338981	0.91944	D	.	0.94600	.	0.93225	.	.	.	.	0.97133	.	.	.	.	.	.	.	.	.	.	0.427055	0.91321	D	0.375659	0.91214	D	0.960605561733246	0.65634	D	.	0.72066	.	.	.	.	.	.	.	.	.	.	0.95241	.	.	0.98903	.	.	.	0.97816370	0.95342	0.965	0.98576	.	.	.	.	.	.	4.89283	0.80384	27.3	0.9950134605667188	0.68072	0.705408	0.65957	D	0.603185148433657	0.73232	5.956009	0.626658052516122	0.76756	6.573638	5.43	4.53	0.54956	.	.	6.216	0.72225	6.589000	0.56088	0.591	0.32125	1.0	0.71675	1.000000	0.68239	0.999	0.91597	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|not_provided|RASopathy|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25209894G>C	ClinGen:CA279964|OMIM:190070.0018	C3809005|C3661900|C5555857	615278	1340|536391	.	Phe	Leu	27634	single nucleotide variant	NM_033360.4(KRAS):c.*22C>G	3845	KRAS	HGNC:6407	Pathogenic	1	Mar 29, 2023	104894362	-	RCV000013426|RCV000157942|RCV001205658|RCV004549359	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder	germline	germline	GRCh38	NC_000012.12	12	25209894	25209894	12p12.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA279964,OMIM:190070.0018	3	12595	25209894	G	C	-	-	-	-	-	-	SCV000207877|SCV001376927|SCV004121369	-	-	*22C>G		NM_033360.4	2	1_Pathogenic																																																																																																									
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						215818	F9_Popp_2025_light_chain_var243519	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.115812176805143			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						215818	F9_Popp_2025_light_chain_var243519	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.115812176805143			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						160786	F9_Popp_2025_carboxy_gla_motif_var253200	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.06646977			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						160786	F9_Popp_2025_carboxy_gla_motif_var253200	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.06646977			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						243334	F9_Popp_2025_strep_2_var262881	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.3803852404443763			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						243334	F9_Popp_2025_strep_2_var262881	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.3803852404443763			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						133270	F9_Popp_2025_carboxy_F9_specific_var224157	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.1024631778626351			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						133270	F9_Popp_2025_carboxy_F9_specific_var224157	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.1024631778626351			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						188302	F9_Popp_2025_heavy_chain_var233838	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.1070931765453395			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
F9	F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic						188302	F9_Popp_2025_heavy_chain_var233838	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548467.0	139548467.0		496			166.0	N	Y	c.496A>T	p.Asn166Tyr	missense_variant	0.1070931765453395			No		Pathogenic	no assertion criteria provided	Apr 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.555																																																											F9_Asn166Tyr	Asn166Tyr	true
SHOC2	SHOC2_Ile112Thr	-1.6941158363159368	0.13407053946967112	2.63387004383908	0.03372243975123364	2025_01_Batch_13-14	0.7843858644027072	0.8124825875291124	0.6855686887880554	0.720513982024652	0.7232494537137047	0.6900349759264535	0.7668552704562939	0.6730345003121042	0.8693878114030118	0.5810832363777728	0.7372104201645804	0.7896689289927031	0.6793015945500798	0.7949508967138319	0.6521663450457388	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
BAP1	BAP1_Cys91Ser	0.5371858858067884	0.607783622798212	-2.6931062589231534	0.0309462574441354	2025_01_Batch_13-14	0.9333529871701809	0.7779180969243228	0.6547280169440957	0.7990596626902846	0.8911419451288887	0.6541532321800272	0.6325873153894371	0.6412806151140473	0.6604418906797691	0.6497839077167271	0.793753109675104	0.70525270615688	0.6480043160290715	0.7297507766850269	0.7704629264228079	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009484		NC_000003.12:52408061:C:G		Cys91Ser																												BAP1_Cys91Ser	3	52408061	C	G	3	allele	272G>C	B02	527_CAVA_Array_P01	C03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408061-C-G	1173081	3	52408061	C	G	C	S	rs1559591264	3	52442077	3	52417117	91	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.272G>C	p.Cys91Ser	c.272G>C	p.Cys91Ser	principal1	Y	1	YES	Select	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.145	0.97505	H	-9.46	0.98771	D	0.955	0.96431	1.0958	0.99480	D	0.9489	0.98331	D	10	0.9872064	0.99064	D	0.596811	0.96431	D	0.962	0.99434	0.905	0.97974	Q92560	C91S	Gain of disorder (P = 0.0084)| Loss of stability (P = 0.0799)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2045)| Loss of catalytic residue at T93 (P = 0.2182)	0.955221855794	0.95437	0.9595328650281908	0.95915	2.72839044085	0.98645	0.864477872849	0.91757	D	0.614019	0.87693	D	0.541235	0.95439	D	0.53967	0.95371	D	0.999951362609863	0.99873	D	0.998731	0.99346	D	0.94517225	0.95709	0.93077695	0.97107	0.94517225	0.95709	0.93077695	0.97108	-12.137	0.85551	D	0.9993	0.98761	P	0.999965302743864	0.99297	0.99989426	0.99864	0.869	0.92884	.	.	.	.	.	.	5.171826	0.86714	29.0	0.99414808621726736	0.63503	0.954506	0.97155	D	1.0231602614017	0.96393	14.66464	0.934896275402238	0.96904	15.33076	5.49	5.49	0.80997	.	.	7.657	0.82777	7.613000	0.62049	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52408061C>G	.	C1535926	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Cys	Ser	1162263	single nucleotide variant	NM_004656.4(BAP1):c.272G>C (p.Cys91Ser)	8314	BAP1	HGNC:950	Pathogenic	1	Apr 06, 2024	1559591264	-	RCV001797187|RCV004762154	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408061	52408061	3p21.1	criteria provided, single submitter	2	-	N	ClinGen:CA353112607	2	1173081	52408061	C	G	-	-	-	-	-	-	SCV005373284	-	-	272G>C 	Cys91Ser	NM_004656.4	1	1_Pathogenic																																																																																																									
F9	F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	1160362	X	139537037	A	G	K	R	rs200505648	X	138619196	X	138446862	39	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.99701738994094546	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.000000	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	1150443	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158	F9	HGNC:3551	Likely benign	0	Jan 30, 2024	200505648	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037	139537037	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529738	2	1160362	139537037	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1	2_Benign						180865	F9_Popp_2025_heavy_chain_var231180	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537037.0	139537037.0		116			39.0	K	R	c.116A>G	p.Lys39Arg	missense_variant	1.0563088854352267			No	0.0000132467986213	Likely benign	criteria provided, single submitter	Jan 30, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.344																																																											F9_Lys39Arg	Lys39Arg	true
F9	F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	1160362	X	139537037	A	G	K	R	rs200505648	X	138619196	X	138446862	39	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.99701738994094546	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.000000	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	1150443	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158	F9	HGNC:3551	Likely benign	0	Jan 30, 2024	200505648	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037	139537037	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529738	2	1160362	139537037	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1	2_Benign						153349	F9_Popp_2025_carboxy_gla_motif_var250542	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537037.0	139537037.0		116			39.0	K	R	c.116A>G	p.Lys39Arg	missense_variant	1.0317782090861911			No	0.0000132467986213	Likely benign	criteria provided, single submitter	Jan 30, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.344																																																											F9_Lys39Arg	Lys39Arg	true
F9	F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	1160362	X	139537037	A	G	K	R	rs200505648	X	138619196	X	138446862	39	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.99701738994094546	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.000000	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	1150443	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158	F9	HGNC:3551	Likely benign	0	Jan 30, 2024	200505648	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037	139537037	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529738	2	1160362	139537037	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1	2_Benign						125833	F9_Popp_2025_carboxy_F9_specific_var221499	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537037.0	139537037.0		116			39.0	K	R	c.116A>G	p.Lys39Arg	missense_variant	1.0335224296642962			No	0.0000132467986213	Likely benign	criteria provided, single submitter	Jan 30, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.344																																																											F9_Lys39Arg	Lys39Arg	true
F9	F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	1160362	X	139537037	A	G	K	R	rs200505648	X	138619196	X	138446862	39	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.99701738994094546	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.000000	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	1150443	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158	F9	HGNC:3551	Likely benign	0	Jan 30, 2024	200505648	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037	139537037	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529738	2	1160362	139537037	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1	2_Benign						208381	F9_Popp_2025_light_chain_var240861	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537037.0	139537037.0		116			39.0	K	R	c.116A>G	p.Lys39Arg	missense_variant	1.0395590160819106			No	0.0000132467986213	Likely benign	criteria provided, single submitter	Jan 30, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.344																																																											F9_Lys39Arg	Lys39Arg	true
F9	F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	1160362	X	139537037	A	G	K	R	rs200505648	X	138619196	X	138446862	39	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.99701738994094546	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.000000	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	1150443	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158	F9	HGNC:3551	Likely benign	0	Jan 30, 2024	200505648	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037	139537037	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529738	2	1160362	139537037	A	G	-	-	-	-	-	-	SCV001709323	-	-	116A>G 	Lys39Arg	NM_000133.4	1	2_Benign						235897	F9_Popp_2025_strep_2_var260223	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537037.0	139537037.0		116			39.0	K	R	c.116A>G	p.Lys39Arg	missense_variant	0.9412971589182256			No	0.0000132467986213	Likely benign	criteria provided, single submitter	Jan 30, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.344																																																											F9_Lys39Arg	Lys39Arg	true
BRCA1	BRCA1_Leu460Pro	1.3818159885120436	0.20951653672145118	0.01042038511580422	0.9919766475766167	2025_01_Batch_13-14	0.9059796392194737	0.8746551314367813	0.8376263836210487	0.8649401026154384	0.8901004495246302	0.9777652492427891	0.9238268256954807	0.9508407908301749	0.975894109288426	0.8550806083866495	0.9418724442311314	0.899240978566131	0.8942335872256117	0.9204171059519322	0.8725905289556398	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013122		NC_000017.11:43071223:A:G		Leu460Pro																												BRCA1_Leu460Pro	17	43071223	A	G	17	allele	1379T>C	H11	527_CAVA_Array_P01	O21	B13A7A8P1_R1	B14A7A8P1_R2				17-43071223-A-G	55262	17	43071223	A	G	L	P	rs56119278	17	41223240	17	38476766	1564	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4691T>C	p.Leu1564Pro	c.4691T>C	p.Leu1564Pro	principal2	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.167	0.45915	T	0.241	0.38212	T	0.828	0.46036	P	0.221	0.37838	B	0.22	0.57141	N	simple_aae	78.0	22.0	1.935	0.51654	L	-1.07	0.60859	N	0.501	0.60290	-0.1563	0.78666	T	0.6710	0.88560	D	10	0.047209352	0.04012	T	0.323959	0.91538	D	0.554	0.81507	.	.	.	.	.	0.776336265085	0.77250	.	0.35316	.	0.15464	0.41346591711	0.26905	T	0.151297	0.48845	T	0.0819011	0.61994	D	0.339011	0.89807	D	0.0181525713158331	0.00535	T	.	0.39375	.	0.15756732	0.35205	0.12383379	0.29781	0.0936192	0.21792	0.106218696	0.25497	-3.859	0.21903	T	0.1809	0.54067	B	0.77319198328768	0.69688	0.99947375	0.99411	0.651	0.80578	.	.	.	.	.	.	2.053966	0.26159	17.0	0.97050371191633666	0.32337	0.297615	0.40519	N	-0.391511225925735	0.25494	1.401419	-0.372425254023125	0.25504	1.422447	4.78	3.71	0.41665	3.93	0.74723	1.355	0.33777	1.823000	0.29140	0.756	0.943	0.825	0.30151	0.000000	0.08389	0.036	0.13876	543	0.72771	6	0.0011980830670926517	6	0.0045385779122541605	0	0.0	0	0.0	0	0.0	0	0.0	184	264690	6.9515285E-4	.	12	109386	1.097030e-04	0	41	207618	1.974780e-04	0	37	236280	1.565940e-04	0	11	7162	1.535880e-03	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9034	0.000000e+00	0	0	13392	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	11	7162	1.535880e-03	0	38	16132	2.355570e-03	0	2	30520	6.553080e-05	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16732	0.000000e+00	0	0	89154	0.000000e+00	0	0	30608	0.000000e+00	0	38	16132	2.355570e-03	0	35	14818	2.361990e-03	0	2	34254	5.838730e-05	0	0	9562	0.000000e+00	0	0	17680	0.000000e+00	0	0	21630	0.000000e+00	0	0	102206	0.000000e+00	0	0	30526	0.000000e+00	0	35	14818	2.361990e-03	0	.	168	1614174	1.040780e-04	1	161	75050	2.145240e-03	1	161	75050	2.145240e-03	1	0	912	0.000000e+00	0	2	60026	3.331890e-05	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180006	0.000000e+00	0	0	91088	0.000000e+00	0	0	173958	0	0	352	0	0	2686	0	18	8832	0.0020380434782608695	0	796	0	0	968	0	0	652	0	0	280	0	1	13314	7.51089079164789E-5	18	9184	0.00195993031358885	0	3338	0	19	201838	9.41349002665504E-5	Benign	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast_neoplasm|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43071223A>G	BRCA1-HCI:BRCA1_00023|ClinGen:CA002980	C3661900|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672|C1458155|CN169374	114480|617883|604370|614320	145|227535|145|1333|140162	.	Leu	Pro	69929	single nucleotide variant	NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	56119278	-	RCV000112385|RCV000148377|RCV000120262|RCV000162687|RCV000587835|RCV001082228|RCV002483063|RCV004804006|RCV004758629	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43071223	43071223	17q21.31	reviewed by expert panel	19	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00023,ClinGen:CA002980	2	55262	43071223	A	G	-	-	-	-	-	-	SCV000244368	-	-	4691T>C 	Leu1564Pro	NM_007294.4	3	2_Benign																																																																																																									
FH	FH_Arg233Leu	1.6531294030768622	0.14939045875507265	-2.3788375489716853	0.04896572564958671	2025_01_Batch_13-14	0.6513057530980929	0.623315681074625	0.7060392869124406	0.7205268032862571	0.5721998696228244	0.6740664054693245	0.6565749262015617	0.7368276161684507	0.69855261265139	0.6449922739380513	0.6626860792837087	0.6399453036380933	0.7214334515404457	0.7095397079688235	0.6085960717804378	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214595	CCSBVarC004050	ALE00004050	NC_000001.11:241508643:C:A	698G>T	Arg233Leu	CEGS2	CegsMutGDEh1040	H07	GDEhDisVCh_40065	E08	1	CegsMutGDDh1040	H07	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0			0			0			FH_Arg233Leu	1	241508643	C	A	1											1-241508643-C-A	16237	1	241508643	C	A	R	L	rs121913123	1	241671943	1	239738566	233	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.698G>T	p.Arg233Leu	c.698G>T	p.Arg233Leu	principal1	Y	1	YES	Select	-	CGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	5.07	0.99905	H	-6.84	0.93080	D	0.963	0.97332	0.9273	0.96051	D	0.9945	0.99874	D	10	0.989849	0.99460	D	0.745296	0.97960	D	0.945	0.98886	0.889	0.97257	P07954	R233L	Loss of phosphorylation at T236 (P = 0.0525)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of methylation at K230 (P = 0.0761)| Loss of MoRF binding (P = 0.0923)| Loss of glycosylation at K230 (P = 0.1752)	0.972808251769	0.97225	0.9751746669812705	0.97494	1.09694667183	0.77481	0.830429792404	0.86606	D	0.995902	0.99993	D	0.51557	0.94692	D	0.599658	0.96962	D	0.999926209449768	0.99730	D	0.988918	0.96274	D	0.99120563	0.99821	0.9549934	0.98673	0.99120563	0.99821	0.9549934	0.98673	-15.96	0.97705	D	0.9946	0.95323	P	0.999900398311514	0.98723	0.93478185	0.92608	1	0.99985	.	.	.	.	.	.	5.201626	0.87283	29.2	0.99866098052584062	0.94461	0.927182	0.90912	D	1.08057729138192	0.97745	16.70746	0.942227821079248	0.97147	15.68653	5.65	5.65	0.86862	6.32	0.99010	7.503	0.80522	7.704000	0.66498	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.948	0.49339	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109390	9.141600e-06	0	1	208074	4.805980e-06	0	1	236740	4.224040e-06	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	0	42766	0.000000e+00	0	1	15688	6.374300e-05	0	1	15688	6.374300e-05	0	0	16216	0.000000e+00	0	0	30494	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	0	89538	0.000000e+00	0	1	30604	3.267550e-05	0	1	30604	3.267550e-05	0	0	14900	0.000000e+00	0	0	34228	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	0	102598	0.000000e+00	0	1	30522	3.276330e-05	0	1	30522	3.276330e-05	0	.	5	1613808	3.098260e-06	0	5	91072	5.490160e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29598	0.000000e+00	0	0	44856	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179792	0.000000e+00	0	5	91072	5.490160e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508643C>A	ClinGen:CA257461|OMIM:136850.0008	C3661900|C1708350|C0027672	150800	523|140162	Fumarate lyase, N-terminal	Arg	Leu	31276	single nucleotide variant	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Mar 04, 2025	121913123	-	RCV000017624|RCV001781272|RCV002362588	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241508643	241508643	1q43	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA257461,OMIM:136850.0008	3	16237	241508643	C	A	-	-	-	-	-	-	SCV000537240|SCV001430110|SCV002219616|SCV002665339|SCV004017822|SCV004025213	-	-	698G>T 	Arg233Leu	NM_000143.4	2	1_Pathogenic	1	241508643	C	A	3.42101e-6																																																																																																				
FH	FH_Arg233Leu	1.6531294030768622	0.14939045875507265	-2.3788375489716853	0.04896572564958671	2025_01_Batch_13-14	0.6513057530980929	0.623315681074625	0.7060392869124406	0.7205268032862571	0.5721998696228244	0.6740664054693245	0.6565749262015617	0.7368276161684507	0.69855261265139	0.6449922739380513	0.6626860792837087	0.6399453036380933	0.7214334515404457	0.7095397079688235	0.6085960717804378	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004050		NC_000001.11:241508643:C:A		Arg233Leu																												FH_Arg233Leu	1	241508643	C	A	1	allele	698G>T	E03	527_CAVA_Array_P03	J05	B13A7A8P1_R1	B14A7A8P1_R2				1-241508643-C-A	16237	1	241508643	C	A	R	L	rs121913123	1	241671943	1	239738566	233	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.698G>T	p.Arg233Leu	c.698G>T	p.Arg233Leu	principal1	Y	1	YES	Select	-	CGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	5.07	0.99905	H	-6.84	0.93080	D	0.963	0.97332	0.9273	0.96051	D	0.9945	0.99874	D	10	0.989849	0.99460	D	0.745296	0.97960	D	0.945	0.98886	0.889	0.97257	P07954	R233L	Loss of phosphorylation at T236 (P = 0.0525)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of methylation at K230 (P = 0.0761)| Loss of MoRF binding (P = 0.0923)| Loss of glycosylation at K230 (P = 0.1752)	0.972808251769	0.97225	0.9751746669812705	0.97494	1.09694667183	0.77481	0.830429792404	0.86606	D	0.995902	0.99993	D	0.51557	0.94692	D	0.599658	0.96962	D	0.999926209449768	0.99730	D	0.988918	0.96274	D	0.99120563	0.99821	0.9549934	0.98673	0.99120563	0.99821	0.9549934	0.98673	-15.96	0.97705	D	0.9946	0.95323	P	0.999900398311514	0.98723	0.93478185	0.92608	1	0.99985	.	.	.	.	.	.	5.201626	0.87283	29.2	0.99866098052584062	0.94461	0.927182	0.90912	D	1.08057729138192	0.97745	16.70746	0.942227821079248	0.97147	15.68653	5.65	5.65	0.86862	6.32	0.99010	7.503	0.80522	7.704000	0.66498	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.948	0.49339	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109390	9.141600e-06	0	1	208074	4.805980e-06	0	1	236740	4.224040e-06	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	0	42766	0.000000e+00	0	1	15688	6.374300e-05	0	1	15688	6.374300e-05	0	0	16216	0.000000e+00	0	0	30494	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	0	89538	0.000000e+00	0	1	30604	3.267550e-05	0	1	30604	3.267550e-05	0	0	14900	0.000000e+00	0	0	34228	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	0	102598	0.000000e+00	0	1	30522	3.276330e-05	0	1	30522	3.276330e-05	0	.	5	1613808	3.098260e-06	0	5	91072	5.490160e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29598	0.000000e+00	0	0	44856	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179792	0.000000e+00	0	5	91072	5.490160e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508643C>A	ClinGen:CA257461|OMIM:136850.0008	C3661900|C1708350|C0027672	150800	523|140162	Fumarate lyase, N-terminal	Arg	Leu	31276	single nucleotide variant	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Mar 04, 2025	121913123	-	RCV000017624|RCV001781272|RCV002362588	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241508643	241508643	1q43	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA257461,OMIM:136850.0008	3	16237	241508643	C	A	-	-	-	-	-	-	SCV000537240|SCV001430110|SCV002219616|SCV002665339|SCV004017822|SCV004025213	-	-	698G>T 	Arg233Leu	NM_000143.4	2	1_Pathogenic	1	241508643	C	A	3.42101e-6																																																																																																				
RAD51D	RAD51D_Arg55Trp	1.021432754244928	0.341046466783239	-0.6516104897040346	0.5354521334844584	2025_01_Batch_13-14	0.5773047600598085	0.7310209948174875	0.731383595365466	0.6615307574655238	0.566970418461294	0.5398752335334411	0.7123554891322557	0.7037045509736447	0.6637786417422724	0.5275149052822954	0.5585899967966248	0.7216882419748716	0.7175440731695554	0.6626546996038981	0.5472426618717947	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024799		NC_000017.11:35118601:G:A		Arg55Trp																												RAD51D_Arg55Trp	17	35118601	G	A	17	allele	163C>T	E12	527_CAVA_Array_P04	J24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118601-G-A	230594	17	35118601	G	A	R	W	rs775268017	17	33445620	17	30469733	55	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.163C>T	p.Arg55Trp	c.163C>T	p.Arg55Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.001	0.83643	D	0.997	0.70687	D	0.915	0.65085	D	0.63	0.78586	D	simple_aae	37.0	63.0	2.6	0.75898	M	-5.15	0.83383	D	0.825	0.81999	-0.5240	0.67624	T	0.2724	0.64261	T	10	0.8072227	0.79845	D	0.111863	0.78916	D	0.374	0.69109	0.598	0.72759	O75771	R55W	Gain of catalytic residue at L53 (P = 0.0031)| Gain of helix (P = 0.005)| Loss of loop (P = 0.0153)| Loss of MoRF binding (P = 0.0884)| Loss of solvent accessibility (P = 0.1202)	0.873687315659	0.87147	.	.	.	.	.	.	.	0.547731	0.84489	D	0.0541436	0.58585	T	-0.0631489	0.65870	T	0.94793289899826	0.62559	D	.	0.72299	.	0.47494522	0.65280	0.46390733	0.68623	0.47494522	0.65280	0.46390733	0.68623	-9.321	0.69817	D	0.4599	0.65611	A	0.00577304038068542	0.19858	0.99482584	0.97637	0.599	0.77554	.	.	.	.	.	.	5.317904	0.89281	29.9	0.99887546840030128	0.96206	0.817233	0.73781	D	0.415643171291693	0.62085	4.441516	0.323933020451451	0.56721	3.859249	4.79	1.09	0.19474	1.94	0.38959	3.953	0.56497	3.143000	0.36573	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	109344	9.145450e-06	0	2	207876	9.621120e-06	0	2	236752	8.447660e-06	0	0	7164	0.000000e+00	0	0	17108	0.000000e+00	0	1	2320	4.310340e-04	0	0	9040	0.000000e+00	0	0	13344	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16164	0.000000e+00	0	0	30520	0.000000e+00	0	1	6206	1.611340e-04	0	0	13410	0.000000e+00	0	0	16684	0.000000e+00	0	0	89422	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14848	0.000000e+00	0	0	34256	0.000000e+00	0	1	9566	1.045370e-04	0	0	17686	0.000000e+00	0	0	21582	0.000000e+00	0	0	102668	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	36	1614066	2.230390e-05	0	31	6084	5.095330e-03	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	2	60004	3.333110e-05	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64002	0.000000e+00	0	31	6084	5.095330e-03	0	0	1180034	0.000000e+00	0	1	91096	1.097740e-05	0	1	19700	5.076142131979695E-5	0	298	0	0	86	0	0	7436	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1928	0	0	7734	0	0	112	0	1	30328	3.297283038776049E-5	Conflicting_classifications_of_pathogenicity	not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118601G>A	ClinGen:CA8499638	CN169374|C3661900|C0027672|C3280345	614291	140162|145	RAD51D, N-terminal domain	Arg	Trp	235907	single nucleotide variant	NM_002878.4(RAD51D):c.163C>T (p.Arg55Trp)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Jan 26, 2025	775268017	-	RCV000222465|RCV000555250|RCV001547298|RCV002229933	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	35118601	35118601	17q12	criteria provided, conflicting classifications	9	-	N	ClinGen:CA8499638	2	230594	35118601	G	A	-	-	-	-	-	-	SCV000274193|SCV000651718|SCV000912002|SCV001766967|SCV002511654|SCV003926632|SCV004033554|SCV004208078|SCV004236536	-	-	163C>T 	Arg55Trp	NM_002878.4	1	3_Conflicting						962260	RAD51D_unpublished_var156507	RAD51D_unpublished	RAD51D	9823.0	-1.0		35118601.0	35118601.0		163	C	T	55.0	R	W	c.163C>T	p.Arg55Trp	missense_variant	0.0105931		functionally_normal	Yes	0.0000223039206575	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jan 18, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.374																																																											RAD51D_Arg55Trp	Arg55Trp	true
F9	F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373808	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	1142361	X	139561529	C	T	H	Y	rs763399530	X	138643688	X	138471354	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.5140	0.81707	D	10	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.52811199848246315	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427000	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	1150446	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158	F9	HGNC:3551	Likely benign	0	Feb 14, 2024	763399530	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529	139561529	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529850	2	1142361	139561529	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1	2_Benign						167769	F9_Popp_2025_carboxy_gla_motif_var255636	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561529.0	139561529.0		844			282.0	H	Y	c.844C>T	p.His282Tyr	missense_variant	1.070452298486182			No	0.0000108249349879	Likely benign	criteria provided, single submitter	Jan 11, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.393																																																											F9_His282Tyr	His282Tyr	true
F9	F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373808	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	1142361	X	139561529	C	T	H	Y	rs763399530	X	138643688	X	138471354	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.5140	0.81707	D	10	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.52811199848246315	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427000	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	1150446	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158	F9	HGNC:3551	Likely benign	0	Feb 14, 2024	763399530	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529	139561529	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529850	2	1142361	139561529	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1	2_Benign						195285	F9_Popp_2025_heavy_chain_var236274	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561529.0	139561529.0		844			282.0	H	Y	c.844C>T	p.His282Tyr	missense_variant	1.0267283664931162			No	0.0000108249349879	Likely benign	criteria provided, single submitter	Jan 11, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.393																																																											F9_His282Tyr	His282Tyr	true
F9	F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373808	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	1142361	X	139561529	C	T	H	Y	rs763399530	X	138643688	X	138471354	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.5140	0.81707	D	10	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.52811199848246315	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427000	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	1150446	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158	F9	HGNC:3551	Likely benign	0	Feb 14, 2024	763399530	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529	139561529	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529850	2	1142361	139561529	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1	2_Benign						222801	F9_Popp_2025_light_chain_var245955	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561529.0	139561529.0		844			282.0	H	Y	c.844C>T	p.His282Tyr	missense_variant	1.0602912554291422			No	0.0000108249349879	Likely benign	criteria provided, single submitter	Jan 11, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.393																																																											F9_His282Tyr	His282Tyr	true
F9	F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373808	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	1142361	X	139561529	C	T	H	Y	rs763399530	X	138643688	X	138471354	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.5140	0.81707	D	10	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.52811199848246315	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427000	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	1150446	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158	F9	HGNC:3551	Likely benign	0	Feb 14, 2024	763399530	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529	139561529	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529850	2	1142361	139561529	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1	2_Benign						250317	F9_Popp_2025_strep_2_var265317	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561529.0	139561529.0		844			282.0	H	Y	c.844C>T	p.His282Tyr	missense_variant	0.9838825621857352			No	0.0000108249349879	Likely benign	criteria provided, single submitter	Jan 11, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.393																																																											F9_His282Tyr	His282Tyr	true
F9	F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373808	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	1142361	X	139561529	C	T	H	Y	rs763399530	X	138643688	X	138471354	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.5140	0.81707	D	10	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.52811199848246315	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427000	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Likely_benign	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	1150446	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158	F9	HGNC:3551	Likely benign	0	Feb 14, 2024	763399530	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529	139561529	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA10529850	2	1142361	139561529	C	T	-	-	-	-	-	-	SCV001684474	-	-	844C>T 	His282Tyr	NM_000133.4	1	2_Benign						140253	F9_Popp_2025_carboxy_F9_specific_var226593	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561529.0	139561529.0		844			282.0	H	Y	c.844C>T	p.His282Tyr	missense_variant	1.0374047023638455			No	0.0000108249349879	Likely benign	criteria provided, single submitter	Jan 11, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.393																																																											F9_His282Tyr	His282Tyr	true
SOS2	SOS2_Pro1318Ser	1.0493118206423042	0.328906085228044	9.648726316236788	0.000027068206037967004	2025_01_Batch_13-14	0.554340213938575	0.6887243058977645	0.870454493436902	0.745988592406421	0.5811270840807448	0.6722103852923178	0.8100490546522804	0.9536180356480155	0.910307686853788	0.6730856149034364	0.6132752996154465	0.7493866802750224	0.9120362645424587	0.8281481396301045	0.6271063494920905	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SOS2		55187		CCSBVarC013771		NC_000014.9:50118391:G:A		Pro1318Ser																												SOS2_Pro1318Ser	14	50118391	G	A	14	allele	3952C>T	D03	527_CAVA_Array_P06	G06	B13A7A8P2_R1	B14A7A8P2_R2				14-50118391-G-A	475758	14	50118391	G	A	P	S	rs140995728	14	50585109	14	49654859	1318	SOS2	ENSG00000100485	ENST00000216373	ENSP00000216373	Q07890	SOS2_HUMAN	c.3952C>T	p.Pro1318Ser	c.3952C>T	p.Pro1318Ser	principal1	Y	1	YES	Select	-	CCA	1	0	G	./.	./.	./.	./.	0.771	0.03390	T	0.183	0.29561	T	0.993	0.65587	D	0.968	0.71743	D	0.38	0.62259	N	simple_aae	62.0	38.0	1.24	0.30804	L	-2.62	0.56328	D	0.107	0.20263	-0.3437	0.73619	T	0.4792	0.79993	T	10	0.014707029	0.00305	T	0.035738	0.56369	D	0.311	0.63079	.	.	.	.	.	0.564192878985	0.55755	0.24931831313751454	0.24653	0.333972655293	0.35131	0.423311650753	0.28258	T	0.459389	0.79546	T	-0.27488	0.10979	T	-0.174886	0.56696	T	0.0457728085513322	0.04699	T	0.754025	0.37784	T	0.1488474	0.33678	0.22177863	0.46827	0.16657373	0.36701	0.19488566	0.42985	-3.805	0.20897	T	0.0792	0.15718	B	0.211387639361191	0.50480	0.92654955	0.92242	0.247	0.51713	.	.	.	.	.	.	1.857218	0.23634	16.08	0.88180507123295981	0.18028	0.426669	0.48918	N	0.376038629970589	0.59920	4.198247	0.407449731798897	0.61823	4.411648	5.37	5.37	0.76916	3.71	0.68166	2.631	0.46269	4.061000	0.41666	0.676	0.76753	0.998	0.41403	1.000000	0.68239	0.996	0.76032	443	0.79891	4	7.987220447284345E-4	0	0.0	3	0.002982107355864811	1	0.001440922190201729	0	0.0	0	0.0	134	264690	5.062526E-4	.	47	109384	4.296790e-04	0	104	208088	4.997890e-04	0	113	236904	4.769860e-04	0	2	7164	2.791740e-04	0	3	17108	1.753570e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	40	42752	9.356290e-04	0	0	15688	0.000000e+00	0	40	42752	9.356290e-04	0	4	16218	2.466400e-04	0	6	30518	1.966050e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	90	89522	1.005340e-03	0	1	30606	3.267330e-05	0	90	89522	1.005340e-03	0	4	14902	2.684200e-04	0	8	34254	2.335490e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	96	102720	9.345790e-04	0	1	30524	3.276110e-05	0	96	102720	9.345790e-04	0	.	1235	1614102	7.651310e-04	1	1160	1180004	9.830480e-04	1	18	75012	2.399620e-04	0	0	912	0.000000e+00	0	17	60006	2.833050e-04	0	1	29606	3.377690e-05	0	0	44886	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	1160	1180004	9.830480e-04	1	2	91086	2.195730e-05	0	146	184512	7.912764481442942E-4	0	360	0	0	2712	0	2	9426	2.121790791427965E-4	0	796	0	0	968	0	0	682	0	0	280	0	13	15606	8.330129437395873E-4	2	9786	2.0437359493153485E-4	0	3394	0	161	215342	7.476479274827948E-4	Benign/Likely_benign	not_specified|not_provided|Cardiovascular_phenotype|SOS2-related_disorder|Noonan_syndrome_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50118391G>A	ClinGen:CA7176682	CN169374|C3661900|CN230736|C4225282	616559	648	.	Pro	Ser	463782	single nucleotide variant	NM_006939.4(SOS2):c.3952C>T (p.Pro1318Ser)	6655	SOS2	HGNC:11188	Benign/Likely benign	0	Jan 22, 2025	140995728	-	RCV000555942|RCV001175493|RCV001644664|RCV002358610|RCV003962607	MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648|MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|	Noonan syndrome 9|not specified|not provided|Cardiovascular phenotype|SOS2-related disorder	germline	germline	GRCh38	NC_000014.9	14	50118391	50118391	14q21.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA7176682	2	475758	50118391	G	A	-	-	-	-	-	-	SCV000656031|SCV001339086|SCV001856913|SCV002621043|SCV002762964|SCV004134072	-	-	3952C>T 	Pro1318Ser	NM_006939.4	2	2_Benign																																																																																																									
KRAS	KRAS_Lys5Asn	0.08584326223585399	0.9339947865923037	3.404403617783895	0.01137409970321642																											true	KRAS	ENSG00000133703	3084	214478	CCSBVarC006087	ALE00006087	NC_000012.12:25245370:T:A	15A>T	Lys5Asn	CEGS2	CegsMutGDEh1038	C11	GDEhDisVCh_40061	C09	1	CegsMutGDDh1038	C11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Lys5Asn	12	25245370	T	A	12											12-25245370-T-A	12594	12	25245370	T	A	K	N	rs104894361	12	25398304	12	25289571	5	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.15A>T	p.Lys5Asn	c.15A>T	p.Lys5Asn	alternative1	Y	1	.	Plus_Clinical	-	AAA	3	2	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.925	0.84244	M	-3.84	0.80714	D	0.972	0.99419	0.7231	0.93439	D	0.7261	0.90593	D	9	0.89535224	0.88765	D	0.199646	0.86630	D	0.764	0.91975	0.746	0.87676	P01116	K5N	Gain of catalytic residue at E3 (P = 8e-04)| Loss of methylation at T5 (P = 0.0037)| Loss of ubiquitination at K5 (P = 0.021)| Gain of glycosylation at K2 (P = 0.1048)| Loss of disorder (P = 0.1189)	0.988022322716	0.98776	0.9939208319203104	0.99388	2.91440076523	0.99109	0.898385763168	0.96255	D	0.815684	0.95403	D	0.180387	0.71872	D	0.0213364	0.71506	D	0.998155415058136	0.93318	D	0.913609	0.69172	D	0.95635056	0.96861	0.89014167	0.94198	0.96346295	0.97588	0.8948088	0.94534	-11.193	0.83720	D	0.992	0.96154	P	0.999992346462973	0.99831	0.99815910	0.98658	0.995	0.99826	.	.	.	.	.	.	4.203335	0.6352	24.6	0.99859761066323194	0.93824	0.371023	0.45534	N	0.614844979912789	0.73972	6.077792	0.563747131663172	0.72208	5.797508	5.68	4.55	0.55376	2.79	0.51050	0.726	0.25745	1.824000	0.29148	-0.137	0.12603	1.0	0.71675	1.000000	0.68239	0.997	0.79771	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|not_provided|Noonan_syndrome|Inborn_genetic_diseases	reviewed_by_expert_panel	NC_000012.12:g.25245370T>A	ClinGen:CA234191|OMIM:190070.0017|UniProtKB:P01116#VAR_064849	C3809005|C3661900|C0028326|C0950123	615278|PS163950	1340|648	Small GTP-binding domain	Lys	Asn	27633	single nucleotide variant	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3845	KRAS	HGNC:6407	Pathogenic	1	Apr 03, 2017	104894361	-	RCV000153427|RCV000520745|RCV000013425|RCV000623267	MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123	not provided|Noonan syndrome|Cardiofaciocutaneous syndrome 2|Inborn genetic diseases	germline	germline	GRCh38	NC_000012.12	12	25245370	25245370	12p12.1	reviewed by expert panel	4	-	N	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	3	12594	25245370	T	A	-	-	-	-	-	-	SCV000616404	-	-	15A>T 	Lys5Asn	NM_033360.4	3	1_Pathogenic																																																																																																									
KRAS	KRAS_Lys5Asn	0.08584326223585399	0.9339947865923037	3.404403617783895	0.01137409970321642																											true	KRAS		3084		CCSBVarC006087		NC_000012.12:25245370:T:A		Lys5Asn																												KRAS_Lys5Asn	12	25245370	T	A	12	allele	15A>T	E07	527_CAVA_Array_P03	J13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245370-T-A	12594	12	25245370	T	A	K	N	rs104894361	12	25398304	12	25289571	5	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.15A>T	p.Lys5Asn	c.15A>T	p.Lys5Asn	alternative1	Y	1	.	Plus_Clinical	-	AAA	3	2	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.925	0.84244	M	-3.84	0.80714	D	0.972	0.99419	0.7231	0.93439	D	0.7261	0.90593	D	9	0.89535224	0.88765	D	0.199646	0.86630	D	0.764	0.91975	0.746	0.87676	P01116	K5N	Gain of catalytic residue at E3 (P = 8e-04)| Loss of methylation at T5 (P = 0.0037)| Loss of ubiquitination at K5 (P = 0.021)| Gain of glycosylation at K2 (P = 0.1048)| Loss of disorder (P = 0.1189)	0.988022322716	0.98776	0.9939208319203104	0.99388	2.91440076523	0.99109	0.898385763168	0.96255	D	0.815684	0.95403	D	0.180387	0.71872	D	0.0213364	0.71506	D	0.998155415058136	0.93318	D	0.913609	0.69172	D	0.95635056	0.96861	0.89014167	0.94198	0.96346295	0.97588	0.8948088	0.94534	-11.193	0.83720	D	0.992	0.96154	P	0.999992346462973	0.99831	0.99815910	0.98658	0.995	0.99826	.	.	.	.	.	.	4.203335	0.6352	24.6	0.99859761066323194	0.93824	0.371023	0.45534	N	0.614844979912789	0.73972	6.077792	0.563747131663172	0.72208	5.797508	5.68	4.55	0.55376	2.79	0.51050	0.726	0.25745	1.824000	0.29148	-0.137	0.12603	1.0	0.71675	1.000000	0.68239	0.997	0.79771	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardiofaciocutaneous_syndrome_2|not_provided|Noonan_syndrome|Inborn_genetic_diseases	reviewed_by_expert_panel	NC_000012.12:g.25245370T>A	ClinGen:CA234191|OMIM:190070.0017|UniProtKB:P01116#VAR_064849	C3809005|C3661900|C0028326|C0950123	615278|PS163950	1340|648	Small GTP-binding domain	Lys	Asn	27633	single nucleotide variant	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3845	KRAS	HGNC:6407	Pathogenic	1	Apr 03, 2017	104894361	-	RCV000153427|RCV000520745|RCV000013425|RCV000623267	MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123	not provided|Noonan syndrome|Cardiofaciocutaneous syndrome 2|Inborn genetic diseases	germline	germline	GRCh38	NC_000012.12	12	25245370	25245370	12p12.1	reviewed by expert panel	4	-	N	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	3	12594	25245370	T	A	-	-	-	-	-	-	SCV000616404	-	-	15A>T 	Lys5Asn	NM_033360.4	3	1_Pathogenic																																																																																																									
ZC4H2	ZC4H2_Ala200Thr	-5.682062973976312	0.0007491281331314925	7.059848916684998	0.00020063357271856742	2025_01_Batch_13-14	0.69241397251165	0.8069410503271048	0.8641759199854547	0.8467151459798945	0.6814470523169307	0.7872116008291188	0.9338751932930486	0.9752223718690706	0.9513696573133672	0.7794601415888701	0.7398127866703844	0.8704081218100768	0.9196991459272627	0.8990424016466309	0.7304535969529005	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009163		NC_000023.11:64917860:C:T		Ala200Thr																												ZC4H2_Ala200Thr	23	64917860	C	T	X	allele	598G>A	F04	527_CAVA_Array_P06	K08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917860-C-T	930963	X	64917860	C	T	A	T	rs1929006117	X	64137740	X	64054465	200	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.598G>A	p.Ala200Thr	c.598G>A	p.Ala200Thr	principal1	Y	1	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.994	0.82066	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-3.52	0.68446	D	0.866	0.87678	-0.8962	0.48170	T	0.1833	0.52977	T	8	0.8993199	0.89172	D	0.645518	0.96983	D	0.493	0.77793	0.541	0.65184	Q9NQZ6	A200T	Gain of phosphorylation at A200 (P = 0.0325)| Loss of MoRF binding (P = 0.1211)| Loss of helix (P = 0.1299)| Loss of catalytic residue at A200 (P = 0.3072)| Loss of stability (P = 0.3362)	0.883420790715	0.88137	0.8527665168203684	0.85148	3.0674637903	0.99314	0.833977639675	0.87150	D	0.861348	0.96901	D	0.478681	0.93601	D	0.449816	0.93521	D	0.997183978557587	0.90886	D	0.958704	0.85578	D	0.8956946	0.90872	0.8811168	0.93554	0.8956946	0.90873	0.8811168	0.93554	-11.278	0.81389	D	0.9998	0.99584	P	0.992700566218043	0.89650	0.99633140	0.98026	0.997	0.99892	.	.	.	.	.	.	5.023812	0.83539	28.1	0.9994258080004339	0.99824	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	criteria_provided,_single_submitter	NC_000023.11:g.64917860C>T	.	C0796200	314580	3454|85283	Zinc finger C4H2-type	Ala	Thr	920050	single nucleotide variant	NM_018684.4(ZC4H2):c.598G>A (p.Ala200Thr)	55906	ZC4H2	HGNC:24931	Pathogenic	1	Mar 23, 2020	1929006117	-	RCV001197017	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	unknown	unknown	GRCh38	NC_000023.11	X	64917860	64917860	Xq11.2	criteria provided, single submitter	1	-	N	ClinGen:CA413411194	2	930963	64917860	C	T	-	-	-	-	-	-	SCV001367652	-	-	598G>A 	Ala200Thr	NM_018684.4	1	1_Pathogenic																																																																																																									
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						203179	F9_Popp_2025_heavy_chain_var239049	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	0.9854773236553624			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						203179	F9_Popp_2025_heavy_chain_var239049	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	0.9854773236553624			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						258211	F9_Popp_2025_strep_2_var268092	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	1.2386178883226602			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						258211	F9_Popp_2025_strep_2_var268092	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	1.2386178883226602			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						148147	F9_Popp_2025_carboxy_F9_specific_var229368	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	1.0132851938930971			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						148147	F9_Popp_2025_carboxy_F9_specific_var229368	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	1.0132851938930971			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						230695	F9_Popp_2025_light_chain_var248730	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	0.980100509			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						230695	F9_Popp_2025_light_chain_var248730	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	0.980100509			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						175663	F9_Popp_2025_carboxy_gla_motif_var258411	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	0.9262422536804956			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
F9	F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406764	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696461	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic						175663	F9_Popp_2025_carboxy_gla_motif_var258411	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561925.0	139561925.0		1240			414.0	P	T	c.1240C>A	p.Pro414Thr	missense_variant	0.9262422536804956			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.993																																																											F9_Pro414Thr	Pro414Thr	true
BRCA1	BRCA1_Asn132Lys	2.212585170847975	0.06255809591849197	2.057481779620184	0.0786569367910109	2025_01_Batch_13-14	0.989883589297884	0.9544798674417163	0.9515149578296669	0.9817695717721739	0.9685390552154329	0.979691614058316	0.9064612890411237	0.9102052356299227	0.9713533990828885	0.920053761064975	0.9847876016781	0.93047057824142	0.9308600967297949	0.9765614854275313	0.944296408140204	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC013093		NC_000017.11:43104167:G:T		Asn132Lys																												BRCA1_Asn132Lys	17	43104167	G	T	17	allele	396C>A	D11	527_CAVA_Array_P01	G21	B13A7A8P1_R1	B14A7A8P1_R2				17-43104167-G-T	55064	17	43104167	G	T	N	K	rs80357413	17	41256184	17	38509710	132	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.396C>A	p.Asn132Lys	c.396C>A	p.Asn132Lys	principal2	Y	1	YES	Select	-	AAC	3	2	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.014	0.74454	D	0.844	0.70687	P	0.23	0.76920	B	0.48	0.78014	N	simple_aae	52.0	48.0	2.535	0.73728	M	-0.84	0.74082	N	0.728	0.84989	-0.7539	0.57554	T	0.2504	0.61845	T	10	0.49917424	0.61126	D	0.537965	0.95677	D	0.661	0.87273	0.734	0.86654	E9PFC7	N132K	Gain of methylation at N132 (P = 0.0115)| Loss of ubiquitination at K135 (P = 0.027)| Gain of helix (P = 0.0325)| Gain of MoRF binding (P = 0.0503)| Loss of loop (P = 0.0804)	0.91044858891	0.90887	.	0.38932	.	0.14104	0.593114554882	0.51867	T	0.312083	0.68213	T	0.105641	0.64645	D	0.0998727	0.76727	D	0.220903346759768	0.21247	T	.	0.79579	.	0.22508949	0.44837	0.18978201	0.42198	0.24349055	0.46959	0.2039367	0.44334	0.181	0.01204	T	0.5123	0.66770	A	0.633096537117509	0.64846	0.99506503	0.97691	0.111	0.30556	.	.	.	.	.	.	1.435024	0.18568	13.79	0.99611497861979004	0.74843	0.533451	0.55132	D	-0.178148358989986	0.33768	1.938592	-0.156487260348686	0.32848	1.893925	5.32	2.3	0.27660	1.8	0.37395	1.172	0.3162	0.730000	0.21161	-0.727	0.03758	1.0	0.71675	0.998000	0.34068	0.941	0.48226	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	5	109376	4.571390e-05	0	10	208078	4.805890e-05	0	9	236888	3.799260e-05	0	0	7164	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13386	0.000000e+00	0	5	42766	1.169150e-04	0	0	15682	0.000000e+00	0	5	42766	1.169150e-04	0	0	16218	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16726	0.000000e+00	0	10	89540	1.116820e-04	0	0	30594	0.000000e+00	0	10	89540	1.116820e-04	0	0	14902	0.000000e+00	0	0	34238	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	9	102730	8.760830e-05	0	0	30512	0.000000e+00	0	9	102730	8.760830e-05	0	.	60	1613926	3.717640e-05	0	58	1179978	4.915350e-05	0	1	74908	1.334970e-05	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29606	0.000000e+00	0	0	44890	0.000000e+00	0	0	64002	0.000000e+00	0	0	6082	0.000000e+00	0	58	1179978	4.915350e-05	0	0	91078	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4596	0	0	2918	0	0	112	0	2	39902	5.0122800862112174E-5	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43104167G>T	BRCA1-HCI:BRCA1_00119|ClinGen:CA002545|UniProtKB:P38398#VAR_070462	C0027672|CN169374|C0006142|C0677776|C3661900|C2676676	604370	140162|145|145	.	Asn	Lys	69731	single nucleotide variant	NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80357413	-	RCV000083203|RCV000162966|RCV000212156|RCV000587325|RCV001083972|RCV001353495	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43104167	43104167	17q21.31	reviewed by expert panel	20	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00119,ClinGen:CA002545,UniProtKB:P38398#VAR_070462	2	55064	43104167	G	T	-	-	-	-	-	-	SCV000244350	-	-	396C>A 	Asn132Lys	NM_007294.4	3	2_Benign																																																																																																									
FANCC	FANCC_Leu496Arg	-1.549280011711085	0.1652455454136042	-6.82618618656796	0.0002472608798740025	2025_01_Batch_13-14	0.6463386509857354	0.8060808157714119	0.8949602032890903	0.8497309349742465	0.8065596656809763	0.7440958622022515	0.9524697932812349	0.967628626732216	0.9287504020434858	0.8719891413627952	0.6952172565939935	0.8792753045263234	0.9312944150106531	0.8892406685088661	0.8392744035218858	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FANCC	ENSG00000158169	7699	13989	CCSBVarC001230	ALE00001230	NC_000009.12:95107112:A:C	1487T>G	Leu496Arg	RC4	RC4_Mut_GDEh1009	C09	GDEhDisVCh_40044	F07	2	RC4_Mut_GDDh1009	C09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FANCC_Leu496Arg	9	95107112	A	C	9											9-95107112-A-C	12050	9	95107112	A	C	L	R	rs121917785	9	97869394	9	96909215	496	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1487T>G	p.Leu496Arg	c.1487T>G	p.Leu496Arg	principal1	Y	1	YES	Select	-	CTC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.99	0.78943	D	0.74	0.84487	A	simple_aae	26.0	74.0	2.395	0.69015	M	-5.08	0.82920	D	0.944	0.95151	-0.0954	0.80115	T	0.3623	0.72245	T	9	0.9910704	0.99622	D	0.041256	0.59673	D	0.522	0.79598	0.932	0.98955	Q00597	L496R	Gain of MoRF binding (P = 0.0166)| Gain of methylation at L496 (P = 0.0294)| Gain of solvent accessibility (P = 0.0584)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.101)	0.91854953846	0.91711	0.7235648123959582	0.72155	0.400379318551	0.40752	0.527930855751	0.42681	T	0.502392	0.82079	D	0.30647	0.83356	D	0.202447	0.83141	D	0.990214049816132	0.80281	D	.	0.39699	.	0.87331074	0.88974	0.7835274	0.87085	0.8566318	0.87667	0.77439195	0.86521	-6.134	0.47446	T	0.5133	0.65167	A	0.939888730715306	0.79344	0.95983505	0.93950	0.809	0.89444	.	.	.	.	.	.	3.643055	0.51746	23.1	0.99737588940490851	0.83280	0.455600	0.50611	N	0.551271328372298	0.70000	5.460852	0.462495863549082	0.65336	4.834584	4.94	4.94	0.64600	5.03	0.90264	5.392	0.66097	11.055000	0.85376	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.023	0.12113	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Fanconi_anemia_complementation_group_C	no_assertion_criteria_provided	NC_000009.12:g.95107112A>C	ClinGen:CA256207|OMIM:613899.0008|UniProtKB:Q00597#VAR_005232	C3468041	227645	84	.	Leu	Arg	27089	single nucleotide variant	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)	2176	FANCC	HGNC:3584	Pathogenic	1	Aug 01, 1999	121917785	-	RCV000012830	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	Fanconi anemia complementation group C	germline	germline	GRCh38	NC_000009.12	9	95107112	95107112	9q22.32	no assertion criteria provided	1	-	N	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	1	12050	95107112	A	C	-	-	-	-	-	-	SCV000033070	-	-	1487T>G 	Leu496Arg	NM_000136.3		1_Pathogenic																																																																																																									
FANCC	FANCC_Leu496Arg	-1.549280011711085	0.1652455454136042	-6.82618618656796	0.0002472608798740025	2025_01_Batch_13-14	0.6463386509857354	0.8060808157714119	0.8949602032890903	0.8497309349742465	0.8065596656809763	0.7440958622022515	0.9524697932812349	0.967628626732216	0.9287504020434858	0.8719891413627952	0.6952172565939935	0.8792753045263234	0.9312944150106531	0.8892406685088661	0.8392744035218858	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FANCC		7699		CCSBVarC001230		NC_000009.12:95107112:A:C		Leu496Arg																												FANCC_Leu496Arg	9	95107112	A	C	9	allele	1487T>G	H11	527_CAVA_Array_P02	O22	B13A7A8P1_R1	B14A7A8P1_R2				9-95107112-A-C	12050	9	95107112	A	C	L	R	rs121917785	9	97869394	9	96909215	496	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1487T>G	p.Leu496Arg	c.1487T>G	p.Leu496Arg	principal1	Y	1	YES	Select	-	CTC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.99	0.78943	D	0.74	0.84487	A	simple_aae	26.0	74.0	2.395	0.69015	M	-5.08	0.82920	D	0.944	0.95151	-0.0954	0.80115	T	0.3623	0.72245	T	9	0.9910704	0.99622	D	0.041256	0.59673	D	0.522	0.79598	0.932	0.98955	Q00597	L496R	Gain of MoRF binding (P = 0.0166)| Gain of methylation at L496 (P = 0.0294)| Gain of solvent accessibility (P = 0.0584)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.101)	0.91854953846	0.91711	0.7235648123959582	0.72155	0.400379318551	0.40752	0.527930855751	0.42681	T	0.502392	0.82079	D	0.30647	0.83356	D	0.202447	0.83141	D	0.990214049816132	0.80281	D	.	0.39699	.	0.87331074	0.88974	0.7835274	0.87085	0.8566318	0.87667	0.77439195	0.86521	-6.134	0.47446	T	0.5133	0.65167	A	0.939888730715306	0.79344	0.95983505	0.93950	0.809	0.89444	.	.	.	.	.	.	3.643055	0.51746	23.1	0.99737588940490851	0.83280	0.455600	0.50611	N	0.551271328372298	0.70000	5.460852	0.462495863549082	0.65336	4.834584	4.94	4.94	0.64600	5.03	0.90264	5.392	0.66097	11.055000	0.85376	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.023	0.12113	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Fanconi_anemia_complementation_group_C	no_assertion_criteria_provided	NC_000009.12:g.95107112A>C	ClinGen:CA256207|OMIM:613899.0008|UniProtKB:Q00597#VAR_005232	C3468041	227645	84	.	Leu	Arg	27089	single nucleotide variant	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)	2176	FANCC	HGNC:3584	Pathogenic	1	Aug 01, 1999	121917785	-	RCV000012830	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	Fanconi anemia complementation group C	germline	germline	GRCh38	NC_000009.12	9	95107112	95107112	9q22.32	no assertion criteria provided	1	-	N	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	1	12050	95107112	A	C	-	-	-	-	-	-	SCV000033070	-	-	1487T>G 	Leu496Arg	NM_000136.3		1_Pathogenic																																																																																																									
CTCF	CTCF_Tyr226Cys	-2.0081090165748017	0.08460141469372065	9.898022384502617	0.00002288890486814957	2025_01_Batch_13-14	0.7492800853906024	0.7696342836386185	0.7975981630763701	0.7179964404154167	0.6719436870404148	0.7548044068723039	0.706860760395464	0.8024246319711629	0.681781111840152	0.7348871972295691	0.7520422461314531	0.7382475220170412	0.8000113975237665	0.6998887761277843	0.703415442134992	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010845		NC_000016.10:67611509:A:G		Tyr226Cys																												CTCF_Tyr226Cys	16	67611509	A	G	16	allele	677A>G	G02	527_CAVA_Array_P02	M04	B13A7A8P1_R1	B14A7A8P1_R2				16-67611509-A-G	1254810	16	67611509	A	G	Y	C	rs2142826609	16	67645412	16	66202913	226	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.677A>G	p.Tyr226Cys	c.677A>G	p.Tyr226Cys	principal4	Y	.	.	.	+	TAC	2	0	A	A/A	A/A	A/A	A/A	.	0.41793	.	.	0.57928	.	0.999	0.77914	D	0.994	0.82066	D	.	0.93300	.	.	.	.	0	0.06502	N	.	0.63348	.	.	0.82100	-1.1031	0.03749	T	0.0480	0.20364	T	10	0.539923	0.63354	D	0.02103	0.43507	T	.	0.68503	0.299	0.26397	P49711	Y226C	Loss of helix (P = 0.0123)| Loss of phosphorylation at Y226 (P = 0.0176)| Gain of loop (P = 0.0195)| Gain of sheet (P = 0.0507)| Loss of solvent accessibility (P = 0.1322)	.	0.57041	.	0.57532	.	0.84168	0.925917685032	0.98740	D	0.788068	0.94419	D	0.0396152	0.56698	T	-0.180872	0.56141	T	0.918294548988342	0.57406	D	.	0.94986	.	0.5466574	0.69471	0.56271493	0.74444	0.5466574	0.69472	0.56271493	0.74445	-4.564	0.31751	T	.	0.82640	.	0.983475363820255	0.86213	0.91155195	0.91636	0.692	0.82910	.	.	.	.	.	.	4.655767	0.74309	26.1	0.99793481628287251	0.87938	0.923554	0.89985	D	0.63659219199805	0.75371	6.317652	0.680657746933852	0.80807	7.405549	5.5	5.5	0.81360	6.5	0.99641	8.886	0.92093	11.212000	0.89448	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.991	0.66489	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614212	6.194970e-07	0	0	75060	0.000000e+00	0	0	75060	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	64044	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180026	0.000000e+00	0	0	91084	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67611509A>G	.	C3809686|C3661900	615502	363611	.	Tyr	Cys	1244743	single nucleotide variant	NM_006565.4(CTCF):c.677A>G (p.Tyr226Cys)	10664	CTCF	HGNC:13723	Pathogenic	1	Sep 17, 2024	2142826609	-	RCV002471133|RCV001658992	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided	germline	germline	GRCh38	NC_000016.10	16	67611509	67611509	16q22.1	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA396307384	2	1254810	67611509	A	G	-	-	-	-	-	-	SCV001875117|SCV002767483	-	-	677A>G 	Tyr226Cys	NM_006565.4	2	1_Pathogenic																																																																																																									
RAD51D	RAD51D_Ile17Val	0.8297191536322671	0.4340774464288859	15.438748804892429	1.1544372823221078e-6	2025_01_Batch_13-14	0.8462395722954139	0.9107998287096768	0.9677655186059482	0.9061313570579054	0.8558146293961573	0.8723700191028847	0.896111988582963	0.9544031038289187	0.9328278757579709	0.7865085636764857	0.8593047956991493	0.9034559086463199	0.9610843112174334	0.9194796164079382	0.8211615965363215	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RAD51D		7201		CCSBVarC024709		NC_000017.11:35119565:T:C		Ile17Val																												RAD51D_Ile17Val	17	35119565	T	C	17	allele	49A>G	F01	527_CAVA_Array_P05	K01	B13A7A8P2_R1	B14A7A8P2_R2				17-35119565-T-C	659719	17	35119565	T	C	I	V	rs1002032036	17	33446584	17	30470697	17	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.49A>G	p.Ile17Val	c.49A>G	p.Ile17Val	principal1	Y	5	.	.	-	ATC	1	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.001	0.04348	B	0.17	0.40172	N	simple_aae	83.0	17.0	-0.695	0.01869	N	-0.03	0.07402	N	0.046	0.02082	-0.9952	0.31138	T	0.0324	0.13833	T	10	0.04814577	0.04229	T	0.024558	0.47336	T	0.028	0.06252	0.37	0.37869	O75771	I17V	Gain of helix (P = 0.0854)| Gain of MoRF binding (P = 0.2615)| Loss of loop (P = 0.3664)| Loss of catalytic residue at L19 (P = 0.4141)| Gain of disorder (P = 0.4367)	0.429666569261	0.42198	.	0.13960	.	0.07621	.	.	.	0.075739	0.34990	T	-0.308413	0.07683	T	-0.680791	0.06732	T	0.0592468314962335	0.06971	T	0.689731	0.29652	T	0.029664483	0.02476	0.046668846	0.06571	0.029664483	0.02476	0.046668846	0.06570	-2.791	0.17524	T	0.0821	0.22858	B	8.01046792450614e-05	0.02668	0.25106364	0.75187	0.018	0.02411	.	.	.	.	.	.	1.523251	0.19582	14.32	0.6845253055721503	0.08798	0.077523	0.15429	N	-0.963300152951958	0.09283	0.4445345	-0.761465596440251	0.15180	0.8120932	4.37	2.36	0.28182	1.23	0.31344	0.452	0.21585	1.583000	0.27571	-0.201	0.08901	0.997	0.40243	0.906000	0.28131	0.792	0.37428	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1612670	8.061170e-06	0	1	60000	1.666670e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	1	60000	1.666670e-05	0	0	29600	0.000000e+00	0	0	44872	0.000000e+00	0	0	62816	0.000000e+00	0	0	6084	0.000000e+00	0	11	1179940	9.322510e-06	0	0	91086	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119565T>C	.	C3280345|C0027672|CN169374|C3661900	614291	145|140162	RAD51D, N-terminal domain	Ile	Val	645822	single nucleotide variant	NM_002878.4(RAD51D):c.49A>G (p.Ile17Val)	5892	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0	Oct 09, 2024	1002032036	-	RCV000816764|RCV001816897|RCV000986016|RCV001183136	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35119565	35119565	17q12	criteria provided, conflicting classifications	7	-	N	ClinGen:CA290007271	2	659719	35119565	T	C	-	-	-	-	-	-	SCV000957288|SCV001134803|SCV001348793|SCV002066151|SCV002642374|SCV005054047|SCV005202652	-	-	49A>G 	Ile17Val	NM_002878.4	1	3_Conflicting						963058	RAD51D_unpublished_var157305	RAD51D_unpublished	RAD51D	9823.0	-1.0		35119565.0	35119565.0		49	A	G	17.0	I	V	c.49A>G	p.Ile17Val	missense_variant	-0.0206904		functionally_normal	Yes	8.0611656445e-6	Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Jul 11, 2024	nucleotide		ENST00000345365.11	NM_002878.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.028																																																											RAD51D_Ile17Val	Ile17Val	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						257987	F9_Popp_2025_strep_2_var268015	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.2630256435449565			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						257987	F9_Popp_2025_strep_2_var268015	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.2630256435449565			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						175439	F9_Popp_2025_carboxy_gla_motif_var258334	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.1058332950544445			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						175439	F9_Popp_2025_carboxy_gla_motif_var258334	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.1058332950544445			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						147923	F9_Popp_2025_carboxy_F9_specific_var229291	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.0852044630902586			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						147923	F9_Popp_2025_carboxy_F9_specific_var229291	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.0852044630902586			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						230471	F9_Popp_2025_light_chain_var248653	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.103006949273624			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						230471	F9_Popp_2025_light_chain_var248653	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.103006949273624			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						202955	F9_Popp_2025_heavy_chain_var238972	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.0976181926572208			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
F9	F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic						202955	F9_Popp_2025_heavy_chain_var238972	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561913.0	139561913.0		1228			410.0	D	H	c.1228G>C	p.Asp410His	missense_variant	1.0976181926572208			No		Pathogenic	no assertion criteria provided	Mar 01, 1992	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.954																																																											F9_Asp410His	Asp410His	true
RPS19	RPS19_Arg101His	-2.407724429948076	0.04693058430635163	-2.3751250467398184	0.049233749168006886	2025_01_Batch_13-14	0.6359937086482905	0.7028646139639885	0.8764398964711966	0.6890256185775911	0.6304028995520288	0.5129238414684217	0.6200651778597204	0.8503985006356812	0.6485003411903558	0.5832903672878459	0.5744587750583561	0.6614648959118544	0.863419198553439	0.6687629798839735	0.6068466334199374	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19	ENSG00000105372	3441	6074	CCSBVarC000468	ALE00000468	NC_000019.10:41869160:G:A	302G>A	Arg101His	RC4	RC4_Mut_GDEh1010	G11	GDEhDisVCh_40042	D02	2	RC4_Mut_GDDh1010	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			RPS19_Arg101His	19	41869160	G	A	19											19-41869160-G-A	1338641	19	41869160	G	A	R	H	rs2123284131	19	42373230	19	47065070	101	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.302G>A	p.Arg101His	c.302G>A	p.Arg101His	principal1	Y	3	.	.	+	CGC	2	0	G	./.	./.	./.	./.	.	.	.	0.043	0.50294	D	0.576	0.38738	P	0.098	0.30481	B	0.98	0.97016	D	simple_aae	2.0	98.0	2.455	0.71058	M	.	.	.	0.85	0.84569	-0.6497	0.62566	T	0.1836	0.53023	T	9	0.9784213	0.97692	D	0.232972	0.88316	D	.	0.78612	0.944	0.99276	P39019	R101H	Loss of stability (P = 0.0435)| Loss of MoRF binding (P = 0.0519)| Loss of phosphorylation at S98 (P = 0.0846)| Loss of disorder (P = 0.1018)| Loss of methylation at K97 (P = 0.1559)	0.990308341565	0.99009	.	0.88980	.	0.79939	0.621480226517	0.55873	T	0.973089	0.99719	D	0.540061	0.95419	D	0.537984	0.95351	D	0.973375916481018	0.69870	D	0.919808	0.70916	D	0.7501296	0.80644	0.5398206	0.73150	0.59962654	0.72387	0.4817109	0.69730	-12.948	0.89171	D	0.9394	0.85818	P	0.998556217770197	0.94646	0.99979788	0.99739	0.552	0.74727	.	.	.	.	.	.	4.811919	0.78331	26.9	0.99767382566551488	0.85596	0.938159	0.93672	D	0.169104588964979	0.49474	3.169182	0.184437639525419	0.48733	3.108112	4.3	4.3	0.50482	.	.	6.962	0.75901	9.866000	0.82120	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.789	0.37304	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869160G>A	.	C3661900|C2676137	105650	124	Small ribosomal subunit protein eS19, conserved site	Arg	His	1329648	single nucleotide variant	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	6223	RPS19	HGNC:10402	Pathogenic/Likely pathogenic	1	Sep 20, 2024	2123284131	-	RCV001818012|RCV004594595	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	not provided|Diamond-Blackfan anemia 1	germline	germline	GRCh38	NC_000019.10	19	41869160	41869160	19q13.2	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA406030502	2	1338641	41869160	G	A	-	-	-	-	-	-	SCV002065830|SCV005087142	-	-	302G>A 	Arg101His	NM_001022.4	2	1_Pathogenic																																																																																																									
RPS19	RPS19_Arg101His	-2.407724429948076	0.04693058430635163	-2.3751250467398184	0.049233749168006886	2025_01_Batch_13-14	0.6359937086482905	0.7028646139639885	0.8764398964711966	0.6890256185775911	0.6304028995520288	0.5129238414684217	0.6200651778597204	0.8503985006356812	0.6485003411903558	0.5832903672878459	0.5744587750583561	0.6614648959118544	0.863419198553439	0.6687629798839735	0.6068466334199374	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19		3441		CCSBVarC000468		NC_000019.10:41869160:G:A		Arg101His																												RPS19_Arg101His	19	41869160	G	A	19	allele	302G>A	G10	527_CAVA_Array_P05	M19	B13A7A8P2_R1	B14A7A8P2_R2				19-41869160-G-A	1338641	19	41869160	G	A	R	H	rs2123284131	19	42373230	19	47065070	101	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.302G>A	p.Arg101His	c.302G>A	p.Arg101His	principal1	Y	3	.	.	+	CGC	2	0	G	./.	./.	./.	./.	.	.	.	0.043	0.50294	D	0.576	0.38738	P	0.098	0.30481	B	0.98	0.97016	D	simple_aae	2.0	98.0	2.455	0.71058	M	.	.	.	0.85	0.84569	-0.6497	0.62566	T	0.1836	0.53023	T	9	0.9784213	0.97692	D	0.232972	0.88316	D	.	0.78612	0.944	0.99276	P39019	R101H	Loss of stability (P = 0.0435)| Loss of MoRF binding (P = 0.0519)| Loss of phosphorylation at S98 (P = 0.0846)| Loss of disorder (P = 0.1018)| Loss of methylation at K97 (P = 0.1559)	0.990308341565	0.99009	.	0.88980	.	0.79939	0.621480226517	0.55873	T	0.973089	0.99719	D	0.540061	0.95419	D	0.537984	0.95351	D	0.973375916481018	0.69870	D	0.919808	0.70916	D	0.7501296	0.80644	0.5398206	0.73150	0.59962654	0.72387	0.4817109	0.69730	-12.948	0.89171	D	0.9394	0.85818	P	0.998556217770197	0.94646	0.99979788	0.99739	0.552	0.74727	.	.	.	.	.	.	4.811919	0.78331	26.9	0.99767382566551488	0.85596	0.938159	0.93672	D	0.169104588964979	0.49474	3.169182	0.184437639525419	0.48733	3.108112	4.3	4.3	0.50482	.	.	6.962	0.75901	9.866000	0.82120	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.789	0.37304	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869160G>A	.	C3661900|C2676137	105650	124	Small ribosomal subunit protein eS19, conserved site	Arg	His	1329648	single nucleotide variant	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	6223	RPS19	HGNC:10402	Pathogenic/Likely pathogenic	1	Sep 20, 2024	2123284131	-	RCV001818012|RCV004594595	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	not provided|Diamond-Blackfan anemia 1	germline	germline	GRCh38	NC_000019.10	19	41869160	41869160	19q13.2	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA406030502	2	1338641	41869160	G	A	-	-	-	-	-	-	SCV002065830|SCV005087142	-	-	302G>A 	Arg101His	NM_001022.4	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Glu143Lys	1.0715681647773336	0.3194625014850119	-1.3011218450965234	0.23440439309487024	2025_01_Batch_13-14	0.9480245505139957	0.8955713661160429	0.9507439270755751	0.936478711330349	0.8952628504353902	0.8999099591246774	0.8491444594512151	0.8788213977275371	0.9218913473514789	0.748151341601417	0.9239672548193365	0.872357912783629	0.914782662401556	0.929185029340914	0.8217070960184036	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013134		NC_000017.11:43104136:C:T		Glu143Lys																												BRCA1_Glu143Lys	17	43104136	C	T	17	allele	427G>A	B12	527_CAVA_Array_P01	C23	B13A7A8P1_R1	B14A7A8P1_R2				17-43104136-C-T	37580	17	43104136	C	T	E	K	rs80356991	17	41256153	17	38509679	143	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.427G>A	p.Glu143Lys	principal2	Y	1	.	.	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.34767	.	.	0.57928	.	0.019	0.68795	B	0.006	0.55829	B	.	0.49097	.	.	.	.	1.5	0.37685	L	.	0.42578	.	.	0.38091	0.5017	0.90534	D	0.8767	0.95897	D	10	.	0.21644	.	0.247707	0.88953	D	.	0.79415	0.303	0.27037	E9PFC7	E143K	Gain of ubiquitination at E143 (P = 0.0025)| Gain of MoRF binding (P = 0.0124)| Gain of methylation at E143 (P = 0.1317)| Gain of relative solvent accessibility (P = 0.1684)| Loss of phosphorylation at S146 (P = 0.184)	.	0.86141	.	0.37990	.	0.10163	0.315168946981	0.12679	T	0.158884	0.49950	T	0.019488	0.54001	T	0.120218	0.78090	D	0.0473425365312362	0.04979	T	0.851115	0.53361	D	0.03369628	0.03605	0.04770675	0.06945	0.034599107	0.03876	0.05370916	0.09113	-4.389	0.42050	T	.	0.13983	.	0.681098547151026	0.66393	0.99696964	0.98220	0.018	0.02411	.	.	.	.	.	.	2.363521	0.30377	18.4	0.99087417036739323	0.52206	0.188915	0.31406	N	-0.366331149050496	0.26398	1.457724	-0.342651888589345	0.26417	1.478785	5.32	3.28	0.36615	2.24	0.42522	1.938	0.39936	1.666000	0.28012	-0.187	0.09644	0.861	0.30721	0.920000	0.28384	0.293	0.24381	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	11	109208	1.007250e-04	0	16	207718	7.702750e-05	0	19	236486	8.034300e-05	0	0	7152	0.000000e+00	0	1	17062	5.860980e-05	0	0	2320	0.000000e+00	0	5	9040	5.530970e-04	0	0	13370	0.000000e+00	0	2	42726	4.680990e-05	0	3	15626	1.919880e-04	0	5	9040	5.530970e-04	0	0	16186	0.000000e+00	0	1	30464	3.282560e-05	0	0	6212	0.000000e+00	0	5	13390	3.734130e-04	0	0	16710	0.000000e+00	0	6	89418	6.710060e-05	0	4	30484	1.312160e-04	0	5	13390	3.734130e-04	0	0	14870	0.000000e+00	0	1	34186	2.925170e-05	0	0	9572	0.000000e+00	0	8	17664	4.528990e-04	0	1	21600	4.629630e-05	0	5	102588	4.873860e-05	0	4	30402	1.315700e-04	0	8	17664	4.528990e-04	0	.	108	1613230	6.694640e-05	0	11	44878	2.451090e-04	0	0	74812	0.000000e+00	0	0	912	0.000000e+00	0	1	59920	1.668890e-05	0	0	29600	0.000000e+00	0	11	44878	2.451090e-04	0	0	63846	0.000000e+00	0	0	6080	0.000000e+00	0	89	1179784	7.543750e-05	0	6	90930	6.598480e-05	0	3	32728	9.166462967489611E-5	0	122	0	0	146	0	0	3824	0	0	500	0	0	628	0	0	56	0	0	104	0	0	6972	0	0	3946	0	0	202	0	3	45080	6.654835847382431E-5	Benign	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43104136C>T	BRCA1-HCI:BRCA1_00055|ClinGen:CA002745	C0346153|C3280442|C2676676|C4554406|CN221562|C0677776|CN169374|C0027672|C3661900	114480|614320|604370|617883	227535|1333|145|145|140162	.	Glu	Lys	46136	single nucleotide variant	NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	80356991	-	RCV000031161|RCV000162967|RCV000588563|RCV000159939|RCV001719704|RCV001798032|RCV002250474|RCV002504841|RCV004758611	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided|Breast and/or ovarian cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43104136	43104136	17q21.31	reviewed by expert panel	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00055,ClinGen:CA002745	2	37580	43104136	C	T	-	-	-	-	-	-	SCV000244359	-	-	427G>A 	Glu143Lys	NM_007294.4	3	2_Benign																																																																																																									
BAP1	BAP1_Pro12Thr	1.2327266947006599	0.2574688649083334	-4.423763667701538	0.0030672880820356166	2025_01_Batch_13-14	0.5225870430891271	0.6416290286580817	0.7147171308588358	0.6437854650790235	0.5746693073816628	0.677657288568963	0.5555168145010463	0.7009330534809918	0.6351656876991867	0.685230249882894	0.600122165829045	0.598572921579564	0.7078250921699138	0.6394755763891051	0.6299497786322784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009495		NC_000003.12:52409845:G:T		Pro12Thr																												BAP1_Pro12Thr	3	52409845	G	T	3	allele	34C>A	E02	527_CAVA_Array_P01	I03	B13A7A8P1_R1	B14A7A8P1_R2				3-52409845-G-T	1064792	3	52409845	G	T	P	T	rs2153228682	3	52443861	3	52418901	12	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.34C>A	p.Pro12Thr	c.34C>A	p.Pro12Thr	principal1	Y	1	YES	Select	-	CCA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.994	0.66535	D	0.943	0.67917	D	.	.	.	.	.	.	3.34	0.90844	M	-7.52	0.95806	D	0.717	0.76196	0.5791	0.91592	D	0.6438	0.87520	D	10	0.9533975	0.94626	D	0.613498	0.96627	D	0.834	0.94750	0.826	0.93687	Q92560	P12T	Gain of catalytic residue at F15 (P = 0.1611)| Loss of stability (P = 0.1989)| Loss of disorder (P = 0.2123)| Loss of glycosylation at P12 (P = 0.257)| Gain of phosphorylation at S10 (P = 0.4485)	0.910963055978	0.90939	0.932184403075094	0.93154	2.47156410767	0.97481	0.78230202198	0.79237	T	0.587622	0.86468	D	0.322782	0.84559	D	0.225878	0.84358	D	0.99904853105545	0.95954	D	0.89941	0.64684	D	0.9520596	0.96419	0.9296314	0.97027	0.9520596	0.96420	0.9296314	0.97028	-13.412	0.91007	D	0.9986	0.97942	P	0.938734357228053	0.79228	0.99978024	0.99714	0.862	0.92474	.	.	.	.	.	.	5.259026	0.88323	29.5	0.99758718307023109	0.84864	0.875323	0.79793	D	0.957361183823445	0.94241	12.63146	0.862850773711547	0.93709	12.2498	4.93	4.93	0.64349	2.88	0.52655	6.576	0.73975	11.420000	0.92722	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Kury-Isidor_syndrome|Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52409845G>T	OMIM:603089.0011	C5676925|C1535926	619762	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Pro	Thr	1053076	single nucleotide variant	NM_004656.4(BAP1):c.34C>A (p.Pro12Thr)	8314	BAP1	HGNC:950	Pathogenic	1	Feb 24, 2022	2153228682	-	RCV001374940|RCV001839042	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0859230,MedGen:C5676925,OMIM:619762	Neurodevelopmental disorder|Kury-Isidor syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409845	52409845	3p21.1	no assertion criteria provided	2	-	N	OMIM:603089.0011,ClinGen:CA353115049	3	1064792	52409845	G	T	-	-	-	-	-	-	SCV001572228|SCV002098941	-	-	34C>A 	Pro12Thr	NM_004656.4		1_Pathogenic																																																																																																									
FH	FH_Asn340Lys	10.63377390618422	0.00004075682484155514	-10.83270980690384	0.0000125974853100848	2025_01_Batch_13-14	0.7936091313455258	0.9166164475515988	0.9732167620651213	0.9632640191032386	0.790202418655738											0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	true	FH	ENSG00000091483	3408	214598	CCSBVarC004054	ALE00004054	NC_000001.11:241504130:A:T	1020T>A	Asn340Lys	CEGS2	CegsMutGDEh1041	D11	GDEhDisVCh_40065	A09	1	CegsMutGDDh1041	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	6	0			0			0			FH_Asn340Lys	1	241504130	A	T	1											1-241504130-A-T	92447	1	241504130	A	T	N	K	rs398123159	1	241667430	1	239734053	340	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1020T>A	p.Asn340Lys	c.1020T>A	p.Asn340Lys	principal1	Y	1	YES	Select	-	AAT	3	2	A	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.43	0.98728	H	-5.97	0.89297	D	0.997	0.99974	1.0745	0.98713	D	0.9852	0.99552	D	10	0.98295367	0.98388	D	0.933702	0.99521	D	0.885	0.96643	0.826	0.93687	P07954	N340K	Gain of MoRF binding (P = 0.0281)| Loss of stability (P = 0.0682)| Gain of ubiquitination at N340 (P = 0.0797)| Loss of catalytic residue at D341 (P = 0.1005)| Gain of loop (P = 0.1069)	0.976600358983	0.97612	0.992874591347995	0.99282	1.05267121501	0.76067	0.819319963455	0.84898	D	0.976563	0.99778	D	0.195964	0.73318	D	0.107358	0.77230	D	0.996594965457916	0.89586	D	0.989601	0.96580	D	0.9459451	0.95788	0.9137381	0.95897	0.9459451	0.95788	0.9137381	0.95898	-10.892	0.79130	D	0.994	0.95051	P	0.99958943095219	0.97080	0.90775520	0.91492	0.975	0.99076	.	.	.	.	.	.	3.413967	0.47456	22.4	0.99842744111750026	0.92321	0.475086	0.51740	N	0.628093012181	0.74823	6.222027	0.508360094466945	0.68379	5.235775	5.73	3.43	0.38299	-0.0628	0.21136	0.55	0.23134	-0.065000	0.12424	0.751	0.87726	0.996	0.3946	0.009000	0.19951	0.994	0.71086	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	segdup	1	109394	9.141270e-06	0	3	208100	1.441610e-05	0	3	236778	1.267010e-05	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	2	89552	2.233340e-05	0	0	30606	0.000000e+00	0	2	89552	2.233340e-05	0	0	14902	0.000000e+00	0	0	34236	0.000000e+00	0	0	9566	0.000000e+00	0	0	17688	0.000000e+00	0	0	21632	0.000000e+00	0	2	102612	1.949090e-05	0	0	30524	0.000000e+00	0	2	102612	1.949090e-05	0	.	10	1614142	6.195240e-06	0	10	1179978	8.474730e-06	0	0	75056	0.000000e+00	0	0	910	0.000000e+00	0	0	60018	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64034	0.000000e+00	0	0	6062	0.000000e+00	0	10	1179978	8.474730e-06	0	0	91078	0.000000e+00	0	1	15752	6.348400203148806E-5	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	1	2772	3.6075036075036075E-4	0	3492	0	0	168	0	2	23038	8.681309141418526E-5	Pathogenic/Likely_pathogenic	FH-related_disorder|Fumarase_deficiency|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504130A>T	ClinGen:CA285319	C0342770|C3661900|C1708350|C0027672	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Asn	Lys	98356	single nucleotide variant	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Jan 11, 2025	398123159	-	RCV000078140|RCV000220396|RCV000445596|RCV003460741|RCV004555535|RCV005007992	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24||MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241504130	241504130	1q43	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA285319	2	92447	241504130	A	T	-	-	-	-	-	-	SCV000109978|SCV000251426|SCV000275280|SCV000283659|SCV000537251|SCV004037791|SCV004117278|SCV004186922|SCV004197347|SCV004218857|SCV005642265	-	-	1020T>A 	Asn340Lys	NM_000143.4	2	1_Pathogenic	1	241504130	A	T	6.84079e-6																																																																																																				
FH	FH_Asn340Lys	10.63377390618422	0.00004075682484155514	-10.83270980690384	0.0000125974853100848	2025_01_Batch_13-14	0.7936091313455258	0.9166164475515988	0.9732167620651213	0.9632640191032386	0.790202418655738											0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	true	FH		3408		CCSBVarC004054		NC_000001.11:241504130:A:T		Asn340Lys																												FH_Asn340Lys	1	241504130	A	T	1	allele	1020T>A	D02	527_CAVA_Array_P03	H03	B13A7A8P1_R1	B14A7A8P1_R2				1-241504130-A-T	92447	1	241504130	A	T	N	K	rs398123159	1	241667430	1	239734053	340	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1020T>A	p.Asn340Lys	c.1020T>A	p.Asn340Lys	principal1	Y	1	YES	Select	-	AAT	3	2	A	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.43	0.98728	H	-5.97	0.89297	D	0.997	0.99974	1.0745	0.98713	D	0.9852	0.99552	D	10	0.98295367	0.98388	D	0.933702	0.99521	D	0.885	0.96643	0.826	0.93687	P07954	N340K	Gain of MoRF binding (P = 0.0281)| Loss of stability (P = 0.0682)| Gain of ubiquitination at N340 (P = 0.0797)| Loss of catalytic residue at D341 (P = 0.1005)| Gain of loop (P = 0.1069)	0.976600358983	0.97612	0.992874591347995	0.99282	1.05267121501	0.76067	0.819319963455	0.84898	D	0.976563	0.99778	D	0.195964	0.73318	D	0.107358	0.77230	D	0.996594965457916	0.89586	D	0.989601	0.96580	D	0.9459451	0.95788	0.9137381	0.95897	0.9459451	0.95788	0.9137381	0.95898	-10.892	0.79130	D	0.994	0.95051	P	0.99958943095219	0.97080	0.90775520	0.91492	0.975	0.99076	.	.	.	.	.	.	3.413967	0.47456	22.4	0.99842744111750026	0.92321	0.475086	0.51740	N	0.628093012181	0.74823	6.222027	0.508360094466945	0.68379	5.235775	5.73	3.43	0.38299	-0.0628	0.21136	0.55	0.23134	-0.065000	0.12424	0.751	0.87726	0.996	0.3946	0.009000	0.19951	0.994	0.71086	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	segdup	1	109394	9.141270e-06	0	3	208100	1.441610e-05	0	3	236778	1.267010e-05	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	2	89552	2.233340e-05	0	0	30606	0.000000e+00	0	2	89552	2.233340e-05	0	0	14902	0.000000e+00	0	0	34236	0.000000e+00	0	0	9566	0.000000e+00	0	0	17688	0.000000e+00	0	0	21632	0.000000e+00	0	2	102612	1.949090e-05	0	0	30524	0.000000e+00	0	2	102612	1.949090e-05	0	.	10	1614142	6.195240e-06	0	10	1179978	8.474730e-06	0	0	75056	0.000000e+00	0	0	910	0.000000e+00	0	0	60018	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64034	0.000000e+00	0	0	6062	0.000000e+00	0	10	1179978	8.474730e-06	0	0	91078	0.000000e+00	0	1	15752	6.348400203148806E-5	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	1	2772	3.6075036075036075E-4	0	3492	0	0	168	0	2	23038	8.681309141418526E-5	Pathogenic/Likely_pathogenic	FH-related_disorder|Fumarase_deficiency|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504130A>T	ClinGen:CA285319	C0342770|C3661900|C1708350|C0027672	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Asn	Lys	98356	single nucleotide variant	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2271	FH	HGNC:3700	Pathogenic/Likely pathogenic	1	Jan 11, 2025	398123159	-	RCV000078140|RCV000220396|RCV000445596|RCV003460741|RCV004555535|RCV005007992	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24||MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241504130	241504130	1q43	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA285319	2	92447	241504130	A	T	-	-	-	-	-	-	SCV000109978|SCV000251426|SCV000275280|SCV000283659|SCV000537251|SCV004037791|SCV004117278|SCV004186922|SCV004197347|SCV004218857|SCV005642265	-	-	1020T>A 	Asn340Lys	NM_000143.4	2	1_Pathogenic	1	241504130	A	T	6.84079e-6																																																																																																				
FLCN	FLCN_Arg239Cys	0.9174070101483766	0.38944335444511674	-15.695201041940072	1.0316623825275126e-6	2025_01_Batch_13-14	0.6408863296451377	0.8484363666697667	0.9442798550729118	0.9041886224631396	0.5304129016913728	0.6063071551797774	0.858095563825877	0.9457511173724349	0.8848038913580585	0.5856402538884513	0.6235967424124575	0.8532659652478218	0.9450154862226734	0.894496256910599	0.558026577789912	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FLCN	ENSG00000154803	7588	13751	CCSBVarC001199	ALE00001199	NC_000017.11:17222565:G:A	715C>T	Arg239Cys	RC4	RC4_Mut_GDEh1002	H08	GDEhDisVCh_40008	C09	2	RC4_Mut_GDDh1002	H08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FLCN_Arg239Cys	17	17222565	G	A	17											17-17222565-G-A	134427	17	17222565	G	A	R	C	rs78683075	17	17125879	17	17066604	239	FLCN	ENSG00000154803	ENST00000285071	ENSP00000285071	Q8NFG4	FLCN_HUMAN	c.715C>T	p.Arg239Cys	c.715C>T	p.Arg239Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	.	0.71237	.	.	.	.	2.82	0.81940	M	-5.68	0.90996	D	0.99	0.99730	0.9576	0.96499	D	0.8908	0.96369	D	10	0.8112291	0.80205	D	0.269279	0.89792	D	0.914	0.97735	.	.	.	.	.	0.92713276706	0.92582	0.8131863604073064	0.81164	1.37465409467	0.84558	0.877251982689	0.93578	D	0.965284	0.99578	D	0.232675	0.76800	D	0.441383	0.93307	D	0.409195610064091	0.28980	T	0.963104	0.86253	D	0.8436355	0.86694	0.653225	0.79478	0.8809669	0.89604	0.6441645	0.78972	-4.512	0.31080	T	0.9888	0.95096	P	0.987758183785664	0.87550	0.95808370	0.93842	0.906	0.95083	.	.	.	.	.	.	5.485253	0.91433	32.0	0.99936625225274212	0.99621	0.883493	0.81176	D	0.838685424223754	0.88390	9.584683	0.79110123621525	0.89107	9.865392	5.71	5.71	0.89013	3.64	0.66725	7.113	0.76785	11.729000	0.94967	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.875	0.41772	794	0.45529	3	5.990415335463259E-4	0	0.0	2	0.0019880715705765406	1	0.001440922190201729	0	0.0	0	0.0	61	264690	2.3045827E-4	.	29	109404	2.650730e-04	0	52	208032	2.499620e-04	0	60	236936	2.532330e-04	0	1	7164	1.395870e-04	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	25	42768	5.845490e-04	0	2	15690	1.274700e-04	0	25	42768	5.845490e-04	0	2	16216	1.233350e-04	0	1	30516	3.276970e-05	0	0	6206	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	44	89476	4.917520e-04	0	3	30608	9.801360e-05	0	44	89476	4.917520e-04	0	2	14902	1.342100e-04	0	2	34254	5.838730e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	52	102740	5.061320e-04	0	3	30526	9.827690e-05	0	52	102740	5.061320e-04	0	.	707	1614232	4.379790e-04	1	660	1180052	5.592970e-04	0	6	75048	7.994880e-05	0	0	912	0.000000e+00	0	5	60034	8.328610e-05	0	1	29602	3.378150e-05	0	1	44880	2.228160e-05	0	1	64044	1.561430e-05	0	1	6062	1.649620e-04	0	660	1180052	5.592970e-04	0	10	91086	1.097860e-04	1	34	50198	6.773178214271485E-4	0	306	0	0	132	0	0	8844	0	0	524	0	0	668	0	0	62	0	0	114	0	7	11386	6.147900930967855E-4	0	9150	0	0	194	0	41	72234	5.675997452723095E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Birt-Hogg-Dube_syndrome|not_specified|not_provided|FLCN-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.17222565G>A	ClinGen:CA159776|UniProtKB:Q8NFG4#VAR_066026	C0027672|C0346010|CN169374|C3661900	PS135150	140162|122	Folliculin/SMCR8, longin domain|Folliculin/SMCR8, tripartite DENN domain	Arg	Cys	138166	single nucleotide variant	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	201163	FLCN	HGNC:27310	Conflicting classifications of pathogenicity	0	Mar 04, 2025	78683075	-	RCV000163388|RCV000121104|RCV000148504|RCV000656850|RCV003945073	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Birt-Hogg-Dube syndrome|not provided|FLCN-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	17222565	17222565	17p11.2	criteria provided, conflicting classifications	15	-	N	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	2	134427	17222565	G	A	-	-	-	-	-	-	SCV000190215|SCV000213928|SCV000291452|SCV000298054|SCV000401012|SCV000616724|SCV001140313|SCV002009831|SCV002530153|SCV002551355|SCV002774598|SCV004142321|SCV005412678	-	-	715C>T 	Arg239Cys	NM_144997.7	1	3_Conflicting	17	17222565	G	A	0.000457627																																																																																																				
FLCN	FLCN_Arg239Cys	0.9174070101483766	0.38944335444511674	-15.695201041940072	1.0316623825275126e-6	2025_01_Batch_13-14	0.6408863296451377	0.8484363666697667	0.9442798550729118	0.9041886224631396	0.5304129016913728	0.6063071551797774	0.858095563825877	0.9457511173724349	0.8848038913580585	0.5856402538884513	0.6235967424124575	0.8532659652478218	0.9450154862226734	0.894496256910599	0.558026577789912	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	FLCN		7588		CCSBVarC001199		NC_000017.11:17222565:G:A		Arg239Cys																												FLCN_Arg239Cys	17	17222565	G	A	17	allele	715C>T	C04	527_CAVA_Array_P03	F07	B13A7A8P1_R1	B14A7A8P1_R2				17-17222565-G-A	134427	17	17222565	G	A	R	C	rs78683075	17	17125879	17	17066604	239	FLCN	ENSG00000154803	ENST00000285071	ENSP00000285071	Q8NFG4	FLCN_HUMAN	c.715C>T	p.Arg239Cys	c.715C>T	p.Arg239Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	.	0.71237	.	.	.	.	2.82	0.81940	M	-5.68	0.90996	D	0.99	0.99730	0.9576	0.96499	D	0.8908	0.96369	D	10	0.8112291	0.80205	D	0.269279	0.89792	D	0.914	0.97735	.	.	.	.	.	0.92713276706	0.92582	0.8131863604073064	0.81164	1.37465409467	0.84558	0.877251982689	0.93578	D	0.965284	0.99578	D	0.232675	0.76800	D	0.441383	0.93307	D	0.409195610064091	0.28980	T	0.963104	0.86253	D	0.8436355	0.86694	0.653225	0.79478	0.8809669	0.89604	0.6441645	0.78972	-4.512	0.31080	T	0.9888	0.95096	P	0.987758183785664	0.87550	0.95808370	0.93842	0.906	0.95083	.	.	.	.	.	.	5.485253	0.91433	32.0	0.99936625225274212	0.99621	0.883493	0.81176	D	0.838685424223754	0.88390	9.584683	0.79110123621525	0.89107	9.865392	5.71	5.71	0.89013	3.64	0.66725	7.113	0.76785	11.729000	0.94967	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.875	0.41772	794	0.45529	3	5.990415335463259E-4	0	0.0	2	0.0019880715705765406	1	0.001440922190201729	0	0.0	0	0.0	61	264690	2.3045827E-4	.	29	109404	2.650730e-04	0	52	208032	2.499620e-04	0	60	236936	2.532330e-04	0	1	7164	1.395870e-04	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	25	42768	5.845490e-04	0	2	15690	1.274700e-04	0	25	42768	5.845490e-04	0	2	16216	1.233350e-04	0	1	30516	3.276970e-05	0	0	6206	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	44	89476	4.917520e-04	0	3	30608	9.801360e-05	0	44	89476	4.917520e-04	0	2	14902	1.342100e-04	0	2	34254	5.838730e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	52	102740	5.061320e-04	0	3	30526	9.827690e-05	0	52	102740	5.061320e-04	0	.	707	1614232	4.379790e-04	1	660	1180052	5.592970e-04	0	6	75048	7.994880e-05	0	0	912	0.000000e+00	0	5	60034	8.328610e-05	0	1	29602	3.378150e-05	0	1	44880	2.228160e-05	0	1	64044	1.561430e-05	0	1	6062	1.649620e-04	0	660	1180052	5.592970e-04	0	10	91086	1.097860e-04	1	34	50198	6.773178214271485E-4	0	306	0	0	132	0	0	8844	0	0	524	0	0	668	0	0	62	0	0	114	0	7	11386	6.147900930967855E-4	0	9150	0	0	194	0	41	72234	5.675997452723095E-4	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Birt-Hogg-Dube_syndrome|not_specified|not_provided|FLCN-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.17222565G>A	ClinGen:CA159776|UniProtKB:Q8NFG4#VAR_066026	C0027672|C0346010|CN169374|C3661900	PS135150	140162|122	Folliculin/SMCR8, longin domain|Folliculin/SMCR8, tripartite DENN domain	Arg	Cys	138166	single nucleotide variant	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	201163	FLCN	HGNC:27310	Conflicting classifications of pathogenicity	0	Mar 04, 2025	78683075	-	RCV000163388|RCV000121104|RCV000148504|RCV000656850|RCV003945073	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Birt-Hogg-Dube syndrome|not provided|FLCN-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	17222565	17222565	17p11.2	criteria provided, conflicting classifications	15	-	N	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	2	134427	17222565	G	A	-	-	-	-	-	-	SCV000190215|SCV000213928|SCV000291452|SCV000298054|SCV000401012|SCV000616724|SCV001140313|SCV002009831|SCV002530153|SCV002551355|SCV002774598|SCV004142321|SCV005412678	-	-	715C>T 	Arg239Cys	NM_144997.7	1	3_Conflicting	17	17222565	G	A	0.000457627																																																																																																				
RHO	RHO_Cys110Tyr	-5.373754793745742	0.001037313511567956	-13.627094674258373	2.697354088123665e-6	2025_01_Batch_13-14	0.8727911260092511	0.9709315205985769	0.9993528754968187	0.9960781336949563	0.9790524850900243	0.8790816179354186	0.9874507908671495	0.9997490029378209	0.9972559771541037	0.985504947476264	0.8759363719723349	0.9791911557328632	0.9995509392173199	0.99666705542453	0.9822787162831441	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	true	RHO		40080645		CCSBVarC013625		NC_000003.12:129529062:G:A		Cys110Tyr																												RHO_Cys110Tyr	3	129529062	G	A	3	allele	329G>A	B10	527_CAVA_Array_P05	C19	B13A7A8P2_R1	B14A7A8P2_R2				3-129529062-G-A	13035	3	129529062	G	A	C	Y	rs104893787	3	129247905	3	130730595	110	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.329G>A	p.Cys110Tyr	c.329G>A	p.Cys110Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.65	0.99359	H	-10.25	0.98944	D	0.973	0.98381	0.7379	0.93623	D	0.6727	0.88624	D	9	0.99468315	0.99956	D	0.356575	0.92389	D	0.790	0.93044	0.936	0.99070	P08100	C110Y	Loss of glycosylation at T108 (P = 0.1174)| Loss of catalytic residue at C110 (P = 0.1303)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.437)| Loss of stability (P = 0.5943)	0.98071754066	0.98031	0.9872522222524879	0.98714	1.14035379566	0.78786	0.632616996765	0.57451	T	0.872212	0.97226	D	0.401147	0.89909	D	0.338444	0.89782	D	0.999984264373779	0.99981	D	0.989657	0.96643	D	0.9926738	0.99885	0.9854278	0.99929	0.99123245	0.99822	0.9922701	0.99991	-9.757	0.72523	D	0.9978	0.97230	P	0.999956226333039	0.99183	0.99990320	0.99879	0.997	0.99892	.	.	.	.	.	.	5.01551	0.83352	28.0	0.9977197502818197	0.86015	0.938668	0.93795	D	1.15131989520089	0.98970	20.11403	1.01875670206705	0.98952	20.03965	5.31	5.31	0.75027	4.99	0.89858	9.996	0.99292	11.806000	0.96796	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.566	0.306	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129529062G>A	ClinGen:CA256681|OMIM:180380.0035|UniProtKB:P08100#VAR_004790	C3661900|C3151001|C0854723	613731	791|71862	GPCR, rhodopsin-like, 7TM	Cys	Tyr	28074	single nucleotide variant	NM_000539.3(RHO):c.329G>A (p.Cys110Tyr)	6010	RHO	HGNC:10012	Pathogenic	1	Dec 19, 2020	104893787	-	RCV000013910|RCV001234924|RCV001073635	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129529062	129529062	3q22.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA256681,UniProtKB:P08100#VAR_004790,OMIM:180380.0035	3	13035	129529062	G	A	-	-	-	-	-	-	SCV001239186|SCV001407585|SCV001779172	-	-	329G>A 	Cys110Tyr	NM_000539.3	2	1_Pathogenic						999325	RHO_Wan_2019_var220532	RHO_Wan_2019	RHO	10012.0	1.0		129529062.0	129529062.0		329	G	A	110.0	C	Y	c.329G>A	p.Cys110Tyr	missense_variant	0.1827611768972291			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Dec 19, 2020	nucleotide	urn:mavedb:00000099-a-1	ENST00000296271.4	NM_000539.3	immortalized human cells	Reporter	Fluorescence	cell surface expression	No	missense_variant		0.79																																																											RHO_Cys110Tyr	Cys110Tyr	true
ABCD1	ABCD1_Arg389Gly	7.214936905963234	0.00017516911910830517	1.732320833545961	0.1268204557777738	2025_01_Batch_13-14	0.557767958912841	0.6887665001171852	0.727044639701077	0.6603323432592614	0.543234493297224	0.8741370157660132	0.7529031388632945	0.7293784355538133	0.8889883508748937	0.7400267442465908	0.7159524873394272	0.7208348194902399	0.7282115376274452	0.7746603470670775	0.6416306187719074	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ABCD1		100008637		CCSBVarC007023		NC_000023.11:153736195:C:G		Arg389Gly																												ABCD1_Arg389Gly	23	153736195	C	G	X	allele	1165C>G	C01	527_CAVA_Array_P01	E01	B13A7A8P1_R1	B14A7A8P1_R2				X-153736195-C-G	11296	X	153736195	C	G	R	G	rs128624215	X	153001649	X	152654843	389	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1165C>G	p.Arg389Gly	c.1165C>G	p.Arg389Gly	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	0.999	0.77914	D	0.975	0.73364	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.46	0.71273	M	-5.91	0.88932	D	0.854	0.84989	0.7399	0.93647	D	0.8189	0.93891	D	9	0.97479206	0.97172	D	0.361811	0.92514	D	0.876	0.96308	0.848	0.95057	P33897	R389G	Loss of helix (P = 3e-04)| Gain of loop (P = 0.002)| Gain of sheet (P = 0.0036)| Loss of MoRF binding (P = 0.0526)| Loss of stability (P = 0.0594)	0.999475327291	0.99945	0.9960308022787095	0.99601	1.06563260916	0.76482	0.685714960098	0.65032	T	0.896327	0.97912	D	0.570331	0.96581	D	0.581464	0.96524	D	0.994085788726807	0.85058	D	0.963104	0.86253	D	0.7260219	0.79256	0.6468293	0.79120	0.7260219	0.79257	0.6468293	0.79121	-8.866	0.66907	D	0.8374	0.79060	P	0.999806454133949	0.98063	0.99975282	0.99678	0.926	0.96292	.	.	.	.	.	.	4.162932	0.62608	24.5	0.99748446393215284	0.84091	.	.	.	.	.	.	.	.	.	4.85	4.85	0.62327	.	.	2.238	0.42822	.	.	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Adrenoleukodystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153736195C>G	ClinGen:CA278102|OMIM:300371.0005|UniProtKB:P33897#VAR_000062	C3661900|C0162309	300100	43	.	Arg	Gly	26335	single nucleotide variant	NM_000033.4(ABCD1):c.1165C>G (p.Arg389Gly)	215	ABCD1	HGNC:61	Pathogenic	1	May 29, 2023	128624215	-	RCV000012048|RCV003488335	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900	Adrenoleukodystrophy|not provided	germline	germline	GRCh38	NC_000023.11	X	153736195	153736195	Xq28	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA278102,UniProtKB:P33897#VAR_000062,OMIM:300371.0005	3	11296	153736195	C	G	-	-	-	-	-	-	SCV000932772|SCV004238662	-	-	1165C>G 	Arg389Gly	NM_000033.4	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Gly596Val	2.2257131093137597	0.06135777408658752	-3.8089973889178856	0.006636562833595199	2025_01_Batch_13-14	0.9381108039505246	0.9650002822404748	0.9443067789577735	0.9621695175747484	0.8710569467787093	0.9683246214166759	0.9827263301360674	0.984221210961115	0.9883622952676646	0.8773427495051593	0.9532177126836002	0.9738633061882711	0.9642639949594443	0.9752659064212066	0.8741998481419343	1.0	1.0	0.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220614	CCSBVarC003171	ALE00003171	NC_000007.14:140753348:C:A	1787G>T	Gly596Val	CEGS2	CegsMutGDEh1020	G07	GDEhDisVCh_40058	F08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Gly596Val	7	140753348	C	A	7											7-140753348-C-A	40387	7	140753348	C	A	G	V	rs397507483	7	140453148	7	140099617	596	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1787G>T	p.Gly596Val	c.1787G>T	p.Gly596Val	principal4	Y	.	YES	Select	-	GGT	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	3.295	0.90281	M	.	.	.	.	.	0.6405	0.92395	D	0.6951	0.89454	D	10	0.99041414	0.99538	D	0.395627	0.93272	D	.	0.99969	0.986	0.99859	P15056	G596V	Loss of sheet (P = 0.0817)| Loss of ubiquitination at K601 (P = 0.0992)| Loss of disorder (P = 0.1248)| Gain of methylation at K591 (P = 0.1331)| Loss of catalytic residue at G596 (P = 0.1549)	.	0.98509	.	0.98578	.	0.96552	0.919968366623	0.98320	D	0.963797	0.99550	D	0.575047	0.96883	D	0.588239	0.96832	D	0.999177873134613	0.96398	D	0.99514	0.98365	D	0.99520737	0.99966	0.98436314	0.99912	0.9940386	0.99934	0.98400426	0.99906	-12.721	0.88207	D	0.9996	0.99584	P	0.999992243767439	0.99831	0.99971479	0.99632	1	0.99985	.	.	.	.	.	.	5.562398	0.92161	32.0	0.99798908246520857	0.88381	0.917943	0.88587	D	0.742007177940642	0.82286	7.749107	0.747081129508623	0.85861	8.732487	5.65	5.65	0.86862	.	.	7.831	0.84961	7.673000	0.64945	0.595	0.32887	1.0	0.71675	1.000000	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Transitional_cell_carcinoma_of_the_bladder|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|Inborn_genetic_diseases|Glioblastoma|not_provided|RASopathy|Multiple_myeloma|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1	reviewed_by_expert_panel	NC_000007.14:g.140753348C>A	ClinGen:CA220161|UniProtKB:P15056#VAR_035098	C0279680|C1275081|C0028326|C0950123|C0017636|C3661900|C5555857|C0026764|C0152013|CN029449	PS115150|PS163950|254500|115150	1340|648|360|536391|29073|85443|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Gly	Val	48857	single nucleotide variant	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	673	BRAF	HGNC:1097	Pathogenic	1	Apr 03, 2017	397507483	-	RCV000033332|RCV000208758|RCV000844615|RCV000856749|RCV000077865|RCV001265809	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	RASopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000007.14	7	140753348	140753348	7q34	reviewed by expert panel	12	-	N	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	3	40387	140753348	C	A	-	-	-	-	-	-	SCV000616388	-	-	1787G>T 	Gly596Val	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Gly596Val	2.2257131093137597	0.06135777408658752	-3.8089973889178856	0.006636562833595199	2025_01_Batch_13-14	0.9381108039505246	0.9650002822404748	0.9443067789577735	0.9621695175747484	0.8710569467787093	0.9683246214166759	0.9827263301360674	0.984221210961115	0.9883622952676646	0.8773427495051593	0.9532177126836002	0.9738633061882711	0.9642639949594443	0.9752659064212066	0.8741998481419343	1.0	1.0	0.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003171		NC_000007.14:140753348:C:A		Gly596Val																												BRAF_Gly596Val	7	140753348	C	A	7	allele	1787G>T	B05	527_CAVA_Array_P01	C09	B13A7A8P1_R1	B14A7A8P1_R2				7-140753348-C-A	40387	7	140753348	C	A	G	V	rs397507483	7	140453148	7	140099617	596	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1787G>T	p.Gly596Val	c.1787G>T	p.Gly596Val	principal4	Y	.	YES	Select	-	GGT	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	3.295	0.90281	M	.	.	.	.	.	0.6405	0.92395	D	0.6951	0.89454	D	10	0.99041414	0.99538	D	0.395627	0.93272	D	.	0.99969	0.986	0.99859	P15056	G596V	Loss of sheet (P = 0.0817)| Loss of ubiquitination at K601 (P = 0.0992)| Loss of disorder (P = 0.1248)| Gain of methylation at K591 (P = 0.1331)| Loss of catalytic residue at G596 (P = 0.1549)	.	0.98509	.	0.98578	.	0.96552	0.919968366623	0.98320	D	0.963797	0.99550	D	0.575047	0.96883	D	0.588239	0.96832	D	0.999177873134613	0.96398	D	0.99514	0.98365	D	0.99520737	0.99966	0.98436314	0.99912	0.9940386	0.99934	0.98400426	0.99906	-12.721	0.88207	D	0.9996	0.99584	P	0.999992243767439	0.99831	0.99971479	0.99632	1	0.99985	.	.	.	.	.	.	5.562398	0.92161	32.0	0.99798908246520857	0.88381	0.917943	0.88587	D	0.742007177940642	0.82286	7.749107	0.747081129508623	0.85861	8.732487	5.65	5.65	0.86862	.	.	7.831	0.84961	7.673000	0.64945	0.595	0.32887	1.0	0.71675	1.000000	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Transitional_cell_carcinoma_of_the_bladder|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|Inborn_genetic_diseases|Glioblastoma|not_provided|RASopathy|Multiple_myeloma|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1	reviewed_by_expert_panel	NC_000007.14:g.140753348C>A	ClinGen:CA220161|UniProtKB:P15056#VAR_035098	C0279680|C1275081|C0028326|C0950123|C0017636|C3661900|C5555857|C0026764|C0152013|CN029449	PS115150|PS163950|254500|115150	1340|648|360|536391|29073|85443|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Gly	Val	48857	single nucleotide variant	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	673	BRAF	HGNC:1097	Pathogenic	1	Apr 03, 2017	397507483	-	RCV000033332|RCV000208758|RCV000844615|RCV000856749|RCV000077865|RCV001265809	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	RASopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000007.14	7	140753348	140753348	7q34	reviewed by expert panel	12	-	N	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	3	40387	140753348	C	A	-	-	-	-	-	-	SCV000616388	-	-	1787G>T 	Gly596Val	NM_004333.6	3	1_Pathogenic																																																																																																									
SHOC2	SHOC2_Ser2Gly	-3.1962184734631762	0.015145173112769224	10.615593920721482	0.000014410874200003568	2025_01_Batch_13-14	0.8812307260582743	0.9445404273697964	0.9778620886638342	0.9103892689734077	0.777721700702442														0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2	ENSG00000108061	11602	203498	CCSBVarC003572	ALE00003572	NC_000010.11:110964362:A:G	4A>G	Ser2Gly	CEGS2	CegsMutGDEh1003	E02	GDEhDisVCh_40089	E02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SHOC2_Ser2Gly	10	110964362	A	G	10											10-110964362-A-G	6821	10	110964362	A	G	S	G	rs267607048	10	112724120	10	112714110	2	SHOC2	ENSG00000108061	ENST00000689118	ENSP00000510554	Q9UQ13	SHOC2_HUMAN	.	.	c.4A>G	p.Ser2Gly	principal1	Y	.	.	.	+	AGT	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.08048	.	0.924	0.54410	P	0.827	0.65195	P	.	0.90832	.	.	.	.	1.95	0.52299	M	.	0.18812	.	.	0.79136	-0.8710	0.50259	T	0.1062	0.38523	T	10	.	0.84179	.	0.02323	0.45962	T	.	0.70445	0.737	0.86913	Q9UQ13	S2G	Loss of phosphorylation at S2 (P = 0.0013)| Gain of sheet (P = 0.0028)| Loss of loop (P = 0.0112)| Gain of ubiquitination at K7 (P = 0.0913)| Loss of methylation at K7 (P = 0.0917)	.	0.50012	.	0.01588	.	0.81400	0.709850311279	0.68519	T	0.168512	0.51307	T	0.158547	0.69846	D	-0.0100348	0.69461	D	0.952564656734467	0.63597	D	0.756024	0.37697	T	0.43829516	0.62973	0.3389099	0.59430	0.3963055	0.60151	0.3356854	0.59147	-3.508	0.17366	T	.	0.20926	.	0.949115075084258	0.80343	0.03609608	0.55985	0.27	0.54055	.	.	.	.	.	.	4.350761	0.66885	25.0	0.99693813541009024	0.80133	0.926990	0.90862	D	0.506295370116211	0.67289	5.084776	0.576779642148786	0.73134	5.944563	5.22	5.22	0.72246	.	.	8.492	0.90332	10.555000	0.83455	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613004	3.719770e-06	0	1	29596	3.378830e-05	0	0	74876	0.000000e+00	0	0	912	0.000000e+00	0	0	59750	0.000000e+00	0	1	29596	3.378830e-05	0	0	44884	0.000000e+00	0	0	63960	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179528	4.238980e-06	0	0	90972	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Noonan_syndrome_and_Noonan-related_syndrome|Noonan_syndrome|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy|Polycystic_kidney_disease_4|Inborn_genetic_diseases|not_provided|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Pectus_excavatum	reviewed_by_expert_panel	NC_000010.11:g.110964362A>G	ClinGen:CA118524|OMIM:602775.0001|UniProtKB:Q9UQ13#VAR_060199	C5681679|C0028326|C1843181|C5555857|C4540575|C0950123|C3661900|C4478716|C2051831	PS163950|PS607721|263200|607721|169300	98733|648|2701|536391|2701	.	Ser	Gly	21860	single nucleotide variant	NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	8036	SHOC2	HGNC:15454	Pathogenic	1	Apr 03, 2017	267607048	-	RCV000213000|RCV000624656|RCV000007223|RCV000208379|RCV002221469|RCV004752691|RCV001813181|RCV003330311|RCV000149834|RCV000853278	MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0033004,MedGen:C4540575,OMIM:263200||MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701;Human Phenotype Ontology:HP:0000767,Human Phenotype Ontology:HP:0006613,Human Phenotype Ontology:HP:0006617,MONDO:MONDO:0008213,MedGen:C2051831,OMIM:169300|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701	not provided|Inborn genetic diseases|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|Polycystic kidney disease 4|SHOC2-related disorder|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|RASopathy|Noonan syndrome-like disorder with loose anagen hair	de novo;germline;unknown	germline	GRCh38	NC_000010.11	10	110964362	110964362	10q25.2	reviewed by expert panel	45	-	N	ClinGen:CA118524,UniProtKB:Q9UQ13#VAR_060199,OMIM:602775.0001	3	6821	110964362	A	G	-	-	-	-	-	-	SCV000616382	-	-	4A>G 	Ser2Gly	NM_007373.4	3	1_Pathogenic	10	110964362	A	G	3.42269e-6																																																																																																				
RET	RET_Arg67His	0.8659334758591015	0.4152170581728022	6.886187755373604	0.0002342201970283017	2025_01_Batch_13-14	0.9388740507962934	0.8188458712910882	0.7395946779055604	0.9125810420403285	0.7370609418645981	0.6316120613680206	0.6718183364343475	0.801327165044326	0.6547224220000333	0.6356580884512563	0.785243056082157	0.7453321038627179	0.7704609214749432	0.7836517320201809	0.6863595151579271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202945	CCSBVarC006873	ALE00006871	NC_000010.11:43100585:G:A	200G>A	Arg67His	CEGS2	CegsMutGDEh1027	E08	GDEhDisVCh_40066	H05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Arg67His	10	43100585	G	A	10											10-43100585-G-A	41839	10	43100585	G	A	R	H	rs192489011	10	43596033	10	42916039	67	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.200G>A	p.Arg67His	c.200G>A	p.Arg67His	principal4	Y	5	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.611	0.05754	T	0.58	0.29952	T	0.002	0.13655	B	0.001	0.06938	B	0.08	0.23785	N	simple_aae	92.0	8.0	0.905	0.23113	L	-0.47	0.15106	N	0.028	0.02855	-0.9730	0.36417	T	0.1253	0.42817	T	10	0.0068158507	0.00152	T	.	.	.	0.125	0.34250	.	.	.	.	.	0.47083157667	0.46339	0.5109484406135018	0.50823	0.934419907037	0.71797	0.233786687255	0.02262	T	0.367069	0.73048	T	-0.494179	0.00587	T	-0.473236	0.24820	T	0.0107988245138953	0.00152	T	0.59724	0.21954	T	0.026211439	0.01639	0.032374926	0.01973	0.043690175	0.06790	0.026637115	0.00770	-4.548	0.31573	T	0.0675	0.06414	B	0.00636577096918478	0.20556	0.98813590	0.96462	0.021	0.03256	.	.	.	.	.	.	0.923631	0.13006	9.492	0.77324054778089801	0.12021	0.064517	0.12358	N	-0.737658851988375	0.14788	0.7503831	-0.60610869746005	0.19037	1.036945	5.51	-0.21	0.12496	-1.31	0.14328	0.08	0.14701	0.062000	0.14201	-0.71	0.03958	0.899	0.31494	0.001000	0.17376	0.362	0.25981	862	0.33096	28	0.005591054313099041	0	0.0	0	0.0	0	0.0	27	0.026785714285714284	1	0.0010224948875255625	139	264690	5.2514265E-4	.	130	109312	1.189260e-03	0	206	207774	9.914620e-04	0	270	236724	1.140570e-03	0	0	7156	0.000000e+00	0	1	17100	5.847950e-05	0	0	2310	0.000000e+00	0	110	9044	1.216280e-02	0	4	13368	2.992220e-04	0	9	42734	2.106050e-04	0	6	15688	3.824580e-04	0	110	9044	1.216280e-02	0	0	16184	0.000000e+00	0	2	30500	6.557380e-05	0	0	6194	0.000000e+00	0	168	13406	1.253170e-02	0	7	16708	4.189610e-04	0	15	89320	1.679360e-04	0	11	30604	3.594300e-04	0	168	13406	1.253170e-02	0	0	14884	0.000000e+00	0	2	34240	5.841120e-05	0	0	9558	0.000000e+00	0	218	17690	1.232330e-02	0	15	21600	6.944440e-04	0	22	102612	2.144000e-04	0	11	30522	3.603960e-04	0	218	17690	1.232330e-02	0	.	646	1613870	4.002800e-04	6	377	44876	8.400930e-03	3	2	75036	2.665390e-05	0	0	912	0.000000e+00	0	8	60018	1.332930e-04	0	0	29604	0.000000e+00	0	377	44876	8.400930e-03	3	53	63766	8.311640e-04	0	2	6060	3.300330e-04	0	116	1180022	9.830330e-05	0	45	91076	4.940930e-04	3	16	174478	9.170210570960235E-5	0	176	0	39	4500	0.008666666666666666	0	4792	0	0	796	0	0	968	0	8	1848	0.004329004329004329	0	280	0	22	16002	0.0013748281464816899	0	4968	0	47	6348	0.0074039067422810335	85	203840	4.1699372056514916E-4	Benign/Likely_benign	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Pheochromocytoma|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100585G>A	ClinGen:CA008548|UniProtKB:P07949#VAR_018153	C1619700|C0027662|C4048306|C3661900|C0027672|C0025268|C3888239|C0031511|CN169374	191830|PS131100|171400|142623|171300	411709|276161|653|140162|247698|653|388|29072	Ret, cadherin like domain 1	Arg	His	50278	single nucleotide variant	NM_020975.6(RET):c.200G>A (p.Arg67His)	5979	RET	HGNC:9967	Benign/Likely benign	0	Feb 02, 2025	192489011	-	RCV000034768|RCV000121986|RCV000271726|RCV000311573|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	not provided|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	germline	germline	GRCh38	NC_000010.11	10	43100585	43100585	10q11.21	criteria provided, multiple submitters, no conflicts	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	2	41839	43100585	G	A	-	-	-	-	-	-	SCV000261427|SCV000362226|SCV000362227|SCV000362228|SCV000362229|SCV000610899|SCV000674752|SCV000807018|SCV000890954|SCV002067190|SCV002529960|SCV002572021|SCV004357215	-	-	200G>A 	Arg67His	NM_020975.6	2	2_Benign	10	43100585	G	A	0.000380405																																																																																																				
RET	RET_Arg67His	0.8659334758591015	0.4152170581728022	6.886187755373604	0.0002342201970283017	2025_01_Batch_13-14	0.9388740507962934	0.8188458712910882	0.7395946779055604	0.9125810420403285	0.7370609418645981	0.6316120613680206	0.6718183364343475	0.801327165044326	0.6547224220000333	0.6356580884512563	0.785243056082157	0.7453321038627179	0.7704609214749432	0.7836517320201809	0.6863595151579271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006873		NC_000010.11:43100585:G:A		Arg67His																												RET_Arg67His	10	43100585	G	A	10	allele	200G>A	D08	527_CAVA_Array_P05	G15	B13A7A8P2_R1	B14A7A8P2_R2				10-43100585-G-A	41839	10	43100585	G	A	R	H	rs192489011	10	43596033	10	42916039	67	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.200G>A	p.Arg67His	c.200G>A	p.Arg67His	principal4	Y	5	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.611	0.05754	T	0.58	0.29952	T	0.002	0.13655	B	0.001	0.06938	B	0.08	0.23785	N	simple_aae	92.0	8.0	0.905	0.23113	L	-0.47	0.15106	N	0.028	0.02855	-0.9730	0.36417	T	0.1253	0.42817	T	10	0.0068158507	0.00152	T	.	.	.	0.125	0.34250	.	.	.	.	.	0.47083157667	0.46339	0.5109484406135018	0.50823	0.934419907037	0.71797	0.233786687255	0.02262	T	0.367069	0.73048	T	-0.494179	0.00587	T	-0.473236	0.24820	T	0.0107988245138953	0.00152	T	0.59724	0.21954	T	0.026211439	0.01639	0.032374926	0.01973	0.043690175	0.06790	0.026637115	0.00770	-4.548	0.31573	T	0.0675	0.06414	B	0.00636577096918478	0.20556	0.98813590	0.96462	0.021	0.03256	.	.	.	.	.	.	0.923631	0.13006	9.492	0.77324054778089801	0.12021	0.064517	0.12358	N	-0.737658851988375	0.14788	0.7503831	-0.60610869746005	0.19037	1.036945	5.51	-0.21	0.12496	-1.31	0.14328	0.08	0.14701	0.062000	0.14201	-0.71	0.03958	0.899	0.31494	0.001000	0.17376	0.362	0.25981	862	0.33096	28	0.005591054313099041	0	0.0	0	0.0	0	0.0	27	0.026785714285714284	1	0.0010224948875255625	139	264690	5.2514265E-4	.	130	109312	1.189260e-03	0	206	207774	9.914620e-04	0	270	236724	1.140570e-03	0	0	7156	0.000000e+00	0	1	17100	5.847950e-05	0	0	2310	0.000000e+00	0	110	9044	1.216280e-02	0	4	13368	2.992220e-04	0	9	42734	2.106050e-04	0	6	15688	3.824580e-04	0	110	9044	1.216280e-02	0	0	16184	0.000000e+00	0	2	30500	6.557380e-05	0	0	6194	0.000000e+00	0	168	13406	1.253170e-02	0	7	16708	4.189610e-04	0	15	89320	1.679360e-04	0	11	30604	3.594300e-04	0	168	13406	1.253170e-02	0	0	14884	0.000000e+00	0	2	34240	5.841120e-05	0	0	9558	0.000000e+00	0	218	17690	1.232330e-02	0	15	21600	6.944440e-04	0	22	102612	2.144000e-04	0	11	30522	3.603960e-04	0	218	17690	1.232330e-02	0	.	646	1613870	4.002800e-04	6	377	44876	8.400930e-03	3	2	75036	2.665390e-05	0	0	912	0.000000e+00	0	8	60018	1.332930e-04	0	0	29604	0.000000e+00	0	377	44876	8.400930e-03	3	53	63766	8.311640e-04	0	2	6060	3.300330e-04	0	116	1180022	9.830330e-05	0	45	91076	4.940930e-04	3	16	174478	9.170210570960235E-5	0	176	0	39	4500	0.008666666666666666	0	4792	0	0	796	0	0	968	0	8	1848	0.004329004329004329	0	280	0	22	16002	0.0013748281464816899	0	4968	0	47	6348	0.0074039067422810335	85	203840	4.1699372056514916E-4	Benign/Likely_benign	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Pheochromocytoma|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100585G>A	ClinGen:CA008548|UniProtKB:P07949#VAR_018153	C1619700|C0027662|C4048306|C3661900|C0027672|C0025268|C3888239|C0031511|CN169374	191830|PS131100|171400|142623|171300	411709|276161|653|140162|247698|653|388|29072	Ret, cadherin like domain 1	Arg	His	50278	single nucleotide variant	NM_020975.6(RET):c.200G>A (p.Arg67His)	5979	RET	HGNC:9967	Benign/Likely benign	0	Feb 02, 2025	192489011	-	RCV000034768|RCV000121986|RCV000271726|RCV000311573|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	not provided|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	germline	germline	GRCh38	NC_000010.11	10	43100585	43100585	10q11.21	criteria provided, multiple submitters, no conflicts	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	2	41839	43100585	G	A	-	-	-	-	-	-	SCV000261427|SCV000362226|SCV000362227|SCV000362228|SCV000362229|SCV000610899|SCV000674752|SCV000807018|SCV000890954|SCV002067190|SCV002529960|SCV002572021|SCV004357215	-	-	200G>A 	Arg67His	NM_020975.6	2	2_Benign	10	43100585	G	A	0.000380405																																																																																																				
G6PD	G6PD_Glu398Lys	-2.2270130039444096	0.061240193067420415	-0.8074387696543632	0.44597881965233355	2025_01_Batch_13-14	0.6375150811257665	0.6857507416320532	0.6899031274081147	0.754685069336219	0.5817260749943405	0.6490455450952126	0.6565875508067958	0.6259642270058572	0.6481168129234808	0.6344998491776213	0.6432803131104896	0.6711691462194245	0.6579336772069859	0.7014009411298499	0.6081129620859809	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	G6PD		4006		CCSBVarC004025		NC_000023.11:154532662:C:T		Glu398Lys																												G6PD_Glu398Lys	23	154532662	C	T	X	allele	1192G>A	H04	527_CAVA_Array_P03	P07	B13A7A8P1_R1	B14A7A8P1_R2				X-154532662-C-T	804134	X	154532662	C	T	E	K	rs137852325	X	153760877	X	153414071	398	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1192G>A	p.Glu398Lys	principal4	Y	.	.	.	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.94956	.	.	.	.	4.61	0.99266	H	.	0.69872	.	.	0.73617	0.9214	0.95965	D	0.9960	0.99908	D	10	.	0.98957	.	0.848963	0.98832	D	.	0.97849	0.949	0.99385	P11413	E398K	Gain of MoRF binding (P = 0.0029)| Gain of methylation at E398 (P = 0.0073)| Loss of stability (P = 0.1334)| Gain of phosphorylation at T402 (P = 0.1773)| Loss of loop (P = 0.2237)	.	0.99692	.	.	.	0.95480	0.819497585297	0.84925	D	0.972763	0.99714	D	0.667932	0.99900	D	0.721661	0.99899	D	0.999545991420746	0.97827	D	0.99725	0.98926	D	0.95874125	0.97108	0.9285496	0.96951	0.9683203	0.98071	0.90745586	0.95445	-11.128	0.80418	D	.	0.90566	.	0.999990459212003	0.99831	0.99881110	0.98976	0.989	0.99628	.	.	.	.	.	.	4.526718	0.71085	25.6	0.99914936147112188	0.98310	.	.	.	.	.	.	.	.	.	5.82	4.96	0.65108	3.01	0.55043	5.668	0.67818	5.880000	0.50706	0.585	0.3052	1.0	0.71675	1.000000	0.68239	0.977	0.56847	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154532662C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Glu	Lys	792173	single nucleotide variant	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2539	G6PD	HGNC:4057	Pathogenic	1	May 20, 2023	137852325	-	RCV000991012	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	154532662	154532662	Xq28	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA337316269	2	804134	154532662	C	T	-	-	-	-	-	-	SCV001142103|SCV002599372|SCV005373641	-	-	1192G>A 	Glu398Lys	NM_001360016.2	2	1_Pathogenic						266779	G6PD_unpublished_var120692	G6PD_unpublished	G6PD	4057.0	-1.0		154532662.0	154532662.0		1192			398.0	E	E	c.1192G>A	p.Glu398Glu	missense_variant	1.039749264017038	1.057171340117224;1.067244693361654;0.994831758572235		No		Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	May 20, 2023	aa		ENST00000393562.10	NM_001360016.2	immortalized human cells	Reporter	Fluorescence	Protein stability	Yes	missense_variant																																																													G6PD_Glu398Glu	Glu398Glu	true
ZC4H2	ZC4H2_Arg18Lys	-6.340999360000492	0.00038856290197054536	7.618121131716513	0.00012439311242996078	2025_01_Batch_13-14	0.7503559799668514	0.9185601696203177	0.963587118979357	0.9064220148723456	0.7522493313481461	0.6601528287397939	0.9393200513331863	0.9789260946638219	0.931944116940673	0.6341990021331609	0.7052544043533227	0.9289401104767521	0.9712566068215894	0.9191830659065093	0.6932241667406536	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009194		NC_000023.11:64976325:C:T		Arg18Lys																												ZC4H2_Arg18Lys	23	64976325	C	T	X	allele	53G>A	C05	527_CAVA_Array_P06	E10	B13A7A8P2_R1	B14A7A8P2_R2				X-64976325-C-T	378045	X	64976325	C	T	R	K	rs1057520299	X	64196205	X	64112930	18	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.53G>A	p.Arg18Lys	c.53G>A	p.Arg18Lys	principal1	Y	1	YES	Select	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.162	0.24024	T	0.428	0.54507	T	0.979	0.59057	D	0.973	0.72925	D	0.39	0.63057	A	simple_aae	61.0	39.0	1.61	0.40979	L	-1.74	0.52471	N	0.866	0.86268	-0.6422	0.62892	T	0.2792	0.64962	T	8	0.76925564	0.76724	D	0.017247	0.38628	T	0.231	0.52992	0.607	0.73845	Q9NQZ6	R18K	Gain of methylation at R18 (P = 0.0377)| Gain of ubiquitination at K15 (P = 0.0632)| Loss of MoRF binding (P = 0.0922)| Loss of phosphorylation at T21 (P = 0.1157)| Loss of glycosylation at K15 (P = 0.2)	0.622178612725	0.61618	0.901597971559674	0.90069	1.62403551474	0.89065	0.773836612701	0.77960	T	0.486907	0.81174	T	0.0608247	0.59433	T	-0.150406	0.58921	T	0.973198473453522	0.69797	D	0.89491	0.63411	D	0.6772347	0.76559	0.5044407	0.71097	0.6783023	0.76618	0.41600963	0.65445	-4.683	0.36534	T	0.7363	0.75522	P	0.99398228578285	0.90367	0.99041635	0.96797	0.321	0.58615	.	.	.	.	.	.	5.580871	0.92311	32.0	0.99599773954017523	0.74191	.	.	.	.	.	.	.	.	.	4.73	4.73	0.59435	4.0	0.76287	5.226	0.65208	7.412000	0.58717	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.967	0.53449	45	0.97779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1209679	8.266660e-07	0	1	45815	2.182690e-05	0	0	57101	0.000000e+00	0	0	687	0.000000e+00	0	1	45815	2.182690e-05	0	0	22031	0.000000e+00	0	0	33732	0.000000e+00	0	0	46659	0.000000e+00	0	0	4372	0.000000e+00	0	0	894933	0.000000e+00	0	0	56759	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64976325C>T	ClinGen:CA16609222|OMIM:300897.0007	C0796200	314580	3454|85283	.	Arg	Lys	380137	single nucleotide variant	NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)	55906	ZC4H2	HGNC:24931	Pathogenic	1	Mar 02, 2017	1057520299	-	RCV000426615	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64976325	64976325	Xq11.2	no assertion criteria provided	1	-	N	ClinGen:CA16609222,OMIM:300897.0007	1	378045	64976325	C	T	-	-	-	-	-	-	SCV000513398	-	-	53G>A 	Arg18Lys	NM_018684.4		1_Pathogenic																																																																																																									
BRCA1	BRCA1_Phe558Ser	1.6111167737238428	0.15118946477997378	4.615270970171342	0.0024397297238219016	2025_01_Batch_13-14	0.9498482441279532	0.9308024365566823	0.9137788511755762	0.9572502165200717	0.8165718573701302	0.9856023871263442	0.9300413434020081	0.9248850903557055	0.9816134932174742	0.9586068154103601	0.9677253156271487	0.9304218899793452	0.9193319707656409	0.9694318548687729	0.8875893363902452	1.0	0.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC013021		NC_000017.11:43070929:A:G		Phe558Ser																												BRCA1_Phe558Ser	17	43070929	A	G	17	allele	1673T>C	E10	527_CAVA_Array_P01	I19	B13A7A8P1_R1	B14A7A8P1_R2				17-43070929-A-G	55339	17	43070929	A	G	F	S	rs28897695	17	41222946	17	38476472	1662	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4985T>C	p.Phe1662Ser	c.4985T>C	p.Phe1662Ser	principal2	Y	1	YES	Select	-	TTT	2	0	A	A/A	A/A	A/A	A/A	0.324	0.13470	T	0.483	0.15624	T	0.327	0.33186	B	0.072	0.28044	B	0.26	0.51279	N	simple_aae	74.0	26.0	0	0.06502	N	-0.41	0.54888	N	0.17	0.20657	-0.8141	0.54115	T	0.2316	0.59602	T	10	0.08930129	0.15320	T	0.095936	0.76440	D	0.521	0.79537	.	.	.	.	.	0.346544149963	0.33848	.	0.38144	.	0.17918	0.32687741518	0.14450	T	0.127873	0.45213	T	-0.0538666	0.43515	T	-0.0894503	0.63948	T	0.0101923026540198	0.00137	T	.	0.29269	.	0.15882574	0.35418	0.05462813	0.09445	0.15678944	0.35072	0.06600715	0.13457	-2.062	0.15503	T	0.1159	0.48135	B	0.242492734673284	0.51903	0.99607220	0.97952	0.115	0.31465	.	.	.	.	.	.	1.575156	0.20196	14.62	0.63349936367485471	0.07307	0.176669	0.30175	N	-1.19592149865023	0.05004	0.2298717	-1.20530321707257	0.05732	0.2786036	4.82	-1.61	0.07934	-3.96	0.06349	0.047	0.13983	1.542000	0.27319	-0.681	0.0423	0.006	0.17427	0.000000	0.08389	0.808	0.38116	544	0.72706	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109362	9.143940e-06	0	2	206954	9.663980e-06	0	3	235478	1.274000e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13350	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9044	1.105710e-04	0	0	16214	0.000000e+00	0	0	30522	0.000000e+00	0	0	6208	0.000000e+00	0	2	13414	1.490980e-04	0	0	16690	0.000000e+00	0	0	88440	0.000000e+00	0	0	30608	0.000000e+00	0	2	13414	1.490980e-04	0	0	14902	0.000000e+00	0	1	34258	2.919030e-05	0	0	9566	0.000000e+00	0	2	17690	1.130580e-04	0	0	21588	0.000000e+00	0	0	101348	0.000000e+00	0	0	30526	0.000000e+00	0	2	17690	1.130580e-04	0	.	21	1614022	1.301100e-05	0	17	44902	3.786020e-04	0	1	74928	1.334610e-05	0	0	912	0.000000e+00	0	1	60004	1.666560e-05	0	0	29608	0.000000e+00	0	17	44902	3.786020e-04	0	0	63964	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180042	1.694850e-06	0	0	91090	0.000000e+00	0	0	85192	0	0	238	0	0	468	0	0	5996	0	0	648	0	0	2154	0	0	126	0	0	168	0	0	2604	0	0	6234	0	0	594	0	0	97594	0	Benign	Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43070929A>G	BRCA1-HCI:BRCA1_00091|ClinGen:CA003117	C0027672|CN169374|C0677776|C3661900|C2676676	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Phe	Ser	70006	single nucleotide variant	NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	28897695	-	RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070929	43070929	17q21.31	reviewed by expert panel	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00091,ClinGen:CA003117	2	55339	43070929	A	G	-	-	-	-	-	-	SCV000244375	-	-	4985T>C 	Phe1662Ser	NM_007294.4	3	2_Benign						45062	BRCA1_Adamovich_2022_HDR_var4616	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43070929.0	43070929.0		4985			1662.0	F	S	c.4985T>C	p.Phe1662Ser	missense_variant,splice_region_variant	-0.3079240295	-0.267857585;-0.25651947;-0.250480607;-0.456838457		No	0.0000130109750672	Benign	reviewed by expert panel	Aug 10, 2015	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant		0.521	Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified																																																		BRCA1_Phe1662Ser	Phe1662Ser	true
SHOC2	SHOC2_Gly53Arg	-1.3521828512316285	0.21837236832015264	4.502630598472021	0.002789525522662503	2025_01_Batch_13-14	0.8216650233696959	0.8816101159079917	0.7569201111391481	0.7687754072288939	0.6632181990751883	0.750939423096193	0.8491425140558854	0.6718651200479084	0.8162824578848482	0.6992104773769182	0.7863022232329444	0.8653763149819385	0.7143926155935283	0.7925289325568711	0.6812143382260533	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2		11602		CCSBVarC028008		NC_000010.11:110964515:G:A		Gly53Arg																												SHOC2_Gly53Arg	10	110964515	G	A	10	allele	157G>A	B02	527_CAVA_Array_P06	C04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964515-G-A	1339314	10	110964515	G	A	G	R	rs2134121169	10	112724273	10	112714263	53	SHOC2	ENSG00000108061	ENST00000691369	ENSP00000509754	Q9UQ13	SHOC2_HUMAN	.	.	c.157G>A	p.Gly53Arg	principal1	Y	.	.	.	+	GGA	1	0	G	G/G	G/G	G/G	G/G	.	0.41793	.	.	0.24765	.	0.982	0.62839	D	0.785	0.63333	P	.	0.88440	.	.	.	.	1.445	0.36203	L	.	0.20730	.	.	0.69502	0.5925	0.91770	D	0.8012	0.93256	D	10	.	0.60049	.	0.084434	0.74238	D	.	0.79415	0.2	0.11319	Q9UQ13	G53R	Gain of MoRF binding (P = 0.0334)| Loss of ubiquitination at K55 (P = 0.0365)| Gain of methylation at K54 (P = 0.0787)| Gain of loop (P = 0.1069)| Loss of glycosylation at K54 (P = 0.1528)	.	0.65811	.	0.19691	.	0.67780	0.874739408493	0.93229	D	0.259483	0.62867	T	0.335781	0.85447	D	0.24455	0.85257	D	0.902562320232391	0.55306	D	.	0.60013	.	0.30022958	0.52593	0.27641422	0.53380	0.30022958	0.52593	0.27641422	0.53379	-5.121	0.38173	T	.	0.64318	.	0.970648187277183	0.83393	0.15046370	0.70447	0.389	0.63863	.	.	.	.	.	.	4.506791	0.70599	25.5	0.99772429166242937	0.86015	0.909199	0.86504	D	0.713091895322115	0.80383	7.305809	0.767502526075403	0.87388	9.229115	5.99	5.99	0.97294	.	.	8.002	0.8806	9.913000	0.82471	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.998	0.85369	915	0.20912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Noonan_syndrome-like_disorder_with_loose_anagen_hair_1	criteria_provided,_single_submitter	NC_000010.11:g.110964515G>A	.	C4478716	607721	2701	.	Gly	Arg	1330365	single nucleotide variant	NM_007373.4(SHOC2):c.157G>A (p.Gly53Arg)	8036	SHOC2	HGNC:15454	Likely pathogenic	1	Jan 05, 2022	2134121169	-	RCV002272501	MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	Noonan syndrome-like disorder with loose anagen hair 1	de novo	germline	GRCh38	NC_000010.11	10	110964515	110964515	10q25.2	criteria provided, single submitter	1	-	N	ClinGen:CA378381906	2	1339314	110964515	G	A	-	-	-	-	-	-	SCV002073494	-	-	157G>A 	Gly53Arg	NM_007373.4	1	1_Pathogenic																																																																																																									
BAP1	BAP1_Thr93Ala	-0.6567658065858207	0.5323213743048774	-1.8287496773019911	0.11014705290189507	2025_01_Batch_13-14	0.6202397851478961	0.6362000012952241	0.7512034716753719	0.6892093396316892	0.6153877231073421	0.5360889193103129	0.5627802399760888	0.7323795754952047	0.6351488821939886	0.63413813268941	0.5781643522291045	0.5994901206356564	0.7417915235852883	0.6621791109128389	0.6247629278983761	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009507		NC_000003.12:52408056:T:C		Thr93Ala																												BAP1_Thr93Ala	3	52408056	T	C	3	allele	277A>G	H02	527_CAVA_Array_P01	O03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408056-T-C	55879	3	52408056	T	C	T	A	rs375129361	3	52442072	3	52417112	93	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.277A>G	p.Thr93Ala	c.277A>G	p.Thr93Ala	principal1	Y	1	YES	Select	-	ACT	1	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.004	0.74454	D	0.999	0.77914	D	0.989	0.78402	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.105	0.97294	H	-4.56	0.80799	D	0.983	0.99488	0.4694	0.90073	D	0.5815	0.84895	D	10	0.9710113	0.96665	D	0.320929	0.91452	D	0.829	0.94563	0.874	0.96509	Q92560	T93A	Gain of helix (P = 0.132)| Loss of glycosylation at T93 (P = 0.3182)| Loss of stability (P = 0.3249)| Loss of catalytic residue at N89 (P = 0.4948)| Gain of disorder (P = 0.6407)	0.838735026799	0.83592	0.8901470396696406	0.88915	2.40817712881	0.97198	0.833551824093	0.87085	D	0.577416	0.85979	D	0.251032	0.78538	D	0.295271	0.87893	D	0.995927274227142	0.88231	D	0.994601	0.98251	D	0.9059349	0.91801	0.8396252	0.90693	0.8751512	0.89125	0.8592254	0.92021	-14.822	0.95431	D	0.9945	0.95276	P	0.999630510295007	0.97271	0.99965429	0.99571	0.818	0.89950	.	.	.	.	.	.	7.074994	0.96116	35.0	0.99807720587773441	0.89183	0.908893	0.86431	D	0.954170017245365	0.94117	12.5385	0.865996819397726	0.93882	12.37055	5.49	5.49	0.80997	3.34	0.60572	7.766	0.84189	7.827000	0.70012	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.995	0.73271	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	106374	0.000000e+00	0	0	202728	0.000000e+00	0	1	231230	4.324700e-06	0	0	6610	0.000000e+00	0	0	16808	0.000000e+00	0	0	2194	0.000000e+00	0	0	8894	0.000000e+00	0	0	13292	0.000000e+00	0	0	41496	0.000000e+00	0	0	15212	0.000000e+00	0	.	.	.	.	0	15408	0.000000e+00	0	0	29904	0.000000e+00	0	0	5990	0.000000e+00	0	0	13312	0.000000e+00	0	0	16576	0.000000e+00	0	0	87104	0.000000e+00	0	0	29660	0.000000e+00	0	.	.	.	.	0	14150	0.000000e+00	0	0	33660	0.000000e+00	0	0	9380	0.000000e+00	0	1	17510	5.711020e-05	0	0	21264	0.000000e+00	0	0	100148	0.000000e+00	0	0	29584	0.000000e+00	0	1	17510	5.711020e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Uncertain_significance	BAP1-related_tumor_predisposition_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52408056T>C	ClinGen:CA143983|OMIM:603089.0008	C3280492|C0027672	614327	289539|140162	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Thr	Ala	70527	single nucleotide variant	NM_004656.4(BAP1):c.277A>G (p.Thr93Ala)	8314	BAP1	HGNC:950	Uncertain significance	1	Dec 03, 2022	375129361	-	RCV000049290|RCV002433548	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	52408056	52408056	3p21.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA143983,OMIM:603089.0008	3	55879	52408056	T	C	-	-	-	-	-	-	SCV002746333|SCV004293103	-	-	277A>G 	Thr93Ala	NM_004656.4	2	4_VUS																																																																																																									
F9	F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	367997	X	139530783	A	T	I	F	rs150190385	X	138612942	X	138440608	7	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.2790	0.75458	T	0.5839	0.85002	D	10	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.25790	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.000000	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	Benign	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	348532	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	150190385	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783	139530783	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3	367997	139530783	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3	2_Benign						123848	F9_Popp_2025_carboxy_F9_specific_var220817	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139530783.0	139530783.0		19			7.0	I	F	c.19A>T	p.Ile7Phe	missense_variant	0.93154916889732			No	0.0012712960689839	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.582																																								367997.0	CA10529708	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BS2,BA1	PS4,BP4	NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c	b888a6e8-55cd-449a-a9d9-bc586edb7b6c	VUS	BS2,BA1	F9_Ile7Phe	Ile7Phe	true
F9	F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	367997	X	139530783	A	T	I	F	rs150190385	X	138612942	X	138440608	7	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.2790	0.75458	T	0.5839	0.85002	D	10	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.25790	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.000000	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	Benign	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	348532	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	150190385	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783	139530783	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3	367997	139530783	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3	2_Benign						151364	F9_Popp_2025_carboxy_gla_motif_var249860	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139530783.0	139530783.0		19			7.0	I	F	c.19A>T	p.Ile7Phe	missense_variant	0.9056385132737776			No	0.0012712960689839	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.582																																								367997.0	CA10529708	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BS2,BA1	PS4,BP4	NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c	b888a6e8-55cd-449a-a9d9-bc586edb7b6c	VUS	BS2,BA1	F9_Ile7Phe	Ile7Phe	true
F9	F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	367997	X	139530783	A	T	I	F	rs150190385	X	138612942	X	138440608	7	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.2790	0.75458	T	0.5839	0.85002	D	10	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.25790	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.000000	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	Benign	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	348532	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	150190385	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783	139530783	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3	367997	139530783	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3	2_Benign						233912	F9_Popp_2025_strep_2_var259541	F9_Popp_2025_strep_2	F9	3551.0	1.0		139530783.0	139530783.0		19			7.0	I	F	c.19A>T	p.Ile7Phe	missense_variant	1.0643644677340538			No	0.0012712960689839	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.582																																								367997.0	CA10529708	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BS2,BA1	PS4,BP4	NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c	b888a6e8-55cd-449a-a9d9-bc586edb7b6c	VUS	BS2,BA1	F9_Ile7Phe	Ile7Phe	true
F9	F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	367997	X	139530783	A	T	I	F	rs150190385	X	138612942	X	138440608	7	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.2790	0.75458	T	0.5839	0.85002	D	10	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.25790	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.000000	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	Benign	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	348532	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	150190385	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783	139530783	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3	367997	139530783	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3	2_Benign						178880	F9_Popp_2025_heavy_chain_var230498	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139530783.0	139530783.0		19			7.0	I	F	c.19A>T	p.Ile7Phe	missense_variant	1.0011792876785426			No	0.0012712960689839	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.582																																								367997.0	CA10529708	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BS2,BA1	PS4,BP4	NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c	b888a6e8-55cd-449a-a9d9-bc586edb7b6c	VUS	BS2,BA1	F9_Ile7Phe	Ile7Phe	true
F9	F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	367997	X	139530783	A	T	I	F	rs150190385	X	138612942	X	138440608	7	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.2790	0.75458	T	0.5839	0.85002	D	10	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.25790	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.000000	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	Benign	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	348532	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	150190385	-	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783	139530783	Xq27.1	reviewed by expert panel	10	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3	367997	139530783	A	T	-	-	-	-	-	-	SCV004363695	-	-	19A>T 	Ile7Phe	NM_000133.4	3	2_Benign						206396	F9_Popp_2025_light_chain_var240179	F9_Popp_2025_light_chain	F9	3551.0	1.0		139530783.0	139530783.0		19			7.0	I	F	c.19A>T	p.Ile7Phe	missense_variant	0.9413312528693004			No	0.0012712960689839	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.582																																								367997.0	CA10529708	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BS2,BA1	PS4,BP4	NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c	b888a6e8-55cd-449a-a9d9-bc586edb7b6c	VUS	BS2,BA1	F9_Ile7Phe	Ile7Phe	true
F9	F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									
BCL10	BCL10_Ala5Ser	-2.11002446113385	0.08861914220244649	-0.22462787367078096	0.8286849004700589	2025_01_Batch_13-14	0.8007408407158935	0.707528895168196	0.7844662272572069	0.7226784793589274	0.7541221803752104	0.7683806146572103	0.8285068625475089	0.7666484723157028	0.8121281617033118	0.541453049244701	0.7845607276865518	0.7680178788578524	0.7755573497864549	0.7674033205311196	0.6477876148099557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BCL10	ENSG00000142867	11832	20120	CCSBVarC001763	ALE00001763	NC_000001.11:85276340:C:A	13G>T	Ala5Ser	RC4	RC4_Mut_GDEh1005	H03	GDEhDisVCh_40010	D03	2	RC4_Mut_GDDh1005	H03	NULL	NULL	VUSMutpDEST2_09	F09	VUSmut_GDEh12	B07	1	1	1	1	0			1	1	1	1	1	1	BCL10_Ala5Ser	1	85276340	C	A	1											1-85276340-C-A	475271	1	85276340	C	A	A	S	rs12037217	1	85742023	1	85514611	5	BCL10	ENSG00000142867	ENST00000648566	ENSP00000498104	O95999	BCL10_HUMAN	c.13G>T	p.Ala5Ser	c.13G>T	p.Ala5Ser	principal1	Y	.	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	0.07361	.	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	0.69	0.16877	N	.	.	.	.	0.00874	-1.0105	0.26684	T	0.0231	0.09750	T	9	0.0015875101	0.00018	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.494869709015	0.38062	T	0.305241	0.67569	T	-0.689941	0.00041	T	-0.667112	0.07582	T	0.0156444791003721	0.00357	T	0.726327	0.33844	T	0.12828135	0.29734	0.16866185	0.38716	0.11355482	0.26579	0.17036171	0.39010	-2.553	0.06160	T	0.0874	0.11803	B	0.00201335097249276	0.13098	0.00011795	0.01318	0.124	0.33416	.	.	.	.	.	.	2.748674	0.36089	20.1	0.99510976220833802	0.68658	0.140710	0.26053	N	-0.418389870164214	0.24553	1.343174	-0.230976240330979	0.30116	1.713435	5.12	3.19	0.35642	2.73	0.49939	1.77	0.38267	3.253000	0.37120	0.599	0.40292	0.983	0.35756	1.000000	0.68239	0.99	0.65338	839	0.37627	175	0.03494408945686901	0	0.0	27	0.0268389662027833	16	0.023054755043227664	118	0.11706349206349206	14	0.014314928425357873	6745	264690	0.02548264	.	3040	109350	2.780060e-02	98	5798	206954	2.801590e-02	191	7068	235746	2.998140e-02	231	28	7152	3.914990e-03	0	320	17098	1.871560e-02	1	191	2320	8.232760e-02	7	1071	9042	1.184470e-01	70	55	13382	4.110000e-03	0	1026	42754	2.399780e-02	12	294	15690	1.873800e-02	7	1071	9042	1.184470e-01	70	67	16198	4.136310e-03	0	551	30502	1.806440e-02	1	519	6202	8.368270e-02	23	1591	13408	1.186610e-01	114	71	16722	4.245900e-03	1	2251	88452	2.544880e-02	33	572	30608	1.868790e-02	14	1591	13408	1.186610e-01	114	61	14888	4.097260e-03	0	655	34240	1.912970e-02	2	845	9560	8.838910e-02	32	2112	17686	1.194160e-01	139	98	21594	4.538300e-03	1	2528	101642	2.487160e-02	38	572	30526	1.873810e-02	14	2112	17686	1.194160e-01	139	.	39674	1613546	2.458810e-02	780	2701	29582	9.130550e-02	124	369	75002	4.919870e-03	2	55	912	6.030700e-02	2	1324	59992	2.206960e-02	15	2701	29582	9.130550e-02	124	3907	44842	8.712810e-02	225	342	64010	5.342920e-03	1	390	6048	6.448410e-02	19	26788	1179642	2.270860e-02	305	1821	91032	2.000400e-02	41	4527	162754	0.027814984577952	1	360	0.002777777777777778	379	4430	0.0855530474040632	90	9000	0.01	29	786	0.03689567430025445	21	966	0.021739130434782608	261	1826	0.1429353778751369	5	274	0.01824817518248175	725	14392	0.05037520844913841	91	9360	0.009722222222222222	640	6256	0.10230179028132992	6038	194788	0.030997802739388465	Benign	BCL10-related_disorder|Immunodeficiency_37	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.85276340C>A	ClinGen:CA929838	C4015195	616098	.	.	Ala	Ser	448386	single nucleotide variant	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	8915	BCL10	HGNC:989	Benign	0	Feb 03, 2025	12037217	-	RCV000532322|RCV004714073|RCV003915633	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900|	Immunodeficiency 37|not provided|BCL10-related disorder	germline	germline	GRCh38	NC_000001.11	1	85276340	85276340	1p22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA929838	2	475271	85276340	C	A	-	-	-	-	-	-	SCV000655451|SCV005280959	-	-	13G>T 	Ala5Ser	NM_003921.5	2	2_Benign	1	85276340	C	A	0.0247372																																																																																																				
BCL10	BCL10_Ala5Ser	-2.11002446113385	0.08861914220244649	-0.22462787367078096	0.8286849004700589	2025_01_Batch_13-14	0.8007408407158935	0.707528895168196	0.7844662272572069	0.7226784793589274	0.7541221803752104	0.7683806146572103	0.8285068625475089	0.7666484723157028	0.8121281617033118	0.541453049244701	0.7845607276865518	0.7680178788578524	0.7755573497864549	0.7674033205311196	0.6477876148099557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BCL10		11832		CCSBVarC001763		NC_000001.11:85276340:C:A		Ala5Ser																												BCL10_Ala5Ser	1	85276340	C	A	1	allele	13G>T	B03	527_CAVA_Array_P01	C05	B13A7A8P1_R1	B14A7A8P1_R2				1-85276340-C-A	475271	1	85276340	C	A	A	S	rs12037217	1	85742023	1	85514611	5	BCL10	ENSG00000142867	ENST00000648566	ENSP00000498104	O95999	BCL10_HUMAN	c.13G>T	p.Ala5Ser	c.13G>T	p.Ala5Ser	principal1	Y	.	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	0.07361	.	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	0.69	0.16877	N	.	.	.	.	0.00874	-1.0105	0.26684	T	0.0231	0.09750	T	9	0.0015875101	0.00018	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.494869709015	0.38062	T	0.305241	0.67569	T	-0.689941	0.00041	T	-0.667112	0.07582	T	0.0156444791003721	0.00357	T	0.726327	0.33844	T	0.12828135	0.29734	0.16866185	0.38716	0.11355482	0.26579	0.17036171	0.39010	-2.553	0.06160	T	0.0874	0.11803	B	0.00201335097249276	0.13098	0.00011795	0.01318	0.124	0.33416	.	.	.	.	.	.	2.748674	0.36089	20.1	0.99510976220833802	0.68658	0.140710	0.26053	N	-0.418389870164214	0.24553	1.343174	-0.230976240330979	0.30116	1.713435	5.12	3.19	0.35642	2.73	0.49939	1.77	0.38267	3.253000	0.37120	0.599	0.40292	0.983	0.35756	1.000000	0.68239	0.99	0.65338	839	0.37627	175	0.03494408945686901	0	0.0	27	0.0268389662027833	16	0.023054755043227664	118	0.11706349206349206	14	0.014314928425357873	6745	264690	0.02548264	.	3040	109350	2.780060e-02	98	5798	206954	2.801590e-02	191	7068	235746	2.998140e-02	231	28	7152	3.914990e-03	0	320	17098	1.871560e-02	1	191	2320	8.232760e-02	7	1071	9042	1.184470e-01	70	55	13382	4.110000e-03	0	1026	42754	2.399780e-02	12	294	15690	1.873800e-02	7	1071	9042	1.184470e-01	70	67	16198	4.136310e-03	0	551	30502	1.806440e-02	1	519	6202	8.368270e-02	23	1591	13408	1.186610e-01	114	71	16722	4.245900e-03	1	2251	88452	2.544880e-02	33	572	30608	1.868790e-02	14	1591	13408	1.186610e-01	114	61	14888	4.097260e-03	0	655	34240	1.912970e-02	2	845	9560	8.838910e-02	32	2112	17686	1.194160e-01	139	98	21594	4.538300e-03	1	2528	101642	2.487160e-02	38	572	30526	1.873810e-02	14	2112	17686	1.194160e-01	139	.	39674	1613546	2.458810e-02	780	2701	29582	9.130550e-02	124	369	75002	4.919870e-03	2	55	912	6.030700e-02	2	1324	59992	2.206960e-02	15	2701	29582	9.130550e-02	124	3907	44842	8.712810e-02	225	342	64010	5.342920e-03	1	390	6048	6.448410e-02	19	26788	1179642	2.270860e-02	305	1821	91032	2.000400e-02	41	4527	162754	0.027814984577952	1	360	0.002777777777777778	379	4430	0.0855530474040632	90	9000	0.01	29	786	0.03689567430025445	21	966	0.021739130434782608	261	1826	0.1429353778751369	5	274	0.01824817518248175	725	14392	0.05037520844913841	91	9360	0.009722222222222222	640	6256	0.10230179028132992	6038	194788	0.030997802739388465	Benign	BCL10-related_disorder|Immunodeficiency_37	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.85276340C>A	ClinGen:CA929838	C4015195	616098	.	.	Ala	Ser	448386	single nucleotide variant	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	8915	BCL10	HGNC:989	Benign	0	Feb 03, 2025	12037217	-	RCV000532322|RCV004714073|RCV003915633	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900|	Immunodeficiency 37|not provided|BCL10-related disorder	germline	germline	GRCh38	NC_000001.11	1	85276340	85276340	1p22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA929838	2	475271	85276340	C	A	-	-	-	-	-	-	SCV000655451|SCV005280959	-	-	13G>T 	Ala5Ser	NM_003921.5	2	2_Benign	1	85276340	C	A	0.0247372																																																																																																				
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	173583	F9_Popp_2025_carboxy_gla_motif_var257678	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.032095445118662			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	173583	F9_Popp_2025_carboxy_gla_motif_var257678	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.032095445118662			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	228615	F9_Popp_2025_light_chain_var247997	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.000491065611329			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	228615	F9_Popp_2025_light_chain_var247997	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.000491065611329			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	146067	F9_Popp_2025_carboxy_F9_specific_var228635	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.053306317400008			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	146067	F9_Popp_2025_carboxy_F9_specific_var228635	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.053306317400008			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	256131	F9_Popp_2025_strep_2_var267359	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.231034116272263			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	256131	F9_Popp_2025_strep_2_var267359	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.231034116272263			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	201099	F9_Popp_2025_heavy_chain_var238316	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.0869858322397092			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	X	139561821	G	A	9.1059e-7	201099	F9_Popp_2025_heavy_chain_var238316	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561821.0	139561821.0		1136			379.0	R	Q	c.1136G>A	p.Arg379Gln	missense_variant	1.0869858322397092			No	8.252833816811848e-7	Pathogenic	criteria provided, multiple submitters, no conflicts	Jun 05, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.631																																																											F9_Arg379Gln	Arg379Gln	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		237850	F9_Popp_2025_strep_2_var260939	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8272562915068931			No					aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		237850	F9_Popp_2025_strep_2_var260939	F9_Popp_2025_strep_2	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8272562915068931			No					aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		127786	F9_Popp_2025_carboxy_F9_specific_var222215	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	-0.018606189			No					aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		127786	F9_Popp_2025_carboxy_F9_specific_var222215	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	-0.018606189			No					aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		210334	F9_Popp_2025_light_chain_var241577	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8803589625521939			No					aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		210334	F9_Popp_2025_light_chain_var241577	F9_Popp_2025_light_chain	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8803589625521939			No					aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		155302	F9_Popp_2025_carboxy_gla_motif_var251258	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8322240601368638			No					aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		155302	F9_Popp_2025_carboxy_gla_motif_var251258	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8322240601368638			No					aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		182818	F9_Popp_2025_heavy_chain_var231896	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8068546545593508			No					aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
F9	F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																		182818	F9_Popp_2025_heavy_chain_var231896	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139537138.0	139537138.0		217			73.0	E	K	c.217G>A	p.Glu73Lys	missense_variant	0.8068546545593508			No					aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.966																																																											F9_Glu73Lys	Glu73Lys	true
BRCA1	BRCA1_His239Arg	1.417428348829569	0.1992960548370097	3.0457234726586315	0.018695506167409243	2025_01_Batch_13-14	0.9834822561252834	0.9312856180684361	0.9240071908703403	0.9549275984709393	0.9457601553816197	0.9743999370205588	0.915422187205631	0.9399060371844637	0.9666856808301896	0.9119806747411504	0.978941096572921	0.9233539026370335	0.931956614027402	0.9608066396505645	0.9288704150613851	1.0	0.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC013119		NC_000017.11:43094815:T:C		His239Arg																												BRCA1_His239Arg	17	43094815	T	C	17	allele	716A>G	G11	527_CAVA_Array_P01	M21	B13A7A8P1_R1	B14A7A8P1_R2				17-43094815-T-C	55677	17	43094815	T	C	H	R	rs80357396	17	41246832	17	38500358	239	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.716A>G	p.His239Arg	principal2	Y	.	.	.	-	CAT	2	0	T	T/T	T/T	T/T	T/T	.	0.32128	.	.	0.54888	.	0.246	0.31119	B	0.088	0.29689	B	.	0.37131	.	.	.	.	1.685	0.43087	L	.	0.47184	.	.	0.46309	-0.9591	0.39179	T	0.1025	0.37609	T	10	.	0.21054	.	0.091977	0.75728	D	.	0.84105	0.1	0.01473	E9PFC7	H239R	Gain of helix (P = 0.0496)| Loss of loop (P = 0.0603)| Gain of phosphorylation at S242 (P = 0.0822)| Gain of catalytic residue at H239 (P = 0.1099)| Loss of glycosylation at S242 (P = 0.135)	.	0.84735	.	0.23229	.	0.28222	0.27954185009	0.07426	T	0.185323	0.53598	T	0.239413	0.77438	D	0.12161	0.78181	D	0.148020625114441	0.16733	T	.	0.43633	.	0.035958365	0.04291	0.04630083	0.06439	0.035795223	0.04242	0.04520483	0.06046	-3.317	0.13969	T	.	0.10254	.	0.0751285277574732	0.40751	0.99015945	0.96756	0.062	0.17126	.	.	.	.	.	.	0.040361	0.04582	1.25	0.79293829124576731	0.12881	0.152364	0.27488	N	-0.571032691664479	0.19588	1.040847	-0.739922874726497	0.15702	0.8425785	4.64	-1.76	0.07559	2.57E-4	0.21563	-0.794	0.04696	-0.577000	0.08433	0.609	0.47831	0.004	0.16649	0.001000	0.17376	0.804	0.3794	494	0.76469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109054	9.169770e-06	0	2	206786	9.671830e-06	0	2	235362	8.497550e-06	0	0	7154	0.000000e+00	0	0	16994	0.000000e+00	0	0	2310	0.000000e+00	0	0	9020	0.000000e+00	0	0	13374	0.000000e+00	0	1	42666	2.343790e-05	0	0	15632	0.000000e+00	0	1	42666	2.343790e-05	0	0	15854	0.000000e+00	0	0	30300	0.000000e+00	0	0	6190	0.000000e+00	0	0	13376	0.000000e+00	0	0	16690	0.000000e+00	0	2	89080	2.245170e-05	0	0	30498	0.000000e+00	0	2	89080	2.245170e-05	0	0	14542	0.000000e+00	0	0	34032	0.000000e+00	0	0	9544	0.000000e+00	0	0	17632	0.000000e+00	0	0	21568	0.000000e+00	0	2	102084	1.959170e-05	0	0	30416	0.000000e+00	0	2	102084	1.959170e-05	0	.	5	1613714	3.098440e-06	0	5	1179908	4.237620e-06	0	0	74988	0.000000e+00	0	0	912	0.000000e+00	0	0	59900	0.000000e+00	0	0	29590	0.000000e+00	0	0	44872	0.000000e+00	0	0	63992	0.000000e+00	0	0	6060	0.000000e+00	0	5	1179908	4.237620e-06	0	0	91010	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43094815T>C	ClinGen:CA003832|UniProtKB:P38398#VAR_007760	C3661900|CN169374|C0677776|C2676676|C0027672	604370	145|145|140162	.	His	Arg	70344	single nucleotide variant	NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	672	BRCA1	HGNC:1100	Benign	0	Jun 18, 2019	80357396	-	RCV000112775|RCV000212160|RCV000509604|RCV001284302|RCV001339091|RCV004730865	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43094815	43094815	17q21.31	reviewed by expert panel	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003832,UniProtKB:P38398#VAR_007760	2	55677	43094815	T	C	-	-	-	-	-	-	SCV001161506	-	-	716A>G 	His239Arg	NM_007294.4	3	2_Benign																																																																																																									
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						173868	F9_Popp_2025_carboxy_gla_motif_var257775	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.9398747041555362			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						173868	F9_Popp_2025_carboxy_gla_motif_var257775	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.9398747041555362			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						146352	F9_Popp_2025_carboxy_F9_specific_var228732	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.915564746657142			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						146352	F9_Popp_2025_carboxy_F9_specific_var228732	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.915564746657142			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						201384	F9_Popp_2025_heavy_chain_var238413	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.8462483567545361			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						201384	F9_Popp_2025_heavy_chain_var238413	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.8462483567545361			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						256416	F9_Popp_2025_strep_2_var267456	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	1.0889826277544734			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						256416	F9_Popp_2025_strep_2_var267456	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	1.0889826277544734			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						228900	F9_Popp_2025_light_chain_var248094	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.9512012593519876			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
F9	F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic						228900	F9_Popp_2025_light_chain_var248094	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	L	c.1151G>T	p.Arg384Leu	missense_variant	0.9512012593519876			No		Pathogenic	no assertion criteria provided	Oct 22, 2009	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.566																																																											F9_Arg384Leu	Arg384Leu	true
BAP1	BAP1_Thr423Lys	-1.3565825611557805	0.21703700719903737	-4.239050177833455	0.003844822069613415	2025_01_Batch_13-14	0.5366318780047523	0.6153002905177806	0.7218464078878021	0.6202442813261588	0.5530089525647295	0.41782162844436666	0.4970009991935067	0.6379777085824948	0.607978353139027	0.4367129258942913	0.4772267532245595	0.5561506448556437	0.6799120582351484	0.6141113172325929	0.49486093922951035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009476		NC_000003.12:52403877:G:T		Thr423Lys																												BAP1_Thr423Lys	3	52403877	G	T	3	allele	1268C>A	G01	527_CAVA_Array_P01	M01	B13A7A8P1_R1	B14A7A8P1_R2				3-52403877-G-T	240045	3	52403877	G	T	T	K	rs115109161	3	52437893	3	52412933	423	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.1268C>A	p.Thr423Lys	c.1268C>A	p.Thr423Lys	principal1	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.034	0.44516	D	0.017	0.60671	D	0.002	0.09864	B	0.002	0.06938	B	0.06	0.18971	N	simple_aae	94.0	6.0	0	0.06502	N	-1.03	0.27007	N	0.324	0.37371	-1.0250	0.22040	T	0.0638	0.26280	T	10	0.007293403	0.00163	T	.	.	.	0.054	0.15198	.	.	.	.	.	0.671732637855	0.66638	0.19555129210449032	0.19291	0.453964407394	0.44793	0.347844183445	0.17586	T	0.024049	0.18095	T	-0.488477	0.00629	T	-0.472382	0.24913	T	0.00967223067305719	0.00125	T	0.729627	0.34303	T	0.07225229	0.15912	0.09052727	0.21201	0.0865195	0.19931	0.09277198	0.21846	-0.415	0.00535	T	0.0922	0.16120	B	0.0551843815255829	0.38039	0.99352360	0.97351	0.092	0.25882	.	.	.	.	.	.	2.376386	0.30551	18.46	0.974649564021286	0.34277	0.073686	0.14558	N	-0.147163113713975	0.35080	2.029722	0.0881182991556912	0.43669	2.686219	6.04	5.1	0.68875	3.9	0.73887	2.575	0.4579	6.351000	0.55560	0.676	0.76753	0.94	0.32731	1.000000	0.68239	0.994	0.71086	68	0.97129	16	0.003194888178913738	16	0.012102874432677761	0	0.0	0	0.0	0	0.0	0	0.0	445	264690	0.001681212	.	52	109312	4.757030e-04	0	93	207980	4.471580e-04	0	91	236828	3.842450e-04	0	43	7164	6.002230e-03	0	8	17106	4.676720e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13304	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	43	7164	6.002230e-03	0	79	16212	4.872930e-03	0	12	30518	3.932110e-04	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16644	0.000000e+00	0	1	89508	1.117220e-05	0	0	30608	0.000000e+00	0	79	16212	4.872930e-03	0	75	14902	5.032880e-03	0	14	34252	4.087350e-04	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21542	0.000000e+00	0	1	102726	9.734630e-06	0	0	30526	0.000000e+00	0	75	14902	5.032880e-03	0	.	427	1614100	2.645440e-04	3	363	75032	4.837940e-03	3	363	75032	4.837940e-03	3	0	912	0.000000e+00	0	31	60026	5.164430e-04	0	0	29598	0.000000e+00	0	0	44890	0.000000e+00	0	0	63940	0.000000e+00	0	0	6062	0.000000e+00	0	11	1180040	9.321720e-06	0	0	91088	0.000000e+00	0	1	173836	5.752548378931867E-6	3	360	0.008333333333333333	0	4504	0	32	9418	0.0033977489912932683	1	796	0.001256281407035176	0	974	0	0	1850	0	0	280	0	4	17418	2.2964749110115972E-4	35	9778	0.003579464103088566	0	6354	0	41	209436	1.9576386103630704E-4	Benign/Likely_benign	not_specified|BAP1-related_tumor_predisposition_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome|Melanoma,_uveal,_susceptibility_to,_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52403877G>T	ClinGen:CA2436837	CN169374|C3280492|C3661900|C0027672|C1847723	614327|606661	289539|140162|39044	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Thr	Lys	239268	single nucleotide variant	NM_004656.4(BAP1):c.1268C>A (p.Thr423Lys)	8314	BAP1	HGNC:950	Benign/Likely benign	0	Feb 04, 2025	115109161	-	RCV000228893|RCV000563367|RCV000844571|RCV001818616|RCV003316284	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Melanoma, uveal, susceptibility to, 2	germline;unknown	germline	GRCh38	NC_000003.12	3	52403877	52403877	3p21.1	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA2436837	2	240045	52403877	G	T	-	-	-	-	-	-	SCV000288737|SCV000445471|SCV000664594|SCV000682561|SCV000986622|SCV002064677|SCV002537251|SCV004016346|SCV005404632	-	-	1268C>A 	Thr423Lys	NM_004656.4	2	2_Benign																																																																																																									
BRCA1	BRCA1_Cys61Gly	0.9686368160707995	0.36499496144588084	4.370983692104869	0.003270140985358988	2025_01_Batch_13-14	0.9816626134163468	0.9382680897369753	0.9381794369642189	0.9675114203479335	0.8882441185541432	0.94979174340731	0.83386982555295	0.8932073113961976	0.9429165361361207	0.9062998562885225	0.9657271784118284	0.8860689576449626	0.9156933741802082	0.955213978242027	0.8972719874213329	1.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC011874		NC_000017.11:43106487:A:C		Cys61Gly																												BRCA1_Cys61Gly	17	43106487	A	C	17	allele	181T>G	D10	527_CAVA_Array_P01	G19	B13A7A8P1_R1	B14A7A8P1_R2				17-43106487-A-C	17661	17	43106487	A	C	C	G	rs28897672	17	41258504	17	38512030	61	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.181T>G	p.Cys61Gly	c.181T>G	p.Cys61Gly	principal2	Y	1	.	.	-	TGT	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.116	0.77914	B	0.026	0.82066	B	.	0.99291	.	.	.	.	4.355	0.98454	H	-2.81	0.99397	D	.	0.99781	0.9506	0.96392	D	0.9929	0.99832	D	10	0.99176705	0.99706	D	0.963103	0.99761	D	0.948	0.98989	0.995	0.99946	E9PFC7	C61G	Gain of disorder (P = 0.0488)| Loss of stability (P = 0.105)| Gain of phosphorylation at S59 (P = 0.1362)| Loss of methylation at K56 (P = 0.1519)| Gain of glycosylation at P62 (P = 0.1609)	0.998499671764	0.99845	.	0.90513	.	0.44456	0.648884236813	0.59765	T	0.479885	0.92979	T	0.433365	0.91638	D	0.565018	0.95972	D	0.983885645866394	0.75212	D	.	0.85963	.	0.9937476	0.99925	0.9444327	0.98025	0.98292416	0.99313	0.9264142	0.96801	-14.65	0.98194	D	0.9865	0.94756	LP	0.998778029465221	0.95035	0.99978560	0.99726	0.984	0.99450	.	.	.	.	.	.	4.174515	0.62863	24.5	0.98518170788822967	0.42557	0.869181	0.78883	D	0.838128507262834	0.88357	9.572342	0.742507123425794	0.85517	8.62807	5.17	5.17	0.70808	5.61	0.95042	5.098	0.64462	11.169000	0.87924	0.667	0.69024	1.0	0.71675	1.000000	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	4	109170	3.664010e-05	0	7	207470	3.373980e-05	0	6	236276	2.539400e-05	0	0	7152	0.000000e+00	0	0	17022	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	1	13390	7.468260e-05	0	3	42724	7.021810e-05	0	0	15618	0.000000e+00	0	3	42724	7.021810e-05	0	0	16132	0.000000e+00	0	0	30412	0.000000e+00	0	0	6194	0.000000e+00	0	0	13404	0.000000e+00	0	1	16718	5.981580e-05	0	6	89312	6.718020e-05	0	0	30448	0.000000e+00	0	6	89312	6.718020e-05	0	0	14822	0.000000e+00	0	0	34140	0.000000e+00	0	0	9556	0.000000e+00	0	0	17674	0.000000e+00	0	1	21614	4.626630e-05	0	5	102510	4.877570e-05	0	0	30366	0.000000e+00	0	5	102510	4.877570e-05	0	.	30	1604818	1.869370e-05	0	28	1172588	2.387880e-05	0	0	74730	0.000000e+00	0	0	912	0.000000e+00	0	0	59940	0.000000e+00	0	0	29524	0.000000e+00	0	0	44766	0.000000e+00	0	1	63978	1.563040e-05	0	0	5856	0.000000e+00	0	28	1172588	2.387880e-05	0	0	90418	0.000000e+00	0	0	10344	0	0	144	0	0	88	0	0	4314	0	0	154	0	0	616	0	0	28	0	0	98	0	0	860	0	0	4458	0	0	116	0	0	16646	0	Pathogenic	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_carcinoma|Breast_neoplasm|Ovarian_neoplasm	reviewed_by_expert_panel	NC_000017.11:g.43106487A>C	BRCA1-HCI:BRCA1_00099|ClinGen:CA001182|OMIM:113705.0002|UniProtKB:P38398#VAR_007757	C2676676|C0346153|C0027672|CN221562|C3661900|C3280442|C4554406|C0677776|C0678222|C1458155|C0919267	604370|114480|614320|617883	145|227535|140162|1333|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Gly	32700	single nucleotide variant	NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	28897672	-	RCV000019229|RCV000415051|RCV000159935|RCV000239114|RCV000047597|RCV000131902|RCV000412714|RCV001270967|RCV000785199|RCV005003390|RCV004802937	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106487	43106487	17q21.31	reviewed by expert panel	59	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:113705.0002,BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757	3	17661	43106487	A	C	-	-	-	-	-	-	SCV000244308	-	-	181T>G 	Cys61Gly	NM_007294.4	3	1_Pathogenic																																																																																																									
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	223948	F9_Popp_2025_light_chain_var246396	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.0817989057893431			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	223948	F9_Popp_2025_light_chain_var246396	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.0817989057893431			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	251464	F9_Popp_2025_strep_2_var265758	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.128190842767414			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	251464	F9_Popp_2025_strep_2_var265758	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.128190842767414			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	196432	F9_Popp_2025_heavy_chain_var236715	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.06892381			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	196432	F9_Popp_2025_heavy_chain_var236715	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.06892381			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	168916	F9_Popp_2025_carboxy_gla_motif_var256077	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.0448265944586022			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	168916	F9_Popp_2025_carboxy_gla_motif_var256077	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.0448265944586022			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	141400	F9_Popp_2025_carboxy_F9_specific_var227034	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.0177519699244646			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
F9	F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368683	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586485	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	X	139561592	C	T	0.000794178	141400	F9_Popp_2025_carboxy_F9_specific_var227034	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561592.0	139561592.0		907			303.0	H	Y	c.907C>T	p.His303Tyr	missense_variant	1.0177519699244646			No	0.0007593360617482	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Jan 29, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.549																																																											F9_His303Tyr	His303Tyr	true
KRAS	KRAS_Met72Leu	-2.4492678134739627	0.04415464746417742	4.235830569813894	0.0038601676600614906																											true	KRAS	ENSG00000133703	3084	214491	CCSBVarC006100	ALE00006100	NC_000012.12:25227310:T:G	214A>C	Met72Leu	CEGS2	CegsMutGDEh1041	F08	GDEhDisVCh_40061	B10	1	CegsMutGDDh1041	F08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Met72Leu	12	25227310	T	G	12											12-25227310-T-G	1016209	12	25227310	T	G	M	L	rs727504662	12	25380244	12	25271511	72	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.214A>C	p.Met72Leu	c.214A>C	p.Met72Leu	alternative1	Y	1	.	Plus_Clinical	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.029	0.46288	D	0.083	0.41751	T	0.236	0.30787	B	0.256	0.39260	B	0.97	0.96253	D	simple_aae	3.0	97.0	0.855	0.21196	L	-2.55	0.55206	D	0.755	0.75268	-0.4018	0.71845	T	0.3464	0.71002	T	10	0.6263549	0.67986	D	0.0458	0.62008	D	0.658	0.87125	0.665	0.80215	P01116	M72L	Gain of catalytic residue at T74 (P = 0.0197)| Loss of phosphorylation at Y71 (P = 0.0909)| Loss of disorder (P = 0.0926)| Loss of helix (P = 0.2271)| Loss of sheet (P = 0.302)	0.869051532231	0.86675	0.8560956093177353	0.85484	1.59547003884	0.88549	0.892316937447	0.95540	D	0.810422	0.95217	D	0.353299	0.86638	D	0.269713	0.86464	D	0.740672528743744	0.42477	D	0.939506	0.77609	D	0.9555017	0.96774	0.87500864	0.93122	0.9538084	0.96601	0.89415234	0.94486	-8.664	0.66608	D	0.8556	0.80172	P	0.999925671145259	0.98892	0.99469410	0.97604	0.986	0.99524	.	.	.	.	.	.	4.690966	0.75207	26.3	0.97578417483957014	0.34888	0.885317	0.81506	D	0.259874108519936	0.53898	3.579291	0.425460968171894	0.62956	4.543828	5.77	5.77	0.91065	3.95	0.75212	8.004	0.88091	7.919000	0.74463	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.999	0.91597	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy	criteria_provided,_single_submitter	NC_000012.12:g.25227310T>G	.	C5555857	.	536391	Small GTP-binding domain	Met	Leu	1010371	single nucleotide variant	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	3845	KRAS	HGNC:6407	Likely pathogenic	1	Jun 19, 2022	727504662	-	RCV001315183	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227310	25227310	12p12.1	criteria provided, single submitter	1	-	N	ClinGen:CA384151976	2	1016209	25227310	T	G	-	-	-	-	-	-	SCV001505744	-	-	214A>C 	Met72Leu	NM_004985.5	1	1_Pathogenic																																																																																																									
KRAS	KRAS_Met72Leu	-2.4492678134739627	0.04415464746417742	4.235830569813894	0.0038601676600614906																											true	KRAS		3084		CCSBVarC006100		NC_000012.12:25227310:T:G		Met72Leu																												KRAS_Met72Leu	12	25227310	T	G	12	allele	214A>C	C08	527_CAVA_Array_P03	F15	B13A7A8P1_R1	B14A7A8P1_R2				12-25227310-T-G	1016209	12	25227310	T	G	M	L	rs727504662	12	25380244	12	25271511	72	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.214A>C	p.Met72Leu	c.214A>C	p.Met72Leu	alternative1	Y	1	.	Plus_Clinical	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.029	0.46288	D	0.083	0.41751	T	0.236	0.30787	B	0.256	0.39260	B	0.97	0.96253	D	simple_aae	3.0	97.0	0.855	0.21196	L	-2.55	0.55206	D	0.755	0.75268	-0.4018	0.71845	T	0.3464	0.71002	T	10	0.6263549	0.67986	D	0.0458	0.62008	D	0.658	0.87125	0.665	0.80215	P01116	M72L	Gain of catalytic residue at T74 (P = 0.0197)| Loss of phosphorylation at Y71 (P = 0.0909)| Loss of disorder (P = 0.0926)| Loss of helix (P = 0.2271)| Loss of sheet (P = 0.302)	0.869051532231	0.86675	0.8560956093177353	0.85484	1.59547003884	0.88549	0.892316937447	0.95540	D	0.810422	0.95217	D	0.353299	0.86638	D	0.269713	0.86464	D	0.740672528743744	0.42477	D	0.939506	0.77609	D	0.9555017	0.96774	0.87500864	0.93122	0.9538084	0.96601	0.89415234	0.94486	-8.664	0.66608	D	0.8556	0.80172	P	0.999925671145259	0.98892	0.99469410	0.97604	0.986	0.99524	.	.	.	.	.	.	4.690966	0.75207	26.3	0.97578417483957014	0.34888	0.885317	0.81506	D	0.259874108519936	0.53898	3.579291	0.425460968171894	0.62956	4.543828	5.77	5.77	0.91065	3.95	0.75212	8.004	0.88091	7.919000	0.74463	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.999	0.91597	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	RASopathy	criteria_provided,_single_submitter	NC_000012.12:g.25227310T>G	.	C5555857	.	536391	Small GTP-binding domain	Met	Leu	1010371	single nucleotide variant	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	3845	KRAS	HGNC:6407	Likely pathogenic	1	Jun 19, 2022	727504662	-	RCV001315183	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227310	25227310	12p12.1	criteria provided, single submitter	1	-	N	ClinGen:CA384151976	2	1016209	25227310	T	G	-	-	-	-	-	-	SCV001505744	-	-	214A>C 	Met72Leu	NM_004985.5	1	1_Pathogenic																																																																																																									
F9	F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	627177	X	139548378	T	C	I	T	rs1603265481	X	138630537	X	138458203	136	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.88180	D	10	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.93640	D	0.451294	0.93561	D	0.265829622745514	0.23290	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.91815137977279504	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.000000	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	615665	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158	F9	HGNC:3551	Likely pathogenic	1	Nov 01, 2024	1603265481	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378	139548378	Xq27.1	reviewed by expert panel	2	-	N	ClinGen:CA414438824	2	627177	139548378	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3	1_Pathogenic						159013	F9_Popp_2025_carboxy_gla_motif_var252573	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548378.0	139548378.0		407			136.0	I	T	c.407T>C	p.Ile136Thr	missense_variant	0.4832918637154912			No		Likely pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.634																																								627177.0	CA414438824	hemophilia B	MONDO:0010604	X-linked inheritance	Likely Pathogenic	PM2_Supporting,PS4,PM1,PP3		NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	Likely Pathogenic	PM2_Supporting,PS4,PM1	F9_Ile136Thr	Ile136Thr	true
F9	F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	627177	X	139548378	T	C	I	T	rs1603265481	X	138630537	X	138458203	136	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.88180	D	10	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.93640	D	0.451294	0.93561	D	0.265829622745514	0.23290	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.91815137977279504	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.000000	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	615665	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158	F9	HGNC:3551	Likely pathogenic	1	Nov 01, 2024	1603265481	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378	139548378	Xq27.1	reviewed by expert panel	2	-	N	ClinGen:CA414438824	2	627177	139548378	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3	1_Pathogenic						241561	F9_Popp_2025_strep_2_var262254	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548378.0	139548378.0		407			136.0	I	T	c.407T>C	p.Ile136Thr	missense_variant	0.6655233363014836			No		Likely pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.634																																								627177.0	CA414438824	hemophilia B	MONDO:0010604	X-linked inheritance	Likely Pathogenic	PM2_Supporting,PS4,PM1,PP3		NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	Likely Pathogenic	PM2_Supporting,PS4,PM1	F9_Ile136Thr	Ile136Thr	true
F9	F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	627177	X	139548378	T	C	I	T	rs1603265481	X	138630537	X	138458203	136	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.88180	D	10	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.93640	D	0.451294	0.93561	D	0.265829622745514	0.23290	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.91815137977279504	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.000000	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	615665	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158	F9	HGNC:3551	Likely pathogenic	1	Nov 01, 2024	1603265481	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378	139548378	Xq27.1	reviewed by expert panel	2	-	N	ClinGen:CA414438824	2	627177	139548378	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3	1_Pathogenic						214045	F9_Popp_2025_light_chain_var242892	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548378.0	139548378.0		407			136.0	I	T	c.407T>C	p.Ile136Thr	missense_variant	0.6736284772469037			No		Likely pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.634																																								627177.0	CA414438824	hemophilia B	MONDO:0010604	X-linked inheritance	Likely Pathogenic	PM2_Supporting,PS4,PM1,PP3		NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	Likely Pathogenic	PM2_Supporting,PS4,PM1	F9_Ile136Thr	Ile136Thr	true
F9	F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	627177	X	139548378	T	C	I	T	rs1603265481	X	138630537	X	138458203	136	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.88180	D	10	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.93640	D	0.451294	0.93561	D	0.265829622745514	0.23290	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.91815137977279504	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.000000	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	615665	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158	F9	HGNC:3551	Likely pathogenic	1	Nov 01, 2024	1603265481	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378	139548378	Xq27.1	reviewed by expert panel	2	-	N	ClinGen:CA414438824	2	627177	139548378	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3	1_Pathogenic						131497	F9_Popp_2025_carboxy_F9_specific_var223530	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548378.0	139548378.0		407			136.0	I	T	c.407T>C	p.Ile136Thr	missense_variant	0.5990003052119737			No		Likely pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.634																																								627177.0	CA414438824	hemophilia B	MONDO:0010604	X-linked inheritance	Likely Pathogenic	PM2_Supporting,PS4,PM1,PP3		NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	Likely Pathogenic	PM2_Supporting,PS4,PM1	F9_Ile136Thr	Ile136Thr	true
F9	F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	627177	X	139548378	T	C	I	T	rs1603265481	X	138630537	X	138458203	136	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.88180	D	10	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.93640	D	0.451294	0.93561	D	0.265829622745514	0.23290	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.91815137977279504	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.000000	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	615665	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158	F9	HGNC:3551	Likely pathogenic	1	Nov 01, 2024	1603265481	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378	139548378	Xq27.1	reviewed by expert panel	2	-	N	ClinGen:CA414438824	2	627177	139548378	T	C	-	-	-	-	-	-	SCV005437143	-	-	407T>C 	Ile136Thr	NM_000133.4	3	1_Pathogenic						186529	F9_Popp_2025_heavy_chain_var233211	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548378.0	139548378.0		407			136.0	I	T	c.407T>C	p.Ile136Thr	missense_variant	0.6038391908519662			No		Likely pathogenic	reviewed by expert panel	Nov 01, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.634																																								627177.0	CA414438824	hemophilia B	MONDO:0010604	X-linked inheritance	Likely Pathogenic	PM2_Supporting,PS4,PM1,PP3		NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	11/1/24	11/1/24	false	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c	Likely Pathogenic	PM2_Supporting,PS4,PM1	F9_Ile136Thr	Ile136Thr	true
BRCA1	BRCA1_Pro510Ser	1.2763374668476026	0.24254813146313225	4.261917325727006	0.003737738849101049	2025_01_Batch_13-14	0.9640036687223583	0.9118111337128814	0.9045387301347584	0.9339901222773391	0.9422400489874985	0.9842508167638085	0.9279514829560971	0.9366244489548248	0.9797877565913151	0.94228323593355	0.9741272427430834	0.9198813083344892	0.9205815895447915	0.9568889394343272	0.9422616424605242	1.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC013098		NC_000017.11:43071074:G:A		Pro510Ser																												BRCA1_Pro510Ser	17	43071074	G	A	17	allele	1528C>T	F11	527_CAVA_Array_P01	K21	B13A7A8P1_R1	B14A7A8P1_R2				17-43071074-G-A	55301	17	43071074	G	A	P	S	rs70953660	17	41223091	17	38476617	1614	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4840C>T	p.Pro1614Ser	c.4840C>T	p.Pro1614Ser	principal2	Y	1	YES	Select	-	CCA	1	0	G	G/G	G/G	G/G	G/G	0.074	0.34767	T	0.331	0.42259	T	0.001	0.11208	B	0.001	0.11213	B	0.2	0.44282	N	simple_aae	80.0	20.0	1.245	0.31258	L	-1.13	0.49862	N	0.197	0.28185	-0.7260	0.58992	T	0.3747	0.73191	T	10	0.013456136	0.00282	T	0.081866	0.73689	D	0.544	0.80920	.	.	.	.	.	0.445007932271	0.43742	.	0.22008	.	0.10213	0.220991373062	0.01370	T	0.118253	0.43590	T	-0.292457	0.09169	T	-0.197798	0.54546	T	0.00209908424908425	0.00022	T	.	0.52390	.	0.01818675	0.00340	0.03539876	0.02796	0.012395442	0.00033	0.035112027	0.02713	-2.617	0.09611	T	0.0853	0.14859	B	0.209477282755653	0.50387	0.99514270	0.97711	0.086	0.24271	.	.	.	.	.	.	0.15678	0.05499	1.947	0.41163095527126975	0.02973	0.128273	0.24383	N	-1.18046810113445	0.05234	0.241072	-1.24446342853677	0.05132	0.2478793	4.36	-1.9	0.07233	0.973	0.28966	-0.1	0.10995	0.294000	0.16973	-0.106	0.15547	0.0	0.06393	0.000000	0.08389	0.008	0.08289	543	0.72771	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	187	264690	7.064868E-4	.	25	109408	2.285020e-04	0	44	208130	2.114060e-04	0	43	236858	1.815430e-04	0	24	7164	3.350080e-03	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	24	7164	3.350080e-03	0	41	16218	2.528060e-03	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	41	16218	2.528060e-03	0	38	14902	2.549990e-03	0	4	34260	1.167540e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102658	9.741080e-06	0	0	30526	0.000000e+00	0	38	14902	2.549990e-03	0	.	178	1614124	1.102770e-04	0	156	75024	2.079330e-03	0	156	75024	2.079330e-03	0	0	910	0.000000e+00	0	7	60006	1.166550e-04	0	0	29602	0.000000e+00	0	0	44892	0.000000e+00	0	0	64026	0.000000e+00	0	0	6062	0.000000e+00	0	4	1180006	3.389810e-06	0	0	91088	0.000000e+00	0	0	163048	0	0	360	0	0	4502	0	13	9362	0.0013885921811578722	0	442	0	0	950	0	0	1848	0	0	280	0	1	13148	7.6057195010648E-5	13	9722	0.0013371734211067683	0	6350	0	14	193940	7.218727441476746E-5	Benign	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer	reviewed_by_expert_panel	NC_000017.11:g.43071074G>A	BRCA1-HCI:BRCA1_00089|ClinGen:CA003048	C3661900|CN169374|C0677776|C0027672|C2676676|CN221562	604370	145|140162|145	.	Pro	Ser	69968	single nucleotide variant	NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	70953660	-	RCV000048676|RCV000112411|RCV000162988|RCV000167771|RCV001811342|RCV003492390	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	43071074	43071074	17q21.31	reviewed by expert panel	13	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00089,ClinGen:CA003048	2	55301	43071074	G	A	-	-	-	-	-	-	SCV000244370	-	-	4840C>T 	Pro1614Ser	NM_007294.4	3	2_Benign																																																																																																									
SOS2	SOS2_Val869Ile	-1.6906881260572169	0.13473984727334107	24.562323565003886	4.723899389812003e-8	2025_01_Batch_13-14	0.660541002024487	0.9818388517981322	0.9961885034785765	0.9811042106268615	0.6985221185630515	0.7995106102292324	0.9874451617829887	0.9972769546312914	0.9931706805698124	0.7139928785959548	0.7300258061268596	0.9846420067905605	0.9967327290549339	0.9871374455983369	0.7062574985795032	0.0	1.0	1.0	1.0	0.0	0.0	1.0	1.0	0.0	0.0	true	SOS2		55187		CCSBVarC013733		NC_000014.9:50145232:C:T		Val869Ile																												SOS2_Val869Ile	14	50145232	C	T	14	allele	2605G>A	A03	527_CAVA_Array_P06	A06	B13A7A8P2_R1	B14A7A8P2_R2				14-50145232-C-T	578603	14	50145232	C	T	V	I	rs373143128	14	50611950	14	49681700	869	SOS2	ENSG00000100485	ENST00000216373	ENSP00000216373	Q07890	SOS2_HUMAN	c.2605G>A	p.Val869Ile	c.2605G>A	p.Val869Ile	principal1	Y	1	YES	Select	-	GTA	1	0	C	C/C	C/C	C/C	C/C	0.186	0.21830	T	0.193	0.28516	T	0.806	0.45244	P	0.067	0.27544	B	0.03	0.13669	N	simple_aae	97.0	3.0	1.69	0.43161	L	-0.57	0.17141	N	0.62	0.64125	-1.0875	0.05974	T	0.0626	0.25856	T	10	0.033977717	0.01592	T	0.00909	0.23643	T	0.119	0.32934	.	.	.	.	.	0.287411543184	0.27937	0.29752872176459394	0.29466	0.438499540432	0.43595	0.60063201189	0.52926	T	0.261454	0.63086	T	-0.250105	0.13817	T	-0.337356	0.40293	T	0.0685817938580168	0.08353	T	0.980102	0.93270	D	0.13867286	0.31788	0.11979879	0.28843	0.14083904	0.32200	0.11895819	0.28644	-11.018	0.79822	D	0.1295	0.27854	B	0.330054574296633	0.55316	0.93892770	0.92805	0.24	0.50956	.	.	.	.	.	.	4.283071	0.65331	24.8	0.99145193650800156	0.53732	0.819462	0.73952	D	0.283462274563088	0.55083	3.695113	0.376110327940654	0.59881	4.193457	5.64	4.74	0.59667	3.55	0.64634	7.851	0.85271	7.653000	0.63864	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.997	0.79771	467	0.78304	.	.	.	.	.	.	.	.	.	.	.	.	33	264690	1.2467414E-4	.	20	109304	1.829760e-04	0	40	207850	1.924460e-04	1	62	236538	2.621140e-04	1	0	7156	0.000000e+00	0	2	17068	1.171780e-04	0	11	2318	4.745470e-03	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	7	42762	1.636970e-04	0	0	15650	0.000000e+00	0	7	42762	1.636970e-04	0	0	16182	0.000000e+00	0	2	30470	6.563830e-05	0	21	6208	3.382730e-03	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	15	89446	1.676990e-04	0	0	30546	0.000000e+00	0	15	89446	1.676990e-04	0	0	14866	0.000000e+00	0	2	34194	5.848980e-05	0	39	9564	4.077790e-03	0	0	17690	0.000000e+00	0	0	21622	0.000000e+00	0	18	102542	1.755380e-04	0	0	30464	0.000000e+00	0	18	102542	1.755380e-04	0	.	208	1610334	1.291660e-04	1	111	29576	3.753040e-03	0	0	74774	0.000000e+00	0	0	912	0.000000e+00	0	4	59956	6.671560e-05	0	111	29576	3.753040e-03	0	0	44786	0.000000e+00	0	0	63994	0.000000e+00	0	4	6070	6.589790e-04	0	73	1176958	6.202430e-05	0	3	90944	3.298730e-05	1	15	42740	3.5095928872250817E-4	0	306	0	0	112	0	0	8044	0	0	500	0	0	628	0	0	56	0	0	98	0	3	8298	3.6153289949385393E-4	0	8350	0	0	168	0	18	60782	2.9614030469546907E-4	Benign/Likely_benign	not_specified|SOS2-related_disorder|Noonan_syndrome_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50145232C>T	.	CN169374|C4225282	616559	648	Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain	Val	Ile	572804	single nucleotide variant	NM_006939.4(SOS2):c.2605G>A (p.Val869Ile)	6655	SOS2	HGNC:11188	Benign/Likely benign	0	Jan 05, 2025	373143128	-	RCV002282338|RCV003928173|RCV000701667	MedGen:CN169374||MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648	not specified|SOS2-related disorder|Noonan syndrome 9	germline	germline	GRCh38	NC_000014.9	14	50145232	50145232	14q21.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA7177001	2	578603	50145232	C	T	-	-	-	-	-	-	SCV000830479|SCV002572201|SCV002763034	-	-	2605G>A 	Val869Ile	NM_006939.4	2	2_Benign																																																																																																									
BRAF	BRAF_Glu501Val	0.06923700484882474	0.9467373185822208	0.8012197285196747	0.4493411824264216	2025_01_Batch_13-14	0.668419559676502	0.5162034704749344	0.6813451882258486	0.6066647733033534	0.6591434827390193	0.42454478615755165	0.5487894135502444	0.6491343945467217	0.5577070481243924	0.4399151595971117	0.5464821729170268	0.5324964420125894	0.6652397913862851	0.5821859107138729	0.5495293211680655	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220607	CCSBVarC003169	ALE00003169	NC_000007.14:140778006:T:A	1502A>T	Glu501Val	CEGS2	CegsMutGDEh1028	A12	GDEhDisVCh_40058	G10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Glu501Val	7	140778006	T	A	7											7-140778006-T-A	40374	7	140778006	T	A	E	V	rs180177039	7	140477806	7	140124275	501	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1502A>T	p.Glu501Val	c.1502A>T	p.Glu501Val	principal4	Y	.	YES	Select	-	GAA	2	0	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97016	.	.	.	.	3.175	0.88626	M	.	.	.	.	.	0.4949	0.90439	D	0.6087	0.86082	D	10	0.9891212	0.99356	D	0.575626	0.96172	D	.	0.99995	0.984	0.99843	P15056	E501V	Gain of MoRF binding (P = 0.016)| Gain of methylation at K499 (P = 0.0368)| Gain of catalytic residue at Q496 (P = 0.0688)| Loss of disorder (P = 0.1462)| Loss of ubiquitination at K499 (P = 0.255)	.	0.99555	.	0.97864	.	0.96099	0.905288159847	0.97002	D	0.959346	0.99462	D	0.583525	0.97036	D	0.600417	0.96988	D	0.999093770980835	0.96125	D	0.984901	0.94804	D	0.970521	0.98280	0.8958858	0.94611	0.9600396	0.97241	0.9024512	0.95083	-13.783	0.92345	D	0.9998	0.99795	P	0.999948727464199	0.99079	0.99934202	0.99310	1	0.99985	.	.	.	.	.	.	5.908522	0.94033	33.0	0.99046473600024798	0.51225	0.901308	0.84728	D	0.603356423307565	0.73242	5.957777	0.588108124975153	0.73943	6.077588	4.96	4.96	0.65108	.	.	7.981	0.87756	7.857000	0.71293	0.605	0.46302	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778006T>A	ClinGen:CA280013	C1275081|C3661900|C5555857|CN029449	PS115150|115150	1340|536391|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Val	48844	single nucleotide variant	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	May 18, 2022	180177039	-	RCV000037924|RCV001852671|RCV000033318|RCV001775071	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiofaciocutaneous syndrome 1	germline;unknown	germline	GRCh38	NC_000007.14	7	140778006	140778006	7q34	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA280013	2	40374	140778006	T	A	-	-	-	-	-	-	SCV000057223|SCV000061588|SCV002011970|SCV002233097	-	-	1502A>T 	Glu501Val	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Glu501Val	0.06923700484882474	0.9467373185822208	0.8012197285196747	0.4493411824264216	2025_01_Batch_13-14	0.668419559676502	0.5162034704749344	0.6813451882258486	0.6066647733033534	0.6591434827390193	0.42454478615755165	0.5487894135502444	0.6491343945467217	0.5577070481243924	0.4399151595971117	0.5464821729170268	0.5324964420125894	0.6652397913862851	0.5821859107138729	0.5495293211680655	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003169		NC_000007.14:140778006:T:A		Glu501Val																												BRAF_Glu501Val	7	140778006	T	A	7	allele	1502A>T	G04	527_CAVA_Array_P01	M07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778006-T-A	40374	7	140778006	T	A	E	V	rs180177039	7	140477806	7	140124275	501	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1502A>T	p.Glu501Val	c.1502A>T	p.Glu501Val	principal4	Y	.	YES	Select	-	GAA	2	0	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97016	.	.	.	.	3.175	0.88626	M	.	.	.	.	.	0.4949	0.90439	D	0.6087	0.86082	D	10	0.9891212	0.99356	D	0.575626	0.96172	D	.	0.99995	0.984	0.99843	P15056	E501V	Gain of MoRF binding (P = 0.016)| Gain of methylation at K499 (P = 0.0368)| Gain of catalytic residue at Q496 (P = 0.0688)| Loss of disorder (P = 0.1462)| Loss of ubiquitination at K499 (P = 0.255)	.	0.99555	.	0.97864	.	0.96099	0.905288159847	0.97002	D	0.959346	0.99462	D	0.583525	0.97036	D	0.600417	0.96988	D	0.999093770980835	0.96125	D	0.984901	0.94804	D	0.970521	0.98280	0.8958858	0.94611	0.9600396	0.97241	0.9024512	0.95083	-13.783	0.92345	D	0.9998	0.99795	P	0.999948727464199	0.99079	0.99934202	0.99310	1	0.99985	.	.	.	.	.	.	5.908522	0.94033	33.0	0.99046473600024798	0.51225	0.901308	0.84728	D	0.603356423307565	0.73242	5.957777	0.588108124975153	0.73943	6.077588	4.96	4.96	0.65108	.	.	7.981	0.87756	7.857000	0.71293	0.605	0.46302	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778006T>A	ClinGen:CA280013	C1275081|C3661900|C5555857|CN029449	PS115150|115150	1340|536391|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Val	48844	single nucleotide variant	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	May 18, 2022	180177039	-	RCV000037924|RCV001852671|RCV000033318|RCV001775071	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiofaciocutaneous syndrome 1	germline;unknown	germline	GRCh38	NC_000007.14	7	140778006	140778006	7q34	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA280013	2	40374	140778006	T	A	-	-	-	-	-	-	SCV000057223|SCV000061588|SCV002011970|SCV002233097	-	-	1502A>T 	Glu501Val	NM_004333.6	2	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Thr37Lys	-0.25728289233865603	0.80435939653231	4.817455604826412	0.0019270976461462776	2025_01_Batch_13-14	0.8174092776879838	0.9099221991247153	0.8751460309326402	0.8792001815247644	0.6670508282803029	0.9365262887156782	0.87455061964549	0.9119290812243445	0.9543367207758721	0.9395910456374548	0.876967783201831	0.8922364093851026	0.8935375560784924	0.9167684511503182	0.8033209369588789	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC011837		NC_000017.11:43115750:G:T		Thr37Lys																												BRCA1_Thr37Lys	17	43115750	G	T	17	allele	110C>A	G08	527_CAVA_Array_P01	M15	B13A7A8P1_R1	B14A7A8P1_R2				17-43115750-G-T	54131	17	43115750	G	T	T	K	rs80356880	17	41267767	17	38521293	37	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.110C>A	p.Thr37Lys	c.110C>A	p.Thr37Lys	principal2	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.979	0.90580	D	0.777	0.92348	P	0.99	0.99291	A	simple_aae	1.0	99.0	2.54	0.73893	M	-0.91	0.87019	N	0.909	0.91390	1.0434	0.97975	D	0.9155	0.97195	D	10	0.9803947	0.97988	D	0.597518	0.96439	D	0.823	0.94336	0.94	0.99178	E9PFC7	T37K	Gain of methylation at T37 (P = 0.0325)| Gain of disorder (P = 0.0355)| Gain of ubiquitination at T37 (P = 0.0369)| Loss of catalytic residue at T37 (P = 0.1105)| Loss of sheet (P = 0.1158)	0.980248173759	0.97984	.	0.87940	.	0.46547	0.74592012167	0.73798	T	0.4401	0.88719	T	0.478281	0.93590	D	0.449241	0.93510	D	0.992633044719696	0.83032	D	.	0.77715	.	0.9560325	0.96828	0.8919265	0.94327	0.96704304	0.97946	0.84243727	0.90882	-15.301	0.98159	D	0.9729	0.92484	P	0.992970792932514	0.89793	0.99969053	0.99611	0.962	0.98414	.	.	.	.	.	.	4.997611	0.82936	27.9	0.99301403670490562	0.58711	0.726971	0.67428	D	0.984277674482382	0.95215	13.43596	0.917667809072401	0.96277	14.52852	5.97	5.97	0.96929	.	.	4.401	0.59561	11.711000	0.94660	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43115750G>T	BRCA1-HCI:BRCA1_00112|ClinGen:CA000742	C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	114480|617883|604370|614320	145|227535|145|1333|140162	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Thr	Lys	68798	single nucleotide variant	NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80356880	-	RCV000111781|RCV000763401|RCV001378528|RCV002433536	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115750	43115750	17q21.31	reviewed by expert panel	7	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00112,ClinGen:CA000742	2	54131	43115750	G	T	-	-	-	-	-	-	SCV000244295	-	-	110C>A 	Thr37Lys	NM_007294.4	3	1_Pathogenic																																																																																																									
CTCF	CTCF_Arg567Leu	1.1800602714906496	0.2765194233427633	2.874101838925229	0.023851750906581655	2025_01_Batch_13-14	0.5725732678815956	0.4704783921339683	0.5519199379916447	0.518320484133521	0.5643612753700188	0.5955774829893721	0.605650616489998	0.5849473574915652	0.5631671404073328	0.5993680619022184	0.5840753754354838	0.5380645043119832	0.568433647741605	0.5407438122704269	0.5818646686361186	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010820		NC_000016.10:67628551:G:T		Arg567Leu																												CTCF_Arg567Leu	16	67628551	G	T	16	allele	1700G>T	D02	527_CAVA_Array_P02	G04	B13A7A8P1_R1	B14A7A8P1_R2				16-67628551-G-T	450577	16	67628551	G	T	R	L	rs761621858	16	67662454	16	66219955	567	CTCF	ENSG00000102974	ENST00000645699	ENSP00000495348	P49711	CTCF_HUMAN	c.1700G>T	p.Arg567Leu	c.1700G>T	p.Arg567Leu	principal4	Y	.	.	.	+	CGG	2	0	G	G/G	G/G	G/G	G/G	.	0.29555	.	.	0.29853	.	0.997	0.70687	D	0.993	0.81117	D	.	0.94378	.	.	.	.	1.59	0.40152	L	.	0.24626	.	.	0.90815	-0.0875	0.80295	T	0.5199	0.81993	D	10	0.6048416	0.66830	D	0.14978	0.83108	D	.	0.79046	0.52	0.62092	P49711	R567L	Loss of disorder (P = 0.0233)| Loss of glycosylation at T565 (P = 0.0575)| Loss of ubiquitination at K562 (P = 0.0666)| Loss of MoRF binding (P = 0.0734)| Loss of phosphorylation at T565 (P = 0.1284)	.	0.92815	.	0.88570	.	0.96651	0.925170183182	0.98690	D	0.711178	0.91685	D	0.317932	0.84211	D	0.218911	0.84006	D	0.84126740694046	0.49158	D	0.872913	0.60159	D	0.48211032	0.65717	0.3656615	0.61669	0.48211032	0.65717	0.3656615	0.61669	-8.963	0.67536	D	0.9523	0.88385	P	0.841414727856592	0.72676	0.95337390	0.93563	0.379	0.63130	.	.	.	.	.	.	5.346011	0.89703	31.0	0.99840494751249931	0.92149	0.947009	0.95695	D	0.451229343520457	0.64086	4.67813	0.577215871047949	0.73164	5.949525	5.72	5.72	0.89363	4.59	0.85410	9.972	0.99137	11.725000	0.94893	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67628551G>T	ClinGen:CA396321079	CN517202	.	.	.	Arg	Leu	445598	single nucleotide variant	NM_006565.4(CTCF):c.1700G>T (p.Arg567Leu)	10664	CTCF	HGNC:13723	Likely benign	0	Dec 18, 2020	761621858	-	RCV000521064	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	67628551	67628551	16q22.1	criteria provided, single submitter	1	-	N	ClinGen:CA396321079	2	450577	67628551	G	T	-	-	-	-	-	-	SCV000619177	-	-	1700G>T 	Arg567Leu	NM_006565.4	1	2_Benign																																																																																																									
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						201414	F9_Popp_2025_heavy_chain_var238424	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.9618802619983524			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						201414	F9_Popp_2025_heavy_chain_var238424	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.9618802619983524			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						228930	F9_Popp_2025_light_chain_var248105	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.8699484344005443			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						228930	F9_Popp_2025_light_chain_var248105	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.8699484344005443			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						173898	F9_Popp_2025_carboxy_gla_motif_var257786	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.8635991262506653			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						173898	F9_Popp_2025_carboxy_gla_motif_var257786	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.8635991262506653			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						256446	F9_Popp_2025_strep_2_var267467	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	1.144264790037835			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						256446	F9_Popp_2025_strep_2_var267467	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	1.144264790037835			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						146382	F9_Popp_2025_carboxy_F9_specific_var228743	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.852812671			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
F9	F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic						146382	F9_Popp_2025_carboxy_F9_specific_var228743	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561836.0	139561836.0		1151			384.0	R	P	c.1151G>C	p.Arg384Pro	missense_variant	0.852812671			No		Pathogenic	no assertion criteria provided	Aug 04, 2016	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.614																																																											F9_Arg384Pro	Arg384Pro	true
ZC4H2	ZC4H2_Cys192Tyr	-5.160461914766019	0.03556021322527632																													true	ZC4H2		4320		CCSBVarC009185		NC_000023.11:64917883:C:T		Cys192Tyr																												ZC4H2_Cys192Tyr	23	64917883	C	T	X	allele	575G>A	H04	527_CAVA_Array_P06	O08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917883-C-T	1164068	X	64917883	C	T	C	Y	rs2147345743	X	64137763	X	64054488	192	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.575G>A	p.Cys192Tyr	c.575G>A	p.Cys192Tyr	principal1	Y	1	YES	Select	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	0.997	0.70687	D	0.995	0.83178	D	0.83	0.88920	D	simple_aae	17.0	83.0	.	.	.	-9.7	0.98608	D	0.899	0.91045	-0.9956	0.31030	T	0.1258	0.42921	T	8	0.93517613	0.92768	D	0.635824	0.96878	D	0.918	0.97887	0.657	0.79395	Q9NQZ6	C192Y	Gain of phosphorylation at C192 (P = 0.0524)| Gain of helix (P = 0.0854)| Gain of MoRF binding (P = 0.0968)| Gain of methylation at K187 (P = 0.1201)| Loss of ubiquitination at K187 (P = 0.1223)	0.935945739039	0.93478	0.9787259826617718	0.97853	3.87732945386	0.99863	0.936483502388	0.99313	D	0.84433	0.96370	D	0.544047	0.95487	D	0.54371	0.95419	D	0.999605476856232	0.98098	D	0.954504	0.82661	D	0.9578642	0.97018	0.96367556	0.99152	0.9578642	0.97018	0.96367556	0.99152	-16.676	0.98612	D	1.0	0.99952	P	0.999120994212341	0.95759	0.99780840	0.98515	0.999	0.99956	.	.	.	.	.	.	5.279833	0.88668	29.7	0.99718193828610802	0.81861	.	.	.	.	.	.	.	.	.	5.27	5.27	0.73761	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome,_female-restricted	no_assertion_criteria_provided	NC_000023.11:g.64917883C>T	.	C5393303	301041	.	Zinc finger C4H2-type	Cys	Tyr	1153067	single nucleotide variant	NM_018684.4(ZC4H2):c.575G>A (p.Cys192Tyr)	55906	ZC4H2	HGNC:24931	Pathogenic	1	May 13, 2021	2147345743	-	RCV001788550	MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	Wieacker-Wolff syndrome, female-restricted	de novo	germline	GRCh38	NC_000023.11	X	64917883	64917883	Xq11.2	no assertion criteria provided	1	-	N	ClinGen:CA413411258	2	1164068	64917883	C	T	-	-	-	-	-	-	SCV001712255	-	-	575G>A 	Cys192Tyr	NM_018684.4		1_Pathogenic																																																																																																									
BRAF	BRAF_Gly464Val	-4.383115862384623	0.003222238147491784	2.1555502654060805	0.06805360380374736	2025_01_Batch_13-14	0.748407048873009	0.8220743875740791	0.8607412739439905	0.8736790115577736	0.6191896953787797	0.7144551952637169	0.819553662058156	0.8129907446191675	0.7329588157391633	0.6091677969392397	0.7314311220683629	0.8208140248161175	0.836866009281579	0.8033189136484684	0.6141787461590097	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220600	CCSBVarC003158	ALE00003158	NC_000007.14:140781617:C:A	1391G>T	Gly464Val	CEGS2	CegsMutGDEh1009	F10	GDEhDisVCh_40058	G01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Gly464Val	7	140781617	C	A	7											7-140781617-C-A	40364	7	140781617	C	A	G	V	rs121913348	7	140481417	7	140127886	464	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1391G>T	p.Gly464Val	c.1391G>T	p.Gly464Val	principal4	Y	.	YES	Select	-	GGA	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.989	0.78402	D	.	0.99291	.	.	.	.	3.33	0.90723	M	.	.	.	.	.	1.0580	0.98290	D	0.9095	0.96994	D	10	0.9907639	0.99584	D	0.535553	0.95644	D	.	0.98743	0.987	0.99867	P15056	G464V	Loss of disorder (P = 0.0738)| Gain of MoRF binding (P = 0.081)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S465 (P = 0.1405)| Loss of loop (P = 0.2237)	.	0.98525	.	0.87595	.	0.96493	0.860752463341	0.91208	D	0.964298	0.99559	D	0.488804	0.93915	D	0.464356	0.93838	D	0.997959613800049	0.92787	D	0.835416	0.50397	T	0.99103737	0.99812	0.9789484	0.99787	0.98836577	0.99669	0.97783434	0.99754	-16.405	0.98310	D	0.9999	0.99795	P	0.999967477835789	0.99297	0.99925166	0.99245	1	0.99985	.	.	.	.	.	.	5.543189	0.91993	32.0	0.99831981023057448	0.91377	0.896613	0.83728	D	1.05336862643538	0.97152	15.69308	0.967625534540837	0.97885	16.98583	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	RASopathy|Neoplasm|Noonan_syndrome_and_Noonan-related_syndrome|not_provided|Non-small_cell_lung_carcinoma|Breast_neoplasm|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781617C>A	ClinGen:CA135076|UniProtKB:P15056#VAR_018616	C5555857|C0027651|C5681679|C3661900|C0007131|C1458155|CN029449	115150	536391|98733|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Val	48834	single nucleotide variant	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Jul 16, 2023	121913348	-	RCV000033302|RCV000037914|RCV001811232|RCV001813221|RCV002250499	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	RASopathy|Non-small cell lung carcinoma|not provided|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1	germline;somatic;unknown	germline/somatic	GRCh38	NC_000007.14	7	140781617	140781617	7q34	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	2	40364	140781617	C	A	-	-	-	-	-	-	SCV000061576|SCV000288405|SCV001471782|SCV002060473|SCV002521451|SCV005086395	-	-	1391G>T 	Gly464Val	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Gly464Val	-4.383115862384623	0.003222238147491784	2.1555502654060805	0.06805360380374736	2025_01_Batch_13-14	0.748407048873009	0.8220743875740791	0.8607412739439905	0.8736790115577736	0.6191896953787797	0.7144551952637169	0.819553662058156	0.8129907446191675	0.7329588157391633	0.6091677969392397	0.7314311220683629	0.8208140248161175	0.836866009281579	0.8033189136484684	0.6141787461590097	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003158		NC_000007.14:140781617:C:A		Gly464Val																												BRAF_Gly464Val	7	140781617	C	A	7	allele	1391G>T	F03	527_CAVA_Array_P01	K05	B13A7A8P1_R1	B14A7A8P1_R2				7-140781617-C-A	40364	7	140781617	C	A	G	V	rs121913348	7	140481417	7	140127886	464	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1391G>T	p.Gly464Val	c.1391G>T	p.Gly464Val	principal4	Y	.	YES	Select	-	GGA	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.989	0.78402	D	.	0.99291	.	.	.	.	3.33	0.90723	M	.	.	.	.	.	1.0580	0.98290	D	0.9095	0.96994	D	10	0.9907639	0.99584	D	0.535553	0.95644	D	.	0.98743	0.987	0.99867	P15056	G464V	Loss of disorder (P = 0.0738)| Gain of MoRF binding (P = 0.081)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S465 (P = 0.1405)| Loss of loop (P = 0.2237)	.	0.98525	.	0.87595	.	0.96493	0.860752463341	0.91208	D	0.964298	0.99559	D	0.488804	0.93915	D	0.464356	0.93838	D	0.997959613800049	0.92787	D	0.835416	0.50397	T	0.99103737	0.99812	0.9789484	0.99787	0.98836577	0.99669	0.97783434	0.99754	-16.405	0.98310	D	0.9999	0.99795	P	0.999967477835789	0.99297	0.99925166	0.99245	1	0.99985	.	.	.	.	.	.	5.543189	0.91993	32.0	0.99831981023057448	0.91377	0.896613	0.83728	D	1.05336862643538	0.97152	15.69308	0.967625534540837	0.97885	16.98583	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	RASopathy|Neoplasm|Noonan_syndrome_and_Noonan-related_syndrome|not_provided|Non-small_cell_lung_carcinoma|Breast_neoplasm|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781617C>A	ClinGen:CA135076|UniProtKB:P15056#VAR_018616	C5555857|C0027651|C5681679|C3661900|C0007131|C1458155|CN029449	115150	536391|98733|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Val	48834	single nucleotide variant	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Jul 16, 2023	121913348	-	RCV000033302|RCV000037914|RCV001811232|RCV001813221|RCV002250499	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	RASopathy|Non-small cell lung carcinoma|not provided|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1	germline;somatic;unknown	germline/somatic	GRCh38	NC_000007.14	7	140781617	140781617	7q34	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	2	40364	140781617	C	A	-	-	-	-	-	-	SCV000061576|SCV000288405|SCV001471782|SCV002060473|SCV002521451|SCV005086395	-	-	1391G>T 	Gly464Val	NM_004333.6	2	1_Pathogenic																																																																																																									
BAP1	BAP1_Asn290Ser	-0.3729935111171861	0.7201914707181801	0.08966665608823118	0.9310637601032032	2025_01_Batch_13-14	0.5102749202430317	0.4980858979057414	0.5608719049035955	0.5879716163221951	0.5234867851259092	0.6559667095793311	0.652278002395132	0.6505931948512813	0.7551754642481316	0.5767050617784881	0.5831208149111814	0.5751819501504367	0.6057325498774384	0.6715735402851634	0.5500959234521987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BAP1		3760		CCSBVarC009478		NC_000003.12:52405827:T:C		Asn290Ser																												BAP1_Asn290Ser	3	52405827	T	C	3	allele	869A>G	H01	527_CAVA_Array_P01	O01	B13A7A8P1_R1	B14A7A8P1_R2				3-52405827-T-C	472716	3	52405827	T	C	N	S	rs747079481	3	52439843	3	52414883	290	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.869A>G	p.Asn290Ser	c.869A>G	p.Asn290Ser	principal1	Y	1	YES	Select	-	AAC	2	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	0.697	0.05881	T	0.0	0.02950	B	0.0	0.01384	B	0.02	0.08015	N	simple_aae	98.0	2.0	-1.525	0.00486	N	-0.57	0.17141	N	0.027	0.00817	-1.0098	0.26903	T	0.0329	0.14050	T	10	0.004228443	0.00083	T	0.005388	0.13568	T	0.078	0.22615	0.356	0.35591	Q92560	N290S	Gain of relative solvent accessibility (P = 0.0024)| Gain of glycosylation at S285 (P = 0.0098)| Gain of solvent accessibility (P = 0.012)| Loss of sheet (P = 0.0228)| Gain of loop (P = 0.0502)	0.328222422547	0.32018	0.2007139702985778	0.19805	0.297888856719	0.31871	0.235256686807	0.02381	T	0.021852	0.16819	T	-0.644951	0.00076	T	-0.70131	0.05566	T	0.0150392539939985	0.00323	T	0.616438	0.23328	T	0.020683967	0.00634	0.020063097	0.00119	0.024449877	0.01269	0.018665047	0.00063	-2.044	0.03355	T	0.048	0.00099	B	4.71611775438763e-05	0.01873	0.94490990	0.93104	0.033	0.07179	.	.	.	.	.	.	1.173624	0.15654	11.99	0.76300458640983959	0.11599	0.027530	0.02227	N	-1.10195154957138	0.06531	0.3046936	-0.841934346995282	0.13249	0.6995833	5.38	3.55	0.39700	-0.00352	0.21537	0.83	0.27208	2.762000	0.34693	-1.018	0.01749	0.826	0.30165	0.995000	0.32549	0.841	0.39729	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	72	264690	2.7201633E-4	.	68	109402	6.215610e-04	0	118	208070	5.671170e-04	0	122	236922	5.149370e-04	0	0	7164	0.000000e+00	0	67	17112	3.915380e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	67	17112	3.915380e-03	0	0	16214	0.000000e+00	0	115	30522	3.767770e-03	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16730	0.000000e+00	0	0	89508	0.000000e+00	0	0	30608	0.000000e+00	0	115	30522	3.767770e-03	0	0	14898	0.000000e+00	0	119	34258	3.473640e-03	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21628	0.000000e+00	0	0	102730	0.000000e+00	0	0	30526	0.000000e+00	0	119	34258	3.473640e-03	0	.	147	1613970	9.107980e-05	0	143	60004	2.383170e-03	0	1	74936	1.334470e-05	0	0	912	0.000000e+00	0	143	60004	2.383170e-03	0	0	29608	0.000000e+00	0	0	44904	0.000000e+00	0	0	64032	0.000000e+00	0	0	5986	0.000000e+00	0	0	1180038	0.000000e+00	0	0	91082	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	2	610	0.003278688524590164	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	2	14050	1.4234875444839857E-4	Benign/Likely_benign	Hereditary_cancer-predisposing_syndrome|not_provided|BAP1-related_disorder|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52405827T>C	ClinGen:CA2436980	C0027672|C3661900|C3280492	614327	140162|289539	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Asn	Ser	453076	single nucleotide variant	NM_004656.4(BAP1):c.869A>G (p.Asn290Ser)	8314	BAP1	HGNC:950	Benign/Likely benign	0	Jan 31, 2025	747079481	-	RCV000562577|RCV001079643|RCV000843751|RCV003952834	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome|not provided|BAP1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	52405827	52405827	3p21.1	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA2436980	2	472716	52405827	T	C	-	-	-	-	-	-	SCV000651904|SCV000664731|SCV000910704|SCV000985789|SCV002537296|SCV004019766|SCV004221522	-	-	869A>G 	Asn290Ser	NM_004656.4	2	2_Benign																																																																																																									
ZC4H2	ZC4H2_Lys217Arg	-4.109348315318837	0.004519611248172494	-0.4673650531179407	0.6544384299817574	2025_01_Batch_13-14	0.5219040011392475	0.8915689837768885	0.9502369389311607	0.9120649636540208	0.863185593859517	0.4234407038208272	0.8677867382073803	0.9321519693497194	0.8982282622915231	0.8374510801141866	0.47267235248003736	0.8796778609921344	0.94119445414044	0.9051466129727719	0.8503183369868518	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	ZC4H2		4320		CCSBVarC009181		NC_000023.11:64917808:T:C		Lys217Arg																												ZC4H2_Lys217Arg	23	64917808	T	C	X	allele	650A>G	G04	527_CAVA_Array_P06	M08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917808-T-C	834097	X	64917808	T	C	K	R	rs1929002470	X	64137688	X	64054413	217	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.650A>G	p.Lys217Arg	c.650A>G	p.Lys217Arg	principal1	Y	1	YES	Select	-	AAG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.941	0.52895	P	0.973	0.72925	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-2.44	0.53442	N	0.465	0.51703	-0.9665	0.37756	T	0.1423	0.46144	T	8	0.3894233	0.54427	D	0.189364	0.86022	D	0.333	0.65341	0.44	0.49343	Q9NQZ6	K217R	Loss of methylation at K217 (P = 0.007)| Loss of glycosylation at K217 (P = 0.0664)| Gain of helix (P = 0.1736)| Loss of ubiquitination at K217 (P = 0.2936)| Loss of solvent accessibility (P = 0.322)	0.814197371498	0.81098	0.5036670474541309	0.50093	2.6112261011	0.98235	0.826741635799	0.86039	D	0.521062	0.83103	D	0.142269	0.68312	D	-0.033417	0.67911	D	0.994114935398102	0.85104	D	0.967303	0.88633	D	0.75298744	0.80812	0.7599174	0.85640	0.75298744	0.80813	0.7599174	0.85641	-6.96	0.53810	T	0.2619	0.49675	B	0.965892135885726	0.82597	0.99151430	0.96976	0.921	0.95990	.	.	.	.	.	.	4.467578	0.69648	25.4	0.9988496640312855	0.96051	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.404	0.79277	7.742000	0.68069	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64917808T>C	OMIM:300897.0011	C0796200	314580	3454|85283	Zinc finger C4H2-type	Lys	Arg	822347	single nucleotide variant	NM_018684.4(ZC4H2):c.650A>G (p.Lys217Arg)	55906	ZC4H2	HGNC:24931	Pathogenic	1	Apr 09, 2020	1929002470	-	RCV001034718	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64917808	64917808	Xq11.2	no assertion criteria provided	1	-	N	OMIM:300897.0011,ClinGen:CA413411045	1	834097	64917808	T	C	-	-	-	-	-	-	SCV001198008	-	-	650A>G 	Lys217Arg	NM_018684.4		1_Pathogenic																																																																																																									
BRAF	BRAF_Phe595Leu	-9.759425206849947	0.010336581546443782																													true	BRAF	ENSG00000157764	71969	36663	CCSBVarC002859	ALE00002859	NC_000007.14:140753350:A:C	1785T>G	Phe595Leu	RC4	RC4_Mut_GDEh1030	D02	GDEhDisVCh_40058	F12	2	RC4_Mut_GDDh1030	D02	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			BRAF_Phe595Leu	7	140753350	A	C	7											7-140753350-A-C	177672	7	140753350	A	C	F	L	rs121913341	7	140453150	7	140099619	595	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1785T>G	p.Phe595Leu	c.1785T>G	p.Phe595Leu	principal4	Y	.	YES	Select	-	TTT	3	2	A	./.	./.	./.	./.	.	0.72322	.	.	.	.	0.999	0.77914	D	0.995	0.83178	D	.	0.91795	.	.	.	.	1.925	0.51193	L	.	0.83515	.	.	.	-0.3087	0.74628	T	0.3667	0.72582	T	10	0.98261863	0.98334	D	0.208711	0.87129	D	.	0.97508	0.975	0.99765	P15056	F595L	Loss of methylation at K591 (P = 0.1346)| Gain of ubiquitination at K591 (P = 0.1989)| Gain of MoRF binding (P = 0.2559)| Gain of helix (P = 0.2684)| Loss of catalytic residue at G596 (P = 0.2908)	.	0.99741	.	0.96605	.	0.91769	0.916151702404	0.98015	D	0.894269	0.97856	D	0.503087	0.94327	D	0.484873	0.94247	D	0.995151042938232	0.86818	D	0.987801	0.95872	D	0.9619178	0.97432	0.903972	0.95192	0.9661887	0.97861	0.88114095	0.93556	-10.584	0.77402	D	1.0	0.99952	P	0.999967702599346	0.99297	0.99931383	0.99288	0.992	0.99727	.	.	.	.	.	.	4.605393	0.73039	25.9	0.99886805542060975	0.96206	0.498533	0.53096	N	0.357877466552978	0.58945	4.092809	0.393216519788526	0.60939	4.310766	5.65	4.51	0.54535	4.29	0.81260	2.3	0.43383	6.153000	0.54294	0.75	0.87077	1.0	0.71675	1.000000	0.68239	1.0	0.97202	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neoplasm|Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Melanoma	reviewed_by_expert_panel	NC_000007.14:g.140753350A>C	ClinGen:CA280058|UniProtKB:P15056#VAR_018625	C0027651|C1275081|C3661900|C5555857|C0025202	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Phe	Leu	174042	single nucleotide variant	NM_004333.6(BRAF):c.1785T>G (p.Phe595Leu)	673	BRAF	HGNC:1097	Pathogenic	1	Apr 03, 2017	121913341	-	RCV000157825|RCV000154266|RCV000522002	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Cardio-facio-cutaneous syndrome|RASopathy	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140753350	140753350	7q34	reviewed by expert panel	7	-	N	ClinGen:CA280058,UniProtKB:P15056#VAR_018625	2	177672	140753350	A	C	-	-	-	-	-	-	SCV000616396	-	-	1785T>G 	Phe595Leu	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Phe595Leu	-9.759425206849947	0.010336581546443782																													true	BRAF		71969		CCSBVarC002859		NC_000007.14:140753350:A:C		Phe595Leu																												BRAF_Phe595Leu	7	140753350	A	C	7	allele	1785T>G	A05	527_CAVA_Array_P01	A09	B13A7A8P1_R1	B14A7A8P1_R2				7-140753350-A-C	177672	7	140753350	A	C	F	L	rs121913341	7	140453150	7	140099619	595	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1785T>G	p.Phe595Leu	c.1785T>G	p.Phe595Leu	principal4	Y	.	YES	Select	-	TTT	3	2	A	./.	./.	./.	./.	.	0.72322	.	.	.	.	0.999	0.77914	D	0.995	0.83178	D	.	0.91795	.	.	.	.	1.925	0.51193	L	.	0.83515	.	.	.	-0.3087	0.74628	T	0.3667	0.72582	T	10	0.98261863	0.98334	D	0.208711	0.87129	D	.	0.97508	0.975	0.99765	P15056	F595L	Loss of methylation at K591 (P = 0.1346)| Gain of ubiquitination at K591 (P = 0.1989)| Gain of MoRF binding (P = 0.2559)| Gain of helix (P = 0.2684)| Loss of catalytic residue at G596 (P = 0.2908)	.	0.99741	.	0.96605	.	0.91769	0.916151702404	0.98015	D	0.894269	0.97856	D	0.503087	0.94327	D	0.484873	0.94247	D	0.995151042938232	0.86818	D	0.987801	0.95872	D	0.9619178	0.97432	0.903972	0.95192	0.9661887	0.97861	0.88114095	0.93556	-10.584	0.77402	D	1.0	0.99952	P	0.999967702599346	0.99297	0.99931383	0.99288	0.992	0.99727	.	.	.	.	.	.	4.605393	0.73039	25.9	0.99886805542060975	0.96206	0.498533	0.53096	N	0.357877466552978	0.58945	4.092809	0.393216519788526	0.60939	4.310766	5.65	4.51	0.54535	4.29	0.81260	2.3	0.43383	6.153000	0.54294	0.75	0.87077	1.0	0.71675	1.000000	0.68239	1.0	0.97202	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neoplasm|Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Melanoma	reviewed_by_expert_panel	NC_000007.14:g.140753350A>C	ClinGen:CA280058|UniProtKB:P15056#VAR_018625	C0027651|C1275081|C3661900|C5555857|C0025202	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Phe	Leu	174042	single nucleotide variant	NM_004333.6(BRAF):c.1785T>G (p.Phe595Leu)	673	BRAF	HGNC:1097	Pathogenic	1	Apr 03, 2017	121913341	-	RCV000157825|RCV000154266|RCV000522002	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Cardio-facio-cutaneous syndrome|RASopathy	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140753350	140753350	7q34	reviewed by expert panel	7	-	N	ClinGen:CA280058,UniProtKB:P15056#VAR_018625	2	177672	140753350	A	C	-	-	-	-	-	-	SCV000616396	-	-	1785T>G 	Phe595Leu	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Leu245Phe	-6.838409603080999	0.00024453937326696584	0.8416317444096693	0.4278071535265413	2025_01_Batch_13-14	0.854239827692258	0.8246017482336747	0.7947755656887654	0.8005495999829777	0.7756869324123206	0.638821106881982	0.749189433932763	0.7786162820182276	0.7664292422276268	0.6076022999835786	0.74653046728712	0.7868955910832189	0.7866959238534965	0.7834894211053023	0.6916446161979496	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220597	CCSBVarC003155	ALE00003155	NC_000007.14:140801537:T:A	735A>T	Leu245Phe	CEGS2	CegsMutGDEh1028	A06	GDEhDisVCh_40058	E10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Leu245Phe	7	140801537	T	A	7											7-140801537-T-A	40348	7	140801537	T	A	L	F	rs397507466	7	140501337	7	140147806	245	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.735A>T	p.Leu245Phe	c.735A>T	p.Leu245Phe	principal4	Y	.	YES	Select	-	TTA	3	2	T	./.	./.	./.	./.	.	0.72322	.	.	0.74454	.	0.817	0.45628	P	0.556	0.49409	P	.	0.93829	.	.	.	.	1.93	0.51259	L	.	0.59576	.	.	0.89792	0.5278	0.90900	D	0.7689	0.92118	D	10	0.9152295	0.90783	D	0.407429	0.93514	D	.	0.94750	0.828	0.93817	P15056	L245F	Loss of ubiquitination at K240 (P = 0.1231)| Gain of MoRF binding (P = 0.2184)| Gain of methylation at K240 (P = 0.3546)| Loss of loop (P = 0.3664)| Loss of helix (P = 0.3949)	.	0.99312	.	0.87638	.	0.95469	0.921125054359	0.98407	D	0.901578	0.98053	D	0.430121	0.91476	D	0.380062	0.91371	D	0.966380715370178	0.67355	D	0.982152	0.93952	D	0.8534249	0.87422	0.7093109	0.82655	0.84129506	0.86525	0.7422232	0.84579	-9.514	0.71025	D	0.9939	0.96927	P	0.997428543660156	0.93122	0.98961290	0.96672	0.984	0.99450	.	.	.	.	.	.	4.42959	0.68734	25.3	0.99892765569899233	0.96668	0.414992	0.48227	N	0.326061389643417	0.57270	3.916485	0.339330026637409	0.57643	3.954269	5.43	4.28	0.50124	4.59	0.85410	3.384	0.5231	5.043000	0.47004	0.661	0.55789	1.0	0.71675	1.000000	0.68239	1.0	0.97202	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_delay|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801537T>A	ClinGen:CA280029|UniProtKB:P15056#VAR_058623	C4022738|C1275081|C0175704|C5681679|C5555857|C3661900	PS115150|PS151100	1340|500|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Leu	Phe	48818	single nucleotide variant	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	673	BRAF	HGNC:1097	Pathogenic	1	May 10, 2019	397507466	-	RCV000055897|RCV002273939|RCV000688777|RCV000033284|RCV000788012|RCV000037957	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Noonan syndrome with multiple lentigines|Neurodevelopmental delay|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801537	140801537	7q34	reviewed by expert panel	6	-	N	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	3	40348	140801537	T	A	-	-	-	-	-	-	SCV000927044	-	-	735A>T 	Leu245Phe	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Leu245Phe	-6.838409603080999	0.00024453937326696584	0.8416317444096693	0.4278071535265413	2025_01_Batch_13-14	0.854239827692258	0.8246017482336747	0.7947755656887654	0.8005495999829777	0.7756869324123206	0.638821106881982	0.749189433932763	0.7786162820182276	0.7664292422276268	0.6076022999835786	0.74653046728712	0.7868955910832189	0.7866959238534965	0.7834894211053023	0.6916446161979496	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003155		NC_000007.14:140801537:T:A		Leu245Phe																												BRAF_Leu245Phe	7	140801537	T	A	7	allele	735A>T	F05	527_CAVA_Array_P01	K09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801537-T-A	40348	7	140801537	T	A	L	F	rs397507466	7	140501337	7	140147806	245	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.735A>T	p.Leu245Phe	c.735A>T	p.Leu245Phe	principal4	Y	.	YES	Select	-	TTA	3	2	T	./.	./.	./.	./.	.	0.72322	.	.	0.74454	.	0.817	0.45628	P	0.556	0.49409	P	.	0.93829	.	.	.	.	1.93	0.51259	L	.	0.59576	.	.	0.89792	0.5278	0.90900	D	0.7689	0.92118	D	10	0.9152295	0.90783	D	0.407429	0.93514	D	.	0.94750	0.828	0.93817	P15056	L245F	Loss of ubiquitination at K240 (P = 0.1231)| Gain of MoRF binding (P = 0.2184)| Gain of methylation at K240 (P = 0.3546)| Loss of loop (P = 0.3664)| Loss of helix (P = 0.3949)	.	0.99312	.	0.87638	.	0.95469	0.921125054359	0.98407	D	0.901578	0.98053	D	0.430121	0.91476	D	0.380062	0.91371	D	0.966380715370178	0.67355	D	0.982152	0.93952	D	0.8534249	0.87422	0.7093109	0.82655	0.84129506	0.86525	0.7422232	0.84579	-9.514	0.71025	D	0.9939	0.96927	P	0.997428543660156	0.93122	0.98961290	0.96672	0.984	0.99450	.	.	.	.	.	.	4.42959	0.68734	25.3	0.99892765569899233	0.96668	0.414992	0.48227	N	0.326061389643417	0.57270	3.916485	0.339330026637409	0.57643	3.954269	5.43	4.28	0.50124	4.59	0.85410	3.384	0.5231	5.043000	0.47004	0.661	0.55789	1.0	0.71675	1.000000	0.68239	1.0	0.97202	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Neurodevelopmental_delay|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801537T>A	ClinGen:CA280029|UniProtKB:P15056#VAR_058623	C4022738|C1275081|C0175704|C5681679|C5555857|C3661900	PS115150|PS151100	1340|500|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Leu	Phe	48818	single nucleotide variant	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	673	BRAF	HGNC:1097	Pathogenic	1	May 10, 2019	397507466	-	RCV000055897|RCV002273939|RCV000688777|RCV000033284|RCV000788012|RCV000037957	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Noonan syndrome with multiple lentigines|Neurodevelopmental delay|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801537	140801537	7q34	reviewed by expert panel	6	-	N	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	3	40348	140801537	T	A	-	-	-	-	-	-	SCV000927044	-	-	735A>T 	Leu245Phe	NM_004333.6	3	1_Pathogenic																																																																																																									
F9	F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	695909	X	139530772	G	A	R	H	rs148060786	X	138612931	X	138440597	3	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.010000	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Benign	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	684952	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	148060786	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772	139530772	Xq27.1	reviewed by expert panel	7	-	N	ClinGen:CA10529706	2	695909	139530772	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3	2_Benign						151153	F9_Popp_2025_carboxy_gla_motif_var249787	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139530772.0	139530772.0		8			3.0	R	H	c.8G>A	p.Arg3His	missense_variant	0.8784470844182611			No	0.0001531185700546	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.532																																								695909.0	CA10529706	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BA1	PS4,PP3,BP4	The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb	2053df3d-ec43-4e86-9818-57fac97974cb	VUS	BA1	F9_Arg3His	Arg3His	true
F9	F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	695909	X	139530772	G	A	R	H	rs148060786	X	138612931	X	138440597	3	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.010000	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Benign	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	684952	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	148060786	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772	139530772	Xq27.1	reviewed by expert panel	7	-	N	ClinGen:CA10529706	2	695909	139530772	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3	2_Benign						206185	F9_Popp_2025_light_chain_var240106	F9_Popp_2025_light_chain	F9	3551.0	1.0		139530772.0	139530772.0		8			3.0	R	H	c.8G>A	p.Arg3His	missense_variant	0.9370607228975518			No	0.0001531185700546	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.532																																								695909.0	CA10529706	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BA1	PS4,PP3,BP4	The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb	2053df3d-ec43-4e86-9818-57fac97974cb	VUS	BA1	F9_Arg3His	Arg3His	true
F9	F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	695909	X	139530772	G	A	R	H	rs148060786	X	138612931	X	138440597	3	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.010000	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Benign	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	684952	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	148060786	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772	139530772	Xq27.1	reviewed by expert panel	7	-	N	ClinGen:CA10529706	2	695909	139530772	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3	2_Benign						233701	F9_Popp_2025_strep_2_var259468	F9_Popp_2025_strep_2	F9	3551.0	1.0		139530772.0	139530772.0		8			3.0	R	H	c.8G>A	p.Arg3His	missense_variant	0.8685173675071735			No	0.0001531185700546	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.532																																								695909.0	CA10529706	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BA1	PS4,PP3,BP4	The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb	2053df3d-ec43-4e86-9818-57fac97974cb	VUS	BA1	F9_Arg3His	Arg3His	true
F9	F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	695909	X	139530772	G	A	R	H	rs148060786	X	138612931	X	138440597	3	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.010000	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Benign	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	684952	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	148060786	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772	139530772	Xq27.1	reviewed by expert panel	7	-	N	ClinGen:CA10529706	2	695909	139530772	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3	2_Benign						178669	F9_Popp_2025_heavy_chain_var230425	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139530772.0	139530772.0		8			3.0	R	H	c.8G>A	p.Arg3His	missense_variant	0.8552991604647007			No	0.0001531185700546	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.532																																								695909.0	CA10529706	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BA1	PS4,PP3,BP4	The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb	2053df3d-ec43-4e86-9818-57fac97974cb	VUS	BA1	F9_Arg3His	Arg3His	true
F9	F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	695909	X	139530772	G	A	R	H	rs148060786	X	138612931	X	138440597	3	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.010000	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Benign	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	684952	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158	F9	HGNC:3551	Benign	0	Feb 09, 2024	148060786	-	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772	139530772	Xq27.1	reviewed by expert panel	7	-	N	ClinGen:CA10529706	2	695909	139530772	G	A	-	-	-	-	-	-	SCV004363691	-	-	8G>A 	Arg3His	NM_000133.4	3	2_Benign						123637	F9_Popp_2025_carboxy_F9_specific_var220744	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139530772.0	139530772.0		8			3.0	R	H	c.8G>A	p.Arg3His	missense_variant	0.9984466091759258			No	0.0001531185700546	Benign	reviewed by expert panel	Feb 09, 2024	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.532																																								695909.0	CA10529706	hemophilia B	MONDO:0010604	X-linked inheritance	Benign	BA1	PS4,PP3,BP4	The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.		Coagulation Factor Deficiency VCEP	https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	2/9/24	7/11/24	false	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb	2053df3d-ec43-4e86-9818-57fac97974cb	VUS	BA1	F9_Arg3His	Arg3His	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						240039	F9_Popp_2025_strep_2_var261709	F9_Popp_2025_strep_2	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.200178129328389			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						240039	F9_Popp_2025_strep_2_var261709	F9_Popp_2025_strep_2	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.200178129328389			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						129975	F9_Popp_2025_carboxy_F9_specific_var222985	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.051387770684173			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						129975	F9_Popp_2025_carboxy_F9_specific_var222985	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.051387770684173			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						157491	F9_Popp_2025_carboxy_gla_motif_var252028	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	0.9378215129456816			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						157491	F9_Popp_2025_carboxy_gla_motif_var252028	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	0.9378215129456816			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						185007	F9_Popp_2025_heavy_chain_var232666	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.1413056500481331			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						185007	F9_Popp_2025_heavy_chain_var232666	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.1413056500481331			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						212523	F9_Popp_2025_light_chain_var242347	F9_Popp_2025_light_chain	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.0855410691429608			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
F9	F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic						212523	F9_Popp_2025_light_chain_var242347	F9_Popp_2025_light_chain	F9	3551.0	1.0		139541126.0	139541126.0		328			110.0	D	N	c.328G>A	p.Asp110Asn	missense_variant	1.0855410691429608			No		Pathogenic	no assertion criteria provided	Oct 09, 2017	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.819																																																											F9_Asp110Asn	Asp110Asn	true
CTCF	CTCF_Asp46Asn	-2.5556236375766055	0.04316233733910241	2.5264609447668644	0.039436363219745474	2025_01_Batch_13-14	0.8442630357834991	0.772836679383644	0.660723892135822	0.7164137896266487	0.8403217673680176	0.7477452984927581	0.7602714305498538	0.5915511730925458	0.6534449308500725	0.6714216910221661	0.7960041671381286	0.7665540549667489	0.6261375326141839	0.6849293602383606	0.7558717291950918	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	CTCF		6173		CCSBVarC010823		NC_000016.10:67610968:G:A		Asp46Asn																												CTCF_Asp46Asn	16	67610968	G	A	16	allele	136G>A	B02	527_CAVA_Array_P02	C04	B13A7A8P1_R1	B14A7A8P1_R2				16-67610968-G-A	975529	16	67610968	G	A	D	N	rs2052054114	16	67644871	16	66202372	46	CTCF	ENSG00000102974	ENST00000642819	ENSP00000494408	P49711	CTCF_HUMAN	c.136G>A	p.Asp46Asn	c.136G>A	p.Asp46Asn	principal4	Y	.	.	.	+	GAT	1	0	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.24550	.	0.18	0.29064	B	0.057	0.26282	B	.	0.23785	.	.	.	.	1.1	0.27864	L	.	0.17556	.	.	0.34213	-1.0391	0.17573	T	0.0244	0.10333	T	10	0.26070982	0.43135	D	0.008032	0.21016	T	.	0.29456	0.222	0.14439	P49711	D46N	Gain of loop (P = 0.069)| Loss of helix (P = 0.079)| Loss of catalytic residue at G48 (P = 0.1983)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.4494)	.	0.54510	.	0.33770	.	0.47360	0.533664166927	0.43488	T	0.37863	0.73981	T	-0.237905	0.15337	T	-0.579511	0.14308	T	0.711651020290767	0.40980	D	.	0.78261	.	0.14355613	0.32709	0.14724985	0.34752	0.14355613	0.32709	0.14724985	0.34751	-4.76	0.34161	T	0.1119	0.24667	LB	0.911406707488065	0.76873	0.35239035	0.78355	0.338	0.59995	.	.	.	.	.	.	4.066878	0.60464	24.2	0.9978644389905249	0.87230	0.903411	0.85191	D	0.173584497680614	0.49687	3.18842	0.363672439989046	0.59120	4.110524	5.19	5.19	0.71389	.	.	8.296	0.89889	11.831000	0.97527	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.946	0.49004	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1595754	6.266630e-07	0	1	1165574	8.579460e-07	0	0	74694	0.000000e+00	0	0	912	0.000000e+00	0	0	59396	0.000000e+00	0	0	29152	0.000000e+00	0	0	44342	0.000000e+00	0	0	63822	0.000000e+00	0	0	5992	0.000000e+00	0	1	1165574	8.579460e-07	0	0	90282	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_benign	Intellectual_disability	no_assertion_criteria_provided	NC_000016.10:g.67610968G>A	.	C3714756	.	.	.	Asp	Asn	963811	single nucleotide variant	NM_006565.4(CTCF):c.136G>A (p.Asp46Asn)	10664	CTCF	HGNC:13723	Likely benign	0	Jan 01, 2019	2052054114	-	RCV001252212	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000016.10	16	67610968	67610968	16q22.1	no assertion criteria provided	1	-	N	ClinGen:CA396302067	2	975529	67610968	G	A	-	-	-	-	-	-	SCV001427963	-	-	136G>A 	Asp46Asn	NM_006565.4		2_Benign																																																																																																									
KRAS	KRAS_Gly12Asp	-1.282954401654033	0.24035037393394657	6.504027749209328	0.00033287040797068537																											true	KRAS	ENSG00000133703	3084	214484	CCSBVarC006090	ALE00006090	NC_000012.12:25245350:C:T	35G>A	Gly12Asp	CEGS2	CegsMutGDEh1034	G11	GDEhDisVCh_40061	F08	1	CegsMutGDDh1034	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly12Asp	12	25245350	C	T	12											12-25245350-C-T	12582	12	25245350	C	T	G	D	rs121913529	12	25398284	12	25289551	12	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>A	p.Gly12Asp	c.35G>A	p.Gly12Asp	alternative1	Y	1	.	Plus_Clinical	-	GGT	2	0	C	./.	./.	./.	./.	0.01	0.56615	D	0.0	0.92967	D	0.517	0.37470	P	0.361	0.43233	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.685	0.78379	M	-5.37	0.90914	D	0.915	0.91737	0.2670	0.86969	D	0.5809	0.84869	D	10	0.897719	0.89008	D	0.164646	0.84329	D	0.875	0.96271	0.772	0.89792	P01116	G12D	Gain of catalytic residue at G13 (P = 0.001)| Gain of ubiquitination at K16 (P = 0.1181)| Loss of methylation at K16 (P = 0.1388)| Gain of solvent accessibility (P = 0.2192)| Loss of sheet (P = 0.302)	0.957447700615	0.95662	0.9871709593781199	0.98706	2.25690945348	0.96132	0.929049253464	0.98932	D	0.839213	0.96205	D	0.397866	0.89719	D	0.33373	0.89591	D	0.965350031852722	0.67026	D	0.331367	0.19106	T	0.92127717	0.93272	0.924745	0.96683	0.9358444	0.94746	0.9112568	0.95720	-14.566	0.96931	D	0.9984	0.98378	P	0.999983137957112	0.99579	0.99778840	0.98508	0.995	0.99826	.	.	.	.	.	.	4.925041	0.81187	27.5	0.99776655469088438	0.86444	0.891815	0.82751	D	0.605638712679719	0.73388	5.981318	0.66049645547495	0.79283	7.073244	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108342	9.230030e-06	0	1	206404	4.844870e-06	0	1	234992	4.255460e-06	0	0	7046	0.000000e+00	0	0	17030	0.000000e+00	0	0	2232	0.000000e+00	0	0	9026	0.000000e+00	0	0	13384	0.000000e+00	0	1	42218	2.368660e-05	0	0	15506	0.000000e+00	0	1	42218	2.368660e-05	0	0	16014	0.000000e+00	0	0	30376	0.000000e+00	0	0	6112	0.000000e+00	0	0	13384	0.000000e+00	0	0	16720	0.000000e+00	0	1	88728	1.127040e-05	0	0	30232	0.000000e+00	0	1	88728	1.127040e-05	0	0	14710	0.000000e+00	0	0	34116	0.000000e+00	0	0	9462	0.000000e+00	0	0	17666	0.000000e+00	0	0	21592	0.000000e+00	0	1	101710	9.831870e-06	0	0	30152	0.000000e+00	0	1	101710	9.831870e-06	0	.	6	1612744	3.720370e-06	0	5	1179306	4.239780e-06	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29524	0.000000e+00	0	0	44868	0.000000e+00	0	0	63988	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179306	4.239780e-06	0	0	90798	0.000000e+00	0	0	90742	0	0	162	0	0	2680	0	0	3944	0	0	436	0	0	928	0	0	624	0	0	276	0	1	2036	4.911591355599214E-4	0	4106	0	0	3304	0	1	101828	9.820481596417489E-6	Pathogenic/Likely_pathogenic	Juvenile_myelomonocytic_leukemia|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Acute_myeloid_leukemia|Gastric_cancer|Congenital_Pulmonary_Airway_Malformations|not_provided|Carcinoma_of_pancreas|Cardiovascular_phenotype|Ovarian_neoplasm|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|Non-small_cell_lung_carcinoma|Capillary_malformation-arteriovenous_malformation_1|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Vascular_Tumors_Including_Pyogenic_Granuloma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Cerebral_arteriovenous_malformation|Lung_carcinoma|Epidermal_nevus	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>T	ClinGen:CA122538|OMIM:190070.0005|OMIM:190070.0025|UniProtKB:P01116#VAR_016026	C0349639|C0406612|C0009404|C0040136|C0023467|C0024623|C3661900|C0235974|CN230736|C0919267|C5555857|C4302356|C0007131|C4747394|C2674723|C3854181|C4552097|C0349579|C1516855|C0917804|C0684249|C0334082	607785|613001|601626|613659|608354|614470|163200|108010|162900	86834|2396|100087|519|1333|217074|536391|137667|90307|268114|2612|46724|79414	Small GTP-binding domain	Gly	Asp	27621	single nucleotide variant	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	3845	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1	Oct 07, 2024	121913529	-	RCV000272938|RCV000433573|RCV000013411|RCV000856666|RCV001799604|RCV000548006|RCV000585796|RCV000662266|RCV002508117|RCV003327361|RCV004018620|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV005007840|RCV001839445|RCV004554600|RCV004668724	MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|12 conditions|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	not provided|Acute myeloid leukemia|Carcinoma of pancreas|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|12 conditions|Encephalocraniocutaneous lipomatosis|Congenital Pulmonary Airway Malformations|Neoplasm	de novo;germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350	25245350	12p12.1	criteria provided, multiple submitters, no conflicts	24	-	N	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	3	12582	25245350	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000329383|SCV000659085|SCV001736991|SCV002318898|SCV002525678|SCV002601600|SCV002821689|SCV004176950|SCV005023563|SCV005044128|SCV005414064|SCV005634967	-	SCV005094257	35G>A 	Gly12Asp	NM_004985.5	2	1_Pathogenic	12	25245350	C	T	2.73867e-6																																																																																																				
KRAS	KRAS_Gly12Asp	-1.282954401654033	0.24035037393394657	6.504027749209328	0.00033287040797068537																											true	KRAS		3084		CCSBVarC006090		NC_000012.12:25245350:C:T		Gly12Asp																												KRAS_Gly12Asp	12	25245350	C	T	12	allele	35G>A	D08	527_CAVA_Array_P03	H15	B13A7A8P1_R1	B14A7A8P1_R2				12-25245350-C-T	12582	12	25245350	C	T	G	D	rs121913529	12	25398284	12	25289551	12	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>A	p.Gly12Asp	c.35G>A	p.Gly12Asp	alternative1	Y	1	.	Plus_Clinical	-	GGT	2	0	C	./.	./.	./.	./.	0.01	0.56615	D	0.0	0.92967	D	0.517	0.37470	P	0.361	0.43233	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.685	0.78379	M	-5.37	0.90914	D	0.915	0.91737	0.2670	0.86969	D	0.5809	0.84869	D	10	0.897719	0.89008	D	0.164646	0.84329	D	0.875	0.96271	0.772	0.89792	P01116	G12D	Gain of catalytic residue at G13 (P = 0.001)| Gain of ubiquitination at K16 (P = 0.1181)| Loss of methylation at K16 (P = 0.1388)| Gain of solvent accessibility (P = 0.2192)| Loss of sheet (P = 0.302)	0.957447700615	0.95662	0.9871709593781199	0.98706	2.25690945348	0.96132	0.929049253464	0.98932	D	0.839213	0.96205	D	0.397866	0.89719	D	0.33373	0.89591	D	0.965350031852722	0.67026	D	0.331367	0.19106	T	0.92127717	0.93272	0.924745	0.96683	0.9358444	0.94746	0.9112568	0.95720	-14.566	0.96931	D	0.9984	0.98378	P	0.999983137957112	0.99579	0.99778840	0.98508	0.995	0.99826	.	.	.	.	.	.	4.925041	0.81187	27.5	0.99776655469088438	0.86444	0.891815	0.82751	D	0.605638712679719	0.73388	5.981318	0.66049645547495	0.79283	7.073244	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108342	9.230030e-06	0	1	206404	4.844870e-06	0	1	234992	4.255460e-06	0	0	7046	0.000000e+00	0	0	17030	0.000000e+00	0	0	2232	0.000000e+00	0	0	9026	0.000000e+00	0	0	13384	0.000000e+00	0	1	42218	2.368660e-05	0	0	15506	0.000000e+00	0	1	42218	2.368660e-05	0	0	16014	0.000000e+00	0	0	30376	0.000000e+00	0	0	6112	0.000000e+00	0	0	13384	0.000000e+00	0	0	16720	0.000000e+00	0	1	88728	1.127040e-05	0	0	30232	0.000000e+00	0	1	88728	1.127040e-05	0	0	14710	0.000000e+00	0	0	34116	0.000000e+00	0	0	9462	0.000000e+00	0	0	17666	0.000000e+00	0	0	21592	0.000000e+00	0	1	101710	9.831870e-06	0	0	30152	0.000000e+00	0	1	101710	9.831870e-06	0	.	6	1612744	3.720370e-06	0	5	1179306	4.239780e-06	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29524	0.000000e+00	0	0	44868	0.000000e+00	0	0	63988	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179306	4.239780e-06	0	0	90798	0.000000e+00	0	0	90742	0	0	162	0	0	2680	0	0	3944	0	0	436	0	0	928	0	0	624	0	0	276	0	1	2036	4.911591355599214E-4	0	4106	0	0	3304	0	1	101828	9.820481596417489E-6	Pathogenic/Likely_pathogenic	Juvenile_myelomonocytic_leukemia|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Acute_myeloid_leukemia|Gastric_cancer|Congenital_Pulmonary_Airway_Malformations|not_provided|Carcinoma_of_pancreas|Cardiovascular_phenotype|Ovarian_neoplasm|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|Non-small_cell_lung_carcinoma|Capillary_malformation-arteriovenous_malformation_1|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Vascular_Tumors_Including_Pyogenic_Granuloma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Cerebral_arteriovenous_malformation|Lung_carcinoma|Epidermal_nevus	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>T	ClinGen:CA122538|OMIM:190070.0005|OMIM:190070.0025|UniProtKB:P01116#VAR_016026	C0349639|C0406612|C0009404|C0040136|C0023467|C0024623|C3661900|C0235974|CN230736|C0919267|C5555857|C4302356|C0007131|C4747394|C2674723|C3854181|C4552097|C0349579|C1516855|C0917804|C0684249|C0334082	607785|613001|601626|613659|608354|614470|163200|108010|162900	86834|2396|100087|519|1333|217074|536391|137667|90307|268114|2612|46724|79414	Small GTP-binding domain	Gly	Asp	27621	single nucleotide variant	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	3845	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1	Oct 07, 2024	121913529	-	RCV000272938|RCV000433573|RCV000013411|RCV000856666|RCV001799604|RCV000548006|RCV000585796|RCV000662266|RCV002508117|RCV003327361|RCV004018620|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV005007840|RCV001839445|RCV004554600|RCV004668724	MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|12 conditions|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	not provided|Acute myeloid leukemia|Carcinoma of pancreas|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|12 conditions|Encephalocraniocutaneous lipomatosis|Congenital Pulmonary Airway Malformations|Neoplasm	de novo;germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350	25245350	12p12.1	criteria provided, multiple submitters, no conflicts	24	-	N	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	3	12582	25245350	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000329383|SCV000659085|SCV001736991|SCV002318898|SCV002525678|SCV002601600|SCV002821689|SCV004176950|SCV005023563|SCV005044128|SCV005414064|SCV005634967	-	SCV005094257	35G>A 	Gly12Asp	NM_004985.5	2	1_Pathogenic	12	25245350	C	T	2.73867e-6																																																																																																				
RPS19	RPS19_Val15Phe	-2.3726616409620696	0.0765985741724703	-5.512693220591865	0.0008944402490659259	2025_01_Batch_13-14	0.684109794739754	0.8354004220502114	0.9476236131613452	0.8981160057662907	0.6773948020766469	0.6498024481967875	0.8311746588573784	0.9456344669283709	0.9173255485788965	0.6438750406079519	0.6669561214682707	0.8332875404537949	0.946629040044858	0.9077207771725936	0.6606349213422994	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19	ENSG00000105372	3441	6053	CCSBVarC000466	ALE00000466	NC_000019.10:41860817:G:T	43G>T	Val15Phe	RC4	RC4_Mut_GDEh1010	E11	GDEhDisVCh_40042	B02	2	RC4_Mut_GDDh1010	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			RPS19_Val15Phe	19	41860817	G	T	19											19-41860817-G-T	242804	19	41860817	G	T	V	F	rs104894717	19	42364887	19	47056727	15	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.43G>T	p.Val15Phe	c.43G>T	p.Val15Phe	principal1	Y	1	YES	Select	+	GTC	1	0	G	./.	./.	./.	./.	.	.	.	0.002	0.83643	D	0.997	0.70687	D	0.961	0.70481	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.395	0.91508	M	.	.	.	0.966	0.97658	-0.2458	0.76366	T	0.3830	0.73812	T	9	0.9739928	0.97062	D	0.40126	0.93389	D	.	.	0.909	0.98139	P39019	V15F	Loss of MoRF binding (P = 0.0787)| Loss of stability (P = 0.3828)| Loss of disorder (P = 0.4358)| Gain of methylation at R16 (P = 0.5521)| Loss of catalytic residue at F14 (P = 0.6366)	0.991857985221	0.99167	0.9614224850641426	0.96106	1.80914359211	0.91745	0.8935765028	0.95692	D	0.984477	0.99897	D	0.554303	0.95835	D	0.558441	0.95771	D	0.983127236366272	0.74730	D	.	0.56568	.	0.9801354	0.99104	0.91802967	0.96206	0.97457075	0.98647	0.9133168	0.95867	-13.184	0.90127	D	0.9629	0.91158	LP	0.997229277562924	0.92904	0.99992170	0.99909	0.795	0.88659	.	.	.	.	.	.	5.206373	0.87374	29.2	0.99412599951109681	0.63408	0.939381	0.93969	D	0.630628753833532	0.74985	6.250244	0.550537727116612	0.71277	5.654391	4.53	3.49	0.38994	.	.	6.938	0.75774	11.663000	0.94018	0.662	0.56385	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000019.10:g.41860817G>T	ClinGen:CA045535|OMIM:603474.0007|UniProtKB:P39019#VAR_018438	C3661900	.	.	.	Val	Phe	21358	single nucleotide variant	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	6223	RPS19	HGNC:10402	Pathogenic	1	Aug 03, 2015	104894717	-	RCV000482973	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	41860817	41860817	19q13.2	criteria provided, single submitter	1	-	N	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	2	242804	41860817	G	T	-	-	-	-	-	-	SCV000567615	-	-	43G>T 	Val15Phe	NM_001022.4	1	1_Pathogenic																																																																																																									
RPS19	RPS19_Val15Phe	-2.3726616409620696	0.0765985741724703	-5.512693220591865	0.0008944402490659259	2025_01_Batch_13-14	0.684109794739754	0.8354004220502114	0.9476236131613452	0.8981160057662907	0.6773948020766469	0.6498024481967875	0.8311746588573784	0.9456344669283709	0.9173255485788965	0.6438750406079519	0.6669561214682707	0.8332875404537949	0.946629040044858	0.9077207771725936	0.6606349213422994	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RPS19		3441		CCSBVarC000466		NC_000019.10:41860817:G:T		Val15Phe																												RPS19_Val15Phe	19	41860817	G	T	19	allele	43G>T	E10	527_CAVA_Array_P05	I19	B13A7A8P2_R1	B14A7A8P2_R2				19-41860817-G-T	242804	19	41860817	G	T	V	F	rs104894717	19	42364887	19	47056727	15	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.43G>T	p.Val15Phe	c.43G>T	p.Val15Phe	principal1	Y	1	YES	Select	+	GTC	1	0	G	./.	./.	./.	./.	.	.	.	0.002	0.83643	D	0.997	0.70687	D	0.961	0.70481	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.395	0.91508	M	.	.	.	0.966	0.97658	-0.2458	0.76366	T	0.3830	0.73812	T	9	0.9739928	0.97062	D	0.40126	0.93389	D	.	.	0.909	0.98139	P39019	V15F	Loss of MoRF binding (P = 0.0787)| Loss of stability (P = 0.3828)| Loss of disorder (P = 0.4358)| Gain of methylation at R16 (P = 0.5521)| Loss of catalytic residue at F14 (P = 0.6366)	0.991857985221	0.99167	0.9614224850641426	0.96106	1.80914359211	0.91745	0.8935765028	0.95692	D	0.984477	0.99897	D	0.554303	0.95835	D	0.558441	0.95771	D	0.983127236366272	0.74730	D	.	0.56568	.	0.9801354	0.99104	0.91802967	0.96206	0.97457075	0.98647	0.9133168	0.95867	-13.184	0.90127	D	0.9629	0.91158	LP	0.997229277562924	0.92904	0.99992170	0.99909	0.795	0.88659	.	.	.	.	.	.	5.206373	0.87374	29.2	0.99412599951109681	0.63408	0.939381	0.93969	D	0.630628753833532	0.74985	6.250244	0.550537727116612	0.71277	5.654391	4.53	3.49	0.38994	.	.	6.938	0.75774	11.663000	0.94018	0.662	0.56385	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	criteria_provided,_single_submitter	NC_000019.10:g.41860817G>T	ClinGen:CA045535|OMIM:603474.0007|UniProtKB:P39019#VAR_018438	C3661900	.	.	.	Val	Phe	21358	single nucleotide variant	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	6223	RPS19	HGNC:10402	Pathogenic	1	Aug 03, 2015	104894717	-	RCV000482973	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	41860817	41860817	19q13.2	criteria provided, single submitter	1	-	N	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	2	242804	41860817	G	T	-	-	-	-	-	-	SCV000567615	-	-	43G>T 	Val15Phe	NM_001022.4	1	1_Pathogenic																																																																																																									
ABCD1	ABCD1_Arg518Gln	6.2907017796871	0.00040780087036125073	0.28092595257451625	0.7868893052001034	2025_01_Batch_13-14	0.7135505295908988	0.7087000096964757	0.7749904408990131	0.739258531964679	0.6905931159218803	0.7870494806388876	0.7733477088703725	0.8030117544768121	0.8436387413301347	0.6804770706761727	0.7503000051148931	0.7410238592834242	0.7890010976879126	0.791448636647407	0.6855350932990265	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ABCD1	ENSG00000101986	100008637	209132	CCSBVarC007021	ALE00007019	NC_000023.11:153740156:G:A	1553G>A	Arg518Gln	CEGS2	CegsMutGDEh1023	H06	GDEhDisVCh_40030	H07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			ABCD1_Arg518Gln	23	153740156	G	A	X											X-153740156-G-A	92317	X	153740156	G	A	R	Q	rs398123102	X	153005610	X	152658804	518	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1553G>A	p.Arg518Gln	c.1553G>A	p.Arg518Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.999	0.77914	D	0.984	0.76117	D	0.8	0.87470	A	simple_aae	20.0	80.0	2.185	0.61163	M	-3.6	0.69394	D	0.814	0.80898	0.9308	0.96101	D	0.9934	0.99846	D	10	0.9942995	0.99935	D	0.874464	0.99039	D	0.942	0.98779	0.971	0.99725	P33897	R518Q	Gain of methylation at K513 (P = 0.0396)| Loss of MoRF binding (P = 0.0759)| Gain of ubiquitination at K513 (P = 0.1295)| Loss of catalytic residue at R518 (P = 0.1494)| Loss of loop (P = 0.2237)	0.999847574799	0.99984	0.9166754227494129	0.91590	1.62602313597	0.89103	0.596089541912	0.52286	T	0.956453	0.99402	D	0.679029	0.99908	D	0.737601	0.99907	D	0.954029619693756	0.63942	D	0.994593	0.98244	D	0.8978354	0.91064	0.8459693	0.91118	0.8978354	0.91065	0.8459693	0.91119	-13.047	0.89579	D	0.9361	0.85514	P	0.999942948768151	0.99079	0.99904543	0.99115	0.977	0.99166	.	.	.	.	.	.	5.329675	0.89461	30.0	0.99951095395162337	0.99945	.	.	.	.	.	.	.	.	.	4.93	4.93	0.64349	.	.	9.996	0.99292	.	.	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.904	0.44015	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	79946	1.250840e-05	0	1	151049	6.620370e-06	0	1	171265	5.838900e-06	0	0	5702	0.000000e+00	0	0	13607	0.000000e+00	0	0	1752	0.000000e+00	0	0	6916	0.000000e+00	0	0	9842	0.000000e+00	0	1	30802	3.246540e-05	0	0	9880	0.000000e+00	0	1	30802	3.246540e-05	0	0	13127	0.000000e+00	0	0	24304	0.000000e+00	0	0	4606	0.000000e+00	0	0	10125	0.000000e+00	0	0	12095	0.000000e+00	0	1	64282	1.555650e-05	0	0	18901	0.000000e+00	0	1	64282	1.555650e-05	0	0	12059	0.000000e+00	0	0	27059	0.000000e+00	0	0	6992	0.000000e+00	0	0	13307	0.000000e+00	0	0	15893	0.000000e+00	0	1	72992	1.370010e-05	0	0	18836	0.000000e+00	0	1	72992	1.370010e-05	0	.	1	1210866	8.258550e-07	0	1	894577	1.117850e-06	0	0	57962	0.000000e+00	0	0	687	0.000000e+00	0	0	46080	0.000000e+00	0	0	22002	0.000000e+00	0	0	33820	0.000000e+00	0	0	46886	0.000000e+00	0	0	4348	0.000000e+00	0	1	894577	1.117850e-06	0	0	56926	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Pathogenic	Adrenoleukodystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153740156G>A	ClinGen:CA278403|UniProtKB:P33897#VAR_000070	C0162309|C3661900	300100	43	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	Arg	Gln	98228	single nucleotide variant	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	215	ABCD1	HGNC:61	Pathogenic	1	Sep 23, 2024	398123102	-	RCV000077955|RCV000723540|RCV004752737	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	Adrenoleukodystrophy|not provided|ABCD1-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	153740156	153740156	Xq28	criteria provided, multiple submitters, no conflicts	13	-	N	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	2	92317	153740156	G	A	-	-	-	-	-	-	SCV000109784|SCV000840437|SCV001207477|SCV001338473|SCV001447138|SCV001812929|SCV002022800|SCV002045832|SCV002822049|SCV004206299|SCV004231793|SCV005418721	-	-	1553G>A 	Arg518Gln	NM_000033.4	2	1_Pathogenic	X	153740156	G	A	9.11811e-7																																																																																																				
ABCD1	ABCD1_Arg518Gln	6.2907017796871	0.00040780087036125073	0.28092595257451625	0.7868893052001034	2025_01_Batch_13-14	0.7135505295908988	0.7087000096964757	0.7749904408990131	0.739258531964679	0.6905931159218803	0.7870494806388876	0.7733477088703725	0.8030117544768121	0.8436387413301347	0.6804770706761727	0.7503000051148931	0.7410238592834242	0.7890010976879126	0.791448636647407	0.6855350932990265	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	ABCD1		100008637		CCSBVarC007021		NC_000023.11:153740156:G:A		Arg518Gln																												ABCD1_Arg518Gln	23	153740156	G	A	X	allele	1553G>A	D01	527_CAVA_Array_P01	G01	B13A7A8P1_R1	B14A7A8P1_R2				X-153740156-G-A	92317	X	153740156	G	A	R	Q	rs398123102	X	153005610	X	152658804	518	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1553G>A	p.Arg518Gln	c.1553G>A	p.Arg518Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.999	0.77914	D	0.984	0.76117	D	0.8	0.87470	A	simple_aae	20.0	80.0	2.185	0.61163	M	-3.6	0.69394	D	0.814	0.80898	0.9308	0.96101	D	0.9934	0.99846	D	10	0.9942995	0.99935	D	0.874464	0.99039	D	0.942	0.98779	0.971	0.99725	P33897	R518Q	Gain of methylation at K513 (P = 0.0396)| Loss of MoRF binding (P = 0.0759)| Gain of ubiquitination at K513 (P = 0.1295)| Loss of catalytic residue at R518 (P = 0.1494)| Loss of loop (P = 0.2237)	0.999847574799	0.99984	0.9166754227494129	0.91590	1.62602313597	0.89103	0.596089541912	0.52286	T	0.956453	0.99402	D	0.679029	0.99908	D	0.737601	0.99907	D	0.954029619693756	0.63942	D	0.994593	0.98244	D	0.8978354	0.91064	0.8459693	0.91118	0.8978354	0.91065	0.8459693	0.91119	-13.047	0.89579	D	0.9361	0.85514	P	0.999942948768151	0.99079	0.99904543	0.99115	0.977	0.99166	.	.	.	.	.	.	5.329675	0.89461	30.0	0.99951095395162337	0.99945	.	.	.	.	.	.	.	.	.	4.93	4.93	0.64349	.	.	9.996	0.99292	.	.	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.904	0.44015	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	79946	1.250840e-05	0	1	151049	6.620370e-06	0	1	171265	5.838900e-06	0	0	5702	0.000000e+00	0	0	13607	0.000000e+00	0	0	1752	0.000000e+00	0	0	6916	0.000000e+00	0	0	9842	0.000000e+00	0	1	30802	3.246540e-05	0	0	9880	0.000000e+00	0	1	30802	3.246540e-05	0	0	13127	0.000000e+00	0	0	24304	0.000000e+00	0	0	4606	0.000000e+00	0	0	10125	0.000000e+00	0	0	12095	0.000000e+00	0	1	64282	1.555650e-05	0	0	18901	0.000000e+00	0	1	64282	1.555650e-05	0	0	12059	0.000000e+00	0	0	27059	0.000000e+00	0	0	6992	0.000000e+00	0	0	13307	0.000000e+00	0	0	15893	0.000000e+00	0	1	72992	1.370010e-05	0	0	18836	0.000000e+00	0	1	72992	1.370010e-05	0	.	1	1210866	8.258550e-07	0	1	894577	1.117850e-06	0	0	57962	0.000000e+00	0	0	687	0.000000e+00	0	0	46080	0.000000e+00	0	0	22002	0.000000e+00	0	0	33820	0.000000e+00	0	0	46886	0.000000e+00	0	0	4348	0.000000e+00	0	1	894577	1.117850e-06	0	0	56926	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Pathogenic	Adrenoleukodystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153740156G>A	ClinGen:CA278403|UniProtKB:P33897#VAR_000070	C0162309|C3661900	300100	43	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	Arg	Gln	98228	single nucleotide variant	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	215	ABCD1	HGNC:61	Pathogenic	1	Sep 23, 2024	398123102	-	RCV000077955|RCV000723540|RCV004752737	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	Adrenoleukodystrophy|not provided|ABCD1-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	153740156	153740156	Xq28	criteria provided, multiple submitters, no conflicts	13	-	N	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	2	92317	153740156	G	A	-	-	-	-	-	-	SCV000109784|SCV000840437|SCV001207477|SCV001338473|SCV001447138|SCV001812929|SCV002022800|SCV002045832|SCV002822049|SCV004206299|SCV004231793|SCV005418721	-	-	1553G>A 	Arg518Gln	NM_000033.4	2	1_Pathogenic	X	153740156	G	A	9.11811e-7																																																																																																				
BRAF	BRAF_Asp565Glu	-2.6309360210738006	0.0338665149617909	2.7720035823390834	0.027614311127530596	2025_01_Batch_13-14	0.552685161673155	0.6687514949660767	0.7068440226909102	0.6391403118674894	0.5217539669056006	0.5001272833154411	0.5939184049658881	0.6536136590776095	0.6767628059356723	0.5102262104531048	0.526406222494298	0.6313349499659824	0.6802288408842598	0.6579515589015809	0.5159900886793527	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220613	CCSBVarC003170	ALE00003170	NC_000007.14:140754233:A:C	1695T>G	Asp565Glu	CEGS2	CegsMutGDEh1012	F06	GDEhDisVCh_40058	F04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Asp565Glu	7	140754233	A	C	7											7-140754233-A-C	40383	7	140754233	A	C	D	E	rs397507480	7	140454033	7	140100502	565	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1695T>G	p.Asp565Glu	c.1695T>G	p.Asp565Glu	principal4	Y	.	YES	Select	-	GAT	3	2	A	A/A	A/A	A/A	A/A	.	.	.	.	.	.	0.008	0.14667	B	0.025	0.20509	B	.	0.76851	.	.	.	.	-0.19	0.04221	N	.	.	.	.	.	-1.0620	0.11274	T	0.0795	0.31365	T	10	0.86869705	0.85975	D	.	.	.	.	0.82085	0.809	0.92541	P15056	D565E	Gain of catalytic residue at D565 (P = 0.0544)| Gain of ubiquitination at K570 (P = 0.1162)| Gain of methylation at K570 (P = 0.1449)| Gain of disorder (P = 0.2432)| Loss of helix (P = 0.3949)	.	0.97114	.	0.85572	.	0.71418	0.891400456429	0.95428	D	0.799272	0.94819	D	0.275835	0.80817	D	0.158442	0.80570	D	0.875816404819489	0.52308	D	0.918508	0.70644	D	0.80036193	0.83724	0.73096305	0.83912	0.8693574	0.88657	0.7036775	0.82332	-8.348	0.63492	D	0.9665	0.94256	P	0.983874848762311	0.86325	0.99816126	0.98658	0.689	0.82741	.	.	.	.	.	.	4.448549	0.69197	25.3	0.99305136928065907	0.58857	0.621801	0.60495	D	0.388200223436253	0.60579	4.271038	0.431391921300296	0.63332	4.588634	5.26	4.11	0.47290	5.52	0.94476	3.206	0.50896	9.383000	0.80559	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	2	426	0.004694835680751174	0	0	0	0	0	0	0	0	0	0	0	0	1	52	0.019230769230769232	2	426	0.004694835680751174	0	0	0	3	478	0.006276150627615063	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140754233A>C	ClinGen:CA280016	C1275081|C5681679|C3661900	PS115150	1340|98733	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Asp	Glu	48853	single nucleotide variant	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Dec 29, 2016	397507480	-	RCV000037927|RCV000207514|RCV001813224	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	de novo;germline	germline	GRCh38	NC_000007.14	7	140754233	140754233	7q34	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA280016	2	40383	140754233	A	C	-	-	-	-	-	-	SCV000061591|SCV000263068|SCV002060706	-	-	1695T>G 	Asp565Glu	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Asp565Glu	-2.6309360210738006	0.0338665149617909	2.7720035823390834	0.027614311127530596	2025_01_Batch_13-14	0.552685161673155	0.6687514949660767	0.7068440226909102	0.6391403118674894	0.5217539669056006	0.5001272833154411	0.5939184049658881	0.6536136590776095	0.6767628059356723	0.5102262104531048	0.526406222494298	0.6313349499659824	0.6802288408842598	0.6579515589015809	0.5159900886793527	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003170		NC_000007.14:140754233:A:C		Asp565Glu																												BRAF_Asp565Glu	7	140754233	A	C	7	allele	1695T>G	H04	527_CAVA_Array_P01	O07	B13A7A8P1_R1	B14A7A8P1_R2				7-140754233-A-C	40383	7	140754233	A	C	D	E	rs397507480	7	140454033	7	140100502	565	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1695T>G	p.Asp565Glu	c.1695T>G	p.Asp565Glu	principal4	Y	.	YES	Select	-	GAT	3	2	A	A/A	A/A	A/A	A/A	.	.	.	.	.	.	0.008	0.14667	B	0.025	0.20509	B	.	0.76851	.	.	.	.	-0.19	0.04221	N	.	.	.	.	.	-1.0620	0.11274	T	0.0795	0.31365	T	10	0.86869705	0.85975	D	.	.	.	.	0.82085	0.809	0.92541	P15056	D565E	Gain of catalytic residue at D565 (P = 0.0544)| Gain of ubiquitination at K570 (P = 0.1162)| Gain of methylation at K570 (P = 0.1449)| Gain of disorder (P = 0.2432)| Loss of helix (P = 0.3949)	.	0.97114	.	0.85572	.	0.71418	0.891400456429	0.95428	D	0.799272	0.94819	D	0.275835	0.80817	D	0.158442	0.80570	D	0.875816404819489	0.52308	D	0.918508	0.70644	D	0.80036193	0.83724	0.73096305	0.83912	0.8693574	0.88657	0.7036775	0.82332	-8.348	0.63492	D	0.9665	0.94256	P	0.983874848762311	0.86325	0.99816126	0.98658	0.689	0.82741	.	.	.	.	.	.	4.448549	0.69197	25.3	0.99305136928065907	0.58857	0.621801	0.60495	D	0.388200223436253	0.60579	4.271038	0.431391921300296	0.63332	4.588634	5.26	4.11	0.47290	5.52	0.94476	3.206	0.50896	9.383000	0.80559	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	2	426	0.004694835680751174	0	0	0	0	0	0	0	0	0	0	0	0	1	52	0.019230769230769232	2	426	0.004694835680751174	0	0	0	3	478	0.006276150627615063	Pathogenic/Likely_pathogenic	Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140754233A>C	ClinGen:CA280016	C1275081|C5681679|C3661900	PS115150	1340|98733	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Asp	Glu	48853	single nucleotide variant	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	673	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1	Dec 29, 2016	397507480	-	RCV000037927|RCV000207514|RCV001813224	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	de novo;germline	germline	GRCh38	NC_000007.14	7	140754233	140754233	7q34	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA280016	2	40383	140754233	A	C	-	-	-	-	-	-	SCV000061591|SCV000263068|SCV002060706	-	-	1695T>G 	Asp565Glu	NM_004333.6	2	1_Pathogenic																																																																																																									
BRAF	BRAF_Val600Gly	3.466058469875043	0.010461482848769289	-2.3131620225658573	0.05393497039622505	2025_01_Batch_13-14	0.7373529082522765	0.8261058599222147	0.7598807105682761	0.742019466013257	0.6857756328655163	0.8034884350566569	0.9460347609785704	0.9197325531156546	0.9277834274342123	0.7887870651356114	0.7704206716544667	0.8860703104503926	0.8398066318419654	0.8349014467237346	0.7372813490005639	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF	ENSG00000157764	71969	220618	CCSBVarC003172	ALE00003172	NC_000007.14:140753336:A:C	1799T>G	Val600Gly	CEGS2	CegsMutGDEh1021	A01	GDEhDisVCh_40058	A09	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Val600Gly	7	140753336	A	C	7											7-140753336-A-C	40389	7	140753336	A	C	V	G	rs113488022	7	140453136	7	140099605	600	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1799T>G	p.Val600Gly	c.1799T>G	p.Val600Gly	principal4	Y	.	YES	Select	-	GTG	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.822	0.45782	P	0.963	0.70837	D	.	0.99291	.	.	.	.	1.53	0.38641	L	.	.	.	.	.	-0.3730	0.72748	T	0.3689	0.72751	T	10	0.9087879	0.90136	D	0.179839	0.85412	D	.	0.98152	0.749	0.87927	P15056	V600G	Loss of stability (P = 0.0081)| Gain of disorder (P = 0.0094)| Gain of ubiquitination at K601 (P = 0.0582)| Gain of phosphorylation at S605 (P = 0.152)| Loss of sheet (P = 0.1907)	.	0.98536	.	0.95955	.	0.91438	0.836802065372	0.87585	D	0.854038	0.96676	D	0.414274	0.90651	D	0.357299	0.90535	D	0.995703637599945	0.87816	D	0.874613	0.58418	D	0.9755868	0.98734	0.95782745	0.98836	0.9773177	0.98880	0.9476951	0.98232	-15.5	0.96920	D	0.9773	0.94797	P	0.999897984516839	0.98645	0.99933314	0.99303	1	0.99985	.	.	.	.	.	.	5.376319	0.90129	31.0	0.99637999643544239	0.76475	0.917884	0.88572	D	0.535279311356242	0.69026	5.322119	0.606101544715016	0.75248	6.300693	5.65	5.65	0.86862	.	.	9.236	0.94487	11.216000	0.89597	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardio-facio-cutaneous_syndrome|RASopathy|Melanoma|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140753336A>C	ClinGen:CA281998|Genetic_Testing_Registry_(GTR):GTR000522729|Genetic_Testing_Registry_(GTR):GTR000569880	C1275081|C5555857|C0025202|C3661900	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	48859	single nucleotide variant	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	673	BRAF	HGNC:1097	Pathogenic	1	Jun 25, 2020	113488022	-	RCV000208774|RCV001354831|RCV000798913	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardio-facio-cutaneous syndrome|not provided|RASopathy	germline;unknown	germline	GRCh38	NC_000007.14	7	140753336	140753336	7q34	reviewed by expert panel	4	-	Y	ClinGen:CA281998	3	40389	140753336	A	C	-	-	-	-	-	-	SCV001424737	-	-	1799T>G 	Val600Gly	NM_004333.6	3	1_Pathogenic																																																																																																									
BRAF	BRAF_Val600Gly	3.466058469875043	0.010461482848769289	-2.3131620225658573	0.05393497039622505	2025_01_Batch_13-14	0.7373529082522765	0.8261058599222147	0.7598807105682761	0.742019466013257	0.6857756328655163	0.8034884350566569	0.9460347609785704	0.9197325531156546	0.9277834274342123	0.7887870651356114	0.7704206716544667	0.8860703104503926	0.8398066318419654	0.8349014467237346	0.7372813490005639	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BRAF		71969		CCSBVarC003172		NC_000007.14:140753336:A:C		Val600Gly																												BRAF_Val600Gly	7	140753336	A	C	7	allele	1799T>G	C05	527_CAVA_Array_P01	E09	B13A7A8P1_R1	B14A7A8P1_R2				7-140753336-A-C	40389	7	140753336	A	C	V	G	rs113488022	7	140453136	7	140099605	600	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1799T>G	p.Val600Gly	c.1799T>G	p.Val600Gly	principal4	Y	.	YES	Select	-	GTG	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.822	0.45782	P	0.963	0.70837	D	.	0.99291	.	.	.	.	1.53	0.38641	L	.	.	.	.	.	-0.3730	0.72748	T	0.3689	0.72751	T	10	0.9087879	0.90136	D	0.179839	0.85412	D	.	0.98152	0.749	0.87927	P15056	V600G	Loss of stability (P = 0.0081)| Gain of disorder (P = 0.0094)| Gain of ubiquitination at K601 (P = 0.0582)| Gain of phosphorylation at S605 (P = 0.152)| Loss of sheet (P = 0.1907)	.	0.98536	.	0.95955	.	0.91438	0.836802065372	0.87585	D	0.854038	0.96676	D	0.414274	0.90651	D	0.357299	0.90535	D	0.995703637599945	0.87816	D	0.874613	0.58418	D	0.9755868	0.98734	0.95782745	0.98836	0.9773177	0.98880	0.9476951	0.98232	-15.5	0.96920	D	0.9773	0.94797	P	0.999897984516839	0.98645	0.99933314	0.99303	1	0.99985	.	.	.	.	.	.	5.376319	0.90129	31.0	0.99637999643544239	0.76475	0.917884	0.88572	D	0.535279311356242	0.69026	5.322119	0.606101544715016	0.75248	6.300693	5.65	5.65	0.86862	.	.	9.236	0.94487	11.216000	0.89597	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Cardio-facio-cutaneous_syndrome|RASopathy|Melanoma|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140753336A>C	ClinGen:CA281998|Genetic_Testing_Registry_(GTR):GTR000522729|Genetic_Testing_Registry_(GTR):GTR000569880	C1275081|C5555857|C0025202|C3661900	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	48859	single nucleotide variant	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	673	BRAF	HGNC:1097	Pathogenic	1	Jun 25, 2020	113488022	-	RCV000208774|RCV001354831|RCV000798913	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardio-facio-cutaneous syndrome|not provided|RASopathy	germline;unknown	germline	GRCh38	NC_000007.14	7	140753336	140753336	7q34	reviewed by expert panel	4	-	Y	ClinGen:CA281998	3	40389	140753336	A	C	-	-	-	-	-	-	SCV001424737	-	-	1799T>G 	Val600Gly	NM_004333.6	3	1_Pathogenic																																																																																																									
BRCA1	BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.9374086932621492	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218428	CCSBVarC003305	ALE00003305	NC_000017.11:43063941:A:T	1773T>A	Phe591Leu	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Phe591Leu	17	43063941	A	T	17											17-43063941-A-T	55389	17	43063941	A	T	F	L	rs80357387	17	41215958	17	38469484	1695	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.70900	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.91899320551777408	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	70056	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Apr 26, 2023	80357387	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941	43063941	17q21.31	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2	55389	43063941	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1	3_Conflicting						37999	BRCA1_Adamovich_2022_Cisplatin_var6347	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43063941.0	43063941.0		5085			1695.0	F	I	c.5085T>A	p.Phe1695Ile	missense_variant	-0.25867165925	-0.582208315;-0.028561318;-0.156309496;-0.267607508		No		Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Apr 26, 2023	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant			Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified												1.0330920372	0.77971092599		0.8055131489792701	0.1	0.08214900502816846	Likely Benign																																BRCA1_Phe1695Ile	Phe1695Ile	true
BRCA1	BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.9374086932621492	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003305		NC_000017.11:43063941:A:T		Phe591Leu																												BRCA1_Phe591Leu	17	43063941	A	T	17	allele	1773T>A	E07	527_CAVA_Array_P01	I13	B13A7A8P1_R1	B14A7A8P1_R2				17-43063941-A-T	55389	17	43063941	A	T	F	L	rs80357387	17	41215958	17	38469484	1695	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.70900	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.91899320551777408	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	70056	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Apr 26, 2023	80357387	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941	43063941	17q21.31	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2	55389	43063941	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1	3_Conflicting						37999	BRCA1_Adamovich_2022_Cisplatin_var6347	BRCA1_Adamovich_2022_Cisplatin	BRCA1	1100.0	-1.0		43063941.0	43063941.0		5085			1695.0	F	I	c.5085T>A	p.Phe1695Ile	missense_variant	-0.25867165925	-0.582208315;-0.028561318;-0.156309496;-0.267607508		No		Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Apr 26, 2023	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Cell Viability	Drug Resistance	Cisplatin resistance	No	missense_variant			Functional	(-0.503, Inf)	Normal	LOF	(-Inf, -0.729)	Abnormal	Intermediate	[-0.729,-0.503]	Not specified												1.0330920372	0.77971092599		0.8055131489792701	0.1	0.08214900502816846	Likely Benign																																BRCA1_Phe1695Ile	Phe1695Ile	true
BRCA1	BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.9374086932621492	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1	ENSG00000012048	14613	218428	CCSBVarC003305	ALE00003305	NC_000017.11:43063941:A:T	1773T>A	Phe591Leu	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Phe591Leu	17	43063941	A	T	17											17-43063941-A-T	55389	17	43063941	A	T	F	L	rs80357387	17	41215958	17	38469484	1695	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.70900	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.91899320551777408	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	70056	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Apr 26, 2023	80357387	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941	43063941	17q21.31	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2	55389	43063941	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1	3_Conflicting						46030	BRCA1_Adamovich_2022_HDR_var4885	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43063941.0	43063941.0		5085			1695.0	F	I	c.5085T>A	p.Phe1695Ile	missense_variant	-0.77592481225	-0.763772346;-0.689828835;-0.943148576;-0.70694949		No		Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Apr 26, 2023	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant			Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified												1.0330920372	0.77971092599		0.8055131489792701	0.1	0.08214900502816846	Likely Benign																																BRCA1_Phe1695Ile	Phe1695Ile	true
BRCA1	BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.9374086932621492	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003305		NC_000017.11:43063941:A:T		Phe591Leu																												BRCA1_Phe591Leu	17	43063941	A	T	17	allele	1773T>A	E07	527_CAVA_Array_P01	I13	B13A7A8P1_R1	B14A7A8P1_R2				17-43063941-A-T	55389	17	43063941	A	T	F	L	rs80357387	17	41215958	17	38469484	1695	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.70900	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.91899320551777408	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	70056	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Apr 26, 2023	80357387	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941	43063941	17q21.31	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2	55389	43063941	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1	3_Conflicting						46030	BRCA1_Adamovich_2022_HDR_var4885	BRCA1_Adamovich_2022_HDR	BRCA1	1100.0	-1.0		43063941.0	43063941.0		5085			1695.0	F	I	c.5085T>A	p.Phe1695Ile	missense_variant	-0.77592481225	-0.763772346;-0.689828835;-0.943148576;-0.70694949		No		Conflicting classifications of pathogenicity	criteria provided, conflicting classifications	Apr 26, 2023	aa		ENST00000357654.9	NM_007294.4	immortalized human cells	Reporter	Fluorescence	Homology Directed Repair	No	missense_variant			Functional	(-0.233, Inf)	Normal	LOF	(-Inf, -0.562)	Abnormal	Intermediate	[-0.562,-0.233]	Not specified												1.0330920372	0.77971092599		0.8055131489792701	0.1	0.08214900502816846	Likely Benign																																BRCA1_Phe1695Ile	Phe1695Ile	true
SHOC2	SHOC2_Ser57Phe	-1.2094902213471577	0.26573292360703604	3.471311167785418	0.010387464454151103	2025_01_Batch_13-14	0.529813433537089	0.6792801073072422	0.6143298928196269	0.5861049791074834	0.49563981606248964	0.9046983987114122	0.8257663079559578	0.7470538531880919	0.9234824052972537	0.6777269059748217	0.7172559161242507	0.7525232076316	0.6806918730038594	0.7547936922023686	0.5866833610186557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	SHOC2		11602		CCSBVarC028011		NC_000010.11:110964528:C:T		Ser57Phe																												SHOC2_Ser57Phe	10	110964528	C	T	10	allele	170C>T	C02	527_CAVA_Array_P06	E04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964528-C-T	179760	10	110964528	C	T	S	F	rs536611911	10	112724286	10	112714276	57	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.170C>T	p.Ser57Phe	principal1	Y	.	.	.	+	TCC	2	0	C	C/C	C/C	C/C	C/C	.	0.48802	.	.	0.59495	.	0.214	0.33016	B	0.191	0.42849	B	.	0.63842	.	.	.	.	1.7	0.43657	L	.	0.42386	.	.	0.41012	0.3313	0.87999	D	0.7029	0.89743	D	10	.	0.24349	.	0.049509	0.63705	D	.	0.73303	0.197	0.10912	Q9UQ13	S57F	Loss of phosphorylation at S57 (P = 0.0075)| Loss of relative solvent accessibility (P = 0.0676)| Loss of loop (P = 0.0804)| Gain of helix (P = 0.0854)| Gain of methylation at K55 (P = 0.0918)	.	0.33999	.	0.11358	.	0.58683	0.648043274879	0.59645	T	0.393088	0.75087	T	-0.0567598	0.43068	T	-0.0642621	0.65789	T	0.111457248625392	0.13402	T	.	0.73431	.	0.24477392	0.47101	0.22556585	0.47330	0.24477392	0.47101	0.22556585	0.47329	-6.9	0.53367	T	.	0.31154	.	0.980925639856185	0.85540	0.01493649	0.46015	0.355	0.61325	.	.	.	.	.	.	3.839	0.55624	23.6	0.99584984580791636	0.73250	0.764929	0.70048	D	0.262239601804826	0.54016	3.590762	0.442202180045834	0.64024	4.67194	5.99	5.99	0.97294	3.68	0.67565	6.109	0.71273	7.666000	0.64570	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.993	0.69292	915	0.20912	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	10	264690	3.7780046E-5	.	7	109336	6.402280e-05	0	21	207858	1.010310e-04	0	23	236064	9.743120e-05	0	0	7148	0.000000e+00	0	2	17094	1.170000e-04	0	0	2320	0.000000e+00	0	0	9036	0.000000e+00	0	0	13392	0.000000e+00	0	4	42762	9.354100e-05	0	1	15672	6.380810e-05	0	2	17094	1.170000e-04	0	0	16156	0.000000e+00	0	4	30470	1.312770e-04	0	0	6204	0.000000e+00	0	0	13392	0.000000e+00	0	0	16728	0.000000e+00	0	14	89460	1.564950e-04	0	3	30590	9.807130e-05	0	14	89460	1.564950e-04	0	0	14884	0.000000e+00	0	5	34202	1.461900e-04	0	0	9540	0.000000e+00	0	0	17678	0.000000e+00	0	0	21616	0.000000e+00	0	15	102040	1.470010e-04	0	3	30508	9.833490e-05	0	15	102040	1.470010e-04	0	.	87	1614030	5.390230e-05	1	1	6062	1.649620e-04	0	0	75008	0.000000e+00	0	0	912	0.000000e+00	0	9	59982	1.500450e-04	0	0	29606	0.000000e+00	0	0	44872	0.000000e+00	0	0	64008	0.000000e+00	0	1	6062	1.649620e-04	0	67	1179988	5.678020e-05	1	6	91084	6.587330e-05	0	4	42688	9.37031484257871E-5	0	306	0	0	112	0	0	8020	0	0	500	0	0	628	0	0	56	0	0	98	0	1	8288	1.2065637065637066E-4	0	8326	0	0	168	0	5	60696	8.237775141689732E-5	Conflicting_classifications_of_pathogenicity	Cardiovascular_phenotype|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964528C>T	ClinGen:CA185080	CN230736|C3661900|C5555857|C4478716|CN169374	607721	536391|2701	.	Ser	Phe	174882	single nucleotide variant	NM_007373.4(SHOC2):c.170C>T (p.Ser57Phe)	8036	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0	Nov 25, 2024	536611911	-	RCV000156558|RCV000680347|RCV000471315|RCV001803094|RCV002399558	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MedGen:CN230736	not specified|not provided|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964528	110964528	10q25.2	criteria provided, conflicting classifications	7	-	N	ClinGen:CA185080	2	179760	110964528	C	T	-	-	-	-	-	-	SCV000206277|SCV000547943|SCV000576695|SCV002048966|SCV002712264|SCV003933893|SCV004127491	-	-	170C>T 	Ser57Phe	NM_007373.4	1	3_Conflicting																																																																																																									
CTCF	CTCF_Arg283His	-2.8543577306982333	0.029015397120621497	7.650237629061512	0.00012112361894122482																											true	CTCF		6173		CCSBVarC010089		NC_000016.10:67612017:G:A		Arg283His																												CTCF_Arg283His	16	67612017	G	A	16	allele	848G>A	H02	527_CAVA_Array_P02	O04	B13A7A8P1_R1	B14A7A8P1_R2				16-67612017-G-A	562205	16	67612017	G	A	R	H	rs1567609067	16	67645920	16	66203421	283	CTCF	ENSG00000102974	ENST00000645699	ENSP00000495348	P49711	CTCF_HUMAN	c.848G>A	p.Arg283His	c.848G>A	p.Arg283His	principal4	Y	.	.	.	+	CGT	2	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.92967	.	1.0	0.90580	D	0.995	0.83178	D	.	0.86984	.	.	.	.	2.24	0.63167	M	.	0.79176	.	.	0.58756	-0.8767	0.49824	T	0.1674	0.50470	T	10	0.6709697	0.70446	D	0.014554	0.34485	T	.	0.76627	0.452	0.51309	P49711	R283H	Gain of ubiquitination at K286 (P = 0.0316)| Gain of catalytic residue at R283 (P = 0.0879)| Loss of helix (P = 0.1299)| Loss of phosphorylation at S287 (P = 0.1428)| Loss of MoRF binding (P = 0.1691)	.	0.73499	.	0.91243	.	0.99706	0.931223094463	0.99055	D	0.828034	0.95832	D	0.123205	0.66453	D	-0.0608014	0.66034	T	0.991913670484721	0.82143	D	0.90471	0.67082	D	0.6065627	0.72760	0.50243187	0.70979	0.5759158	0.71095	0.5171902	0.71847	-14.045	0.93215	D	0.9988	0.98152	P	0.988895031134616	0.87966	0.86772230	0.90157	0.94	0.97139	.	.	.	.	.	.	5.495371	0.91538	32.0	0.99945887693281887	0.99901	0.927010	0.90866	D	0.877484641891404	0.90563	10.48455	0.857972629028617	0.93436	12.06598	5.18	5.18	0.71100	4.73	0.87084	10.003	0.9969	11.852000	0.98109	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.982	0.59239	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614106	6.195380e-07	0	1	1179998	8.474590e-07	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	60010	0.000000e+00	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	64016	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179998	8.474590e-07	0	0	91084	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67612017G>A	.	C3809686	615502	363611	Zinc finger C2H2-type|Zinc finger C2H2-type|Zinc finger C2H2-type|Zinc finger C2H2-type	Arg	His	553394	single nucleotide variant	NM_006565.4(CTCF):c.848G>A (p.Arg283His)	10664	CTCF	HGNC:13723	Likely pathogenic	1	Dec 21, 2019	1567609067	-	RCV000681644	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	de novo	germline	GRCh38	NC_000016.10	16	67612017	67612017	16q22.1	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA396309112	2	562205	67612017	G	A	-	-	-	-	-	-	SCV000809090|SCV002026290	-	-	848G>A 	Arg283His	NM_006565.4	2	1_Pathogenic						963647	CTCF_unpublished_var157894	CTCF_unpublished	CTCF	13723.0	1.0		67612017.0	67612017.0		848	G	A	283.0	R	H	c.848G>A	p.Arg283His	missense_variant	-0.00907555		functionally_normal	Yes	6.195379981240389e-7	Likely pathogenic	criteria provided, multiple submitters, no conflicts	Dec 21, 2019	nucleotide		ENST00000264010.10	NM_006565.4	immortalized human cells	Cell viability	Cell survival	overall function	Yes	missense_variant		0.475																																																											CTCF_Arg283His	Arg283His	true
BRCA1	BRCA1_Arg71Lys	0.07187573777971566	0.9447113095236084	2.3731690749830956	0.049375562988145376	2025_01_Batch_13-14	0.9330729959912141	0.9452772116535713	0.8545819894997295	0.9024167501696188	0.7431486177108632	0.9796857254805389	0.9318387526566191	0.937694960222789	0.9745554138250025	0.9081625358729246	0.9563793607358765	0.9385579821550951	0.8961384748612593	0.9384860819973107	0.8256555767918938	1.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	true	BRCA1		14613		CCSBVarC003297		NC_000017.11:43106456:C:T		Arg71Lys																												BRCA1_Arg71Lys	17	43106456	C	T	17	allele	212G>A	H06	527_CAVA_Array_P01	O11	B13A7A8P1_R1	B14A7A8P1_R2				17-43106456-C-T	54471	17	43106456	C	T	R	K	rs80356913	17	41258473	17	38511999	71	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.212G>A	p.Arg71Lys	c.212G>A	p.Arg71Lys	principal2	Y	1	.	.	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.016	0.68204	D	0.9	0.59057	P	0.275	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	-0.66	0.59576	N	.	0.78462	0.7801	0.94146	D	0.8430	0.94745	D	9	0.82008123	0.81025	D	0.514985	0.95351	D	0.737	0.90816	0.727	0.86044	E9PFC7	R71K	Gain of methylation at R71 (P = 0.0062)| Gain of relative solvent accessibility (P = 0.0522)| Gain of ubiquitination at R71 (P = 0.068)| Gain of disorder (P = 0.0771)| Gain of solvent accessibility (P = 0.1456)	0.968767862813	0.96814	.	0.47432	.	0.17790	0.610298812389	0.54292	T	0.29865	0.66937	T	0.411382	0.90492	D	0.353145	0.90373	D	0.960748553276062	0.65672	D	.	0.27626	.	0.80958927	0.84328	0.4717919	0.69118	0.759881	0.81221	0.3838624	0.63093	-8.907	0.67174	D	0.7791	0.80812	LP	0.996372846491178	0.92086	0.99942493	0.99371	0.917	0.95747	.	.	.	.	.	.	5.467383	0.91245	32.0	0.99505402231752338	0.68305	0.849361	0.76532	D	0.589132871463434	0.72350	5.814887	0.56907193894025	0.72585	5.856808	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43106456C>T	ClinGen:CA001420|UniProtKB:P38398#VAR_020681	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	.	Arg	Lys	69138	single nucleotide variant	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	672	BRCA1	HGNC:1100	Pathogenic	1	Jul 30, 2024	80356913	-	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106456	43106456	17q21.31	criteria provided, multiple submitters, no conflicts	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	2	54471	43106456	C	T	-	-	-	-	-	-	SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672	-	-	212G>A 	Arg71Lys	NM_007294.4	2	1_Pathogenic	17	43106456	C	T	0.0																																																																																																				
BRCA1	BRCA1_Met548Ile	0.2873204807817469	0.7821863607221871	4.279146156570467	0.003659222814302877	2025_01_Batch_13-14	0.9785719900798429	0.9429073217627154	0.924181783445701	0.9557560006145543	0.8910223522970666	0.9890623605680183	0.9493701734682697	0.9512223971201553	0.9882025107135686	0.9632357125212221	0.9838171753239306	0.9461387476154925	0.9377020902829282	0.9719792556640614	0.9271290324091443	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	true	BRCA1		14613		CCSBVarC013069		NC_000017.11:43070958:C:T		Met548Ile																												BRCA1_Met548Ile	17	43070958	C	T	17	allele	1644G>A	G10	527_CAVA_Array_P01	M19	B13A7A8P1_R1	B14A7A8P1_R2				17-43070958-C-T	41830	17	43070958	C	T	M	I	rs1799967	17	41222975	17	38476501	1652	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4956G>A	p.Met1652Ile	principal2	Y	1	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	.	0.33898	.	.	0.36968	.	0.0	0.28566	B	0.004	0.29523	B	.	0.16373	.	.	.	.	0.175	0.08964	N	.	0.38141	.	.	0.33676	-0.8538	0.51511	T	0.1432	0.46308	T	10	.	0.00157	.	.	.	.	.	0.73230	.	.	.	.	.	.	.	.	0.30010	.	0.10046	0.360434174538	0.19429	T	0.099528	0.40156	T	-0.195766	0.21097	T	-0.0261181	0.68398	D	0.0072100418028408	0.00082	T	.	0.64025	.	0.19599688	0.41094	0.13775083	0.32824	0.25679418	0.48390	0.11591255	0.27917	-4.756	0.35788	T	.	0.64691	.	0.164986458329954	0.48018	0.95295440	0.93539	0.216	0.48172	.	.	.	.	.	.	2.32095	0.29778	18.21	0.96644426836776054	0.30766	0.454853	0.50568	N	-0.274289964374125	0.29865	1.678113	-0.0674097859341404	0.36444	2.142461	4.82	3.78	0.42561	3.78	0.69545	1.313	0.33295	2.710000	0.34310	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	544	0.72706	56	0.011182108626198083	0	0.0	16	0.015904572564612324	3	0.004322766570605188	0	0.0	37	0.03783231083844581	2323	264690	0.008776304	.	2157	109398	1.971700e-02	48	3761	207690	1.810870e-02	80	4287	236388	1.813540e-02	88	10	7164	1.395870e-03	0	64	17110	3.740500e-03	0	67	2320	2.887930e-02	0	1	9046	1.105460e-04	0	723	13386	5.401170e-02	25	632	42768	1.477740e-02	3	626	15690	3.989800e-02	20	626	15690	3.989800e-02	20	30	16216	1.850020e-03	0	114	30522	3.735010e-03	0	157	6210	2.528180e-02	1	2	13416	1.490760e-04	0	890	16726	5.321060e-02	31	1317	89130	1.477620e-02	11	1163	30608	3.799660e-02	37	1163	30608	3.799660e-02	37	27	14902	1.811840e-03	0	144	34258	4.203400e-03	0	225	9568	2.351590e-02	2	2	17692	1.130450e-04	0	1113	21624	5.147060e-02	37	1517	102208	1.484230e-02	12	1159	30526	3.796760e-02	37	1159	30526	3.796760e-02	37	.	23606	1614160	1.462430e-02	338	3175	64006	4.960470e-02	99	143	75032	1.905850e-03	0	7	910	7.692310e-03	0	271	60024	4.514860e-03	0	679	29608	2.293300e-02	8	5	44892	1.113780e-04	0	3175	64006	4.960470e-02	99	143	6062	2.358960e-02	3	15052	1180032	1.275560e-02	119	3269	91088	3.588840e-02	99	3242	204736	0.015835026570803375	1	394	0.0025380710659898475	0	4556	0	31	10580	0.0029300567107750472	8	818	0.009779951100244499	9	1028	0.008754863813229572	0	1850	0	6	280	0.02142857142857143	228	18068	0.012618994908124861	32	10974	0.00291598323309641	0	6406	0	3525	242310	0.014547480500185712	Benign	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43070958C>T	BRCA1-HCI:BRCA1_00107|ClinGen:CA003103|UniProtKB:P38398#VAR_007795	C3661900|C0677776|C0027672|CN169374|C2676676|C0346153|C0006142	604370|114480	145|140162|145|227535	BRCT domain|BRCT domain|BRCT domain	Met	Ile	50269	single nucleotide variant	NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	1799967	-	RCV000034756|RCV000128916|RCV000048709|RCV000112434|RCV000120261|RCV000476093|RCV001270155|RCV004803120	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070958	43070958	17q21.31	reviewed by expert panel	46	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795	2	41830	43070958	C	T	-	-	-	-	-	-	SCV000244374	-	-	4956G>A 	Met1652Ile	NM_007294.4	3	2_Benign																																																																																																									
F9	F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066757	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		175250	F9_Popp_2025_carboxy_gla_motif_var258270	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139561904.0	139561904.0		1219			407.0	C	R	c.1219T>C	p.Cys407Arg	missense_variant	0.6380485317766402			No					aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Cys407Arg	Cys407Arg	true
F9	F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066757	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		230282	F9_Popp_2025_light_chain_var248589	F9_Popp_2025_light_chain	F9	3551.0	1.0		139561904.0	139561904.0		1219			407.0	C	R	c.1219T>C	p.Cys407Arg	missense_variant	0.65979911			No					aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Cys407Arg	Cys407Arg	true
F9	F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066757	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		147734	F9_Popp_2025_carboxy_F9_specific_var229227	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139561904.0	139561904.0		1219			407.0	C	R	c.1219T>C	p.Cys407Arg	missense_variant	0.5418123518159481			No					aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Cys407Arg	Cys407Arg	true
F9	F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066757	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		202766	F9_Popp_2025_heavy_chain_var238908	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139561904.0	139561904.0		1219			407.0	C	R	c.1219T>C	p.Cys407Arg	missense_variant	0.7058586342175659			No					aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Cys407Arg	Cys407Arg	true
F9	F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066757	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																		257798	F9_Popp_2025_strep_2_var267951	F9_Popp_2025_strep_2	F9	3551.0	1.0		139561904.0	139561904.0		1219			407.0	C	R	c.1219T>C	p.Cys407Arg	missense_variant	0.8486724561616644			No					aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.969																																																											F9_Cys407Arg	Cys407Arg	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						133516	F9_Popp_2025_carboxy_F9_specific_var224241	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	0.019039701			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						133516	F9_Popp_2025_carboxy_F9_specific_var224241	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	0.019039701			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						216064	F9_Popp_2025_light_chain_var243603	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	0.004052954			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						216064	F9_Popp_2025_light_chain_var243603	F9_Popp_2025_light_chain	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	0.004052954			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						243580	F9_Popp_2025_strep_2_var262965	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	0.0135093224369561			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						243580	F9_Popp_2025_strep_2_var262965	F9_Popp_2025_strep_2	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	0.0135093224369561			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						188548	F9_Popp_2025_heavy_chain_var233922	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	-0.002632687			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						188548	F9_Popp_2025_heavy_chain_var233922	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	-0.002632687			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						161032	F9_Popp_2025_carboxy_gla_motif_var253284	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	-0.001641377			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
F9	F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039861	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545488	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	true	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic						161032	F9_Popp_2025_carboxy_gla_motif_var253284	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139548480.0	139548480.0		509			170.0	C	Y	c.509G>A	p.Cys170Tyr	missense_variant	-0.001641377			No		Pathogenic	criteria provided, single submitter	Jun 28, 2019	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.971																																																											F9_Cys170Tyr	Cys170Tyr	true
BCL10	BCL10_Leu8Leu	-1.5935383687852434	0.1862617008735539	1.7560029875605396	0.12251506527087934	2025_01_Batch_13-14	0.5357539018783427	0.6352976459867357	0.6633090920136241	0.6918685112520384	0.4938630142328672	0.8823529411764706	0.7592329523787694	0.7647016099856008	0.8212394456232323	0.579185520361991	0.7090534215274067	0.6972652991827526	0.7140053509996125	0.7565539784376354	0.5365242672974291	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BCL10	ENSG00000142867	11832	20121	CCSBVarC001764	ALE00001764	NC_000001.11:85276329:G:C	24C>G	Leu8Leu	RC4	RC4_Mut_GDEh1005	A04	GDEhDisVCh_40010	E03	2	RC4_Mut_GDDh1005	A04	NULL	NULL	VUSMutpDEST2_09	G09	VUSmut_GDEh12	C07	1	1	1	1	0			1	1	1	1	1	1	BCL10_Leu8Leu	1	85276329	G	C	1											1-85276329-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																													1	85276329	G	C	0.295966																																																																																																				
BCL10	BCL10_Leu8Leu	-1.5935383687852434	0.1862617008735539	1.7560029875605396	0.12251506527087934	2025_01_Batch_13-14	0.5357539018783427	0.6352976459867357	0.6633090920136241	0.6918685112520384	0.4938630142328672	0.8823529411764706	0.7592329523787694	0.7647016099856008	0.8212394456232323	0.579185520361991	0.7090534215274067	0.6972652991827526	0.7140053509996125	0.7565539784376354	0.5365242672974291	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	BCL10		11832		CCSBVarC001764		NC_000001.11:85276329:G:C		Leu8Leu																												BCL10_Leu8Leu	1	85276329	G	C	1	allele	24C>G	D03	527_CAVA_Array_P01	G05	B13A7A8P1_R1	B14A7A8P1_R2				1-85276329-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																													1	85276329	G	C	0.295966																																																																																																				
RET	RET_Arg313Gln	-2.285823693071175	0.05615212771343529	5.8231339538018	0.0006480669481361119	2025_01_Batch_13-14	0.9161398862175612	0.8072101041676472	0.7295364397706064	0.7379005221049658	0.9027683134943302	0.7932106296157398	0.8362920594514416	0.8350719839598196	0.8951382626290518	0.6446830720386535	0.8546752579166506	0.8217510818095444	0.782304211865213	0.8165193923670089	0.7737256927664918	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET	ENSG00000165731	8858	202958	CCSBVarC006882	ALE00006880	NC_000010.11:43106446:G:A	938G>A	Arg313Gln	CEGS2	CegsMutGDEh1024	A02	GDEhDisVCh_40066	A05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Arg313Gln	10	43106446	G	A	10											10-43106446-G-A	13932	10	43106446	G	A	R	Q	rs77702891	10	43601894	10	42921900	313	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.938G>A	p.Arg313Gln	c.938G>A	p.Arg313Gln	principal4	Y	5	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.017	0.51407	D	0.116	0.36834	T	0.943	0.56216	P	0.173	0.45142	B	0.64	0.79151	D	simple_aae	36.0	64.0	2.44	0.70564	M	-0.65	0.18812	N	0.45	0.48537	-0.6073	0.64360	T	0.3274	0.69436	T	10	0.22862077	0.39382	T	0.13682	0.81879	D	0.552	0.81390	0.723	0.85693	P07949	R313Q	Gain of sheet (P = 0.0049)| Gain of loop (P = 0.0312)| Loss of stability (P = 0.1084)| Loss of phosphorylation at T315 (P = 0.1211)| Gain of glycosylation at S316 (P = 0.2382)	0.928844329528	0.92757	0.8295473270931635	0.82810	0.306023030952	0.32606	0.403721630573	0.25557	T	0.452479	0.79124	T	-0.102543	0.35646	T	-0.0018559	0.69996	D	0.158066955150649	0.17507	T	0.875612	0.58615	D	0.2721727	0.49956	0.13592933	0.32442	0.18244144	0.39154	0.08550162	0.19721	-4.117	0.26502	T	0.1404	0.33018	B	0.547894901457323	0.62233	0.99958426	0.99505	0.446	0.67864	.	.	.	.	.	.	3.504925	0.49142	22.7	0.9989321191735554	0.96668	0.080145	0.16005	N	0.0737859261210792	0.44985	2.784067	0.0662528309478524	0.42582	2.600265	5.32	2.2	0.26894	2.0	0.39643	2.392	0.44189	6.435000	0.55709	0.672	0.70176	0.959	0.33632	1.000000	0.68239	0.71	0.34491	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	13	108632	1.196700e-04	0	26	206054	1.261810e-04	0	30	234958	1.276820e-04	0	0	7066	0.000000e+00	0	13	17006	7.644360e-04	0	0	2304	0.000000e+00	0	0	8992	0.000000e+00	0	0	13308	0.000000e+00	0	0	42460	0.000000e+00	0	0	15588	0.000000e+00	0	13	17006	7.644360e-04	0	0	15982	0.000000e+00	0	24	30344	7.909310e-04	0	1	6162	1.622850e-04	0	0	13304	0.000000e+00	0	0	16628	0.000000e+00	0	1	88370	1.131610e-05	0	0	30438	0.000000e+00	0	24	30344	7.909310e-04	0	0	14734	0.000000e+00	0	26	34094	7.625980e-04	0	1	9550	1.047120e-04	0	0	17626	0.000000e+00	0	0	21064	0.000000e+00	0	2	101936	1.962020e-05	0	0	30362	0.000000e+00	0	26	34094	7.625980e-04	0	.	45	1613324	2.789270e-05	0	30	59952	5.004000e-04	0	1	74906	1.335010e-05	0	0	912	0.000000e+00	0	30	59952	5.004000e-04	0	1	29586	3.379980e-05	0	0	44874	0.000000e+00	0	0	63780	0.000000e+00	0	0	6052	0.000000e+00	0	9	1179830	7.628220e-06	0	2	90976	2.198380e-05	0	0	15826	0	0	122	0	0	146	0	1	3804	2.628811777076761E-4	0	146	0	0	610	0	0	56	0	0	104	0	0	2876	0	1	3926	2.5471217524197657E-4	0	202	0	1	23690	4.2211903756859436E-5	Uncertain_significance	Multiple_endocrine_neoplasia,_type_2|not_provided|Pheochromocytoma|Hirschsprung_disease,_susceptibility_to,_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43106446G>A	ClinGen:CA009384|OMIM:164761.0028|UniProtKB:P07949#VAR_009465	C4048306|C3661900|C0031511|C3888239|C1833921|C0025268|C0025269|C0027672	171300|142623|155240|171400|162300	653|29072|388|653|99361|247698|653|247709|653|140162	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	28971	single nucleotide variant	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	5979	RET	HGNC:9967	Uncertain significance	0	Jan 24, 2025	77702891	-	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361|MedGen:C3661900	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Multiple endocrine neoplasia type 2B;Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Familial medullary thyroid carcinoma|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106446	43106446	10q11.21	criteria provided, multiple submitters, no conflicts	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	3	13932	43106446	G	A	-	-	-	-	-	-	SCV000674841|SCV000776486|SCV000785424|SCV000896054|SCV003798648|SCV004018491|SCV005623124	-	-	938G>A 	Arg313Gln	NM_020975.6	2	4_VUS	10	43106446	G	A	0.0000287445																																																																																																				
RET	RET_Arg313Gln	-2.285823693071175	0.05615212771343529	5.8231339538018	0.0006480669481361119	2025_01_Batch_13-14	0.9161398862175612	0.8072101041676472	0.7295364397706064	0.7379005221049658	0.9027683134943302	0.7932106296157398	0.8362920594514416	0.8350719839598196	0.8951382626290518	0.6446830720386535	0.8546752579166506	0.8217510818095444	0.782304211865213	0.8165193923670089	0.7737256927664918	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	RET		8858		CCSBVarC006882		NC_000010.11:43106446:G:A		Arg313Gln																												RET_Arg313Gln	10	43106446	G	A	10	allele	938G>A	A09	527_CAVA_Array_P05	A17	B13A7A8P2_R1	B14A7A8P2_R2				10-43106446-G-A	13932	10	43106446	G	A	R	Q	rs77702891	10	43601894	10	42921900	313	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.938G>A	p.Arg313Gln	c.938G>A	p.Arg313Gln	principal4	Y	5	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.017	0.51407	D	0.116	0.36834	T	0.943	0.56216	P	0.173	0.45142	B	0.64	0.79151	D	simple_aae	36.0	64.0	2.44	0.70564	M	-0.65	0.18812	N	0.45	0.48537	-0.6073	0.64360	T	0.3274	0.69436	T	10	0.22862077	0.39382	T	0.13682	0.81879	D	0.552	0.81390	0.723	0.85693	P07949	R313Q	Gain of sheet (P = 0.0049)| Gain of loop (P = 0.0312)| Loss of stability (P = 0.1084)| Loss of phosphorylation at T315 (P = 0.1211)| Gain of glycosylation at S316 (P = 0.2382)	0.928844329528	0.92757	0.8295473270931635	0.82810	0.306023030952	0.32606	0.403721630573	0.25557	T	0.452479	0.79124	T	-0.102543	0.35646	T	-0.0018559	0.69996	D	0.158066955150649	0.17507	T	0.875612	0.58615	D	0.2721727	0.49956	0.13592933	0.32442	0.18244144	0.39154	0.08550162	0.19721	-4.117	0.26502	T	0.1404	0.33018	B	0.547894901457323	0.62233	0.99958426	0.99505	0.446	0.67864	.	.	.	.	.	.	3.504925	0.49142	22.7	0.9989321191735554	0.96668	0.080145	0.16005	N	0.0737859261210792	0.44985	2.784067	0.0662528309478524	0.42582	2.600265	5.32	2.2	0.26894	2.0	0.39643	2.392	0.44189	6.435000	0.55709	0.672	0.70176	0.959	0.33632	1.000000	0.68239	0.71	0.34491	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	13	108632	1.196700e-04	0	26	206054	1.261810e-04	0	30	234958	1.276820e-04	0	0	7066	0.000000e+00	0	13	17006	7.644360e-04	0	0	2304	0.000000e+00	0	0	8992	0.000000e+00	0	0	13308	0.000000e+00	0	0	42460	0.000000e+00	0	0	15588	0.000000e+00	0	13	17006	7.644360e-04	0	0	15982	0.000000e+00	0	24	30344	7.909310e-04	0	1	6162	1.622850e-04	0	0	13304	0.000000e+00	0	0	16628	0.000000e+00	0	1	88370	1.131610e-05	0	0	30438	0.000000e+00	0	24	30344	7.909310e-04	0	0	14734	0.000000e+00	0	26	34094	7.625980e-04	0	1	9550	1.047120e-04	0	0	17626	0.000000e+00	0	0	21064	0.000000e+00	0	2	101936	1.962020e-05	0	0	30362	0.000000e+00	0	26	34094	7.625980e-04	0	.	45	1613324	2.789270e-05	0	30	59952	5.004000e-04	0	1	74906	1.335010e-05	0	0	912	0.000000e+00	0	30	59952	5.004000e-04	0	1	29586	3.379980e-05	0	0	44874	0.000000e+00	0	0	63780	0.000000e+00	0	0	6052	0.000000e+00	0	9	1179830	7.628220e-06	0	2	90976	2.198380e-05	0	0	15826	0	0	122	0	0	146	0	1	3804	2.628811777076761E-4	0	146	0	0	610	0	0	56	0	0	104	0	0	2876	0	1	3926	2.5471217524197657E-4	0	202	0	1	23690	4.2211903756859436E-5	Uncertain_significance	Multiple_endocrine_neoplasia,_type_2|not_provided|Pheochromocytoma|Hirschsprung_disease,_susceptibility_to,_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43106446G>A	ClinGen:CA009384|OMIM:164761.0028|UniProtKB:P07949#VAR_009465	C4048306|C3661900|C0031511|C3888239|C1833921|C0025268|C0025269|C0027672	171300|142623|155240|171400|162300	653|29072|388|653|99361|247698|653|247709|653|140162	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	28971	single nucleotide variant	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	5979	RET	HGNC:9967	Uncertain significance	0	Jan 24, 2025	77702891	-	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361|MedGen:C3661900	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Multiple endocrine neoplasia type 2B;Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Familial medullary thyroid carcinoma|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106446	43106446	10q11.21	criteria provided, multiple submitters, no conflicts	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	3	13932	43106446	G	A	-	-	-	-	-	-	SCV000674841|SCV000776486|SCV000785424|SCV000896054|SCV003798648|SCV004018491|SCV005623124	-	-	938G>A 	Arg313Gln	NM_020975.6	2	4_VUS	10	43106446	G	A	0.0000287445																																																																																																				
RHO	RHO_Arg135Leu	-12.702939872581677	0.000014596173777115511	-16.56586795614291	7.132389771413138e-7																											true	RHO		40080645		CCSBVarC013572		NC_000003.12:129530918:G:T		Arg135Leu																												RHO_Arg135Leu	3	129530918	G	T	3	allele	404G>T	H09	527_CAVA_Array_P05	O17	B13A7A8P2_R1	B14A7A8P2_R2				3-129530918-G-T	13024	3	129530918	G	T	R	L	rs104893774	3	129249761	3	130732451	135	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.404G>T	p.Arg135Leu	c.404G>T	p.Arg135Leu	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.91	0.92786	A	simple_aae	9.0	91.0	4.615	0.99277	H	-6.23	0.90509	D	0.97	0.98079	1.0503	0.98119	D	0.9764	0.99265	D	9	0.9948666	0.99965	D	0.840639	0.98765	D	0.968	0.99597	0.974	0.99756	P08100	R135L	Loss of helix (P = 0.1299)| Loss of catalytic residue at R135 (P = 0.2691)| Loss of sheet (P = 0.3635)| Loss of MoRF binding (P = 0.5071)| Loss of methylation at R135 (P = 0.5619)	0.98827829176	0.98802	0.9888686249646876	0.98877	0.96835728464	0.73109	0.741208970547	0.73104	T	0.917148	0.98469	D	0.601351	0.97648	D	0.626023	0.97612	D	0.999884724617004	0.99520	D	0.987601	0.95789	D	0.99405295	0.99935	0.990934	0.99984	0.9952068	0.99966	0.9928624	0.99993	-14.459	0.94464	D	0.9903	0.93677	P	0.999591189859181	0.97117	0.99994111	0.99939	1	0.99985	.	.	.	.	.	.	5.717174	0.93214	33.0	0.99862863388442769	0.94097	0.913237	0.87450	D	1.11802429763009	0.98445	18.32383	0.99406423223557	0.98501	18.48321	5.26	5.26	0.73443	4.99	0.89858	9.996	0.99292	11.810000	0.96911	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.996	0.76032	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	not_provided|Retinitis_pigmentosa_4	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129530918G>T	ClinGen:CA256671|OMIM:180380.0011|UniProtKB:P08100#VAR_004796	C3661900|C3151001	613731	791	GPCR, rhodopsin-like, 7TM	Arg	Leu	28063	single nucleotide variant	NM_000539.3(RHO):c.404G>T (p.Arg135Leu)	6010	RHO	HGNC:10012	Pathogenic	1	Sep 26, 2022	104893774	-	RCV000013898|RCV000256085	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900	Retinitis pigmentosa 4|not provided	germline	germline	GRCh38	NC_000003.12	3	129530918	129530918	3q22.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA256671,UniProtKB:P08100#VAR_004796,OMIM:180380.0011	3	13024	129530918	G	T	-	-	-	-	-	-	SCV000322377|SCV001573657|SCV001590839	-	-	404G>T 	Arg135Leu	NM_000539.3	2	1_Pathogenic						999340	RHO_Wan_2019_var220547	RHO_Wan_2019	RHO	10012.0	1.0		129530918.0	129530918.0		404	G	T	135.0	R	L	c.404G>T	p.Arg135Leu	missense_variant	0.5848284926450827			No		Pathogenic	criteria provided, multiple submitters, no conflicts	Sep 26, 2022	nucleotide	urn:mavedb:00000099-a-1	ENST00000296271.4	NM_000539.3	immortalized human cells	Reporter	Fluorescence	cell surface expression	No	missense_variant		0.968																																																											RHO_Arg135Leu	Arg135Leu	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9	ENSG00000101981	52861	204367	CCSBVarC004381	ALE00004381	NC_000023.11:139560821:T:G	804T>G	Cys268Trp	CEGS2	CegsMutGDEh1017	E01	GDEhDisVCh_40052	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys268Trp	23	139560821	T	G	X											X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						249462	F9_Popp_2025_strep_2_var265024	F9_Popp_2025_strep_2	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	-0.024638799			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9		52861		CCSBVarC004381		NC_000023.11:139560821:T:G		Cys268Trp																												F9_Cys268Trp	23	139560821	T	G	X	allele	804T>G	F09	527_CAVA_Array_P02	K18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						249462	F9_Popp_2025_strep_2_var265024	F9_Popp_2025_strep_2	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	-0.024638799			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-a-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9	ENSG00000101981	52861	204367	CCSBVarC004381	ALE00004381	NC_000023.11:139560821:T:G	804T>G	Cys268Trp	CEGS2	CegsMutGDEh1017	E01	GDEhDisVCh_40052	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys268Trp	23	139560821	T	G	X											X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						139398	F9_Popp_2025_carboxy_F9_specific_var226300	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.0142588923527011			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9		52861		CCSBVarC004381		NC_000023.11:139560821:T:G		Cys268Trp																												F9_Cys268Trp	23	139560821	T	G	X	allele	804T>G	F09	527_CAVA_Array_P02	K18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						139398	F9_Popp_2025_carboxy_F9_specific_var226300	F9_Popp_2025_carboxy_F9_specific	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.0142588923527011			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-d-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9	ENSG00000101981	52861	204367	CCSBVarC004381	ALE00004381	NC_000023.11:139560821:T:G	804T>G	Cys268Trp	CEGS2	CegsMutGDEh1017	E01	GDEhDisVCh_40052	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys268Trp	23	139560821	T	G	X											X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						166914	F9_Popp_2025_carboxy_gla_motif_var255343	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.0230767202642477			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9		52861		CCSBVarC004381		NC_000023.11:139560821:T:G		Cys268Trp																												F9_Cys268Trp	23	139560821	T	G	X	allele	804T>G	F09	527_CAVA_Array_P02	K18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						166914	F9_Popp_2025_carboxy_gla_motif_var255343	F9_Popp_2025_carboxy_gla_motif	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.0230767202642477			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-e-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9	ENSG00000101981	52861	204367	CCSBVarC004381	ALE00004381	NC_000023.11:139560821:T:G	804T>G	Cys268Trp	CEGS2	CegsMutGDEh1017	E01	GDEhDisVCh_40052	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys268Trp	23	139560821	T	G	X											X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						221946	F9_Popp_2025_light_chain_var245662	F9_Popp_2025_light_chain	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.0113070409321454			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9		52861		CCSBVarC004381		NC_000023.11:139560821:T:G		Cys268Trp																												F9_Cys268Trp	23	139560821	T	G	X	allele	804T>G	F09	527_CAVA_Array_P02	K18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						221946	F9_Popp_2025_light_chain_var245662	F9_Popp_2025_light_chain	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.0113070409321454			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-c-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9	ENSG00000101981	52861	204367	CCSBVarC004381	ALE00004381	NC_000023.11:139560821:T:G	804T>G	Cys268Trp	CEGS2	CegsMutGDEh1017	E01	GDEhDisVCh_40052	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys268Trp	23	139560821	T	G	X											X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						194430	F9_Popp_2025_heavy_chain_var235981	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.002334575			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys268Trp			1.9756930984659165	0.08874341761188416																											true	F9		52861		CCSBVarC004381		NC_000023.11:139560821:T:G		Cys268Trp																												F9_Cys268Trp	23	139560821	T	G	X	allele	804T>G	F09	527_CAVA_Array_P02	K18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560821-T-G	10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic						194430	F9_Popp_2025_heavy_chain_var235981	F9_Popp_2025_heavy_chain	F9	3551.0	1.0		139560821.0	139560821.0		804			268.0	C	W	c.804T>G	p.Cys268Trp	missense_variant	0.002334575			No		Pathogenic	no assertion criteria provided	Sep 01, 1989	aa	urn:mavedb:00001200-b-1	ENST00000218099.7	NM_000133.4	immortalized human cells	Reporter			No	missense_variant		0.828																																																											F9_Cys268Trp	Cys268Trp	true
F9	F9_Cys124Tyr			8.951997130377087	0.000044166321269130565																											true	F9		52861						Cys124Tyr																												F9_Cys124Tyr						allele	509G>A	C11	527_CAVA_Array_P02	E22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									
GSS	GSS_Arg125Cys					2025_01_Batch_13-14	0.6020717464597054	0.6530716599756321	0.7632120678816032	0.7237004988017183	0.5664566229065157	0.539236634922278	0.6194553452155342	0.5489669160702033	0.649187245267796	0.49930948990852253	0.5706541906909917	0.6362635025955832	0.6560894919759033	0.6864438720347572	0.5328830564075191	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	true	GSS	ENSG00000100983	5132	215352	CCSBVarC006739	ALE00006737	NC_000020.11:34942606:G:A	373C>T	Arg125Cys	CEGS2	CegsMutGDEh1044	F03	GDEhDisVCh_40044	H01	2	CegsMutGDDh1044	F03	VUSN2Hmut_GDN2h_09	D05	VUSMutpDEST2_04	F12	VUSmut_GDEh09	D05	1	1	1	1	1	1	1	1	1	1	1	1	1	GSS_Arg125Cys	20	34942606	G	A	20											20-34942606-G-A	8529	20	34942606	G	A	R	C	rs28936396	20	33530409	20	32994070	125	GSS	ENSG00000100983	ENST00000651619	ENSP00000498303	P48637	GSHB_HUMAN	c.373C>T	p.Arg125Cys	c.373C>T	p.Arg125Cys	principal1	Y	.	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	.	.	.	.	.	.	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.785	0.95215	H	.	.	.	.	.	1.0907	0.99266	D	0.9543	0.98514	D	9	.	0.91808	.	0.366447	0.92624	D	.	.	.	.	.	.	.	.	.	.	0.93149	.	.	0.761953830719	0.76178	T	0.979491	0.99825	D	0.272164	0.80492	D	0.567727	0.96156	D	0.988271415233612	0.78469	D	.	0.92613	.	0.96310127	0.97551	0.8506926	0.91438	0.96134293	0.97374	0.837919	0.90580	-12.5	0.87232	D	.	0.85836	.	0.998758874737846	0.94998	0.98256360	0.95785	0.884	0.93768	.	.	.	.	.	.	6.177047	0.94738	34.0	0.99944690997760832	0.99886	0.948579	0.96020	D	1.09872351892217	0.98099	17.45189	1.02848604687915	0.99100	20.69962	5.77	5.77	0.91065	3.8	0.70283	9.908	0.98664	11.765000	0.95724	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	67	264690	2.531263E-4	.	6	109394	5.484760e-05	0	13	208114	6.246580e-05	0	13	236900	5.487550e-05	0	5	7162	6.981290e-04	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	1	15690	6.373490e-05	0	5	7162	6.981290e-04	0	10	16216	6.166750e-04	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	2	16724	1.195890e-04	0	0	89554	0.000000e+00	0	1	30606	3.267330e-05	0	10	16216	6.166750e-04	0	10	14900	6.711410e-04	0	0	34256	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	2	21622	9.249840e-05	0	0	102716	0.000000e+00	0	1	30524	3.276110e-05	0	10	14900	6.711410e-04	0	.	67	1613906	4.151420e-05	0	56	74906	7.476040e-04	0	56	74906	7.476040e-04	0	0	910	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44882	0.000000e+00	0	2	64012	3.124410e-05	0	0	6084	0.000000e+00	0	4	1179972	3.389910e-06	0	2	91078	2.195920e-05	0	2	30460	6.565988181221274E-5	0	298	0	0	120	0	5	7872	6.351626016260162E-4	0	146	0	0	610	0	0	26	0	0	104	0	0	2294	0	5	8170	6.119951040391676E-4	0	146	0	7	41930	1.669449081803005E-4	Pathogenic/Likely_pathogenic	Glutathione_synthetase_deficiency_with_5-oxoprolinuria|Inherited_glutathione_synthetase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000020.11:g.34942606G>A	ClinGen:CA119694|OMIM:601002.0005	C0398746|CN030166|C3661900	266130	289846|32	.	Arg	Cys	23568	single nucleotide variant	NM_000178.4(GSS):c.373C>T (p.Arg125Cys)	2937	GSS	HGNC:4624	Pathogenic/Likely pathogenic	1	Feb 14, 2024	28936396	-	RCV000009055|RCV003488332|RCV004566701|RCV005025041	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:C3661900|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846;MONDO:MONDO:0009284,MedGen:C1856399,OMIM:231900,Orphanet:289849,Orphanet:32	Inherited glutathione synthetase deficiency|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria	germline	germline	GRCh38	NC_000020.11	20	34942606	34942606	20q11.22	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA119694,OMIM:601002.0005	3	8529	34942606	G	A	-	-	-	-	-	-	SCV002204728|SCV002819864|SCV004238234|SCV005661820	-	-	373C>T 	Arg125Cys	NM_000178.4	2	1_Pathogenic	20	34942606	G	A	0.0000205224																																																																																																				
